Citrus Sinensis ID: 038713
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 252 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | no | no | 0.956 | 0.289 | 0.479 | 5e-63 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.976 | 0.296 | 0.448 | 2e-57 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.996 | 0.287 | 0.457 | 4e-56 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.976 | 0.297 | 0.443 | 4e-52 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.968 | 0.297 | 0.391 | 1e-48 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.924 | 0.292 | 0.420 | 3e-45 | |
| Q96285 | 661 | L-type lectin-domain cont | no | no | 0.940 | 0.358 | 0.392 | 2e-42 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.976 | 0.364 | 0.395 | 6e-42 | |
| O22833 | 658 | L-type lectin-domain cont | no | no | 0.940 | 0.360 | 0.380 | 8e-42 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.952 | 0.275 | 0.365 | 9e-42 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 241 bits (614), Expect = 5e-63, Method: Compositional matrix adjust.
Identities = 119/248 (47%), Positives = 165/248 (66%), Gaps = 7/248 (2%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ E+EFK E+ IG+ HH+N VRL+G+ + ++++VY+++ G+L + LF +P+W
Sbjct: 571 DNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFR-RPRPSWE 629
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
+R IA IARGI YLH+EC QIIH DIKPQNIL+DE +ISDFGLAKL+ +QT T
Sbjct: 630 DRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYT 689
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWIC 183
T IRGT+ YVA EW RN PIT K DVYS+GV+LLEIVC ++ +D LED IL W
Sbjct: 690 LTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVD---LEDNVILINWAY 746
Query: 184 QCFENGNLSQLVEDEE---VDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIP 240
CF G L L ED+ D + ++R +K+ + CI +E +R M+ V MLEG +++
Sbjct: 747 DCFRQGRLEDLTEDDSEAMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVF 806
Query: 241 IPQNPTSF 248
P NP+ +
Sbjct: 807 DPPNPSPY 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 222 bits (565), Expect = 2e-57, Method: Composition-based stats.
Identities = 114/254 (44%), Positives = 158/254 (62%), Gaps = 8/254 (3%)
Query: 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE--KQ 59
+ +GE++F+ E+ I THH N VRL+G+ +++LVY++M NGSL + LFT + K
Sbjct: 517 IEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKF 576
Query: 60 PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD 119
W R IA A+GI YLH+EC I+H DIKP+NIL+D+ AK+SDFGLAKL+ P
Sbjct: 577 LTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPK 636
Query: 120 QTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAIL 178
R + +RGTR Y+A EW NLPIT K+DVYS+G+VLLE+V +R D + +
Sbjct: 637 DNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKF 696
Query: 179 QEWICQCFENGNL-----SQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233
W + FE GN ++L ED+ VD +Q+ RM+K CI ++P R M KV+ ML
Sbjct: 697 SIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQML 756
Query: 234 EGTVEIPIPQNPTS 247
EG EI P P +
Sbjct: 757 EGITEIKNPLCPKT 770
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (554), Expect = 4e-56, Method: Compositional matrix adjust.
Identities = 118/258 (45%), Positives = 162/258 (62%), Gaps = 7/258 (2%)
Query: 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPN 61
L+ GEREF TE+N IG HH N VRL GY + S+++LVY+YM NGSL +F+ E+ N
Sbjct: 564 LSHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTAN 623
Query: 62 ---WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP 118
W R IA A+GI Y H++C +IIH DIKP+NIL+D+ C K+SDFGLAK+M
Sbjct: 624 LLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGR 683
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAIL 178
+ + T IRGTR Y+A EW N PITVKADVYS+G++LLEIV RR LD + +
Sbjct: 684 EHSHVVTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFY 743
Query: 179 QEWICQCFENGNLSQLVEDE---EVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235
W + NG + V+ +++++ + +KV CI DE S+R +M +V+ +LEG
Sbjct: 744 PGWAYKELTNGTSLKAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEG 803
Query: 236 TV-EIPIPQNPTSFLSTI 252
T EI +P P + L I
Sbjct: 804 TSDEINLPPMPQTILELI 821
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (520), Expect = 4e-52, Method: Compositional matrix adjust.
Identities = 113/255 (44%), Positives = 155/255 (60%), Gaps = 9/255 (3%)
Query: 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP- 60
+++GE++F+TE+ IG H N VRL G+ + S K+LVYDYM NGSL LF + +
Sbjct: 526 ISQGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEK 585
Query: 61 ---NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
W R IA ARG+ YLHDEC IIH DIKP+NIL+D + C K++DFGLAKL+
Sbjct: 586 IVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVG 645
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAI 177
D +R T +RGTR Y+A EW + IT KADVYS+G++L E+V RR +Q+ E
Sbjct: 646 RDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRF 705
Query: 178 LQEWICQCF-ENGNLSQLV----EDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232
W ++G++ LV E + VD +++ R KV CI DE S R AM +V+ +
Sbjct: 706 FPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQI 765
Query: 233 LEGTVEIPIPQNPTS 247
LEG +E+ P P S
Sbjct: 766 LEGVLEVNPPPFPRS 780
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 193 bits (490), Expect = 1e-48, Method: Compositional matrix adjust.
Identities = 99/253 (39%), Positives = 160/253 (63%), Gaps = 9/253 (3%)
Query: 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP- 60
+ +G++EF+ E++ IG HH + VRL G+ + ++++L Y+++S GSL +F +
Sbjct: 526 IGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDV 585
Query: 61 --NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP 118
+W R IA A+G+ YLH++C+A+I+H DIKP+NIL+D+ AK+SDFGLAKLM
Sbjct: 586 LLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTR 645
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAIL 178
+Q+ FT +RGTR Y+A EW N I+ K+DVYS+G+VLLE++ R+ D + ++
Sbjct: 646 EQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHF 705
Query: 179 QEWICQCFENGNLSQLVEDE----EVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
+ + E G L +V+ + +V +++QR +K L CI ++ R +M KV+ MLE
Sbjct: 706 PSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLE 765
Query: 235 GTVEIPIPQNPTS 247
G P+ Q P+S
Sbjct: 766 GV--FPVVQPPSS 776
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (460), Expect = 3e-45, Method: Compositional matrix adjust.
Identities = 103/245 (42%), Positives = 139/245 (56%), Gaps = 12/245 (4%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLF-TPEKQPN 61
GE EF+ E+ IG H N VRL G+ + +++LVYDYM GSL L T K +
Sbjct: 496 GSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLS 555
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
W R IA A+GI YLH+ C IIH DIKP+NIL+D AK+SDFGLAKL+ D +
Sbjct: 556 WETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFS 615
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCL--------DQNLLE 173
R +RGT YVA EW LPIT KADVYSFG+ LLE++ RR + ++
Sbjct: 616 RVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEP 675
Query: 174 DRAILQEWICQCFENGNLSQLVE---DEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230
++ W + GN+ +V+ + E + +++ RM V + CI D +R AM V+
Sbjct: 676 EKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVV 735
Query: 231 LMLEG 235
MLEG
Sbjct: 736 KMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96285|LRK55_ARATH L-type lectin-domain containing receptor kinase V.5 OS=Arabidopsis thaliana GN=LECRK55 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (435), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 95/242 (39%), Positives = 139/242 (57%), Gaps = 5/242 (2%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP--N 61
+G EF E++ IGR H N VRLLGY N LVYDYM NGSL L E Q
Sbjct: 375 QGMSEFLAEISTIGRLRHPNLVRLLGYCRHKENLYLVYDYMPNGSLDKYLNRSENQERLT 434
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
W +R I +D+A + +LH E IIH DIKP N+L+D + A++ DFGLAKL
Sbjct: 435 WEQRFRIIKDVATALLHLHQEWVQVIIHRDIKPANVLIDNEMNARLGDFGLAKLYDQGFD 494
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEW 181
+ + GT Y+A E+ R T DVY+FG+V+LE+VC RR +++ E+ L +W
Sbjct: 495 PETSKVAGTFGYIAPEFLRTGRATTSTDVYAFGLVMLEVVCGRRIIERRAAENEEYLVDW 554
Query: 182 ICQCFENGNLSQLVED---EEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238
I + +ENG + E+ +E ++ Q++ ++K+G+ C S+R AM V+ +L G +
Sbjct: 555 ILELWENGKIFDAAEESIRQEQNRGQVELVLKLGVLCSHQAASIRPAMSVVMRILNGVSQ 614
Query: 239 IP 240
+P
Sbjct: 615 LP 616
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (432), Expect = 6e-42, Method: Compositional matrix adjust.
Identities = 100/253 (39%), Positives = 146/253 (57%), Gaps = 7/253 (2%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP--N 61
+GE EFKTE+ + + HRN VRLLG+S +ILVY+YM N SL +LF P KQ +
Sbjct: 387 QGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQIQLD 446
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
W++R I IARGI YLH + IIH D+K NIL+D KI+DFG+A++ DQT
Sbjct: 447 WMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQT 506
Query: 122 RTFTG-IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQE 180
+ T I GT Y+A E+ + ++K+DVYSFGV++LEI+ R+ + L
Sbjct: 507 QDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFGESDGAQDLLT 566
Query: 181 WICQCFENGNLSQLVED---EEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML-EGT 236
+ + N LV+ E ++ R I +GL C+ ++P+ R A+ V +ML T
Sbjct: 567 HAWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQEDPAKRPAISTVFMMLTSNT 626
Query: 237 VEIPIPQNPTSFL 249
V +P+P+ P F+
Sbjct: 627 VTLPVPRQPGFFI 639
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O22833|LRK54_ARATH L-type lectin-domain containing receptor kinase V.4 OS=Arabidopsis thaliana GN=LECRK54 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (431), Expect = 8e-42, Method: Compositional matrix adjust.
Identities = 92/242 (38%), Positives = 142/242 (58%), Gaps = 5/242 (2%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLF--TPEKQPN 61
+G +EF E++ IGR H+N VRL GY LVYD+M NGSL L+ ++Q
Sbjct: 371 QGMQEFLAEISTIGRLRHQNLVRLQGYCRYKEELYLVYDFMPNGSLDKYLYHRANQEQLT 430
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
W +R I +DIA + YLH E +IH DIKP N+L+D + A++ DFGLAKL
Sbjct: 431 WNQRFKIIKDIASALCYLHHEWVQVVIHRDIKPANVLIDHQMNARLGDFGLAKLYDQGYD 490
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEW 181
+ + GT Y+A E R+ T DVY+FG+ +LE+ C RR +++ D +L EW
Sbjct: 491 PQTSRVAGTFWYIAPELIRSGRATTGTDVYAFGLFMLEVSCGRRLIERRTASDEVVLAEW 550
Query: 182 ICQCFENGNLSQLVED---EEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238
+C+ENG++ + V D E +++QL+ ++K+G+ C ++R M KV+ +L G ++
Sbjct: 551 TLKCWENGDILEAVNDGIRHEDNREQLELVLKLGVLCSHQAVAIRPDMSKVVQILGGDLQ 610
Query: 239 IP 240
+P
Sbjct: 611 LP 612
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 170 bits (430), Expect = 9e-42, Method: Compositional matrix adjust.
Identities = 96/263 (36%), Positives = 145/263 (55%), Gaps = 23/263 (8%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP-NW 62
G +EF TE+ IG H N V+L G+ +LVY+YM++GSL LF+ W
Sbjct: 551 HGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEW 610
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
ER IA ARG+ YLH C+ +IIH D+KP+NIL+ + KISDFGL+KL+ +++
Sbjct: 611 QERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESS 670
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV-----CLRRCLDQNLLEDR-- 175
FT +RGTR Y+A EW N I+ KADVYS+G+VLLE+V C R ++ ED
Sbjct: 671 LFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQ 730
Query: 176 ------------AILQEWICQCFENGNLSQLVE---DEEVDQKQLQRMIKVGLRCILDEP 220
+ E G +L + + V ++ ++++++ L C+ +EP
Sbjct: 731 NHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEP 790
Query: 221 SLRRAMKKVLLMLEGTVEIPIPQ 243
+LR M V+ M EG++ + P+
Sbjct: 791 ALRPTMAAVVGMFEGSIPLGNPR 813
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 252 | ||||||
| 359477044 | 768 | PREDICTED: G-type lectin S-receptor-like | 1.0 | 0.328 | 0.702 | 1e-103 | |
| 224078930 | 488 | predicted protein [Populus trichocarpa] | 1.0 | 0.516 | 0.690 | 1e-101 | |
| 359477040 | 774 | PREDICTED: G-type lectin S-receptor-like | 1.0 | 0.325 | 0.694 | 1e-100 | |
| 225431551 | 768 | PREDICTED: G-type lectin S-receptor-like | 1.0 | 0.328 | 0.686 | 1e-100 | |
| 296088590 | 321 | unnamed protein product [Vitis vinifera] | 1.0 | 0.785 | 0.694 | 1e-100 | |
| 255582003 | 817 | ATP binding protein, putative [Ricinus c | 1.0 | 0.308 | 0.687 | 7e-98 | |
| 255582007 | 783 | ATP binding protein, putative [Ricinus c | 1.0 | 0.321 | 0.683 | 4e-97 | |
| 359493028 | 815 | PREDICTED: G-type lectin S-receptor-like | 0.996 | 0.307 | 0.654 | 1e-93 | |
| 359477052 | 767 | PREDICTED: G-type lectin S-receptor-like | 0.980 | 0.322 | 0.608 | 1e-84 | |
| 225431565 | 791 | PREDICTED: G-type lectin S-receptor-like | 0.980 | 0.312 | 0.604 | 4e-84 |
| >gi|359477044|ref|XP_002275760.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 380 bits (977), Expect = e-103, Method: Compositional matrix adjust.
Identities = 177/252 (70%), Positives = 212/252 (84%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+LAEG+REF+ E+ IGRTHHRN VRLLGY + N++LVY+YMSNGSL D+LFTP KQP
Sbjct: 517 VLAEGQREFQNELKVIGRTHHRNLVRLLGYCLEGPNRLLVYEYMSNGSLADLLFTPGKQP 576
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
W+ERMGIA ++ARG+ YLH+ECE QIIH DIKPQNILMDE + AKISDFGLAKL+ DQ
Sbjct: 577 CWIERMGIALNVARGVLYLHEECETQIIHCDIKPQNILMDEYKRAKISDFGLAKLLMHDQ 636
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQE 180
T TFTGIRGTR YVA EWHR LP+TVKADVYS+G+VLLE +C R+ +D +L E+ AIL+E
Sbjct: 637 TNTFTGIRGTRGYVAPEWHRKLPVTVKADVYSYGIVLLETICCRKNVDWSLPEEEAILEE 696
Query: 181 WICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIP 240
W+ CFE G L +LV DEEVD++QL+RM+KVGL CILDEPSLR +MKKVLLMLEGTV+IP
Sbjct: 697 WVYHCFEAGELGKLVGDEEVDKRQLERMVKVGLWCILDEPSLRPSMKKVLLMLEGTVDIP 756
Query: 241 IPQNPTSFLSTI 252
+P +P SFLS I
Sbjct: 757 VPPSPVSFLSAI 768
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224078930|ref|XP_002335729.1| predicted protein [Populus trichocarpa] gi|222834660|gb|EEE73123.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 375 bits (962), Expect = e-101, Method: Compositional matrix adjust.
Identities = 174/252 (69%), Positives = 215/252 (85%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+LAEGEREF+ EM IG+THHRN VRLLGY D +++LVY+YMSNGSL D+LF+ EK+P
Sbjct: 237 VLAEGEREFQNEMKVIGKTHHRNLVRLLGYCHDGHHRLLVYEYMSNGSLADILFSLEKRP 296
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
+ ER+ IAR+IARGI YLH+ECE QIIH DIKPQNIL+DE RC K+SDFGLAKL+K DQ
Sbjct: 297 CFPERLEIARNIARGIVYLHEECETQIIHCDIKPQNILIDESRCPKVSDFGLAKLLKSDQ 356
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQE 180
T+TFTGIRGTR YVA EWHRN+P+TVKADVYSFGV+LLEI C R+ +D +L ED A+L++
Sbjct: 357 TKTFTGIRGTRGYVAPEWHRNMPVTVKADVYSFGVMLLEITCCRKNVDWSLPEDEAVLEQ 416
Query: 181 WICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIP 240
W+ QCF++G++ +LV DE V++KQL RM+KVG+ C LDEPSLR +MKKVLLMLEGTVEIP
Sbjct: 417 WVYQCFQDGDMDKLVGDEIVEKKQLDRMVKVGIWCTLDEPSLRPSMKKVLLMLEGTVEIP 476
Query: 241 IPQNPTSFLSTI 252
IP +PTSF++ I
Sbjct: 477 IPPSPTSFITAI 488
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477040|ref|XP_002275651.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 370 bits (950), Expect = e-100, Method: Compositional matrix adjust.
Identities = 175/252 (69%), Positives = 206/252 (81%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+LAEGE EF+ E+ IGRTHHRN VRLLGY D N++LVY+YMSNGSL D LFTP KQP
Sbjct: 523 VLAEGEIEFQNELKVIGRTHHRNLVRLLGYCLDGPNRLLVYEYMSNGSLADWLFTPGKQP 582
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
W ERMGIA ++ARGI YLH+ECE IIH DIKPQNILMDE RCAKISDFGLAKL+ DQ
Sbjct: 583 RWSERMGIALNVARGILYLHEECETCIIHCDIKPQNILMDEYRCAKISDFGLAKLLMHDQ 642
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQE 180
T T TGIRGTR YVA EWHR P++VKADVYS+G+VLLE +C RR +D +L ++ IL+E
Sbjct: 643 TNTSTGIRGTRGYVAPEWHRKQPVSVKADVYSYGIVLLETICCRRNVDWSLPDEEVILEE 702
Query: 181 WICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIP 240
W+ QCFE G L +LV DEEVD++QL M+KVGL CILD+PSLR +MKKVLLMLEGTV+IP
Sbjct: 703 WVYQCFEAGELGKLVGDEEVDRRQLDMMVKVGLWCILDDPSLRPSMKKVLLMLEGTVDIP 762
Query: 241 IPQNPTSFLSTI 252
+P +P SFLS+I
Sbjct: 763 VPPSPVSFLSSI 774
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431551|ref|XP_002275615.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 370 bits (949), Expect = e-100, Method: Compositional matrix adjust.
Identities = 173/252 (68%), Positives = 209/252 (82%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+LAE +REF+ E+ +GRTHHRN VRLLGY D N++LVY+YMSNGSL D+LFTP KQP
Sbjct: 517 VLAEWQREFQNELKVLGRTHHRNLVRLLGYCLDGRNRLLVYEYMSNGSLADLLFTPAKQP 576
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
WVER+ IA ++A+G+ YLH+ECE QIIH DIKPQNILMDE RCAKISDFGLAKL+ DQ
Sbjct: 577 CWVERVRIALNVAKGVLYLHEECETQIIHCDIKPQNILMDEYRCAKISDFGLAKLLMHDQ 636
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQE 180
T TFTGIRGTR YVA EWHR L +TVKADVYS+G+VLLE +C RR +D +L E+ AIL+E
Sbjct: 637 TNTFTGIRGTRGYVAPEWHRKLAVTVKADVYSYGIVLLETICCRRNVDWSLPEEEAILEE 696
Query: 181 WICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIP 240
W+ C E G L +LV DEEVD++QL+RM+KVGL CILDEPSLR +M KVLL+LEGTV+IP
Sbjct: 697 WVYHCLEAGELGKLVGDEEVDKRQLERMVKVGLWCILDEPSLRPSMNKVLLILEGTVDIP 756
Query: 241 IPQNPTSFLSTI 252
+P +P SFLS+I
Sbjct: 757 VPPSPGSFLSSI 768
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088590|emb|CBI37581.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 369 bits (946), Expect = e-100, Method: Compositional matrix adjust.
Identities = 175/252 (69%), Positives = 206/252 (81%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+LAEGE EF+ E+ IGRTHHRN VRLLGY D N++LVY+YMSNGSL D LFTP KQP
Sbjct: 32 VLAEGEIEFQNELKVIGRTHHRNLVRLLGYCLDGPNRLLVYEYMSNGSLADWLFTPGKQP 91
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
W ERMGIA ++ARGI YLH+ECE IIH DIKPQNILMDE RCAKISDFGLAKL+ DQ
Sbjct: 92 RWSERMGIALNVARGILYLHEECETCIIHCDIKPQNILMDEYRCAKISDFGLAKLLMHDQ 151
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQE 180
T T TGIRGTR YVA EWHR P++VKADVYS+G+VLLE +C RR +D +L ++ IL+E
Sbjct: 152 TNTSTGIRGTRGYVAPEWHRKQPVSVKADVYSYGIVLLETICCRRNVDWSLPDEEVILEE 211
Query: 181 WICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIP 240
W+ QCFE G L +LV DEEVD++QL M+KVGL CILD+PSLR +MKKVLLMLEGTV+IP
Sbjct: 212 WVYQCFEAGELGKLVGDEEVDRRQLDMMVKVGLWCILDDPSLRPSMKKVLLMLEGTVDIP 271
Query: 241 IPQNPTSFLSTI 252
+P +P SFLS+I
Sbjct: 272 VPPSPVSFLSSI 283
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582003|ref|XP_002531799.1| ATP binding protein, putative [Ricinus communis] gi|223528565|gb|EEF30587.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 362 bits (929), Expect = 7e-98, Method: Compositional matrix adjust.
Identities = 174/253 (68%), Positives = 207/253 (81%), Gaps = 1/253 (0%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+LA+G+REF+TEM IG+THHRN V LLGY + N++LVYD+MSNGSL DVLF+PEK+P
Sbjct: 531 VLADGDREFQTEMKVIGKTHHRNLVCLLGYCNEGLNRLLVYDFMSNGSLSDVLFSPEKRP 590
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
+ ER+ IAR+IARGI YLH+ECE QIIH DIKP+NILMD C KISDFGLAKL+KPDQ
Sbjct: 591 CFTERIEIARNIARGILYLHEECETQIIHCDIKPENILMDAYMCPKISDFGLAKLLKPDQ 650
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQE 180
T+T TGIRGTR YVA EWHR LP+T KADVYSFG+VLLEI C R+ +D + E IL E
Sbjct: 651 TKTMTGIRGTRGYVAPEWHRKLPVTTKADVYSFGIVLLEIACCRKHVDLSAPEHECILVE 710
Query: 181 WICQCFENGNLSQLV-EDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239
W+ CFENG L +LV +D+EVD++Q+ RMIKVGL C LDEPSLR +MKKVLLMLEGTV+I
Sbjct: 711 WVYNCFENGELDELVGDDKEVDKRQMNRMIKVGLWCTLDEPSLRPSMKKVLLMLEGTVDI 770
Query: 240 PIPQNPTSFLSTI 252
P P +PTSFLS I
Sbjct: 771 PTPPSPTSFLSCI 783
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582007|ref|XP_002531801.1| ATP binding protein, putative [Ricinus communis] gi|223528567|gb|EEF30589.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 360 bits (923), Expect = 4e-97, Method: Compositional matrix adjust.
Identities = 173/253 (68%), Positives = 208/253 (82%), Gaps = 1/253 (0%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+LA+G+REF+TEM AIG+THH+N VRLLGY + N++LVY++MSNGSL DVLF+PE +P
Sbjct: 531 VLADGDREFQTEMKAIGKTHHKNLVRLLGYCNEGPNRLLVYEFMSNGSLSDVLFSPENRP 590
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
+ ER+ IAR+IARGI YLH+ECE QIIH DIKP+NILMD C KISDFGLAKL+KPDQ
Sbjct: 591 CFAERIEIARNIARGILYLHEECETQIIHCDIKPENILMDAYMCPKISDFGLAKLLKPDQ 650
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQE 180
T+T T IRGTR YVA EWHR LP+TVKADVYSFG+VLLEI C R+ +D + E IL E
Sbjct: 651 TKTMTDIRGTRGYVAPEWHRKLPVTVKADVYSFGIVLLEITCCRKNVDLSAPERECILVE 710
Query: 181 WICQCFENGNLSQLV-EDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239
W+ CF +G L +LV +DEEVD++Q+ RMIKVGL C LDEPSLR +MKKVLLMLEGTV+I
Sbjct: 711 WVYDCFASGELDKLVGDDEEVDKRQMNRMIKVGLWCTLDEPSLRPSMKKVLLMLEGTVDI 770
Query: 240 PIPQNPTSFLSTI 252
PIP +PTSFLS I
Sbjct: 771 PIPPSPTSFLSCI 783
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493028|ref|XP_002264274.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 348 bits (893), Expect = 1e-93, Method: Compositional matrix adjust.
Identities = 165/252 (65%), Positives = 203/252 (80%), Gaps = 1/252 (0%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
M+AEGE EF+ EM +IGRTHH+N VRLLGY D SN++LVY+YM+NGSL D LF E++P
Sbjct: 559 MMAEGEWEFQNEMKSIGRTHHKNLVRLLGYCHDGSNRLLVYEYMTNGSLADFLFKSERKP 618
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
W ER+ IA +ARGI YLH+ECE QIIH DIKP+NILMDEK CAKI+DFGLAKL+ P+Q
Sbjct: 619 IWEERIEIALSVARGILYLHEECETQIIHCDIKPENILMDEKGCAKIADFGLAKLLMPNQ 678
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQE 180
TRT+TGIRGTR YVA EWHRNLPITVKADVYSFG++L+EI+C RR LD ++ E+ +L +
Sbjct: 679 TRTYTGIRGTRGYVAPEWHRNLPITVKADVYSFGIMLMEIICCRRSLDMDVSENEVVLVD 738
Query: 181 WICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIP 240
++ CFE L +LV DEEVD +LQRM+KVGL CI DEPS+R MKKV+LM+EGTV+IP
Sbjct: 739 YVYDCFEARELDKLVRDEEVDGMKLQRMVKVGLWCIQDEPSVRPLMKKVVLMMEGTVDIP 798
Query: 241 IPQNPTSFLSTI 252
P SF S++
Sbjct: 799 APPR-ASFASSM 809
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477052|ref|XP_002276297.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 318 bits (815), Expect = 1e-84, Method: Compositional matrix adjust.
Identities = 151/248 (60%), Positives = 194/248 (78%), Gaps = 1/248 (0%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
M+ EGEREF+ EM AIGRTHH+N VRLLGY + S ++LVY+YMSN SL D+LF + +P
Sbjct: 517 MVEEGEREFRAEMRAIGRTHHKNLVRLLGYCTEGSRRLLVYEYMSNRSLADILFKSKTRP 576
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
W ER+ IA D+ARGI YLH+ECEA IIH DIKPQNILMD+ AKISDFGLAKL+ PDQ
Sbjct: 577 PWDERVRIALDVARGILYLHEECEAPIIHCDIKPQNILMDDFWTAKISDFGLAKLLMPDQ 636
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLE-DRAILQ 179
TRTFTG+RGTR Y+A EW +N+PI+VKADVYS+G+VLLE+VC RR L+ N+ E + +L
Sbjct: 637 TRTFTGVRGTRGYLAPEWQQNIPISVKADVYSYGIVLLELVCCRRNLEVNVSEPEEIVLS 696
Query: 180 EWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239
W +CF G L +L+ EEV++K L++M+K+GL CI DEP+LR ++K ++LMLEG EI
Sbjct: 697 NWAYKCFVAGELHKLLGGEEVERKSLEQMVKLGLWCIQDEPALRPSIKSIVLMLEGITEI 756
Query: 240 PIPQNPTS 247
+P PT+
Sbjct: 757 AVPPCPTT 764
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431565|ref|XP_002276127.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 317 bits (811), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 150/248 (60%), Positives = 193/248 (77%), Gaps = 1/248 (0%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
M+ EGEREF+ EM AIGRTHH+N VRLLGY + S ++LVY+YMSN SL D+LF + +P
Sbjct: 541 MVEEGEREFRAEMRAIGRTHHKNLVRLLGYCTEGSKRLLVYEYMSNRSLADILFKSKTRP 600
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
W ER+ IA D+ARGI YLH+ECEA IIH DIKPQNILMD+ AKISDFGLAKL+ PDQ
Sbjct: 601 PWDERVRIALDVARGILYLHEECEAPIIHCDIKPQNILMDDFWTAKISDFGLAKLLMPDQ 660
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLE-DRAILQ 179
TRTFTG+RGTR Y+A EW +N+PI+VKADVYS+G+VLLE+VC RR L+ N+ + + +L
Sbjct: 661 TRTFTGVRGTRGYLAPEWQQNIPISVKADVYSYGIVLLELVCCRRNLEVNVSKPEEIVLS 720
Query: 180 EWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239
W +CF G L +L+ EEV++K L+ M+K+GL CI DEP+LR ++K ++LMLEG EI
Sbjct: 721 NWAYKCFVAGELYKLLGGEEVERKSLEEMVKLGLWCIQDEPALRPSIKSIVLMLEGITEI 780
Query: 240 PIPQNPTS 247
+P PT+
Sbjct: 781 AVPPCPTT 788
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 252 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.968 | 0.294 | 0.452 | 9.9e-52 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.996 | 0.303 | 0.434 | 4.5e-48 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.968 | 0.297 | 0.391 | 2.4e-45 | |
| TAIR|locus:2097493 | 661 | HLECRK "lectin-receptor kinase | 0.940 | 0.358 | 0.392 | 5.7e-41 | |
| TAIR|locus:2147635 | 452 | AT5G20050 [Arabidopsis thalian | 0.956 | 0.533 | 0.383 | 2.6e-40 | |
| TAIR|locus:2043909 | 658 | AT2G43700 [Arabidopsis thalian | 0.940 | 0.360 | 0.380 | 3.4e-40 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.976 | 0.363 | 0.385 | 4.3e-40 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.936 | 0.225 | 0.397 | 4.9e-40 | |
| TAIR|locus:2099941 | 684 | AT3G55550 [Arabidopsis thalian | 0.944 | 0.347 | 0.363 | 1.7e-39 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.638 | 0.184 | 0.475 | 2.3e-39 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 541 (195.5 bits), Expect = 9.9e-52, P = 9.9e-52
Identities = 114/252 (45%), Positives = 157/252 (62%)
Query: 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE--KQ 59
+ +GE++F+ E+ I THH N VRL+G+ +++LVY++M NGSL + LFT + K
Sbjct: 517 IEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKF 576
Query: 60 PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD 119
W R IA A+GI YLH+EC I+H DIKP+NIL+D+ AK+SDFGLAKL+ P
Sbjct: 577 LTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPK 636
Query: 120 QTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAIL 178
R + +RGTR Y+A EW NLPIT K+DVYS+G+VLLE+V +R D + +
Sbjct: 637 DNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKF 696
Query: 179 QEWICQCFENGNL-----SQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233
W + FE GN ++L ED+ VD +Q+ RM+K CI ++P R M KV+ ML
Sbjct: 697 SIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQML 756
Query: 234 EGTVEIPIPQNP 245
EG EI P P
Sbjct: 757 EGITEIKNPLCP 768
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 508 (183.9 bits), Expect = 4.5e-48, P = 4.5e-48
Identities = 113/260 (43%), Positives = 157/260 (60%)
Query: 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPN 61
+++GE++F+TE+ IG H N VRL G+ + S K+LVYDYM NGSL LF + +
Sbjct: 526 ISQGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEK 585
Query: 62 ----WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
W R IA ARG+ YLHDEC IIH DIKP+NIL+D + C K++DFGLAKL+
Sbjct: 586 IVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVG 645
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAI 177
D +R T +RGTR Y+A EW + IT KADVYS+G++L E+V RR +Q+ E
Sbjct: 646 RDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRF 705
Query: 178 LQEWICQCF-ENGNLSQLV----EDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232
W ++G++ LV E + VD +++ R KV CI DE S R AM +V+ +
Sbjct: 706 FPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQI 765
Query: 233 LEGTVEIPIPQNPTSFLSTI 252
LEG +E+ P P S + +
Sbjct: 766 LEGVLEVNPPPFPRSIQALV 785
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 483 (175.1 bits), Expect = 2.4e-45, P = 2.4e-45
Identities = 99/253 (39%), Positives = 160/253 (63%)
Query: 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP- 60
+ +G++EF+ E++ IG HH + VRL G+ + ++++L Y+++S GSL +F +
Sbjct: 526 IGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDV 585
Query: 61 --NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP 118
+W R IA A+G+ YLH++C+A+I+H DIKP+NIL+D+ AK+SDFGLAKLM
Sbjct: 586 LLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTR 645
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAIL 178
+Q+ FT +RGTR Y+A EW N I+ K+DVYS+G+VLLE++ R+ D + ++
Sbjct: 646 EQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHF 705
Query: 179 QEWICQCFENGNLSQLVEDE----EVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
+ + E G L +V+ + +V +++QR +K L CI ++ R +M KV+ MLE
Sbjct: 706 PSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLE 765
Query: 235 GTVEIPIPQNPTS 247
G P+ Q P+S
Sbjct: 766 GV--FPVVQPPSS 776
|
|
| TAIR|locus:2097493 HLECRK "lectin-receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 438 (159.2 bits), Expect = 5.7e-41, P = 5.7e-41
Identities = 95/242 (39%), Positives = 139/242 (57%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPN-- 61
+G EF E++ IGR H N VRLLGY N LVYDYM NGSL L E Q
Sbjct: 375 QGMSEFLAEISTIGRLRHPNLVRLLGYCRHKENLYLVYDYMPNGSLDKYLNRSENQERLT 434
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
W +R I +D+A + +LH E IIH DIKP N+L+D + A++ DFGLAKL
Sbjct: 435 WEQRFRIIKDVATALLHLHQEWVQVIIHRDIKPANVLIDNEMNARLGDFGLAKLYDQGFD 494
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEW 181
+ + GT Y+A E+ R T DVY+FG+V+LE+VC RR +++ E+ L +W
Sbjct: 495 PETSKVAGTFGYIAPEFLRTGRATTSTDVYAFGLVMLEVVCGRRIIERRAAENEEYLVDW 554
Query: 182 ICQCFENGNLSQLVED---EEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238
I + +ENG + E+ +E ++ Q++ ++K+G+ C S+R AM V+ +L G +
Sbjct: 555 ILELWENGKIFDAAEESIRQEQNRGQVELVLKLGVLCSHQAASIRPAMSVVMRILNGVSQ 614
Query: 239 IP 240
+P
Sbjct: 615 LP 616
|
|
| TAIR|locus:2147635 AT5G20050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 429 (156.1 bits), Expect = 2.6e-40, P = 2.6e-40
Identities = 102/266 (38%), Positives = 159/266 (59%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVS-NK--ILVYDYMSNGSLVDVLFTPEKQP 60
+GEREF++E+ AI H+N VRL GYS S N+ LVYDY+ N SL D+ P++
Sbjct: 138 KGEREFRSEVAAIASVQHKNLVRLYGYSSSTSANRPRFLVYDYIVNSSL-DIWIFPDRGN 196
Query: 61 ---------NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFG 111
+W +R +A D+A+ + YLH +C ++I+H D+KP+NIL+DE A ++DFG
Sbjct: 197 RGRSGGGCLSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKPENILLDENFRAVVTDFG 256
Query: 112 LAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQ-N 170
L+KL+ D++R T IRGTR Y+A EW I+ K+DVYS+G+VLLE++ RR + +
Sbjct: 257 LSKLIARDESRVLTDIRGTRGYLAPEWLLEHGISEKSDVYSYGIVLLEMIGGRRSISRVE 316
Query: 171 LLEDRAILQEW----ICQCFENGNLSQ-----LVEDEEVDQKQLQRMIKVGLRCILDEPS 221
+ E + E+ + Q + + L+E EVD++++ +++ V L CI ++
Sbjct: 317 VKETKKKKLEYFPRIVNQKMRERKIMEIVDQRLIEVNEVDEEEVMKLVCVALWCIQEKSK 376
Query: 222 LRRAMKKVLLMLEGTVEIPIPQNPTS 247
R M V+ MLEG V P+ + P S
Sbjct: 377 KRPDMTMVIEMLEGRV--PVNEPPDS 400
|
|
| TAIR|locus:2043909 AT2G43700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 431 (156.8 bits), Expect = 3.4e-40, P = 3.4e-40
Identities = 92/242 (38%), Positives = 142/242 (58%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLF--TPEKQPN 61
+G +EF E++ IGR H+N VRL GY LVYD+M NGSL L+ ++Q
Sbjct: 371 QGMQEFLAEISTIGRLRHQNLVRLQGYCRYKEELYLVYDFMPNGSLDKYLYHRANQEQLT 430
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
W +R I +DIA + YLH E +IH DIKP N+L+D + A++ DFGLAKL
Sbjct: 431 WNQRFKIIKDIASALCYLHHEWVQVVIHRDIKPANVLIDHQMNARLGDFGLAKLYDQGYD 490
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEW 181
+ + GT Y+A E R+ T DVY+FG+ +LE+ C RR +++ D +L EW
Sbjct: 491 PQTSRVAGTFWYIAPELIRSGRATTGTDVYAFGLFMLEVSCGRRLIERRTASDEVVLAEW 550
Query: 182 ICQCFENGNLSQLVED---EEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238
+C+ENG++ + V D E +++QL+ ++K+G+ C ++R M KV+ +L G ++
Sbjct: 551 TLKCWENGDILEAVNDGIRHEDNREQLELVLKLGVLCSHQAVAIRPDMSKVVQILGGDLQ 610
Query: 239 IP 240
+P
Sbjct: 611 LP 612
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 431 (156.8 bits), Expect = 4.3e-40, P = 4.3e-40
Identities = 99/257 (38%), Positives = 148/257 (57%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP--N 61
+GE EFKTE+ + + HRN VRLLG+S +ILVY+YM N SL +LF P KQ +
Sbjct: 389 QGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLD 448
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
W++R I IARGI YLH + IIH D+K NIL+D KI+DFG+A++ DQT
Sbjct: 449 WMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQT 508
Query: 122 RTFTG-IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR--CLDQNLLEDRAIL 178
+ T I GT Y+A E+ + ++K+DVYSFGV++LEI+ R+ D++ +
Sbjct: 509 QDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLT 568
Query: 179 QEWICQCFENGNLSQLVED---EEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML-E 234
W + + N LV+ ++ R I +GL C+ ++P+ R + V +ML
Sbjct: 569 HTW--RLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTS 626
Query: 235 GTVEIPIPQNPTSFLST 251
TV +P+P+ P F+ +
Sbjct: 627 NTVTLPVPRQPGFFIQS 643
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 437 (158.9 bits), Expect = 4.9e-40, P = 4.9e-40
Identities = 95/239 (39%), Positives = 139/239 (58%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEK-QPNW 62
+G+ +F E+ AI HRN V+L G F+ +++LVY+Y+ NGSL LF + +W
Sbjct: 746 QGKGQFVAEIIAISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKSLHLDW 805
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
R I +ARG+ YLH+E +IIH D+K NIL+D + K+SDFGLAKL +T
Sbjct: 806 STRYEICLGVARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTH 865
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWI 182
T + GT Y+A E+ +T K DVY+FGVV LE+V R+ D+NL E + L EW
Sbjct: 866 ISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWA 925
Query: 183 CQCFENGNLSQLVEDE--EVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239
E +L++DE E + ++++RMI + L C +LR M +V+ ML G E+
Sbjct: 926 WNLHEKNRDVELIDDELSEYNMEEVKRMIGIALLCTQSSYALRPPMSRVVAMLSGDAEV 984
|
|
| TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 426 (155.0 bits), Expect = 1.7e-39, P = 1.7e-39
Identities = 89/245 (36%), Positives = 148/245 (60%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLF--TPEKQPN 61
+G REF +E+++IG HRN V+LLG+ + +LVYD+M NGSL LF PE
Sbjct: 383 QGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPEVILT 442
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
W +R I + +A G+ YLH+ E +IH DIK N+L+D + ++ DFGLAKL +
Sbjct: 443 WKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSD 502
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEW 181
T + GT Y+A E ++ +T DVY+FG VLLE+ C RR ++ + L + ++ +W
Sbjct: 503 PGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEELVMVDW 562
Query: 182 ICQCFENGNLSQLVE---DEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238
+ +++G++ +V+ + E D++++ +IK+GL C + P +R M++V++ LE +
Sbjct: 563 VWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLEK--Q 620
Query: 239 IPIPQ 243
P P+
Sbjct: 621 FPSPE 625
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 373 (136.4 bits), Expect = 2.3e-39, Sum P(2) = 2.3e-39
Identities = 77/162 (47%), Positives = 105/162 (64%)
Query: 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP-NWV 63
G +EF TE+ IG H N V+L G+ +LVY+YM++GSL LF+ W
Sbjct: 552 GRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQ 611
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
ER IA ARG+ YLH C+ +IIH D+KP+NIL+ + KISDFGL+KL+ +++
Sbjct: 612 ERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSL 671
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
FT +RGTR Y+A EW N I+ KADVYS+G+VLLE+V R+
Sbjct: 672 FTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRK 713
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00034870001 | SubName- Full=Chromosome chr4 scaffold_73, whole genome shotgun sequence; (723 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 252 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-30 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-20 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-14 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-06 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 4e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-05 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 3e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 3e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.003 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.003 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.003 | |
| COG2334 | 331 | COG2334, COG2334, Putative homoserine kinase type | 0.003 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.003 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-42
Identities = 57/171 (33%), Positives = 88/171 (51%), Gaps = 10/171 (5%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
E E+ + + +H N V+L G D ++ LV +Y GSL D+L E + + E
Sbjct: 35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEI 94
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKR-CAKISDFGLAKLMKPDQTRTF 124
+ I I G+ YLH IIH D+KP+NIL+D K++DFGL+KL+
Sbjct: 95 LRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLL 150
Query: 125 TGIRGTRAYVAAE-WHRNLPITVKADVYSFGVVLLEIV----CLRRCLDQN 170
I GT AY+A E + K+D++S GV+L E+ +R+ L ++
Sbjct: 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKD 201
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-33
Identities = 50/157 (31%), Positives = 76/157 (48%), Gaps = 8/157 (5%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMG 67
E+ + + H N VRL F+ +K+ LV +Y G L D+L + R
Sbjct: 44 ILREIKILKKLKHPNIVRLYD-VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF- 101
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
R I + YLH I+H D+KP+NIL+DE K++DFGLA+ + P + T
Sbjct: 102 YLRQILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTF 156
Query: 128 RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
GT Y+A E D++S GV+L E++ +
Sbjct: 157 VGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-31
Identities = 51/171 (29%), Positives = 74/171 (43%), Gaps = 29/171 (16%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ EF E + + H N V+LLG + +V +YM G L+ L + +
Sbjct: 42 EQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSL 101
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
+ + A IARG+ YL + IH D+ +N L+ E KISDFGL++ + D
Sbjct: 102 SDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-- 156
Query: 123 TFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEI 160
Y LPI T K+DV+SFGV+L EI
Sbjct: 157 ----------YYRKR-GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEI 196
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 53/172 (30%), Positives = 77/172 (44%), Gaps = 30/172 (17%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL-FTPEKQPN 61
+ EF E + + H N V+LLG + ++V +YM G L+D L K+ +
Sbjct: 42 EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELS 101
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
+ + A IARG+ YL + IH D+ +N L+ E KISDFGL++ + D
Sbjct: 102 LSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158
Query: 122 RTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEI 160
Y LPI T K+DV+SFGV+L EI
Sbjct: 159 -----------YKVK--GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 8e-30
Identities = 52/170 (30%), Positives = 76/170 (44%), Gaps = 28/170 (16%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM 66
EF E + + + H N VRLLG +V +YM G L+D L ++ + +
Sbjct: 46 EEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLL 105
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG 126
+A IA+G+ YL + +H D+ +N L+ E KISDFGL++ + D
Sbjct: 106 QMALQIAKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY----- 157
Query: 127 IRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIVCL 163
Y LPI T K+DV+SFGV+L EI L
Sbjct: 158 ------YRKRG-GGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-29
Identities = 57/158 (36%), Positives = 78/158 (49%), Gaps = 6/158 (3%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
++ + E+ + R H N VRL+ D + LV +Y G L D L + E
Sbjct: 42 DQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEA 100
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
IA I RG+ YLH IIH D+KP+NIL+DE KI+DFGLAK + + T
Sbjct: 101 KKIALQILRGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS-LT 156
Query: 126 GIRGTRAYVAAEWHR-NLPITVKADVYSFGVVLLEIVC 162
GT Y+A E K DV+S GV+L E++
Sbjct: 157 TFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLT 194
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-28
Identities = 51/178 (28%), Positives = 75/178 (42%), Gaps = 36/178 (20%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL--------FTPEK 58
++F E + + H N VRLLG + LV +YM G L+D L +
Sbjct: 41 KDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKS 100
Query: 59 QPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP 118
+ + + A IA+G+ YL + +H D+ +N L+ E KISDFGL++ +
Sbjct: 101 TLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIVCL 163
D LPI T K+DV+SFGV+L EI L
Sbjct: 158 DDYYRKKT------------GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-27
Identities = 50/153 (32%), Positives = 80/153 (52%), Gaps = 8/153 (5%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP-NWVERMG 67
F E + + H N V+LLG + +V +YM+ GSLVD L + + +++G
Sbjct: 47 FLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG 106
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
A D+ G+ YL E +H D+ +N+L+ E AK+SDFGLAK + ++
Sbjct: 107 FALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSG 159
Query: 128 RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+ + A E R + K+DV+SFG++L EI
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 8e-25
Identities = 50/145 (34%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 21 HRNPVRLLGYSFDVSNK-ILVY-DYMSNGSLVDVLFTPEKQPNWVERMGI---ARDIARG 75
H N VR G D + ++ +Y+S GSL +L +K E + I R I G
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPV-IRKYTRQILEG 113
Query: 76 IRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG-IRGTRAYV 134
+ YLH I+H DIK NIL+D K++DFG AK + +T TG +RGT ++
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 135 AAEWHRNLPITVKADVYSFGVVLLE 159
A E R AD++S G ++E
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIE 195
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 6e-24
Identities = 55/161 (34%), Positives = 86/161 (53%), Gaps = 14/161 (8%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNW 62
E ++ E+ + V+ G +F +I +V +YM GSL D+L +K
Sbjct: 41 EFRKQLLRELKTLRSCESPYVVKCYG-AFYKEGEISIVLEYMDGGSLADLL---KKVGKI 96
Query: 63 VERM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP-- 118
E + IAR I +G+ YLH + IIH DIKP N+L++ K KI+DFG++K+++
Sbjct: 97 PEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
DQ TF GT Y++ E + + AD++S G+ LLE
Sbjct: 155 DQCNTFV---GTVTYMSPERIQGESYSYAADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 7e-21
Identities = 53/159 (33%), Positives = 81/159 (50%), Gaps = 4/159 (2%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMG 67
F E + + H V+L + +V +YMS GSL+D L + E K+ + +
Sbjct: 48 FLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD 107
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
+A IA G+ YL IH D+ +NIL+ E KI+DFGLA+L++ D+ G
Sbjct: 108 MAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164
Query: 128 RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRC 166
+ + A E T+K+DV+SFG++L EIV R
Sbjct: 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 88.6 bits (218), Expect = 2e-20
Identities = 49/157 (31%), Positives = 74/157 (47%), Gaps = 14/157 (8%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER--MGIARDIARGIR 77
H N V+L + D + LV +Y+ GSL D+L ++ E + I I +
Sbjct: 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 78 YLHDECEAQIIHGDIKPQNILMDEKRC-AKISDFGLAKLMKPDQTRT-----FTGIRGTR 131
YLH IIH DIKP+NIL+D K+ DFGLAKL+ + + + GT
Sbjct: 116 YLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 132 AYVAAEWHRNL---PITVKADVYSFGVVLLEIVCLRR 165
Y+A E L + +D++S G+ L E++
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 6e-20
Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 25/158 (15%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFT-----PEKQPNWVER 65
E+ + + H N V+ G S+ +++ +V ++ S GSL D+L + E Q
Sbjct: 47 EIQILKKCKHPNIVKYYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ------ 99
Query: 66 MGIA---RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
IA +++ +G+ YLH IIH DIK NIL+ K+ DFGL+ + + R
Sbjct: 100 --IAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR 154
Query: 123 -TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
T GT ++A E P KAD++S G+ +E
Sbjct: 155 NTMV---GTPYWMAPEVINGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-19
Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 7/159 (4%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPE-KQPNWVERM 66
F E N + + H VRL Y+ I ++ +YM NGSLVD L TPE + + +
Sbjct: 48 FLAEANLMKQLQHPRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLI 105
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG 126
+A IA G+ ++ IH D++ NIL+ E C KI+DFGLA+L++ ++ G
Sbjct: 106 DMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
+ + A E T+K+DV+SFG++L EIV R
Sbjct: 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 5e-19
Identities = 59/179 (32%), Positives = 89/179 (49%), Gaps = 31/179 (17%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ E +F E + + +H+N VRL+G SF+ + ++ + M+ G L F E +P
Sbjct: 51 QDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS--FLRENRPRPE 108
Query: 64 --------ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEK---RCAKISDFGL 112
+ + ARD+A+G +YL E IH DI +N L+ K R AKI+DFG+
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165
Query: 113 AKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP--------ITVKADVYSFGVVLLEIVCL 163
A+ D R +G RA + +W +P T K DV+SFGV+L EI L
Sbjct: 166 AR----DIYRASYYRKGGRAMLPIKW---MPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 7e-19
Identities = 61/231 (26%), Positives = 111/231 (48%), Gaps = 16/231 (6%)
Query: 11 TEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIAR 70
+E+ +G+ H N V+L+G L+++Y+ +L +VL + +W R IA
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAI 787
Query: 71 DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGT 130
IA+ +R+LH C ++ G++ P+ I++D K + L L+ D +
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS---- 842
Query: 131 RAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGN 190
AYVA E IT K+D+Y FG++L+E++ + D +I+ EW C+ + +
Sbjct: 843 -AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV-EWARYCYSDCH 900
Query: 191 LSQLVE-----DEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236
L ++ D V+Q ++ ++ + L C +P+ R VL LE
Sbjct: 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (205), Expect = 7e-19
Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 8/96 (8%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM--KPDQTRTFTGIRG 129
+ ++YLH +I+H DIKPQNI + K+ DFG++K++ D +T G
Sbjct: 112 LCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV---G 165
Query: 130 TRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
T Y++ E +N P K+D++S G VL E+ L+
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 8e-19
Identities = 49/157 (31%), Positives = 83/157 (52%), Gaps = 8/157 (5%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM 66
+F TE + +G+ H N +RL G +++ +YM NGSL L + + + +
Sbjct: 50 LDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV 109
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-LMKPDQTRTFT 125
G+ R IA G++YL + +H D+ +NIL++ K+SDFGL++ L + T T
Sbjct: 110 GMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
Query: 126 GIRGTRAYVAAE--WHRNLPITVKADVYSFGVVLLEI 160
G + + A E +R T +DV+SFG+V+ E+
Sbjct: 167 GGKIPIRWTAPEAIAYRKF--TSASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 1e-18
Identities = 52/154 (33%), Positives = 75/154 (48%), Gaps = 7/154 (4%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI 68
TE N + R +H V+L Y+F K+ LV +Y G L L + R
Sbjct: 41 LTERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYA 99
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIR 128
A +I + YLH II+ D+KP+NIL+D K++DFGLAK + + +RT T
Sbjct: 100 A-EIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FC 154
Query: 129 GTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
GT Y+A E D +S GV+L E++
Sbjct: 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-18
Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 12 EMNAIGRTHHRNPVRLLG-YSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMG-- 67
E+ V+ G + + S+ I + +Y GSL + +K+ R+G
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGG---RIGEK 105
Query: 68 ----IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
IA + +G+ YLH +IIH DIKP NIL+ K K+ DFG++ + T
Sbjct: 106 VLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT 162
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
FT GT Y+A E + P ++ +DV+S G+ LLE+ R
Sbjct: 163 FT---GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 6e-18
Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 29/169 (17%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI--LVYDYMSNGSLVDVLFTPEKQPNWVE 64
+F+ E+ + H N V+ G + L+ +Y+ +GSL D L Q N
Sbjct: 51 SDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR 110
Query: 65 RMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF 124
+ + I +G+ YL + + IH D+ +NIL++ + KISDFGLAK++ D
Sbjct: 111 LLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPED----- 162
Query: 125 TGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEI 160
+ Y + PI + +DV+SFGV L E+
Sbjct: 163 ------KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 6e-18
Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 3/158 (1%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
A E +F E + + H V+L G + S LV+++M +G L D L + +
Sbjct: 40 AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQ 99
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
+G+ D+ G+ YL +IH D+ +N L+ E + K+SDFG+ + + DQ
Sbjct: 100 ETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+ TG + + + E + K+DV+SFGV++ E+
Sbjct: 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-17
Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 6/166 (3%)
Query: 1 MLAEG---EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE 57
M+ EG E EF E + + H V+L G +V +YMSNG L++ L
Sbjct: 35 MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG 94
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
K+ + + + +D+ G+ YL + Q IH D+ +N L+D++ C K+SDFGL++ +
Sbjct: 95 KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL 151
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
D+ + G + + E + K+DV++FGV++ E+ L
Sbjct: 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSL 197
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-17
Identities = 44/149 (29%), Positives = 80/149 (53%), Gaps = 9/149 (6%)
Query: 18 RTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM--GIARDIARG 75
+ + V G ++ + + +YM GSL +L + + ER+ IA + +G
Sbjct: 55 KCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIP--ERILGKIAVAVLKG 112
Query: 76 IRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVA 135
+ YLH++ +IIH D+KP NIL++ + K+ DFG++ + +TF GT +Y+A
Sbjct: 113 LTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMA 167
Query: 136 AEWHRNLPITVKADVYSFGVVLLEIVCLR 164
E + +VK+D++S G+ L+E+ R
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-17
Identities = 48/157 (30%), Positives = 85/157 (54%), Gaps = 5/157 (3%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM 66
R+F +E + +G+ H N + L G ++V +YM NGSL L + Q ++ +
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV 109
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK--PDQTRTF 124
G+ R IA G++YL D +H D+ +NIL++ K+SDFGL+++++ P+ T
Sbjct: 110 GMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 166
Query: 125 TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
G + + A E T +DV+S+G+V+ E++
Sbjct: 167 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 7e-17
Identities = 47/156 (30%), Positives = 87/156 (55%), Gaps = 5/156 (3%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMG 67
+F +E + +G+ H N +RL G +++ +YM NG+L L + + + + +G
Sbjct: 52 DFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG 111
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK--PDQTRTFT 125
+ R IA G++YL D +H D+ +NIL++ K+SDFGL+++++ P+ T T +
Sbjct: 112 MLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS 168
Query: 126 GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
G + + A E T +DV+SFG+V+ E++
Sbjct: 169 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 9e-17
Identities = 43/144 (29%), Positives = 74/144 (51%), Gaps = 8/144 (5%)
Query: 20 HHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78
H N V S+ V +++ +V +YM GSL D++ + N + + R++ +G+ Y
Sbjct: 73 KHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEY 131
Query: 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL-AKLMKPDQTRTFTGIRGTRAYVAAE 137
LH +IH DIK NIL+ + K++DFG A+L K R + GT ++A E
Sbjct: 132 LH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVVGTPYWMAPE 186
Query: 138 WHRNLPITVKADVYSFGVVLLEIV 161
+ K D++S G++ +E+
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-16
Identities = 49/176 (27%), Positives = 78/176 (44%), Gaps = 30/176 (17%)
Query: 10 KTEMNAIGR-THHRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMG 67
K E + R H ++L Y+F D N V +Y NG L+ + K + E+
Sbjct: 49 KIEKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCT 104
Query: 68 --IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ----- 120
A +I + YLH IIH D+KP+NIL+D+ KI+DFG AK++ P+
Sbjct: 105 RFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161
Query: 121 --------------TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
R F GT YV+ E P +D+++ G ++ +++
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-16
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 7/157 (4%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM 66
++F+ E+ A+ R H++ + L ++ + M GSL+ L +PE Q V +
Sbjct: 47 QDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL 106
Query: 67 -GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD-QTRTF 124
+A +A G+ YL ++ IH D+ +NIL+ E K++DFGLA+L+K D +
Sbjct: 107 IDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD 163
Query: 125 TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
I A H + K+DV+SFG++L E+
Sbjct: 164 KKIPYKWTAPEAASHGTF--STKSDVWSFGILLYEMF 198
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-16
Identities = 46/159 (28%), Positives = 86/159 (54%), Gaps = 7/159 (4%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM 66
R+F +E + +G+ H N + L G +++ ++M NG+L L + Q ++ +
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLV 109
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFT 125
G+ R IA G++YL E +H D+ +NIL++ K+SDFGL++ ++ D + T+T
Sbjct: 110 GMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 166
Query: 126 GIRGTRA---YVAAEWHRNLPITVKADVYSFGVVLLEIV 161
G + + A E T +DV+S+G+V+ E++
Sbjct: 167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-16
Identities = 50/158 (31%), Positives = 85/158 (53%), Gaps = 9/158 (5%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP-NWVERMG 67
F E + + HH+N VRLLG I V + MS G+LV+ L T + + ++ +
Sbjct: 46 FLEETAVMTKLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQ 104
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
+ D+A G+ YL + +++H D+ +NIL+ E AK+SDFGLA++ + +
Sbjct: 105 FSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV 161
Query: 128 RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
+ T A E ++ + K+DV+S+GV+L E+ R
Sbjct: 162 KWT----APEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-16
Identities = 49/161 (30%), Positives = 83/161 (51%), Gaps = 12/161 (7%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMG 67
+ E+ + R +H + +R+LG + + S+ L ++M+ GS+ +L K + E +
Sbjct: 49 ALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVI 105
Query: 68 IA--RDIARGIRYLHDECEAQIIHGDIKPQNILMDEK-RCAKISDFGLAKLMKPDQTRT- 123
I + RG+ YLH+ QIIH D+K N+L+D + +I+DFG A + T
Sbjct: 106 INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG 162
Query: 124 -FTG-IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
F G + GT A++A E R DV+S G V++E+
Sbjct: 163 EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-16
Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 4/154 (2%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP-NWVERM 66
EF E + H N V+LLG ++ ++M+ G+L+D L +Q N V +
Sbjct: 48 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 107
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG 126
+A I+ + YL + IH D+ +N L+ E K++DFGL++LM D G
Sbjct: 108 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+ + A E ++K+DV++FGV+L EI
Sbjct: 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-16
Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 6/156 (3%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERM 66
+F E + + H ++L +V + M GSL++ L + + +
Sbjct: 47 DFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI 106
Query: 67 GIARDIARGIRYLHDECEAQ-IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+A +A G+ YL EAQ IH D+ +N+L+ E K++DFGLA+++K D
Sbjct: 107 DMAAQVASGMAYL----EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162
Query: 126 GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
G + + A E ++K+DV+SFG++L EIV
Sbjct: 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 9e-16
Identities = 48/165 (29%), Positives = 71/165 (43%), Gaps = 10/165 (6%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM 66
+E EM + H N V+ G + +Y S G+L ++L V R+
Sbjct: 44 KEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV 103
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT- 125
+ G+ YLH I+H DIKP NI +D K+ DFG A +K + T
Sbjct: 104 -YTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159
Query: 126 --GIRGTRAYVAAEWHRNLPITVK---ADVYSFGVVLLEIVCLRR 165
+ GT AY+A E AD++S G V+LE+ +R
Sbjct: 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-15
Identities = 50/141 (35%), Positives = 67/141 (47%), Gaps = 15/141 (10%)
Query: 28 LGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVE---RMGIARDIARGIRYLHDEC 83
L YSF D N LV D + G D+ + ++ + E + I +I + YLH
Sbjct: 65 LWYSFQDEENMYLVVDLLLGG---DLRYHLSQKVKFSEEQVKFWIC-EIVLALEYLH--- 117
Query: 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP 143
IIH DIKP NIL+DE+ I+DF +A + PD T GT Y+A E
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQG 175
Query: 144 ITVKADVYSFGVVLLEIVCLR 164
+V D +S GV E CLR
Sbjct: 176 YSVAVDWWSLGVTAYE--CLR 194
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-15
Identities = 40/126 (31%), Positives = 62/126 (49%), Gaps = 4/126 (3%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARD 71
E+ A+ H V+LL S +LV +YM L +VL E+ + R
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRM 107
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+ +G+ Y+H I+H D+KP N+L+ KI+DFGLA+L ++ R ++ TR
Sbjct: 108 LLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR 164
Query: 132 AYVAAE 137
Y A E
Sbjct: 165 WYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-15
Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 21/157 (13%)
Query: 23 NPVRLL---------GY--SFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIAR 70
N +R+L Y +F NK+ +V +Y G L + +K+ + I R
Sbjct: 48 NEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR 107
Query: 71 ---DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
+ RG++ LH++ +I+H D+K NIL+ KI D G++K++K + +T
Sbjct: 108 IFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-- 162
Query: 128 RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
GT Y+A E + P + K+D++S G +L E+
Sbjct: 163 -GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-15
Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 6/163 (3%)
Query: 1 MLAEG---EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE 57
M+ EG E +F E + + H N V+L G +V +YM+NG L++ L +
Sbjct: 35 MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK 94
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
+ + + D+ + YL IH D+ +N L+ E K+SDFGLA+ +
Sbjct: 95 GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
DQ + G + + E + K+DV+SFGV++ E+
Sbjct: 152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-15
Identities = 41/110 (37%), Positives = 60/110 (54%), Gaps = 10/110 (9%)
Query: 54 FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA 113
FT E+ N +M +A +RYLH E +I+H D+ P NI++ E I+DFGLA
Sbjct: 110 FTEERIWNIFVQMVLA------LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
Query: 114 KLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
K +P+ T + GT Y E +N P KADV++FG +L ++ L
Sbjct: 162 KQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTL 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-14
Identities = 46/154 (29%), Positives = 78/154 (50%), Gaps = 4/154 (2%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM-G 67
F E N + H VRL ++ +YM+ GSL+D L + E + ++
Sbjct: 48 FLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID 107
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
+ IA G+ Y+ + IH D++ N+L+ E KI+DFGLA++++ ++ G
Sbjct: 108 FSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 164
Query: 128 RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+ + A E T+K+DV+SFG++L EIV
Sbjct: 165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-14
Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL--FTPEKQPNWVE 64
++ + E+ + + H N V+ LG + N + + + GSL +L + +P V
Sbjct: 47 KQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP--VI 104
Query: 65 RMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-LMKPDQTRT 123
R+ R I G+ YLHD +H DIK NIL+D K++DFG+AK +++ ++
Sbjct: 105 RL-YTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160
Query: 124 FTGIRGTRAYVAAE-WHRNLPITVKADVYSFGVVLLEIV 161
F +G+ ++A E + + AD++S G +LE+
Sbjct: 161 F---KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMA 196
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-14
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 12/162 (7%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKIL--VYDYMSNGSLVDVLFTPEKQPNWVER---M 66
E+N + H N VR D SN+ L V +Y G L ++ +K+ ++E
Sbjct: 49 EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108
Query: 67 GIARDIARGIRYLHDECEA--QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ--TR 122
I + + H+ + ++H D+KP NI +D K+ DFGLAK++ D +
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
T+ GT Y++ E ++ K+D++S G ++ E+ L
Sbjct: 169 TYV---GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIAR 70
E+ + + H N V L +F ++ LV++Y+ +L+++L E P + +
Sbjct: 50 EVKVLRQLRHENIVNLKE-AFRRKGRLYLVFEYVER-TLLELL---EASPGGLPPDAVRS 104
Query: 71 DI---ARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
I + I Y H IIH DIKP+NIL+ E K+ DFG A+ ++ T
Sbjct: 105 YIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT-- 159
Query: 128 RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
YVA W+R + V Y V + I C+
Sbjct: 160 ----DYVATRWYRAPELLVGDTNYGKPVDVWAIGCI 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-14
Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 9/156 (5%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIA 69
E+ + H N V+ LG S D + + +Y+ GS+ +L + R
Sbjct: 54 AREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFV 112
Query: 70 RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG--- 126
R I +G+ YLH+ IIH DIK NIL+D K KISDFG++K ++ + T T
Sbjct: 113 RQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169
Query: 127 --IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
++G+ ++A E + T KAD++S G +++E+
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 53/175 (30%), Positives = 83/175 (47%), Gaps = 23/175 (13%)
Query: 4 EGERE---FKTEMNAIGRTHHRNPVRLLGYSFDVSNKIL--VYDYMSNGSLVDVLFTPEK 58
E E + F+ E R +H N V LL S + +L V++Y+ +L +VL
Sbjct: 17 EEEHQRARFRRETALCARLYHPNIVALLD-SGEAPPGLLFAVFEYVPGRTLREVLAADGA 75
Query: 59 QPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILM---DEKRCAKISDFGLAKL 115
P E + + + H+ I+H D+KPQNI++ + AK+ DFG+ L
Sbjct: 76 LPA-GETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTL 131
Query: 116 MKPD------QTRTFTG-IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
+ P T T T + GT Y A E R P+T +D+Y++G++ LE CL
Sbjct: 132 L-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE--CL 183
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 3e-14
Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARD 71
E + H V L G D SN LV +Y+ G L L + P V R A
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA-Q 109
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+ + YLH I++ D+KP+N+L+D KI+DFG AK +K RT+T + GT
Sbjct: 110 VVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK---GRTYT-LCGTP 162
Query: 132 AYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
Y+A E + D ++ G+++ E++
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-14
Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 17/159 (10%)
Query: 12 EMNAIGRTHHRNPVRLLGY--SFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI 68
E+ A+ + +H N ++ Y SF V +++ LV Y+S GSL+D++ + + E + I
Sbjct: 49 EVQAMSQCNHPN---VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI-I 104
Query: 69 A---RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL-AKLMKP--DQTR 122
A +++ +G+ YLH IH DIK NIL+ E KI+DFG+ A L +
Sbjct: 105 ATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161
Query: 123 TFTGIRGTRAYVAAE-WHRNLPITVKADVYSFGVVLLEI 160
GT ++A E + KAD++SFG+ +E+
Sbjct: 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-14
Identities = 41/164 (25%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+ + +R+F E + + H N V+L+G +V + + GSL+ L + +
Sbjct: 31 LPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRL 90
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
+ + ++ D A G+ YL + IH D+ +N L+ E KISDFG++ + ++
Sbjct: 91 TVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMS---REEE 144
Query: 121 TRTFTGIRGTR----AYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+T G + + A E T ++DV+S+G++L E
Sbjct: 145 GGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-14
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 5/154 (3%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMG 67
E E + H + VRLLG S L+ M G L+D + + +
Sbjct: 55 EILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLN 113
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTG 126
IA+G+ YL E +++H D+ +N+L+ + KI+DFGLAKL+ D+ G
Sbjct: 114 WCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG 170
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+ ++A E + T K+DV+S+GV + E+
Sbjct: 171 GKVPIKWMALESILHRIYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-14
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 9/159 (5%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM- 66
F E + + + H N V+LLG + +V +YM+ GSLVD L + + + +
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG 126
+ D+ + YL +H D+ +N+L+ E AK+SDFGL K Q
Sbjct: 106 KFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 162
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
++ T A E R + K+DV+SFG++L EI R
Sbjct: 163 VKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 8e-14
Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMG 67
E++ + H N V+ +G + ++ +Y NGSL ++ P E +
Sbjct: 45 SIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP---ESL- 100
Query: 68 IARDIA---RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA-KLMKPDQTRT 123
+A + +G+ YLH++ +IH DIK NIL + K++DFG+A KL D ++
Sbjct: 101 VAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKD 155
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
+ GT ++A E + +D++S G ++E
Sbjct: 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIE 191
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-13
Identities = 65/232 (28%), Positives = 114/232 (49%), Gaps = 31/232 (13%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVD-------VLFTPEKQPN 61
K E+ + + H N V SF + ++ +V +Y G L+ VLF+ ++ +
Sbjct: 47 KKEVILLAKMKHPNIVTFFA-SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILS 105
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEK-RCAKISDFGLAKLMKPDQ 120
W + I+ G++++HD +I+H DIK QNI + + AK+ DFG+A+ +
Sbjct: 106 WFVQ------ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQE 180
+T + GT Y++ E +N P K D++S G VL E+ L+ + N L + +L+
Sbjct: 157 ELAYTCV-GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-QLVLK- 213
Query: 181 WICQCFENGNLSQLVEDEEVDQKQL-QRMIKVGLRCILDEPSLRRAMKKVLL 231
ICQ G + + + D + L ++ KV R D PS+ +K+ L
Sbjct: 214 -ICQ----GYFAPISPNFSRDLRSLISQLFKVSPR---DRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-13
Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 5/131 (3%)
Query: 31 SFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIH 89
S+ + + +V +Y GS+ D++ K E I +G+ YLH + IH
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIH 122
Query: 90 GDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKAD 149
DIK NIL++E+ AK++DFG++ + + T I GT ++A E + + KAD
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNNKAD 181
Query: 150 VYSFGVVLLEI 160
++S G+ +E+
Sbjct: 182 IWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 1e-13
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 8/97 (8%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSN--GSLVDVLFTPEKQPNWVERMGIARDIARGIR 77
H N V+LL LV++Y +D P PN ++ I + RG+
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPL-SPNLIKS--IMYQLLRGLA 112
Query: 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114
Y H +I+H D+KPQNIL++ K++DFGLA+
Sbjct: 113 YCH---SHRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-13
Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 11/165 (6%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI--LVYDYMSNGSLVDVLFTPEKQPNWV 63
+K E+N + +H N V+ G + K L+ +Y+ GSL D L P+ + N
Sbjct: 50 TSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLA 107
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
+ + A+ I G+ YLH + IH D+ +N+L+D R KI DFGLAK +
Sbjct: 108 QLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 164
Query: 124 FTGIRGTRA--YVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRC 166
G + A E + + +DV+SFGV L E+ L C
Sbjct: 165 RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL--LTHC 207
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-13
Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 7/146 (4%)
Query: 20 HHRNPVRLLGYSFDVSNKILV-YDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78
H N + LLG LV YM +G L + + + P + +G +A+G+ Y
Sbjct: 54 SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM---KPDQTRTFTGIRGTRAYVA 135
L + +H D+ +N ++DE K++DFGLA+ + + TG + ++A
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 136 AEWHRNLPITVKADVYSFGVVLLEIV 161
E + T K+DV+SFGV+L E++
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-13
Identities = 45/135 (33%), Positives = 66/135 (48%), Gaps = 9/135 (6%)
Query: 39 LVYDYMSNGSLVDVLFTPEKQP---NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQ 95
+V +Y NG L +L +P + V R I I G+ +LH + +I+H DIK
Sbjct: 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLHSK---KILHRDIKSL 130
Query: 96 NILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGV 155
N+ +D KI D G+AKL+ T I GT Y++ E + P K+DV++ GV
Sbjct: 131 NLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGV 189
Query: 156 VLLEIVCLRRCLDQN 170
VL E + D N
Sbjct: 190 VLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-13
Identities = 45/127 (35%), Positives = 71/127 (55%), Gaps = 10/127 (7%)
Query: 39 LVYDYMSNGSLVDVLFTPE----KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKP 94
+V +YMS GSL+D L E K PN V+ +A +A G+ Y+ IH D++
Sbjct: 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVD---MAAQVAAGMAYIE---RMNYIHRDLRS 130
Query: 95 QNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFG 154
NIL+ + KI+DFGLA+L++ ++ G + + A E T+K+DV+SFG
Sbjct: 131 ANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190
Query: 155 VVLLEIV 161
++L E+V
Sbjct: 191 ILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-13
Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 13/175 (7%)
Query: 6 EREFKTEMNAI---GRTHHRNPVRLLGYSFDVSNKILV-YDYMSNGSLVDVLFTPEKQPN 61
E+E + +N I H N + F N +L+ +Y + G+L D + +K
Sbjct: 40 EKERRDALNEIVILSLLQHPNIIAYYN-HFMDDNTLLIEMEYANGGTLYDKI-VRQKGQL 97
Query: 62 WVERMGIAR--DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD 119
+ E M + I + Y+H +A I+H DIK NI + + K+ DFG++K++ +
Sbjct: 98 FEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154
Query: 120 QTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLD-QNLLE 173
+ T + GT Y++ E + + K+D+++ G VL E++ L+R D N L
Sbjct: 155 YSMAETVV-GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-13
Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSL----------VDVLFTPE 57
EF+ E + H N V LLG ++++Y+++G L DV
Sbjct: 54 EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 58 ----KQPNWV-ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL 112
K + + IA IA G+ YL +H D+ +N L+ E KISDFGL
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGL 170
Query: 113 AKLMKPD-----QTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
++ + Q+++ +R ++ E T ++D++SFGVVL EI
Sbjct: 171 SRDIYSADYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-13
Identities = 47/184 (25%), Positives = 75/184 (40%), Gaps = 41/184 (22%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT------- 55
+ ++F+ E + H N V+ G + I+V++YM +G L L +
Sbjct: 49 NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAF 108
Query: 56 ------PEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISD 109
P + + + IA IA G+ YL + +H D+ +N L+ KI D
Sbjct: 109 LKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGD 165
Query: 110 FGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVV 156
FG+++ + T Y H LPI T ++DV+SFGVV
Sbjct: 166 FGMSRDVY------------TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVV 213
Query: 157 LLEI 160
L EI
Sbjct: 214 LWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 8e-13
Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 20 HHRNPVRLLG--YSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77
H N VRL S + +V++YM + L +L +PE + + + + G++
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114
Query: 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
YLH I+H DIK NIL++ K++DFGLA+ + +T
Sbjct: 115 YLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-13
Identities = 56/186 (30%), Positives = 84/186 (45%), Gaps = 47/186 (25%)
Query: 7 REFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP---EKQPNW 62
R+F E+ + + HH N + LLG + + +Y G+L+D L E P +
Sbjct: 47 RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAF 106
Query: 63 VERMGIAR------------DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDF 110
+ G A D+A G++YL ++ Q IH D+ +N+L+ E +KI+DF
Sbjct: 107 AKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADF 163
Query: 111 GLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVL 157
GL+ RG YV R LP+ T K+DV+SFGV+L
Sbjct: 164 GLS--------------RGEEVYVKKTMGR-LPVRWMAIESLNYSVYTTKSDVWSFGVLL 208
Query: 158 LEIVCL 163
EIV L
Sbjct: 209 WEIVSL 214
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 57/186 (30%), Positives = 82/186 (44%), Gaps = 47/186 (25%)
Query: 7 REFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP---EKQPNW 62
R+F E+ + + HH N + LLG L +Y +G+L+D L E P +
Sbjct: 52 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 111
Query: 63 V------------ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDF 110
+ + A D+ARG+ YL + Q IH D+ +NIL+ E AKI+DF
Sbjct: 112 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADF 168
Query: 111 GLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVL 157
GL+ RG YV R LP+ T +DV+S+GV+L
Sbjct: 169 GLS--------------RGQEVYVKKTMGR-LPVRWMAIESLNYSVYTTNSDVWSYGVLL 213
Query: 158 LEIVCL 163
EIV L
Sbjct: 214 WEIVSL 219
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-12
Identities = 39/120 (32%), Positives = 71/120 (59%), Gaps = 8/120 (6%)
Query: 42 DYMSNGSLVDVLFTPEKQP-NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMD 100
++M GSL VL + P N + ++ IA + RG+ YL ++ +I+H D+KP NIL++
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILGKISIA--VLRGLTYLREK--HKIMHRDVKPSNILVN 134
Query: 101 EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+ K+ DFG++ + +F GTR+Y++ E + TV++D++S G+ L+E+
Sbjct: 135 SRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLG--YSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
AE R+F+ E+ + H N V+ G YS N LV +Y+ GSL D L ++
Sbjct: 46 AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL 105
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM---- 116
+ + + A I +G+ YL + +H D+ +NIL++ + KI DFGL K++
Sbjct: 106 DHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162
Query: 117 ------KPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+P ++ F + A E +V +DV+SFGVVL E+
Sbjct: 163 EYYKVREPGESPIF--------WYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 47/139 (33%), Positives = 71/139 (51%), Gaps = 14/139 (10%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMG--IARDIARGIRYLHDECE 84
L YSF ++K+ V DY++ G L F +++ ++ E A +IA + YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLH---S 114
Query: 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTGIRGTRAYVAAEWHRNL 142
II+ D+KP+NIL+D + ++DFGL K + T TF GT Y+A E R
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC---GTPEYLAPEVLRKQ 171
Query: 143 PITVKADVYSFGVVLLEIV 161
P D + G VL E++
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 17/158 (10%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLV-----DVLFTPEKQPNWV 63
K E + + +H V+L Y+F K+ L+ D++ G L +V+FT E ++
Sbjct: 46 KMERDILAEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 104
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
+ +A D +LH II+ D+KP+NIL+DE+ K++DFGL+K + +
Sbjct: 105 AELALALD------HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
++ GT Y+A E T AD +SFGV++ E++
Sbjct: 156 YS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-12
Identities = 57/186 (30%), Positives = 80/186 (43%), Gaps = 47/186 (25%)
Query: 7 REFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP---EKQPNW 62
R+F E+ + + HH N + LLG L +Y +G+L+D L E P +
Sbjct: 40 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 99
Query: 63 VERMG------------IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDF 110
A D+ARG+ YL + Q IH D+ +NIL+ E AKI+DF
Sbjct: 100 AIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADF 156
Query: 111 GLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVL 157
GL+ RG YV R LP+ T +DV+S+GV+L
Sbjct: 157 GLS--------------RGQEVYVKKTMGR-LPVRWMAIESLNYSVYTTNSDVWSYGVLL 201
Query: 158 LEIVCL 163
EIV L
Sbjct: 202 WEIVSL 207
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 30/163 (18%)
Query: 12 EMNAIGRTHHRNPVRLL----GYSFDVSNKILVYDYMSN--GSLVDVLFTPEKQPNWVER 65
E+ + H N V L G D + LV +Y SL+D + TP + +
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLD--SIFLVMEYCEQDLASLLDNMPTPFSES---QV 110
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK-PDQTRTF 124
+ + RG++YLH+ IIH D+K N+L+ +K C KI+DFGLA+ P + T
Sbjct: 111 KCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTP 167
Query: 125 TGIRGTRAYVAAEWHRNLPI-------TVKADVYSFGVVLLEI 160
V W+R + T D+++ G +L E+
Sbjct: 168 K--------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-12
Identities = 44/173 (25%), Positives = 85/173 (49%), Gaps = 13/173 (7%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGY--SFDVSNKI-LVYDYMSNGSLVDVLFTPE 57
M + + E + H N ++ Y +F + +V +Y G+L + + +
Sbjct: 38 MTKDERLAAQNECQVLKLLSHPN---IIEYYENFLEDKALMIVMEYAPGGTLAEYI---Q 91
Query: 58 KQPN-WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKR-CAKISDFGLAKL 115
K+ N ++ I + + LH I+H D+K QNIL+D+ + KI DFG++K+
Sbjct: 92 KRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI 151
Query: 116 MKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLD 168
+ +++ +T + GT Y++ E P K+D+++ G VL E+ L+R +
Sbjct: 152 LS-SKSKAYTVV-GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-12
Identities = 40/121 (33%), Positives = 59/121 (48%), Gaps = 6/121 (4%)
Query: 42 DYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDE 101
+Y G L +L + R IA + YLH+ II+ D+KP+N+L+D
Sbjct: 73 EYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEYLHNR---GIIYRDLKPENLLLDS 128
Query: 102 KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
K+ DFG AK +K Q +T+T GT YVA E N D +S G++L E++
Sbjct: 129 NGYVKLVDFGFAKKLKSGQ-KTWTFC-GTPEYVAPEIILNKGYDFSVDYWSLGILLYELL 186
Query: 162 C 162
Sbjct: 187 T 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-12
Identities = 44/156 (28%), Positives = 67/156 (42%), Gaps = 7/156 (4%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM- 66
+F E + H N +RL G +V + GSL+D L + +
Sbjct: 42 DFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLC 100
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK--PDQTRTF 124
A IA G+RYL + + IH D+ +NIL+ KI DFGL + + D
Sbjct: 101 DYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157
Query: 125 TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
++ A+ A E R + +DV+ FGV L E+
Sbjct: 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-12
Identities = 41/126 (32%), Positives = 69/126 (54%), Gaps = 8/126 (6%)
Query: 36 NKILVYDYMSNGSLVDVLFTPEKQPNWVERMG-IARDIARGIRYLHDECEAQIIHGDIKP 94
N + ++M GSL + + P VE +G IA + G+ YL++ +I+H DIKP
Sbjct: 77 NICMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKP 132
Query: 95 QNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFG 154
NIL++ + K+ DFG++ + TF GT Y++ E + TVK+DV+S G
Sbjct: 133 SNILVNSRGQIKLCDFGVSGELINSIADTFV---GTSTYMSPERIQGGKYTVKSDVWSLG 189
Query: 155 VVLLEI 160
+ ++E+
Sbjct: 190 ISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-12
Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 23/172 (13%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW----- 62
EF E + + +H N V+LLG + ++ + M G L+ L +
Sbjct: 45 EFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT 104
Query: 63 -VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEK-----RCAKISDFGLAK-L 115
E + I D+A+G YL IH D+ +N L+ EK R KI DFGLA+ +
Sbjct: 105 LKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161
Query: 116 MKPDQTRTFTGIRGTRA----YVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
K D R G ++A E + T ++DV+SFGV++ EI+ L
Sbjct: 162 YKSDYYR----KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTL 209
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-12
Identities = 38/100 (38%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL----MKPDQTRTFTGIRGTRAYV 134
+H +IH DIK NIL+ K+ DFG +K+ + D RTF G T YV
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG---TPYYV 212
Query: 135 AAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLED 174
A E R P + KAD++S GV+L E++ L+R D +E+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE 252
|
Length = 496 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 8 EFKTEMNAIGRTHHRNPVRLL-GYSFDVSNKILVY-DYMSNGSLVDVLFTPEKQPNWVER 65
+F E++ + H N V L Y ++ NK+ + ++ G+L ++ E+ +
Sbjct: 48 DFMVEIDILSECKHPNIVGLYEAYFYE--NKLWILIEFCDGGALDSIMLELERGLTEPQI 105
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL-AKLMKPDQTR-T 123
+ R + + +LH ++IH D+K NIL+ K++DFG+ AK Q R T
Sbjct: 106 RYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162
Query: 124 FTGIRGTRA--YVAAEWHRNLPITVKADVYSFGVVLLEI 160
F G A VA E ++ P KAD++S G+ L+E+
Sbjct: 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-12
Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 3 AEGERE-FKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPN 61
AE E E + E+ + + R G + ++ +Y+ GS +D+L +P
Sbjct: 42 AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPG 96
Query: 62 WVERMGIA---RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP 118
+E IA R+I +G+ YLH E + IH DIK N+L+ E+ K++DFG+A +
Sbjct: 97 PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
Q + T + GT ++A E + KAD++S G+ +E+
Sbjct: 154 TQIKRNTFV-GTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-12
Identities = 35/160 (21%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARD 71
E+ + +H N ++LL + LV+++M L ++ ++
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ 106
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+ +G+ + H I+H D+KP+N+L++ + K++DFGLA+ R +T
Sbjct: 107 LLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYT------ 156
Query: 132 AYVAAEWHRNLPI-------TVKADVYSFGVVLLEIVCLR 164
YV W+R + + D++S G + E++ R
Sbjct: 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-12
Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 11/161 (6%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVY---DYMSNGSLVDVLFTPEKQPNWVER 65
F E N + H V+L V K +Y ++M+ GSL+D L + E + +
Sbjct: 48 FLAEANVMKTLQHDKLVKLHA----VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK 103
Query: 66 M-GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF 124
+ + IA G+ ++ + IH D++ NIL+ KI+DFGLA++++ ++
Sbjct: 104 LIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160
Query: 125 TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
G + + A E T+K+DV+SFG++L+EIV R
Sbjct: 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 4e-12
Identities = 50/188 (26%), Positives = 74/188 (39%), Gaps = 54/188 (28%)
Query: 8 EFKTEMNAIGRT-----------HHRNPVRLLGYSFDV----SNKILVYDYMS------- 45
E K + I T H N + LL DV SN LV+++M
Sbjct: 37 ERKEAKDGINFTALREIKLLQELKHPNIIGLL----DVFGHKSNINLVFEFMETDLEKVI 92
Query: 46 -NGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRC 104
+ S+V TP +++ M RG+ YLH I+H D+KP N+L+
Sbjct: 93 KDKSIV---LTPADIKSYM-LM-----TLRGLEYLHSN---WILHRDLKPNNLLIASDGV 140
Query: 105 AKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------TVKADVYSFGVVL 157
K++DFGLA+ R T V W+R + V D++S G +
Sbjct: 141 LKLADFGLARSF-GSPNRKMT------HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIF 193
Query: 158 LEIVCLRR 165
E+ LR
Sbjct: 194 AEL-LLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-12
Identities = 43/141 (30%), Positives = 69/141 (48%), Gaps = 22/141 (15%)
Query: 28 LGYSFDVSNKI-LVYDYMSNG---SLVDVL-FTPEKQPNWVERMGIARDIARGIRYLHDE 82
L YSF + + LV +Y++ G SL+ L PE +W ++ ++ G+ LH
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE---DWAKQY--IAEVVLGVEDLHQR 116
Query: 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTGIRGTRAYVAAEWHR 140
IIH DIKP+N+L+D+ K++DFGL++ L GT Y+A E
Sbjct: 117 ---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-------FVGTPDYLAPETIL 166
Query: 141 NLPITVKADVYSFGVVLLEIV 161
+ +D +S G V+ E +
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 4e-12
Identities = 50/161 (31%), Positives = 72/161 (44%), Gaps = 13/161 (8%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGI 68
TE + + + V+L YSF N LV +Y+ G L +L V R+ I
Sbjct: 41 LTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYI 99
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-------LMKPDQT 121
A +I + YLH IIH D+KP NIL+D K++DFGL+K + D
Sbjct: 100 A-EIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
+ I GT Y+A E + D +S G +L E +
Sbjct: 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-12
Identities = 48/139 (34%), Positives = 73/139 (52%), Gaps = 14/139 (10%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMG--IARDIARGIRYLHDECE 84
L YSF + K+ V DY++ G L F +++ ++E A ++A I YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHSL-- 115
Query: 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKL-MKP-DQTRTFTGIRGTRAYVAAEWHRNL 142
II+ D+KP+NIL+D + ++DFGL K ++P + T TF GT Y+A E R
Sbjct: 116 -NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC---GTPEYLAPEVLRKE 171
Query: 143 PITVKADVYSFGVVLLEIV 161
P D + G VL E++
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-12
Identities = 52/159 (32%), Positives = 76/159 (47%), Gaps = 31/159 (19%)
Query: 15 AIGRT-HHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERM--GIAR 70
I R +H N V+ FD + +I ++ ++M GSL E E+ +AR
Sbjct: 124 EILRDVNHPNVVKCHDM-FDHNGEIQVLLEFMDGGSL-------EGTHIADEQFLADVAR 175
Query: 71 DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFG----LAKLMKPDQTRTFTG 126
I GI YLH I+H DIKP N+L++ + KI+DFG LA+ M P +
Sbjct: 176 QILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--- 229
Query: 127 IRGTRAYVAAEWHRNLPITVKA------DVYSFGVVLLE 159
GT AY++ E N + A D++S GV +LE
Sbjct: 230 --GTIAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-12
Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 14/94 (14%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
I RG++Y+H A ++H D+KP NIL++E KI DFGLA++ P TG TR
Sbjct: 117 ILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTR 169
Query: 132 AYVAAE----WHRNLPITVKADVYSFGVVLLEIV 161
Y A E W + V+ D++S G + E++
Sbjct: 170 YYRAPEIMLTWQK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-12
Identities = 42/127 (33%), Positives = 69/127 (54%), Gaps = 10/127 (7%)
Query: 39 LVYDYMSNGSLVDVLFTPE----KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKP 94
+V ++M GSL+D L + K P V+ +A IA G+ Y+ IH D++
Sbjct: 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVD---MAAQIADGMAYIE---RMNYIHRDLRA 130
Query: 95 QNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFG 154
NIL+ + KI+DFGLA+L++ ++ G + + A E T+K+DV+SFG
Sbjct: 131 ANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190
Query: 155 VVLLEIV 161
++L E+V
Sbjct: 191 ILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-12
Identities = 49/196 (25%), Positives = 91/196 (46%), Gaps = 40/196 (20%)
Query: 1 MLAEGE-----REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSL------ 49
ML E R+ +E N + + +H + ++L G +L+ +Y GSL
Sbjct: 37 MLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRE 96
Query: 50 ----------------VDVLFTPEKQP-NWVERMGIARDIARGIRYLHDECEAQIIHGDI 92
L P+++ + + A I+RG++YL E +++H D+
Sbjct: 97 SRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDL 153
Query: 93 KPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-----TVK 147
+N+L+ E R KISDFGL++ + + + ++ ++ + +W + T +
Sbjct: 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSY----VKRSKGRIPVKWMAIESLFDHIYTTQ 209
Query: 148 ADVYSFGVVLLEIVCL 163
+DV+SFGV+L EIV L
Sbjct: 210 SDVWSFGVLLWEIVTL 225
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 7e-12
Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 19/172 (11%)
Query: 3 AEGEREFKTEMNAIGR-THHRNPVRLLGYSFDVSNKI------LVYDYMSNGSLVDVLFT 55
+ E E K E N + + ++H N G + LV + GS+ D++
Sbjct: 43 EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG 102
Query: 56 PEKQPNWVERMGIA---RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL 112
K+ ++ IA R+ RG+ YLH+ ++IH DIK QNIL+ + K+ DFG+
Sbjct: 103 LRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159
Query: 113 AKLMKPDQTRTFTGIRGTRAY-----VAAEWHRNLPITVKADVYSFGVVLLE 159
+ + R T I GT + +A + + ++DV+S G+ +E
Sbjct: 160 SAQLDSTLGRRNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 9e-12
Identities = 51/194 (26%), Positives = 74/194 (38%), Gaps = 62/194 (31%)
Query: 6 EREFKTEMNAIGRTHHRNP--VRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
ER+ + + +P V+L YSF D + LV +YM G L+ N
Sbjct: 51 ERDILADAD--------SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLM----------NL 91
Query: 63 VERMGIAR-DIAR--------GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA 113
+ R + + AR + +H IH DIKP NIL+D K++DFGL
Sbjct: 92 LIRKDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLC 148
Query: 114 KLMKPDQTRTFTGIR----------------------------GTRAYVAAEWHRNLPIT 145
K M + R + GT Y+A E R P
Sbjct: 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG 208
Query: 146 VKADVYSFGVVLLE 159
++ D +S GV+L E
Sbjct: 209 LECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 39/124 (31%), Positives = 72/124 (58%), Gaps = 8/124 (6%)
Query: 42 DYMSNGSLVDVLFTPEKQPNWVERMG-IARDIARGIRYLHDECEAQIIHGDIKPQNILMD 100
++M GSL VL ++ P E +G ++ + RG+ YL ++ QI+H D+KP NIL++
Sbjct: 83 EHMDGGSLDQVLKEAKRIPE--EILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVN 138
Query: 101 EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+ K+ DFG++ + +F GTR+Y++ E + +V++D++S G+ L+E+
Sbjct: 139 SRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 161 VCLR 164
R
Sbjct: 196 AIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 9/157 (5%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSL-VDVLFTPEKQPNWVERMGI- 68
E + + H R V L Y+F + LV M+ G L + E+ P + E
Sbjct: 43 EKRILAKVHSRFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF 101
Query: 69 -ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
I G+ +LH + +II+ D+KP+N+L+D +ISD GLA +K Q++T G
Sbjct: 102 YTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT-KGY 157
Query: 128 RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
GT ++A E + D ++ GV L E++ R
Sbjct: 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 21/167 (12%)
Query: 13 MNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL---------------FTPE 57
M IG+ H+N + LLG +V +Y ++G+L D L PE
Sbjct: 69 MKMIGK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-LM 116
+ + + A +ARG+ +L + + IH D+ +N+L+ E KI+DFGLA+ +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
D R T R ++A E + T ++DV+SFGV+L EI L
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 47/137 (34%), Positives = 68/137 (49%), Gaps = 10/137 (7%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86
L YSF + K+ V D+++ G L L P R A +IA + YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SIN 116
Query: 87 IIHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTGIRGTRAYVAAEWHRNLPI 144
I++ D+KP+NIL+D + ++DFGL K + + D T TF GT Y+A E R P
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC---GTPEYLAPEVIRKQPY 173
Query: 145 TVKADVYSFGVVLLEIV 161
D + G VL E++
Sbjct: 174 DNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 7/162 (4%)
Query: 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPN 61
+A G++EF E + + + H VRL+G +LV + G L+ L + P
Sbjct: 36 IAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV 94
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
+ +A +A G+ YL +H D+ +N+L+ + AKISDFG+++ +
Sbjct: 95 -SDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150
Query: 122 --RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
R T R + A E + K+DV+S+GV L E
Sbjct: 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 38/99 (38%), Positives = 56/99 (56%), Gaps = 5/99 (5%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
I RG++YLH A I+H DIKP N+L++ KI DFGLA++ +PD+++ T T+
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 132 AYVAAEWHRNLP-ITVKADVYSFGVVLLEIVCLRRCLDQ 169
Y A E T D++S G + E++ RR L Q
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLG-RRILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-11
Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 13/157 (8%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVL----FTPEKQPNWV 63
F E + + H V+L Y+ I +V +YMS GSL+D L + P V
Sbjct: 48 FLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 105
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
+ +A IA G+ Y+ +H D++ NIL+ E K++DFGLA+L++ ++
Sbjct: 106 D---MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
G + + A E T+K+DV+SFG++L E+
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-11
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 37/198 (18%)
Query: 6 ER-EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVD-------VLFTPE 57
ER E + E+ + H N V+ + N +V DY G L VLF +
Sbjct: 42 EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED 101
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
+ +W ++ +A ++++HD +I+H DIK QNI + + K+ DFG+A+++
Sbjct: 102 QILDWFVQICLA------LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAI 177
T I GT Y++ E N P K+D+++ G VL E+ L+
Sbjct: 153 STVELARTCI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK------------- 198
Query: 178 LQEWICQCFENGNLSQLV 195
FE GN+ LV
Sbjct: 199 ------HAFEAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-11
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 21/167 (12%)
Query: 13 MNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSL---------------VDVLFTPE 57
M IG+ H+N + LLG ++ +Y S G+L D+ P+
Sbjct: 74 MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-LM 116
+Q + + + +ARG+ YL + + IH D+ +N+L+ E KI+DFGLA+ +
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVN 188
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
D + T R ++A E + T ++DV+SFGV++ EI L
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-11
Identities = 45/139 (32%), Positives = 67/139 (48%), Gaps = 11/139 (7%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86
L +SF + + LV DYMS G L L + + IA ++ + +LH +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH---KYD 116
Query: 87 IIHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTGIRGTRAYVAAE-WHRNLP 143
I++ D+KP+NIL+D + DFGL+K L T TF GT Y+A E
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLLDEKG 173
Query: 144 ITVKADVYSFGVVLLEIVC 162
T D +S GV++ E+ C
Sbjct: 174 YTKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 21/167 (12%)
Query: 13 MNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSL---------------VDVLFTPE 57
M IG+ H+N + LLG ++ +Y S G+L D PE
Sbjct: 71 MKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPE 128
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-LM 116
+Q + + + A +ARG+ YL + + IH D+ +N+L+ E KI+DFGLA+ +
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
D + T R ++A E + T ++DV+SFGV+L EI L
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-11
Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL------FTPEKQP 60
+E M A+G H VRLLG S + LV GSL+D + P++
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLL 112
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
NW + IA+G+ YL + ++H ++ +NIL+ +I+DFG+A L+ PD
Sbjct: 113 NWCVQ------IAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163
Query: 121 TRTF-TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+ F + + ++A E T ++DV+S+GV + E++
Sbjct: 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 6e-11
Identities = 38/124 (30%), Positives = 62/124 (50%), Gaps = 16/124 (12%)
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTG 126
A +I G+++LH E II+ D+K N+L+D + KI+DFG+ K ++ T TF
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC- 157
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLD--------QNLLEDRAIL 178
GT Y+A E P D ++ GV+L E++ + + Q++LED
Sbjct: 158 --GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY 215
Query: 179 QEWI 182
W+
Sbjct: 216 PRWL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-11
Identities = 49/157 (31%), Positives = 73/157 (46%), Gaps = 33/157 (21%)
Query: 21 HRNPVRLLGYSFDVSNKILVY-DYMSNGSLVDVLFTPEKQPNWVERMGI--ARDIARGIR 77
HRN V+ LG S + ++ + + GSL +L + E+ I + I G++
Sbjct: 64 HRNIVQYLG-SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 78 YLHDECEAQIIHGDIKPQNILMDE-KRCAKISDFGLAKLM---KPDQTRTFTGI------ 127
YLHD QI+H DIK N+L++ KISDFG +K + P T TFTG
Sbjct: 123 YLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAP 178
Query: 128 ----RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+G R Y A AD++S G ++E+
Sbjct: 179 EVIDKGPRGYGAP-----------ADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-11
Identities = 38/139 (27%), Positives = 67/139 (48%), Gaps = 17/139 (12%)
Query: 39 LVYDYMSNGSLVDV-------LFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGD 91
+V +Y G L+ LF + W +M + G++++H++ +++H D
Sbjct: 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK---RVLHRD 125
Query: 92 IKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVY 151
IK +NI + + K+ DFG A+L+ T + GT YV E N+P K+D++
Sbjct: 126 IKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDIW 184
Query: 152 SFGVVLLEIVCLRRCLDQN 170
S G +L E+ L+ N
Sbjct: 185 SLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-11
Identities = 43/142 (30%), Positives = 76/142 (53%), Gaps = 8/142 (5%)
Query: 21 HRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79
H N V L S+ V +++ +V +Y++ GSL DV+ E + + + R+ + + +L
Sbjct: 75 HPNIVNYLD-SYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFL 131
Query: 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWH 139
H Q+IH DIK NIL+ K++DFG + P+Q++ T + GT ++A E
Sbjct: 132 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 187
Query: 140 RNLPITVKADVYSFGVVLLEIV 161
K D++S G++ +E+V
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 17/164 (10%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIA 69
++E+ + H N V+ LG+ + +Y+ GS+ L T + + R
Sbjct: 56 RSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF-FT 114
Query: 70 RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK----LMKPDQTRTFT 125
+ G+ YLH + I+H D+K N+L+D KISDFG++K + DQ
Sbjct: 115 EQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---M 168
Query: 126 GIRGTRAYVAAE----WHRNLPITVKADVYSFGVVLLEIVCLRR 165
++G+ ++A E + + + K D++S G V+LE+ RR
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 39/126 (30%), Positives = 67/126 (53%), Gaps = 16/126 (12%)
Query: 40 VYDYMSNGSLVDVLFTPEKQPNWVERMGIA---RDIARGIRYLHDECEAQIIHGDIKPQN 96
+ +Y GS +D+L +P ++ IA R++ G+ YLH+E IH DIK N
Sbjct: 77 IMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAAN 128
Query: 97 ILMDEKRCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFG 154
IL+ E+ K++DFG++ + ++ TF GT ++A E + KAD++S G
Sbjct: 129 ILLSEEGDVKLADFGVSGQLTSTMSKRNTFV---GTPFWMAPEVIKQSGYDEKADIWSLG 185
Query: 155 VVLLEI 160
+ +E+
Sbjct: 186 ITAIEL 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 51/167 (30%), Positives = 83/167 (49%), Gaps = 21/167 (12%)
Query: 13 MNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL---------------FTPE 57
M IG+ H+N + LLG ++ +Y S G+L + L PE
Sbjct: 77 MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-LM 116
+Q ++ + + A +ARG+ YL + + IH D+ +N+L+ E KI+DFGLA+ +
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
D + T R ++A E + T ++DV+SFGV+L EI L
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 39/125 (31%), Positives = 67/125 (53%), Gaps = 12/125 (9%)
Query: 39 LVYDYMSNGSLVDVLFTPEKQPNWVERMGIA---RDIARGIRYLHDECEAQIIHGDIKPQ 95
++ +Y+ GS +D+L +P ++ IA R+I +G+ YLH E + IH DIK
Sbjct: 79 IIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAA 130
Query: 96 NILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGV 155
N+L+ E K++DFG+A + Q + GT ++A E + KAD++S G+
Sbjct: 131 NVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 189
Query: 156 VLLEI 160
+E+
Sbjct: 190 TAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 42/158 (26%), Positives = 65/158 (41%), Gaps = 48/158 (30%)
Query: 19 THHRNPVRLLGYSFDV---SNKI---LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDI 72
H N V+LL +V N LV++YM E + V R I D+
Sbjct: 64 GDHPNIVKLL----NVIKAENDKDIYLVFEYM------------ETDLHAVIRANILEDV 107
Query: 73 ---------ARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
+ ++Y+H +IH D+KP NIL++ K++DFGLA R+
Sbjct: 108 HKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLA--------RS 156
Query: 124 FTGIRGTRA------YVAAEWHRNLPITVKADVYSFGV 155
+ + YVA W+R I + + Y+ GV
Sbjct: 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGV 194
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-10
Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 8/155 (5%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIA 69
+ E+ + H V+ G D + +YM GS+ D L V R
Sbjct: 52 ECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK-YT 110
Query: 70 RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIR- 128
R I G+ YLH I+H DIK NIL D K+ DFG +K ++ + TG++
Sbjct: 111 RQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG-TGMKS 166
Query: 129 --GTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
GT +++ E KADV+S G ++E++
Sbjct: 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 13 MNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSL---------------VDVLFTPE 57
M IG+ H+N + LLG ++ +Y + G+L D+ PE
Sbjct: 71 MKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-LM 116
+Q ++ + + A +ARG+ YL + IH D+ +N+L+ E KI+DFGLA+ +
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
D + + R ++A E + T ++DV+SFG+++ EI L
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 2e-10
Identities = 36/123 (29%), Positives = 66/123 (53%), Gaps = 6/123 (4%)
Query: 39 LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNIL 98
+V +Y++ GSL DV+ E + + + R+ + + +LH Q+IH DIK N+L
Sbjct: 93 VVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVL 147
Query: 99 MDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158
+ K++DFG + P+Q++ T + GT ++A E K D++S G++ +
Sbjct: 148 LGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAI 206
Query: 159 EIV 161
E+V
Sbjct: 207 EMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-10
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 13/161 (8%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
R F E +G+ H N VRL G + ++V +YMSNG+L L E Q +
Sbjct: 50 RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL 109
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
MG+ +A G++YL E +H + +L++ KIS F +L + +T
Sbjct: 110 MGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYT 164
Query: 126 GIRGTR-----AYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+ G A A ++H +DV+SFG+V+ E++
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSS---ASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-10
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 8/95 (8%)
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTG 126
A +IA G+ +LH + II+ D+K N+++D + KI+DFG+ K + TRTF
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC- 162
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
GT Y+A E P D ++FGV+L E++
Sbjct: 163 --GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-10
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 23/162 (14%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
IA ++YLH E I+H D+K QN+ + K+ D G+A++++ +Q + + GT
Sbjct: 111 IAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTP 166
Query: 132 AYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCL---DQNLLEDRAILQEWICQCFEN 188
Y++ E N P K+DV++ G + E+ L+ D N L R I
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII----------E 216
Query: 189 GNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230
G L + +D +L +I + P R ++K +L
Sbjct: 217 GKLPPMPKDYS---PELGELIA---TMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-10
Identities = 39/158 (24%), Positives = 74/158 (46%), Gaps = 3/158 (1%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
A E +F E + + H V+L G +V ++M NG L++ L + + +
Sbjct: 40 AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK 99
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
+ + +D+ G+ YL IH D+ +N L+ K+SDFG+ + + D+
Sbjct: 100 DMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+ +G + + E + K+DV+SFGV++ E+
Sbjct: 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-10
Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 23/171 (13%)
Query: 6 EREFKTEMNAIGR-THHRNPVRLLGYSFDVSNK-------ILVYDYMSNGSLVDVLFTPE 57
E E K E+N + + +HHRN G +F N LV ++ GS+ D++ +
Sbjct: 46 EEEIKQEINMLKKYSHHRNIATYYG-AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 104
Query: 58 K---QPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114
+ W+ I R+I RG+ +LH + ++IH DIK QN+L+ E K+ DFG++
Sbjct: 105 GNTLKEEWIAY--ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159
Query: 115 LMKPDQTRTFTGIRGTRAYVAAE-----WHRNLPITVKADVYSFGVVLLEI 160
+ R T I GT ++A E + + K+D++S G+ +E+
Sbjct: 160 QLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-10
Identities = 37/124 (29%), Positives = 71/124 (57%), Gaps = 8/124 (6%)
Query: 42 DYMSNGSLVDVLFTPEKQPNWV-ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMD 100
++M GSL VL + P + ++ IA + +G+ YL ++ +I+H D+KP NIL++
Sbjct: 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK--HKIMHRDVKPSNILVN 138
Query: 101 EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+ K+ DFG++ + +F GTR+Y++ E + +V++D++S G+ L+E+
Sbjct: 139 SRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195
Query: 161 VCLR 164
R
Sbjct: 196 AIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-10
Identities = 54/191 (28%), Positives = 85/191 (44%), Gaps = 29/191 (15%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMG 67
+F E+ + R + N +RLLG ++ +YM NG L L E + +
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 68 I-----------ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-L 115
I A IA G++YL +H D+ +N L+ KI+DFG+++ L
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
Query: 116 MKPDQTRTFTGIRGTRAYVAAEWHRNLPI-----TVKADVYSFGVVLLEIVCLRRCLDQ- 169
D R I+G RA + W I T +DV++FGV L E+ L C +Q
Sbjct: 180 YSGDYYR----IQG-RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL--CKEQP 232
Query: 170 -NLLEDRAILQ 179
+LL D +++
Sbjct: 233 YSLLSDEQVIE 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 5e-10
Identities = 42/174 (24%), Positives = 73/174 (41%), Gaps = 60/174 (34%)
Query: 19 THHRNPVRLLGYSFDV--SNKIL--VYDYMSNGSLVDV-------LFTPEKQPNWVERMG 67
H N V+L +V N L V++YM G+L + F+ + +
Sbjct: 55 NEHPNIVKL----KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSII---- 105
Query: 68 IARDIARGIRYLHDECEAQIIHG----DIKPQNILMDEKRCAKISDFGLAKLM--KPDQT 121
I +G+ ++H HG D+KP+N+L+ KI+DFGLA+ + +P T
Sbjct: 106 --YQILQGLAHIHK-------HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156
Query: 122 RTFTGIRGTRAYVAAEWHR-----------NLPITVKADVYSFGVVLLEIVCLR 164
YV+ W+R + P+ D+++ G ++ E+ LR
Sbjct: 157 ----------DYVSTRWYRAPEILLRSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-10
Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 6/123 (4%)
Query: 39 LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNIL 98
+V +Y++ GSL DV+ E + + + R+ + + +LH Q+IH DIK NIL
Sbjct: 93 VVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNIL 147
Query: 99 MDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158
+ K++DFG + P+Q++ T + GT ++A E K D++S G++ +
Sbjct: 148 LGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAI 206
Query: 159 EIV 161
E+V
Sbjct: 207 EMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 6e-10
Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 18/98 (18%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP--DQTRTFTGIRG 129
I RG++Y+H A ++H D+KP N+L++ KI DFGLA++ P D T T
Sbjct: 115 ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT---- 167
Query: 130 TRAYVAAEWHRNLPI-------TVKADVYSFGVVLLEI 160
YVA W+R I T D++S G +L E+
Sbjct: 168 --EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 6e-10
Identities = 38/103 (36%), Positives = 53/103 (51%), Gaps = 15/103 (14%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ--TRTFTGIRG 129
I RG++YLH A +IH D+KP NIL++ KI DFGLA+ + PD+ T
Sbjct: 112 ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 130 TRAYVAAE----WHR-NLPITVKADVYSFGVVLLEIVCLRRCL 167
TR Y A E R I D++S G + E++ R+ L
Sbjct: 169 TRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELL-TRKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-10
Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 19/156 (12%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIAR- 70
E+ + + H N V L+ LV++++ + L D+ EK PN ++ + +
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKY 105
Query: 71 --DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-LMKPDQTRTFTGI 127
I RGI + H IIH DIKP+NIL+ + K+ DFG A+ L P + T
Sbjct: 106 LFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT---- 158
Query: 128 RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
YVA W+R + V Y V + + CL
Sbjct: 159 ----DYVATRWYRAPELLVGDTKYGRAVDIWAVGCL 190
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-10
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 12/96 (12%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
I + + YL ++ +IH D+KP NIL+D K+ DFG++ + + +T + G
Sbjct: 123 IVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCA 178
Query: 132 AYVAAEWHRNLPIT------VKADVYSFGVVLLEIV 161
AY+A E R P ++ADV+S G+ L+E+
Sbjct: 179 AYMAPE--RIDPPDPNPKYDIRADVWSLGISLVELA 212
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 7e-10
Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 8/100 (8%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM--KPDQTRTF-TGIR 128
+ RG++Y+H A +IH D+KP N+L++E +I DFG+A+ + P + + F T
Sbjct: 116 LLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 129 GTRAYVAAEWHRNLP-ITVKADVYSFGVVLLEIVCLRRCL 167
TR Y A E +LP T D++S G + E++ RR L
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 9e-10
Identities = 37/122 (30%), Positives = 66/122 (54%), Gaps = 6/122 (4%)
Query: 39 LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNIL 98
++ +Y+ GS +D+L + M ++I +G+ YLH E + IH DIK N+L
Sbjct: 79 IIMEYLGGGSALDLLRAGPFDEFQIATM--LKEILKGLDYLHSE---KKIHRDIKAANVL 133
Query: 99 MDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158
+ E+ K++DFG+A + Q + T + GT ++A E + KAD++S G+ +
Sbjct: 134 LSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKADIWSLGITAI 192
Query: 159 EI 160
E+
Sbjct: 193 EL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 9/140 (6%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI--ARDIARGIRYLHDECE 84
L Y+F+ + + LV M+ G L ++ +P + E I A I G+ +LH
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFPEARAIFYAAQIICGLEHLHQR-- 114
Query: 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI 144
+I++ D+KP+N+L+D+ +ISD GLA + + G GT Y+A E +
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKI-KGRAGTPGYMAPEVLQGEVY 171
Query: 145 TVKADVYSFGVVLLEIVCLR 164
D ++ G L E++ R
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 35/143 (24%), Positives = 71/143 (49%), Gaps = 8/143 (5%)
Query: 20 HHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78
H N V + S+ V +++ +V +++ G+L D++ + + + + + +
Sbjct: 74 QHPNIVEMYS-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT--VCLAVLKALSF 130
Query: 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEW 138
LH + +IH DIK +IL+ K+SDFG + + R + GT ++A E
Sbjct: 131 LHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR-KSLVGTPYWMAPEV 186
Query: 139 HRNLPITVKADVYSFGVVLLEIV 161
LP + D++S G++++E+V
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNK------ILVYDYMSNGSLVDVLFTP--EKQ 59
EF +E + H N ++L+G F+ S+ +++ +M +G L L
Sbjct: 47 EFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL 106
Query: 60 PNWVERMGIAR---DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116
P + + + DIA G+ YL + IH D+ +N ++ E ++DFGL+K
Sbjct: 107 PEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK-- 161
Query: 117 KPDQTRTFTG--IRGTRA------YVAAEWHRNLPITVKADVYSFGVVLLEI 160
+ ++G R R ++A E + T K+DV++FGV + EI
Sbjct: 162 -----KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 13/167 (7%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT--PEKQ----- 59
EF E + + + + VRLLG ++V + M+ G L L + PE +
Sbjct: 54 IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGL 113
Query: 60 --PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM- 116
P + + +A +IA G+ YL + +H D+ +N ++ E KI DFG+ + +
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY 170
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
+ D R ++A E ++ T K+DV+SFGVVL E+ L
Sbjct: 171 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 2e-09
Identities = 35/123 (28%), Positives = 66/123 (53%), Gaps = 6/123 (4%)
Query: 39 LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNIL 98
+V +Y++ GSL DV+ E + + + R+ + + +LH Q+IH DIK NIL
Sbjct: 94 VVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNIL 148
Query: 99 MDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158
+ K++DFG + P+Q++ + + GT ++A E K D++S G++ +
Sbjct: 149 LGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAI 207
Query: 159 EIV 161
E++
Sbjct: 208 EMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 4 EGEREFKTEMNAIGR-THHRNPVRLLGYSFDVS------NKILVYDYMSNGSLVDVLFTP 56
+ E E K E+N + + +HHRN G S LV ++ GS+ D++
Sbjct: 54 DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT 113
Query: 57 EK---QPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA 113
+ + +W+ I R+I RG+ +LH ++IH DIK QN+L+ E K+ DFG++
Sbjct: 114 KGNALKEDWIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168
Query: 114 KLMKPDQTR--TFTGIRGTRA--YVAAEWHRNLPITVKADVYSFGVVLLEI 160
+ R TF G A +A + + + ++D++S G+ +E+
Sbjct: 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-09
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
I + I G+RYLH + +IIH D+K +NI +++ I D G A+ P F G+
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGL 216
Query: 128 RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
GT A E KAD++S G+VL E++
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 57/248 (22%), Positives = 99/248 (39%), Gaps = 38/248 (15%)
Query: 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSL--------VDVLFTP 56
++F E + H + V+ G + I+V++YM +G L D +
Sbjct: 50 ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMA 109
Query: 57 EKQP----NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL 112
E + + IA+ IA G+ YL + +H D+ +N L+ E KI DFG+
Sbjct: 110 EGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGM 166
Query: 113 AK-LMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-----TVKADVYSFGVVLLEIVCLRRC 166
++ + D R G + W I T ++DV+S GVVL EI +
Sbjct: 167 SRDVYSTDYYRV-----GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
Query: 167 LDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226
L + I +C G + Q + + + + L C EP +R +
Sbjct: 222 PWYQLSNNEVI------ECITQGRVLQR------PRTCPKEVYDLMLGCWQREPHMRLNI 269
Query: 227 KKVLLMLE 234
K++ +L+
Sbjct: 270 KEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 13/96 (13%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
I G++Y+H A ++H D+KP N+L++ KI DFGLA+ + +
Sbjct: 114 ILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE-- 168
Query: 132 AYVAAEWHR-------NLPITVKADVYSFGVVLLEI 160
YVA W+R T DV+S G +L E+
Sbjct: 169 -YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-09
Identities = 44/132 (33%), Positives = 70/132 (53%), Gaps = 9/132 (6%)
Query: 31 SFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIH 89
SF N++ + +++ G L L + PN V + A ++ YLH II+
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA-ELVLAFEYLH---SKDIIY 141
Query: 90 GDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKAD 149
D+KP+N+L+D K K++DFG AK + PD RTFT + GT Y+A E ++ D
Sbjct: 142 RDLKPENLLLDNKGHVKVTDFGFAKKV-PD--RTFT-LCGTPEYLAPEVIQSKGHGKAVD 197
Query: 150 VYSFGVVLLEIV 161
++ GV+L E +
Sbjct: 198 WWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 15/165 (9%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNK------ILVYDYMSNGSLVDVLFTPE--KQ 59
+F +E + H N +RL+G +++ +M +G L L
Sbjct: 46 DFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC 105
Query: 60 PNWVERMGIAR---DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA-KL 115
P ++ + + DIA G+ YL + IH D+ +N +++E ++DFGL+ K+
Sbjct: 106 PQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKI 162
Query: 116 MKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
D R + ++A E + T K+DV+SFGV + EI
Sbjct: 163 YNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-09
Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
E+ E + H +RL D ++ +Y+ G L L + N
Sbjct: 45 EQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL 104
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
A +I + YLH + +I++ D+KP+NIL+D++ K++DFG AK ++ RT+T
Sbjct: 105 F-YASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR---DRTWT 157
Query: 126 GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+ GT Y+A E ++ D ++ G+++ E++
Sbjct: 158 -LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-09
Identities = 41/145 (28%), Positives = 70/145 (48%), Gaps = 5/145 (3%)
Query: 21 HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYL 79
H N V LLG +++ +Y G L++ L E + + + +A+G+ +L
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG-IRGTRAYVAAEW 138
+ IH D+ +N+L+ + KI DFGLA+ + D G R ++A E
Sbjct: 158 ASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214
Query: 139 HRNLPITVKADVYSFGVVLLEIVCL 163
N T ++DV+S+G++L EI L
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSL 239
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-09
Identities = 41/129 (31%), Positives = 68/129 (52%), Gaps = 17/129 (13%)
Query: 42 DYMSNGSLVDVLF----TPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNI 97
+YM GSL D L+ E P V R I + +G+++L +E IIH D+KP N+
Sbjct: 79 EYMDAGSL-DKLYAGGVATEGIPEDVLRR-ITYAVVKGLKFLKEE--HNIIHRDVKPTNV 134
Query: 98 LMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR------NLPITVKADVY 151
L++ K+ DFG++ + +T G ++Y+A E + N TV++DV+
Sbjct: 135 LVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERIKSGGPNQNPTYTVQSDVW 191
Query: 152 SFGVVLLEI 160
S G+ +LE+
Sbjct: 192 SLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIR 128
A +I G+ LH E +I++ D+KP+NIL+D+ +ISD GLA + Q T G
Sbjct: 108 AAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRV 162
Query: 129 GTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
GT Y+A E +N T D ++ G +L E++
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 43/139 (30%), Positives = 72/139 (51%), Gaps = 14/139 (10%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMG--IARDIARGIRYLHDECE 84
L +SF ++K+ V DY++ G L + +++ ++E A +IA + YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAEIASALGYLH---S 114
Query: 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKL-MKPD-QTRTFTGIRGTRAYVAAEWHRNL 142
I++ D+KP+NIL+D + ++DFGL K ++ + T TF GT Y+A E
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC---GTPEYLAPEVLHKQ 171
Query: 143 PITVKADVYSFGVVLLEIV 161
P D + G VL E++
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 12/103 (11%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
IA I + + YLH + +IH D+KP N+L++ K+ DFG++ + +T
Sbjct: 108 IAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA- 164
Query: 128 RGTRAYVAAEWHRNLPIT------VKADVYSFGVVLLEIVCLR 164
G + Y+A E R P VK+DV+S G+ ++E+ R
Sbjct: 165 -GCKPYMAPE--RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-09
Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 24/161 (14%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIAR- 70
E++ + H N VRL LV++Y+ +D+ + P++ + + +
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKT 106
Query: 71 ---DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA-KISDFGLAKLMK-PDQTRTFT 125
I RGI Y H +++H D+KPQN+L+D + A K++DFGLA+ P RTFT
Sbjct: 107 YLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VRTFT 161
Query: 126 GIRGTRAYVAAEW-----HRNLPITVKADVYSFGVVLLEIV 161
T Y A E H + P+ D++S G + E+V
Sbjct: 162 HEVVTLWYRAPEILLGSRHYSTPV----DIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-09
Identities = 42/132 (31%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 31 SFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMG-IARDIARGIRYLHDECEAQII 88
+F V N+I + ++M GSL DV K P V +G IA + +G+ YL +I+
Sbjct: 67 AFFVENRISICTEFMDGGSL-DVY---RKIPEHV--LGRIAVAVVKGLTYLWS---LKIL 117
Query: 89 HGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKA 148
H D+KP N+L++ + K+ DFG++ + +T+ GT AY+A E + +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERISGEQYGIHS 174
Query: 149 DVYSFGVVLLEI 160
DV+S G+ +E+
Sbjct: 175 DVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-09
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 54/199 (27%)
Query: 1 MLAEG-----EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL-- 53
ML E + +F+ E + H N V+LLG L+++YM+ G L + L
Sbjct: 42 MLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRH 101
Query: 54 FTPEKQP-------------------NWVERMGIARDIARGIRYLHDECEAQIIHGDIKP 94
+P Q + E++ IA+ +A G+ YL E + +H D+
Sbjct: 102 RSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLAT 158
Query: 95 QNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI---------- 144
+N L+ E KI+DFGL++ I Y A+E + +PI
Sbjct: 159 RNCLVGENMVVKIADFGLSR-----------NIYSADYYKASE-NDAIPIRWMPPESIFY 206
Query: 145 ---TVKADVYSFGVVLLEI 160
T ++DV+++GVVL EI
Sbjct: 207 NRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-09
Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 7/137 (5%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86
L Y+F K+ L+ DY++ G L L+ E R+ IA +I + +LH +
Sbjct: 70 LHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---QLG 125
Query: 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-- 144
II+ DIK +NIL+D + ++DFGL+K ++ GT Y+A E R
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 145 TVKADVYSFGVVLLEIV 161
D +S GV+ E++
Sbjct: 186 DKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-09
Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 32/196 (16%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT------------ 55
+F E+ + R N +RLLG D ++ +YM NG L L +
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 56 ------PEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISD 109
++ + +A IA G++YL +H D+ +N L+ E KI+D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 110 FGLAK-LMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-----TVKADVYSFGVVLLEIVCL 163
FG+++ L D R I+G RA + W I T +DV++FGV L EI+ L
Sbjct: 182 FGMSRNLYAGDYYR----IQG-RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236
Query: 164 RRCLDQNLLEDRAILQ 179
+ L D +++
Sbjct: 237 CKEQPYGELTDEQVIE 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-09
Identities = 45/152 (29%), Positives = 66/152 (43%), Gaps = 12/152 (7%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARD 71
E+ + + H N + G LV +Y GS D+L +K VE I
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHG 123
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+G+ YLH IH DIK NIL+ E K++DFG A L+ P + GT
Sbjct: 124 ALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTP 175
Query: 132 AYVAAEWHRNL---PITVKADVYSFGVVLLEI 160
++A E + K DV+S G+ +E+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-09
Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
IA + + YL +E +IIH D+KP NIL+D K+ DFG++ + +T
Sbjct: 112 IAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA- 168
Query: 128 RGTRAYVAAEWHRNLPIT-----VKADVYSFGVVLLEI 160
G R Y+A E R P V++DV+S G+ L E+
Sbjct: 169 -GCRPYMAPE--RIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-09
Identities = 41/139 (29%), Positives = 72/139 (51%), Gaps = 7/139 (5%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVER-MGIARDIARGIRYLHDECEA 85
L Y+F+ + LV M+ G L ++ ++ +ER + + I GI +LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SM 114
Query: 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPIT 145
I++ D+KP+N+L+D++ ++SD GLA +K +T T GT Y+A E + P +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 146 VKADVYSFGVVLLEIVCLR 164
D ++ G + E+V R
Sbjct: 173 YPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-09
Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 7/157 (4%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMG 67
++ E++ + H N V+LL + +N ++ ++ + G++ V+ E+ +
Sbjct: 48 DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV 107
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL-AKLMKPDQTR-TFT 125
+ + + YLH E +IIH D+K NIL K++DFG+ AK + Q R +F
Sbjct: 108 VCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164
Query: 126 GIRGTRA--YVAAEWHRNLPITVKADVYSFGVVLLEI 160
G A V E ++ P KADV+S G+ L+E+
Sbjct: 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-09
Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT------PEKQPN 61
EF+ E++ + H+N VRLLG + ++ +Y G L L K P
Sbjct: 54 EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113
Query: 62 W--VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD 119
+++ + IA G+ +L + A+ +H D+ +N L+ +R K+S L+K +
Sbjct: 114 LSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170
Query: 120 QTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+ ++A E + + K+DV+SFGV++ E+
Sbjct: 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-09
Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 5/155 (3%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMG 67
EF E + H + VRLLG + + LV M +G L+D + + +
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLN 113
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTG 126
IA+G+ YL E +++H D+ +N+L+ KI+DFGLA+L++ D+ G
Sbjct: 114 WCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+ ++A E T ++DV+S+GV + E++
Sbjct: 171 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 8/151 (5%)
Query: 11 TEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIAR 70
+E + +H V L G D S LV +++ G L ++ PN V A
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-YAA 138
Query: 71 DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGT 130
I YL I++ D+KP+N+L+D+ K++DFG AK++ TRT+T + GT
Sbjct: 139 QIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGT 191
Query: 131 RAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
Y+A E N+ AD ++ G+ + EI+
Sbjct: 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 40/165 (24%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 6 EREFKT---EMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL--FTPEKQP 60
E+E++ E++ + H N V+ LG D + + +++ GS+ +L F P +P
Sbjct: 43 EKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEP 102
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM---- 116
+ + + I G+ YLH+ C ++H DIK N+++ K+ DFG A+ +
Sbjct: 103 VFCK---YTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156
Query: 117 -KPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+ + GT ++A E K+D++S G + E+
Sbjct: 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 32/155 (20%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARD-------- 71
+H N VRLL + LV++++ +D+ +K + G+
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLD----LDL----KKYMDSSPLTGLDPPLIKSYLYQ 107
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+ +GI Y H +++H D+KPQN+L+D + K++DFGLA R F G+ R
Sbjct: 108 LLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA--------RAF-GVP-VR 154
Query: 132 AY---VAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
Y V W+R I + + YS V + I C+
Sbjct: 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCI 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-LMK-PDQTRTFTGIRG 129
+ARG+ +L + IH D+ +NIL+ E KI DFGLA+ + K PD R R
Sbjct: 182 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA-RL 237
Query: 130 TRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
++A E + T ++DV+SFGV+L EI L
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 36/152 (23%), Positives = 66/152 (43%), Gaps = 14/152 (9%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+ + ++H +I+H DIKP N+ + K+ D GL + T + + GT
Sbjct: 115 LCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTP 170
Query: 132 AYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNL 191
Y++ E K+D++S G +L E+ L+ D+ L +C+ E +
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYS-LCKKIEKCDY 225
Query: 192 SQLVEDEEVDQKQLQRMIKVGLRCILDEPSLR 223
L D + +L+ ++ RCI +P R
Sbjct: 226 PPLPADHYSE--ELRDLVS---RCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 42/132 (31%), Positives = 58/132 (43%), Gaps = 16/132 (12%)
Query: 21 HRNPVRLLGYSFDVSNKI--------LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDI 72
H N V L+ + + +K +V YM + L +L P + + +
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQL 124
Query: 73 ARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK-PDQTRTFTGIRGTR 131
GI YLH E I+H DIK NIL+D + KI+DFGLA+ P G GTR
Sbjct: 125 LEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 132 AY---VAAEWHR 140
Y V W+R
Sbjct: 182 KYTNLVVTRWYR 193
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 20/98 (20%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
I RG++Y+H A IIH D+KP NI ++E KI DFGLA+ + T
Sbjct: 127 ILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT---------- 173
Query: 132 AYVAAEWHRNLPI-------TVKADVYSFGVVLLEIVC 162
YVA W+R I D++S G ++ E++
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 51/178 (28%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL--FTPEKQPNWVER 65
+F E+ + R N +RLL ++ +YM NG L L P++ +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 66 MGI--------ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-LM 116
+ I A IA G++YL +H D+ +N L+ + KI+DFG+++ L
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPI-----TVKADVYSFGVVLLEIVCLRRCLDQ 169
D R I+G RA + W I T +DV++FGV L EI+ L C +Q
Sbjct: 182 SGDYYR----IQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTL--CKEQ 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 29/175 (16%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSL--------VDVLFTPEK 58
++F+ E + H + V+ G D I+V++YM +G L D + +
Sbjct: 52 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 111
Query: 59 QP-------NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFG 111
QP + + IA IA G+ YL + +H D+ +N L+ KI DFG
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFG 168
Query: 112 LAK-LMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-----TVKADVYSFGVVLLEI 160
+++ + D R G + W I T ++DV+SFGV+L EI
Sbjct: 169 MSRDVYSTDYYRV-----GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 20/100 (20%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
I RG++Y+H A IIH D+KP N+ ++E KI DFGLA+ + T
Sbjct: 129 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---------- 175
Query: 132 AYVAAEWHRNLPI-------TVKADVYSFGVVLLEIVCLR 164
YVA W+R I D++S G ++ E++ R
Sbjct: 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 51/182 (28%), Positives = 78/182 (42%), Gaps = 40/182 (21%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER-- 65
+F E+ + R N RLLG ++ +YM NG L L + + +
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 66 --------MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-LM 116
+ +A IA G+RYL +H D+ +N L+ + KI+DFG+++ L
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIVCL 163
D R ++G RA LPI T K+DV++FGV L EI+ L
Sbjct: 182 SSDYYR----VQG-RAP--------LPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228
Query: 164 RR 165
R
Sbjct: 229 CR 230
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-08
Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 16/165 (9%)
Query: 4 EGEREFKTEMNAIGRTHHR--NP--VRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQ 59
E E+ + EM H+ NP VR++G + +LV + S G L L + +
Sbjct: 33 ENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDE 91
Query: 60 ---PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116
N VE M ++ G++YL +H D+ +N+L+ + AKISDFGL+K +
Sbjct: 92 ITVSNVVELM---HQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145
Query: 117 KPDQT--RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
D + + + + + A E + ++DV+S+G+ + E
Sbjct: 146 GADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 40/144 (27%), Positives = 77/144 (53%), Gaps = 10/144 (6%)
Query: 20 HHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78
HH N V + S+ V +++ +V +++ G+L D++ + N + + + R + Y
Sbjct: 77 HHENVVDMYN-SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSY 133
Query: 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL-AKLMKPDQTRTFTGIRGTRAYVAAE 137
LH++ +IH DIK +IL+ K+SDFG A++ K R + GT ++A E
Sbjct: 134 LHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--KSLVGTPYWMAPE 188
Query: 138 WHRNLPITVKADVYSFGVVLLEIV 161
LP + D++S G++++E++
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-08
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTGIRG 129
+A+G+ +L + IH D+ +NIL+ E KI DFGLA+ PD R R
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA-RL 243
Query: 130 TRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
++A E + T+++DV+SFGV+L EI L
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-08
Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 23/171 (13%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL--FTPEKQ------ 59
EF E + + + + VRLLG +++ + M+ G L L PE +
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 60 -PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-LMK 117
P+ + + +A +IA G+ YL+ + +H D+ +N ++ E KI DFG+ + + +
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171
Query: 118 PDQTRTFTGIRGTRAYVAAEWH-----RNLPITVKADVYSFGVVLLEIVCL 163
D R +G + + W ++ T +DV+SFGVVL EI L
Sbjct: 172 TDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-08
Identities = 42/144 (29%), Positives = 66/144 (45%), Gaps = 10/144 (6%)
Query: 28 LGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86
L Y+F D N LV +Y G L+ +L E Q + E M +A + +H +
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD--EDM-AQFYLAELVLAIHSVHQMG 122
Query: 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITV 146
+H DIKP+N+L+D K++DFG A + ++ GT Y+A E +
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 147 KA------DVYSFGVVLLEIVCLR 164
K D +S GV+ E++ R
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 35/94 (37%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTGIRG 129
+ARG+ +L + IH D+ +NIL+ E KI DFGLA+ PD R + R
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA-RL 238
Query: 130 TRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
++A E + T ++DV+SFGV+L EI L
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-08
Identities = 43/160 (26%), Positives = 81/160 (50%), Gaps = 11/160 (6%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGY-SFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVER 65
+ K E+ + +H N V+ G + D N I L+ +++ +GSL + L + + N ++
Sbjct: 52 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQ 111
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+ A I +G+ YL Q +H D+ +N+L++ + KI DFGL K ++ D + +
Sbjct: 112 LKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD--KEYY 166
Query: 126 GIRGTRA----YVAAEWHRNLPITVKADVYSFGVVLLEIV 161
++ + A E + +DV+SFGV L E++
Sbjct: 167 TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-08
Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 28/174 (16%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLF------------- 54
EF+ E + + HH N V LLG ++++Y++ G L + L
Sbjct: 53 EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 55 ---TPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFG 111
T + + + + IA IA G+ YL +H D+ +NIL+ E+ KISD G
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLG 169
Query: 112 LAK-LMKPD----QTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
L++ + D Q ++ IR ++ E + +D++SFGVVL EI
Sbjct: 170 LSREIYSADYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-08
Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVD-VLFTPEKQPNWVERM 66
++ E+ + +H V+LLG +F K+ + G VD ++ ++ +
Sbjct: 55 DYMVEIEILATCNHPYIVKLLG-AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 113
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL-AKLMKPDQTR-TF 124
I R + ++YLH +IIH D+K N+L+ K++DFG+ AK +K Q R +F
Sbjct: 114 VICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF 170
Query: 125 TGIRGTRA--YVAAEWHRNLPITVKADVYSFGVVLLEI 160
G A V E ++ P KAD++S G+ L+E+
Sbjct: 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-08
Identities = 51/158 (32%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86
L +SF K+ LV +++ G L L + R A ++ + LH +
Sbjct: 58 LKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLH---KFN 113
Query: 87 IIHGDIKPQNILMDEKRCAKISDFGLAKL--MKPDQTRTFTGIRGTRAYVAAEWHRNLPI 144
+I+ D+KP+NIL+D + + DFGL KL D+T TF GT Y+A E
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAPELLLGHGY 170
Query: 145 TVKADVYSFGVVLLEIVC-LRRCLDQNLLED-RAILQE 180
T D ++ GV+L E++ L D+N+ E R ILQE
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-08
Identities = 45/174 (25%), Positives = 75/174 (43%), Gaps = 28/174 (16%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT----------- 55
++F+ E + H++ VR G + ++V++YM +G L L +
Sbjct: 52 QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 56 ---PEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL 112
Q + + IA IA G+ YL +H D+ +N L+ + KI DFG+
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGM 168
Query: 113 AK-LMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-----TVKADVYSFGVVLLEI 160
++ + D R G R + W I T ++D++SFGVVL EI
Sbjct: 169 SRDIYSTDYYRV-----GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 7e-08
Identities = 21/48 (43%), Positives = 31/48 (64%), Gaps = 3/48 (6%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115
+ R + RG+ +LH I+H D+KPQNIL+ KI+DFGLA++
Sbjct: 112 LMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-08
Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 10/158 (6%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKILV--YDYMSNGSLVDVLFTPEKQPNWVERM 66
+ E+ + H V+ G D + K L +YM GS+ D L V R
Sbjct: 51 LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRK 110
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG 126
R I G+ YLH I+H DIK NIL D K+ DFG +K ++ + TG
Sbjct: 111 -YTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ-TICMSGTG 165
Query: 127 IR---GTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
IR GT +++ E KADV+S G ++E++
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-08
Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 15/166 (9%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNK------ILVYDYMSNGSLVDVLFTPE--KQ 59
EF E + H N ++L+G S K +++ +M +G L L ++
Sbjct: 47 EFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEE 106
Query: 60 PNWVERMGIAR---DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA-KL 115
P + + R DIA G+ YL + IH D+ +N +++E ++DFGL+ K+
Sbjct: 107 PFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKI 163
Query: 116 MKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
D R + ++A E + T +DV++FGV + EI+
Sbjct: 164 YSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-08
Identities = 34/101 (33%), Positives = 57/101 (56%), Gaps = 10/101 (9%)
Query: 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM--KPDQTRTFTGIRGTRA 132
G+ Y+H + +I+H D+K +NI + + KI DFG+++L+ D TFTG T
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTG---TPY 170
Query: 133 YVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLD-QNLL 172
Y++ E ++ K+D++S G +L E+ CL + QN L
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-08
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 4/93 (4%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG-IRGT 130
+A+G+ +L + IH D+ +NIL+ R KI DFGLA+ ++ D G R
Sbjct: 223 VAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 131 RAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
++A E N T ++DV+S+G++L EI L
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 312
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-08
Identities = 37/127 (29%), Positives = 68/127 (53%), Gaps = 13/127 (10%)
Query: 39 LVYDYMSNGSLVDVLFTPEKQPNWVERMGI--ARDIARGIRYLHDECEAQIIHGDIKPQN 96
V +Y++ G D+++ ++ + E + A +I+ G+ +LH II+ D+K N
Sbjct: 78 FVMEYVNGG---DLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDN 131
Query: 97 ILMDEKRCAKISDFGLAK--LMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFG 154
+++D + KI+DFG+ K ++ TRTF GT Y+A E P D +++G
Sbjct: 132 VMLDSEGHIKIADFGMCKEHMVDGVTTRTFC---GTPDYIAPEIIAYQPYGKSVDWWAYG 188
Query: 155 VVLLEIV 161
V+L E++
Sbjct: 189 VLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-08
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 17/155 (10%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL--FTPEKQ-------PNWVERMGIAR 70
HH VRLLG ++V + M++G L L PE + P E + +A
Sbjct: 69 HH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 71 DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-LMKPDQTRTF-TGIR 128
+IA G+ YL+ + + +H D+ +N ++ KI DFG+ + + + D R G+
Sbjct: 127 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 129 GTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
R ++A E ++ T +D++SFGVVL EI L
Sbjct: 184 PVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITSL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 5/137 (3%)
Query: 26 RLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85
RLLG S LV M G L+D + + + + + IA+G+ YL E
Sbjct: 73 RLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EV 128
Query: 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT-GIRGTRAYVAAEWHRNLPI 144
+++H D+ +N+L+ KI+DFGLA+L+ D+T G + ++A E +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 145 TVKADVYSFGVVLLEIV 161
T ++DV+S+GV + E++
Sbjct: 189 THQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 13/138 (9%)
Query: 35 SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMG--IARDIARGIRYLHDECEAQIIHGDI 92
S LV +Y++ G D++F ++Q E A +I + +LH E II+ D+
Sbjct: 69 SRLFLVIEYVNGG---DLMFHMQRQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDL 122
Query: 93 KPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADV 150
K N+L+D K++D+G+ K L D T TF GT Y+A E R D
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC---GTPNYIAPEILRGEEYGFSVDW 179
Query: 151 YSFGVVLLEIVCLRRCLD 168
++ GV++ E++ R D
Sbjct: 180 WALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-07
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 10/160 (6%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMG 67
+F E + + H N VRL+G +V + + G + L T + E +
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ 98
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
+ + A G+ YL + IH D+ +N L+ EK KISDFG+++ + D TG
Sbjct: 99 MVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTG- 153
Query: 128 RGTR----AYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
G + + A E + ++DV+SFG++L E L
Sbjct: 154 -GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSL 192
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 40/137 (29%), Positives = 71/137 (51%), Gaps = 9/137 (6%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI--ARDIARGIRYLHDECE 84
L Y+++ + + LV M+ G L ++ P + E+ I A ++ G+ L E
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI 144
+I++ D+KP+NIL+D++ +ISD GLA ++ + T G GT Y+A E N
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 145 TVKADVYSFGVVLLEIV 161
T D + G ++ E++
Sbjct: 179 TFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 23/150 (15%)
Query: 21 HRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVD---VLFTP--EKQPNWVERMGIARDIAR 74
H N V G S+ +K+ +V +Y GSL D V P E Q +V R+ +
Sbjct: 59 HPNIVAYFG-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYV-----CRETLK 112
Query: 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAY- 133
G+ YLH E IH DIK NIL+ E K++DFG++ + + + I GT Y
Sbjct: 113 GLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GT-PYW 167
Query: 134 ----VAAEWHRNLPITVKADVYSFGVVLLE 159
VAA R K D+++ G+ +E
Sbjct: 168 MAPEVAAV-ERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER- 65
+E E + + + RLLG S L+ M G L+D + E + N +
Sbjct: 54 KEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLD--YVREHKDNIGSQY 110
Query: 66 -MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF 124
+ IA+G+ YL E +++H D+ +N+L+ + KI+DFGLAKL+ D+
Sbjct: 111 LLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167
Query: 125 T-GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
G + ++A E + T ++DV+S+GV + E++
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-07
Identities = 38/144 (26%), Positives = 74/144 (51%), Gaps = 10/144 (6%)
Query: 20 HHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78
H N V + S+ V +++ +V +++ G+L D++ + + +A + + +
Sbjct: 75 QHENVVEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA--VLKALSV 131
Query: 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL-AKLMKPDQTRTFTGIRGTRAYVAAE 137
LH + +IH DIK +IL+ K+SDFG A++ K R + GT ++A E
Sbjct: 132 LHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPE 186
Query: 138 WHRNLPITVKADVYSFGVVLLEIV 161
LP + D++S G++++E+V
Sbjct: 187 LISRLPYGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTG 126
A +I G+++LH + II+ D+K N+++D KI+DFG+ K + ++ TF
Sbjct: 102 AAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC- 157
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
GT Y+A E + L T D +SFGV+L E++
Sbjct: 158 --GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIR 128
A +I G+ LH E +I++ D+KP+NIL+D+ +ISD GLA + + T G
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRGRV 162
Query: 129 GTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
GT Y+A E +N T D + G ++ E++
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 9/137 (6%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI--ARDIARGIRYLHDECE 84
L Y+++ + + LV M+ G L ++ P + E + A +I G+ LH E
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLHRE-- 121
Query: 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI 144
++ D+KP+NIL+D+ +ISD GLA +K + + G GT Y+A E N
Sbjct: 122 -NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRY 178
Query: 145 TVKADVYSFGVVLLEIV 161
T+ D + G ++ E++
Sbjct: 179 TLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 4/105 (3%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG-IRGT 130
+A+G+ +L + IH D+ +N+L+ + R AKI DFGLA+ + D G R
Sbjct: 221 VAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 131 RAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDR 175
++A E + TV++DV+S+G++L EI L + +L +
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 17/94 (18%)
Query: 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK------LMKPDQTRTFTGIR 128
GI++LH A IIH D+KP NI++ KI DFGLA+ +M P
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV------- 179
Query: 129 GTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
TR Y A E + D++S G ++ E++
Sbjct: 180 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 36/134 (26%), Positives = 58/134 (43%), Gaps = 24/134 (17%)
Query: 39 LVYDYMSNGSLVDVLFTPEKQPNWVER---MGIARDIARGIRYLHDECEAQIIHGDIKPQ 95
LV++Y + VL EK P V I + + + H IH D+KP+
Sbjct: 77 LVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPE 129
Query: 96 NILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITV-------KA 148
NIL+ ++ K+ DFG A+++ +T YVA W+R + V
Sbjct: 130 NILITKQGQIKLCDFGFARILTG-PGDDYTD------YVATRWYRAPELLVGDTQYGPPV 182
Query: 149 DVYSFGVVLLEIVC 162
DV++ G V E++
Sbjct: 183 DVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 17/96 (17%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+ RG++Y+H A ++H D+KP N+L++ KI DFGLA+ T + G T
Sbjct: 117 LLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR------TTSEKGDFMTE 167
Query: 132 AYVAAEWHRNLPI-------TVKADVYSFGVVLLEI 160
YV W+R + T DV+S G + E+
Sbjct: 168 -YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-07
Identities = 29/90 (32%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRG 129
++ G++YL E +H D+ +N+L+ + AKISDFGL+K + D+ + T +
Sbjct: 104 VSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160
Query: 130 TRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
+ A E + K+DV+SFGV++ E
Sbjct: 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 35/122 (28%), Positives = 62/122 (50%), Gaps = 4/122 (3%)
Query: 39 LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNIL 98
LV++Y+ +++++L E+ PN V + I + I+ +H + I+H DIKP+N+L
Sbjct: 77 LVFEYVEK-NMLELL---EEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLL 132
Query: 99 MDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158
+ K+ DFG A+ + +T TR Y + E P D++S G +L
Sbjct: 133 ISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILG 192
Query: 159 EI 160
E+
Sbjct: 193 EL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-07
Identities = 45/152 (29%), Positives = 66/152 (43%), Gaps = 12/152 (7%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARD 71
E+ + R H N + G LV +Y GS D+L +K VE I
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHG 133
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+G+ YLH +IH DIK NIL+ E K++DFG A + P + GT
Sbjct: 134 ALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTP 185
Query: 132 AYVAAEWHRNL---PITVKADVYSFGVVLLEI 160
++A E + K DV+S G+ +E+
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 39/143 (27%), Positives = 68/143 (47%), Gaps = 15/143 (10%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLV-----DVLFTPEKQPNWVERMGIARDIARGIRYLHD 81
L YSF +++ V +Y + G L + +F+ ++ + +I + YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY------GAEIVSALDYLHS 113
Query: 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN 141
E +++ D+K +N+++D+ KI+DFGL K D T GT Y+A E +
Sbjct: 114 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLED 170
Query: 142 LPITVKADVYSFGVVLLEIVCLR 164
D + GVV+ E++C R
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 8/155 (5%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI 68
+TE N + + L Y+F K+ L+ DY+S G + L+ + R
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS 111
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK-LMKPDQTRTFTGI 127
+I + +LH + I++ DIK +NIL+D + ++DFGL+K + ++ RT++
Sbjct: 112 G-EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-F 166
Query: 128 RGTRAYVAAEWHRNLPITVKA-DVYSFGVVLLEIV 161
GT Y+A E R KA D +S G+++ E++
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 38/118 (32%), Positives = 53/118 (44%), Gaps = 9/118 (7%)
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+ I R + R I+YLH E +IIH DIK +NI ++ + DFG A +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 126 GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL------RRCLDQNLLEDRAI 177
G GT A A E P D++S G+VL E+ + LD + DR I
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI 299
|
Length = 391 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-07
Identities = 41/138 (29%), Positives = 68/138 (49%), Gaps = 13/138 (9%)
Query: 35 SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMG--IARDIARGIRYLHDECEAQIIHGDI 92
S V +Y++ G D++F ++Q E + +I+ + YLH E II+ D+
Sbjct: 69 SRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDL 122
Query: 93 KPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADV 150
K N+L+D + K++D+G+ K L D T TF GT Y+A E R D
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEILRGEDYGFSVDW 179
Query: 151 YSFGVVLLEIVCLRRCLD 168
++ GV++ E++ R D
Sbjct: 180 WALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-07
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 16/95 (16%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT-FTGIRGT 130
+ +G++Y+H A IIH D+KP N+ ++E KI DFGLA+ QT + TG T
Sbjct: 127 MLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVT 178
Query: 131 RAYVAAE----WHRNLPITVKADVYSFGVVLLEIV 161
R Y A E W T D++S G ++ E++
Sbjct: 179 RWYRAPEVILNWMH---YTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-07
Identities = 43/163 (26%), Positives = 76/163 (46%), Gaps = 23/163 (14%)
Query: 11 TEMNAIGRTHHRNP-VRLLGYSFDVSNKI-LVYDYMSNGSLV-----DVLFTPEKQPNWV 63
TE + T H P + L YSF +++ V +Y + G L + +F+ ++ +
Sbjct: 44 TESRVLQNTRH--PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY- 100
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQT 121
+I + YLH +++ D+K +N+++D+ KI+DFGL K +
Sbjct: 101 -----GAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
+TF GT Y+A E + D + GVV+ E++C R
Sbjct: 153 KTFC---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-07
Identities = 37/160 (23%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNK----ILVYDYMSNGSLVDVLFTPEKQPNW 62
+ E+ + R N +++ G+ D+ + L+ +Y + G L +VL EK ++
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSF 121
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
++ +A D +G+ L+ + ++ + L+ E KI GL K++ +
Sbjct: 122 KTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKIL---SSP 176
Query: 123 TFTGIRGTRAYVAAEWHRNL--PITVKADVYSFGVVLLEI 160
F + Y + + ++ T+K D+YS GVVL EI
Sbjct: 177 PFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEI 215
|
Length = 283 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-07
Identities = 32/89 (35%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 25 VRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83
V+L YSF D N V DY+ G ++ +L + R IA ++ I +H
Sbjct: 64 VKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH--- 118
Query: 84 EAQIIHGDIKPQNILMDEKRCAKISDFGL 112
+ IH DIKP NIL+D K++DFGL
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTG 126
A +I G+++LH + II+ D+K N+L+D+ KI+DFG+ K + + TF
Sbjct: 102 AAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC- 157
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
GT Y+A E + D +SFGV+L E++
Sbjct: 158 --GTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 39/139 (28%), Positives = 68/139 (48%), Gaps = 13/139 (9%)
Query: 34 VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMG--IARDIARGIRYLHDECEAQIIHGD 91
S V +++S G D++F ++Q E + +I+ + +LH E II+ D
Sbjct: 68 ESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNFLH---ERGIIYRD 121
Query: 92 IKPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKAD 149
+K N+L+D + K++D+G+ K + D T TF GT Y+A E R D
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC---GTPNYIAPEILRGEDYGFSVD 178
Query: 150 VYSFGVVLLEIVCLRRCLD 168
++ GV++ E++ R D
Sbjct: 179 WWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 23/163 (14%)
Query: 11 TEMNAIGRTHHRNP-VRLLGYSFDVSNKI-LVYDYMSNGSLV-----DVLFTPEKQPNWV 63
TE + T H P + L Y+F +++ V +Y + G L + +FT E+ +
Sbjct: 44 TESRVLQNTRH--PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY- 100
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-- 121
+I + YLH +++ DIK +N+++D+ KI+DFGL K D
Sbjct: 101 -----GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
+TF GT Y+A E + D + GVV+ E++C R
Sbjct: 153 KTFC---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-07
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 20/95 (21%)
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAY 133
RG++Y+H A IIH D+KP N+ ++E +I DFGLA+ + T Y
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT----------GY 175
Query: 134 VAAEWHRNLPITVK-------ADVYSFGVVLLEIV 161
VA W+R I + D++S G ++ E++
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-07
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 25/105 (23%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--TFT 125
I R++ ++Y+H + +IH DIK NIL+ K+ DFG+A L+ + ++ TF
Sbjct: 106 IIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV 162
Query: 126 G---------IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
G I + Y KAD++S G+ + E+
Sbjct: 163 GTPYWMAPEVITEGKYY-----------DTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 15/96 (15%)
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAY 133
R ++Y+H A + H D+KP+NIL + KI DFGLA++ D T T I T Y
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFND---TPTAIFWTD-Y 166
Query: 134 VAAEWHRNLPI--------TVKADVYSFGVVLLEIV 161
VA W+R + T D++S G + E++
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 202
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-07
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 8/95 (8%)
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD--QTRTFTG 126
A +IA G+ +LH + II+ D+K N+++D + KI+DFG+ K D T+TF
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC- 162
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
GT Y+A E P D ++FGV+L E++
Sbjct: 163 --GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-07
Identities = 44/152 (28%), Positives = 65/152 (42%), Gaps = 12/152 (7%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARD 71
E+ + + H N + G LV +Y GS D+L +K VE I
Sbjct: 71 EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHG 129
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+G+ YLH +IH DIK NIL+ E K++DFG A P + GT
Sbjct: 130 ALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-----FVGTP 181
Query: 132 AYVAAEWHRNL---PITVKADVYSFGVVLLEI 160
++A E + K DV+S G+ +E+
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-07
Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 29/140 (20%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI 68
K E N + H V L+ Y+F K+ L+ +Y+S G L F +ER GI
Sbjct: 48 KAERNILEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL----FMH------LEREGI 96
Query: 69 ---------ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK--LMK 117
+I+ + +LH + II+ D+KP+NIL+D + K++DFGL K + +
Sbjct: 97 FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153
Query: 118 PDQTRTFTGIRGTRAYVAAE 137
T TF GT Y+A E
Sbjct: 154 GTVTHTFC---GTIEYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-07
Identities = 41/125 (32%), Positives = 54/125 (43%), Gaps = 19/125 (15%)
Query: 53 LFTPEKQPNWVERMG---------IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKR 103
LFT +V+R G I R + + YLH IIH D+K +NI +DE
Sbjct: 172 LFT------YVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPE 222
Query: 104 CAKISDFGLA-KLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
A + DFG A KL T G GT + E P K D++S G+VL E+
Sbjct: 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282
Query: 163 LRRCL 167
L
Sbjct: 283 KNVTL 287
|
Length = 392 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-07
Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 16/95 (16%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
I +GI + H +++H D+KPQN+L+D K K++DFGLA R F GI R
Sbjct: 110 ILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA--------RAF-GIP-VR 156
Query: 132 AY---VAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
Y V W+R + + + YS V + I +
Sbjct: 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTI 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-07
Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 11 TEMNAIGRTHHRNP-VRLLGYSFDVSNKI-LVYDYMSNGSLV-----DVLFTPEKQPNWV 63
TE + T H P + L YSF +++ V +Y++ G L + +F+ ++ +
Sbjct: 44 TESRVLKNTRH--PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFY- 100
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
+I + YLH +I++ D+K +N+++D+ KI+DFGL K D T
Sbjct: 101 -----GAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-T 151
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
GT Y+A E + D + GVV+ E++C R
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-07
Identities = 35/127 (27%), Positives = 58/127 (45%), Gaps = 20/127 (15%)
Query: 12 EMNAIGRTHHRNPVRL----------LGYSFDVSNKILVYDYMSN---GSLVDVLFTPEK 58
E+ + + +HRN V L L + D LV++YM + G L L +
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 59 QPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP 118
+ + G+ Y H + +H DIK NIL++ K K++DFGLA+L
Sbjct: 116 DHI----KSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 119 DQTRTFT 125
+++R +T
Sbjct: 169 EESRPYT 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-07
Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 14/151 (9%)
Query: 21 HRNPVRLLGYSFDVSNKIL--VYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78
H V+ G D + L ++M GS+ D L + V R R I G+ Y
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK-YTRQILEGVSY 121
Query: 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG-----IRGTRAY 133
LH I+H DIK NIL D K+ DFG +K + QT +G + GT +
Sbjct: 122 LHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKSVTGTPYW 175
Query: 134 VAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
++ E KAD++S G ++E++ +
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-07
Identities = 43/152 (28%), Positives = 66/152 (43%), Gaps = 12/152 (7%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARD 71
E+ + + H N ++ G LV +Y GS D+L +K VE +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHG 123
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+G+ YLH +IH D+K NIL+ E K+ DFG A +M P GT
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTP 175
Query: 132 AYVAAEWHRNL---PITVKADVYSFGVVLLEI 160
++A E + K DV+S G+ +E+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 40/160 (25%), Positives = 75/160 (46%), Gaps = 5/160 (3%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMG 67
+F +E + + H N V+L+G +V + + G + L + + + +
Sbjct: 38 KFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVK 97
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
A D A G+ YL + IH D+ +N L+ E KISDFG+++ + D + +G+
Sbjct: 98 FALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGL 153
Query: 128 RGTR-AYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRC 166
+ + A E + ++DV+S+G++L E L C
Sbjct: 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVC 193
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 31/110 (28%), Positives = 56/110 (50%), Gaps = 17/110 (15%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
I RG+ Y H +++H D+KPQN+L++E+ K++DFGLA+ K T+T++
Sbjct: 113 ILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSN----- 163
Query: 132 AYVAAEWHRNLPI-------TVKADVYSFGVVLLEIVCLRRCLDQNLLED 174
V W+R + + + D++ G + E+ R + +ED
Sbjct: 164 -EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 20/115 (17%)
Query: 7 REFKTEMNAIGRTHHRNPVRL----LGYSFDVSNKI-LVYDYMSNG--SLVDVLFTPEKQ 59
RE + H N V + +G +KI +V +Y+ + SL++ + P Q
Sbjct: 53 REINILLKL----QHPNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQ 105
Query: 60 PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114
E + + G+ +LHD I+H D+K N+L++ + KI DFGLA+
Sbjct: 106 S---EVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 29/90 (32%), Positives = 51/90 (56%), Gaps = 10/90 (11%)
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAY 133
RG+ Y H + +I+H D+KPQN+L++EK K++DFGLA+ K T+T++
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSN------E 163
Query: 134 VAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
V W+R + + + YS + + + C+
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCI 193
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTG 126
A +I G+++LH + I++ D+K NIL+D KI+DFG+ K ++ +T TF
Sbjct: 102 AAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC- 157
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
GT Y+A E D +SFGV+L E++
Sbjct: 158 --GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 31/110 (28%), Positives = 50/110 (45%), Gaps = 20/110 (18%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ----------- 120
I I Y+H + ++H D+KP NIL+ I D+G A K ++
Sbjct: 122 ICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 121 -----TRTFTG-IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
+ T G I GT Y+A E +P + D+Y+ GV+L +++ L
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228
|
Length = 932 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 15/94 (15%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVL-----FTPEKQPNWVERMGIARDIARGIRYLHD 81
L YS +N + LV +Y+ G + +L F E ++ + +A D YLH
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD------YLH- 121
Query: 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115
IIH D+KP N+L+ + K++DFGL+K+
Sbjct: 122 --RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 6/104 (5%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGI 68
K E + + + V+L YSF D N V DY+ G ++ +L E P + R I
Sbjct: 49 KAERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYI 107
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL 112
A ++ I +H + IH DIKP NIL+D K++DFGL
Sbjct: 108 A-ELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 37/154 (24%), Positives = 68/154 (44%), Gaps = 19/154 (12%)
Query: 21 HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL------FTPEKQPNWVERMGIARDIAR 74
H N ++ LG + +LV ++ G L + L Q + ++RM A ++A
Sbjct: 54 HPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVAS 111
Query: 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD-----QTRTFTGIRG 129
G+ +LH +A IH D+ +N + KI D+GLA P+ + +R
Sbjct: 112 GLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 130 TRAYVAAEWHRNL---PITVKADVYSFGVVLLEI 160
+ ++L T K++++S GV + E+
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 39/143 (27%), Positives = 63/143 (44%), Gaps = 12/143 (8%)
Query: 20 HHRNPVRLLGYSFDVSNK-ILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78
+ N ++L YS +L+ DY+ +G L D+L K E I R + +
Sbjct: 67 DNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSE-AEVKKIIRQLVEALND 124
Query: 79 LHDECEAQIIHGDIKPQNILMDEKRC-AKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAE 137
LH + IIH DIK +N+L D + + D+GL K++ GT Y + E
Sbjct: 125 LH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPE 176
Query: 138 WHRNLPITVKADVYSFGVVLLEI 160
+ V D ++ GV+ E+
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYEL 199
|
Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 22/153 (14%)
Query: 21 HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVE-RMGIARDIARGIRYL 79
H++ V+L G N I+V +Y+ G L DV EK + ++ +A+ +A + YL
Sbjct: 60 HKHLVKLYGVCVRDEN-IMVEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 80 HDECEAQIIHGDIKPQNILM--DEKR-----CAKISDFGLAKLMKPDQTRTFTGIRGTRA 132
D+ +++HG++ +NIL+ K+SD G+ + + R R
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE------ERVERI 168
Query: 133 -YVAAEWHRNLP--ITVKADVYSFGVVLLEIVC 162
++A E RN +T+ AD +SFG LLEI
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICS 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTG 126
A +I + +LHD+ II+ D+K N+L+D + K++DFG+ K + T TF
Sbjct: 102 AAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC- 157
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
GT Y+A E + + D ++ GV+L E++C
Sbjct: 158 --GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 12/122 (9%)
Query: 47 GSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAK 106
+ D L ++++ +G + +A G+ +L + +H D+ +N+L+ E + K
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVK 279
Query: 107 ISDFGLAKLMKPDQT-----RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
I DFGLA+ + D TF ++ ++A E N T +DV+SFG++L EI
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLK----WMAPESIFNNLYTTLSDVWSFGILLWEIF 335
Query: 162 CL 163
L
Sbjct: 336 TL 337
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 17/94 (18%)
Query: 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK------LMKPDQTRTFTGIR 128
GI++LH A IIH D+KP NI++ KI DFGLA+ +M P
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV------- 187
Query: 129 GTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
TR Y A E + D++S G ++ E++
Sbjct: 188 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 19/47 (40%), Positives = 31/47 (65%), Gaps = 4/47 (8%)
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPD 119
RG++Y+H A ++H D+KP N+ ++ E KI DFGLA+++ P
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH 168
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 14/136 (10%)
Query: 31 SFDVSNKIL-VYDYMSNGSLVDVLFTPEKQPNWVERMG--IARDIARGIRYLHDECEAQI 87
F +++ V +Y++ G D++F ++ + E A ++ + +LH +
Sbjct: 64 CFQTKDRLFFVMEYVNGG---DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHGV 117
Query: 88 IHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQTRTFTGIRGTRAYVAAEWHRNLPIT 145
I+ D+K NIL+D + K++DFG+ K ++ T TF GT Y+A E + L
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC---GTPDYIAPEILQELEYG 174
Query: 146 VKADVYSFGVVLLEIV 161
D ++ GV++ E++
Sbjct: 175 PSVDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 19/45 (42%), Positives = 26/45 (57%), Gaps = 7/45 (15%)
Query: 75 GIRYLHDECEAQIIHGDIKPQNILM----DEKRCAKISDFGLAKL 115
G+ YLH ++H D+KP NIL+ E+ KI D GLA+L
Sbjct: 120 GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-06
Identities = 40/125 (32%), Positives = 58/125 (46%), Gaps = 12/125 (9%)
Query: 42 DYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDE 101
+YM GS+ D L V R R I +G+ YLH I+H DIK NIL D
Sbjct: 86 EYMPGGSIKDQLKAYGALTENVTRR-YTRQILQGVSYLHSN---MIVHRDIKGANILRDS 141
Query: 102 KRCAKISDFGLAKLMKPDQTRTFTG-----IRGTRAYVAAEWHRNLPITVKADVYSFGVV 156
K+ DFG +K + QT +G + GT +++ E KADV+S
Sbjct: 142 AGNVKLGDFGASKRI---QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACT 198
Query: 157 LLEIV 161
++E++
Sbjct: 199 VVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 28/90 (31%), Positives = 50/90 (55%), Gaps = 10/90 (11%)
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAY 133
RG+ Y H +++H D+KPQN+L++E+ K++DFGLA+ K T+T++
Sbjct: 115 RGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSN------E 164
Query: 134 VAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
V W+R I + + YS + + + C+
Sbjct: 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCI 194
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 31/88 (35%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL-MKP-DQTRTFTGIRGTRA 132
G++YLH+ +I++ D+K N+L+D + KI+DFGL K M D+T TF GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC---GTPE 166
Query: 133 YVAAEWHRNLPITVKADVYSFGVVLLEI 160
++A E T D + GV++ E+
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-06
Identities = 30/123 (24%), Positives = 63/123 (51%), Gaps = 6/123 (4%)
Query: 39 LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNIL 98
++ +++ G+L D++ + + N + + + + + YLH + +IH DIK +IL
Sbjct: 95 VLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSIL 149
Query: 99 MDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158
+ K+SDFG + D + + GT ++A E P + D++S G++++
Sbjct: 150 LTLDGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVI 208
Query: 159 EIV 161
E+V
Sbjct: 209 EMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 20/101 (19%)
Query: 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK-PDQTRTFTGIRGTRAY 133
G+ + H +++H D+KPQN+L++ + K++DFGLA+ P RT+T
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYT------HE 160
Query: 134 VAAEWHRNLPI-------TVKADVYSFGVVLLEIVCLRRCL 167
V W+R I + D++S G + E+V RR L
Sbjct: 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-06
Identities = 37/168 (22%), Positives = 78/168 (46%), Gaps = 9/168 (5%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQ 59
M A+ ++ E++ + + +H N ++ L SF N++ +V + G L ++ +KQ
Sbjct: 41 MDAKARQDCVKEIDLLKQLNHPNVIKYLD-SFIEDNELNIVLELADAGDLSQMIKYFKKQ 99
Query: 60 PNWVERMGIAR---DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116
+ + + + + ++H +++H DIKP N+ + K+ D GL +
Sbjct: 100 KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
T + + GT Y++ E K+D++S G +L E+ L+
Sbjct: 157 SSKTTAAHS-LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 4e-06
Identities = 29/85 (34%), Positives = 41/85 (48%), Gaps = 13/85 (15%)
Query: 30 YSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIH 89
Y D K +V +Y+ L DVL E P V ++G +A+ LH A I+H
Sbjct: 404 YDVDPEEKTIVMEYIGGKDLKDVL---EGNPELVRKVG--EIVAK----LHK---AGIVH 451
Query: 90 GDIKPQNILMDEKRCAKISDFGLAK 114
GD+ N ++ + R I DFGL K
Sbjct: 452 GDLTTSNFIVRDDRLYLI-DFGLGK 475
|
Length = 535 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 20/52 (38%), Positives = 35/52 (67%), Gaps = 4/52 (7%)
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
RG+ Y H +++H D+KPQN+L+ E+ K++DFGLA+ K ++T++
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYS 161
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 36/103 (34%), Positives = 49/103 (47%), Gaps = 15/103 (14%)
Query: 28 LGYSF-DVSNKILVYDYMSNGSLVDVL-----FTPEKQPNWVERMGIARDIARGIRYLHD 81
L YSF D + L+ +Y+ G ++ +L FT E R IA I I +H
Sbjct: 66 LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-----ETRFYIAETIL-AIDSIH- 118
Query: 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF 124
+ IH DIKP N+L+D K K+SDFGL +K F
Sbjct: 119 --KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-06
Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 6/99 (6%)
Query: 64 ERMG-IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
ERM + + GI++LH A IIH D+KP NI++ KI DFGLA+ +
Sbjct: 123 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM 179
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
T + TR Y A E + D++S G ++ E+V
Sbjct: 180 TPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-06
Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 11/141 (7%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDECEA 85
L Y+F N + LV DY G L+ +L E + P + R IA ++ I +H +
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA-EMVLAIHSIH---QL 121
Query: 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPIT 145
+H DIKP N+L+D +++DFG M D T + GT Y++ E + +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 146 V-----KADVYSFGVVLLEIV 161
+ + D +S GV + E++
Sbjct: 182 MGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 8e-06
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 16/93 (17%)
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAY 133
G++Y+H A IIH D+KP N+ ++E KI DFGLA+ + TG TR Y
Sbjct: 128 CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWY 180
Query: 134 VAAE----W-HRNLPITVKADVYSFGVVLLEIV 161
A E W H N + D++S G ++ E++
Sbjct: 181 RAPEVILNWMHYNQTV----DIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-06
Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 11/144 (7%)
Query: 25 VRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQ-PNWVERMGIARDIARGIRYLHDE 82
+ L Y+F D +N LV DY G L+ +L E + P + R +A ++ I +H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVIAIDSVH-- 119
Query: 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL 142
+ +H DIKP NILMD +++DFG + D T + GT Y++ E + +
Sbjct: 120 -QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 143 P-----ITVKADVYSFGVVLLEIV 161
+ D +S GV + E++
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 9e-06
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 21/96 (21%)
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI--RGTR 131
+G+ + H ++H D+KPQN+L+++ K++DFGLA R F GI R
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA--------RAF-GIPVRCYS 157
Query: 132 AYVAAEWHRNLPITVKA-------DVYSFGVVLLEI 160
A V W+R + A D++S G + E+
Sbjct: 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 9e-06
Identities = 44/156 (28%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 20 HHRNPVRLLGYSFDVSNKILV-YDYMSNGSLVDVLFTPEKQPNWVER---------MGIA 69
H+N + +L + V Y YM+ G+L L + M I
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI- 124
Query: 70 RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRG 129
IA G+ YLH +IH DI +N ++DE+ KI+D L++ + P G
Sbjct: 125 -QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL-GDNE 179
Query: 130 TRA--YVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
R ++A E N + +DV+SFGV+L E++ L
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL 215
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 40/175 (22%), Positives = 69/175 (39%), Gaps = 47/175 (26%)
Query: 12 EMNAIGR-THHRNPVRLLGYSFDVSNKIL----------VYDYMSNGSLVDVLFTPEKQP 60
E+ A+ R + H N +RL+ FD L +Y+ + K+P
Sbjct: 47 EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKG----------RKRP 96
Query: 61 ---NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
V+ + + + ++H I H DIKP+NIL+ K++DFG + +
Sbjct: 97 LPEKRVKSY--MYQLLKSLDHMH---RNGIFHRDIKPENILIK-DDILKLADFGSCRGI- 149
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLP--------ITVKADVYSFGVVLLEIVCLR 164
+T Y++ W+R P K D+++ G V EI+ L
Sbjct: 150 -YSKPPYT------EYISTRWYRA-PECLLTDGYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 39/137 (28%), Positives = 66/137 (48%), Gaps = 7/137 (5%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86
L Y+F K+ L+ DY++ G L L E+ ++ +I + +LH +
Sbjct: 70 LHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-EIVLALEHLH---KLG 125
Query: 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR--NLPI 144
II+ DIK +NIL+D ++DFGL+K D+ GT Y+A + R +
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH 185
Query: 145 TVKADVYSFGVVLLEIV 161
D +S GV++ E++
Sbjct: 186 DKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 4/93 (4%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT-G 126
+AR + I Y+H E IIH DIK +N+L++ + DFG A + + F G
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
I GT A E P T D++S G+V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 12/97 (12%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+ARG+ +L + +H D+ +N+L+ + + KI DFGLA+ + D G
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG----S 298
Query: 132 AYVAAEWHRNLPI-----TVKADVYSFGVVLLEIVCL 163
++ +W I T +DV+S+G++L EI L
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSL 335
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 19/96 (19%)
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK-PDQTRTFTGIRGTRA 132
RG+ Y+H + I+H D+KPQN+L+ K++DFGLA+ P QT + +
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS--------S 162
Query: 133 YVAAEWHRNLPITVKA-------DVYSFGVVLLEIV 161
V W+R + + A D++ G + +E++
Sbjct: 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 17/99 (17%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
+ R RG+ +LH C I+H D+KP+NIL+ K++DFGLA++ T
Sbjct: 113 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT---- 165
Query: 128 RGTRAYVAAEWHRNLPITVKA------DVYSFGVVLLEI 160
V W+R + +++ D++S G + E+
Sbjct: 166 ----PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 18/169 (10%)
Query: 6 EREFKTEMNAI-GRTHHRNPVRLLG--YSFDVSNK---ILVYDYMSNGSLVDVLFTPEKQ 59
+ E + E N + + H N V+ G Y DV N LV + + GS+ D++ K+
Sbjct: 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR 117
Query: 60 PNWVERMGIA---RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116
+E IA + G+++LH + IH D+K NIL+ + K+ DFG++ +
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174
Query: 117 KPDQTRTFTGIRGTRAY-----VAAEWHRNLPITVKADVYSFGVVLLEI 160
+ R T + GT + +A E + + DV+S G+ +E+
Sbjct: 175 TSTRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 19/141 (13%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVER--MGIARDIARGIRYLHDECE 84
+ Y+F +K+ + D M+ G D+ + + + E+ A +I G+ ++H+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGG---DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF- 117
Query: 85 AQIIHGDIKPQNILMDEKRCAKISDFGLA---KLMKPDQTRTFTGIRGTRAYVAAE-WHR 140
+++ D+KP NIL+DE +ISD GLA KP + GT Y+A E +
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS------VGTHGYMAPEVLQK 169
Query: 141 NLPITVKADVYSFGVVLLEIV 161
AD +S G +L +++
Sbjct: 170 GTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 33/117 (28%), Positives = 52/117 (44%), Gaps = 16/117 (13%)
Query: 28 LGYSF-DVSNKILVYDYMSNGSLVDVL------FTPEKQPNWVERMGIARDIARGIRYLH 80
L Y+F D +N LV DY G L+ +L + ++ M +A D + Y
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY-- 123
Query: 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAE 137
+H DIKP N+L+D+ +++DFG + D T GT Y++ E
Sbjct: 124 -------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 13/97 (13%)
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA---KLMKPDQTRTFT 125
A +I G+ ++H+ +++ D+KP NIL+DE +ISD GLA KP +
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 126 GIRGTRAYVAAE-WHRNLPITVKADVYSFGVVLLEIV 161
GT Y+A E + + AD +S G +L +++
Sbjct: 156 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 6/104 (5%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGI 68
K E + + + VRL YSF D N V DY+ G ++ +L P + R I
Sbjct: 49 KAERDILAEADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYI 107
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL 112
A ++ + +H + IH DIKP NIL+D K++DFGL
Sbjct: 108 A-ELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 9/85 (10%)
Query: 30 YSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIH 89
Y D N I+V +Y+ L D++ N +E + ++R+I R + LH A IIH
Sbjct: 67 YFVDPENFIIVMEYIEGEPLKDLI-----NSNGMEELELSREIGRLVGKLH---SAGIIH 118
Query: 90 GDIKPQNILMDEKRCAKISDFGLAK 114
GD+ N+++ + I DFGLA+
Sbjct: 119 GDLTTSNMILSGGKIYLI-DFGLAE 142
|
Length = 211 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 12/85 (14%)
Query: 30 YSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIH 89
Y D NK +V +Y+ L DV+ E + +G R + + LH +A I+H
Sbjct: 65 YDVDPDNKTIVMEYIEGKPLKDVIE--EGNDELLREIG--RLVGK----LH---KAGIVH 113
Query: 90 GDIKPQNILMDEKRCAKISDFGLAK 114
GD+ NI++ + + I DFGL K
Sbjct: 114 GDLTTSNIIVRDDKLYLI-DFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 45/158 (28%), Positives = 67/158 (42%), Gaps = 12/158 (7%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
R TE + + T V+LL Y+F D L +Y+ G +L R
Sbjct: 46 RHVLTERDILTTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR 104
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+A + LH E IH D+KP+N L+D K++DFGL+K T+
Sbjct: 105 FYMAEMFE-AVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYA 155
Query: 126 -GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
+ G+ Y+A E R D +S G +L E +C
Sbjct: 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 31/87 (35%), Positives = 44/87 (50%), Gaps = 5/87 (5%)
Query: 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYV 134
GI++LH A IIH D+KP NI++ KI DFGLA+ + T TR Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 185
Query: 135 AAEWHRNLPITVKADVYSFGVVLLEIV 161
A E + D++S G ++ E+V
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 36/168 (21%), Positives = 76/168 (45%), Gaps = 9/168 (5%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQ 59
M A+ + E++ + + +H N ++ SF N++ +V + G L ++ +KQ
Sbjct: 41 MDAKARADCIKEIDLLKQLNHPNVIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQ 99
Query: 60 PNWVERMGIAR---DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116
+ + + + + ++H +++H DIKP N+ + K+ D GL +
Sbjct: 100 KRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
T + + GT Y++ E K+D++S G +L E+ L+
Sbjct: 157 SSKTTAAHS-LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-05
Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 27/173 (15%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSL--------VDVLFTPE 57
+ +F E H N ++ LG +V+ +LV ++ G L L TP+
Sbjct: 39 QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPD 98
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL-- 115
P ++RM A +IA G+ +LH + IH D+ +N L+ KI D+GL+
Sbjct: 99 --PTTLQRM--ACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151
Query: 116 -----MKPDQTRTFTGIRGTRAYVAAEWHRNLPI---TVKADVYSFGVVLLEI 160
+ PDQ + +R + E H NL + T +++V+S GV + E+
Sbjct: 152 KEDYYVTPDQ--LWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-05
Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 17/102 (16%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA----------KLMK 117
I +D+ + Y+H E I HGDIKP+NI++D I D+G+A + K
Sbjct: 131 IMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
+ RGT Y + H +T + D+ S G +L+
Sbjct: 188 EQKDLH----RGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 29/87 (33%), Positives = 45/87 (51%), Gaps = 5/87 (5%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86
L YSF + + L+ +++ G L+ +L + V R +A + I +H +
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVLAIEAVH---KLG 121
Query: 87 IIHGDIKPQNILMDEKRCAKISDFGLA 113
IH DIKP NIL+D K+SDFGL+
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-05
Identities = 26/93 (27%), Positives = 47/93 (50%), Gaps = 17/93 (18%)
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAY 133
RG+ +LH +++H D+KPQNIL+ K++DFGLA R ++ +
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA--------RIYSFQMALTSV 169
Query: 134 VAAEWHRNLPITVKA------DVYSFGVVLLEI 160
V W+R + +++ D++S G + E+
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-05
Identities = 36/130 (27%), Positives = 64/130 (49%), Gaps = 15/130 (11%)
Query: 39 LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNIL 98
+V +YM G LV+++ + W + ++ + +H +IH D+KP N+L
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFY--TAEVVLALDAIH---SMGLIHRDVKPDNML 174
Query: 99 MDEKRCAKISDFGLAKLMKPDQT---RTFTGIRGTRAYVAAEWHRNLP----ITVKADVY 151
+D+ K++DFG MK D+T R T + GT Y++ E ++ + D +
Sbjct: 175 LDKHGHLKLADFGTC--MKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 152 SFGVVLLEIV 161
S GV L E++
Sbjct: 232 SVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-05
Identities = 26/91 (28%), Positives = 48/91 (52%), Gaps = 9/91 (9%)
Query: 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAY- 133
G+++LH+ +IIH D+K NIL+ + K+ DFG++ + + R T + GT +
Sbjct: 140 GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 195
Query: 134 ----VAAEWHRNLPITVKADVYSFGVVLLEI 160
+A E + + DV+S G+ +E+
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 9e-05
Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 11/128 (8%)
Query: 39 LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNIL 98
+V +YM G LV+++ + W R A ++ + +H IH D+KP N+L
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEKWA-RFYTA-EVVLALDAIH---SMGFIHRDVKPDNML 174
Query: 99 MDEKRCAKISDFGLAKLMKPD-QTRTFTGIRGTRAYVAAEWHRNLPITV----KADVYSF 153
+D+ K++DFG M + R T + GT Y++ E ++ + D +S
Sbjct: 175 LDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 154 GVVLLEIV 161
GV L E++
Sbjct: 234 GVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-05
Identities = 43/176 (24%), Positives = 71/176 (40%), Gaps = 33/176 (18%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVD--VLFTPEKQ------ 59
EFK E R H N V LLG +++ Y S+ L + V+ +P
Sbjct: 54 EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113
Query: 60 ----------PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISD 109
++V I IA G+ +L ++H D+ +N+L+ +K KISD
Sbjct: 114 DKTVKSTLEPADFVH---IVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISD 167
Query: 110 FGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPIT-----VKADVYSFGVVLLEI 160
GL + + G + + W I + +D++S+GVVL E+
Sbjct: 168 LGLFREVYAADYYKLMG----NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 27/103 (26%), Positives = 44/103 (42%), Gaps = 10/103 (9%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK----LMKPDQTRT 123
I I G+ LH + +H D+ P NI ++ K KI+DFGLA+ D
Sbjct: 124 ILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 124 FTGIRGTRAY---VAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
++ V W+R + + A+ Y F V + + C+
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCI 223
|
Length = 335 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 5/96 (5%)
Query: 30 YSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQII 88
YSF D N L+ +++ G ++ +L + + IA + I +H + I
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL-AIDSIH---QLGFI 123
Query: 89 HGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF 124
H DIKP N+L+D K K+SDFGL +K F
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 24/92 (26%), Positives = 45/92 (48%), Gaps = 13/92 (14%)
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPDQTRTFT-GIRGTR 131
+G+ + H ++H D+KPQN+L+D +K KI+D GL R F+ ++
Sbjct: 121 KGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG--------RAFSIPVKSYT 169
Query: 132 AYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163
+ W+R + + + YS V + + C+
Sbjct: 170 HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCI 201
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 16/110 (14%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDV----SNKILVYDYMSNG--SLVDVLFTPEK-QPNWVE 64
E++ + H N VRL DV + +LV++YM +D PN V+
Sbjct: 48 EISLMKELKHENIVRL----HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVK 103
Query: 65 RMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114
+ +GI + H E +++H D+KPQN+L++++ K++DFGLA+
Sbjct: 104 --SFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 5/96 (5%)
Query: 30 YSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQII 88
YSF D N L+ +++ G ++ +L + + IA + I +H + I
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-AIDAIH---QLGFI 123
Query: 89 HGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF 124
H DIKP N+L+D K K+SDFGL +K F
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 26/97 (26%), Positives = 51/97 (52%), Gaps = 17/97 (17%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+ RG+ Y+H + I+H D+KPQN+L+ + K++DFGLA+ K + T++
Sbjct: 112 LLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSN----- 162
Query: 132 AYVAAEWHRNLPITVKA-------DVYSFGVVLLEIV 161
V W+R + + + D++ G + +E++
Sbjct: 163 -EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 81 DECEAQ-IIHGDIKPQNILMDEKRCAKISDFGLAKL----MKPDQTRTFTGIRGTRAYVA 135
DE ++ ++H D+K NI + K+ DFG +K + D +F G T Y+A
Sbjct: 183 DEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG---TPYYLA 239
Query: 136 AE-WHRNLPITVKADVYSFGVVLLEIVCLRR 165
E W R + KAD++S GV+L E++ L R
Sbjct: 240 PELWERK-RYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 40/138 (28%), Positives = 66/138 (47%), Gaps = 24/138 (17%)
Query: 35 SNKILVYDYMSNGSLVDVLFTPEKQPNWVE-RMGIARDIARGIRYLHDECEAQIIHGDIK 93
S I+V +++ +G L DV EK V ++ +A+ +A + YL D+ ++HG++
Sbjct: 89 SENIMVEEFVEHGPL-DVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVC 144
Query: 94 PQNILMDEKRCAKISDFGLAKLMKP-----DQTRTFTGI-RGTRA----YVAAEWHRNL- 142
+NIL+ GLA+ P D +FT + R R ++A E
Sbjct: 145 AKNILLARL--------GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGN 196
Query: 143 PITVKADVYSFGVVLLEI 160
++ AD +SFG LLEI
Sbjct: 197 SLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 36/128 (28%), Positives = 62/128 (48%), Gaps = 11/128 (8%)
Query: 39 LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNIL 98
+V +YM G LV+++ + W R A ++ + +H IH D+KP N+L
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWA-RFYTA-EVVLALDAIH---SMGFIHRDVKPDNML 174
Query: 99 MDEKRCAKISDFGLA-KLMKPDQTRTFTGIRGTRAYVAAEWHRNLP----ITVKADVYSF 153
+D+ K++DFG K+ K R T + GT Y++ E ++ + D +S
Sbjct: 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 154 GVVLLEIV 161
GV L E++
Sbjct: 234 GVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 3e-04
Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 12/85 (14%)
Query: 30 YSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIH 89
Y D N ++V +Y+ L D L P+ + +G R + + LH +A I+H
Sbjct: 67 YDVDPDNGLIVMEYIEGELLKDALEEAR--PDLLREVG--RLVGK----LH---KAGIVH 115
Query: 90 GDIKPQNILMDEKRCAKISDFGLAK 114
GD+ NI++ R I DFGL +
Sbjct: 116 GDLTTSNIILSGGRIYFI-DFGLGE 139
|
Length = 204 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 41/140 (29%), Positives = 56/140 (40%), Gaps = 34/140 (24%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDE-KRCAKISDFGLAK------------ 114
I R I + LH I+H D+KPQNI+ E KI D G A
Sbjct: 260 IMRQILFALDGLHS---TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKE 316
Query: 115 -LMKPDQTRTFTGIRGTR------AYVAAE-----WHRNLPITVKADVYSFGVVLLEIV- 161
L+ P I T+ A VA W NLP + D+YS G++ L++
Sbjct: 317 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD--RFDIYSAGLIFLQMAF 374
Query: 162 -CLRRCLDQNLLEDRAILQE 180
LR D NL++ L+
Sbjct: 375 PNLRS--DSNLIQFNRQLKR 392
|
Length = 566 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 8e-04
Identities = 23/89 (25%), Positives = 45/89 (50%), Gaps = 3/89 (3%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
++ + YL + + +H DI +N+L+ C K+ DFGL++ ++ + + +
Sbjct: 116 LSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPI 172
Query: 132 AYVAAEWHRNLPITVKADVYSFGVVLLEI 160
++A E T +DV+ FGV + EI
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 8e-04
Identities = 36/150 (24%), Positives = 65/150 (43%), Gaps = 14/150 (9%)
Query: 21 HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT----PEKQPNWVERMGIARDIARGI 76
H N V G + ++ GSL D+ E Q +V +R+ +G+
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYV-----SRETLQGL 119
Query: 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD--QTRTFTGIRGTRAYV 134
YLH + + +H DIK NIL+ + K++DFG++ + + ++F G A
Sbjct: 120 YYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE 176
Query: 135 AAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
A R D+++ G+ +E+ L+
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQ 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 9e-04
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 14/161 (8%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT----PEKQPNWVER 65
+ E+ + H N V G + +Y GSL D+ E Q +V
Sbjct: 54 QQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYV-- 111
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD--QTRT 123
R+ +G+ YLH + + +H DIK NIL+ + K++DFG+A + + ++
Sbjct: 112 ---CRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS 165
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
F G A A +N D+++ G+ +E+ L+
Sbjct: 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQ 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 37/146 (25%), Positives = 65/146 (44%), Gaps = 7/146 (4%)
Query: 21 HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80
H++ V G I+V +Y+ GSL L + N ++ +A+ +A + +L
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE 117
Query: 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG--IRGTR-AYVAAE 137
D+ + HG++ +N+L+ + K + KL P + T I R +V E
Sbjct: 118 DK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 138 WHRN-LPITVKADVYSFGVVLLEIVC 162
N +++ AD +SFG L EI
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 18/137 (13%)
Query: 39 LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNIL 98
+V +Y+ G +L P + RM A + + YLH+ I+H D+KP N+L
Sbjct: 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLHN---YGIVHRDLKPDNLL 133
Query: 99 MDEKRCAKISDFGLAK--LMK----------PDQTRTFTG--IRGTRAYVAAEWHRNLPI 144
+ K++DFGL+K LM TR F + GT Y+A E
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193
Query: 145 TVKADVYSFGVVLLEIV 161
D ++ G++L E +
Sbjct: 194 GKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 39/161 (24%), Positives = 75/161 (46%), Gaps = 14/161 (8%)
Query: 8 EFKTEMNAIGRTHHRNPV------RLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPN 61
+ + E+ A+GR +H N + R ++ ++ K YD+ + D F + +P
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQK---YDFDLYSFMYDEAFDWKDRPL 265
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA-KLMKPDQ 120
+ I + + + Y+HD+ ++IH DIK +NI ++ + DFG A K +
Sbjct: 266 LKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+ G GT A + E D++S G++LL+++
Sbjct: 323 AFDY-GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 7/92 (7%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEK-RCAKISDFGLAKLMKPDQTRTFTGIRGT 130
+ R + Y+H + I H D+KPQN+L+D K+ DFG AK + Q R+ + I +
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-RSVSYI-CS 233
Query: 131 RAYVAAEWHRNLP-ITVKADVYSFGVVLLEIV 161
R Y A E T D++S G ++ E++
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.003
Identities = 27/95 (28%), Positives = 43/95 (45%), Gaps = 12/95 (12%)
Query: 21 HRNPVRLLGY--SFDVSNKI-LVYDYMSNGSLVDVLFT--PEKQPNWVERMGIARDIARG 75
H N +L Y SF V +++ +V M+ GS D+L T PE P I +D+
Sbjct: 58 HPN---ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNA 113
Query: 76 IRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDF 110
+ Y+H + IH +K +IL+ +S
Sbjct: 114 LDYIHSK---GFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 20/47 (42%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA 113
G+ R + G+R LH I+H DIKP+N+L+ KI DFG A
Sbjct: 313 GVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.003
Identities = 21/96 (21%), Positives = 32/96 (33%), Gaps = 19/96 (19%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79
N +R L + +L D + L R + + R + L
Sbjct: 144 ERPNALRRLEWDILEPRALLRLDLVEPEDL---------------RAALLAALDRLLARL 188
Query: 80 H---DECEAQIIHGDIKPQNILMDEKRC-AKISDFG 111
QIIHGD+ P N+L D+ + DF
Sbjct: 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFD 224
|
Length = 331 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 0.003
Identities = 31/107 (28%), Positives = 49/107 (45%), Gaps = 12/107 (11%)
Query: 31 SFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIAR----DIARGIRYLHDECEA 85
SF + LV DY G L +L ++QP +AR ++ + YLH
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSEEVARFYAAEVLLALEYLH--LLG 123
Query: 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP-DQTRTFTGIRGTR 131
I++ D+KP+NIL+ E +SDF L+K + +G+R
Sbjct: 124 -IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 16/40 (40%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114
G+ Y+H +I+H D+K NIL+ + K++DFGLA+
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 252 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.66 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.64 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.63 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.55 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.53 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.53 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.49 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.05 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.02 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.98 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.98 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.96 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.86 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.76 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.33 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.31 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.09 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.08 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.97 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.95 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.84 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.74 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.42 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.35 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.29 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.1 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.93 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.92 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.78 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.49 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.18 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.11 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.94 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.9 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.7 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.19 | |
| PLN02236 | 344 | choline kinase | 95.12 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 93.82 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.24 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 93.17 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.13 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.87 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 92.87 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 92.76 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.55 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 92.48 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.42 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.2 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.18 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 92.06 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 91.66 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 91.64 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 91.03 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 90.55 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 89.73 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 89.18 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 88.05 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 87.6 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 87.2 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=305.83 Aligned_cols=215 Identities=26% Similarity=0.366 Sum_probs=179.7
Q ss_pred chHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCc-EEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSN-KILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 2 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
.+.-++++.+|+++++.++|||||+++|.|+.++. .+++||||++|||.+.+... +.+++...-+++.+|++||.|||
T Consensus 117 ~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh 195 (364)
T KOG0581|consen 117 DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLH 195 (364)
T ss_pred CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh
Confidence 45678999999999999999999999999999885 99999999999999999654 56999999999999999999999
Q ss_pred h-cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 81 D-ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 81 ~-~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
+ + +|+||||||+|+|++.+|.+||+|||.+...... ......||..|||||.+.+..|+.++||||||++++|
T Consensus 196 ~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE 269 (364)
T KOG0581|consen 196 EER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLE 269 (364)
T ss_pred hcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHH
Confidence 6 7 9999999999999999999999999999876544 4455779999999999999999999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcH-HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQ-KQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+++|+.||....... ....+.......+... .+ +. .....+..+|..||++||.+|||+.|+++
T Consensus 270 ~a~GrfP~~~~~~~~-~~~~~Ll~~Iv~~ppP-~l------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 270 LAIGRFPYPPPNPPY-LDIFELLCAIVDEPPP-RL------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HhhCCCCCCCcCCCC-CCHHHHHHHHhcCCCC-CC------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999998752211 1222223223332222 21 22 35556778888999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=294.90 Aligned_cols=223 Identities=20% Similarity=0.332 Sum_probs=186.2
Q ss_pred CchHhHHHHHHHHHHHhCCCCCCCcceee-eEecCCc-EEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHH
Q 038713 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLG-YSFDVSN-KILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARG 75 (252)
Q Consensus 1 ~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~-~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~ 75 (252)
|+...+++...|+.+|++|+|||||++++ .+.+++. +++|||||++|||.+.++. ..+.+++.++|+++.|++.|
T Consensus 57 md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~A 136 (375)
T KOG0591|consen 57 MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRA 136 (375)
T ss_pred ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHH
Confidence 67788999999999999999999999999 4555555 8999999999999999843 56779999999999999999
Q ss_pred HHHHhhcCC-CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHH
Q 038713 76 IRYLHDECE-AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFG 154 (252)
Q Consensus 76 l~~lh~~~~-~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 154 (252)
|..+|..+. ..+.||||||.|||++.+|.+|++|||+++......... ...+||+.||+||.+.+.+|+.++||||+|
T Consensus 137 L~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslG 215 (375)
T KOG0591|consen 137 LYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLG 215 (375)
T ss_pred HHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHH
Confidence 999999432 349999999999999999999999999999876554433 457899999999999999999999999999
Q ss_pred HHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 155 VVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 155 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
|++|||.+.+.||.+...-. ..+.+.+|....+. +...+.++..+|..|+..||+.||+.-.++..++
T Consensus 216 CllyEMcaL~~PF~g~n~~~-------L~~KI~qgd~~~~p-----~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 216 CLLYEMCALQSPFYGDNLLS-------LCKKIEQGDYPPLP-----DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHHHHHHhcCCCcccccHHH-------HHHHHHcCCCCCCc-----HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 99999999999998872222 33445555544332 2445566888899999999999999777666666
Q ss_pred cC
Q 038713 235 GT 236 (252)
Q Consensus 235 ~~ 236 (252)
+.
T Consensus 284 ~~ 285 (375)
T KOG0591|consen 284 SE 285 (375)
T ss_pred HH
Confidence 53
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=306.00 Aligned_cols=217 Identities=32% Similarity=0.467 Sum_probs=183.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCC-cEEEEEecCCCCCHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVS-NKILVYDYMSNGSLVDVLFT-PEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+++|.+|+.+|++++|||||+++|++.+.. .+++||||+++|+|.+++.. ..+.+++..+++|+.||+.|+.|||++
T Consensus 83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~- 161 (362)
T KOG0192|consen 83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE- 161 (362)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-
Confidence 679999999999999999999999999887 89999999999999999987 477899999999999999999999999
Q ss_pred CCC-eeeeccCCCCEEecCCC-ceEEcccCcccccCCCCCcccccccCCcccccccccc--CCCCCCcccchhHHHHHHH
Q 038713 84 EAQ-IIHGDIKPQNILMDEKR-CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR--NLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 84 ~~~-i~h~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~slG~~l~~ 159 (252)
+ |+|||+|+.|+|++.++ ++||+|||+++...... .......||..|||||++. +..++.|+||||||+++||
T Consensus 162 --~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWE 238 (362)
T KOG0192|consen 162 --GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWE 238 (362)
T ss_pred --CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHH
Confidence 8 99999999999999997 99999999998765432 2223367899999999999 5589999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
|+||+.||.......- +......+....+ +..+...+..++.+||+.||..||++.+++..|+.+..
T Consensus 239 l~t~~~Pf~~~~~~~~------~~~v~~~~~Rp~~------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 239 LLTGEIPFEDLAPVQV------ASAVVVGGLRPPI------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred HHHCCCCCCCCCHHHH------HHHHHhcCCCCCC------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 9999999987755221 1112222222221 22255668888889999999999999999999997544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=302.75 Aligned_cols=233 Identities=41% Similarity=0.693 Sum_probs=204.2
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCC-cEEEEEecCCCCCHHhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVS-NKILVYDYMSNGSLVDVLFTPEK-QPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.++|.+|+.++.+++|||+|+++|||.+.+ ..++|+||+++|+|.+++..... .++|..+++|+.++|+||+|||..|
T Consensus 115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~ 194 (361)
T KOG1187|consen 115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC 194 (361)
T ss_pred hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC
Confidence 456999999999999999999999999988 59999999999999999987666 8999999999999999999999998
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccc-cCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI-RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
...|+|||||++|||++.+...|++|||+++..... ....... .||.+|+|||+......+.++||||||+++.|++|
T Consensus 195 ~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElit 273 (361)
T KOG1187|consen 195 PPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELIT 273 (361)
T ss_pred CCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHh
Confidence 888999999999999999999999999999665431 1111112 78999999999998889999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccc----hhcH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDE----EVDQ-KQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
|+.+.+.........+.+|....+..+....++++. .++. .....+..++.+|++.+|++||+|.||+++|+...
T Consensus 274 gr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 274 GRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 999888766555566889998999998888888876 2232 67888999999999999999999999999997654
Q ss_pred CC
Q 038713 238 EI 239 (252)
Q Consensus 238 ~~ 239 (252)
..
T Consensus 354 ~~ 355 (361)
T KOG1187|consen 354 SL 355 (361)
T ss_pred cc
Confidence 44
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=307.14 Aligned_cols=210 Identities=24% Similarity=0.342 Sum_probs=181.2
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
+.+++...+|+++.++|+|||||+++++|++.+++|+|.|+|..++|..+++ ..+.+++.++..+..||+.||.|||+.
T Consensus 59 ~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~ 137 (592)
T KOG0575|consen 59 PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSL 137 (592)
T ss_pred cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 4578899999999999999999999999999999999999999999999996 777899999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+|+|||+|..|+|++++.++||+|||+|.....+.... ....||+.|.|||++.....+..+||||+||++|.|+.
T Consensus 138 ---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk-~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~ 213 (592)
T KOG0575|consen 138 ---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK-KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLV 213 (592)
T ss_pred ---CceecccchhheeecCcCcEEecccceeeeecCccccc-ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhh
Confidence 99999999999999999999999999999887554333 34679999999999999999999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|++||+.....+.... +..... ..|........+||.++|+.||.+|||+++|++
T Consensus 214 G~PPFetk~vkety~~-------Ik~~~Y-------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 214 GRPPFETKTVKETYNK-------IKLNEY-------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred CCCCcccchHHHHHHH-------HHhcCc-------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 9999997755542221 111111 112233444667778999999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=302.16 Aligned_cols=219 Identities=28% Similarity=0.370 Sum_probs=185.8
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT-PEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++|.+|+++|++|+|+|||+++++|.....+||||||+..|+|.++|.. .++.++....+.++.|||+|++||+++
T Consensus 245 ~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~-- 322 (468)
T KOG0197|consen 245 PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK-- 322 (468)
T ss_pred hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC--
Confidence 47899999999999999999999999998899999999999999999986 567799999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-C
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-L 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 163 (252)
+++|||+.++||||+++..+||+|||+++...++.-....+..-+..|.|||.+...+++.++||||||+++||++| |
T Consensus 323 -~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G 401 (468)
T KOG0197|consen 323 -NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYG 401 (468)
T ss_pred -CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccC
Confidence 99999999999999999999999999999655544444444455678999999999999999999999999999998 5
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCCC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIP 240 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 240 (252)
+.||......+ +-+.+..|..-. .|..++..+.++|..||+.+|++|||++.+...|++.....
T Consensus 402 ~~py~~msn~e-------v~~~le~GyRlp------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 402 RVPYPGMSNEE-------VLELLERGYRLP------RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCCCCCCHHH-------HHHHHhccCcCC------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 55655554433 234444544432 34456667999999999999999999999999998866543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=291.14 Aligned_cols=210 Identities=23% Similarity=0.333 Sum_probs=170.8
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
.+..+|+++|++|+|||||++.++++.....||||||++||+|.+.+- ..+.+.+.....++.|++.|+.|||++ |
T Consensus 221 ~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv-~nk~l~ed~~K~~f~Qll~avkYLH~~---G 296 (475)
T KOG0615|consen 221 RDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVV-ANKYLREDLGKLLFKQLLTAVKYLHSQ---G 296 (475)
T ss_pred hhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHH-hccccccchhHHHHHHHHHHHHHHHHc---C
Confidence 345799999999999999999999999999999999999999999995 444677778888999999999999999 9
Q ss_pred eeeeccCCCCEEecCC---CceEEcccCcccccCCCCCcccccccCCccccccccccCCCC---CCcccchhHHHHHHHH
Q 038713 87 IIHGDIKPQNILMDEK---RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI---TVKADVYSFGVVLLEI 160 (252)
Q Consensus 87 i~h~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Di~slG~~l~~l 160 (252)
|+||||||+|||++.+ ..+|+.|||+++..... .......||+.|.|||++.+... ..+.|+||+||++|-+
T Consensus 297 I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvc 374 (475)
T KOG0615|consen 297 IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVC 374 (475)
T ss_pred cccccCCcceEEeccCCcceEEEecccchhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEE
Confidence 9999999999999876 56899999999987532 23345679999999999987653 3477999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|.+||........ ..+.+..|...... ....+-.....++|.+||..||+.|||+.++++
T Consensus 375 LsG~pPFS~~~~~~s------l~eQI~~G~y~f~p---~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 375 LSGYPPFSEEYTDPS------LKEQILKGRYAFGP---LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred eccCCCcccccCCcc------HHHHHhcCcccccC---hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 999999976543321 22334444443322 234444555667777999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=280.07 Aligned_cols=168 Identities=27% Similarity=0.412 Sum_probs=151.9
Q ss_pred CchHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 1 ~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
+++..++.+..|+.+|+.++|||||+++++++.++.+|+|||||+||||.+|+... +.+++..+...+.||+.|+++||
T Consensus 48 l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~ 126 (429)
T KOG0595|consen 48 LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLH 126 (429)
T ss_pred cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 35678889999999999999999999999999999999999999999999999654 46899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCC------CceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEK------RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFG 154 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 154 (252)
++ +|+|||+||.|||++.+ ..+||+|||+++...+.. ......|++-|||||++....|+.|+|+||+|
T Consensus 127 ~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG 201 (429)
T KOG0595|consen 127 EN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIG 201 (429)
T ss_pred HC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHH
Confidence 99 99999999999999865 457999999999876433 34456799999999999999999999999999
Q ss_pred HHHHHHHhCCccccccchhh
Q 038713 155 VVLLEIVCLRRCLDQNLLED 174 (252)
Q Consensus 155 ~~l~~l~~g~~p~~~~~~~~ 174 (252)
+++|++++|+.||+.....+
T Consensus 202 ~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 202 TILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred HHHHHHHhCCCCccccCHHH
Confidence 99999999999999776554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=297.85 Aligned_cols=224 Identities=25% Similarity=0.387 Sum_probs=189.9
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-------------CCCCCHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-------------EKQPNWVERMGIA 69 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~ 69 (252)
.+.+++|.||++++..++|||||+++|+|.+++.+|+|+|||+.|||.++|... ...++..+.+.|+
T Consensus 530 ~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA 609 (774)
T KOG1026|consen 530 NQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIA 609 (774)
T ss_pred HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHH
Confidence 358999999999999999999999999999999999999999999999999331 1237888999999
Q ss_pred HHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCccccc-CCCCCcccccccCCccccccccccCCCCCCcc
Q 038713 70 RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM-KPDQTRTFTGIRGTRAYVAAEWHRNLPITVKA 148 (252)
Q Consensus 70 ~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~-~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 148 (252)
.|||.|+.||-++ .+||||+-.+|+||+++-.|||+|||+++.. ..+.-+..+...-..+|||||-+...+++.++
T Consensus 610 ~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteS 686 (774)
T KOG1026|consen 610 TQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTES 686 (774)
T ss_pred HHHHHHHHHHHhC---cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchh
Confidence 9999999999999 9999999999999999999999999999853 22221222233446799999999999999999
Q ss_pred cchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 149 DVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 149 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
||||+|+++||+++ |+.||.+...++ +.+++++|.. + ..+..++..+++||..||+.+|++|||++
T Consensus 687 DVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe~i~~g~l--L----~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~ 753 (774)
T KOG1026|consen 687 DVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIECIRAGQL--L----SCPENCPTEVYSLMLECWNENPKRRPSFK 753 (774)
T ss_pred hhhhhhhhhhhhhccccCcccccchHH-------HHHHHHcCCc--c----cCCCCCCHHHHHHHHHHhhcCcccCCCHH
Confidence 99999999999995 888988776664 4566677766 2 23555566699999999999999999999
Q ss_pred HHHHHhhcCcCCCCC
Q 038713 228 KVLLMLEGTVEIPIP 242 (252)
Q Consensus 228 ~i~~~l~~~~~~~~~ 242 (252)
||-..|+...+.+.+
T Consensus 754 eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 754 EIHSRLQAWAQASPK 768 (774)
T ss_pred HHHHHHHHHHhcCcc
Confidence 999999997665544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=276.21 Aligned_cols=216 Identities=25% Similarity=0.350 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCC--cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVS--NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.+.+.+|+.+|++++|||||+++|...... .++++|||+.+|+|.+++...++.+++..+.+...||++||.|||++
T Consensus 58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~- 136 (313)
T KOG0198|consen 58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK- 136 (313)
T ss_pred HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 567899999999999999999999755444 68899999999999999987665789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecC-CCceEEcccCcccccCC--CCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDE-KRCAKISDFGLAKLMKP--DQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLE 159 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~-~~~~~l~d~~~~~~~~~--~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~ 159 (252)
+++||||||.|||++. ++.+||+|||.+..... ..........||+.|||||++.. .....++|||||||++.|
T Consensus 137 --g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvE 214 (313)
T KOG0198|consen 137 --GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVE 214 (313)
T ss_pred --CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEe
Confidence 9999999999999999 79999999999886653 22233345779999999999995 333459999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
|+||..||....... +++.......... ..+...+....+++.+|+..+|++||||+++++----
T Consensus 215 M~Tg~~PW~~~~~~~-----~~~~~ig~~~~~P------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 215 MLTGKPPWSEFFEEA-----EALLLIGREDSLP------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ccCCCCcchhhcchH-----HHHHHHhccCCCC------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 999999998641111 1111222222111 2233344446667779999999999999999976544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=276.25 Aligned_cols=236 Identities=22% Similarity=0.300 Sum_probs=191.2
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecC--CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDV--SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.-..||+.+|++|.||||+++.+...+. +.+|+|||||+. ||..++....-.+++.++..++.|++.||.|||.+
T Consensus 161 ~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~-- 237 (560)
T KOG0600|consen 161 ITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR-- 237 (560)
T ss_pred HHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc--
Confidence 3456999999999999999999988875 799999999977 99999988887899999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|||||.+|||++++|.+||+|||+++++...........+.|.+|+|||++.|. .|+.+.|+||.||++.||++|
T Consensus 238 -gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~g 316 (560)
T KOG0600|consen 238 -GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLG 316 (560)
T ss_pred -CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcC
Confidence 999999999999999999999999999998887776667777889999999999987 699999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcc--ccc-----ccc--------hhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLS--QLV-----EDE--------EVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-----~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
++.|.+....++...+-.+........|. .+. .+. +.........++|+..+|..||.+|.|+.+
T Consensus 317 kPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~ 396 (560)
T KOG0600|consen 317 KPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS 396 (560)
T ss_pred CCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH
Confidence 99999887777666544333222222222 111 000 111122455778888999999999999999
Q ss_pred HHHHhhcC-cCCCCCCCCCCC
Q 038713 229 VLLMLEGT-VEIPIPQNPTSF 248 (252)
Q Consensus 229 i~~~l~~~-~~~~~~~~~~~~ 248 (252)
+++- +. ...|.|..|.++
T Consensus 397 aL~s--eyF~t~p~~~~p~~L 415 (560)
T KOG0600|consen 397 ALQS--EYFTTEPLPCDPSSL 415 (560)
T ss_pred HhcC--cccccCCCCCCcccC
Confidence 8752 22 355556666554
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=278.72 Aligned_cols=206 Identities=26% Similarity=0.409 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHhCCC-CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|+.++++++ ||||+++++++......++||||+.||+|.+++.+ .+.+.+.++..++.|+++|++|||+.
T Consensus 63 ~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~-- 139 (370)
T KOG0583|consen 63 DELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR-- 139 (370)
T ss_pred chhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC--
Confidence 445668999999998 99999999999999999999999999999999977 77889999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCC-CceEEcccCcccccCCCCCcccccccCCccccccccccCCC-CC-CcccchhHHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEK-RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP-IT-VKADVYSFGVVLLEIV 161 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~Di~slG~~l~~l~ 161 (252)
+|+||||||+|++++.+ +.+|++|||++.... ..........|++.|+|||++.+.. |+ .++||||+|+++|.|+
T Consensus 140 -gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml 217 (370)
T KOG0583|consen 140 -GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLL 217 (370)
T ss_pred -CEeeCCCCHHHEEecCCCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHH
Confidence 99999999999999999 999999999999774 2223444567899999999999977 76 7899999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHH-HHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQ-LQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
+|..||+...... . ...+..+...- +... ...+..++.+|+..||..|+|+.+|+
T Consensus 218 ~G~~PF~d~~~~~---l----~~ki~~~~~~~-------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 218 CGRLPFDDSNVPN---L----YRKIRKGEFKI-------PSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred hCCCCCCCccHHH---H----HHHHhcCCccC-------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 9999999732222 1 11123333222 1111 45577888899999999999999999
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=278.28 Aligned_cols=213 Identities=21% Similarity=0.340 Sum_probs=181.9
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCc-EEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSN-KILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
...++...+|+.++++++|||||.+.+.|.+++. ++|||+||+||++.+.+.+.+ ..++++.+++|+.|++.|+.|||
T Consensus 44 ~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH 123 (426)
T KOG0589|consen 44 EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH 123 (426)
T ss_pred chhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 3456688999999999999999999999999888 999999999999999997755 67899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+. +|+|||+|+.|||++.++.++++|||+++....... ......||+-|++||++.+..|..|+|||||||++|+|
T Consensus 124 ~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm 199 (426)
T KOG0589|consen 124 EN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEM 199 (426)
T ss_pred hh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHH
Confidence 98 999999999999999999999999999998876552 34557899999999999999999999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
++.+++|...+-.. .+.+... +... ..+......+..+|..|++.+|..||++.+++..
T Consensus 200 ~~lk~aF~a~~m~~------Li~ki~~-~~~~------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 200 CTLKPAFKASNMSE------LILKINR-GLYS------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HhcccccCccchHH------HHHHHhh-ccCC------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 99999998764442 1222222 2211 2244445557788889999999999999999865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=274.71 Aligned_cols=214 Identities=21% Similarity=0.308 Sum_probs=174.5
Q ss_pred HHHHHHHhCCC-CCCCcceeeeEecCC-cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 038713 10 KTEMNAIGRTH-HRNPVRLLGYSFDVS-NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQI 87 (252)
Q Consensus 10 ~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i 87 (252)
.||+..|++++ |||||++.+++.+.. .+++|||||+. +|.+.++..++.+++..+..|+.||++||+|+|++ |+
T Consensus 56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---Gf 131 (538)
T KOG0661|consen 56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GF 131 (538)
T ss_pred HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---Cc
Confidence 48999999998 999999999998877 99999999955 99999998899999999999999999999999999 99
Q ss_pred eeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHhCCcc
Q 038713 88 IHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCLRRC 166 (252)
Q Consensus 88 ~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p 166 (252)
.|||+||+|||+..+..+||+|||+++....... ....+.|.+|+|||++.. ..|+.+.|+|++||+++|+.+.++.
T Consensus 132 FHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPL 209 (538)
T KOG0661|consen 132 FHRDLKPENILISGNDVIKIADFGLAREVRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPL 209 (538)
T ss_pred ccccCChhheEecccceeEecccccccccccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhccc
Confidence 9999999999999999999999999997654332 233456889999998764 4699999999999999999999999
Q ss_pred ccccchhhhHHHHHHHHHHHhcCCccccccc-------------------chhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 167 LDQNLLEDRAILQEWICQCFENGNLSQLVED-------------------EEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
|.+...-++-.. +..++..-......+. ...-+....++.+++.+|+.+||++||||.
T Consensus 210 FPG~sE~Dqi~K---Ic~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~ 286 (538)
T KOG0661|consen 210 FPGASEIDQIYK---ICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTAS 286 (538)
T ss_pred CCCCcHHHHHHH---HHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHH
Confidence 987755544322 2222222111111110 012223567789999999999999999999
Q ss_pred HHHHH
Q 038713 228 KVLLM 232 (252)
Q Consensus 228 ~i~~~ 232 (252)
|.++.
T Consensus 287 ~al~~ 291 (538)
T KOG0661|consen 287 QALQH 291 (538)
T ss_pred HHhcC
Confidence 99874
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=264.23 Aligned_cols=217 Identities=24% Similarity=0.315 Sum_probs=175.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.....|.+|+.++++++||||+++++++...+..++||||+++|+|.+++......+++..++.++.|++.||+|||+.
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~- 126 (266)
T cd05064 48 KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM- 126 (266)
T ss_pred HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3456799999999999999999999999999999999999999999999976666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++|+||+|+||+++.++.++++|||.+...............++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 127 --~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~ 204 (266)
T cd05064 127 --GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSY 204 (266)
T ss_pred --CEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999876532222111112234568999999998889999999999999999775
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
|..||....... . . .....+.... .+...+..+.+++.+||+.+|++|||+++|.+.|++.
T Consensus 205 g~~p~~~~~~~~---~---~-~~~~~~~~~~------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 205 GERPYWDMSGQD---V---I-KAVEDGFRLP------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCcCcCCHHH---H---H-HHHHCCCCCC------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999997654332 1 1 1122222111 1222344578888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=281.35 Aligned_cols=224 Identities=28% Similarity=0.338 Sum_probs=187.2
Q ss_pred chHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 2 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
++++.+.|++|+++|++++|||||++||+......+++|||+|.||+|.++|.+..+.++..++..++.+.+.||+|||+
T Consensus 201 ~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~ 280 (474)
T KOG0194|consen 201 TKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS 280 (474)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH
Confidence 57889999999999999999999999999999999999999999999999998888789999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
. +++||||-++|+|++.++.+|++|||+++.......... ...-...|+|||.+....++.++||||||+++||++
T Consensus 281 k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~-~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 281 K---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKF-LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred C---CCcchhHhHHHheecCCCeEEeCccccccCCcceeeccc-cccCcceecChhhhccCccccccchhheeeeEEeee
Confidence 9 999999999999999999999999999886542222221 123467899999999989999999999999999999
Q ss_pred h-CCccccccchhhhHHHHHHHHHHH-hcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCC
Q 038713 162 C-LRRCLDQNLLEDRAILQEWICQCF-ENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 162 ~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~ 239 (252)
+ |..||.+....+ +...+ .++...... ...+..+..++.+||..+|++||||.++.+.|+.....
T Consensus 357 ~~g~~Py~g~~~~~-------v~~kI~~~~~r~~~~------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 357 ENGAEPYPGMKNYE-------VKAKIVKNGYRMPIP------SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred ccCCCCCCCCCHHH-------HHHHHHhcCccCCCC------CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 8 677887665442 22223 333333322 23344466666799999999999999999999997776
Q ss_pred CCC
Q 038713 240 PIP 242 (252)
Q Consensus 240 ~~~ 242 (252)
..+
T Consensus 424 ~~~ 426 (474)
T KOG0194|consen 424 KEA 426 (474)
T ss_pred ccc
Confidence 554
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=280.92 Aligned_cols=211 Identities=26% Similarity=0.363 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
-..+.+|+.+|+.+.|||++++|++++++..+|+|.||++||.|.+++-.+ +.+++.++.+.+.||+.|+.|+|..
T Consensus 56 ~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~--- 131 (786)
T KOG0588|consen 56 PAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAF--- 131 (786)
T ss_pred ccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhh---
Confidence 455789999999999999999999999999999999999999999999644 4688889999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCC-CcccchhHHHHHHHHHhCC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPIT-VKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~ 164 (252)
+|+|||+||+|+|++..+.+||+|||.+..-.+.. ......|.++|.+||++.|..|+ .++||||.|+++|.+++|+
T Consensus 132 ~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~ 209 (786)
T KOG0588|consen 132 NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGK 209 (786)
T ss_pred cceeccCCchhhhhhcccCEeeeccceeecccCCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCC
Confidence 99999999999999999889999999998754433 33445789999999999999875 7899999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEGT 236 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~~ 236 (252)
.||+....+. +...++.|.+.- +.....+..+|+.+|+..||..|.|++||+. .|.+.
T Consensus 210 LPFdDdNir~-------LLlKV~~G~f~M-------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 210 LPFDDDNIRV-------LLLKVQRGVFEM-------PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred CCCCCccHHH-------HHHHHHcCcccC-------CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 9998443222 222334454432 3333445778888999999999999999987 34443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=272.63 Aligned_cols=219 Identities=23% Similarity=0.373 Sum_probs=172.7
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecC-CcEEEEEecCCCCCHHhhhcCCC-------------------------
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDV-SNKILVYDYMSNGSLVDVLFTPE------------------------- 57 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~------------------------- 57 (252)
..+.+.+|+.+++++ +||||+++++++... +..+++|||+++|+|.+++....
T Consensus 53 ~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (338)
T cd05102 53 EHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132 (338)
T ss_pred HHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhc
Confidence 456799999999999 999999999988764 46889999999999999985421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecC
Q 038713 58 ------------------------------------KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDE 101 (252)
Q Consensus 58 ------------------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~ 101 (252)
..+++..+..++.||+.||.|||+. +++||||||+||+++.
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~ 209 (338)
T cd05102 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSE 209 (338)
T ss_pred cccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcC
Confidence 2367788899999999999999999 9999999999999999
Q ss_pred CCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-CCccccccchhhhHHHH
Q 038713 102 KRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQ 179 (252)
Q Consensus 102 ~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~ 179 (252)
++.++++|||.++........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||........ +
T Consensus 210 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~- 286 (338)
T cd05102 210 NNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--F- 286 (338)
T ss_pred CCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--H-
Confidence 999999999999765332221 1122335678999999988889999999999999999997 9999876533221 1
Q ss_pred HHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 180 EWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
......+..... +......+.+++.+||+.||++|||+.++++.|++++.
T Consensus 287 ---~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 287 ---CQRLKDGTRMRA------PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ---HHHHhcCCCCCC------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 112222222111 11223458889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=265.68 Aligned_cols=213 Identities=20% Similarity=0.258 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEec----CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFD----VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
.+.|.+|+.+|++++||||+++++++.+ ....++||||+++|+|.+++.+ .+.+++...+.++.|++.||.+||+
T Consensus 62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~ 140 (283)
T PHA02988 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYK 140 (283)
T ss_pred HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHh
Confidence 4678899999999999999999999876 4578999999999999999965 4468889999999999999999997
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC--CCCCCcccchhHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN--LPITVKADVYSFGVVLLE 159 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~ 159 (252)
. .+++|+||||+||+++.++.++++|||.+....... ....++..|+|||++.+ ..++.++||||||+++|+
T Consensus 141 ~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~e 214 (283)
T PHA02988 141 Y--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWE 214 (283)
T ss_pred c--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHH
Confidence 3 178899999999999999999999999987643322 12346789999999876 578999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
|++|..||......+ + .......+.... .+......+.+++.+||+.||++|||+++++..|+...
T Consensus 215 l~~g~~Pf~~~~~~~---~---~~~i~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 215 IFTGKIPFENLTTKE---I---YDLIINKNNSLK------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHCCCCCCCCCHHH---H---HHHHHhcCCCCC------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 999999998654332 1 111111111111 11123345788888999999999999999999998743
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=257.59 Aligned_cols=221 Identities=20% Similarity=0.259 Sum_probs=176.9
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+-.+||+++|+++.|+|+|.++++|.....+++|||||+. ++.+-+.......+.+.+..++.|++.|+.|+|++
T Consensus 45 kKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~--- 120 (396)
T KOG0593|consen 45 KKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN--- 120 (396)
T ss_pred HHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---
Confidence 56789999999999999999999999999999999999988 45555655555678888899999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHhCC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+|||++.+|.+|++|||+++.... ........+.|.+|+|||.+.| ..|....|||++||++.||++|.
T Consensus 121 n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~ 199 (396)
T KOG0593|consen 121 NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE 199 (396)
T ss_pred CeecccCChhheEEecCCcEEeccchhhHhhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC
Confidence 999999999999999999999999999998764 3345556678999999999998 57999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHH--------HHHhc-CCcccc-----cccc---hhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 165 RCLDQNLLEDRAILQEWIC--------QCFEN-GNLSQL-----VEDE---EVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~--------~~~~~-~~~~~~-----~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
+.|.+..+.++...+.... +.... ..+.-+ .... ..-+....-+++++..||+.||++|+|-+
T Consensus 200 pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ 279 (396)
T KOG0593|consen 200 PLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCE 279 (396)
T ss_pred cCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHH
Confidence 9999887777655433211 11111 111111 1111 11222234688889999999999999999
Q ss_pred HHHH
Q 038713 228 KVLL 231 (252)
Q Consensus 228 ~i~~ 231 (252)
|++.
T Consensus 280 qll~ 283 (396)
T KOG0593|consen 280 QLLH 283 (396)
T ss_pred HHhc
Confidence 9863
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=264.43 Aligned_cols=218 Identities=24% Similarity=0.334 Sum_probs=175.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|+..|+.++||||++++..|..+..+|+||.||.+||+.+.++.. ...+++..+..++.++++||.|||.+
T Consensus 67 ~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~- 145 (516)
T KOG0582|consen 67 DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN- 145 (516)
T ss_pred hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc-
Confidence 3578899999999999999999999999999999999999999999999652 23488999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc---ccccccCCcccccccccc--CCCCCCcccchhHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR---TFTGIRGTRAYVAAEWHR--NLPITVKADVYSFGVVLL 158 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~slG~~l~ 158 (252)
|.+|||||+.|||++.+|.++|+|||.+..+.+.... .+....|+++|||||++. ..+|+.|+||||||++..
T Consensus 146 --G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ 223 (516)
T KOG0582|consen 146 --GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITAC 223 (516)
T ss_pred --CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHH
Confidence 9999999999999999999999999998766543321 113457999999999954 346999999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCccccc--ccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLV--EDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|+.+|..||.....-.- ....+++....... .+.+......+.+.+++..||.+||.+|||+.+++.
T Consensus 224 ELA~G~aPf~k~pPmkv------Ll~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 224 ELAHGHAPFSKYPPMKV------LLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHhcCCCCcccCChHHH------HHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 99999999986543321 11222222221111 111333444567889999999999999999999885
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=264.78 Aligned_cols=223 Identities=22% Similarity=0.308 Sum_probs=172.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC------------------CCCCHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE------------------KQPNWVER 65 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~ 65 (252)
..+++|.+|++++++++||||+++++++.+.+..++||||+++|+|.+++.... ..+++..+
T Consensus 61 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (304)
T cd05096 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSL 140 (304)
T ss_pred HHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHH
Confidence 456789999999999999999999999999999999999999999999984421 23677888
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCC
Q 038713 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPI 144 (252)
Q Consensus 66 ~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~ 144 (252)
+.++.||+.||.|||+. +++|+||||+||+++.++.++++|||.++........ ......++..|+|||++.+..+
T Consensus 141 ~~i~~~i~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 217 (304)
T cd05096 141 LHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF 217 (304)
T ss_pred HHHHHHHHHHHHHHHHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC
Confidence 99999999999999999 9999999999999999999999999998765332221 1122334678999999988889
Q ss_pred CCcccchhHHHHHHHHHh--CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCC
Q 038713 145 TVKADVYSFGVVLLEIVC--LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSL 222 (252)
Q Consensus 145 ~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 222 (252)
+.++|+||||+++|+|++ +..||....... ....+.............. .+...+..+.+++.+||+.+|++
T Consensus 218 ~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 218 TTASDVWAFGVTLWEILMLCKEQPYGELTDEQ---VIENAGEFFRDQGRQVYLF---RPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred CchhhhHHHHHHHHHHHHccCCCCCCcCCHHH---HHHHHHHHhhhcccccccc---CCCCCCHHHHHHHHHHccCCchh
Confidence 999999999999999986 556776543222 1111222222211111111 11223345888999999999999
Q ss_pred CCCHHHHHHHhhc
Q 038713 223 RRAMKKVLLMLEG 235 (252)
Q Consensus 223 Rps~~~i~~~l~~ 235 (252)
|||+.+|.+.|++
T Consensus 292 RPs~~~i~~~l~~ 304 (304)
T cd05096 292 RPSFSDIHAFLTE 304 (304)
T ss_pred CcCHHHHHHHHhC
Confidence 9999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=274.13 Aligned_cols=210 Identities=26% Similarity=0.364 Sum_probs=175.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++-+.+|+.+|+..+|+|||++++.|...+.+++||||++||+|.+.+.. ..+++.++..|+.++++||+|||.+
T Consensus 313 ~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~-- 388 (550)
T KOG0578|consen 313 KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHAR-- 388 (550)
T ss_pred chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhc--
Confidence 356678999999999999999999999999999999999999999999843 3488999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+|+|||||.+||+++.+|.+|++|||+...+...... .....||+-|||||+.....|..+.||||||+++.||+-|+
T Consensus 389 -gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGE 466 (550)
T KOG0578|consen 389 -GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGE 466 (550)
T ss_pred -ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCC
Confidence 9999999999999999999999999999987766553 34468999999999999999999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+||.....-.- +.....+|... +.. +......|.+++.+||..|+++|+|+.++|+
T Consensus 467 PPYlnE~PlrA------lyLIa~ng~P~-lk~----~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 467 PPYLNENPLRA------LYLIATNGTPK-LKN----PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccCCChHHH------HHHHhhcCCCC-cCC----ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 99986433221 11122333332 112 2333344777777999999999999999986
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=294.01 Aligned_cols=224 Identities=25% Similarity=0.398 Sum_probs=184.6
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC------CCCCCHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP------EKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l 76 (252)
.+...+|++|+.+|+.++|||||+++|++.+....++++|||+||||..+|.+. ...++..+++.++.|||+|.
T Consensus 736 ~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~ 815 (1025)
T KOG1095|consen 736 EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGM 815 (1025)
T ss_pred HHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhh
Confidence 467889999999999999999999999999999999999999999999999776 56799999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccC-CCCCcccccccCCccccccccccCCCCCCcccchhHHH
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK-PDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGV 155 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 155 (252)
.||+++ +++||||.++|+|++....+|++|||+++.+- .+.........-...|||||.+....++.|+||||||+
T Consensus 816 ~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGV 892 (1025)
T KOG1095|consen 816 NYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGV 892 (1025)
T ss_pred HHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHH
Confidence 999999 99999999999999999999999999999332 22212212123356899999999989999999999999
Q ss_pred HHHHHHhCC-ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 156 VLLEIVCLR-RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 156 ~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
++||++|.+ .||......+-. .-....|.+ +.+..++..+++||.+||+.+|++||++..|+..+.
T Consensus 893 llWEifslG~~PY~~~~n~~v~------~~~~~ggRL-------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~ 959 (1025)
T KOG1095|consen 893 LLWEIFSLGATPYPSRSNFEVL------LDVLEGGRL-------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDP 959 (1025)
T ss_pred HHHHHHhCCCCCCCCcchHHHH------HHHHhCCcc-------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence 999999855 566555444311 113444522 235566677899999999999999999999999887
Q ss_pred cCcCCCCC
Q 038713 235 GTVEIPIP 242 (252)
Q Consensus 235 ~~~~~~~~ 242 (252)
.++....|
T Consensus 960 ~i~~~~~~ 967 (1025)
T KOG1095|consen 960 AISNAALG 967 (1025)
T ss_pred hhhhhhcc
Confidence 75554433
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=257.74 Aligned_cols=213 Identities=21% Similarity=0.344 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.++|.+|++++++++||||+++++++......+++|||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--- 119 (256)
T cd05114 43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN--- 119 (256)
T ss_pred HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46799999999999999999999999999999999999999999999976556689999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-CC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-LR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~ 164 (252)
+++|+|++|+||+++.++.++++|||.++..............++..|+|||.+.+..++.++|+||||+++|++++ |+
T Consensus 120 ~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~ 199 (256)
T cd05114 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199 (256)
T ss_pred CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999887553322222122234567999999988889999999999999999999 88
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
.||......+ . +.. ...+... ..+.. ....+.+++.+||+.+|++|||++++++.|.
T Consensus 200 ~p~~~~~~~~---~---~~~-i~~~~~~--~~~~~----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 200 MPFEKKSNYE---V---VEM-ISRGFRL--YRPKL----ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCHHH---H---HHH-HHCCCCC--CCCCC----CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 8986553322 1 111 1212111 11111 2245788888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=260.61 Aligned_cols=217 Identities=24% Similarity=0.336 Sum_probs=175.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------------CCCCHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------------KQPNWVERMGI 68 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i 68 (252)
...++|.+|+.++++++||||+++++++.+....+++|||+++|+|.+++.... ..+++..++.+
T Consensus 50 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 129 (283)
T cd05048 50 KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129 (283)
T ss_pred HHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHH
Confidence 346779999999999999999999999999999999999999999999985421 45788899999
Q ss_pred HHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCc
Q 038713 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVK 147 (252)
Q Consensus 69 ~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~ 147 (252)
+.|++.||.|||+. +++|+||||+||++++++.++++|||.+........ .......++..|+|||.+.+..++.+
T Consensus 130 ~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 206 (283)
T cd05048 130 AIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE 206 (283)
T ss_pred HHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh
Confidence 99999999999999 999999999999999999999999999875432221 11122345678999999988889999
Q ss_pred ccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 148 ADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 148 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
+|+||||+++|++++ |..||......+ +. ..+..+.... .+...+..+.+++.+||+.||++|||+
T Consensus 207 sDv~slG~il~el~~~g~~p~~~~~~~~---~~----~~i~~~~~~~------~~~~~~~~~~~l~~~c~~~~p~~Rp~~ 273 (283)
T cd05048 207 SDIWSFGVVLWEIFSYGLQPYYGFSNQE---VI----EMIRSRQLLP------CPEDCPARVYALMIECWNEIPARRPRF 273 (283)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHcCCcCC------CcccCCHHHHHHHHHHccCChhhCcCH
Confidence 999999999999998 999987654332 11 1122222221 123344568889999999999999999
Q ss_pred HHHHHHhhcC
Q 038713 227 KKVLLMLEGT 236 (252)
Q Consensus 227 ~~i~~~l~~~ 236 (252)
.+|++.|+++
T Consensus 274 ~~i~~~l~~~ 283 (283)
T cd05048 274 KDIHTRLRSW 283 (283)
T ss_pred HHHHHHHhcC
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=263.99 Aligned_cols=215 Identities=29% Similarity=0.475 Sum_probs=167.8
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
.+..++|.+|++.+++++||||++++|++...+..++|+||+++|+|.+++... ...+++..++.|+.||+.||.|||+
T Consensus 42 ~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~ 121 (259)
T PF07714_consen 42 EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS 121 (259)
T ss_dssp HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH
T ss_pred cccceeeeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 345789999999999999999999999999888899999999999999999766 5678999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
. +++|++|+++||+++.++.+|++|||.+........ ...........|+|||.+.+..++.++||||||+++|++
T Consensus 122 ~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei 198 (259)
T PF07714_consen 122 N---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEI 198 (259)
T ss_dssp T---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHH
T ss_pred c---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9 999999999999999999999999999987632222 222233456789999999888899999999999999999
Q ss_pred Hh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 038713 161 VC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233 (252)
Q Consensus 161 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l 233 (252)
++ |+.||....... + . .....+..... +......+.+++.+||+.+|++|||+.++++.|
T Consensus 199 ~~~~~~p~~~~~~~~---~---~-~~~~~~~~~~~------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 199 LTLGKFPFSDYDNEE---I---I-EKLKQGQRLPI------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HTTSSGTTTTSCHHH---H---H-HHHHTTEETTS------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccccccccccc---c---c-cccccccccee------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 99 678876553322 1 1 12222222111 122234478888999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=258.39 Aligned_cols=202 Identities=25% Similarity=0.279 Sum_probs=166.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+...+|.++|.+++||.||+++-.|++...+|+|+||+.||.|..+|+ .++.+++..+.=++..|+.||.|||+.
T Consensus 68 e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~-- 144 (357)
T KOG0598|consen 68 EVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSK-- 144 (357)
T ss_pred hHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhC--
Confidence 35667899999999999999999999999999999999999999999995 455688888888999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+|+|||+||+|||++..|+++|+|||+++......... ....||+.|||||++.+..|+..+|.||||+++|+|++|.
T Consensus 145 -gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t-~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~ 222 (357)
T KOG0598|consen 145 -GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT-RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGK 222 (357)
T ss_pred -CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc-ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCC
Confidence 99999999999999999999999999998655443322 2367899999999999999999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
+||........ .++ +..++. ...... ......+++.++|..||++|.
T Consensus 223 pPF~~~~~~~~------~~~-I~~~k~---~~~p~~---ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 223 PPFYAEDVKKM------YDK-ILKGKL---PLPPGY---LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCcCccHHHH------HHH-HhcCcC---CCCCcc---CCHHHHHHHHHHhccCHHHhc
Confidence 99987754431 112 222221 111121 223356666699999999996
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=255.49 Aligned_cols=216 Identities=25% Similarity=0.335 Sum_probs=174.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|++++++++||||+++++++...+..+++|||+++++|.+++... ...+++..++.++.|++.||+|||+.
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~- 123 (263)
T cd05052 45 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK- 123 (263)
T ss_pred HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3567899999999999999999999999999999999999999999999653 34578899999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++|+||+|+||++++++.++++|||.+...............++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 124 --~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~ 201 (263)
T cd05052 124 --NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 201 (263)
T ss_pred --CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999987654332222222234567999999998889999999999999999998
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
|..||......+.. .....+... . .+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 202 g~~p~~~~~~~~~~-------~~~~~~~~~--~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 202 GMSPYPGIDLSQVY-------ELLEKGYRM--E----RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCHHHHH-------HHHHCCCCC--C----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 88888765333211 111221111 1 1112234578888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=254.77 Aligned_cols=217 Identities=25% Similarity=0.379 Sum_probs=176.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+++|.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++....+.+++..++.++.|++.|+.|||+.
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~- 125 (266)
T cd05033 47 KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM- 125 (266)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4567899999999999999999999999999999999999999999999977666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 126 --~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~ 203 (266)
T cd05033 126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203 (266)
T ss_pred --CcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHc
Confidence 999999999999999999999999999987642111 11112234567999999998889999999999999999997
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
|..||....... .. .....+.... . +......+.+++.+||+.+|++|||++++++.|++.
T Consensus 204 ~g~~p~~~~~~~~---~~----~~~~~~~~~~--~----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 204 YGERPYWDMSNQD---VI----KAVEDGYRLP--P----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred cCCCCCCCCCHHH---HH----HHHHcCCCCC--C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 888886543322 11 1112211111 1 112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=254.91 Aligned_cols=213 Identities=23% Similarity=0.382 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.|.+|+.++++++||||+++++++.+....+++|||+.+|+|.+++......+++..++.++.|++.||+|||+.
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--- 119 (256)
T cd05113 43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK--- 119 (256)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 46789999999999999999999999998999999999999999999976555789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-CC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-LR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~ 164 (252)
+++|+||+|+||+++.++.++++|||.+...............++..|+|||...+..++.++|+||||+++|++++ |.
T Consensus 120 ~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~ 199 (256)
T cd05113 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199 (256)
T ss_pred CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999999987654333222222335568999999988889999999999999999998 88
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
.||....... . . .....+..... + ......+.+++.+||+.+|++|||+.+|+..|+
T Consensus 200 ~p~~~~~~~~---~---~-~~~~~~~~~~~--~----~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 200 MPYERFNNSE---T---V-EKVSQGLRLYR--P----HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCcCcCCHHH---H---H-HHHhcCCCCCC--C----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 8986543322 1 1 11122221111 1 112356788888999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=264.82 Aligned_cols=208 Identities=21% Similarity=0.220 Sum_probs=169.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
....+.+|+.++++++||||+++++++...+..++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.
T Consensus 38 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~-- 114 (323)
T cd05571 38 EVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSC-- 114 (323)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 456788999999999999999999999999999999999999999999854 44688999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+||+++.++.++++|||.++...... .......|+..|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 115 -~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 192 (323)
T cd05571 115 -DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192 (323)
T ss_pred -CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCC
Confidence 99999999999999999999999999987532211 1222345899999999999988999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
.||......... .....+... .+......+.+++.+||+.||++|| ++.++++
T Consensus 193 ~Pf~~~~~~~~~-------~~~~~~~~~-------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 193 LPFYNQDHEKLF-------ELILMEEIR-------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCCHHHHH-------HHHHcCCCC-------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 999765332211 111122211 1122234577888899999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=257.73 Aligned_cols=218 Identities=24% Similarity=0.371 Sum_probs=176.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC---------------CCCCCHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP---------------EKQPNWVERMGIA 69 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~ 69 (252)
..+.|.+|+.++++++||||+++++++......++||||+++++|.+++... .+.+++..++.++
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 129 (291)
T cd05094 50 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129 (291)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHH
Confidence 4567999999999999999999999999999999999999999999998542 2347889999999
Q ss_pred HHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcc
Q 038713 70 RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKA 148 (252)
Q Consensus 70 ~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~ 148 (252)
.|++.||+|||++ +++|+||+|+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++
T Consensus 130 ~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 206 (291)
T cd05094 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206 (291)
T ss_pred HHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchh
Confidence 9999999999999 999999999999999999999999999875533221 111223456789999999988899999
Q ss_pred cchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 149 DVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 149 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
|+||||+++|+|++ |..||....... . . .....+..... +...+..+.+++.+||+.+|++|||+.
T Consensus 207 Di~slG~il~el~t~g~~p~~~~~~~~---~---~-~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~ 273 (291)
T cd05094 207 DVWSFGVILWEIFTYGKQPWFQLSNTE---V---I-ECITQGRVLER------PRVCPKEVYDIMLGCWQREPQQRLNIK 273 (291)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHH---H---H-HHHhCCCCCCC------CccCCHHHHHHHHHHcccChhhCcCHH
Confidence 99999999999998 999986654332 1 1 11222322221 112234578888899999999999999
Q ss_pred HHHHHhhcCcC
Q 038713 228 KVLLMLEGTVE 238 (252)
Q Consensus 228 ~i~~~l~~~~~ 238 (252)
+++++|+++..
T Consensus 274 ~v~~~l~~~~~ 284 (291)
T cd05094 274 EIYKILHALGK 284 (291)
T ss_pred HHHHHHHHHHh
Confidence 99999999744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=263.19 Aligned_cols=209 Identities=19% Similarity=0.192 Sum_probs=167.6
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.....+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.
T Consensus 35 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~- 112 (312)
T cd05585 35 SEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKF- 112 (312)
T ss_pred hHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3456788999999999999999999999999999999999999999999965 34588999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.+........ ......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 113 --~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg 189 (312)
T cd05585 113 --NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189 (312)
T ss_pred --CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhC
Confidence 999999999999999999999999999875322221 22234578999999999998899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
..||....... ..... ..+... .+......+.+++.+||+.||++||++..+.+
T Consensus 190 ~~pf~~~~~~~------~~~~~-~~~~~~-------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 190 LPPFYDENVNE------MYRKI-LQEPLR-------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred CCCcCCCCHHH------HHHHH-HcCCCC-------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 99997653322 11111 112111 11222345778888999999999986543333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=252.46 Aligned_cols=215 Identities=24% Similarity=0.361 Sum_probs=174.2
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..++|.+|+.++++++||||+++++++...+..+++|||+++++|.+++.... ..+++..++.++.|++.|+.+||+.
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~- 122 (261)
T cd05068 44 DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ- 122 (261)
T ss_pred cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 35679999999999999999999999999999999999999999999996543 5689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++|+||+|+||+++.++.++++|||.+............+...+..|+|||+..+..++.++|+||||++++++++
T Consensus 123 --~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~ 200 (261)
T cd05068 123 --NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTY 200 (261)
T ss_pred --CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhc
Confidence 99999999999999999999999999998765332222222233457999999998889999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
|+.||....... .. .....+.... .+......+.+++.+||+.+|++||++.+++..|++
T Consensus 201 g~~p~~~~~~~~---~~----~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 201 GRMPYPGMTNAE---VL----QQVDQGYRMP------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCCCCHHH---HH----HHHHcCCCCC------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 888886543221 11 1111111110 112233558888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=263.00 Aligned_cols=220 Identities=20% Similarity=0.310 Sum_probs=170.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+++.+|++++++++||||+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~- 122 (331)
T cd06649 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREK- 122 (331)
T ss_pred HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhc-
Confidence 44678999999999999999999999999999999999999999999999543 4588999999999999999999985
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
.+++|+||||+||+++.++.++++|||.+....... .....|+..|+|||++.+..++.++|+||||+++|++++|
T Consensus 123 -~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 198 (331)
T cd06649 123 -HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198 (331)
T ss_pred -CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence 159999999999999999999999999987553322 1234578899999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCC---cccc----------------------------------cccchhcHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGN---LSQL----------------------------------VEDEEVDQKQLQ 206 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~----------------------------------~~~~~~~~~~~~ 206 (252)
+.||......+.... .......+. .... ..+.........
T Consensus 199 ~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (331)
T cd06649 199 RYPIPPPDAKELEAI---FGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTP 275 (331)
T ss_pred CCCCCCCCHHHHHHH---hcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccH
Confidence 999975543221111 000000000 0000 000000112335
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 207 RMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 207 ~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
.+.+++.+||+.||++|||++++++.
T Consensus 276 ~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 276 DFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcC
Confidence 68889999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=242.96 Aligned_cols=234 Identities=19% Similarity=0.209 Sum_probs=182.4
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
....||++.|+.++|+||+.++++|-+.+++.+|+||++. +|...++.+...++...+..++.++++|++|||++ .
T Consensus 46 ~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~ 121 (318)
T KOG0659|consen 46 RTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---W 121 (318)
T ss_pred HHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---h
Confidence 3568999999999999999999999999999999999965 99999999888999999999999999999999999 9
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhCCc
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
|+|||+||.|+|++++|.+|++|||+++.+........ ..+.|.+|+|||.+.|. .|....|+||.||++.|++-|.+
T Consensus 122 IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P 200 (318)
T KOG0659|consen 122 ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP 200 (318)
T ss_pred hhcccCCccceEEcCCCcEEeecccchhccCCCCcccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC
Confidence 99999999999999999999999999998765544322 23568899999998876 59999999999999999997776
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccc--------------hhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDE--------------EVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
-|.+..+-++...+-.+........|..+..-. ..-+....+.++++.+|+..||.+|+|+.|+++
T Consensus 201 ~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 201 FFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred CCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 666665555444322111111111111111100 122233456789999999999999999999986
Q ss_pred HhhcCcCCCCCCCCC
Q 038713 232 MLEGTVEIPIPQNPT 246 (252)
Q Consensus 232 ~l~~~~~~~~~~~~~ 246 (252)
.= -..+.|.|..|.
T Consensus 281 ~~-yf~~~P~pt~~~ 294 (318)
T KOG0659|consen 281 HP-YFKSLPLPTPPS 294 (318)
T ss_pred ch-hhhcCCCCCChh
Confidence 52 233455555444
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=257.81 Aligned_cols=224 Identities=18% Similarity=0.208 Sum_probs=171.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|+.+++.++||||+++++++...+..++||||++++.+..+. .....+++..++.++.|++.||.|||+.
T Consensus 42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~- 119 (287)
T cd07848 42 EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKN- 119 (287)
T ss_pred cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34567889999999999999999999999999999999999887665544 4445689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||||+||+++.++.++++|||.+...............|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 120 --~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g 197 (287)
T cd07848 120 --DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197 (287)
T ss_pred --CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhC
Confidence 999999999999999999999999999886543332233334678899999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHH---------HHHHhcCCccccc-----ccc----hhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 164 RRCLDQNLLEDRAILQEWI---------CQCFENGNLSQLV-----EDE----EVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~-----~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
+.||......+........ ............. ... .........+.+++.+||+.||++|||
T Consensus 198 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s 277 (287)
T cd07848 198 QPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL 277 (287)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC
Confidence 9999765433321111100 0000000000000 000 001113445889999999999999999
Q ss_pred HHHHHH
Q 038713 226 MKKVLL 231 (252)
Q Consensus 226 ~~~i~~ 231 (252)
++|+++
T Consensus 278 ~~~~l~ 283 (287)
T cd07848 278 TEQCLN 283 (287)
T ss_pred HHHHhc
Confidence 999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=253.04 Aligned_cols=213 Identities=24% Similarity=0.363 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
..+|.+|++++++++||||+++++++...+..++||||+++++|.+++......+++..++.++.|++.|++|||+.
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--- 119 (256)
T cd05059 43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN--- 119 (256)
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 45789999999999999999999999999999999999999999999976566789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-CC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-LR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~ 164 (252)
+++|+||+|+||+++.++.++++|||.++..............++..|+|||.+.+..++.++|+||||+++|++++ |.
T Consensus 120 ~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~ 199 (256)
T cd05059 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred CcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCC
Confidence 99999999999999999999999999987654322211122223457999999998889999999999999999998 78
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
.||......+. ... ...+... .. +...+..+.+++.+||..+|++|||+.++++.|.
T Consensus 200 ~p~~~~~~~~~------~~~-~~~~~~~--~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 200 MPYERFSNSEV------VES-VSAGYRL--YR----PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCHHHH------HHH-HHcCCcC--CC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 88875533321 111 1111111 11 1112345888888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=251.99 Aligned_cols=216 Identities=19% Similarity=0.272 Sum_probs=173.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.|.+|+.++++++||||+++++++. ....++||||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 37 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~- 114 (257)
T cd05115 37 SVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK- 114 (257)
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc-
Confidence 34567999999999999999999999886 4578999999999999999976666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc--cccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT--FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||||+||+++.++.++++|||.+.......... .....++..|+|||.+.+..++.++|+||||+++|+++
T Consensus 115 --~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 192 (257)
T cd05115 115 --NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAF 192 (257)
T ss_pred --CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHh
Confidence 99999999999999999999999999987543322211 11122346799999998888899999999999999999
Q ss_pred h-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 162 C-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 162 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
+ |..||....... . ......+.... .+......+.+++.+||..+|++||++.+|.+.|++.
T Consensus 193 ~~g~~p~~~~~~~~---~----~~~~~~~~~~~------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 193 SYGQKPYKKMKGPE---V----MSFIEQGKRLD------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred cCCCCCcCcCCHHH---H----HHHHHCCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 6 999997654332 1 12222222211 1122334577888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=266.90 Aligned_cols=217 Identities=22% Similarity=0.342 Sum_probs=171.7
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC--------------------------
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-------------------------- 57 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------- 57 (252)
..+.+.+|+.+++.+ +||||+++++++.+.+..++||||+++|+|.+++....
T Consensus 81 ~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (375)
T cd05104 81 EREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREM 160 (375)
T ss_pred HHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcc
Confidence 456789999999999 89999999999999999999999999999999985422
Q ss_pred ------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 038713 58 ------------------------------------------------KQPNWVERMGIARDIARGIRYLHDECEAQIIH 89 (252)
Q Consensus 58 ------------------------------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h 89 (252)
..+++..++.++.||+.||.|||+. +++|
T Consensus 161 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH 237 (375)
T cd05104 161 SCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIH 237 (375)
T ss_pred cchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence 1367788899999999999999999 9999
Q ss_pred eccCCCCEEecCCCceEEcccCcccccCCCCCccc-ccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-CCccc
Q 038713 90 GDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF-TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-LRRCL 167 (252)
Q Consensus 90 ~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~ 167 (252)
+||||+||+++.++.++++|||.+........... ....++..|+|||++.+..++.++|+||||+++|++++ |..||
T Consensus 238 ~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~ 317 (375)
T cd05104 238 RDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317 (375)
T ss_pred cCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999876543322111 12234567999999998889999999999999999998 78888
Q ss_pred cccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 168 DQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
....... .+.. ....+.... .+ ......+.+++.+||+.||++|||+.+|++.|++.
T Consensus 318 ~~~~~~~--~~~~----~~~~~~~~~--~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 318 PGMPVDS--KFYK----MIKEGYRML--SP----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCchH--HHHH----HHHhCccCC--CC----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 6543221 1111 122221111 11 11124578888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=274.33 Aligned_cols=211 Identities=20% Similarity=0.268 Sum_probs=170.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
....+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 108 ~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~ 187 (478)
T PTZ00267 108 QAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS 187 (478)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345678899999999999999999999999999999999999999998753 23457889999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
. +++||||||+||+++.++.++++|||++........ .......|++.|+|||++.+..++.++||||||+++|+|
T Consensus 188 ~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 264 (478)
T PTZ00267 188 R---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYEL 264 (478)
T ss_pred C---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHH
Confidence 9 999999999999999999999999999986543322 122334589999999999988899999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|+.||....... ...... .+..... +......+.+++.+||+.+|++|||+++++.
T Consensus 265 ~tg~~Pf~~~~~~~------~~~~~~-~~~~~~~------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 265 LTLHRPFKGPSQRE------IMQQVL-YGKYDPF------PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HhCCCCCCCCCHHH------HHHHHH-hCCCCCC------CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 99999997653322 111111 1222111 1122345788888999999999999999864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=254.12 Aligned_cols=215 Identities=25% Similarity=0.366 Sum_probs=173.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-------------CCCCHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-------------KQPNWVERMGIARD 71 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~ 71 (252)
..+.|.+|+++++.++||||+++++++......+++|||+++|+|.+++.... ..+++..++.++.|
T Consensus 51 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 130 (280)
T cd05049 51 ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130 (280)
T ss_pred HHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHH
Confidence 56889999999999999999999999999999999999999999999995432 34678888999999
Q ss_pred HHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccc
Q 038713 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADV 150 (252)
Q Consensus 72 i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 150 (252)
++.|+.+||+. +++|+||+|+||+++.++.++++|||.+........ .......++..|+|||++.+..++.++|+
T Consensus 131 i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 207 (280)
T cd05049 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 207 (280)
T ss_pred HHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhH
Confidence 99999999999 999999999999999999999999999875432221 11122334678999999998889999999
Q ss_pred hhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 151 YSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 151 ~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
||||+++|++++ |..||....... .. .....+..... +......+.+++.+||+.||++|||+.|+
T Consensus 208 ~slG~il~e~~~~g~~p~~~~~~~~---~~----~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 274 (280)
T cd05049 208 WSFGVVLWEIFTYGKQPWYGLSNEE---VI----ECITQGRLLQR------PRTCPSEVYDIMLGCWKRDPQQRINIKDI 274 (280)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHHcCCcCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 999999999998 999987554332 11 11223332221 11223457888889999999999999999
Q ss_pred HHHhhc
Q 038713 230 LLMLEG 235 (252)
Q Consensus 230 ~~~l~~ 235 (252)
++.|++
T Consensus 275 l~~l~~ 280 (280)
T cd05049 275 HERLQK 280 (280)
T ss_pred HHHhhC
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=250.43 Aligned_cols=216 Identities=22% Similarity=0.278 Sum_probs=172.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+....|.+|++++++++||||+++++++...+..++||||+++++|.+++......+++..++.++.|++.||.|||+.
T Consensus 35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~- 113 (252)
T cd05084 35 DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK- 113 (252)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4567899999999999999999999999999999999999999999999976666689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCccc-ccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF-TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|.||+++.++.++++|||.+........... .....+..|+|||.+.+..++.++|+||||+++|++++
T Consensus 114 --~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~ 191 (252)
T cd05084 114 --HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191 (252)
T ss_pred --CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999875432211111 11122456999999988889999999999999999997
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
|..||......... .....+.... .+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 192 ~~~~p~~~~~~~~~~-------~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 192 LGAVPYANLSNQQTR-------EAIEQGVRLP------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CCCCCccccCHHHHH-------HHHHcCCCCC------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 88888654333211 1111111111 111223457888889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=255.37 Aligned_cols=207 Identities=20% Similarity=0.319 Sum_probs=177.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.--.+.+|+++|+.|+||||+.++++|++.+...+||||..+|.|.+|+.. .+.+++.+..+++.||++|+.|+|++
T Consensus 96 DlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHkn-- 172 (668)
T KOG0611|consen 96 DLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKN-- 172 (668)
T ss_pred HHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhc--
Confidence 344578999999999999999999999999999999999999999999954 45799999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCC-CcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPIT-VKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g 163 (252)
+++|||+|.+|||++.|+.+|++|||++-.+.... ......|++-|.+||++.|..|. +..|.||||+++|.++.|
T Consensus 173 -rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyG 249 (668)
T KOG0611|consen 173 -RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYG 249 (668)
T ss_pred -cceecccchhheeecCCCCeeeeccchhhhhcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhc
Confidence 99999999999999999999999999998775433 33446789999999999998875 789999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
..||++.+... .-..+..|..+....+. +..-||++||..||+.|.|+++|...
T Consensus 250 tMPFDG~Dhk~-------lvrQIs~GaYrEP~~PS--------dA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 250 TMPFDGRDHKR-------LVRQISRGAYREPETPS--------DASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ccccCCchHHH-------HHHHhhcccccCCCCCc--------hHHHHHHHHHhcCcccchhHHHHhhh
Confidence 99999875543 22345566666554432 24456779999999999999999764
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=256.32 Aligned_cols=220 Identities=24% Similarity=0.380 Sum_probs=176.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC------------CCCCHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE------------KQPNWVERMGIARD 71 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~ 71 (252)
...+.+.+|++++++++||||+++++++...+..++++||+++++|.+++.... ..+++..++.++.|
T Consensus 49 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 128 (288)
T cd05093 49 NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128 (288)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHH
Confidence 346679999999999999999999999999999999999999999999985322 34899999999999
Q ss_pred HHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccc
Q 038713 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADV 150 (252)
Q Consensus 72 i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 150 (252)
++.||.|||+. +++|+||||+||++++++.++++|||.+........ .......++..|+|||.+.+..++.++|+
T Consensus 129 l~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi 205 (288)
T cd05093 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 205 (288)
T ss_pred HHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhH
Confidence 99999999999 999999999999999999999999999875532221 11122334668999999998889999999
Q ss_pred hhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 151 YSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 151 ~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
||||+++|+|++ |..||....... . . .....+...... .. ....+.+++.+||+.||.+|||+.++
T Consensus 206 wslG~il~~l~t~g~~p~~~~~~~~---~---~-~~i~~~~~~~~~--~~----~~~~l~~li~~~l~~~p~~Rpt~~~v 272 (288)
T cd05093 206 WSLGVVLWEIFTYGKQPWYQLSNNE---V---I-ECITQGRVLQRP--RT----CPKEVYDLMLGCWQREPHMRLNIKEI 272 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHH---H---H-HHHHcCCcCCCC--CC----CCHHHHHHHHHHccCChhhCCCHHHH
Confidence 999999999998 888886554322 1 1 112222221111 11 22348888999999999999999999
Q ss_pred HHHhhcCcCC
Q 038713 230 LLMLEGTVEI 239 (252)
Q Consensus 230 ~~~l~~~~~~ 239 (252)
.+.|+++...
T Consensus 273 ~~~l~~~~~~ 282 (288)
T cd05093 273 HSLLQNLAKA 282 (288)
T ss_pred HHHHHHHHHh
Confidence 9999987644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=252.18 Aligned_cols=215 Identities=23% Similarity=0.348 Sum_probs=173.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|+.++++++|+||+++++.+.+.+..++++||+.+|+|.+++... ...+++..++.++.|++.||+|||+.
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~- 122 (261)
T cd05072 44 SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK- 122 (261)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4578999999999999999999999999999999999999999999999653 45688889999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++|+||+|+||+++.++.++++|||.+...............++..|+|||...+..++.++|+||||+++|++++
T Consensus 123 --~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~ 200 (261)
T cd05072 123 --NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTY 200 (261)
T ss_pred --CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHcc
Confidence 99999999999999999999999999998654332222222334668999999988888999999999999999998
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
|..||....... .. .....+..... ....+..+.+++.+||+.+|++|||++++.+.|++
T Consensus 201 g~~p~~~~~~~~---~~----~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 201 GKIPYPGMSNSD---VM----SALQRGYRMPR------MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCCHHH---HH----HHHHcCCCCCC------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 888986543322 11 11122211111 11123457788889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=265.22 Aligned_cols=221 Identities=20% Similarity=0.194 Sum_probs=168.1
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
++.+.+|++++++++||||+++++++......++|+|++ +++|..++... +.+++..++.++.||+.||.|||+.
T Consensus 127 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~--- 201 (391)
T PHA03212 127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHEN--- 201 (391)
T ss_pred hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 456889999999999999999999999999999999999 46898888544 4578999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
+++||||||+||+++.++.++|+|||.+...............|+..|+|||++.+..++.++|+||||+++|+|++|+.
T Consensus 202 ~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 281 (391)
T PHA03212 202 RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281 (391)
T ss_pred CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999987543322223334568999999999998889999999999999999999998
Q ss_pred cccccchh-----hhHHHHHHHHHH---------------------HhcCCccccccc--chhcHHHHHHHHHHHhhccC
Q 038713 166 CLDQNLLE-----DRAILQEWICQC---------------------FENGNLSQLVED--EEVDQKQLQRMIKVGLRCIL 217 (252)
Q Consensus 166 p~~~~~~~-----~~~~~~~~~~~~---------------------~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~ 217 (252)
||...... ....+...+... ............ ..........+.+++.+||+
T Consensus 282 p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~ 361 (391)
T PHA03212 282 SLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLA 361 (391)
T ss_pred CcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhc
Confidence 87543211 011111111000 000000000000 01112234568889999999
Q ss_pred CCCCCCCCHHHHHH
Q 038713 218 DEPSLRRAMKKVLL 231 (252)
Q Consensus 218 ~~p~~Rps~~~i~~ 231 (252)
.||.+|||++|+++
T Consensus 362 ~dP~~Rpta~elL~ 375 (391)
T PHA03212 362 FDAHHRPSAEALLD 375 (391)
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=263.66 Aligned_cols=209 Identities=24% Similarity=0.323 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+-..+|-++|.+| .||.|++++--|++..++|+|+||+++|+|.++|++. +.+++....-.+.+|+.||.|||+.
T Consensus 117 vkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~-- 193 (604)
T KOG0592|consen 117 VKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSN-- 193 (604)
T ss_pred cchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhc--
Confidence 44566899999999 9999999999999999999999999999999999654 5688888899999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc------------ccccccCCccccccccccCCCCCCcccchh
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR------------TFTGIRGTRAYVAAEWHRNLPITVKADVYS 152 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 152 (252)
||+||||||+|||++.+++++|.|||.+..+.+.... .....+||-.|++||++....-+..+|+|+
T Consensus 194 -GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWA 272 (604)
T KOG0592|consen 194 -GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWA 272 (604)
T ss_pred -CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHH
Confidence 9999999999999999999999999999887643221 113467999999999999988999999999
Q ss_pred HHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 153 FGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 153 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
|||++|.|+.|.+||.....-- .+...+ . ..- ..+...+....+||.+.|-.||.+|+|+.||-+.
T Consensus 273 lGCilyQmlaG~PPFra~Neyl--iFqkI~-~--l~y---------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 273 LGCILYQMLAGQPPFRAANEYL--IFQKIQ-A--LDY---------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHHHhcCCCCCccccHHH--HHHHHH-H--hcc---------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 9999999999999998653221 111111 0 010 1122223456777779999999999999888653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=263.30 Aligned_cols=205 Identities=20% Similarity=0.207 Sum_probs=168.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++||||+++++++.+.+..++||||+.+|+|.+++... +.+++..+..++.|++.||.|||+.
T Consensus 61 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~-- 137 (329)
T PTZ00263 61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSK-- 137 (329)
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4567899999999999999999999999999999999999999999999643 4578888889999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||||+||+++.++.++++|||.+....... ....|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 138 -~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 212 (329)
T PTZ00263 138 -DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGY 212 (329)
T ss_pred -CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCC
Confidence 99999999999999999999999999987654322 2245788999999999988999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-----MKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~i~~ 231 (252)
.||....... . . .....+.... +......+.+++.+||+.||++||+ ++++++
T Consensus 213 ~pf~~~~~~~---~---~-~~i~~~~~~~-------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 213 PPFFDDTPFR---I---Y-EKILAGRLKF-------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCCCCCHHH---H---H-HHHhcCCcCC-------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 9997653321 1 1 1122222211 1112234678888999999999997 677663
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=281.00 Aligned_cols=222 Identities=25% Similarity=0.421 Sum_probs=193.0
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..+|.+|+.|+.||.+++||||+++.|+....+.+.+|+|||++|+|..+|..+.++++.-++..|+..|+.|++||.+.
T Consensus 671 ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm 750 (996)
T KOG0196|consen 671 EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM 750 (996)
T ss_pred HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc
Confidence 46789999999999999999999999999999999999999999999999998889999999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccc--cCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI--RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~--~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
++||||+.++||||+.+-.+|+.|||+++...++........ .-..+|.|||.+...+++.++||||+|+++||.
T Consensus 751 ---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEV 827 (996)
T KOG0196|consen 751 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 827 (996)
T ss_pred ---CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEe
Confidence 999999999999999999999999999998765553332222 234689999999999999999999999999998
Q ss_pred H-hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCC
Q 038713 161 V-CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 161 ~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~ 239 (252)
+ .|.+||......+ +.+.+++|..-. .+.+++..|..|++.||++|-..||.+.||+..|.+.+..
T Consensus 828 mSyGERPYWdmSNQd-------VIkaIe~gyRLP------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 828 MSYGERPYWDMSNQD-------VIKAIEQGYRLP------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred cccCCCcccccchHH-------HHHHHHhccCCC------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 8 4889998776654 334444444322 2556677799999999999999999999999999997655
Q ss_pred C
Q 038713 240 P 240 (252)
Q Consensus 240 ~ 240 (252)
|
T Consensus 895 P 895 (996)
T KOG0196|consen 895 P 895 (996)
T ss_pred c
Confidence 4
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=259.97 Aligned_cols=206 Identities=20% Similarity=0.266 Sum_probs=168.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.|++.||+|||+.
T Consensus 44 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~-- 120 (291)
T cd05612 44 QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSK-- 120 (291)
T ss_pred HHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4567889999999999999999999999999999999999999999999643 4688899999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||||+||+++.++.++++|||.+....... ....|+..|+|||++.+..++.++||||||+++|+|++|+
T Consensus 121 -~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~ 195 (291)
T cd05612 121 -EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195 (291)
T ss_pred -CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987653321 2235788999999999888999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-----MKKVLLM 232 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~i~~~ 232 (252)
.||....... . . .....+.... +......+.+++.+||+.||.+||+ ++++++.
T Consensus 196 ~pf~~~~~~~---~---~-~~i~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 196 PPFFDDNPFG---I---Y-EKILAGKLEF-------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCCCCCHHH---H---H-HHHHhCCcCC-------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 9997654322 1 1 1112222111 1112334778888999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=252.93 Aligned_cols=218 Identities=22% Similarity=0.312 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+++..|+..++++.||||+++++++.. ...++++||+.+|+|.+++....+.+++..++.++.||+.||.|||+.
T Consensus 53 ~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--- 128 (279)
T cd05111 53 FQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128 (279)
T ss_pred HHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 4678888889999999999999998764 557899999999999999977667789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-C
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-L 163 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 163 (252)
+++|+||||+||+++.++.++++|||.++....... .......++..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus 129 ~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g 208 (279)
T cd05111 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYG 208 (279)
T ss_pred CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999976543222 11222345678999999988889999999999999999998 9
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCCC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIP 240 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 240 (252)
..||....... . ......+..... +.. ....+.+++.+||..+|++|||+.++++.|..+...|
T Consensus 209 ~~p~~~~~~~~---~----~~~~~~~~~~~~--~~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 209 AEPYAGMRPHE---V----PDLLEKGERLAQ--PQI----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CCCCCCCCHHH---H----HHHHHCCCcCCC--CCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 98987653332 1 112222222111 111 2234677888999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=262.42 Aligned_cols=214 Identities=20% Similarity=0.200 Sum_probs=171.3
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++..++||||+++++++.+.+..++||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~-- 120 (333)
T cd05600 44 EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHEL-- 120 (333)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 456788999999999999999999999999999999999999999999954 34688899999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||||+||+++.++.++++|||.+..... ......|+..|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 121 -~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~ 195 (333)
T cd05600 121 -GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGF 195 (333)
T ss_pred -CccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCC
Confidence 999999999999999999999999999875433 223345789999999999989999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
.||......+.... +... ....... ............+.+++.+||..+|++|||++++++.
T Consensus 196 ~pf~~~~~~~~~~~---i~~~--~~~~~~~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 196 PPFSGSTPNETWEN---LKYW--KETLQRP-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCCCHHHHHHH---HHhc--cccccCC-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 99976544332111 1100 0001110 0000011234457788889999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=259.65 Aligned_cols=210 Identities=21% Similarity=0.240 Sum_probs=169.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+....+.+|+++++.++||||+++++++.+.+..++||||+++|+|..++.. .+.+++..++.++.||+.||.|||+.
T Consensus 37 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~- 114 (328)
T cd05593 37 DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSG- 114 (328)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3456788999999999999999999999999999999999999999998854 34688999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.+....... .......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 115 --~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 191 (328)
T cd05593 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (328)
T ss_pred --CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhC
Confidence 99999999999999999999999999987532211 122234578999999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLLM 232 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~~ 232 (252)
+.||........ ... ...+... .+......+.+++.+||+.||++|| ++.++++.
T Consensus 192 ~~Pf~~~~~~~~------~~~-~~~~~~~-------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 192 RLPFYNQDHEKL------FEL-ILMEDIK-------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCCCHHHH------HHH-hccCCcc-------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 999976533221 111 1111111 1112234577888899999999997 88988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=247.87 Aligned_cols=214 Identities=22% Similarity=0.259 Sum_probs=172.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
....|.+|++++++++||||+++++++...+..++||||+++++|.+++......+++..++.++.|++.||.|+|+.
T Consensus 35 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-- 112 (250)
T cd05085 35 LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK-- 112 (250)
T ss_pred HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 455789999999999999999999999999999999999999999999976666789999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-C
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-L 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 163 (252)
+++|+|++|+||+++.++.++++|||.+...............++..|+|||++.+..++.++|+||||+++|++++ |
T Consensus 113 -~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g 191 (250)
T cd05085 113 -NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLG 191 (250)
T ss_pred -CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999987543322211111233567999999988889999999999999999998 8
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
..||........ . .....+.... .+......+.+++.+||..+|++|||+.++++.|.
T Consensus 192 ~~p~~~~~~~~~---~----~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 192 VCPYPGMTNQQA---R----EQVEKGYRMS------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCHHHH---H----HHHHcCCCCC------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 889865533221 1 1111221111 11123356888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=257.67 Aligned_cols=221 Identities=20% Similarity=0.240 Sum_probs=167.5
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
...+.+|+.++++++||||+++++++.+.+..++||||+++ +|.+++......++...+..++.||+.||+|||+.
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--- 122 (288)
T cd07871 47 PCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR--- 122 (288)
T ss_pred chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 45678999999999999999999999999999999999965 99999876666678899999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHhCC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||||+||+++.++.++++|||.+........ ......++..|+|||++.+ ..++.++|+||+|+++|+|++|+
T Consensus 123 ~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~ 201 (288)
T cd07871 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201 (288)
T ss_pred CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999875432221 2223456889999999875 46899999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHH-----HHh----cCCcccccccc-------hhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQ-----CFE----NGNLSQLVEDE-------EVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~-----~~~----~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
.||......+.......... .+. .........+. .........+.+++.+||+.||.+|||++|
T Consensus 202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~ 281 (288)
T cd07871 202 PMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA 281 (288)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 99976544332211100000 000 00000000000 001112345778888999999999999999
Q ss_pred HHH
Q 038713 229 VLL 231 (252)
Q Consensus 229 i~~ 231 (252)
+++
T Consensus 282 ~l~ 284 (288)
T cd07871 282 ALR 284 (288)
T ss_pred Hhc
Confidence 974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=260.48 Aligned_cols=209 Identities=22% Similarity=0.226 Sum_probs=168.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+....+.+|+.+++.++||||+++++.+...+..++||||+++|+|..++.. .+.+++..++.++.||+.||.|||+.
T Consensus 37 ~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~- 114 (323)
T cd05595 37 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR- 114 (323)
T ss_pred HHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3456678999999999999999999999999999999999999999988854 34689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||||+||+++.++.++++|||.+....... .......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 115 --~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g 191 (323)
T cd05595 115 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (323)
T ss_pred --CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhC
Confidence 99999999999999999999999999876432211 122234578999999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
+.||......... .. ...+... .+......+.+++.+||+.||++|| ++.++++
T Consensus 192 ~~Pf~~~~~~~~~------~~-~~~~~~~-------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 192 RLPFYNQDHERLF------EL-ILMEEIR-------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCCCHHHHH------HH-HhcCCCC-------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 9999765433211 11 1111111 1112234467888899999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=264.65 Aligned_cols=218 Identities=22% Similarity=0.354 Sum_probs=172.0
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC--------------------------
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-------------------------- 57 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------- 57 (252)
.++.+.+|+++++.+ +||||+++++.+...+..++||||+.+|+|.+++....
T Consensus 84 ~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (374)
T cd05106 84 EREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLE 163 (374)
T ss_pred HHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchh
Confidence 456789999999999 89999999999999999999999999999999884321
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCC
Q 038713 58 -------------------------------------------KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKP 94 (252)
Q Consensus 58 -------------------------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~ 94 (252)
..+++..++.++.||+.||.|||+. +++||||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp 240 (374)
T cd05106 164 KKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAA 240 (374)
T ss_pred cccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCch
Confidence 2367788899999999999999999 999999999
Q ss_pred CCEEecCCCceEEcccCcccccCCCCCccc-ccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-CCccccccch
Q 038713 95 QNILMDEKRCAKISDFGLAKLMKPDQTRTF-TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-LRRCLDQNLL 172 (252)
Q Consensus 95 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~ 172 (252)
+||++++++.++++|||.++.......... ....++..|+|||++.+..++.++|+||||+++|+|++ |..||.....
T Consensus 241 ~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~ 320 (374)
T cd05106 241 RNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320 (374)
T ss_pred heEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence 999999999999999999876543322111 12234567999999988889999999999999999997 9999976533
Q ss_pred hhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 173 EDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
.. .+. .....+. .. ..+.. .+..+.+++.+||+.+|++|||+.++++.|++.+
T Consensus 321 ~~--~~~----~~~~~~~-~~-~~~~~----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 321 NS--KFY----KMVKRGY-QM-SRPDF----APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cH--HHH----HHHHccc-Cc-cCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 22 111 1111111 11 01111 1345788888999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=254.92 Aligned_cols=212 Identities=22% Similarity=0.236 Sum_probs=169.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
....+.+|+.++++++|+||+++++++.+.+..++|+||+++|+|.+++... ...+++..++.++.|++.||.|||+.
T Consensus 43 ~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~- 121 (285)
T cd05631 43 GEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE- 121 (285)
T ss_pred hHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3456889999999999999999999999999999999999999999888543 34588999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.+....... ......|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 122 --~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g 197 (285)
T cd05631 122 --RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG 197 (285)
T ss_pred --CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhC
Confidence 99999999999999999999999999987653322 22334678999999999998999999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-----MKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~i~~ 231 (252)
+.||.......... .+......... ..+......+.+++.+||+.||++||| ++++++
T Consensus 198 ~~pf~~~~~~~~~~---~~~~~~~~~~~-------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 198 QSPFRKRKERVKRE---EVDRRVKEDQE-------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCCCCCCCcchhHH---HHHHHhhcccc-------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 99998654332111 11111111111 111222345778888999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=250.44 Aligned_cols=217 Identities=26% Similarity=0.421 Sum_probs=175.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..++.|.+|+.++++++||||+++++++.+++..++||||+++++|.+++....+.+++.+++.++.|++.||.+||+.
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~- 125 (267)
T cd05066 47 KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM- 125 (267)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3567899999999999999999999999999999999999999999999977666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccc--cccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT--GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||+|+||+++.++.++++|||.+............ ...++..|+|||.+.+..++.++|+||||+++|+++
T Consensus 126 --~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell 203 (267)
T cd05066 126 --GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203 (267)
T ss_pred --CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHh
Confidence 9999999999999999999999999998865433221111 122345799999999888999999999999999988
Q ss_pred h-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 162 C-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 162 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
+ |..||....... ... ....+.. ... +...+..+.+++.+||+.+|.+|||+.++++.|++.
T Consensus 204 ~~g~~p~~~~~~~~---~~~----~~~~~~~--~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 204 SYGERPYWEMSNQD---VIK----AIEEGYR--LPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred cCCCCCcccCCHHH---HHH----HHhCCCc--CCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 6 999987654332 111 1112211 111 112234578888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=254.64 Aligned_cols=218 Identities=26% Similarity=0.360 Sum_probs=174.4
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---------------CCCCCCHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---------------PEKQPNWVERMG 67 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---------------~~~~~~~~~~~~ 67 (252)
+...++.+|+++++++ +||||+++++++...+..+++|||+.+|+|.+++.. ..+.+++..++.
T Consensus 57 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 136 (293)
T cd05053 57 KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136 (293)
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHH
Confidence 3456789999999999 899999999999999999999999999999999853 234688999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCC
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITV 146 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~ 146 (252)
++.|++.||+|||+. +++|+||+|.||+++.++.++++|||.++........ ......++..|+|||++.+..++.
T Consensus 137 i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 213 (293)
T cd05053 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH 213 (293)
T ss_pred HHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCc
Confidence 999999999999999 9999999999999999999999999998865432221 112223456799999998888999
Q ss_pred cccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 147 KADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 147 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
++|+||||+++|++++ |..||......... .....+.... .+......+.+++.+||+.+|++|||
T Consensus 214 ~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps 280 (293)
T cd05053 214 QSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-------KLLKEGYRME------KPQNCTQELYHLMRDCWHEVPSQRPT 280 (293)
T ss_pred ccceeehhhHHHHHhcCCCCCCCCCCHHHHH-------HHHHcCCcCC------CCCCCCHHHHHHHHHHcccCcccCcC
Confidence 9999999999999997 88888655333211 1122221111 12223345888999999999999999
Q ss_pred HHHHHHHhhcCc
Q 038713 226 MKKVLLMLEGTV 237 (252)
Q Consensus 226 ~~~i~~~l~~~~ 237 (252)
+.++++.|++.+
T Consensus 281 ~~eil~~l~~~~ 292 (293)
T cd05053 281 FKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHHHHhh
Confidence 999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=257.68 Aligned_cols=219 Identities=21% Similarity=0.335 Sum_probs=175.4
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...++|.+|+.+++.++||||+++++++... ..+++++|+.+|+|.+++......++...++.++.||+.||.|||+.
T Consensus 51 ~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~- 128 (316)
T cd05108 51 KANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER- 128 (316)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc-
Confidence 4567899999999999999999999998864 57899999999999999977666788999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||||+||+++.++.++++|||.++........ ......++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 129 --~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t 206 (316)
T cd05108 129 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206 (316)
T ss_pred --CeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHc
Confidence 9999999999999999999999999999876533221 1112233567999999998889999999999999999997
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCC
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~ 239 (252)
|..||....... +. .....+.... . +......+.+++.+||+.+|++|||+.+++..|......
T Consensus 207 ~g~~p~~~~~~~~---~~----~~~~~~~~~~--~----~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 207 FGSKPYDGIPASE---IS----SILEKGERLP--Q----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCCCCCCHHH---HH----HHHhCCCCCC--C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 899987543322 11 1122221111 1 112234578889999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=240.29 Aligned_cols=224 Identities=21% Similarity=0.287 Sum_probs=174.2
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEec-----CCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFD-----VSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIAR 74 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~ 74 (252)
.++.+..++|++..++++|||+++++++... +...|++++|...|+|.+.+.. ++...++.+++.|+.+|++
T Consensus 59 ~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~ 138 (302)
T KOG2345|consen 59 QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICR 138 (302)
T ss_pred hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHH
Confidence 4678889999999999999999999998764 3358999999999999999854 4457899999999999999
Q ss_pred HHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--------ccccccCCccccccccccC---CC
Q 038713 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--------TFTGIRGTRAYVAAEWHRN---LP 143 (252)
Q Consensus 75 ~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~---~~ 143 (252)
||.+||+. .+.++|+||||.||++++++.++++|||.++...-.... .......+..|+|||.+.- ..
T Consensus 139 gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~t 217 (302)
T KOG2345|consen 139 GLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCT 217 (302)
T ss_pred HHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcc
Confidence 99999998 223999999999999999999999999998765422111 1112346889999999864 35
Q ss_pred CCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCC
Q 038713 144 ITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLR 223 (252)
Q Consensus 144 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 223 (252)
.+.++|||||||++|.|+.|..||+...... .++ .-.+.++.+..+ .....+..+.++|.+|++.||.+|
T Consensus 218 i~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-gSl----aLAv~n~q~s~P-----~~~~yse~l~~lik~mlqvdP~qR 287 (302)
T KOG2345|consen 218 ITERTDIWSLGCTLYAMMFGESPFERIYQQG-GSL----ALAVQNAQISIP-----NSSRYSEALHQLIKSMLQVDPNQR 287 (302)
T ss_pred cccccchhhhhHHHHHHHHcCCcchHHhhcC-CeE----EEeeeccccccC-----CCCCccHHHHHHHHHHhcCCcccC
Confidence 7899999999999999999999997442211 000 001112222221 122256678899999999999999
Q ss_pred CCHHHHHHHhhcCc
Q 038713 224 RAMKKVLLMLEGTV 237 (252)
Q Consensus 224 ps~~~i~~~l~~~~ 237 (252)
|++.+++..+.+.+
T Consensus 288 P~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 288 PTIPELLSKLDDLI 301 (302)
T ss_pred CCHHHHHHHHHhhc
Confidence 99999999988753
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=249.71 Aligned_cols=217 Identities=24% Similarity=0.404 Sum_probs=175.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..++++.+|++++++++|||++++++++.+.+..++||||+++++|.+++....+.+++..++.++.|++.|++|||+.
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~- 126 (268)
T cd05063 48 KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM- 126 (268)
T ss_pred HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3467899999999999999999999999999999999999999999999976666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccc--cccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT--GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+|++|+||+++.++.++++|||.+............ ....+..|+|||++.+..++.++|+||||+++|+++
T Consensus 127 --~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell 204 (268)
T cd05063 127 --NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 204 (268)
T ss_pred --CeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHH
Confidence 9999999999999999999999999998765432221111 112245799999998888899999999999999999
Q ss_pred h-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 162 C-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 162 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
+ |..||....... . . .....+... .. .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 205 ~~g~~p~~~~~~~~---~---~-~~i~~~~~~--~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 205 SFGERPYWDMSNHE---V---M-KAINDGFRL--PA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred hCCCCCCCcCCHHH---H---H-HHHhcCCCC--CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 7 999996553322 1 1 111111111 11 112234578889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=251.31 Aligned_cols=224 Identities=22% Similarity=0.305 Sum_probs=171.5
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-----------CCCCHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-----------KQPNWVERMGIARD 71 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~ 71 (252)
...+++|.+|++++++++|||++++++++...+..++||||+.+++|.+++.... ..+++..++.++.|
T Consensus 58 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 137 (295)
T cd05097 58 KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQ 137 (295)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999985421 13678888999999
Q ss_pred HHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccc
Q 038713 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADV 150 (252)
Q Consensus 72 i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di 150 (252)
++.||+|||+. +++|+||||+||+++.++.++++|||.+......... ......++..|+|||...+..++.++|+
T Consensus 138 i~~al~~lH~~---~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 214 (295)
T cd05097 138 IASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDV 214 (295)
T ss_pred HHHHHHHHHhc---CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhH
Confidence 99999999999 9999999999999999999999999998755332211 1122234668999999988889999999
Q ss_pred hhHHHHHHHHHh--CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 151 YSFGVVLLEIVC--LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 151 ~slG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
||||++++++++ +..||....... .+.. +.+............. +...+..+.+++.+||+.+|++|||+++
T Consensus 215 wSlG~~l~el~~~~~~~p~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~ 288 (295)
T cd05097 215 WAFGVTLWEMFTLCKEQPYSLLSDEQ--VIEN-TGEFFRNQGRQIYLSQ---TPLCPSPVFKLMMRCWSRDIKDRPTFNK 288 (295)
T ss_pred HHHHHHHHHHHHcCCCCCCcccChHH--HHHH-HHHhhhhccccccCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 999999999988 566776543322 1111 1111111111111110 1112345888999999999999999999
Q ss_pred HHHHhhc
Q 038713 229 VLLMLEG 235 (252)
Q Consensus 229 i~~~l~~ 235 (252)
|++.|++
T Consensus 289 i~~~l~~ 295 (295)
T cd05097 289 IHHFLRE 295 (295)
T ss_pred HHHHHhC
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=248.66 Aligned_cols=214 Identities=26% Similarity=0.372 Sum_probs=174.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+++.+|+.+++.++||||+++++++.+....++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~- 123 (261)
T cd05148 45 KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ- 123 (261)
T ss_pred hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4567899999999999999999999999999999999999999999999763 34589999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++|+||+|+||+++.++.++++|||.+.......... ....++..|+|||...+..++.++|+||||+++|++++
T Consensus 124 --~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~ 200 (261)
T cd05148 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200 (261)
T ss_pred --CeeccccCcceEEEcCCceEEEccccchhhcCCccccc-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999987654332211 22345668999999988889999999999999999998
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
|..||........ + .... .+.... .+......+.+++.+||+.+|++|||+.++++.|++
T Consensus 201 g~~p~~~~~~~~~--~----~~~~-~~~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 201 GQVPYPGMNNHEV--Y----DQIT-AGYRMP------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCcCCHHHH--H----HHHH-hCCcCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 7888865542221 1 1111 111110 112233457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=247.68 Aligned_cols=212 Identities=25% Similarity=0.328 Sum_probs=173.9
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
....+++.+|+.+++.++|||++++++++.+.+..++|+||+++++|.+++... ...++...++.++.|++.||.|||+
T Consensus 40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~ 119 (256)
T cd08529 40 RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119 (256)
T ss_pred HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999999664 4568899999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
. +++|+|++|+||+++.++.++++|||.+......... .....++..|+|||+..+..++.++|+||||+++++++
T Consensus 120 ~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 195 (256)
T cd08529 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECC 195 (256)
T ss_pred C---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence 9 9999999999999999999999999998765433221 12235678899999999888999999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|+.||....... . ... ...+..... +......+.+++.+||+.+|++||++.++++
T Consensus 196 ~g~~p~~~~~~~~---~---~~~-~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 196 TGKHPFDANNQGA---L---ILK-IIRGVFPPV------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred hCCCCCCCCCHHH---H---HHH-HHcCCCCCC------ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 9999997654221 1 111 112222111 1133455888888999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=239.29 Aligned_cols=214 Identities=21% Similarity=0.305 Sum_probs=174.9
Q ss_pred chHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 2 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
++.+.+++.+|+.+-+.|+||||+++.+........|+|+|+++||+|..-+-.. ...++..+.....||++||.|+|.
T Consensus 50 ~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~ 128 (355)
T KOG0033|consen 50 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHS 128 (355)
T ss_pred ccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHh
Confidence 3456788999999999999999999999999999999999999999998777433 457788888999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecC---CCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDE---KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
+ +|+|||+||.|+++.. ..-+|++|||++...+ ......+..|+++|+|||+....+++..+|||+.|+++|
T Consensus 129 n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLf 203 (355)
T KOG0033|consen 129 N---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILY 203 (355)
T ss_pred c---CceeccCChhheeeeeccCCCceeecccceEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHH
Confidence 9 9999999999999963 3458999999999877 334556688999999999999999999999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
-++.|..||.+..... +.+.+.+|.........+...+. ..+|+++||..||++|.|+.|.++
T Consensus 204 iLL~G~~PF~~~~~~r-------lye~I~~g~yd~~~~~w~~is~~---Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 204 ILLVGYPPFWDEDQHR-------LYEQIKAGAYDYPSPEWDTVTPE---AKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHhCCCCCCCccHHH-------HHHHHhccccCCCCcccCcCCHH---HHHHHHHHhccChhhhccHHHHhC
Confidence 9999999998754332 22334444443222222333333 455666999999999999999774
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=247.70 Aligned_cols=216 Identities=23% Similarity=0.297 Sum_probs=171.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.|.+|+.+++.+.||||+++++++. ....++||||+++|+|.+++.. .+.+++..++.++.|++.||.+||+.
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~- 114 (257)
T cd05116 38 ALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEET- 114 (257)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 35678999999999999999999999886 4567899999999999999954 34689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc--cccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT--FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||||.||+++.++.++++|||.+.......... .....++..|+|||.+.+..++.++|+||||+++|+++
T Consensus 115 --~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 192 (257)
T cd05116 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAF 192 (257)
T ss_pred --CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHH
Confidence 99999999999999999999999999987654332211 11122356899999998878899999999999999999
Q ss_pred h-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 162 C-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 162 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
+ |..||....... .. .....+..... +......+.++|.+||+.||++|||+.+|...|++..
T Consensus 193 t~g~~p~~~~~~~~---~~----~~i~~~~~~~~------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 193 SYGQKPYKGMKGNE---VT----QMIESGERMEC------PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred hCCCCCCCCCCHHH---HH----HHHHCCCCCCC------CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 8 899997553332 11 11222222111 1122344778888999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=251.50 Aligned_cols=215 Identities=21% Similarity=0.317 Sum_probs=169.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------CCCCHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------KQPNWVERMGIARDIARG 75 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~ 75 (252)
...+|.+|+.+++.++||||+++++++...+..++||||+++|+|.+++.... ..+++..+..++.|++.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (277)
T cd05062 52 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131 (277)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHH
Confidence 45678999999999999999999999999999999999999999999985422 235777888999999999
Q ss_pred HHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc-cccccCCccccccccccCCCCCCcccchhHH
Q 038713 76 IRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT-FTGIRGTRAYVAAEWHRNLPITVKADVYSFG 154 (252)
Q Consensus 76 l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 154 (252)
|.|||+. +++|+||||+||++++++.++++|||.+.......... .....++..|+|||++.+..++.++|+||||
T Consensus 132 l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 208 (277)
T cd05062 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 208 (277)
T ss_pred HHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHH
Confidence 9999999 99999999999999999999999999987543322211 1112346689999999988899999999999
Q ss_pred HHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 038713 155 VVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233 (252)
Q Consensus 155 ~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l 233 (252)
+++|++++ |..||....... . . .....+..... +......+.+++.+||+.+|++|||+.++++.|
T Consensus 209 ~~l~el~~~~~~p~~~~~~~~---~---~-~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 209 VVLWEIATLAEQPYQGMSNEQ---V---L-RFVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred HHHHHHHcCCCCCCCCCCHHH---H---H-HHHHcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 99999998 678886543321 1 1 11122222111 112234578888899999999999999999998
Q ss_pred hc
Q 038713 234 EG 235 (252)
Q Consensus 234 ~~ 235 (252)
++
T Consensus 276 ~~ 277 (277)
T cd05062 276 KE 277 (277)
T ss_pred hC
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=260.65 Aligned_cols=206 Identities=22% Similarity=0.210 Sum_probs=169.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++||||+++++++.+.+..++||||+.+|+|.+++... +.+++..+..++.|++.||.|||+.
T Consensus 74 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~-- 150 (340)
T PTZ00426 74 QVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSL-- 150 (340)
T ss_pred hHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4567889999999999999999999999999999999999999999999644 4688999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+||+++.++.++++|||.+....... ....|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 151 -~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~ 225 (340)
T PTZ00426 151 -NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGC 225 (340)
T ss_pred -CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCC
Confidence 99999999999999999999999999987653221 2346788999999999888999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLLM 232 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~~ 232 (252)
.||....... . ......+.... +......+.+++.+||+.+|++|+ |++++++.
T Consensus 226 ~Pf~~~~~~~---~----~~~i~~~~~~~-------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 226 PPFYANEPLL---I----YQKILEGIIYF-------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCCHHH---H----HHHHhcCCCCC-------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 9998653321 1 11122222211 111223467788899999999995 88888653
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=258.24 Aligned_cols=207 Identities=23% Similarity=0.222 Sum_probs=167.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
...+.+|+.+++.++||||+++++++..++..++||||+.+|+|.+++.. .+.+.+..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--- 119 (323)
T cd05584 44 TAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQ--- 119 (323)
T ss_pred HHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 35678999999999999999999999999999999999999999999854 34578888888999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
+++|+||||+||+++.++.++|+|||.+........ ......|+..|+|||++.+..++.++||||||+++|+|++|..
T Consensus 120 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 198 (323)
T cd05584 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198 (323)
T ss_pred CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCC
Confidence 999999999999999999999999999864332221 1123457899999999998889999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
||........ ... ...+... .+......+.+++.+||+.+|++|| +++++++
T Consensus 199 pf~~~~~~~~------~~~-~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 199 PFTAENRKKT------IDK-ILKGKLN-------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCHHHH------HHH-HHcCCCC-------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 9976543321 111 1122211 1112234577888899999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=260.14 Aligned_cols=214 Identities=21% Similarity=0.222 Sum_probs=171.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.+++......+++..+..++.|++.||.|||+.
T Consensus 43 ~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~- 121 (330)
T cd05601 43 ETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM- 121 (330)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4567789999999999999999999999999999999999999999999977666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc------CCCCCCcccchhHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR------NLPITVKADVYSFGVVL 157 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Di~slG~~l 157 (252)
+++||||||+||+++.++.++|+|||.+...............|+..|+|||++. +..++.++||||||+++
T Consensus 122 --~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 199 (330)
T cd05601 122 --GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIA 199 (330)
T ss_pred --CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeeccccee
Confidence 9999999999999999999999999999866543332223346788999999986 34578999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|+|++|..||........ ................. .....+.+++.+||. +|++|||+++++.
T Consensus 200 ~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~~----~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 200 YEMIYGRSPFHEGTSAKT------YNNIMNFQRFLKFPEDP----KVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred eeeccCCCCCCCCCHHHH------HHHHHcCCCccCCCCCC----CCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 999999999976543321 11111111111111111 123447778889997 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=254.38 Aligned_cols=223 Identities=23% Similarity=0.325 Sum_probs=177.0
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------------CCCCHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------------KQPNWVERMG 67 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~ 67 (252)
+..+++.+|+.+++.+ +||||+++++++......+++|||+.+|+|.+++.... ..+++..++.
T Consensus 62 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (304)
T cd05101 62 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141 (304)
T ss_pred HHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHH
Confidence 4456799999999999 89999999999999999999999999999999986431 3467888899
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc-cccccCCccccccccccCCCCCC
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT-FTGIRGTRAYVAAEWHRNLPITV 146 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~ 146 (252)
++.|++.||.|||+. +++|+||||+||+++.++.++++|||.++......... .....++..|+|||++.+..++.
T Consensus 142 ~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 218 (304)
T cd05101 142 CTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 218 (304)
T ss_pred HHHHHHHHHHHHHHC---CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCc
Confidence 999999999999999 99999999999999999999999999988664332211 11223456799999998888999
Q ss_pred cccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 147 KADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 147 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
++|+||||+++|++++ |..||....... ... ....+.... .+......+.+++.+||+.+|++|||
T Consensus 219 ~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~-~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rps 285 (304)
T cd05101 219 QSDVWSFGVLMWEIFTLGGSPYPGIPVEE------LFK-LLKEGHRMD------KPANCTNELYMMMRDCWHAIPSHRPT 285 (304)
T ss_pred hhhHHHHHHHHHHHHcCCCCCcccCCHHH------HHH-HHHcCCcCC------CCCCCCHHHHHHHHHHcccChhhCCC
Confidence 9999999999999998 777776543322 111 122221111 11223345778888999999999999
Q ss_pred HHHHHHHhhcCcCCCCC
Q 038713 226 MKKVLLMLEGTVEIPIP 242 (252)
Q Consensus 226 ~~~i~~~l~~~~~~~~~ 242 (252)
+.++++.|++++...++
T Consensus 286 ~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 286 FKQLVEDLDRILTLTTN 302 (304)
T ss_pred HHHHHHHHHHHHHhhhc
Confidence 99999999998766543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=265.62 Aligned_cols=224 Identities=25% Similarity=0.364 Sum_probs=185.4
Q ss_pred chHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 2 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
++++.+.|.+|+.++++-+|.||+-+.|++..... .||+.+|+|.+|..++......++....++|+.||++|+.|||.
T Consensus 428 t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA 506 (678)
T KOG0193|consen 428 TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA 506 (678)
T ss_pred CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh
Confidence 57789999999999999999999999999998776 99999999999999998888889999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccC---CCCCCcccchhHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRN---LPITVKADVYSFGVVL 157 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l 157 (252)
+ +|+|+|+|..|||+.+++.|+|+|||++....-... .......|...|||||++.. ..|+..+||||||+++
T Consensus 507 K---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~ 583 (678)
T KOG0193|consen 507 K---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVW 583 (678)
T ss_pred h---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHH
Confidence 9 999999999999999999999999999976543322 22233457788999999874 3589999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
|||+||..||.....+. +.-.+..|... .+.......+.+.+.+|+..||.+++++||++.+|+..|++.+
T Consensus 584 YELltg~lPysi~~~dq-------IifmVGrG~l~--pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 584 YELLTGELPYSIQNRDQ-------IIFMVGRGYLM--PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred HHHHhCcCCcCCCChhh-------eEEEecccccC--ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 99999999998332221 11123334322 2222345566777888888999999999999999999888755
Q ss_pred C
Q 038713 238 E 238 (252)
Q Consensus 238 ~ 238 (252)
.
T Consensus 655 ~ 655 (678)
T KOG0193|consen 655 P 655 (678)
T ss_pred h
Confidence 4
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=246.34 Aligned_cols=214 Identities=28% Similarity=0.393 Sum_probs=176.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC--------CCCCCHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP--------EKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l 76 (252)
..+++.+|++.++.++|+|++++++++.+....+++|||+++++|.+++... ...+++..++.++.|++.||
T Consensus 39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al 118 (262)
T cd00192 39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118 (262)
T ss_pred HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence 3678999999999999999999999999999999999999999999999765 46789999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchhHHH
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGV 155 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 155 (252)
.+||+. +++|+||+|+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|+||||+
T Consensus 119 ~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (262)
T cd00192 119 EYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGV 195 (262)
T ss_pred HHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHH
Confidence 999999 999999999999999999999999999987654321 1222344677899999998888999999999999
Q ss_pred HHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 156 VLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 156 ~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
++|++++ |..||....... +. .....+.... .+......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 196 il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 196 LLWEIFTLGATPYPGLSNEE---VL----EYLRKGYRLP------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHhcCCCCCCCCCHHH---HH----HHHHcCCCCC------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 9999998 588887663322 11 1111111111 12222456888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=248.24 Aligned_cols=217 Identities=24% Similarity=0.406 Sum_probs=174.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...++|.+|+.++++++||||+++++++.+....++||||+++|+|.+++....+.+++..++.++.|++.||.|||+.
T Consensus 47 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~- 125 (269)
T cd05065 47 KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM- 125 (269)
T ss_pred HHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4567899999999999999999999999999999999999999999999977667789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-cccc-cc--CCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTG-IR--GTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~-~~--~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
+++|+||+|+||+++.++.++++|||.+......... .... .. .+..|+|||.+.+..++.++|+||||+++|+
T Consensus 126 --g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e 203 (269)
T cd05065 126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 203 (269)
T ss_pred --CEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHH
Confidence 9999999999999999999999999998755432211 1111 11 1347999999998889999999999999999
Q ss_pred HHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 160 IVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 160 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
+++ |..||....... ....+ ... . .... +.+.+..+.+++.+||+.+|++||++++|+..|+++
T Consensus 204 ~l~~g~~p~~~~~~~~---~~~~i----~~~-~-~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 204 VMSYGERPYWDMSNQD---VINAI----EQD-Y-RLPP----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HhcCCCCCCCCCCHHH---HHHHH----HcC-C-cCCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 886 999987654332 11111 111 1 1111 112234577888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=249.99 Aligned_cols=219 Identities=17% Similarity=0.303 Sum_probs=175.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
+..++|.+|+++++.++||||+++++++.+.+..++++||+++|+|.+++.. ....++...++.++.|++.||.|||
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 123 (267)
T cd08228 44 KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123 (267)
T ss_pred HHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh
Confidence 4566799999999999999999999999999999999999999999988743 3345788999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+. +++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+..++.++|+||+|+++|++
T Consensus 124 ~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el 199 (267)
T cd08228 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred hC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHH
Confidence 99 999999999999999999999999999876543222 11224567889999999888889999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
++|+.||....... ..+ .. .......... ........+.+++.+||..+|++|||++++++.++..
T Consensus 200 ~~g~~p~~~~~~~~-~~~---~~-~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 200 AALQSPFYGDKMNL-FSL---CQ-KIEQCDYPPL-----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred hcCCCCCccccccH-HHH---HH-HHhcCCCCCC-----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 99999986543221 111 11 1222111111 1122345588888899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=247.02 Aligned_cols=215 Identities=23% Similarity=0.311 Sum_probs=171.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+++.+|+.+++++.|||++++++++. .+..++||||+.+|+|.+++.... .+++..++.++.|++.||.|||..
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~-- 114 (257)
T cd05060 39 GKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESK-- 114 (257)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhc--
Confidence 4568999999999999999999999876 456899999999999999996544 689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCccc--ccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF--TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.++.......... ....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 115 -~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 193 (257)
T cd05060 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193 (257)
T ss_pred -CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHc
Confidence 999999999999999999999999999876543322111 11123457999999988889999999999999999998
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
|..||....... +... ...+... . .+......+.+++.+||+.+|++|||+.++++.|++..
T Consensus 194 ~g~~p~~~~~~~~---~~~~----~~~~~~~--~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 194 YGAKPYGEMKGAE---VIAM----LESGERL--P----RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCcccCCHHH---HHHH----HHcCCcC--C----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 899987553321 2111 1122111 1 11222345788888999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=261.54 Aligned_cols=205 Identities=23% Similarity=0.232 Sum_probs=166.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
....+.+|++++++++||||+++++++.+.+..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.
T Consensus 41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~-- 117 (318)
T cd05582 41 DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSL-- 117 (318)
T ss_pred hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 455678999999999999999999999999999999999999999999854 34589999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||||+||+++.++.++++|||.+........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|+
T Consensus 118 -~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 195 (318)
T cd05582 118 -GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGS 195 (318)
T ss_pred -CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCC
Confidence 999999999999999999999999999875433221 122346788999999999888899999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
.||........ ... ...+... .+......+.+++.+||+.||++|||+.+
T Consensus 196 ~p~~~~~~~~~------~~~-i~~~~~~-------~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 196 LPFQGKDRKET------MTM-ILKAKLG-------MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHH------HHH-HHcCCCC-------CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 99976543221 111 1111111 11122344778888999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=249.35 Aligned_cols=216 Identities=27% Similarity=0.357 Sum_probs=170.8
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------------CCCCHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------------KQPNWVERMG 67 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~ 67 (252)
...+.+.+|+++++++ +||||+++++++...+..+++|||+++|+|.+++.... ..+++..++.
T Consensus 37 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 116 (270)
T cd05047 37 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116 (270)
T ss_pred HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHH
Confidence 4567899999999999 89999999999999999999999999999999985432 2478889999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCc
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVK 147 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 147 (252)
++.|++.||.|||+. +++|+||||+||+++.++.++++|||++........ ......+..|+|||++.+..++.+
T Consensus 117 ~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~ 191 (270)
T cd05047 117 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTN 191 (270)
T ss_pred HHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCCccccchhhh--ccCCCCccccCChHHHccCCCCch
Confidence 999999999999999 999999999999999999999999998753221111 111123457999999988889999
Q ss_pred ccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 148 ADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 148 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
+|+||||+++|++++ |..||....... . .... ..+.... .+......+.+++.+||+.+|.+|||+
T Consensus 192 ~Di~slG~il~el~~~g~~pf~~~~~~~---~---~~~~-~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~ 258 (270)
T cd05047 192 SDVWSYGVLLWEIVSLGGTPYCGMTCAE---L---YEKL-PQGYRLE------KPLNCDDEVYDLMRQCWREKPYERPSF 258 (270)
T ss_pred hhHHHHHHHHHHHHcCCCCCccccCHHH---H---HHHH-hCCCCCC------CCCcCCHHHHHHHHHHcccChhhCCCH
Confidence 999999999999997 999986543322 1 1111 1111111 111223457888889999999999999
Q ss_pred HHHHHHhhcCc
Q 038713 227 KKVLLMLEGTV 237 (252)
Q Consensus 227 ~~i~~~l~~~~ 237 (252)
.+++..|++++
T Consensus 259 ~~il~~l~~~~ 269 (270)
T cd05047 259 AQILVSLNRML 269 (270)
T ss_pred HHHHHHHHHhh
Confidence 99999998865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=248.97 Aligned_cols=219 Identities=19% Similarity=0.288 Sum_probs=175.3
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
.+..+.|.+|+.++++++||||+++++++.+ ...++||||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 48 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 126 (270)
T cd05056 48 PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK 126 (270)
T ss_pred HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456789999999999999999999998876 457899999999999999976666689999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.+...............++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 127 ---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 203 (270)
T cd05056 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203 (270)
T ss_pred ---CeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHH
Confidence 99999999999999999999999999987654432222222234567999999988889999999999999999986
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
|..||......+.. .....+..... +...+..+.+++.+|+..+|++|||+.++++.|++...
T Consensus 204 ~g~~pf~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 204 LGVKPFQGVKNNDVI-------GRIENGERLPM------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred cCCCCCCCCCHHHHH-------HHHHcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99999765433211 11122221111 11223457888889999999999999999999988553
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=262.64 Aligned_cols=206 Identities=23% Similarity=0.383 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|+++++.++||||+.++++|+...++++|.|||.| +|..++. ..+.++++.+..++.++++||.|||+.
T Consensus 45 l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~--- 119 (808)
T KOG0597|consen 45 LKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSN--- 119 (808)
T ss_pred HHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhc---
Confidence 45589999999999999999999999999999999999966 9999995 455689999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
+|.|||+||.||++..+|.+|++|||+++.+... ........||+-|||||+..+..|+..+|.||+||++||+++|++
T Consensus 120 rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~P 198 (808)
T KOG0597|consen 120 RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQP 198 (808)
T ss_pred CcccccCCcceeeecCCCceeechhhhhhhcccC-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999999976542 234455789999999999999999999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||..... ...++..... +. ..+......+..++...|.+||.+|.|+.+++.
T Consensus 199 PF~a~si------~~Lv~~I~~d-~v-------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 199 PFYARSI------TQLVKSILKD-PV-------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CchHHHH------HHHHHHHhcC-CC-------CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 9986532 2333333221 22 223345556888889999999999999999874
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=255.98 Aligned_cols=163 Identities=22% Similarity=0.351 Sum_probs=142.6
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+++.+|++++++++||||+++++++.+.+..++||||+.+|+|.+++.. .+.+++..+..++.|++.||.|||+.
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~- 122 (333)
T cd06650 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREK- 122 (333)
T ss_pred HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhc-
Confidence 3457799999999999999999999999999999999999999999999954 34578888999999999999999974
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
.+++|+||||+||+++.++.++++|||.+........ ....++..|+|||++.+..++.++|+||||+++|++++|
T Consensus 123 -~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g 198 (333)
T cd06650 123 -HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198 (333)
T ss_pred -CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc---ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 1699999999999999999999999999875432211 224578899999999988899999999999999999999
Q ss_pred Cccccccch
Q 038713 164 RRCLDQNLL 172 (252)
Q Consensus 164 ~~p~~~~~~ 172 (252)
+.||.....
T Consensus 199 ~~p~~~~~~ 207 (333)
T cd06650 199 RYPIPPPDA 207 (333)
T ss_pred CCCCCCcch
Confidence 999976543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=250.19 Aligned_cols=216 Identities=25% Similarity=0.332 Sum_probs=171.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC----------------CCCCCHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP----------------EKQPNWVERMG 67 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~ 67 (252)
+..+.|.+|+.++++++||||+++++++......+++|||+++|+|.+++... ...+++...+.
T Consensus 49 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 128 (283)
T cd05090 49 QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128 (283)
T ss_pred HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHH
Confidence 34567999999999999999999999999999999999999999999998422 12467888899
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCC
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITV 146 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~ 146 (252)
++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.
T Consensus 129 i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 205 (283)
T cd05090 129 IAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205 (283)
T ss_pred HHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCc
Confidence 999999999999999 999999999999999999999999999876543221 1112233456799999998888999
Q ss_pred cccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 147 KADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 147 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
++|+||||+++|++++ |..||....... +. .....+..... +......+.+++.+||+.+|++||+
T Consensus 206 ~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~ 272 (283)
T cd05090 206 DSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VI----EMVRKRQLLPC------SEDCPPRMYSLMTECWQEGPSRRPR 272 (283)
T ss_pred hhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHcCCcCCC------CCCCCHHHHHHHHHHcccCcccCcC
Confidence 9999999999999998 888886543221 11 12222222111 1122345778888999999999999
Q ss_pred HHHHHHHhhc
Q 038713 226 MKKVLLMLEG 235 (252)
Q Consensus 226 ~~~i~~~l~~ 235 (252)
+.+|++.|..
T Consensus 273 ~~~i~~~l~~ 282 (283)
T cd05090 273 FKDIHTRLRS 282 (283)
T ss_pred HHHHHHHhhc
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=246.37 Aligned_cols=215 Identities=25% Similarity=0.364 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++|.+|++++++++||||+++++.+.+ ...++||||+++|+|.+++... ...+++..++.++.|++.||.+||+.
T Consensus 45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-- 121 (262)
T cd05071 45 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM-- 121 (262)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4679999999999999999999998754 5579999999999999999653 34578899999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-C
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-L 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 163 (252)
+++|+||+|+||++++++.++++|||.+...............++..|+|||...+..++.++|+||||+++|++++ |
T Consensus 122 -~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g 200 (262)
T cd05071 122 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 200 (262)
T ss_pred -CccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999987654333222223345668999999988889999999999999999999 7
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
..||........ . .....+... .........+.+++.+|++.+|++|||++++++.|++.+
T Consensus 201 ~~p~~~~~~~~~------~-~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 201 RVPYPGMVNREV------L-DQVERGYRM------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCCCCChHHH------H-HHHhcCCCC------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 778865533321 1 111111111 112234456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=251.85 Aligned_cols=218 Identities=26% Similarity=0.360 Sum_probs=173.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-----------------------CCCCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-----------------------EKQPN 61 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----------------------~~~~~ 61 (252)
..+++.+|+.+++.++||||+++++.+...+..++++||+.+|+|.+++... ...++
T Consensus 46 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 125 (290)
T cd05045 46 ELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125 (290)
T ss_pred HHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccC
Confidence 4567999999999999999999999999999999999999999999987532 13477
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCcccccccccc
Q 038713 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHR 140 (252)
Q Consensus 62 ~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~ 140 (252)
+..++.++.|++.||.|||+. +++|+||+|+||++++++.++++|||.++........ ......++..|+|||.+.
T Consensus 126 ~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 202 (290)
T cd05045 126 MGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF 202 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc
Confidence 888999999999999999999 9999999999999999999999999998754322211 111223456899999998
Q ss_pred CCCCCCcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCC
Q 038713 141 NLPITVKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDE 219 (252)
Q Consensus 141 ~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 219 (252)
+..++.++|+||||+++++|++ |..||....... +.+ ....+... .. +......+.+++.+||+.+
T Consensus 203 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~--~~----~~~~~~~~~~~i~~cl~~~ 269 (290)
T cd05045 203 DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER---LFN----LLKTGYRM--ER----PENCSEEMYNLMLTCWKQE 269 (290)
T ss_pred cCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHhCCCCC--CC----CCCCCHHHHHHHHHHccCC
Confidence 8889999999999999999998 888886553332 111 11211111 11 1122345888899999999
Q ss_pred CCCCCCHHHHHHHhhcCcC
Q 038713 220 PSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 220 p~~Rps~~~i~~~l~~~~~ 238 (252)
|++|||+.++++.|++.+.
T Consensus 270 P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 270 PDKRPTFADISKELEKMMV 288 (290)
T ss_pred cccCCCHHHHHHHHHHHHh
Confidence 9999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=263.54 Aligned_cols=208 Identities=27% Similarity=0.372 Sum_probs=175.6
Q ss_pred HHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 038713 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIH 89 (252)
Q Consensus 10 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h 89 (252)
..+++-|++|.||||+++.|+|....-+|||||||..|-|..+|+ .++.++.+....|..+|+.|+.|||.+ .|+|
T Consensus 160 ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIH 235 (904)
T KOG4721|consen 160 ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIH 235 (904)
T ss_pred hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhh
Confidence 357788999999999999999999999999999999999999995 455688999999999999999999999 9999
Q ss_pred eccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccc
Q 038713 90 GDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQ 169 (252)
Q Consensus 90 ~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 169 (252)
||+|.-|||++.+..+||+|||-++...+.. ......||..|||||++..+.-+.|.||||||++||||+||..||..
T Consensus 236 RDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 236 RDLKSPNILISYDDVVKISDFGTSKELSDKS--TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred hccCCCceEeeccceEEeccccchHhhhhhh--hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 9999999999999999999999998765442 23446799999999999999999999999999999999999999975
Q ss_pred cchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 170 NLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
.+... ..+.-|...-.+ ..+..++.-|.-|+++||+..|..|||+.||+..|.=
T Consensus 314 VdssA---------IIwGVGsNsL~L---pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 314 VDSSA---------IIWGVGSNSLHL---PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cchhe---------eEEeccCCcccc---cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 43321 122222221111 3355666668888899999999999999999988753
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=247.88 Aligned_cols=216 Identities=23% Similarity=0.324 Sum_probs=172.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC---------CCCCCHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP---------EKQPNWVERMGIARDIAR 74 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~~i~~ 74 (252)
.....|.+|+.+++.++||||+++++++......++||||+++|+|.+++... ...+++..++.++.|++.
T Consensus 51 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 130 (277)
T cd05032 51 RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999998542 224678889999999999
Q ss_pred HHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhH
Q 038713 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSF 153 (252)
Q Consensus 75 ~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 153 (252)
||.|||+. +++|+||+|+||+++.++.++++|||.++........ ......++..|+|||.+.+..++.++|+|||
T Consensus 131 ~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05032 131 GMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF 207 (277)
T ss_pred HHHHHHhC---CccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHH
Confidence 99999999 9999999999999999999999999998765433221 1122345678999999988889999999999
Q ss_pred HHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 154 GVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 154 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
|+++|++++ |..||....... ... ....+..... +......+.+++.+||+.+|++|||+.++++.
T Consensus 208 G~il~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 208 GVVLWEMATLAEQPYQGLSNEE---VLK----FVIDGGHLDL------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred HHHHHHhhccCCCCCccCCHHH---HHH----HHhcCCCCCC------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999998 888886543332 111 1122221111 11124558888999999999999999999999
Q ss_pred hhc
Q 038713 233 LEG 235 (252)
Q Consensus 233 l~~ 235 (252)
|++
T Consensus 275 l~~ 277 (277)
T cd05032 275 LKD 277 (277)
T ss_pred hcC
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=248.46 Aligned_cols=220 Identities=22% Similarity=0.339 Sum_probs=176.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|+.+++.++||||+++++++.. ...+++++|+++|+|.+++....+.+++..++.++.|++.||.|||+.
T Consensus 51 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~- 128 (279)
T cd05109 51 KANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV- 128 (279)
T ss_pred HHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 346778999999999999999999999875 457899999999999999977666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||||+||++++++.++++|||.++........ ......++..|+|||...+..++.++|+||||+++|++++
T Consensus 129 --~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t 206 (279)
T cd05109 129 --RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206 (279)
T ss_pred --CeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHc
Confidence 9999999999999999999999999998866433221 1112234567999999988889999999999999999998
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCCC
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIP 240 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 240 (252)
|..||....... +.. ....+..... +......+.+++.+||+.||++|||+.++++.|+++...|
T Consensus 207 ~g~~p~~~~~~~~---~~~----~~~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 207 FGAKPYDGIPARE---IPD----LLEKGERLPQ------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CCCCCCCCCCHHH---HHH----HHHCCCcCCC------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 888886543322 111 1222221111 1123345788888999999999999999999999876655
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=245.82 Aligned_cols=216 Identities=24% Similarity=0.313 Sum_probs=173.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
+..++|.+|+.++++++||||+++++++.+ ...++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+.
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 116 (257)
T cd05040 38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116 (257)
T ss_pred HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC
Confidence 456789999999999999999999999988 88999999999999999996654 5689999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--ccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||+|+||+++.++.++++|||.+......... ......++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 117 ---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el 193 (257)
T cd05040 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193 (257)
T ss_pred ---CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHH
Confidence 9999999999999999999999999998866432211 11123456789999999988899999999999999999
Q ss_pred Hh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 161 VC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 161 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
++ |..||......+ ... .....+.. .. .+...+..+.+++.+||+.+|++|||+.++++.|.+
T Consensus 194 ~t~g~~p~~~~~~~~---~~~---~~~~~~~~--~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 194 FTYGEEPWAGLSGSQ---ILK---KIDKEGER--LE----RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred HhCCCCCCCCCCHHH---HHH---HHHhcCCc--CC----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 98 999986553332 111 11111111 11 111233558888889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=259.66 Aligned_cols=208 Identities=21% Similarity=0.222 Sum_probs=167.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD-EC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~ 83 (252)
....+.+|+++++.++||||+++++++...+..++||||+++|+|..++.. .+.+++..++.++.||+.||.|||+ .
T Consensus 38 ~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~- 115 (325)
T cd05594 38 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEK- 115 (325)
T ss_pred HHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcC-
Confidence 456778999999999999999999999999999999999999999998854 3468999999999999999999997 7
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++|+|||.+........ ......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 116 --~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG 192 (325)
T cd05594 116 --NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192 (325)
T ss_pred --CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccC
Confidence 999999999999999999999999999865322211 12234588999999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
..||......... .....+.... +......+.+++.+||+.||++|+ ++.++++
T Consensus 193 ~~Pf~~~~~~~~~-------~~i~~~~~~~-------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 193 RLPFYNQDHEKLF-------ELILMEEIRF-------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCCCCHHHHH-------HHHhcCCCCC-------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 9999765433211 1111111111 111233477888899999999997 8999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=248.09 Aligned_cols=216 Identities=23% Similarity=0.302 Sum_probs=171.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC--------------CCCCHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE--------------KQPNWVERMGIA 69 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~ 69 (252)
...++|.+|+++++.++|+||+++++++.+....+++|||+.+|+|.+++.... ..+++..++.++
T Consensus 49 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 128 (280)
T cd05092 49 SARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128 (280)
T ss_pred HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHH
Confidence 345789999999999999999999999999999999999999999999985432 347888999999
Q ss_pred HHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcc
Q 038713 70 RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKA 148 (252)
Q Consensus 70 ~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~ 148 (252)
.|++.|++|||+. +++|+||+|+||++++++.++++|||.+......... ......++..|+|||.+.+..++.++
T Consensus 129 ~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 205 (280)
T cd05092 129 SQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTES 205 (280)
T ss_pred HHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchh
Confidence 9999999999999 9999999999999999999999999998754322211 11222346789999999988899999
Q ss_pred cchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 149 DVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 149 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
|+||||+++|++++ |..||........ .... ..+... ..+.. .+..+.+++.+||+.+|.+||+++
T Consensus 206 Di~slG~il~el~~~g~~p~~~~~~~~~------~~~~-~~~~~~--~~~~~----~~~~~~~li~~cl~~~P~~Rp~~~ 272 (280)
T cd05092 206 DIWSFGVVLWEIFTYGKQPWYQLSNTEA------IECI-TQGREL--ERPRT----CPPEVYAIMQGCWQREPQQRMVIK 272 (280)
T ss_pred hHHHHHHHHHHHHcCCCCCCccCCHHHH------HHHH-HcCccC--CCCCC----CCHHHHHHHHHHccCChhhCCCHH
Confidence 99999999999998 8888865433321 1111 111111 11112 223477888899999999999999
Q ss_pred HHHHHhhc
Q 038713 228 KVLLMLEG 235 (252)
Q Consensus 228 ~i~~~l~~ 235 (252)
+|++.|+.
T Consensus 273 ~l~~~l~~ 280 (280)
T cd05092 273 DIHSRLQA 280 (280)
T ss_pred HHHHHHhC
Confidence 99999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=249.31 Aligned_cols=216 Identities=25% Similarity=0.328 Sum_probs=170.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC------CCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE------KQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~ 77 (252)
.....|.+|+.++++++|+||+++++++.+....++||||+++|+|.+++.... ..+++..++.++.||+.||.
T Consensus 51 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 130 (277)
T cd05036 51 QDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHH
Confidence 345679999999999999999999999999999999999999999999985432 24788999999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCC---ceEEcccCcccccCCCCCcc-cccccCCccccccccccCCCCCCcccchhH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKR---CAKISDFGLAKLMKPDQTRT-FTGIRGTRAYVAAEWHRNLPITVKADVYSF 153 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 153 (252)
|||+. +++|+||+|+||+++.++ .++++|||.++......... ......+..|+|||++.+..++.++|||||
T Consensus 131 ~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 207 (277)
T cd05036 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSF 207 (277)
T ss_pred HHHHC---CEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHH
Confidence 99999 999999999999998654 58999999987653221111 111223457999999988889999999999
Q ss_pred HHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 154 GVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 154 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
|+++|++++ |..||........ ........... .+...+..+.+++.+||+.+|++|||+.+|++.
T Consensus 208 G~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~-------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 208 GVLLWEIFSLGYMPYPGRTNQEV------MEFVTGGGRLD-------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHH------HHHHHcCCcCC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999997 8888876543321 11111111111 112223457888889999999999999999999
Q ss_pred hhc
Q 038713 233 LEG 235 (252)
Q Consensus 233 l~~ 235 (252)
|++
T Consensus 275 l~~ 277 (277)
T cd05036 275 IQY 277 (277)
T ss_pred hhC
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=252.40 Aligned_cols=222 Identities=25% Similarity=0.342 Sum_probs=174.4
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------------CCCCHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------------KQPNWVERMG 67 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~ 67 (252)
...+.|.+|+.+++++ +||||+++++++...+..++++||+++|+|.+++.... ..+++..++.
T Consensus 44 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 123 (297)
T cd05089 44 NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123 (297)
T ss_pred HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHH
Confidence 3457799999999999 79999999999999999999999999999999985422 3478889999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCc
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVK 147 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 147 (252)
++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+......... .....+..|+|||...+..++.+
T Consensus 124 i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~ 198 (297)
T cd05089 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK--TMGRLPVRWMAIESLNYSVYTTK 198 (297)
T ss_pred HHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCcCCCccccceecc--CCCCcCccccCchhhccCCCCch
Confidence 999999999999999 9999999999999999999999999988643211111 11122456999999988889999
Q ss_pred ccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 148 ADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 148 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
+||||||+++|+|++ |..||........ ... ...+..... +......+.+++.+||+.+|.+|||+
T Consensus 199 ~DvwSlG~il~el~t~g~~pf~~~~~~~~------~~~-~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~ 265 (297)
T cd05089 199 SDVWSFGVLLWEIVSLGGTPYCGMTCAEL------YEK-LPQGYRMEK------PRNCDDEVYELMRQCWRDRPYERPPF 265 (297)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHH-HhcCCCCCC------CCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 999999999999997 9999976543321 111 111111111 11123457788889999999999999
Q ss_pred HHHHHHhhcCcCCCCCC
Q 038713 227 KKVLLMLEGTVEIPIPQ 243 (252)
Q Consensus 227 ~~i~~~l~~~~~~~~~~ 243 (252)
+++++.|++++....+.
T Consensus 266 ~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 266 AQISVQLSRMLEARKAY 282 (297)
T ss_pred HHHHHHHHHHHHhhccc
Confidence 99999999877755443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=249.65 Aligned_cols=215 Identities=23% Similarity=0.293 Sum_probs=171.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC---------------CCCCCHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP---------------EKQPNWVERMGIA 69 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~ 69 (252)
.++.|.+|+.++++++||||+++++++.+....++++||+.+++|.+++... ...+++..++.++
T Consensus 51 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 130 (283)
T cd05091 51 LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130 (283)
T ss_pred HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHH
Confidence 3567899999999999999999999999999999999999999999998421 2347788889999
Q ss_pred HHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcc
Q 038713 70 RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKA 148 (252)
Q Consensus 70 ~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~ 148 (252)
.|++.||.|||+. +++|+||||.||++++++.++++|||.++....... .......++..|+|||.+.+..++.++
T Consensus 131 ~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 207 (283)
T cd05091 131 TQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS 207 (283)
T ss_pred HHHHHHHHHHHHc---CccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcch
Confidence 9999999999999 999999999999999999999999999875532221 111223356789999999887899999
Q ss_pred cchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 149 DVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 149 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
|+||||+++|++++ |..||......+ . . .....+..... +......+.+++.+||+.+|++|||++
T Consensus 208 Dv~slG~~l~el~~~g~~p~~~~~~~~---~---~-~~i~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~RP~~~ 274 (283)
T cd05091 208 DIWSYGVVLWEVFSYGLQPYCGYSNQD---V---I-EMIRNRQVLPC------PDDCPAWVYTLMLECWNEFPSRRPRFK 274 (283)
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHH---H---H-HHHHcCCcCCC------CCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence 99999999999998 777876543322 1 1 12222222111 122334478888899999999999999
Q ss_pred HHHHHhhc
Q 038713 228 KVLLMLEG 235 (252)
Q Consensus 228 ~i~~~l~~ 235 (252)
+|++.|++
T Consensus 275 ~i~~~l~~ 282 (283)
T cd05091 275 DIHSRLRT 282 (283)
T ss_pred HHHHHhhC
Confidence 99999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=261.61 Aligned_cols=220 Identities=20% Similarity=0.320 Sum_probs=174.2
Q ss_pred HhHHHHHHHHHHHhCCC-CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-------------------------
Q 038713 4 EGEREFKTEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE------------------------- 57 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------- 57 (252)
..++.|.+|+++++++. ||||+++++++.+....++||||+++|+|.+++....
T Consensus 82 ~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (400)
T cd05105 82 SEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADE 161 (400)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccc
Confidence 34678999999999995 9999999999999999999999999999999874321
Q ss_pred ----------------------------------------------------------------------CCCCHHHHHH
Q 038713 58 ----------------------------------------------------------------------KQPNWVERMG 67 (252)
Q Consensus 58 ----------------------------------------------------------------------~~~~~~~~~~ 67 (252)
..+++..++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~ 241 (400)
T cd05105 162 STRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLS 241 (400)
T ss_pred cccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHH
Confidence 2367778889
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCC
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITV 146 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~ 146 (252)
++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+......... ......++..|+|||.+.+..++.
T Consensus 242 ~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 318 (400)
T cd05105 242 FTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318 (400)
T ss_pred HHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCc
Confidence 999999999999999 9999999999999999999999999998765432221 112234567899999998888999
Q ss_pred cccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 147 KADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 147 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
++||||||+++|+|++ |+.||........ +. .....+.... .+......+.+++.+||+.+|++|||
T Consensus 319 ~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~----~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt 386 (400)
T cd05105 319 LSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY----NKIKSGYRMA------KPDHATQEVYDIMVKCWNSEPEKRPS 386 (400)
T ss_pred hhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH----HHHhcCCCCC------CCccCCHHHHHHHHHHCccCHhHCcC
Confidence 9999999999999997 8889875432211 11 1122221111 11223456888999999999999999
Q ss_pred HHHHHHHhhcCcC
Q 038713 226 MKKVLLMLEGTVE 238 (252)
Q Consensus 226 ~~~i~~~l~~~~~ 238 (252)
+.+|.+.|++.++
T Consensus 387 ~~~l~~~l~~l~~ 399 (400)
T cd05105 387 FLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHHHHHcC
Confidence 9999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=265.68 Aligned_cols=220 Identities=20% Similarity=0.315 Sum_probs=189.7
Q ss_pred chHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 2 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
+++.++.|++|+.+|+++.||||++++|+|.+ ...++|||.++.|.|..|++.+...++.......+.||+.||+|||+
T Consensus 431 t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS 509 (974)
T KOG4257|consen 431 TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES 509 (974)
T ss_pred ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh
Confidence 35678999999999999999999999999986 46899999999999999999888889999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
. ..|||||..+||||.....+|++|||+++...++.....+...-..-|||||-+...+++.++|||-||+++||++
T Consensus 510 k---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl 586 (974)
T KOG4257|consen 510 K---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEIL 586 (974)
T ss_pred h---chhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHH
Confidence 9 9999999999999999999999999999988776655555444566899999999999999999999999999997
Q ss_pred h-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 162 C-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 162 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
+ |..||.+....+ +...+++|... ..++.++..++.++-+||.++|.+||.+.+|...|+++++
T Consensus 587 ~lGvkPfqgvkNsD-------VI~~iEnGeRl------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 587 SLGVKPFQGVKNSD-------VIGHIENGERL------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HhcCCccccccccc-------eEEEecCCCCC------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 5 778998654443 22233333332 3466677779999999999999999999999998887665
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=252.61 Aligned_cols=212 Identities=22% Similarity=0.251 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
.+.+..|++++++++||||+++.+++......++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.
T Consensus 37 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 116 (280)
T cd05608 37 YEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116 (280)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45678999999999999999999999999999999999999999988743 334689999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||||+||+++.++.++++|||.+......... .....|+..|+|||++.+..++.++|+||||+++|++++
T Consensus 117 ---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~ 192 (280)
T cd05608 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIA 192 (280)
T ss_pred ---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHh
Confidence 9999999999999999999999999998765433221 223457889999999999899999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
|+.||.......... . .......... ..+......+.+++.+||+.||++|| |++++++
T Consensus 193 g~~pf~~~~~~~~~~--~-~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 193 ARGPFRARGEKVENK--E-LKQRILNDSV-------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCCCCCCCCcchhHH--H-HHHhhcccCC-------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 999997543321110 0 1111111111 11222344577888899999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=249.33 Aligned_cols=223 Identities=22% Similarity=0.323 Sum_probs=174.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC----------CCCCHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE----------KQPNWVERMGIARDIA 73 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~ 73 (252)
...+.|.+|++++++++||||+++++++......++++|++.+++|.+++.... ..+++..++.++.|++
T Consensus 61 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 140 (296)
T cd05051 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA 140 (296)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHH
Confidence 457789999999999999999999999999999999999999999999985433 2589999999999999
Q ss_pred HHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchh
Q 038713 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYS 152 (252)
Q Consensus 74 ~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 152 (252)
.||+|||+. +++|+||||+||+++.++.++++|||.+......... ......++..|+|||.+.+..++.++|+||
T Consensus 141 ~al~~LH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 217 (296)
T cd05051 141 SGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217 (296)
T ss_pred HHHHHHHHc---CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhh
Confidence 999999999 9999999999999999999999999998754332211 112234567899999998888999999999
Q ss_pred HHHHHHHHHh--CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 153 FGVVLLEIVC--LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 153 lG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
||+++|++++ +..||....... .+ .........+....... .+...+..+.+++.+||+.+|++|||+.+|+
T Consensus 218 lG~~l~el~~~~~~~p~~~~~~~~--~~-~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 218 FGVTLWEILTLCREQPYEHLTDQQ--VI-ENAGHFFRDDGRQIYLP---RPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred hHHHHHHHHhcCCCCCCCCcChHH--HH-HHHHhccccccccccCC---CccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 9999999987 667776543222 11 11111111111111111 1122235688999999999999999999999
Q ss_pred HHhhc
Q 038713 231 LMLEG 235 (252)
Q Consensus 231 ~~l~~ 235 (252)
+.|++
T Consensus 292 ~~L~~ 296 (296)
T cd05051 292 LFLQR 296 (296)
T ss_pred HHhcC
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=271.95 Aligned_cols=224 Identities=24% Similarity=0.292 Sum_probs=177.9
Q ss_pred hHhHHHHHHHHHHHhCC-CCCCCcceeeeEe-c------CCcEEEEEecCCCCCHHhhhcC-CCCCCCHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRT-HHRNPVRLLGYSF-D------VSNKILVYDYMSNGSLVDVLFT-PEKQPNWVERMGIARDIA 73 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~-~------~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~ 73 (252)
.++-+...+|+++|++| .|+|||.+++... . ...++++||||.||.|.++++. .+..+++.++++|+.+++
T Consensus 75 e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~ 154 (738)
T KOG1989|consen 75 EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVC 154 (738)
T ss_pred HHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHH
Confidence 45677889999999999 5999999999332 1 2357899999999999999964 334599999999999999
Q ss_pred HHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--------ccccccCCccccccccc---cCC
Q 038713 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--------TFTGIRGTRAYVAAEWH---RNL 142 (252)
Q Consensus 74 ~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~---~~~ 142 (252)
+|+++||.. ...++|||||.+|||++.+|.+||||||.+......... ......-|+.|+|||.+ .+.
T Consensus 155 ~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~ 233 (738)
T KOG1989|consen 155 EAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGL 233 (738)
T ss_pred HHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCC
Confidence 999999996 556999999999999999999999999999754322211 11123468899999975 577
Q ss_pred CCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCC
Q 038713 143 PITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSL 222 (252)
Q Consensus 143 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 222 (252)
.++.|+|||+|||+||.|+....||+....- .+..+....+. .+.....+.+||+.||+.||.+
T Consensus 234 pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----------aIlng~Y~~P~-----~p~ys~~l~~LI~~mL~~nP~~ 297 (738)
T KOG1989|consen 234 PIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----------AILNGNYSFPP-----FPNYSDRLKDLIRTMLQPNPDE 297 (738)
T ss_pred CCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----------eEEeccccCCC-----CccHHHHHHHHHHHHhccCccc
Confidence 8999999999999999999999999865111 12233333221 2456677999999999999999
Q ss_pred CCCHHHHHHHhhcCcCCCCCC
Q 038713 223 RRAMKKVLLMLEGTVEIPIPQ 243 (252)
Q Consensus 223 Rps~~~i~~~l~~~~~~~~~~ 243 (252)
||++.|++..+.++...+-|-
T Consensus 298 RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 298 RPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred CCCHHHHHHHHHHHhcCCCCc
Confidence 999999999998866555443
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=257.13 Aligned_cols=223 Identities=19% Similarity=0.230 Sum_probs=164.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecC-----CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDV-----SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
...++.+|++++++++||||+++++++... ...++||||+ +++|.+++... ..+++..+..++.||++||.||
T Consensus 42 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~L 119 (338)
T cd07859 42 DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYI 119 (338)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHH
Confidence 345789999999999999999999988643 3589999999 56899988543 4589999999999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--cccccccCCccccccccccC--CCCCCcccchhHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRN--LPITVKADVYSFGV 155 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~ 155 (252)
|+. +++|+||||+||+++.++.++++|||.++....... .......|+..|+|||++.+ ..++.++||||||+
T Consensus 120 H~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGv 196 (338)
T cd07859 120 HTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 196 (338)
T ss_pred HHC---CeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHH
Confidence 999 999999999999999999999999999875432221 12233467899999999875 56889999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHH------------H-----HHHHhcCCcccccccchhcHHHHHHHHHHHhhccCC
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEW------------I-----CQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILD 218 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~------------~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 218 (252)
++|+|++|+.||.............. + ......-..................+.+++.+||+.
T Consensus 197 vl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 276 (338)
T cd07859 197 IFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAF 276 (338)
T ss_pred HHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCc
Confidence 99999999999976543221111000 0 000000000000000000011234467888999999
Q ss_pred CCCCCCCHHHHHHH
Q 038713 219 EPSLRRAMKKVLLM 232 (252)
Q Consensus 219 ~p~~Rps~~~i~~~ 232 (252)
||++|||++++++.
T Consensus 277 ~P~~Rpt~~e~l~h 290 (338)
T cd07859 277 DPKDRPTAEEALAD 290 (338)
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=247.95 Aligned_cols=223 Identities=22% Similarity=0.280 Sum_probs=171.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC----------CCCCHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE----------KQPNWVERMGIARDIA 73 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~ 73 (252)
..+++|.+|+++++.++|+||+++++++.+.+..+++|||+++|+|.+++.... ..+++..++.++.|++
T Consensus 61 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 140 (296)
T cd05095 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIA 140 (296)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHH
Confidence 356789999999999999999999999999999999999999999999985432 2367788999999999
Q ss_pred HHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc-cccccCCccccccccccCCCCCCcccchh
Q 038713 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT-FTGIRGTRAYVAAEWHRNLPITVKADVYS 152 (252)
Q Consensus 74 ~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 152 (252)
.||+|||+. +++|+||||+||+++.++.++++|||.+.......... .....++..|++||...+..++.++|+||
T Consensus 141 ~al~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwS 217 (296)
T cd05095 141 SGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWA 217 (296)
T ss_pred HHHHHHHHC---CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhH
Confidence 999999999 99999999999999999999999999987553322111 11123356799999888878999999999
Q ss_pred HHHHHHHHHh--CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 153 FGVVLLEIVC--LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 153 lG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
||+++|++++ |..||........ .................. .+......+.+++.+||+.||++|||+.+|+
T Consensus 218 lG~~l~el~~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 218 FGVTLWEILTLCKEQPYSQLSDEQV---IENTGEFFRDQGRQVYLP---KPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred HHHHHHHHHHhCCCCCccccChHHH---HHHHHHHHhhccccccCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 9999999998 7788865433221 111111111111111111 1122335688899999999999999999999
Q ss_pred HHhhc
Q 038713 231 LMLEG 235 (252)
Q Consensus 231 ~~l~~ 235 (252)
+.|++
T Consensus 292 ~~l~~ 296 (296)
T cd05095 292 ATLLE 296 (296)
T ss_pred HHHhC
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=245.71 Aligned_cols=219 Identities=23% Similarity=0.372 Sum_probs=170.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEe-cCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
+..+.+.+|+.+++.++||||+++++++. .++..++++||+.+|+|.+++.......++..+..++.|++.||.|||+.
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 117 (262)
T cd05058 38 EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117 (262)
T ss_pred HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34678899999999999999999999776 45668899999999999999976666678888889999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC---cccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT---RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
+++|+||+|+||+++.++.++++|||.++....... .......++..|+|||.+.+..++.++|+||||+++|+
T Consensus 118 ---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 194 (262)
T cd05058 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 194 (262)
T ss_pred ---CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHH
Confidence 999999999999999999999999999875433211 11112334668999999988889999999999999999
Q ss_pred HHhCCcc-ccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 160 IVCLRRC-LDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 160 l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
+++|+.| |...... .. ... ...+.... .+ ...+..+.+++.+||+.+|++|||+.++++.|++...
T Consensus 195 l~~~~~~~~~~~~~~---~~---~~~-~~~~~~~~--~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 195 LMTRGAPPYPDVDSF---DI---TVY-LLQGRRLL--QP----EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHcCCCCCCCCCCHH---HH---HHH-HhcCCCCC--CC----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 9996554 4432211 11 111 11221111 11 1123457888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=256.70 Aligned_cols=215 Identities=20% Similarity=0.247 Sum_probs=167.9
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|..++.++ +||||+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 38 ~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~- 115 (329)
T cd05588 38 DIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHER- 115 (329)
T ss_pred HHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 345688999999988 7999999999999999999999999999999988543 5689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.+....... .......|+..|+|||++.+..++.++|+||||+++|++++|
T Consensus 116 --~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g 192 (329)
T cd05588 116 --GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192 (329)
T ss_pred --CeEecCCCHHHeEECCCCCEEECcCccccccccCC-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHC
Confidence 99999999999999999999999999886422111 122234678999999999998899999999999999999999
Q ss_pred Cccccccchhh--hHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 038713 164 RRCLDQNLLED--RAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA------MKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps------~~~i~~ 231 (252)
+.||....... ......+.......+.... +......+.+++.+||+.||.+||| ++++++
T Consensus 193 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 193 RSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI-------PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCcccccccccccccchHHHHHHHHcCCCCC-------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 99996422111 1111122222222222211 1122344778888999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=246.75 Aligned_cols=218 Identities=22% Similarity=0.307 Sum_probs=170.2
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecC------CcEEEEEecCCCCCHHhhhcC-----CCCCCCHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDV------SNKILVYDYMSNGSLVDVLFT-----PEKQPNWVERMGIARD 71 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~ 71 (252)
.+..+.|.+|+.+++.++||||+++++++... ...++++||+.+|+|.+++.. ....+++..++.++.|
T Consensus 41 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (272)
T cd05075 41 RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120 (272)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHH
Confidence 34567899999999999999999999987532 346899999999999988732 2344789999999999
Q ss_pred HHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc-cccccCCccccccccccCCCCCCcccc
Q 038713 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT-FTGIRGTRAYVAAEWHRNLPITVKADV 150 (252)
Q Consensus 72 i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di 150 (252)
++.||.|||+. +++|+||||+||+++.++.++++|||.+.......... .....++..|++||...+..++.++|+
T Consensus 121 i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di 197 (272)
T cd05075 121 IASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDV 197 (272)
T ss_pred HHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHH
Confidence 99999999999 99999999999999999999999999988654322211 111234667999999998889999999
Q ss_pred hhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 151 YSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 151 ~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
||||+++|++++ |..||....... +. .....+..... +......+.+++.+||+.+|++|||+.++
T Consensus 198 ~slG~il~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~l 264 (272)
T cd05075 198 WSFGVTMWEIATRGQTPYPGVENSE---IY----DYLRQGNRLKQ------PPDCLDGLYSLMSSCWLLNPKDRPSFETL 264 (272)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 999999999999 788886543321 11 12222222111 11223447888889999999999999999
Q ss_pred HHHhhcC
Q 038713 230 LLMLEGT 236 (252)
Q Consensus 230 ~~~l~~~ 236 (252)
++.|+++
T Consensus 265 ~~~l~~~ 271 (272)
T cd05075 265 RCELEKA 271 (272)
T ss_pred HHHHHhh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=253.69 Aligned_cols=219 Identities=18% Similarity=0.210 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
...+.+|+.+++.++||||+++++++.+....++||||+. ++|.+++....+.+++..+..++.|++.||.|||+.
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--- 122 (303)
T cd07869 47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR--- 122 (303)
T ss_pred chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 3467899999999999999999999999999999999995 688888876666789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhCC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||||+||+++.++.++++|||.+....... .......++..|+|||++.+. .++.++|+||||+++|+|++|.
T Consensus 123 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 201 (303)
T cd07869 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGV 201 (303)
T ss_pred CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987543222 122334578899999998754 5788999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCC---ccc-------------ccccchh-----cHHHHHHHHHHHhhccCCCCCCC
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGN---LSQ-------------LVEDEEV-----DQKQLQRMIKVGLRCILDEPSLR 223 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~-------------~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~R 223 (252)
.||........ .+.. +........ +.. ...+... .......+.+++.+||+.||++|
T Consensus 202 ~pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R 279 (303)
T cd07869 202 AAFPGMKDIQD-QLER-IFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNR 279 (303)
T ss_pred CCCCCCccHHH-HHHH-HHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhc
Confidence 99976533211 1111 111110000 000 0000000 00012346788889999999999
Q ss_pred CCHHHHHH
Q 038713 224 RAMKKVLL 231 (252)
Q Consensus 224 ps~~~i~~ 231 (252)
||++|+++
T Consensus 280 ~s~~~~l~ 287 (303)
T cd07869 280 LSAQAALS 287 (303)
T ss_pred cCHHHHhc
Confidence 99999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=244.90 Aligned_cols=213 Identities=26% Similarity=0.372 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.|.+|++++++++|||++++++++.. +..+++|||+.+|+|.+++... ...+++..++.++.|++.||.|||+.
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-- 121 (260)
T cd05069 45 PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM-- 121 (260)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4678999999999999999999998754 5688999999999999999653 34578999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-C
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-L 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 163 (252)
+++|+||+|+||++++++.++++|||.+...............++..|+|||...+...+.++|+||||+++|++++ |
T Consensus 122 -~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g 200 (260)
T cd05069 122 -NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG 200 (260)
T ss_pred -CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999997654332222222345668999999988889999999999999999999 8
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
..||....... ... . ...+... ..+......+.+++.+||..+|++|||+++++++|++
T Consensus 201 ~~p~~~~~~~~---~~~---~-~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 201 RVPYPGMVNRE---VLE---Q-VERGYRM------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCCCHHH---HHH---H-HHcCCCC------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 88887543322 111 1 1111111 1112234558888889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=245.72 Aligned_cols=214 Identities=26% Similarity=0.370 Sum_probs=170.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..++|.+|+.++++++|+|++++++++. ....+++|||+++++|.+++... ...+++..++.++.|++.||.|||+.
T Consensus 44 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~- 121 (260)
T cd05070 44 SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM- 121 (260)
T ss_pred CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3567999999999999999999999885 45689999999999999999653 34589999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++|+||+|.||++++++.++++|||.+...............++..|+|||...+..++.++|+||||+++|++++
T Consensus 122 --~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~ 199 (260)
T cd05070 122 --NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred --CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhc
Confidence 99999999999999999999999999997654332222222334567999999988889999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
|..||......+ . ... ...+.... .+......+.+++.+||.++|++|||++++.+.|++
T Consensus 200 g~~p~~~~~~~~---~---~~~-~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 200 GRVPYPGMNNRE---V---LEQ-VERGYRMP------CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCCHHH---H---HHH-HHcCCCCC------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 888886543221 1 111 11111111 112223458888899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=251.70 Aligned_cols=223 Identities=24% Similarity=0.343 Sum_probs=171.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
...+.|.+|++++++++||||+++++++.. ....+++|||+++|+|.+++... .+++..++.++.|++.||.|||+
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~ 125 (283)
T cd05080 48 QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHS 125 (283)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999998765 34578999999999999999543 48999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--ccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
. +++|+||||+||+++.++.++++|||.+......... ......++..|+|||...+..++.++|+||||+++|+
T Consensus 126 ~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~e 202 (283)
T cd05080 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYE 202 (283)
T ss_pred C---CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHH
Confidence 9 9999999999999999999999999998765432221 1111234567999999988889999999999999999
Q ss_pred HHhCCccccccchhhhHHHH--------HHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQ--------EWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|++|..|+............ .........+.. ...+...+..+.+++.+||+.+|++|||++++++
T Consensus 203 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 203 LLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99999998654322110000 000000000100 0112223456888899999999999999999999
Q ss_pred HhhcCc
Q 038713 232 MLEGTV 237 (252)
Q Consensus 232 ~l~~~~ 237 (252)
.|+++.
T Consensus 277 ~l~~~~ 282 (283)
T cd05080 277 ILKEMH 282 (283)
T ss_pred HHHHhh
Confidence 998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=243.32 Aligned_cols=236 Identities=19% Similarity=0.185 Sum_probs=178.7
Q ss_pred HHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 9 FKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 9 ~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
..||+.+|.+++|||||.+-.+... -+..|+|||||+. ||.+.+.+....+...++..+..|+++|++|||.. .
T Consensus 122 sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---w 197 (419)
T KOG0663|consen 122 SLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---W 197 (419)
T ss_pred hHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---e
Confidence 4699999999999999999998874 5679999999977 99999988888899999999999999999999999 9
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC-CCCcccchhHHHHHHHHHhCCc
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP-ITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~ 165 (252)
|+|||+|++|+|++..|.+|++|||+++.+..+. ......+.|.+|+|||.+.|.+ |+...|+||+||++.+++++++
T Consensus 198 ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kP 276 (419)
T KOG0663|consen 198 ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKP 276 (419)
T ss_pred eEecccchhheeeccCCcEEecccchhhhhcCCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCC
Confidence 9999999999999999999999999999887653 3345566799999999999874 8999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccc--------hhcH---------H-HHHHHHHHHhhccCCCCCCCCCHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDE--------EVDQ---------K-QLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~---------~-~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
.|.+...-++.+.+-..........|..+.... ..+. . ....-++++..+|..||++|.|++
T Consensus 277 lf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~ 356 (419)
T KOG0663|consen 277 LFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAE 356 (419)
T ss_pred CCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHH
Confidence 998775554433321111111111111100000 0000 0 234566777899999999999999
Q ss_pred HHHHHhhcCcCCCCCCCCCCCCCC
Q 038713 228 KVLLMLEGTVEIPIPQNPTSFLST 251 (252)
Q Consensus 228 ~i~~~l~~~~~~~~~~~~~~~~~~ 251 (252)
|.+. .+.+...+-+.+++++.|
T Consensus 357 ~~L~--h~~F~e~P~p~~P~~~Pt 378 (419)
T KOG0663|consen 357 DGLK--HEYFRETPLPIDPSMFPT 378 (419)
T ss_pred Hhhc--ccccccCCCCCChhhcCC
Confidence 9876 233333333334444444
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=245.77 Aligned_cols=213 Identities=24% Similarity=0.397 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
..+|.+|++++++++|||++++++++......++++||+++++|.+++......+++..++.++.|++.|+.+||+.
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--- 119 (256)
T cd05112 43 EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS--- 119 (256)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46799999999999999999999999999999999999999999999976666788999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-CC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-LR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~ 164 (252)
+++|+||+|+||+++.++.++++|||.+...............++..|+|||...+..++.++|+||||+++|++++ |.
T Consensus 120 ~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~ 199 (256)
T cd05112 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred CccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999987654332222222334568999999998889999999999999999998 88
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
.||....... . ... ...+.. ...+.. ....+.+++.+||+.+|++|||+.++++.|.
T Consensus 200 ~p~~~~~~~~---~---~~~-~~~~~~--~~~~~~----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 200 TPYENRSNSE---V---VET-INAGFR--LYKPRL----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCcCCHHH---H---HHH-HhCCCC--CCCCCC----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 8887543322 1 111 111111 011111 2345888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=247.11 Aligned_cols=219 Identities=16% Similarity=0.267 Sum_probs=175.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
..+++|.+|+.+++.++||||+++++++.+.+..++++||+++++|.+++.. ....+++..++.++.|++.||.|||
T Consensus 44 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 123 (267)
T cd08229 44 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123 (267)
T ss_pred HHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3567899999999999999999999999999999999999999999998853 2345899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+. +++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++
T Consensus 124 ~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l 199 (267)
T cd08229 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred HC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHH
Confidence 99 9999999999999999999999999988765432221 1224567889999999888899999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
++|..||........ .... ......... .........+.+++.+||..+|++|||+++|++.+++.
T Consensus 200 ~~g~~p~~~~~~~~~----~~~~-~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 200 AALQSPFYGDKMNLY----SLCK-KIEQCDYPP-----LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HhCCCCcccccchHH----HHhh-hhhcCCCCC-----CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 999999965432211 1111 111111111 11122344578888899999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=246.49 Aligned_cols=214 Identities=21% Similarity=0.312 Sum_probs=169.4
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|+++++.++|||++++++++...+..++|+||+++|+|..++....+.+++..++.++.|++.||.|||+.
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~- 122 (282)
T cd06643 44 EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN- 122 (282)
T ss_pred HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3466789999999999999999999999999999999999999999998866566789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc-----CCCCCCcccchhHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-----NLPITVKADVYSFGVVLL 158 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~ 158 (252)
+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||++. +..++.++|+||+|+++|
T Consensus 123 --~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~ 199 (282)
T cd06643 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 199 (282)
T ss_pred --CeeecCCCcccEEEccCCCEEEcccccccccccccc-ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHH
Confidence 999999999999999999999999999865432221 122245788999999874 345778999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
++++|+.||....... ... ... .+.......+ ......+.+++.+||+.+|.+|||++++++.
T Consensus 200 el~~g~~p~~~~~~~~--~~~----~~~-~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 200 EMAQIEPPHHELNPMR--VLL----KIA-KSEPPTLAQP----SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHccCCCCccccCHHH--HHH----HHh-hcCCCCCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999987543221 111 111 1111111111 1223457888889999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=257.49 Aligned_cols=210 Identities=25% Similarity=0.346 Sum_probs=163.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|+++++.++|+||+++++++.+.+..++||||+++|+|.+.. ..++..+..++.||+.||.|||+.
T Consensus 114 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~- 187 (353)
T PLN00034 114 TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRR- 187 (353)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34577999999999999999999999999999999999999999986543 345677888999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-----CCCCCcccchhHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-----LPITVKADVYSFGVVLL 158 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~ 158 (252)
+++|+||||+||+++.++.++|+|||.+........ ......|+..|+|||++.. ...+.++||||||+++|
T Consensus 188 --~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~ 264 (353)
T PLN00034 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264 (353)
T ss_pred --CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHH
Confidence 999999999999999999999999999876543221 1223467899999998743 23456899999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
+|++|+.||......+.... .......... ..+......+.+++.+||+.||++|||+.|+++.
T Consensus 265 el~~g~~pf~~~~~~~~~~~---~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 265 EFYLGRFPFGVGRQGDWASL---MCAICMSQPP-------EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHhCCCCCCCCCCccHHHH---HHHHhccCCC-------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999974332221111 1111111110 1122233457888889999999999999999874
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=255.72 Aligned_cols=203 Identities=21% Similarity=0.291 Sum_probs=164.5
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|..++..+ +||||+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 38 ~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~- 115 (320)
T cd05590 38 DVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDK- 115 (320)
T ss_pred HHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 456778899999876 7999999999999999999999999999999988544 4688999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.+....... .......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 116 --~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 192 (320)
T cd05590 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192 (320)
T ss_pred --CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhC
Confidence 99999999999999999999999999987532211 122234578999999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
+.||....... . . .....+.... +......+.+++.+||+.||++||++
T Consensus 193 ~~Pf~~~~~~~---~---~-~~i~~~~~~~-------~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 193 HAPFEAENEDD---L---F-EAILNDEVVY-------PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCCCHHH---H---H-HHHhcCCCCC-------CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 99997654332 1 1 1122222111 11223457788889999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=253.39 Aligned_cols=210 Identities=24% Similarity=0.333 Sum_probs=165.6
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHhhc
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQ-PNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
.++..+|+.+|++++|||||+++++..+ .+.+|||+|||..|.+...- ..+. +++.+++.++.+++.||.|||.+
T Consensus 152 ~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Q 229 (576)
T KOG0585|consen 152 IEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQ 229 (576)
T ss_pred HHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhc
Confidence 3678999999999999999999999986 67899999999988765432 3334 89999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCC----CCcccccccCCccccccccccCCC----CCCcccchhHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD----QTRTFTGIRGTRAYVAAEWHRNLP----ITVKADVYSFG 154 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG 154 (252)
+|+||||||+|+|++.+|++||+|||.+...... .........||+.|+|||...+.. ...+.||||+|
T Consensus 230 ---giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalG 306 (576)
T KOG0585|consen 230 ---GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALG 306 (576)
T ss_pred ---CeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhh
Confidence 9999999999999999999999999999865322 112334478999999999987632 35789999999
Q ss_pred HHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 155 VVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 155 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
+++|-++.|+.||.....-+. - ..+.+..+.... ..+....+.+||++||++||++|.++.+|...
T Consensus 307 VTLYCllfG~~PF~~~~~~~l------~-~KIvn~pL~fP~-----~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 307 VTLYCLLFGQLPFFDDFELEL------F-DKIVNDPLEFPE-----NPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred hhHHHhhhccCCcccchHHHH------H-HHHhcCcccCCC-----cccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 999999999999986533221 1 112222222221 11334557788889999999999999998654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=259.69 Aligned_cols=213 Identities=23% Similarity=0.289 Sum_probs=172.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|++++..++||||+++++++.+.+..++||||+++|+|.+++... +.++...++.++.|++.||.|||+.
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~- 120 (350)
T cd05573 43 NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL- 120 (350)
T ss_pred cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34567899999999999999999999999999999999999999999999655 5689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCC----------------------------CcccccccCCccccc
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ----------------------------TRTFTGIRGTRAYVA 135 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~a 135 (252)
+++|+||||+||+++.++.++++|||.+....... ........|+..|+|
T Consensus 121 --giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 198 (350)
T cd05573 121 --GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIA 198 (350)
T ss_pred --CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccC
Confidence 99999999999999999999999999987654332 112223458899999
Q ss_pred cccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhc-CCcccccccchhcHHHHHHHHHHHhh
Q 038713 136 AEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFEN-GNLSQLVEDEEVDQKQLQRMIKVGLR 214 (252)
Q Consensus 136 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~ 214 (252)
||++.+..++.++|||||||++|+|++|+.||......... ...... ..... ..... ....+.+++.+
T Consensus 199 PE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~------~~i~~~~~~~~~-p~~~~----~~~~~~~li~~ 267 (350)
T cd05573 199 PEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY------NKIINWKESLRF-PPDPP----VSPEAIDLICR 267 (350)
T ss_pred HHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH------HHHhccCCcccC-CCCCC----CCHHHHHHHHH
Confidence 99999989999999999999999999999999866533211 111110 11111 11011 23457788889
Q ss_pred ccCCCCCCCCC-HHHHHHH
Q 038713 215 CILDEPSLRRA-MKKVLLM 232 (252)
Q Consensus 215 cl~~~p~~Rps-~~~i~~~ 232 (252)
|+. +|.+||+ ++++++.
T Consensus 268 ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 268 LLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred Hcc-ChhhcCCCHHHHhcC
Confidence 997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=245.22 Aligned_cols=207 Identities=21% Similarity=0.322 Sum_probs=164.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.|.+|+.+++.++|||++++++++......++||||+++|+|.+++......+++..++.++.||+.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-- 119 (258)
T cd05078 42 YSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK-- 119 (258)
T ss_pred HHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 346789999999999999999999999998999999999999999999977666789999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCc--------eEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRC--------AKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGV 155 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~ 155 (252)
+++|+||||+||+++.++. ++++|||.+...... ....++..|+|||++.+. .++.++|+||||+
T Consensus 120 -~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 193 (258)
T cd05078 120 -GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGT 193 (258)
T ss_pred -CeecCCCccceEEEecccccccCCCceEEecccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHH
Confidence 9999999999999987665 589999987654321 123467789999999874 5789999999999
Q ss_pred HHHHHHhCC-ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 156 VLLEIVCLR-RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 156 ~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
++|++++|. .|+.......... .... .. . .+......+.+++.+||+.+|++|||++++++.|.
T Consensus 194 ~l~~l~~g~~~~~~~~~~~~~~~-------~~~~-~~-~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 194 TLWEIFSGGDKPLSALDSQKKLQ-------FYED-RH-Q------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHHcCCCCChhhccHHHHHH-------HHHc-cc-c------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 999999996 4544332221111 1111 11 1 11112245778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=244.22 Aligned_cols=211 Identities=27% Similarity=0.355 Sum_probs=168.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEe-cCCcEEEEEecCCCCCHHhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEK-QPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..+.|.+|+.++++++|+|++++++++. ..+..++++||+++|+|.+++..... .+++..++.++.|++.||+|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 121 (256)
T cd05082 42 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121 (256)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3567899999999999999999999764 55678999999999999999965443 478899999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.+........ ...++..|+|||++.+..++.++|+||||+++|+|++
T Consensus 122 ---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~ 194 (256)
T cd05082 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred ---CEeccccchheEEEcCCCcEEecCCccceeccccCC----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHh
Confidence 999999999999999999999999999875432221 1223567999999988889999999999999999997
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
|+.||....... ... ....+.... .+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 195 ~g~~p~~~~~~~~---~~~----~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 195 FGRVPYPRIPLKD---VVP----RVEKGYKMD------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCCHHH---HHH----HHhcCCCCC------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 888886543322 111 111221111 112233457888889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=255.44 Aligned_cols=212 Identities=19% Similarity=0.200 Sum_probs=166.4
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|+++++.+ +||||+++++++...+..++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.
T Consensus 48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-- 124 (332)
T cd05614 48 VEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKL-- 124 (332)
T ss_pred HHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 45688999999999 699999999999999999999999999999999854 34588999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.+...............|+..|+|||++.+. .++.++||||||+++|+|++|
T Consensus 125 -~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg 203 (332)
T cd05614 125 -GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203 (332)
T ss_pred -CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcC
Confidence 999999999999999999999999999876543332222335689999999998875 478899999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
..||.......... . +......... ..+......+.+++.+||+.||++|| +++++++
T Consensus 204 ~~pf~~~~~~~~~~--~-~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 204 ASPFTLEGERNTQS--E-VSRRILKCDP-------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCCCCCCCHH--H-HHHHHhcCCC-------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 99997543221111 1 1111111111 01112233467788899999999999 6677764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=246.41 Aligned_cols=218 Identities=23% Similarity=0.347 Sum_probs=175.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+....+.+|+.++++++||||+++++++.. ...++++||+.+|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 51 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~- 128 (279)
T cd05057 51 KANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK- 128 (279)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 356789999999999999999999999987 789999999999999999977666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc-cccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT-FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.++......... .....++..|+|||.+....++.++|+||||+++|++++
T Consensus 129 --~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~ 206 (279)
T cd05057 129 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206 (279)
T ss_pred --CEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhc
Confidence 99999999999999999999999999998654322211 111223467999999988888999999999999999998
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
|..||......+ +. .....+.... . +......+.+++.+||..+|++|||+.++++.|.++..
T Consensus 207 ~g~~p~~~~~~~~---~~----~~~~~~~~~~--~----~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 207 FGAKPYEGIPAVE---IP----DLLEKGERLP--Q----PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCCCHHH---HH----HHHhCCCCCC--C----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 999997654332 11 1122221111 1 11122457788889999999999999999999998644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=244.82 Aligned_cols=216 Identities=25% Similarity=0.353 Sum_probs=171.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC------CCCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP------EKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~ 77 (252)
+....|.+|+.+++.++||||+++++++......+++|||+++|+|.+++... ...+++..++.++.|++.||.
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 120 (269)
T cd05044 41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120 (269)
T ss_pred hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999999999999999999999999999999542 234788899999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCC-----ceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccch
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKR-----CAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVY 151 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~-----~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 151 (252)
|||+. +++|+|++|+||+++.++ .++++|||.+........ .......++..|+|||.+.+..++.++|+|
T Consensus 121 ~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 197 (269)
T cd05044 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVW 197 (269)
T ss_pred HHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHH
Confidence 99999 999999999999999877 899999999875432211 111122346789999999988899999999
Q ss_pred hHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 152 SFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 152 slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
|||+++|+|++ |..||....... ... ....+.... .+...+..+.+++.+||+.+|.+|||+.+++
T Consensus 198 slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 264 (269)
T cd05044 198 SFGVLMWEILTLGQQPYPALNNQE---VLQ----HVTAGGRLQ------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQ 264 (269)
T ss_pred HHHHHHHHHHHcCCCCCcccCHHH---HHH----HHhcCCccC------CcccchHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 99999999998 899986543322 111 111111111 1122334577888899999999999999999
Q ss_pred HHhhc
Q 038713 231 LMLEG 235 (252)
Q Consensus 231 ~~l~~ 235 (252)
+.|++
T Consensus 265 ~~l~~ 269 (269)
T cd05044 265 EILQN 269 (269)
T ss_pred HHHhC
Confidence 99874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=243.46 Aligned_cols=213 Identities=21% Similarity=0.347 Sum_probs=174.6
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
....+++.+|++++++++|+||+++++++.+.+..+++|||+++|+|.+++... ...+++..+..++.|++.|+.|||+
T Consensus 40 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 119 (256)
T cd08221 40 EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119 (256)
T ss_pred hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 455678999999999999999999999999999999999999999999999654 4568999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
. +++|+|++|+||+++.++.++++|||.+........ ......++..|+|||...+..++.++|+||||+++++++
T Consensus 120 ~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~ 195 (256)
T cd08221 120 A---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195 (256)
T ss_pred C---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHH
Confidence 9 999999999999999999999999999876543332 223345788999999998888899999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
+|..||....... ..... ..+..... .......+.+++.+||+.+|++|||++++++.
T Consensus 196 ~g~~~~~~~~~~~------~~~~~-~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 196 TLKRTFDATNPLN------LVVKI-VQGNYTPV------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HCCCCCCCCCHHH------HHHHH-HcCCCCCC------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 9999997543321 11111 22332221 12223457788889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=244.25 Aligned_cols=212 Identities=21% Similarity=0.260 Sum_probs=169.3
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|++++++++||||+++++++.+....++++||+++++|.+++.. .+.++...+..++.|++.||.|||+.
T Consensus 47 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~-- 123 (263)
T cd06625 47 EVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSN-- 123 (263)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 346789999999999999999999999999999999999999999999854 34578888999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCccc--ccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF--TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.+........... ....++..|+|||...+..++.++|+||||+++|++++
T Consensus 124 -~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 202 (263)
T cd06625 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202 (263)
T ss_pred -CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHh
Confidence 999999999999999999999999999875533221111 22346778999999999889999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
|+.||........ ........... ..+......+.+++.+||..+|++|||+.++++.
T Consensus 203 g~~p~~~~~~~~~------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 203 EKPPWAEFEAMAA------IFKIATQPTNP------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCccccchHHH------HHHHhccCCCC------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 9999975432211 11111111111 1122233457788889999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=251.92 Aligned_cols=217 Identities=27% Similarity=0.381 Sum_probs=170.5
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------------CCCCHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------------KQPNWVERMG 67 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~ 67 (252)
...+.|.+|++++.++ +||||+++++++.+.+..++|+||+++|+|.+++.... ..+++..++.
T Consensus 49 ~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 128 (303)
T cd05088 49 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128 (303)
T ss_pred HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHH
Confidence 4566889999999999 89999999999999999999999999999999985432 2478899999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCc
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVK 147 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 147 (252)
++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+......... ....++..|+|||.+.+..++.+
T Consensus 129 ~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~ 203 (303)
T cd05088 129 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTN 203 (303)
T ss_pred HHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCccccCcccchhhhc--ccCCCcccccCHHHHhccCCccc
Confidence 999999999999999 9999999999999999999999999998632211111 11123557999999988888999
Q ss_pred ccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 148 ADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 148 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
+|+||||+++|++++ |..||......+ . . .....+.... . +......+.+++.+||+.+|++|||+
T Consensus 204 ~Di~slG~il~ellt~g~~p~~~~~~~~---~---~-~~~~~~~~~~--~----~~~~~~~~~~li~~~l~~~p~~Rp~~ 270 (303)
T cd05088 204 SDVWSYGVLLWEIVSLGGTPYCGMTCAE---L---Y-EKLPQGYRLE--K----PLNCDDEVYDLMRQCWREKPYERPSF 270 (303)
T ss_pred ccchhhhhHHHHHHhcCCCCcccCChHH---H---H-HHHhcCCcCC--C----CCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 999999999999998 999986543322 1 1 1111111100 1 11123347788889999999999999
Q ss_pred HHHHHHhhcCcC
Q 038713 227 KKVLLMLEGTVE 238 (252)
Q Consensus 227 ~~i~~~l~~~~~ 238 (252)
.+++..|+..++
T Consensus 271 ~~il~~l~~~~~ 282 (303)
T cd05088 271 AQILVSLNRMLE 282 (303)
T ss_pred HHHHHHHHHHHH
Confidence 999999887543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=246.63 Aligned_cols=206 Identities=21% Similarity=0.317 Sum_probs=164.6
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
...|.+|+.++++++||||+++++++.+.+..++||||+++|+|..++....+.+++..+..++.|++.||.|||+.
T Consensus 60 ~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--- 136 (274)
T cd05076 60 ALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK--- 136 (274)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---
Confidence 45788999999999999999999999999999999999999999999976666789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCC-------ceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHH
Q 038713 86 QIIHGDIKPQNILMDEKR-------CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVL 157 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l 157 (252)
+++|+||||+||+++..+ .+++.|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++
T Consensus 137 ~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l 211 (274)
T cd05076 137 NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTL 211 (274)
T ss_pred CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHH
Confidence 999999999999997543 3799999987543221 11345778999998875 4588999999999999
Q ss_pred HHHH-hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 158 LEIV-CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 158 ~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
|+++ +|..||.......... ....... . +.. ....+.+++.+||+.+|++|||+.++++.|+
T Consensus 212 ~el~~~g~~p~~~~~~~~~~~-------~~~~~~~--~--~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 212 LEICFDGEVPLKERTPSEKER-------FYEKKHR--L--PEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHhCCCCCccccChHHHHH-------HHHhccC--C--CCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 9984 7888887654332111 1111110 0 001 1234788889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=249.14 Aligned_cols=217 Identities=20% Similarity=0.335 Sum_probs=173.3
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..+.+.+|+++++++ +||||+++++++...+..+++|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.
T Consensus 81 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~ 160 (302)
T cd05055 81 EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK 160 (302)
T ss_pred HHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 356799999999999 89999999999999999999999999999999996543 3479999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||+|+||+++.++.++++|||.+......... ......++..|+|||.+.+..++.++|+||+|+++|+++
T Consensus 161 ---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~ 237 (302)
T cd05055 161 ---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 237 (302)
T ss_pred ---CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHH
Confidence 9999999999999999999999999998755432211 111223466899999998888999999999999999999
Q ss_pred h-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 162 C-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 162 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
+ |..||........ +. .....+.... . +......+.+++.+||+.+|++|||+.|+++.|++.
T Consensus 238 t~g~~p~~~~~~~~~--~~----~~~~~~~~~~--~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 238 SLGSNPYPGMPVDSK--FY----KLIKEGYRMA--Q----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred hCCCCCcCCCCchHH--HH----HHHHcCCcCC--C----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 8 8889875533221 11 1122221111 1 111224578888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=254.51 Aligned_cols=208 Identities=18% Similarity=0.215 Sum_probs=167.3
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+..|.+++..+ +||||+++++++.+.+..++||||+++|+|..++... +.+++..+..++.||+.||.|||+.
T Consensus 38 ~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~- 115 (321)
T cd05591 38 DVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRH- 115 (321)
T ss_pred HHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 456688899999866 8999999999999999999999999999999988543 4588889999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.+........ ......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 116 --~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg 192 (321)
T cd05591 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG 192 (321)
T ss_pred --CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcC
Confidence 999999999999999999999999999875332221 12234578899999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-------AMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-------s~~~i~~ 231 (252)
+.||........ ... ...+.... +......+.+++.+||+.||++|| ++.++++
T Consensus 193 ~~Pf~~~~~~~~------~~~-i~~~~~~~-------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 193 QPPFEADNEDDL------FES-ILHDDVLY-------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCCCCHHHH------HHH-HHcCCCCC-------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 999986543321 111 11222111 111234577888899999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=253.78 Aligned_cols=208 Identities=20% Similarity=0.239 Sum_probs=167.9
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
....+.+|..+++.+ +||||+++++++.+.+..++||||+++|+|.+++... +.+++..+..++.|++.||.|||+.
T Consensus 38 ~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~- 115 (318)
T cd05570 38 DVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHER- 115 (318)
T ss_pred HHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 456678899999888 7999999999999999999999999999999988544 4689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||||+||+++.++.++++|||.+........ ......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 116 --~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G 192 (318)
T cd05570 116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG 192 (318)
T ss_pred --CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhC
Confidence 999999999999999999999999998864322111 11224578899999999998999999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM-----KKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~i~~ 231 (252)
..||....... .. .....+... .+......+.+++.+||+.||++|||+ .++++
T Consensus 193 ~~pf~~~~~~~---~~----~~i~~~~~~-------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 193 QSPFEGDDEDE---LF----QSILEDEVR-------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCCCCCHHH---HH----HHHHcCCCC-------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 99997654322 11 111122211 111223457888889999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=253.18 Aligned_cols=206 Identities=21% Similarity=0.250 Sum_probs=163.4
Q ss_pred HHHHHHHHHHH---hCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 6 EREFKTEMNAI---GRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 6 ~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
.+.+.+|++++ +.++||||+++++++.+.+..|+||||+++|+|..++.. +.+++..++.++.||+.||.|||+.
T Consensus 43 ~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~ 120 (324)
T cd05589 43 VESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHEN 120 (324)
T ss_pred HHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45677776665 566899999999999999999999999999999988843 4589999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++.++++|||.+........ ......|+..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 121 ---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 196 (324)
T cd05589 121 ---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLV 196 (324)
T ss_pred ---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHh
Confidence 999999999999999999999999998764322221 1223457889999999999889999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
|+.||........ . .....+.... +......+.+++.+||+.||++|| ++.++++
T Consensus 197 G~~pf~~~~~~~~------~-~~i~~~~~~~-------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 197 GESPFPGDDEEEV------F-DSIVNDEVRY-------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCCCCHHHH------H-HHHHhCCCCC-------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 9999976543321 1 1112222111 111234467888899999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=248.33 Aligned_cols=216 Identities=24% Similarity=0.329 Sum_probs=171.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------------------CCCCH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------------------KQPNW 62 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~ 62 (252)
+..++|.+|+.++++++||||+++++++.+....++++||+++|+|.+++.... ..+++
T Consensus 50 ~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 129 (288)
T cd05050 50 DMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129 (288)
T ss_pred HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCH
Confidence 446779999999999999999999999999999999999999999999985321 23677
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccC
Q 038713 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRN 141 (252)
Q Consensus 63 ~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~ 141 (252)
..++.++.|++.||.|||.. +++|+||+|+||+++.++.++++|||.+........ ........+..|+|||.+.+
T Consensus 130 ~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (288)
T cd05050 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY 206 (288)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc
Confidence 88899999999999999999 999999999999999999999999999875432221 11112234567999999988
Q ss_pred CCCCCcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCC
Q 038713 142 LPITVKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEP 220 (252)
Q Consensus 142 ~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 220 (252)
..++.++|+||||+++|+|++ |..||......+ .. .....+..... +......+.+++.+||+.+|
T Consensus 207 ~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~------~~-~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p 273 (288)
T cd05050 207 NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE------VI-YYVRDGNVLSC------PDNCPLELYNLMRLCWSKLP 273 (288)
T ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HH-HHHhcCCCCCC------CCCCCHHHHHHHHHHcccCc
Confidence 889999999999999999997 777886543322 11 12222322111 11223458889999999999
Q ss_pred CCCCCHHHHHHHhhc
Q 038713 221 SLRRAMKKVLLMLEG 235 (252)
Q Consensus 221 ~~Rps~~~i~~~l~~ 235 (252)
++|||+.|+++.|++
T Consensus 274 ~~Rpt~~el~~~l~~ 288 (288)
T cd05050 274 SDRPSFASINRILQR 288 (288)
T ss_pred ccCCCHHHHHHHhhC
Confidence 999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=244.69 Aligned_cols=211 Identities=21% Similarity=0.301 Sum_probs=171.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT-PEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|+.++++++|||++++++.+.+.+..++++||+++|+|.+++.. ....++...++.++.|++.||.+||+.
T Consensus 41 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~- 119 (255)
T cd08219 41 AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK- 119 (255)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC-
Confidence 456788999999999999999999999999999999999999999998854 334578999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 120 --~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g 196 (255)
T cd08219 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL 196 (255)
T ss_pred --CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhc
Confidence 999999999999999999999999999876543222 11234577889999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
..||........ . .....+..... +......+.+++.+||+.||++|||+.+++..
T Consensus 197 ~~p~~~~~~~~~------~-~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 197 KHPFQANSWKNL------I-LKVCQGSYKPL------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCCCCCCCHHHH------H-HHHhcCCCCCC------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 999976533221 1 11222222211 11223447788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=238.53 Aligned_cols=212 Identities=24% Similarity=0.326 Sum_probs=175.6
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
+-++.-.+|+.+|+++ .||+|+++.++++.+.-+++|+|.|+.|.|.+++.+ .-.+++.+..++..|+..|+.|||..
T Consensus 64 ~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~ 142 (411)
T KOG0599|consen 64 EMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHAR 142 (411)
T ss_pred HHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHh
Confidence 3466778999999999 899999999999999999999999999999999954 44588899999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC------CCCCCcccchhHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN------LPITVKADVYSFGVV 156 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Di~slG~~ 156 (252)
+|+|||+||+|||++++..+++.|||+++...+... .....||++|+|||.+.. .+|+...|+|+.|++
T Consensus 143 ---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVI 217 (411)
T KOG0599|consen 143 ---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVI 217 (411)
T ss_pred ---hhhhcccChhheeeccccceEEeccceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHH
Confidence 999999999999999999999999999998765443 344679999999998753 458889999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|.++.|.+||.....- .....+.+|+...-... ..+......++|.+||+.||.+|.|++|.++
T Consensus 218 myTLLaGcpPFwHRkQm-------lMLR~ImeGkyqF~spe---Wadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 218 MYTLLAGCPPFWHRKQM-------LMLRMIMEGKYQFRSPE---WADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHcCCCchhHHHHH-------HHHHHHHhcccccCCcc---hhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 99999999999765211 12234455655443333 3334444566666999999999999999875
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=243.09 Aligned_cols=205 Identities=20% Similarity=0.335 Sum_probs=163.7
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.|.+|+.+++.++||||+++++++......+++|||+++|+|..++......+++..++.++.||++||+|||+.
T Consensus 48 ~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--- 124 (262)
T cd05077 48 SLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK--- 124 (262)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---
Confidence 45788999999999999999999999999999999999999999999876666789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCc-------eEEcccCcccccCCCCCcccccccCCcccccccccc-CCCCCCcccchhHHHHH
Q 038713 86 QIIHGDIKPQNILMDEKRC-------AKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-NLPITVKADVYSFGVVL 157 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~-------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l 157 (252)
+++|+||||+||+++.++. ++++|||.+...... ....++..|+|||.+. +..++.++||||||+++
T Consensus 125 ~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 199 (262)
T cd05077 125 DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTL 199 (262)
T ss_pred CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHH
Confidence 9999999999999986654 899999988654321 1234677899999886 45688999999999999
Q ss_pred HHHH-hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 038713 158 LEIV-CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233 (252)
Q Consensus 158 ~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l 233 (252)
|+++ +|..||......+.. ... .+.... . ......+.+++.+||+.||++||++.+|++.+
T Consensus 200 ~el~~~~~~p~~~~~~~~~~-------~~~-~~~~~~-~------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 200 WEICYNGEIPLKDKTLAEKE-------RFY-EGQCML-V------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHHhCCCCCCCCcchhHHH-------HHH-hcCccC-C------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 9997 577777654322211 111 111111 1 11123477888899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=243.42 Aligned_cols=215 Identities=29% Similarity=0.413 Sum_probs=173.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+++.+|+.++++++||||+++++++......+++|||+++++|.+++.... ..+++..+..++.|++.|+.|||+.
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~- 122 (261)
T cd05034 44 SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR- 122 (261)
T ss_pred CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 35679999999999999999999999999899999999999999999996643 4689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++|+||+|+||+++.++.++++|||.+...............++..|+|||.+.+...+.++|+||+|++++++++
T Consensus 123 --~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~ 200 (261)
T cd05034 123 --NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTY 200 (261)
T ss_pred --CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999987654322211122334568999999998889999999999999999998
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
|+.||....... .. ... ..+... .. +...+..+.+++.+||+.+|++|||++++.+.|++
T Consensus 201 g~~p~~~~~~~~--~~----~~~-~~~~~~--~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 201 GRVPYPGMTNRE--VL----EQV-ERGYRM--PR----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHH--HH----HHH-HcCCCC--CC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 898886543221 11 111 111110 11 11113457888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=252.55 Aligned_cols=207 Identities=20% Similarity=0.245 Sum_probs=164.4
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+..|..++... +||||+++++++......++||||+++|+|.+++... +.+++..+..++.|++.||.|||+.
T Consensus 38 ~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~- 115 (316)
T cd05592 38 DVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKK- 115 (316)
T ss_pred hHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 345567788887754 8999999999999999999999999999999998644 4688999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.+....... .......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 116 --~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G 192 (316)
T cd05592 116 --GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG 192 (316)
T ss_pred --CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhC
Confidence 99999999999999999999999999987543222 122334578999999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK-KVL 230 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~i~ 230 (252)
..||....... . ... ...... ..+......+.+++.+||+.+|++||++. +++
T Consensus 193 ~~Pf~~~~~~~---~---~~~-i~~~~~-------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 193 QSPFHGEDEDE---L---FDS-ILNDRP-------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCCCHHH---H---HHH-HHcCCC-------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 99998654322 1 111 111111 11122234467788899999999999976 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=250.33 Aligned_cols=218 Identities=23% Similarity=0.350 Sum_probs=172.4
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC---------------CCCCCHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP---------------EKQPNWVERMG 67 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~ 67 (252)
.....+.+|+++++++ +||||+++++++.+.+..++++||+.+|+|.+++... ...+++..+..
T Consensus 59 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 138 (314)
T cd05099 59 KDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138 (314)
T ss_pred HHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHH
Confidence 3456789999999999 6999999999999999999999999999999999542 23478889999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc-cccccCCccccccccccCCCCCC
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT-FTGIRGTRAYVAAEWHRNLPITV 146 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~ 146 (252)
++.|++.||.|||+. +++|+||||+||+++.++.++++|||.++......... .....++..|+|||.+.+..++.
T Consensus 139 ~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (314)
T cd05099 139 CAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH 215 (314)
T ss_pred HHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCc
Confidence 999999999999999 99999999999999999999999999997654322111 11122345799999998888999
Q ss_pred cccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 147 KADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 147 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
++|+||||+++|++++ |..||....... ..+ ....+..... +......+.+++.+||+.+|++|||
T Consensus 216 ~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps 282 (314)
T cd05099 216 QSDVWSFGILMWEIFTLGGSPYPGIPVEE---LFK----LLREGHRMDK------PSNCTHELYMLMRECWHAVPTQRPT 282 (314)
T ss_pred cchhhHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCcC
Confidence 9999999999999998 788886543322 111 1122211111 1222345778888999999999999
Q ss_pred HHHHHHHhhcCc
Q 038713 226 MKKVLLMLEGTV 237 (252)
Q Consensus 226 ~~~i~~~l~~~~ 237 (252)
+.++++.|++..
T Consensus 283 ~~~ll~~l~~~~ 294 (314)
T cd05099 283 FKQLVEALDKVL 294 (314)
T ss_pred HHHHHHHHHHHH
Confidence 999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=260.13 Aligned_cols=211 Identities=23% Similarity=0.351 Sum_probs=171.1
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCc--EEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSN--KILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
++..++|+.|+.+|+.|+||||+++|++|.+..+ .-+|+|.+..|+|..|++ ..+..+...+..|+.||++||.|||
T Consensus 82 ~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~k-k~~~vn~kaik~W~RQILkGL~yLH 160 (632)
T KOG0584|consen 82 PEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRK-KHRRVNIKAIKSWCRQILKGLVYLH 160 (632)
T ss_pred hHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHH-HhccCCHHHHHHHHHHHHHHhhhhh
Confidence 4556999999999999999999999999987555 678999999999999995 4456888899999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEec-CCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
++ .+.|+|||||..||||+ .-|.|||+|+|++........ ..+.||+.|||||+.. +.|+...||||||+++.|
T Consensus 161 s~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLE 235 (632)
T KOG0584|consen 161 SQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLE 235 (632)
T ss_pred cC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHH
Confidence 98 78899999999999998 558999999999997654332 3367999999999998 689999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|+|+.+||....... .++. .+..|....-+.. .... .+.++|.+|+.. ..+|||+.|++.
T Consensus 236 MvT~eYPYsEC~n~A--QIYK----KV~SGiKP~sl~k--V~dP---evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 236 MVTSEYPYSECTNPA--QIYK----KVTSGIKPAALSK--VKDP---EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHhccCChhhhCCHH--HHHH----HHHcCCCHHHhhc--cCCH---HHHHHHHHHhcC-chhccCHHHHhh
Confidence 999999998664442 2322 2223322221111 1122 256666699999 899999999985
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=243.13 Aligned_cols=214 Identities=21% Similarity=0.303 Sum_probs=172.2
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|++++++++||||+++++++.+...++++|||+.+++|.+++......++...++.++.|++.||.|||+.
T Consensus 43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~-- 120 (262)
T cd06613 43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET-- 120 (262)
T ss_pred hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 467899999999999999999999999999999999999999999999876656789999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC---CCCCcccchhHHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL---PITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+|++|+||+++.++.++++|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|+|+
T Consensus 121 -~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~ 198 (262)
T cd06613 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198 (262)
T ss_pred -CceecCCChhhEEECCCCCEEECccccchhhhhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHH
Confidence 999999999999999999999999999876543221 11224567789999998776 7889999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||........... .......... ..........+.+++.+||..+|.+|||+.+++.
T Consensus 199 tg~~p~~~~~~~~~~~~-------~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 199 ELQPPMFDLHPMRALFL-------ISKSNFPPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hCCCCCCCCCHHHHHHH-------HHhccCCCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999976543322111 1111111100 0112233455888899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=262.06 Aligned_cols=217 Identities=24% Similarity=0.335 Sum_probs=184.5
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.|+.|+.+|+.+.|||+|+++|+|......|||+|||..|+|.+||.+- +...+..-++.|+.||.+|+.||..+
T Consensus 307 veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk-- 384 (1157)
T KOG4278|consen 307 VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK-- 384 (1157)
T ss_pred HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh--
Confidence 578999999999999999999999999999999999999999999999764 34577778889999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-C
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-L 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 163 (252)
+++|||+..+|+||.++..+|++|||+++++..+.-....+.....-|.|||-+....++.++|||+||+++||+.| |
T Consensus 385 -nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYG 463 (1157)
T KOG4278|consen 385 -NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYG 463 (1157)
T ss_pred -hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcC
Confidence 99999999999999999999999999999987665544444455678999999999899999999999999999987 5
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
..||.+-+... +...++.|... +.+..++..+++|+++||+++|.+||++.|+-+.++..+.
T Consensus 464 MsPYPGidlSq-------VY~LLEkgyRM------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 464 MSPYPGIDLSQ-------VYGLLEKGYRM------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCCCCCccHHH-------HHHHHhccccc------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 66766543332 22334444332 3355666779999999999999999999999999988654
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=247.19 Aligned_cols=223 Identities=21% Similarity=0.353 Sum_probs=172.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecC--CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDV--SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
...+.+.+|+.++++++|||++++++++... ...++||||++|++|.+++......+++..++.++.|++.||.|||+
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~ 127 (284)
T cd05079 48 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127 (284)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456799999999999999999999998875 56889999999999999996655568999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--ccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
. +++|+||||+||+++.++.++++|||.+......... ......++..|+|||...+..++.++|+||||+++|+
T Consensus 128 ~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~e 204 (284)
T cd05079 128 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204 (284)
T ss_pred C---CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhh
Confidence 9 9999999999999999999999999998865432221 1112345667999999988889999999999999999
Q ss_pred HHhCCccccccchh---------hhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 160 IVCLRRCLDQNLLE---------DRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 160 l~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
+++++.|....... ........+ .....+..... +......+.+++.+||+.+|++|||+.+++
T Consensus 205 llt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 277 (284)
T cd05079 205 LLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVLEEGKRLPR------PPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277 (284)
T ss_pred hhcCCCCCccccchhhhhcccccccccHHHHH-HHHHcCccCCC------CCCCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 99987665322111 000111111 11222221111 112345688899999999999999999999
Q ss_pred HHhhcC
Q 038713 231 LMLEGT 236 (252)
Q Consensus 231 ~~l~~~ 236 (252)
+.|+++
T Consensus 278 ~~l~~~ 283 (284)
T cd05079 278 EGFEAI 283 (284)
T ss_pred HHHHhh
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=252.85 Aligned_cols=232 Identities=16% Similarity=0.169 Sum_probs=171.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|+.+++.++||||+++++++..++..++|+||+++|+|.+++... .+.+++..++.++.|++.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~- 120 (327)
T cd08227 42 MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM- 120 (327)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3456788999999999999999999999999999999999999999999653 34588999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc------ccccccCCccccccccccC--CCCCCcccchhHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR------TFTGIRGTRAYVAAEWHRN--LPITVKADVYSFGV 155 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~ 155 (252)
+++|+||||+||+++.++.+++.||+........... ......++..|+|||++.+ ..++.++|+||||+
T Consensus 121 --~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~ 198 (327)
T cd08227 121 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 198 (327)
T ss_pred --CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHH
Confidence 9999999999999999999999998765432211110 0111235667999999876 35889999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccc---------------------------------------
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVE--------------------------------------- 196 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------- 196 (252)
++|++++|..||........ ..... .+......+
T Consensus 199 il~el~~g~~pf~~~~~~~~--~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (327)
T cd08227 199 TACELANGHVPFKDMPATQM--LLEKL-----NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESS 271 (327)
T ss_pred HHHHHHHCCCCCCCcchhHH--HHHHh-----cCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCc
Confidence 99999999999975432211 11100 000000000
Q ss_pred cchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCcCCCCCCCCC
Q 038713 197 DEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEGTVEIPIPQNPT 246 (252)
Q Consensus 197 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~~~~~~~~~~~~ 246 (252)
...........+.+++.+||+.||++|||++++++ .++.....+..+.|.
T Consensus 272 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~~~~~~~~ 323 (327)
T cd08227 272 SHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPE 323 (327)
T ss_pred ccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchhhhhhhhh
Confidence 00011123446888999999999999999999987 455544444444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=244.40 Aligned_cols=217 Identities=23% Similarity=0.352 Sum_probs=171.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCc------EEEEEecCCCCCHHhhhcCC-----CCCCCHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSN------KILVYDYMSNGSLVDVLFTP-----EKQPNWVERMGIARDI 72 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i 72 (252)
...+.+.+|+..++.++||||+++++++..... .++++||+++|+|..++... ...+++..++.++.|+
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i 122 (273)
T cd05035 43 SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122 (273)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHH
Confidence 345679999999999999999999998876444 79999999999999988432 2458889999999999
Q ss_pred HHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCccc-ccccCCccccccccccCCCCCCcccch
Q 038713 73 ARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF-TGIRGTRAYVAAEWHRNLPITVKADVY 151 (252)
Q Consensus 73 ~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Di~ 151 (252)
+.||.|||+. +++|+||||+||++++++.++++|||.++.......... ....++..|+|||.+.+..++.++|+|
T Consensus 123 ~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~ 199 (273)
T cd05035 123 ALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW 199 (273)
T ss_pred HHHHHHHHhC---CeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchH
Confidence 9999999999 999999999999999999999999999886543322111 112245679999999888899999999
Q ss_pred hHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 152 SFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 152 slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
|||+++|++++ |..||....... +. .....+.... .+......+.+++.+||+.||++|||+.+++
T Consensus 200 SlG~il~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~ 266 (273)
T cd05035 200 AFGVTMWEIATRGQTPYPGVENHE---IY----DYLRHGNRLK------QPEDCLDELYDLMYSCWRADPKDRPTFTKLR 266 (273)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCCC------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 99999999999 888886543221 11 1122222111 1222345688889999999999999999999
Q ss_pred HHhhcC
Q 038713 231 LMLEGT 236 (252)
Q Consensus 231 ~~l~~~ 236 (252)
+.|+++
T Consensus 267 ~~l~~~ 272 (273)
T cd05035 267 EVLENI 272 (273)
T ss_pred HHHHhh
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=254.50 Aligned_cols=210 Identities=20% Similarity=0.253 Sum_probs=163.7
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|+.++.++ +||||+++++++...+..++||||+++|+|..++.. .+.+++..++.++.|++.||.|||+.
T Consensus 38 ~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~- 115 (329)
T cd05618 38 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER- 115 (329)
T ss_pred HHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 445678899998877 899999999999999999999999999999998854 34689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.++....... ......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 116 --~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 192 (329)
T cd05618 116 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192 (329)
T ss_pred --CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhC
Confidence 999999999999999999999999999875322111 12234678999999999998899999999999999999999
Q ss_pred Cccccccchh--hhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 164 RRCLDQNLLE--DRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 164 ~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
..||...... .......++......+... .+......+.+++.+||+.||++|||+
T Consensus 193 ~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-------~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 193 RSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-------IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCccCCCcCCcccccHHHHHHHHhcCCCC-------CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 9999632111 0111111222222222221 112223446788889999999999994
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=242.74 Aligned_cols=211 Identities=29% Similarity=0.416 Sum_probs=172.3
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+++.+|+.+++.++|+||+++++++.+....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~- 121 (256)
T cd05039 43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK- 121 (256)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 35789999999999999999999999999999999999999999999996543 3689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++|+||+|+||+++.++.++++|||.+........ ....+..|+|||.+.+..++.++|+||||++++++++
T Consensus 122 --~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~ 195 (256)
T cd05039 122 --NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195 (256)
T ss_pred --CccchhcccceEEEeCCCCEEEcccccccccccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999876532221 2234567999999988888999999999999999997
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
|..||....... + ......+.... .+...+..+.+++.+||..+|++|||+.++++.|++
T Consensus 196 g~~p~~~~~~~~---~----~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 196 GRVPYPRIPLKD---V----VPHVEKGYRME------APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCCCCCCHHH---H----HHHHhcCCCCC------CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 888886553332 1 11111111111 111223557888889999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=254.21 Aligned_cols=207 Identities=20% Similarity=0.321 Sum_probs=178.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
....+++|+.-|+.++|||||++|++......+|+|.|+-++|+|.+||.+....++++...+++.||+.||.|+|+.
T Consensus 60 st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL-- 137 (864)
T KOG4717|consen 60 STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL-- 137 (864)
T ss_pred hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh--
Confidence 455689999999999999999999999999999999999999999999988888899999999999999999999999
Q ss_pred CCeeeeccCCCCEEec-CCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCC-CcccchhHHHHHHHHHh
Q 038713 85 AQIIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPIT-VKADVYSFGVVLLEIVC 162 (252)
Q Consensus 85 ~~i~h~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~ 162 (252)
.+||||+||+|+.+. +-|-+|+.|||++-.+.+... .....|...|-|||++.|..|+ ++.||||||+++|.+++
T Consensus 138 -HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVC 214 (864)
T KOG4717|consen 138 -HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVC 214 (864)
T ss_pred -hhhcccCCcceeEEeeecCceEeeeccccccCCCcch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHh
Confidence 999999999999655 678899999999987665443 3345688999999999998775 78999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccc-hhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDE-EVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|+.||+...+.+.... +++-. ..+......+.+||..||..||++|.|.++|+.
T Consensus 215 Gq~PFqeANDSETLTm---------------ImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 215 GQPPFQEANDSETLTM---------------IMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred CCCccccccchhhhhh---------------hhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 9999997766543222 12211 346667788999999999999999999999875
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=252.97 Aligned_cols=211 Identities=25% Similarity=0.331 Sum_probs=178.3
Q ss_pred hHHHHHHHHHHHhCCC-CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.+....+|+.+|++++ |||||.+.+++++...+++|||+|.||.|.+.+... .+++..+..++.|++.|++|||+.
T Consensus 78 ~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~- 154 (382)
T KOG0032|consen 78 DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL- 154 (382)
T ss_pred cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4578999999999998 999999999999999999999999999999999766 399999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCC----CceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEK----RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
|++|||+||+|+|+... +.++++|||++..... ........|++.|+|||+..+..++..+|+||+|+++|.
T Consensus 155 --gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yi 230 (382)
T KOG0032|consen 155 --GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYI 230 (382)
T ss_pred --CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHH
Confidence 99999999999999633 4799999999998776 345566789999999999999999999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
|++|..||.......... .+..+.+....+. .........++|..|+..||.+|+|+.++++-
T Consensus 231 LL~G~~PF~~~~~~~~~~-------~i~~~~~~f~~~~---w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 231 LLSGVPPFWGETEFEIFL-------AILRGDFDFTSEP---WDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HhhCCCCCcCCChhHHHH-------HHHcCCCCCCCCC---ccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 999999998775544222 3334444322222 22334445666669999999999999999983
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=246.98 Aligned_cols=214 Identities=21% Similarity=0.241 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+..|++++++++||||+++++++.+....++||||++||+|.+++.... ..+++..++.++.|++.||.|||+.
T Consensus 37 ~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-- 114 (277)
T cd05607 37 EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM-- 114 (277)
T ss_pred hHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4456789999999999999999999999999999999999999998885433 4578888899999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||+++.++.++++|||.+....... ......++..|+|||++.+..++.++|+||+|+++|++++|.
T Consensus 115 -~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~ 191 (277)
T cd05607 115 -DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191 (277)
T ss_pred -CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987654322 122345788999999998888999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l 233 (252)
.||........ ........ ..+.... .. ......+.+++.+||+.||++||++.|+++.+
T Consensus 192 ~p~~~~~~~~~--~~~~~~~~-~~~~~~~--~~----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 192 TPFKDHKEKVA--KEELKRRT-LEDEVKF--EH----QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCCCCCcchhh--HHHHHHHh-hcccccc--cc----ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 99975432211 11111111 1111111 00 11233477888899999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=242.03 Aligned_cols=214 Identities=23% Similarity=0.383 Sum_probs=171.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.|.+|++++++++|+||+++++++.+ ...+++|||+++|+|.+++... ....++..++.++.|++.||.|||+.
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~- 121 (260)
T cd05073 44 SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR- 121 (260)
T ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC-
Confidence 45679999999999999999999999887 7789999999999999999653 44578888999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++|+||+|+||+++.++.++++|||.+...............++..|+|||++.+..++.++|+||||+++|++++
T Consensus 122 --~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~ 199 (260)
T cd05073 122 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 199 (260)
T ss_pred --CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhc
Confidence 99999999999999999999999999987654322222222334567999999988888999999999999999998
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
|..||....... ... ....+..... .......+.+++.+||+++|++|||+.++...|++
T Consensus 200 g~~p~~~~~~~~---~~~----~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 200 GRIPYPGMSNPE---VIR----ALERGYRMPR------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCCCCCHHH---HHH----HHhCCCCCCC------cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 888887543322 111 1122211111 11223457888889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=254.43 Aligned_cols=210 Identities=20% Similarity=0.224 Sum_probs=165.6
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|+.++.++ +||||+++++.+.+.+..++||||+++|+|..++... +.+++..++.++.||+.||.|||+.
T Consensus 38 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~- 115 (327)
T cd05617 38 DIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHER- 115 (327)
T ss_pred HHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 456688999999888 7999999999999999999999999999999988543 4689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.+....... .......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 116 --~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g 192 (327)
T cd05617 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192 (327)
T ss_pred --CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhC
Confidence 99999999999999999999999999887432211 122234578999999999998899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
..||............+............. +......+.+++.+||+.||++|+++
T Consensus 193 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 193 RSPFDIITDNPDMNTEDYLFQVILEKPIRI-------PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCccCCCcccccHHHHHHHHHhCCCCC-------CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 999965432222112222222222222211 11122446778889999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=241.91 Aligned_cols=205 Identities=22% Similarity=0.360 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.|.+|+.++++++||||+++++++.. ...++|+||+++|+|.+++......+++..++.++.||+.||.|||+.
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--- 120 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK--- 120 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---
Confidence 5789999999999999999999999988 778999999999999999976655789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCC-------ceEEcccCcccccCCCCCcccccccCCccccccccccCC--CCCCcccchhHHHH
Q 038713 86 QIIHGDIKPQNILMDEKR-------CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL--PITVKADVYSFGVV 156 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~ 156 (252)
+++|+||||+||+++.++ .++++|||.+..... .....+...|+|||++.+. .++.++|+||||++
T Consensus 121 ~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~ 195 (259)
T cd05037 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTT 195 (259)
T ss_pred CeecccCccceEEEecCccccCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHH
Confidence 999999999999999877 799999999876433 1123456689999999876 68999999999999
Q ss_pred HHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 157 LLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 157 l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
+|++++ |..||........... ......... . ....+.+++.+||..+|.+|||+.++++.|+
T Consensus 196 ~~~l~~~~~~p~~~~~~~~~~~~-------~~~~~~~~~----~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 196 LLEICSNGEEPLSTLSSSEKERF-------YQDQHRLPM----P----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHHHHhCCCCCcccCCchhHHHH-------HhcCCCCCC----C----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 999999 4667765532221111 111111100 0 0156788888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=250.50 Aligned_cols=219 Identities=25% Similarity=0.346 Sum_probs=172.8
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------------CCCCHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------------KQPNWVERMG 67 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~ 67 (252)
...+++.+|+++++.+ +||||+++++++...+..++||||+.+|+|.+++.... ..+++..++.
T Consensus 65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 144 (307)
T cd05098 65 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144 (307)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence 3456788999999999 89999999999999999999999999999999996432 2478889999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc-cccccCCccccccccccCCCCCC
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT-FTGIRGTRAYVAAEWHRNLPITV 146 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~ 146 (252)
++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+.......... .....++..|+|||.+.+..++.
T Consensus 145 ~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 221 (307)
T cd05098 145 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 221 (307)
T ss_pred HHHHHHHHHHHHHHC---CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc
Confidence 999999999999999 99999999999999999999999999987554222111 11122346799999998888999
Q ss_pred cccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 147 KADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 147 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
++|+||||+++|+|++ |..||......+ + ......+.... .+......+.+++.+||..+|++|||
T Consensus 222 ~~DvwslG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps 288 (307)
T cd05098 222 QSDVWSFGVLLWEIFTLGGSPYPGVPVEE---L----FKLLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPT 288 (307)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCcCCHHH---H----HHHHHcCCCCC------CCCcCCHHHHHHHHHHcccChhhCcC
Confidence 9999999999999998 778886543221 1 11122222111 11223345778888999999999999
Q ss_pred HHHHHHHhhcCcC
Q 038713 226 MKKVLLMLEGTVE 238 (252)
Q Consensus 226 ~~~i~~~l~~~~~ 238 (252)
+.++++.|++++.
T Consensus 289 ~~evl~~l~~~~~ 301 (307)
T cd05098 289 FKQLVEDLDRILA 301 (307)
T ss_pred HHHHHHHHHHHHH
Confidence 9999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=242.99 Aligned_cols=219 Identities=18% Similarity=0.313 Sum_probs=175.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
+..+++.+|++++++++|+|++++++.+.+.+..+++|||+++|+|.+++.. ....++...++.++.+++.||.|||
T Consensus 44 ~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 123 (267)
T cd08224 44 KARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123 (267)
T ss_pred hhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 3477899999999999999999999999999999999999999999998853 2345789999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+. +++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++
T Consensus 124 ~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l 199 (267)
T cd08224 124 SK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred hC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHH
Confidence 99 9999999999999999999999999998754332211 1223567789999999888899999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
++|+.||....... .... .....+...... .......+.+++.+||+.+|++|||+.+|++.|++.
T Consensus 200 ~~g~~p~~~~~~~~----~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 200 AALQSPFYGDKMNL----YSLC-KKIEKCDYPPLP-----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHCCCCcccCCccH----HHHH-hhhhcCCCCCCC-----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 99999986543221 1111 111222221111 112334577888899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=240.68 Aligned_cols=216 Identities=22% Similarity=0.297 Sum_probs=172.4
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.|.+|++++++++||||+++++++.+.+..++|+||+++++|.+++.......+...++.++.+++.||.|||+.
T Consensus 34 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~- 112 (251)
T cd05041 34 DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK- 112 (251)
T ss_pred HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3567899999999999999999999999999999999999999999999966556688999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCccc-ccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF-TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.+........... .....+..|+|||.+.+..++.++|+||||+++|++++
T Consensus 113 --~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t 190 (251)
T cd05041 113 --NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS 190 (251)
T ss_pred --CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHh
Confidence 999999999999999999999999999875432211111 11123456999999988889999999999999999998
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
|..||......... .....+. ... .+......+.+++.+||+.+|++|||+.++++.|++
T Consensus 191 ~~~~p~~~~~~~~~~-------~~~~~~~--~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 191 LGDTPYPGMSNQQTR-------ERIESGY--RMP----APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ccCCCCccCCHHHHH-------HHHhcCC--CCC----CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 77787655332211 1111111 011 112233458888889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=255.25 Aligned_cols=212 Identities=19% Similarity=0.222 Sum_probs=167.2
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.
T Consensus 86 ~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~-- 161 (370)
T cd05596 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSM-- 161 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 345678999999999999999999999999999999999999999999854 3478888888999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC----CCCCcccchhHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL----PITVKADVYSFGVVLLEI 160 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~Di~slG~~l~~l 160 (252)
+++||||||+||+++.++.++|+|||.+...............|++.|+|||++.+. .++.++|+||||+++|+|
T Consensus 162 -~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyel 240 (370)
T cd05596 162 -GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240 (370)
T ss_pred -CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHH
Confidence 999999999999999999999999999876543322222335689999999998653 378899999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSL--RRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~i~~ 231 (252)
++|..||........ ................ ......+.+++.+||+.+|++ |||++++++
T Consensus 241 ltG~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~----~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 241 LVGDTPFYADSLVGT------YSKIMDHKNSLTFPDD----IEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HhCCCCcCCCCHHHH------HHHHHcCCCcCCCCCc----CCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 999999986543321 1111111111111111 112345777888999999987 999999965
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=243.87 Aligned_cols=222 Identities=21% Similarity=0.242 Sum_probs=170.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEec-----CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFD-----VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
..++..||+++|+.++|+||+.+++++.. -+.+|+|+|+| +.+|.+.++. ++.++...+.-..+|++.||.|+
T Consensus 64 ~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyi 141 (359)
T KOG0660|consen 64 DAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYI 141 (359)
T ss_pred HHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchh
Confidence 45778999999999999999999998875 56799999999 6699999954 44588888888999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccC-CCCCCcccchhHHHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVL 157 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l 157 (252)
|+. +++|||+||+|++++.+...|++|||+++....... ........|.+|+|||+... ..|+...||||+||++
T Consensus 142 HSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~ 218 (359)
T KOG0660|consen 142 HSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCIL 218 (359)
T ss_pred hcc---cccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHH
Confidence 999 999999999999999999999999999998754322 22345667999999998764 4799999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHH-----------------HHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCC
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEW-----------------ICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEP 220 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 220 (252)
.||++|+.-|.+.+..++..+.-. +..++.+-.......=...-+......++++.+||..||
T Consensus 219 AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP 298 (359)
T KOG0660|consen 219 AEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDP 298 (359)
T ss_pred HHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCc
Confidence 999999999987765554433211 111111111111000001111223446777889999999
Q ss_pred CCCCCHHHHHH
Q 038713 221 SLRRAMKKVLL 231 (252)
Q Consensus 221 ~~Rps~~~i~~ 231 (252)
.+|+|++|+++
T Consensus 299 ~kRita~eAL~ 309 (359)
T KOG0660|consen 299 KKRITAEEALA 309 (359)
T ss_pred cccCCHHHHhc
Confidence 99999999875
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=242.68 Aligned_cols=219 Identities=18% Similarity=0.271 Sum_probs=163.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---KQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
+..+.|.+|+.+++.++||||+++++.+.+....++||||+++|+|.+++.+.. ...+...++.++.||+.||+|||
T Consensus 37 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 116 (268)
T cd05086 37 KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116 (268)
T ss_pred HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 346789999999999999999999999999999999999999999999996532 34566777889999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCC-CCcccccccCCccccccccccC-------CCCCCcccchh
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD-QTRTFTGIRGTRAYVAAEWHRN-------LPITVKADVYS 152 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~s 152 (252)
+. +++|+||||+||+++.++.++++|||.+...... .........++..|+|||+... ..++.++|+||
T Consensus 117 ~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 193 (268)
T cd05086 117 KH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA 193 (268)
T ss_pred HC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHH
Confidence 99 9999999999999999999999999987532211 1111123456788999998743 23578999999
Q ss_pred HHHHHHHHHhC-CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 153 FGVVLLEIVCL-RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 153 lG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||+++|+|+++ ..||......+ ........+.. ....+. ........+.+++..|| .+|++|||+++|++
T Consensus 194 lG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 194 LGVTLWELFENAAQPYSHLSDRE------VLNHVIKDQQV-KLFKPQ-LELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhhccc-ccCCCc-cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 99999999974 56775443221 11111222211 111111 11112345777888999 67999999999999
Q ss_pred Hhh
Q 038713 232 MLE 234 (252)
Q Consensus 232 ~l~ 234 (252)
.|.
T Consensus 265 ~l~ 267 (268)
T cd05086 265 LLT 267 (268)
T ss_pred Hhc
Confidence 885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=251.96 Aligned_cols=219 Identities=23% Similarity=0.349 Sum_probs=172.5
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEec-CCcEEEEEecCCCCCHHhhhcCCC-------------------------
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFD-VSNKILVYDYMSNGSLVDVLFTPE------------------------- 57 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~------------------------- 57 (252)
..+.+.+|+.++.++ +||||+++++++.. ...+++++||+++|+|.+++....
T Consensus 53 ~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (337)
T cd05054 53 EYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132 (337)
T ss_pred HHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccc
Confidence 456788999999999 89999999998865 567889999999999999985321
Q ss_pred -----------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCC
Q 038713 58 -----------------------------------KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEK 102 (252)
Q Consensus 58 -----------------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~ 102 (252)
..+++..+..++.||+.||.|||+. +++|+||||+||+++.+
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~ 209 (337)
T cd05054 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSEN 209 (337)
T ss_pred cccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCC
Confidence 2568888999999999999999999 99999999999999999
Q ss_pred CceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-CCccccccchhhhHHHHH
Q 038713 103 RCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQE 180 (252)
Q Consensus 103 ~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 180 (252)
+.++++|||.+......... ......++..|+|||++.+..++.++|+|||||++|++++ |..||......+ .+.
T Consensus 210 ~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~- 286 (337)
T cd05054 210 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC- 286 (337)
T ss_pred CcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH-
Confidence 99999999999865432221 1122345668999999998899999999999999999998 999986543221 111
Q ss_pred HHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 181 WICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
.....+.... . +......+.+++.+||+.+|++|||+.++++.|+++++
T Consensus 287 ---~~~~~~~~~~--~----~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 287 ---RRLKEGTRMR--A----PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ---HHHhccCCCC--C----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1122221111 1 11223458889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=237.60 Aligned_cols=197 Identities=22% Similarity=0.260 Sum_probs=166.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
+.+-..+|..+|+.+.||+++++++.+.+.+++++||||.+||.|.+++.+.+ .+++..+.=++.||+.||.|||+.
T Consensus 87 QveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~-- 163 (355)
T KOG0616|consen 87 QVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSL-- 163 (355)
T ss_pred HHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhc--
Confidence 45667899999999999999999999999999999999999999999996554 577777777999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
++++||+||+|||++.+|.+|+.|||+++..... .....||+.|+|||++++..+..++|-|+||+++|||++|.
T Consensus 164 -~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~ 238 (355)
T KOG0616|consen 164 -DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGY 238 (355)
T ss_pred -CeeeccCChHHeeeccCCcEEEEeccceEEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999999876433 34467899999999999999999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCC
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLR 223 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 223 (252)
+||.....- .++ +.+.+++.+ .++....++.+|+.+.|+.|-.+|
T Consensus 239 pPF~~~~~~---~iY----~KI~~~~v~-------fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 239 PPFYDDNPI---QIY----EKILEGKVK-------FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCCcCCChH---HHH----HHHHhCccc-------CCcccCHHHHHHHHHHHhhhhHhh
Confidence 999876552 222 222333332 233444457777779999998888
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=256.77 Aligned_cols=209 Identities=22% Similarity=0.335 Sum_probs=174.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+++.+|+.++.+++++||.++|+.+..+..++++||||.||++.+.+. ....+.+..+.-++.+++.|+.|||.+
T Consensus 54 eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~-- 130 (467)
T KOG0201|consen 54 EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSE-- 130 (467)
T ss_pred hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhc--
Confidence 45678899999999999999999999999999999999999999999994 343447777778899999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+.+|+|||+.||++..+|.++++|||++.......... ....||+.|||||++.+..|+.++||||||++.+||++|.
T Consensus 131 -~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~Ge 208 (467)
T KOG0201|consen 131 -KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGE 208 (467)
T ss_pred -ceecccccccceeEeccCcEEEEecceeeeeechhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCC
Confidence 99999999999999999999999999999877666555 5578999999999999989999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|+.....-.-.. .+... .+..........+.++|..||++||+.||||.+++.
T Consensus 209 PP~s~~hPmrvlf-------lIpk~------~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 209 PPHSKLHPMRVLF-------LIPKS------APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCCcccCcceEEE-------eccCC------CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 9997654321000 00000 111222245566788888999999999999999875
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=250.52 Aligned_cols=225 Identities=19% Similarity=0.232 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
...+.+|+.++++++||||+++++++...+..++||||+++ +|.+++......++...+..++.|++.||.|||+.
T Consensus 48 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--- 123 (309)
T cd07872 48 PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR--- 123 (309)
T ss_pred chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 34678999999999999999999999999999999999965 89888876666689999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHhCC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+||+++.++.++++|||.+........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+
T Consensus 124 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~ 202 (309)
T cd07872 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202 (309)
T ss_pred CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999875432221 1122346789999998865 45789999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHH---------HH-----hcCCcccccc--cchhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQ---------CF-----ENGNLSQLVE--DEEVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~---------~~-----~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
.||......+.......... .. .......... ...........+.+++.+||+.||++|||+.|
T Consensus 203 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 282 (309)
T cd07872 203 PLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEE 282 (309)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHH
Confidence 99976654432221110000 00 0000000000 00011122345778889999999999999999
Q ss_pred HHH--Hhhc
Q 038713 229 VLL--MLEG 235 (252)
Q Consensus 229 i~~--~l~~ 235 (252)
+++ .++.
T Consensus 283 ~l~h~~~~~ 291 (309)
T cd07872 283 AMKHAYFRS 291 (309)
T ss_pred HhcChhhhh
Confidence 987 4444
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=244.34 Aligned_cols=213 Identities=19% Similarity=0.289 Sum_probs=168.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|+.+++.++|||++++++.+..++..++||||+++++|..++.+....+++..++.++.|++.|+.|||+.
T Consensus 51 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~- 129 (292)
T cd06644 51 EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM- 129 (292)
T ss_pred HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC-
Confidence 4567789999999999999999999999999999999999999999998866666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-----CCCCCcccchhHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-----LPITVKADVYSFGVVLL 158 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~ 158 (252)
+++|+|++|+||+++.++.++++|||.+....... .......++..|+|||++.+ ..++.++|+||||+++|
T Consensus 130 --~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~ 206 (292)
T cd06644 130 --KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 206 (292)
T ss_pred --CeeecCCCcceEEEcCCCCEEEccCccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHH
Confidence 99999999999999999999999999876543221 11123456788999998853 34678999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++++|..||....... . .... .......... +......+.+++.+||+.+|++||+++++++
T Consensus 207 el~~g~~p~~~~~~~~--~----~~~~-~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 207 EMAQIEPPHHELNPMR--V----LLKI-AKSEPPTLSQ----PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHhcCCCCCccccHHH--H----HHHH-hcCCCccCCC----CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 9999999997643221 1 1111 1111111111 1222345788888999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=241.76 Aligned_cols=211 Identities=23% Similarity=0.334 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+++.+|++++++++||||+++++++.+....++++||+.+++|.+++......+++..++.++.|++.|+.|||..
T Consensus 42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~--- 118 (256)
T cd06612 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN--- 118 (256)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 57899999999999999999999999999999999999999999999976667789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
+++|+|++|+||+++.++.++++|||.+........ ......++..|+|||.+.+..++.++|+||||+++|++++|+.
T Consensus 119 ~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~ 197 (256)
T cd06612 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKP 197 (256)
T ss_pred CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999876543322 1122346788999999988889999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||.......... .......... ..+......+.+++.+||+.+|++|||+.|++.
T Consensus 198 p~~~~~~~~~~~-------~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 198 PYSDIHPMRAIF-------MIPNKPPPTL----SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCcchhhhhh-------hhccCCCCCC----CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 997653332110 0111111111 112223345888899999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=245.82 Aligned_cols=219 Identities=22% Similarity=0.317 Sum_probs=172.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------CCCCHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------KQPNWVERMGIARDIARG 75 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~ 75 (252)
....+.+|+.+++.++||||+++++++.+.+..++||||+.+|+|.+++.... ...+...+..++.|++.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (288)
T cd05061 52 ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHH
Confidence 34578899999999999999999999999999999999999999999995421 234667888999999999
Q ss_pred HHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc-cccccCCccccccccccCCCCCCcccchhHH
Q 038713 76 IRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT-FTGIRGTRAYVAAEWHRNLPITVKADVYSFG 154 (252)
Q Consensus 76 l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 154 (252)
|.|||+. +++|+||||+||+++.++.++++|||.++......... .....++..|+|||.+.+..++.++|+||||
T Consensus 132 l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG 208 (288)
T cd05061 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG 208 (288)
T ss_pred HHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHH
Confidence 9999999 99999999999999999999999999987543322211 1112345679999999888889999999999
Q ss_pred HHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 038713 155 VVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233 (252)
Q Consensus 155 ~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l 233 (252)
+++|++++ |..||......+ . .......+... . +......+.+++.+||+.+|++|||+.++++.|
T Consensus 209 ~~l~el~~~~~~p~~~~~~~~---~---~~~~~~~~~~~-~------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l 275 (288)
T cd05061 209 VVLWEITSLAEQPYQGLSNEQ---V---LKFVMDGGYLD-Q------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275 (288)
T ss_pred HHHHHHHhCCCCCCCCCCHHH---H---HHHHHcCCCCC-C------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99999998 677886543322 1 11111222111 1 111234588888899999999999999999999
Q ss_pred hcCcCC
Q 038713 234 EGTVEI 239 (252)
Q Consensus 234 ~~~~~~ 239 (252)
++.+..
T Consensus 276 ~~~~~~ 281 (288)
T cd05061 276 KDDLHP 281 (288)
T ss_pred HhhcCC
Confidence 986544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=248.34 Aligned_cols=217 Identities=21% Similarity=0.257 Sum_probs=163.7
Q ss_pred HHHHHHHHHHHhCC---CCCCCcceeeeEe-----cCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRT---HHRNPVRLLGYSF-----DVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 6 ~~~~~~E~~~l~~l---~h~~iv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l 76 (252)
...+.+|+.+++.+ .||||+++++++. .....++||||+. ++|.+++... ...+++..++.++.|++.||
T Consensus 45 ~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL 123 (290)
T cd07862 45 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123 (290)
T ss_pred hHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHH
Confidence 34567788877765 6999999999885 3456899999995 6899998653 34588999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHH
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVV 156 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~ 156 (252)
.|||+. +++|+||||+||+++.++.++++|||.+....... ......|+..|+|||.+.+..++.++|+||||++
T Consensus 124 ~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 198 (290)
T cd07862 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 198 (290)
T ss_pred HHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHH
Confidence 999999 99999999999999999999999999987654321 2223457889999999988889999999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHHHHhc---CCccc-------cc------ccchhcHHHHHHHHHHHhhccCCCC
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQCFEN---GNLSQ-------LV------EDEEVDQKQLQRMIKVGLRCILDEP 220 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~-------~~------~~~~~~~~~~~~l~~li~~cl~~~p 220 (252)
+|+|++|..||......+.. ...+ ..... ..+.. .. ............+.+++.+||+.||
T Consensus 199 l~el~~g~~~f~~~~~~~~~--~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 275 (290)
T cd07862 199 FAEMFRRKPLFRGSSDVDQL--GKIL-DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 275 (290)
T ss_pred HHHHHcCCCCcCCCCHHHHH--HHHH-HHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCc
Confidence 99999999999876443221 1111 11000 00000 00 0001111233456788889999999
Q ss_pred CCCCCHHHHHH
Q 038713 221 SLRRAMKKVLL 231 (252)
Q Consensus 221 ~~Rps~~~i~~ 231 (252)
++|||+.++++
T Consensus 276 ~~R~s~~~~l~ 286 (290)
T cd07862 276 AKRISAYSALS 286 (290)
T ss_pred hhcCCHHHHhc
Confidence 99999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=242.18 Aligned_cols=213 Identities=28% Similarity=0.411 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++|.+|+.++++++||||+++++++. .+..+++|||+.+|+|.+++... ...+++..++.++.|++.||.|||+.
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-- 121 (260)
T cd05067 45 PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK-- 121 (260)
T ss_pred HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--
Confidence 467999999999999999999999874 45689999999999999998543 35688899999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-C
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-L 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 163 (252)
+++|+||+|+||+++.++.++++|||.+...............++..|+|||++.+..++.++|+||||+++|++++ |
T Consensus 122 -~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g 200 (260)
T cd05067 122 -NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYG 200 (260)
T ss_pred -CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987654322222222345668999999988888999999999999999998 9
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
..||....... ... ....+..... +......+.+++.+||+.+|++|||+++++..|++
T Consensus 201 ~~p~~~~~~~~---~~~----~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 201 RIPYPGMTNPE---VIQ----NLERGYRMPR------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCChHH---HHH----HHHcCCCCCC------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 99997553322 111 1122211111 11223458888889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=246.53 Aligned_cols=211 Identities=23% Similarity=0.268 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
...+.+|+.+++.++||||+++++.+...+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-- 121 (285)
T cd05605 44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-- 121 (285)
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 456889999999999999999999999999999999999999999888543 34589999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||++++++.++++|||.+........ .....|+..|+|||++.+..++.++|+||+|+++|++++|.
T Consensus 122 -~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~ 198 (285)
T cd05605 122 -RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198 (285)
T ss_pred -CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCC
Confidence 999999999999999999999999999876532221 12345788999999998888999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
.||......... +.+......+.. ..+......+.+++.+||+.||++|| +++++++
T Consensus 199 ~pf~~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 199 SPFRQRKEKVKR---EEVERRVKEDQE-------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred CCCCCCchhhHH---HHHHHHhhhccc-------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 999865332211 111111111111 11222344577888899999999999 8888854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=240.56 Aligned_cols=213 Identities=28% Similarity=0.407 Sum_probs=172.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQ-PNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|+..++.++|+||+++++++.+.+..+++|||+++++|.+++...... +++..++.++.|++.||++||+.
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~- 122 (258)
T smart00219 44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK- 122 (258)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC-
Confidence 5778999999999999999999999999999999999999999999999665444 89999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++|+||+|+||+++.++.++++|||.+...............++..|+|||.+.+..++.++|+||+|++++++++
T Consensus 123 --~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~ 200 (258)
T smart00219 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200 (258)
T ss_pred --CeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998665442222212336778999999988889999999999999999998
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l 233 (252)
|..||....... .. .....+..... +......+.+++.+||..+|++|||+.|+++.|
T Consensus 201 g~~p~~~~~~~~---~~----~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 201 GESPYPGMSNEE---VL----EYLKKGYRLPK------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCCCCHHH---HH----HHHhcCCCCCC------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 677776532221 11 11122221111 111345588888999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=250.98 Aligned_cols=219 Identities=25% Similarity=0.347 Sum_probs=173.8
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC---------------CCCCCHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP---------------EKQPNWVERMG 67 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~ 67 (252)
+..+.+.+|+++++++ +||||+++++++.+.+..++++||+.+|+|.+++... ...+++..++.
T Consensus 59 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 138 (334)
T cd05100 59 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138 (334)
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence 3457899999999999 8999999999999999999999999999999998642 23477888899
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCC
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITV 146 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~ 146 (252)
++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.++........ ......++..|+|||++.+..++.
T Consensus 139 ~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (334)
T cd05100 139 CAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 215 (334)
T ss_pred HHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc
Confidence 999999999999999 9999999999999999999999999998765432211 111122345799999999888999
Q ss_pred cccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 147 KADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 147 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
++|+||||+++|+|++ |..||........ . .....+.... .+......+.+++.+||+.+|++|||
T Consensus 216 ~~Di~slG~il~el~~~g~~p~~~~~~~~~------~-~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps 282 (334)
T cd05100 216 QSDVWSFGVLLWEIFTLGGSPYPGIPVEEL------F-KLLKEGHRMD------KPANCTHELYMIMRECWHAVPSQRPT 282 (334)
T ss_pred hhhhHHHHHHHHHHHhcCCCCCCCCCHHHH------H-HHHHcCCCCC------CCCCCCHHHHHHHHHHcccChhhCcC
Confidence 9999999999999998 7788865533321 1 1112221111 11122345778888999999999999
Q ss_pred HHHHHHHhhcCcC
Q 038713 226 MKKVLLMLEGTVE 238 (252)
Q Consensus 226 ~~~i~~~l~~~~~ 238 (252)
+.++++.|++++.
T Consensus 283 ~~ell~~l~~~~~ 295 (334)
T cd05100 283 FKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHHHHhh
Confidence 9999999998773
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=244.17 Aligned_cols=214 Identities=21% Similarity=0.320 Sum_probs=170.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.|.+|++++++++||||+++++++......++||||+++++|.+++....+.+++..++.++.|++.|+.|||+.
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~- 122 (280)
T cd06611 44 EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH- 122 (280)
T ss_pred HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3456799999999999999999999999999999999999999999999977666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc-----CCCCCCcccchhHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-----NLPITVKADVYSFGVVLL 158 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~ 158 (252)
+++|+|++|+||+++.++.++++|||.+........ ......++..|+|||.+. +..++.++|+||||+++|
T Consensus 123 --~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~ 199 (280)
T cd06611 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199 (280)
T ss_pred --CcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence 999999999999999999999999998765433222 112245688899999875 334678999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
++++|..||....... . ... ...+....... +......+.+++.+||+.+|++|||++++++.
T Consensus 200 ~l~~g~~p~~~~~~~~--~----~~~-~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 200 ELAQMEPPHHELNPMR--V----LLK-ILKSEPPTLDQ----PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHhCCCCcccCCHHH--H----HHH-HhcCCCCCcCC----cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 9999999997553221 1 111 12222211111 11223447788889999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=256.93 Aligned_cols=220 Identities=20% Similarity=0.244 Sum_probs=169.1
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
+.+.+|++++++++||||+++++++......+++||++. ++|.+++ .....+++..++.++.||+.||.|||+. +
T Consensus 131 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~---g 205 (392)
T PHA03207 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGR---G 205 (392)
T ss_pred ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 345789999999999999999999999999999999994 6899988 4455689999999999999999999999 9
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
++||||||+||+++.++.++++|||.+........ .......|+..|+|||++.+..++.++|+||||+++|+|++|+.
T Consensus 206 ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~ 285 (392)
T PHA03207 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285 (392)
T ss_pred ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999876543222 12223568999999999998889999999999999999999999
Q ss_pred cccccchhhh-HHHHHHHHHHHhcCCccccc-----------------------ccchhcHHHHHHHHHHHhhccCCCCC
Q 038713 166 CLDQNLLEDR-AILQEWICQCFENGNLSQLV-----------------------EDEEVDQKQLQRMIKVGLRCILDEPS 221 (252)
Q Consensus 166 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~cl~~~p~ 221 (252)
||........ ..+.. +............. ............+.++|.+||..||+
T Consensus 286 pf~~~~~~~~~~~l~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~ 364 (392)
T PHA03207 286 TLFGKQVKSSSSQLRS-IIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQE 364 (392)
T ss_pred CCCCCCCCCcHHHHHH-HHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChh
Confidence 9976543321 11211 11111111100000 00000111234577888899999999
Q ss_pred CCCCHHHHHHH
Q 038713 222 LRRAMKKVLLM 232 (252)
Q Consensus 222 ~Rps~~~i~~~ 232 (252)
+|||+.+++..
T Consensus 365 ~Rpsa~e~l~~ 375 (392)
T PHA03207 365 FRPSAQDILSL 375 (392)
T ss_pred hCCCHHHHhhC
Confidence 99999999874
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=243.33 Aligned_cols=218 Identities=22% Similarity=0.279 Sum_probs=164.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC----CCCCHHHHHHHHHHHHHHHHHHh
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE----KQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
....|.+|+.+++.++||||+++++.+.+....++||||+++|+|.+++.... ...++...+.++.||+.||+|||
T Consensus 38 ~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 117 (269)
T cd05042 38 EQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117 (269)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 35678999999999999999999999999999999999999999999996533 23467778899999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccC-------CCCCCcccchh
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRN-------LPITVKADVYS 152 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~s 152 (252)
+. +++|+||||+||+++.++.++++|||.+........ .......++..|+|||+... ..++.++|+||
T Consensus 118 ~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 194 (269)
T cd05042 118 QA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS 194 (269)
T ss_pred hc---CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHH
Confidence 99 999999999999999999999999999865432211 11122345667999998643 34678999999
Q ss_pred HHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 153 FGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 153 lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||+++|++++ |..||......+ . .......+.... ..+ ..+......+.+++..|| .||++|||+++|++
T Consensus 195 lG~~l~el~~~~~~p~~~~~~~~--~----~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 195 LGVTMWELFTAADQPYPDLSDEQ--V----LKQVVREQDIKL-PKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHHHhCCCCCCCcCCHHH--H----HHHHhhccCccC-CCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 9999999998 677776543322 1 112222222111 111 112233345667777888 59999999999999
Q ss_pred Hhh
Q 038713 232 MLE 234 (252)
Q Consensus 232 ~l~ 234 (252)
.|.
T Consensus 266 ~l~ 268 (269)
T cd05042 266 LLT 268 (269)
T ss_pred Hhc
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=250.48 Aligned_cols=207 Identities=22% Similarity=0.253 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+..|..+++.. +||||+++++++.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.
T Consensus 39 ~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~-- 115 (316)
T cd05619 39 VECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSK-- 115 (316)
T ss_pred HHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 45677888888764 999999999999999999999999999999999854 34578899999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||||+||+++.++.++++|||.+........ ......|+..|+|||++.+..++.++|+||+|+++|+|++|+
T Consensus 116 -~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~ 193 (316)
T cd05619 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193 (316)
T ss_pred -CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCC
Confidence 999999999999999999999999999864322111 122345788999999999888999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK-KVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~i~~ 231 (252)
.||........ . .....+... .+......+.+++.+||+.||++||++. ++.+
T Consensus 194 ~pf~~~~~~~~---~----~~i~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 194 SPFHGHDEEEL---F----QSIRMDNPC-------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCCCCCHHHH---H----HHHHhCCCC-------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 99976543321 1 111111111 1112234467888899999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=252.62 Aligned_cols=203 Identities=24% Similarity=0.243 Sum_probs=161.6
Q ss_pred HHHHHHHHH-HHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMN-AIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|.. +++.++||||+++++.+.+.+..++||||+++|+|..++.. .+.+++..+..++.||+.||.|||+.
T Consensus 39 ~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-- 115 (323)
T cd05575 39 QKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSL-- 115 (323)
T ss_pred HHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 345566655 46788999999999999999999999999999999999854 44688889999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+||+++.++.++++|||++....... .......|+..|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 116 -givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~ 193 (323)
T cd05575 116 -NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGL 193 (323)
T ss_pred -CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCC
Confidence 99999999999999999999999999886432221 1222345789999999999988999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
.||........ .... ..+.... .......+.+++.+||+.||++||++.
T Consensus 194 ~pf~~~~~~~~------~~~i-~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 194 PPFYSRDTAEM------YDNI-LNKPLRL-------KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHHHH------HHHH-HcCCCCC-------CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 99976543321 1111 1121111 111234577888899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=242.47 Aligned_cols=218 Identities=22% Similarity=0.283 Sum_probs=164.3
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC----CCCCHHHHHHHHHHHHHHHHHHh
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE----KQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
....|.+|+.++++++||||+++++.+.+....++||||+++|+|.+++.... ...+...+..++.|++.|+.|||
T Consensus 38 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 117 (269)
T cd05087 38 EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117 (269)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 44578999999999999999999999999999999999999999999985422 24566777889999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCC-------CCCCcccchh
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNL-------PITVKADVYS 152 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-------~~~~~~Di~s 152 (252)
+. +++|+||||+||+++.++.++++|||.+......... ......++..|+|||++.+. .++.++|+||
T Consensus 118 ~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 194 (269)
T cd05087 118 KN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS 194 (269)
T ss_pred HC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHH
Confidence 99 9999999999999999999999999998654322211 11223456789999987642 3578999999
Q ss_pred HHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 153 FGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 153 lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||+++|++++ |..||........... ....... ....+ .........+.+++.+|| .+|++|||+++|++
T Consensus 195 lG~~l~el~~~g~~p~~~~~~~~~~~~------~~~~~~~-~~~~~-~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 195 LGVTIWELFELGSQPYRHLSDEQVLTY------TVREQQL-KLPKP-RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHHHHHHHHhCCCCCCCCCChHHHHHH------HhhcccC-CCCCC-ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 9999999996 9999976543321111 1111111 11111 111112234667778999 68999999999999
Q ss_pred Hhh
Q 038713 232 MLE 234 (252)
Q Consensus 232 ~l~ 234 (252)
.|+
T Consensus 266 ~l~ 268 (269)
T cd05087 266 LLS 268 (269)
T ss_pred Hhc
Confidence 886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=257.95 Aligned_cols=224 Identities=25% Similarity=0.357 Sum_probs=181.9
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHhh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQ-PNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
...+++|.+|+++|.+++||||++++++|..++.+++|+||++.|+|.+++...... .......+|+.||++|++||.+
T Consensus 576 ~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes 655 (807)
T KOG1094|consen 576 KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES 655 (807)
T ss_pred hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh
Confidence 456899999999999999999999999999999999999999999999999765433 3555667899999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCC-CCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP-DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
. +++|||+.+.|+|++.++++|++|||.++..=. +.-...+...-..+|+|||-+.-.+++.++|+|+||+++||+
T Consensus 656 ~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~ 732 (807)
T KOG1094|consen 656 L---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEV 732 (807)
T ss_pred h---chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHH
Confidence 9 999999999999999999999999999984422 222233333456799999999888999999999999999998
Q ss_pred H--hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 161 V--CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 161 ~--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
+ +...||....++. ..+-.......+....... .+.-++..+++++.+||+.+.++|||++++...|++
T Consensus 733 ~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~l~---~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 733 FMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVVLS---RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred HHHHhhCchhhhhHHH---HHHhhhhhcCCCCcceecc---CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 5 6888887664442 2222333344444333332 344555668899999999999999999999999987
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=250.05 Aligned_cols=207 Identities=19% Similarity=0.243 Sum_probs=164.7
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+..|..++... +||||+++++++.+.+..++||||+.+|+|.+++.. ...+++..+..++.|++.||.|||+.
T Consensus 38 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~- 115 (316)
T cd05620 38 DVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSK- 115 (316)
T ss_pred hHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 345677888888754 999999999999999999999999999999999854 34588899999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.+....... .......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 116 --~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g 192 (316)
T cd05620 116 --GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG 192 (316)
T ss_pred --CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhC
Confidence 99999999999999999999999999886432111 122334578999999999998899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK-KVL 230 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~i~ 230 (252)
+.||....... ..+ ....+... .+......+.+++.+||+.||++||++. ++.
T Consensus 193 ~~Pf~~~~~~~---~~~----~~~~~~~~-------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 193 QSPFHGDDEDE---LFE----SIRVDTPH-------YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCCHHH---HHH----HHHhCCCC-------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 99997654322 111 11111111 1111234477888899999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=243.21 Aligned_cols=216 Identities=22% Similarity=0.326 Sum_probs=171.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC--------CCCCHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE--------KQPNWVERMGIARDIARGI 76 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l 76 (252)
..+.|.+|++++++++||||+++++++.+....++||||+++|+|.+++.... ..+++..++.++.|++.||
T Consensus 51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l 130 (275)
T cd05046 51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130 (275)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence 35679999999999999999999999999999999999999999999996433 1578999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHH
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVV 156 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~ 156 (252)
.|||+. +++|+||||+||+++.++.++++|||.+...............++..|+|||.+.+...+.++|+||||++
T Consensus 131 ~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~ 207 (275)
T cd05046 131 DHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVL 207 (275)
T ss_pred HHhhhc---CcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHH
Confidence 999999 99999999999999999999999999876443222222223345667999999888788999999999999
Q ss_pred HHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 157 LLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 157 l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
+|++++ |..||....... .. .....+...... . ......+.+++.+||+.+|++|||+.++++.|++
T Consensus 208 l~~l~~~~~~p~~~~~~~~---~~----~~~~~~~~~~~~-~----~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 208 MWEVFTQGELPFYGLSDEE---VL----NRLQAGKLELPV-P----EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HHHHHhCCCCCccccchHH---HH----HHHHcCCcCCCC-C----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 999998 777886443221 11 112222222111 1 1123457888889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=255.20 Aligned_cols=222 Identities=21% Similarity=0.262 Sum_probs=167.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCC-----cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVS-----NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
..+++.+|+.+++.++||||+++++++.... ..++|+||+. ++|.+.+.. .+.++...+..++.||+.||.||
T Consensus 42 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~L 119 (372)
T cd07853 42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYL 119 (372)
T ss_pred HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999998766 7899999995 588888854 44689999999999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLL 158 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~ 158 (252)
|+. +++|+||||+||+++.++.++++|||.++..............++..|+|||.+.+. .++.++|+||+||++|
T Consensus 120 H~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 196 (372)
T cd07853 120 HSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196 (372)
T ss_pred HhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHH
Confidence 999 999999999999999999999999999986543333333334568899999998875 4789999999999999
Q ss_pred HHHhCCccccccchhhhHHHHH----------------HHHHHHhcCCccccccc--chhcHHHHHHHHHHHhhccCCCC
Q 038713 159 EIVCLRRCLDQNLLEDRAILQE----------------WICQCFENGNLSQLVED--EEVDQKQLQRMIKVGLRCILDEP 220 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p 220 (252)
+|++|+.||............. ................. ..........+.+++.+||+.||
T Consensus 197 el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 276 (372)
T cd07853 197 ELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDP 276 (372)
T ss_pred HHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCCh
Confidence 9999999997654332211100 00011111111000000 00111123457888999999999
Q ss_pred CCCCCHHHHHH
Q 038713 221 SLRRAMKKVLL 231 (252)
Q Consensus 221 ~~Rps~~~i~~ 231 (252)
++|||+.|+++
T Consensus 277 ~~R~t~~e~l~ 287 (372)
T cd07853 277 DKRISAADALA 287 (372)
T ss_pred hhCcCHHHHhc
Confidence 99999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=249.71 Aligned_cols=203 Identities=24% Similarity=0.247 Sum_probs=160.9
Q ss_pred HHHHHHHHH-HHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMN-AIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|.. +++.++||||+++++++.+.+..++||||+++|+|..++.. .+.+++..+..++.||+.||.|||+.
T Consensus 39 ~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~-- 115 (321)
T cd05603 39 QNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSL-- 115 (321)
T ss_pred HHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 445666655 57889999999999999999999999999999999988854 44678888899999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||||+||+++.++.++++|||.+....... .......|+..|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 116 -~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 193 (321)
T cd05603 116 -NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGL 193 (321)
T ss_pred -CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCC
Confidence 99999999999999999999999999887532221 1222345788999999999888999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
.||....... . ... ...+... .+......+.+++.+||+.+|.+||++.
T Consensus 194 ~pf~~~~~~~---~---~~~-i~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 194 PPFYSRDVSQ---M---YDN-ILHKPLQ-------LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHH---H---HHH-HhcCCCC-------CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 9997653322 1 111 1112111 1112234477888899999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=251.70 Aligned_cols=207 Identities=22% Similarity=0.233 Sum_probs=162.1
Q ss_pred HHHHHHHH-HHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 7 REFKTEMN-AIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 7 ~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
..+.+|.. +++.++||||+++++++...+..++||||+++|+|.+++... +.++...+..++.||+.||.|||+.
T Consensus 40 ~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~--- 115 (325)
T cd05602 40 KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSL--- 115 (325)
T ss_pred HHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 34455544 467889999999999999999999999999999999999653 4577888888999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
+++||||||+||+++.++.++++|||.+........ ......|+..|+|||++.+..++.++|+||||+++|+|++|..
T Consensus 116 giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 194 (325)
T cd05602 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 194 (325)
T ss_pred CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCC
Confidence 999999999999999999999999999875332221 1223458899999999999889999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
||........ ..... .+... ........+.+++.+||+.+|.+||++.+.+..
T Consensus 195 pf~~~~~~~~------~~~i~-~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 195 PFYSRNTAEM------YDNIL-NKPLQ-------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCCHHHH------HHHHH-hCCcC-------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 9976543321 11111 11111 111223346778889999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=253.88 Aligned_cols=213 Identities=20% Similarity=0.231 Sum_probs=166.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|+.+++.++||||+++++++.+.+..++||||+.+|+|.+++... +.+++..+..++.|++.||.|||+.
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~- 120 (364)
T cd05599 43 EQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKL- 120 (364)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34566889999999999999999999999999999999999999999999654 4689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-------------------------------------cccc
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-------------------------------------TFTG 126 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-------------------------------------~~~~ 126 (252)
+++||||||+||+++.++.++++|||.+......... ....
T Consensus 121 --~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (364)
T cd05599 121 --GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYS 198 (364)
T ss_pred --CeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccc
Confidence 9999999999999999999999999998654321100 0112
Q ss_pred ccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHH
Q 038713 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQ 206 (252)
Q Consensus 127 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (252)
..||+.|+|||++.+..++.++|+|||||++|+|++|..||........ ................. ....
T Consensus 199 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~~----~~s~ 268 (364)
T cd05599 199 TVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET------YRKIINWKETLQFPDEV----PLSP 268 (364)
T ss_pred cccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHH------HHHHHcCCCccCCCCCC----CCCH
Confidence 3589999999999988899999999999999999999999976543321 11111111111111111 1123
Q ss_pred HHHHHHhhccCCCCCCCCC---HHHHHH
Q 038713 207 RMIKVGLRCILDEPSLRRA---MKKVLL 231 (252)
Q Consensus 207 ~l~~li~~cl~~~p~~Rps---~~~i~~ 231 (252)
.+.+++.+|+. +|.+|++ ++++++
T Consensus 269 ~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 269 EAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 46677779996 9999998 888766
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=243.92 Aligned_cols=224 Identities=25% Similarity=0.354 Sum_probs=169.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
...+.|.+|++++++++||||+++++++.. ....++|+||+++|+|.+++......+++..++.++.|++.||.|||+
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~ 126 (284)
T cd05081 47 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126 (284)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345688999999999999999999998754 456899999999999999997666678999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCccc--ccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF--TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
. +++|+||||+||+++.++.++++|||.+........... ....++..|+|||...+..++.++|+||||+++++
T Consensus 127 ~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 203 (284)
T cd05081 127 K---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 203 (284)
T ss_pred C---CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHH
Confidence 9 999999999999999999999999999886543322111 11223446999999988889999999999999999
Q ss_pred HHhCCccccccchhhhH---------HHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRA---------ILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
+++|..++......... ............+.... .+......+.+++.+||+.+|++|||+.+|+
T Consensus 204 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~ 277 (284)
T cd05081 204 LFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP------APPGCPAEIYAIMKECWNNDPSQRPSFSELA 277 (284)
T ss_pred HhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 99987765432111000 00000011111111100 1112234588888899999999999999999
Q ss_pred HHhhcC
Q 038713 231 LMLEGT 236 (252)
Q Consensus 231 ~~l~~~ 236 (252)
+.|+.+
T Consensus 278 ~~l~~~ 283 (284)
T cd05081 278 LQVEAI 283 (284)
T ss_pred HHHHhc
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=243.33 Aligned_cols=219 Identities=21% Similarity=0.233 Sum_probs=173.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEec-CCcEEEEEecCCCCCHHhhhcCCC-------CCCCHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFD-VSNKILVYDYMSNGSLVDVLFTPE-------KQPNWVERMGIARDIARG 75 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~ 75 (252)
...+.+.+|+.++++++||||+++++++.. ....+++++|+.+|+|.+++.... ..+++..++.++.|++.|
T Consensus 50 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~ 129 (280)
T cd05043 50 IQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129 (280)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHH
Confidence 446778999999999999999999998776 577899999999999999985432 458899999999999999
Q ss_pred HHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhHH
Q 038713 76 IRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFG 154 (252)
Q Consensus 76 l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 154 (252)
|.|||+. +++|+||+|+||+++.++.++++|||.++........ ......++..|+|||++.+..++.++||||||
T Consensus 130 l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG 206 (280)
T cd05043 130 MSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFG 206 (280)
T ss_pred HHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhH
Confidence 9999999 9999999999999999999999999999765432221 11122346679999999888899999999999
Q ss_pred HHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 038713 155 VVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233 (252)
Q Consensus 155 ~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l 233 (252)
+++|++++ |+.||....... +.. ....+.... . +...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 207 ~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~~--~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 207 VLLWELMTLGQTPYVEIDPFE---MAA----YLKDGYRLA--Q----PINCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred HHHHHHhcCCCCCcCcCCHHH---HHH----HHHcCCCCC--C----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 99999998 999987543321 211 122221111 1 111234578889999999999999999999999
Q ss_pred hcCcC
Q 038713 234 EGTVE 238 (252)
Q Consensus 234 ~~~~~ 238 (252)
++..+
T Consensus 274 ~~~~~ 278 (280)
T cd05043 274 TDFHA 278 (280)
T ss_pred HHHHh
Confidence 98653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=247.51 Aligned_cols=218 Identities=20% Similarity=0.307 Sum_probs=168.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD-EC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~ 83 (252)
..+++.+|++++++++||||+++++.+.+.+.+++++||+++++|.+++... +.+++..+..++.|++.||.|||+ .
T Consensus 42 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~- 119 (308)
T cd06615 42 IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKH- 119 (308)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC-
Confidence 4567899999999999999999999999999999999999999999999654 568889999999999999999997 5
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+........ ....++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus 120 --~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 194 (308)
T cd06615 120 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194 (308)
T ss_pred --CEEECCCChHHEEEecCCcEEEccCCCccccccccc---ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhC
Confidence 899999999999999999999999998865432221 224568899999999888889999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCccc---------ccc-----------------cchh-cHHHHHHHHHHHhhcc
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQ---------LVE-----------------DEEV-DQKQLQRMIKVGLRCI 216 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~-----------------~~~~-~~~~~~~l~~li~~cl 216 (252)
+.||........... ............ ... +... .......+.+++.+||
T Consensus 195 ~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 271 (308)
T cd06615 195 RYPIPPPDAKELEAM---FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCL 271 (308)
T ss_pred CCCCCCcchhhHHHh---hcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHc
Confidence 999865432221111 100000000000 000 0000 0012345788899999
Q ss_pred CCCCCCCCCHHHHHHH
Q 038713 217 LDEPSLRRAMKKVLLM 232 (252)
Q Consensus 217 ~~~p~~Rps~~~i~~~ 232 (252)
+.+|++|||++++++.
T Consensus 272 ~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 272 KKNPKERADLKELTKH 287 (308)
T ss_pred cCChhhCcCHHHHhcC
Confidence 9999999999998875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=252.00 Aligned_cols=164 Identities=23% Similarity=0.293 Sum_probs=143.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++.+++||||+++++.+.+....++||||++||+|.+++.. .+.+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~-- 120 (363)
T cd05628 44 QVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQL-- 120 (363)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 456788999999999999999999999999999999999999999999964 34689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC----------------------------------cccccccCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT----------------------------------RTFTGIRGT 130 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----------------------------------~~~~~~~~~ 130 (252)
+++||||||+||+++.++.++++|||+++....... .......|+
T Consensus 121 -givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt 199 (363)
T cd05628 121 -GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGT 199 (363)
T ss_pred -CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCC
Confidence 999999999999999999999999999875432110 001234689
Q ss_pred ccccccccccCCCCCCcccchhHHHHHHHHHhCCccccccch
Q 038713 131 RAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLL 172 (252)
Q Consensus 131 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 172 (252)
..|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 200 ~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~ 241 (363)
T cd05628 200 PDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241 (363)
T ss_pred ccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 999999999998899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=253.72 Aligned_cols=215 Identities=21% Similarity=0.256 Sum_probs=165.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.+++... +.+++..+..++.||+.||.|||+.
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~- 120 (381)
T cd05626 43 NQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKM- 120 (381)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 34567899999999999999999999999999999999999999999998643 4578888888999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC------------------------------------------
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT------------------------------------------ 121 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~------------------------------------------ 121 (252)
+++||||||+||+++.++.++++|||++........
T Consensus 121 --givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (381)
T cd05626 121 --GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATK 198 (381)
T ss_pred --CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccc
Confidence 999999999999999999999999998753210000
Q ss_pred ----cccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCccccccc
Q 038713 122 ----RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVED 197 (252)
Q Consensus 122 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (252)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||.......... ..............
T Consensus 199 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~------~i~~~~~~~~~~~~ 272 (381)
T cd05626 199 QHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQL------KVINWENTLHIPPQ 272 (381)
T ss_pred cccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHH------HHHccccccCCCCC
Confidence 00112458899999999998889999999999999999999999998664432111 11111111111111
Q ss_pred chhcHHHHHHHHHHHhh--ccCCCCCCCCCHHHHHHH
Q 038713 198 EEVDQKQLQRMIKVGLR--CILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 198 ~~~~~~~~~~l~~li~~--cl~~~p~~Rps~~~i~~~ 232 (252)
...+ ..+.+++.+ |+..+|..|||++++++.
T Consensus 273 ~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 273 VKLS----PEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred CCCC----HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1122 335566666 556677779999999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=242.45 Aligned_cols=214 Identities=21% Similarity=0.310 Sum_probs=167.1
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
.+..+.|.+|++++++++||||+++++.+...+..++|+||+++++|..+. .+++..+..++.|++.||.|||+.
T Consensus 40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~ 114 (279)
T cd06619 40 VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL 114 (279)
T ss_pred hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678999999999999999999999999999999999999999997653 467788889999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.+....... .....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 115 ---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 188 (279)
T cd06619 115 ---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELAL 188 (279)
T ss_pred ---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHh
Confidence 99999999999999999999999999987653322 122457889999999998889999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
|+.||.............-............. . .......+.+++.+||+.+|++||+++++++.
T Consensus 189 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 189 GRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL-P----VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCchhhcccccccchHHHHHHHhccCCCCC-C----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 99999754322111110001111111111111 0 11122347788889999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=243.97 Aligned_cols=222 Identities=24% Similarity=0.349 Sum_probs=174.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..++|.+|+++++.++||||+++++++.. ....+++|||+++++|.+++......+++..++.++.|++.||.|||+.
T Consensus 49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 128 (284)
T cd05038 49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128 (284)
T ss_pred HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 46789999999999999999999999887 6678999999999999999976666789999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc--cccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT--FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||+|+||+++.++.++++|||.+.......... .....++..|++||...+..++.++|+||||+++++|
T Consensus 129 ---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el 205 (284)
T cd05038 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205 (284)
T ss_pred ---CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhhee
Confidence 99999999999999999999999999998765322211 1112345579999999888899999999999999999
Q ss_pred HhCCccccccchhhhH---------HHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRA---------ILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..|+......... ...... .....+.... .+......+.+++.+||+.+|++|||+.+|++
T Consensus 206 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 206 FTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL-ELLKEGERLP------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred eccCCCcccccchhccccccccccccHHHHH-HHHHcCCcCC------CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999998654222100 011111 1111111111 11122355888999999999999999999999
Q ss_pred HhhcC
Q 038713 232 MLEGT 236 (252)
Q Consensus 232 ~l~~~ 236 (252)
+|+++
T Consensus 279 ~l~~i 283 (284)
T cd05038 279 IVDRL 283 (284)
T ss_pred HHhhc
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=243.17 Aligned_cols=212 Identities=27% Similarity=0.387 Sum_probs=169.1
Q ss_pred HHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 038713 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQI 87 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i 87 (252)
...+|+.++++++||||+++++++.+....+++||++++++|.+++. ..+.++...++.++.|++.||.+||+. ++
T Consensus 44 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i 119 (260)
T PF00069_consen 44 ENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSK---GI 119 (260)
T ss_dssp HHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhhhhhhcccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccc---cc
Confidence 44669999999999999999999999999999999999999999996 455689999999999999999999999 99
Q ss_pred eeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc-CCCCCCcccchhHHHHHHHHHhCCcc
Q 038713 88 IHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-NLPITVKADVYSFGVVLLEIVCLRRC 166 (252)
Q Consensus 88 ~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p 166 (252)
+|+||+|+||+++.++.++++|||.+..... .........++..|+|||++. +...+.++|+||+|+++++|++|..|
T Consensus 120 ~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p 198 (260)
T PF00069_consen 120 VHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLP 198 (260)
T ss_dssp EESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSS
T ss_pred ccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999875421 222333456788999999998 77899999999999999999999999
Q ss_pred ccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 167 LDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|.......................... .......+.+++.+||+.||++|||++++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 199 FEESNSDDQLEIIEKILKRPLPSSSQQ-------SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp STTSSHHHHHHHHHHHHHTHHHHHTTS-------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccchhhhhhhhhcccccccccccc-------cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 987633322222211111000000000 0001156888888999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=256.61 Aligned_cols=222 Identities=22% Similarity=0.194 Sum_probs=167.4
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
..+.+|++++++++||||+++++++...+..++|+|++ .++|.+++....+.+++..++.++.|++.||.|||+. +
T Consensus 205 ~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---g 280 (461)
T PHA03211 205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---G 280 (461)
T ss_pred cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 45679999999999999999999999999999999999 5689999876666799999999999999999999999 9
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
++||||||+|||++.++.++|+|||+++........ ......|+..|+|||++.+..++.++||||||+++|++++|..
T Consensus 281 IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~ 360 (461)
T PHA03211 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTA 360 (461)
T ss_pred EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999998765432221 1223468999999999999889999999999999999999886
Q ss_pred cccccchh-----hhHHHHHHHHHHHhc-CCcccccc----------------------cchhcHHHHHHHHHHHhhccC
Q 038713 166 CLDQNLLE-----DRAILQEWICQCFEN-GNLSQLVE----------------------DEEVDQKQLQRMIKVGLRCIL 217 (252)
Q Consensus 166 p~~~~~~~-----~~~~~~~~~~~~~~~-~~~~~~~~----------------------~~~~~~~~~~~l~~li~~cl~ 217 (252)
++...... ....+...+...... ........ ...........+.+++.+||+
T Consensus 361 ~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 440 (461)
T PHA03211 361 SLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALT 440 (461)
T ss_pred CcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcc
Confidence 65432111 111122222111000 00000000 000000112357788889999
Q ss_pred CCCCCCCCHHHHHHH
Q 038713 218 DEPSLRRAMKKVLLM 232 (252)
Q Consensus 218 ~~p~~Rps~~~i~~~ 232 (252)
.||++|||+.|+++.
T Consensus 441 ~DP~~RPsa~elL~h 455 (461)
T PHA03211 441 FDGARRPSAAELLRL 455 (461)
T ss_pred cChhhCcCHHHHhhC
Confidence 999999999999864
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=246.20 Aligned_cols=218 Identities=23% Similarity=0.359 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
...+.+|+.+++.++||||+++++++... ..++++||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 53 ~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--- 128 (303)
T cd05110 53 NVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 128 (303)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---
Confidence 45789999999999999999999998754 46799999999999999977666788999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-C
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-L 163 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 163 (252)
+++|+||||+||+++.++.++++|||.++........ ......++..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus 129 ~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g 208 (303)
T cd05110 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 208 (303)
T ss_pred CeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999999865432221 1122334668999999998889999999999999999997 8
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCCC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIP 240 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 240 (252)
+.||....... ... ....+..... +......+.+++.+||..+|++|||++++++.|+.....+
T Consensus 209 ~~p~~~~~~~~---~~~----~~~~~~~~~~------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 209 GKPYDGIPTRE---IPD----LLEKGERLPQ------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCCCCCCCHHH---HHH----HHHCCCCCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 89986543222 111 1222221111 1112345788889999999999999999999999855443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=251.86 Aligned_cols=207 Identities=23% Similarity=0.225 Sum_probs=163.4
Q ss_pred hHHHHHHHHHH-HhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNA-IGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|... ++.++||||+++++.+...+..++||||+.+|+|..++.. .+.+++..+..++.||+.||.|||+.
T Consensus 38 ~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~- 115 (325)
T cd05604 38 EQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSI- 115 (325)
T ss_pred HHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34556666654 6778999999999999999999999999999999998854 44688999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.+....... .......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 116 --givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G 192 (325)
T cd05604 116 --NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192 (325)
T ss_pred --CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcC
Confidence 99999999999999999999999999986432211 122234578999999999998899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
..||........ .... ..+.... .......+.+++.+|++.+|.+||++.+.+
T Consensus 193 ~~pf~~~~~~~~------~~~~-~~~~~~~-------~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 193 LPPFYCRDVAEM------YDNI-LHKPLVL-------RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCCCCHHHH------HHHH-HcCCccC-------CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 999976543321 1111 1121111 111234467788899999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=252.00 Aligned_cols=213 Identities=19% Similarity=0.227 Sum_probs=165.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++||||+++++.+.+.+..++||||+++|+|.+++... .+++..+..++.||+.||.|||+.
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~-- 161 (370)
T cd05621 86 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSM-- 161 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3456889999999999999999999999999999999999999999999543 478888899999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC----CCCcccchhHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP----ITVKADVYSFGVVLLEI 160 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~~l~~l 160 (252)
+++||||||+||+++.++.++|+|||.+...............|+..|+|||++.+.. ++.++|+||+|+++|+|
T Consensus 162 -~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyel 240 (370)
T cd05621 162 -GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240 (370)
T ss_pred -CeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHH
Confidence 9999999999999999999999999999865433322233456899999999987643 67899999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCC--CCCCHHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPS--LRRAMKKVLLM 232 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~--~Rps~~~i~~~ 232 (252)
++|..||........ ............... .......+.+++.+|+..++. .|+|+.++++.
T Consensus 241 l~G~~Pf~~~~~~~~------~~~i~~~~~~~~~p~----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 241 LVGDTPFYADSLVGT------YSKIMDHKNSLNFPE----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HhCCCCCCCCCHHHH------HHHHHhCCcccCCCC----cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 999999986543321 111111111111111 111233456667788875554 38899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=239.70 Aligned_cols=209 Identities=23% Similarity=0.347 Sum_probs=167.8
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|+.++++++||||+++++++.+....++++||+++++|.+++... +.++...+..++.|++.||.|||+.
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~--- 125 (267)
T cd06628 50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNR--- 125 (267)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhc---
Confidence 467889999999999999999999999999999999999999999999543 5678888999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-----ccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-----TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||+|+||++++++.++++|||.+......... ......++..|+|||.+.+..++.++|+||||+++|++
T Consensus 126 ~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l 205 (267)
T cd06628 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEM 205 (267)
T ss_pred CcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHH
Confidence 9999999999999999999999999998766422110 11123467789999999888889999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||........ . ... ....... .+......+.+++.+||+.+|++||++.++++
T Consensus 206 ~~g~~p~~~~~~~~~--~----~~~-~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 206 LTGKHPFPDCTQLQA--I----FKI-GENASPE------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred hhCCCCCCCccHHHH--H----HHH-hccCCCc------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 999999976432211 1 111 1111111 11223345778888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=253.09 Aligned_cols=213 Identities=19% Similarity=0.182 Sum_probs=163.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|++++++++||||+++++++.+.+..|+||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~-- 120 (377)
T cd05629 44 QLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKL-- 120 (377)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 456788999999999999999999999999999999999999999999964 45688888999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-------------c-----------------------------
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-------------R----------------------------- 122 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-------------~----------------------------- 122 (252)
+++||||||+||+++.++.++++|||+++....... .
T Consensus 121 -givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (377)
T cd05629 121 -GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKK 199 (377)
T ss_pred -CeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 999999999999999999999999998863211000 0
Q ss_pred ----ccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccc
Q 038713 123 ----TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDE 198 (252)
Q Consensus 123 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (252)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||......... .............+..
T Consensus 200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~~p~~~ 273 (377)
T cd05629 200 NRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETY------RKIINWRETLYFPDDI 273 (377)
T ss_pred cccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHH------HHHHccCCccCCCCCC
Confidence 000135888999999999888999999999999999999999999765433211 1111100001111110
Q ss_pred hhcHHHHHHHHHHHhhccCCCCCCC---CCHHHHHHH
Q 038713 199 EVDQKQLQRMIKVGLRCILDEPSLR---RAMKKVLLM 232 (252)
Q Consensus 199 ~~~~~~~~~l~~li~~cl~~~p~~R---ps~~~i~~~ 232 (252)
.....+.+++.+|+. +|.+| +|+.+++..
T Consensus 274 ----~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 274 ----HLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred ----CCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 112346677779997 66665 599988764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=241.66 Aligned_cols=214 Identities=23% Similarity=0.340 Sum_probs=172.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-c
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD-E 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~ 82 (252)
+.++++.+|++++++++||||+++++.+...+..++++||+.+++|.+++......+++..++.++.|++.|+.|||+ .
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 120 (265)
T cd06605 41 AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120 (265)
T ss_pred HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC
Confidence 456789999999999999999999999999999999999999999999997655678999999999999999999999 8
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.+.......... ..++..|+|||.+.+..++.++|+||||++++++++
T Consensus 121 ---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~---~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 194 (265)
T cd06605 121 ---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT---FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELAT 194 (265)
T ss_pred ---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc---ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999887553222111 456778999999998889999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQK-QLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|+.||....... ....+........... .. +.. ....+.++|.+||..+|++|||+.+++.
T Consensus 195 g~~p~~~~~~~~-~~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 195 GRFPYPPENDPP-DGIFELLQYIVNEPPP-RL------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCCCCcccccc-ccHHHHHHHHhcCCCC-CC------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 999997553211 1111222222221111 11 111 3455788888999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=243.34 Aligned_cols=209 Identities=23% Similarity=0.315 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|+.+++.+.|||++++++.+......++||||+++++|.+++.. ..++...++.++.|++.||.|||+.
T Consensus 61 ~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~--- 135 (296)
T cd06654 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN--- 135 (296)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46788999999999999999999999999999999999999999999853 3478889999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+..++.++|+||||+++|++++|+.
T Consensus 136 gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~ 214 (296)
T cd06654 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (296)
T ss_pred CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998875432221 1122357789999999988888999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||........ +. .....+.. .... +......+.+++.+||..+|++|||+.++++
T Consensus 215 pf~~~~~~~~--~~----~~~~~~~~-~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 215 PYLNENPLRA--LY----LIATNGTP-ELQN----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCCCHHHh--HH----HHhcCCCC-CCCC----ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 9976543221 11 11111111 1111 2223345788888999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=254.46 Aligned_cols=213 Identities=20% Similarity=0.222 Sum_probs=164.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|++++++++||||+++++.+.+.+..++||||+++|+|.+++... +.++...+..++.||+.||+|||+.
T Consensus 44 ~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~-- 120 (376)
T cd05598 44 QAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKM-- 120 (376)
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4567889999999999999999999999999999999999999999999543 4578888899999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCC------------------------------------------Cc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ------------------------------------------TR 122 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~------------------------------------------~~ 122 (252)
+++||||||+||+++.++.++++|||++....... ..
T Consensus 121 -~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (376)
T cd05598 121 -GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRC 199 (376)
T ss_pred -CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccc
Confidence 99999999999999999999999999874221000 00
Q ss_pred ccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcH
Q 038713 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQ 202 (252)
Q Consensus 123 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (252)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......... ................
T Consensus 200 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~~~~~~~~~~~~~~--- 270 (376)
T cd05598 200 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQL------KVINWETTLHIPSQAK--- 270 (376)
T ss_pred cccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHH------HHhccCccccCCCCCC---
Confidence 0112458899999999999889999999999999999999999998765432211 1111000001111111
Q ss_pred HHHHHHHHHHhhccCCCCCCCC---CHHHHHHH
Q 038713 203 KQLQRMIKVGLRCILDEPSLRR---AMKKVLLM 232 (252)
Q Consensus 203 ~~~~~l~~li~~cl~~~p~~Rp---s~~~i~~~ 232 (252)
....+.+++.+|+ .+|.+|+ |+.++++.
T Consensus 271 -~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 271 -LSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred -CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 2233566666766 5999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=241.33 Aligned_cols=215 Identities=20% Similarity=0.260 Sum_probs=167.2
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
....+.+|+.++++++||||+++++++......++|+||+++++|.+++.. .+.+++..+..++.|++.|+.|||+.
T Consensus 49 ~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-- 125 (267)
T cd06646 49 DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSK-- 125 (267)
T ss_pred hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 345688999999999999999999999999999999999999999998854 34678999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc---CCCCCCcccchhHHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR---NLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+|++|+||+++.++.++++|||.+........ ......++..|+|||.+. ...++.++|+||+|+++|+|+
T Consensus 126 -~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~ 203 (267)
T cd06646 126 -GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred -CccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHH
Confidence 999999999999999999999999999876543221 112245678899999874 334678999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l 233 (252)
+|+.||.......... .......... ...........+.+++.+||..+|++|||++++++.|
T Consensus 204 ~g~~p~~~~~~~~~~~-------~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 204 ELQPPMFDLHPMRALF-------LMSKSNFQPP--KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred hCCCCccccchhhhhe-------eeecCCCCCC--CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 9999986443221100 0011111110 0011112335678888999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=240.25 Aligned_cols=211 Identities=20% Similarity=0.306 Sum_probs=170.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|+.+++.++|||++++++++...+..++++||+.+++|.+++.. +.++...++.++.|++.|+++||+.
T Consensus 58 ~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~- 134 (285)
T cd06648 58 QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ- 134 (285)
T ss_pred hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3466789999999999999999999999999999999999999999999865 4588899999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+......... .....|+..|+|||...+..++.++|+||||+++|++++|
T Consensus 135 --~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g 211 (285)
T cd06648 135 --GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211 (285)
T ss_pred --CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999987654332221 1224578899999999888889999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+.||........ ... ...+....... .......+.+++.+||+.+|++|||+.++++
T Consensus 212 ~~p~~~~~~~~~------~~~-~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 212 EPPYFNEPPLQA------MKR-IRDNLPPKLKN----LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCCCcCCCHHHH------HHH-HHhcCCCCCcc----cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 999875432211 111 11111111111 1112345888899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=250.00 Aligned_cols=213 Identities=19% Similarity=0.220 Sum_probs=165.2
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++||||+++++.+.+.+..++||||+++|+|.+++... .++...+..++.||+.||.|||+.
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~-- 161 (371)
T cd05622 86 DSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM-- 161 (371)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3456889999999999999999999999999999999999999999998543 478888889999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC----CCCcccchhHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP----ITVKADVYSFGVVLLEI 160 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~~l~~l 160 (252)
+++||||||+||+++.++.++|+|||.+...............|++.|+|||++.+.. ++.++|+||||+++|+|
T Consensus 162 -~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyel 240 (371)
T cd05622 162 -GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240 (371)
T ss_pred -CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHH
Confidence 9999999999999999999999999999866433322233456899999999987543 78899999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSL--RRAMKKVLLM 232 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~i~~~ 232 (252)
++|..||........ ................ ......+.+++.+|+..++.+ |++++++++.
T Consensus 241 l~G~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~----~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 241 LVGDTPFYADSLVGT------YSKIMNHKNSLTFPDD----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HhCCCCCCCCCHHHH------HHHHHcCCCcccCCCc----CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 999999986543321 1112221111111111 122334667777999844433 7899988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=260.06 Aligned_cols=214 Identities=24% Similarity=0.309 Sum_probs=169.7
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCC--------cEEEEEecCCCCCHHhhhcCC---CCCCCHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVS--------NKILVYDYMSNGSLVDVLFTP---EKQPNWVERMGIARD 71 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~ 71 (252)
.+....+.+|+..+..++|+|++++.+.+.... ..++||||+++|+|.+++... ...+++..++.++.|
T Consensus 72 ~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~q 151 (496)
T PTZ00283 72 EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151 (496)
T ss_pred HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHH
Confidence 445677899999999999999999988765422 368999999999999998542 346889999999999
Q ss_pred HHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccc
Q 038713 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADV 150 (252)
Q Consensus 72 i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 150 (252)
++.||.|||+. +++||||||+||+++.++.++|+|||+++....... .......|++.|+|||++.+..++.++||
T Consensus 152 ll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DV 228 (496)
T PTZ00283 152 VLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADM 228 (496)
T ss_pred HHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHH
Confidence 99999999999 999999999999999999999999999876543222 12223468899999999999889999999
Q ss_pred hhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 151 YSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 151 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
||||+++|+|++|+.||....... ..... ..+..... +......+.+++.+||+.+|++|||+.+++
T Consensus 229 wSlGvilyeLltG~~Pf~~~~~~~------~~~~~-~~~~~~~~------~~~~~~~l~~li~~~L~~dP~~RPs~~ell 295 (496)
T PTZ00283 229 FSLGVLLYELLTLKRPFDGENMEE------VMHKT-LAGRYDPL------PPSISPEMQEIVTALLSSDPKRRPSSSKLL 295 (496)
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHH------HHHHH-hcCCCCCC------CCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 999999999999999997653322 11111 12222111 122334578888899999999999999987
Q ss_pred HH
Q 038713 231 LM 232 (252)
Q Consensus 231 ~~ 232 (252)
+.
T Consensus 296 ~~ 297 (496)
T PTZ00283 296 NM 297 (496)
T ss_pred hC
Confidence 63
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=252.29 Aligned_cols=155 Identities=25% Similarity=0.337 Sum_probs=136.1
Q ss_pred HHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 038713 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQI 87 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i 87 (252)
....|+.++++++||||+++++++......++|+|++ .++|.+++....+.+++..++.++.||+.||.|||+. ++
T Consensus 103 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i 178 (357)
T PHA03209 103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RI 178 (357)
T ss_pred ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 3467999999999999999999999999999999999 5689999877777899999999999999999999999 99
Q ss_pred eeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccc
Q 038713 88 IHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCL 167 (252)
Q Consensus 88 ~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 167 (252)
+||||||+||+++.++.++++|||.+....... ......|+..|+|||++.+..++.++|+||||+++|+|+++..++
T Consensus 179 vHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 179 IHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ecCCCCHHHEEECCCCCEEEecCccccccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999999999999999999999999987432211 122345788999999999988999999999999999999876665
Q ss_pred c
Q 038713 168 D 168 (252)
Q Consensus 168 ~ 168 (252)
.
T Consensus 257 f 257 (357)
T PHA03209 257 F 257 (357)
T ss_pred c
Confidence 3
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=252.22 Aligned_cols=213 Identities=20% Similarity=0.224 Sum_probs=163.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|+.++++++||||+++++.+.+.+..++||||+++|+|.+++... +.+++..+..++.||+.||.|||+.
T Consensus 43 ~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~- 120 (382)
T cd05625 43 NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKM- 120 (382)
T ss_pred HHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 34567899999999999999999999999999999999999999999998544 4578888899999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCC-------------------------------------------
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ------------------------------------------- 120 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~------------------------------------------- 120 (252)
+++||||||+|||++.++.++++|||++.......
T Consensus 121 --~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (382)
T cd05625 121 --GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAAR 198 (382)
T ss_pred --CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcc
Confidence 99999999999999999999999999864321000
Q ss_pred ---CcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCccccccc
Q 038713 121 ---TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVED 197 (252)
Q Consensus 121 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (252)
........|+..|+|||++.+..++.++|+|||||++|+|++|..||......... ...............
T Consensus 199 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~~p~~ 272 (382)
T cd05625 199 QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQ------MKVINWQTSLHIPPQ 272 (382)
T ss_pred ccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHH------HHHHccCCCcCCCCc
Confidence 00011235889999999999889999999999999999999999999865433211 111111111111111
Q ss_pred chhcHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 038713 198 EEVDQKQLQRMIKVGLRCILDEPSLRRA---MKKVLL 231 (252)
Q Consensus 198 ~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~i~~ 231 (252)
...+ ....+++.+|+ .+|++|++ +.++++
T Consensus 273 ~~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 273 AKLS----PEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred ccCC----HHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 1122 33556666765 59999998 777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=240.05 Aligned_cols=209 Identities=22% Similarity=0.308 Sum_probs=170.3
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+++++.++|+|++++++++.+....++|+||+++++|.+++... .+++..++.++.|++.|+.|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~-- 117 (274)
T cd06609 42 EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE-- 117 (274)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4567899999999999999999999999999999999999999999999644 689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+|++|+||++++++.++++|||.++....... ......++..|+|||.+.+..++.++|+||||+++|++++|.
T Consensus 118 -~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~ 195 (274)
T cd06609 118 -GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195 (274)
T ss_pred -CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999887654322 222345677899999999888999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.||....... . . .....+........ . ....+.+++.+||..+|++|||++++++
T Consensus 196 ~p~~~~~~~~---~---~-~~~~~~~~~~~~~~-~----~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 196 PPLSDLHPMR---V---L-FLIPKNNPPSLEGN-K----FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCcccCchHH---H---H-HHhhhcCCCCCccc-c----cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 9997543221 1 1 11111111111110 1 3345788888999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=240.94 Aligned_cols=216 Identities=21% Similarity=0.316 Sum_probs=171.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-c
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD-E 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~ 82 (252)
...+++.+|+++++.++||||+++++++...+.+++|+||+++++|.+++.. .+.+++..+..++.+++.||.|||+ .
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~ 123 (284)
T cd06620 45 SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVH 123 (284)
T ss_pred hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 3467899999999999999999999999999999999999999999998854 4468999999999999999999997 5
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+|++|+||++++++.++++|||.+........ ....++..|+|||++.+..++.++|+||||+++|++++
T Consensus 124 ---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~t 197 (284)
T cd06620 124 ---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL 197 (284)
T ss_pred ---CeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc---CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHh
Confidence 899999999999999999999999998765432221 12457889999999988888999999999999999999
Q ss_pred CCccccccchh-----hhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 163 LRRCLDQNLLE-----DRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 163 g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
|..||...... ....+.+........... .. . .......+.+++.+||+.||++|||+.|+++.
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 198 GKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP-RL-P----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred CCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC-CC-C----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 99999865432 111122222222211111 11 0 11133457888889999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=246.76 Aligned_cols=219 Identities=23% Similarity=0.257 Sum_probs=163.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCC------cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVS------NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
...+.+.+|+.+++.++||||+++++++.... ..++||||+++ +|.+.+. ..++...+..++.|++.||.
T Consensus 62 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~ 137 (359)
T cd07876 62 THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIK 137 (359)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHH
Confidence 34667889999999999999999999987543 57999999965 6766663 24788888999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 157 (252)
|||+. +++||||||+||+++.++.++++|||.++...... ......++..|+|||++.+..++.++|+||||+++
T Consensus 138 ~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 212 (359)
T cd07876 138 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 212 (359)
T ss_pred HHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHH
Confidence 99999 99999999999999999999999999987543221 12234578899999999998999999999999999
Q ss_pred HHHHhCCccccccchhhhHHH----------------HHHHHHHHhcCCccc------cccc------chhcHHHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRAIL----------------QEWICQCFENGNLSQ------LVED------EEVDQKQLQRMI 209 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~------~~~~------~~~~~~~~~~l~ 209 (252)
|+|++|..||........... ...+........... .... ..........+.
T Consensus 213 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (359)
T cd07876 213 GELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQAR 292 (359)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHH
Confidence 999999999986543221100 000111111100000 0000 001111234578
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 038713 210 KVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 210 ~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+++.+||..||++|||++|+++
T Consensus 293 ~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 293 DLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHhccCcccCCCHHHHhc
Confidence 8889999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=247.50 Aligned_cols=204 Identities=21% Similarity=0.260 Sum_probs=162.4
Q ss_pred HhHHHHHHHHHHHhCCCC-CCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHH-RNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
...+.+..|..++..+.| ++|+++++++.+.+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.
T Consensus 42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~ 120 (324)
T cd05587 42 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSK 120 (324)
T ss_pred hHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678899999999965 46888999999999999999999999999998543 4578899999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++.++++|||.+....... .......|+..|+|||++.+..++.++|+||+|+++|+|++
T Consensus 121 ---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt 196 (324)
T cd05587 121 ---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196 (324)
T ss_pred ---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHh
Confidence 99999999999999999999999999886432211 12223457899999999999889999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
|+.||........ . .....+... .+......+.+++.+||..||.+|++.
T Consensus 197 G~~pf~~~~~~~~--~-----~~i~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 197 GQPPFDGEDEDEL--F-----QSIMEHNVS-------YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCCHHHH--H-----HHHHcCCCC-------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 9999976543321 1 111111111 111223447788889999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=241.81 Aligned_cols=210 Identities=22% Similarity=0.318 Sum_probs=169.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++|||++++++++......++|+||+++++|..++.. ..+++..+..++.|++.|+.+||+.
T Consensus 59 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~-- 134 (296)
T cd06655 59 KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHAN-- 134 (296)
T ss_pred hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 356788999999999999999999999999999999999999999998853 3478999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++++|.
T Consensus 135 -~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~ 212 (296)
T cd06655 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (296)
T ss_pred -CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999988754432221 12235678999999998888899999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.||........... .... ....... +......+.+++.+||..+|.+|||+.+++.
T Consensus 213 ~pf~~~~~~~~~~~------~~~~-~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 213 PPYLNENPLRALYL------IATN-GTPELQN----PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCCCCCCHHHHHHH------HHhc-CCcccCC----cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 99977644332111 1111 1111111 1122334778888999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=236.03 Aligned_cols=210 Identities=28% Similarity=0.426 Sum_probs=167.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|+.++++++|||++++++++... ..+++|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~- 119 (254)
T cd05083 42 TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK- 119 (254)
T ss_pred hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 346789999999999999999999998764 4799999999999999996543 4578999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++|+|++|+||+++.++.++++|||.+....... .....+..|+|||.+.+..++.++|+||||+++|++++
T Consensus 120 --~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~ 193 (254)
T cd05083 120 --KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSY 193 (254)
T ss_pred --CeeccccCcceEEEcCCCcEEECCCccceeccccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999987543221 11223567999999988889999999999999999997
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
|..||........ . .....+.... . +...+..+.+++.+||+.+|++|||+++++..|++
T Consensus 194 g~~p~~~~~~~~~------~-~~~~~~~~~~--~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 194 GRAPYPKMSLKEV------K-ECVEKGYRME--P----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCccCCHHHH------H-HHHhCCCCCC--C----CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 8888876543321 1 1122221111 1 11223457788889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=243.09 Aligned_cols=217 Identities=17% Similarity=0.157 Sum_probs=170.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|+++++.++||||+++++.+...+..++||||++|++|.+++... +.+++..+..++.|++.|+.|||+.
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~- 120 (305)
T cd05609 43 NQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNY- 120 (305)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34567889999999999999999999999999999999999999999999544 4688899999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--------------cccccccCCccccccccccCCCCCCccc
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--------------RTFTGIRGTRAYVAAEWHRNLPITVKAD 149 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--------------~~~~~~~~~~~~~aPE~~~~~~~~~~~D 149 (252)
+++|+|++|+||+++.++.++++|||.++....... .......++..|+|||.+.+..++.++|
T Consensus 121 --~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 198 (305)
T cd05609 121 --GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVD 198 (305)
T ss_pred --CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhh
Confidence 999999999999999999999999998763211000 0001234677899999998888999999
Q ss_pred chhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 150 VYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 150 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
+||||+++|++++|..||....... ... ....+........ ......+.+++.+||+.+|++|||..++
T Consensus 199 i~slG~vl~el~~g~~pf~~~~~~~------~~~-~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~ 267 (305)
T cd05609 199 WWAMGIILYEFLVGCVPFFGDTPEE------LFG-QVISDDIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGA 267 (305)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHH------HHH-HHHhcccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCH
Confidence 9999999999999999997543321 111 1111221111111 1233447788889999999999998777
Q ss_pred HHHhhc
Q 038713 230 LLMLEG 235 (252)
Q Consensus 230 ~~~l~~ 235 (252)
.+.|+.
T Consensus 268 ~~ll~~ 273 (305)
T cd05609 268 FEVKQH 273 (305)
T ss_pred HHHHhC
Confidence 777776
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=242.17 Aligned_cols=220 Identities=22% Similarity=0.309 Sum_probs=170.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++||||+++++++.+....++|+||+ +++|.+++....+.+++..++.++.|++.||.|||+.
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-- 118 (286)
T cd07832 42 IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN-- 118 (286)
T ss_pred hhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3567999999999999999999999999999999999999 9999999976667799999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+...............++..|+|||.+.+. .++.++|+||+|++++++++|
T Consensus 119 -~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg 197 (286)
T cd07832 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197 (286)
T ss_pred -CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcC
Confidence 999999999999999999999999999886654332223334578899999998654 468999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcC---------------Cccccccc----chhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENG---------------NLSQLVED----EEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
..+|......... ..+....... ........ .....+....+.+++.+||+.+|++||
T Consensus 198 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 274 (286)
T cd07832 198 SPLFPGENDIEQL---AIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL 274 (286)
T ss_pred CcCcCCCCHHHHH---HHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCC
Confidence 8877654332211 1111111000 00000000 001112236688899999999999999
Q ss_pred CHHHHHH
Q 038713 225 AMKKVLL 231 (252)
Q Consensus 225 s~~~i~~ 231 (252)
|+++++.
T Consensus 275 ~~~~~l~ 281 (286)
T cd07832 275 SAAEALR 281 (286)
T ss_pred CHHHHhh
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=245.17 Aligned_cols=221 Identities=19% Similarity=0.222 Sum_probs=167.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
...+.+|+.+++.++||||+++++++...+..++|+||++ ++|.+++......+++..++.++.|++.||.|||+.
T Consensus 48 ~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--- 123 (301)
T cd07873 48 PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR--- 123 (301)
T ss_pred hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 3567899999999999999999999999999999999996 589999877666789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhCC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|+
T Consensus 124 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 202 (301)
T cd07873 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202 (301)
T ss_pred CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999875432221 11223457789999988754 4788999999999999999999
Q ss_pred ccccccchhhhHHHHHHHH---------HHHhcCCcccccccc-------hhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 165 RCLDQNLLEDRAILQEWIC---------QCFENGNLSQLVEDE-------EVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
.||................ .............+. .........+.+++.+||+.||.+|||++|
T Consensus 203 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~e 282 (301)
T cd07873 203 PLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE 282 (301)
T ss_pred CCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 9997664432211110000 000000000000000 001122345778889999999999999999
Q ss_pred HHH
Q 038713 229 VLL 231 (252)
Q Consensus 229 i~~ 231 (252)
+++
T Consensus 283 il~ 285 (301)
T cd07873 283 AMK 285 (301)
T ss_pred Hhc
Confidence 986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=237.14 Aligned_cols=211 Identities=21% Similarity=0.339 Sum_probs=171.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
...+++.+|+.++++++||||+++++++...+..++|+||+.+++|.+++.... ..+++..++.++.|++.|+.|||+.
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (256)
T cd08218 41 KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120 (256)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 345689999999999999999999999999999999999999999999986533 3578899999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||+..+...+.++|+||||++++++++
T Consensus 121 ---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08218 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196 (256)
T ss_pred ---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHc
Confidence 999999999999999999999999999876543221 1122346778999999988888999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|..||......+ .+..... +.... .+......+.+++.+||+.+|++||++.+++.
T Consensus 197 g~~~~~~~~~~~------~~~~~~~-~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 197 LKHAFEAGNMKN------LVLKIIR-GSYPP------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCCccCCCHHH------HHHHHhc-CCCCC------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 999997553332 1112221 22111 12223445788888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=237.66 Aligned_cols=212 Identities=21% Similarity=0.331 Sum_probs=171.8
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCC---CCCCCHHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTP---EKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~ 77 (252)
....+++.+|++++++++||||+++++++.. ....++++||+++++|.+++... ...+++..++.++.|++.||.
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~ 119 (265)
T cd08217 40 EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119 (265)
T ss_pred HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHH
Confidence 4556789999999999999999999997764 45678999999999999998542 456899999999999999999
Q ss_pred HHh-----hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchh
Q 038713 78 YLH-----DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYS 152 (252)
Q Consensus 78 ~lh-----~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 152 (252)
+|| +. +++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+||
T Consensus 120 ~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~s 195 (265)
T cd08217 120 ECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWS 195 (265)
T ss_pred HHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHH
Confidence 999 66 9999999999999999999999999998876543321 12245788999999999888899999999
Q ss_pred HHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 153 FGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 153 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||++++++++|..||....... .. .....+.... .+......+.+++.+||+.+|++|||+.+|++
T Consensus 196 lG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~~~------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 196 LGCLIYELCALSPPFTARNQLQ---LA----SKIKEGKFRR------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHHHHHHHHCCCcccCcCHHH---HH----HHHhcCCCCC------CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 9999999999999998654221 11 2222222221 22234456888899999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=239.16 Aligned_cols=212 Identities=18% Similarity=0.241 Sum_probs=165.4
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
...+.+|+.+++.++||||+++++.+...+..++++||+++++|.+++.. .+.+++..++.++.|++.|+.|||+.
T Consensus 50 ~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--- 125 (267)
T cd06645 50 FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSK--- 125 (267)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 35678999999999999999999999999999999999999999999854 34689999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc---CCCCCCcccchhHHHHHHHHHh
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR---NLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.+........ ......|+..|+|||++. ...++.++|+||||+++|++++
T Consensus 126 ~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~ 204 (267)
T cd06645 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE 204 (267)
T ss_pred CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhc
Confidence 999999999999999999999999999875542221 122345788999999874 3457889999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|..||......... .. ........... .........+.+++.+||..+|++|||++++++
T Consensus 205 ~~~p~~~~~~~~~~------~~-~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 205 LQPPMFDLHPMRAL------FL-MTKSNFQPPKL--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCCcccccchhhH------Hh-hhccCCCCCcc--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 99998654322111 00 11111111000 000112234778888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=235.70 Aligned_cols=211 Identities=20% Similarity=0.322 Sum_probs=169.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEec-CCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFD-VSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
...+.+.+|++++++++|||++++++.+.. .+.+++++||+++++|.+++... ...+++..++.++.+++.|+.+||+
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~ 120 (257)
T cd08223 41 RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120 (257)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345678999999999999999999998764 44678999999999999999653 3458999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
. +++|+||+|+||+++.++.++++|||.+........ ......++..|+|||+..+..++.++|+||||+++++++
T Consensus 121 ~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~ 196 (257)
T cd08223 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA 196 (257)
T ss_pred C---CeeccCCCchhEEEecCCcEEEecccceEEecccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHH
Confidence 9 999999999999999999999999999876543221 122345678999999999888899999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|+.||........ ... ...+.... .+......+.+++.+||+.+|++|||+.+++.
T Consensus 197 ~g~~~~~~~~~~~~------~~~-~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 197 TLKHAFNAKDMNSL------VYR-IIEGKLPP------MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cCCCCCCCCCHHHH------HHH-HHhcCCCC------CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 99999875432211 111 12222211 12233355788888999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=246.62 Aligned_cols=203 Identities=21% Similarity=0.258 Sum_probs=163.0
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+..|..++..+ +|++|+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~- 120 (323)
T cd05616 43 DVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSK- 120 (323)
T ss_pred HHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 345678888888877 6899999999999999999999999999999998543 4588899999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.+........ ......|++.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 121 --~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg 197 (323)
T cd05616 121 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197 (323)
T ss_pred --CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhC
Confidence 999999999999999999999999999875332221 12234578999999999998899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
+.||....... ... ....+... .+......+.+++.+||+.+|.+|++.
T Consensus 198 ~~Pf~~~~~~~---~~~----~i~~~~~~-------~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 198 QAPFEGEDEDE---LFQ----SIMEHNVA-------YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCCCCHHH---HHH----HHHhCCCC-------CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 99997654332 111 11122211 111223457788889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=244.29 Aligned_cols=161 Identities=23% Similarity=0.309 Sum_probs=133.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCC--------CCCCCHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTP--------EKQPNWVERMGIARDIARG 75 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~ 75 (252)
...+.+|+.++++++||||+++++++.. ....++++||+. ++|.+++... ...++...+..++.||+.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07868 42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence 3467899999999999999999998864 456889999985 5888877421 2247888999999999999
Q ss_pred HHHHhhcCCCCeeeeccCCCCEEe----cCCCceEEcccCcccccCCCCC--cccccccCCccccccccccCC-CCCCcc
Q 038713 76 IRYLHDECEAQIIHGDIKPQNILM----DEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNL-PITVKA 148 (252)
Q Consensus 76 l~~lh~~~~~~i~h~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~ 148 (252)
|.|||+. +++||||||+||++ +.++.++++|||.++....... .......++..|+|||++.+. .++.++
T Consensus 121 l~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 197 (317)
T cd07868 121 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 197 (317)
T ss_pred HHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchh
Confidence 9999999 99999999999999 4567899999999986543221 122345678899999998774 588999
Q ss_pred cchhHHHHHHHHHhCCcccccc
Q 038713 149 DVYSFGVVLLEIVCLRRCLDQN 170 (252)
Q Consensus 149 Di~slG~~l~~l~~g~~p~~~~ 170 (252)
|+||+|+++|+|++|+.||...
T Consensus 198 DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 198 DIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred hHHHHHHHHHHHHhCCCCccCC
Confidence 9999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=242.37 Aligned_cols=212 Identities=20% Similarity=0.297 Sum_probs=168.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|+.+++.++|||++++++.+...+..++||||+++++|.+++.. +.+++..++.++.||+.||.|||+.
T Consensus 61 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~- 137 (292)
T cd06658 61 QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQ- 137 (292)
T ss_pred HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3466789999999999999999999999999999999999999999998843 3478899999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||++++++.++++|||.+........ ......++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus 138 --~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g 214 (292)
T cd06658 138 --GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214 (292)
T ss_pred --CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999998875432221 11224578899999999888899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
..||.......... ............ .......+.+++.+||..+|.+|||++++++.
T Consensus 215 ~~p~~~~~~~~~~~-------~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 215 EPPYFNEPPLQAMR-------RIRDNLPPRVKD----SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCCCCCCCHHHHHH-------HHHhcCCCcccc----ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 99997553322111 111111111111 11123346677889999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=235.94 Aligned_cols=211 Identities=20% Similarity=0.369 Sum_probs=169.7
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
.+..+.+.+|++++++++|||++++++.+...+..++|+||+++++|.+++.... ..+++..++.++.+++.|+.|||+
T Consensus 40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 119 (256)
T cd08220 40 KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119 (256)
T ss_pred cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456789999999999999999999999999999999999999999999996543 457899999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCC-ceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKR-CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
. +++|+||+|+||+++.++ .++++|||.+........ .....++..|+|||.+.+..++.++|+||||+++|++
T Consensus 120 ~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l 194 (256)
T cd08220 120 K---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194 (256)
T ss_pred C---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHH
Confidence 9 999999999999998554 579999999876543221 1223567889999999988889999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|+.||........ .... ..+..... +......+.+++.+||+.+|++|||+.|+++
T Consensus 195 ~~~~~~~~~~~~~~~------~~~~-~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 195 ASLKRAFEAANLPAL------VLKI-MSGTFAPI------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HhCCCCcccCchHHH------HHHH-HhcCCCCC------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 999999976533221 1111 11111111 1122345778888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=237.50 Aligned_cols=210 Identities=21% Similarity=0.322 Sum_probs=171.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|+.+++++.||||+++++.+.+.+..++||||+++|+|.+++.. +.++...+..++.|++.||.+||+.
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~- 120 (277)
T cd06640 44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSE- 120 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3456799999999999999999999999999999999999999999999853 3578888999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus 121 --~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg 197 (277)
T cd06640 121 --KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197 (277)
T ss_pred --CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHC
Confidence 9999999999999999999999999998765432211 1223467789999999888899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
..||......... .....+.. ..........+.+++.+||+.+|++|||+++++..
T Consensus 198 ~~p~~~~~~~~~~-------~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 198 EPPNSDMHPMRVL-------FLIPKNNP------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCCcChHhHh-------hhhhcCCC------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 9999755332211 11111111 12233445668889999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=265.44 Aligned_cols=222 Identities=19% Similarity=0.250 Sum_probs=170.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC----------CCCCCHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP----------EKQPNWVERMGIARDIA 73 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~ 73 (252)
..+++|.+|++++++++||||+++++++.+.+..+++|||++||+|.+++... ....+...++.++.||+
T Consensus 44 ~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa 123 (932)
T PRK13184 44 LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123 (932)
T ss_pred HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHH
Confidence 34678999999999999999999999999999999999999999999988531 12345667889999999
Q ss_pred HHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-----------------cccccccCCcccccc
Q 038713 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-----------------RTFTGIRGTRAYVAA 136 (252)
Q Consensus 74 ~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----------------~~~~~~~~~~~~~aP 136 (252)
+||.|||+. +++||||||+||+++.++.++++|||.+........ .......|++.|+||
T Consensus 124 ~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP 200 (932)
T PRK13184 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP 200 (932)
T ss_pred HHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence 999999999 999999999999999999999999999976521100 011124589999999
Q ss_pred ccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhcc
Q 038713 137 EWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCI 216 (252)
Q Consensus 137 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 216 (252)
|.+.+..++.++|+||||+++|+|++|+.||........... ... ........ ..+.+..+.+++.+||
T Consensus 201 E~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~-----~~i--~~P~~~~p----~~~iP~~L~~LI~rcL 269 (932)
T PRK13184 201 ERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR-----DVI--LSPIEVAP----YREIPPFLSQIAMKAL 269 (932)
T ss_pred HHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh-----hhc--cChhhccc----cccCCHHHHHHHHHHc
Confidence 999998899999999999999999999999976432211000 000 00000000 1122344778888999
Q ss_pred CCCCCCCC-CHHHHHHHhhcCcCC
Q 038713 217 LDEPSLRR-AMKKVLLMLEGTVEI 239 (252)
Q Consensus 217 ~~~p~~Rp-s~~~i~~~l~~~~~~ 239 (252)
+.||++|| +++++++.|+..+..
T Consensus 270 ~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 270 AVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred cCChhhCcCHHHHHHHHHHHHHhc
Confidence 99999996 566677777775543
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=240.49 Aligned_cols=210 Identities=24% Similarity=0.278 Sum_probs=167.6
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|+.++++++|+|++++++.+.+.+..++||||+.+|+|.+++... ...+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-- 121 (285)
T cd05630 44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-- 121 (285)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 456789999999999999999999999999999999999999999988543 34588899999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||+++.++.++++|||.+....... ......|+..|+|||++.+..++.++|+||+|+++|++++|.
T Consensus 122 -~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 198 (285)
T cd05630 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198 (285)
T ss_pred -CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987543222 112346788999999999888999999999999999999999
Q ss_pred ccccccchhhh-HHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038713 165 RCLDQNLLEDR-AILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-----MKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~i~~ 231 (252)
.||........ .......... .. ..+......+.+++.+||+.||++||| ++|+++
T Consensus 199 ~Pf~~~~~~~~~~~~~~~~~~~-~~----------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 199 SPFQQRKKKIKREEVERLVKEV-QE----------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CCCCCCCccchHHHHHhhhhhh-hh----------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 99986533211 1111111110 00 011112234678888999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=236.65 Aligned_cols=212 Identities=19% Similarity=0.269 Sum_probs=168.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|++++++++|+||+++++++.+.+..++++||+++++|.+++.+. ..++...++.++.|++.||.|||+.
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~-- 121 (265)
T cd06631 45 EYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNN-- 121 (265)
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 3467899999999999999999999999999999999999999999999543 4578888999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCC-----CcccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ-----TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
+++|+||+|+||+++.++.++++|||.+....... ........++..|+|||++.+..++.++|+||||+++|+
T Consensus 122 -~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ 200 (265)
T cd06631 122 -CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFE 200 (265)
T ss_pred -CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHH
Confidence 99999999999999999999999999887542211 111123457889999999998888999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+++|..||......... .......+..... +......+.+++.+||+.+|++|||+.+++.
T Consensus 201 l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 201 MATGKPPLASMDRLAAM-----FYIGAHRGLMPRL------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHhCCCccccCChHHHH-----HHhhhccCCCCCC------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 99999999754322211 0000111111111 1123344778888999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=239.56 Aligned_cols=209 Identities=22% Similarity=0.333 Sum_probs=169.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|++++++++||||+++++.+...+..++|+||+++++|.+++.. ..+++..++.++.|++.|+.|||+.
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~- 120 (277)
T cd06642 44 DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSE- 120 (277)
T ss_pred HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC-
Confidence 3456789999999999999999999999999999999999999999998853 4578899999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||++++++.++++|||.+........ ......++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus 121 --~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg 197 (277)
T cd06642 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 197 (277)
T ss_pred --CeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999876543221 11223467789999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+.|+........ . .....+.... ........+.+++.+||+.+|++|||+.+++.
T Consensus 198 ~~p~~~~~~~~~------~-~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 198 EPPNSDLHPMRV------L-FLIPKNSPPT------LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCCcccchhhH------H-hhhhcCCCCC------CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 999864432211 0 1111111111 11223345778888999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=246.42 Aligned_cols=216 Identities=20% Similarity=0.189 Sum_probs=165.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.|.+|..++..++|+||+++++++.+.+..++||||+++|+|.+++......+++..+..++.||+.||+|||+.
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-- 121 (331)
T cd05597 44 ETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL-- 121 (331)
T ss_pred hHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 356688999999999999999999999999999999999999999999976566789999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-----CCCCCcccchhHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-----LPITVKADVYSFGVVLLE 159 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~ 159 (252)
+++|+||||+||+++.++.++++|||.+...............|+..|+|||++.+ ..++.++|+||+|+++|+
T Consensus 122 -~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~e 200 (331)
T cd05597 122 -GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE 200 (331)
T ss_pred -CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHH
Confidence 99999999999999999999999999987654333222222457899999999863 346789999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILD--EPSLRRAMKKVLLM 232 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--~p~~Rps~~~i~~~ 232 (252)
|++|+.||......+.. ............... .......+.+++.+|+.. ++..||+++++++.
T Consensus 201 l~~g~~Pf~~~~~~~~~------~~i~~~~~~~~~~~~---~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 201 MLYGETPFYAESLVETY------GKIMNHKEHFQFPPD---VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HhhCCCCCCCCCHHHHH------HHHHcCCCcccCCCc---cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999765433211 111111111111111 111233466666687754 33447899888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=236.76 Aligned_cols=220 Identities=21% Similarity=0.268 Sum_probs=171.7
Q ss_pred HHHHHHHHHhCCCCCC-CcceeeeEecCC------cEEEEEecCCCCCHHhhhcCCC---CCCCHHHHHHHHHHHHHHHH
Q 038713 8 EFKTEMNAIGRTHHRN-PVRLLGYSFDVS------NKILVYDYMSNGSLVDVLFTPE---KQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~-iv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~ 77 (252)
...+|+-+++.++|+| |+++++++...+ .+++||||++. +|..++.... ...+...+..+..||+.||+
T Consensus 56 taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~ 134 (323)
T KOG0594|consen 56 TAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLA 134 (323)
T ss_pred hhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHH
Confidence 3579999999999999 999999999877 89999999955 9999997644 35777889999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVV 156 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~ 156 (252)
|||++ +|+|||+||.||+++++|.+|++|||+++...-+.. ......+|.+|+|||++.|. .|+...|+||+||+
T Consensus 135 ~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcI 210 (323)
T KOG0594|consen 135 FLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCI 210 (323)
T ss_pred HHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHH
Confidence 99999 999999999999999999999999999996553332 24455678999999999987 69999999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccc-------------cchhcH---HHHHHHHHHHhhccCCCC
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVE-------------DEEVDQ---KQLQRMIKVGLRCILDEP 220 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~---~~~~~l~~li~~cl~~~p 220 (252)
+.||++++.-|.+....++...+-.+........|..... +..... .......+++.+||+.+|
T Consensus 211 faEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p 290 (323)
T KOG0594|consen 211 FAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDP 290 (323)
T ss_pred HHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCc
Confidence 9999999999987766544333222111111111211110 111111 111367888889999999
Q ss_pred CCCCCHHHHHHH
Q 038713 221 SLRRAMKKVLLM 232 (252)
Q Consensus 221 ~~Rps~~~i~~~ 232 (252)
++|.|++.++..
T Consensus 291 ~~R~Sa~~al~h 302 (323)
T KOG0594|consen 291 AKRISAKGALTH 302 (323)
T ss_pred ccCcCHHHHhcC
Confidence 999999999885
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=237.87 Aligned_cols=213 Identities=24% Similarity=0.310 Sum_probs=166.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP--NWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~lh~ 81 (252)
+..+.+.+|+.++++++|+||+++++++...+..++++||+++++|.+++....... +...+..++.|++.||.|||+
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 126 (268)
T cd06624 47 RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126 (268)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH
Confidence 355689999999999999999999999999999999999999999999997654444 778888899999999999999
Q ss_pred cCCCCeeeeccCCCCEEecC-CCceEEcccCcccccCCCCCcccccccCCccccccccccCC--CCCCcccchhHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDE-KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL--PITVKADVYSFGVVLL 158 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~ 158 (252)
. +++|+|++|+||+++. ++.++++|||.+......... .....++..|+|||.+.+. .++.++|+||+|+++|
T Consensus 127 ~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~ 202 (268)
T cd06624 127 N---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIV 202 (268)
T ss_pred C---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-cccCCCCccccChhhhccccccCCchhhhHHHHHHHH
Confidence 9 9999999999999975 678999999998755322221 1223467899999998654 3788999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++++|..||........... ..+.... ....+......+.+++.+||+.+|++|||+.+++.
T Consensus 203 ~l~~g~~p~~~~~~~~~~~~--------~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 203 EMATGKPPFIELGEPQAAMF--------KVGMFKI---HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHhCCCCCccccChhhhHh--------hhhhhcc---CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 99999999975432211110 0000000 00112223345778888999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=241.70 Aligned_cols=219 Identities=21% Similarity=0.242 Sum_probs=164.2
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP--EKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.+.+.+|+.++++++|||++++++++.+++..++||||+. ++|.+++... ...+++..++.++.|++.||.|||+.
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~- 120 (285)
T cd07861 43 PSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR- 120 (285)
T ss_pred hHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4678899999999999999999999999999999999996 6898888543 25689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.+....... .......++..|+|||.+.+. .++.++|+||||+++|++++
T Consensus 121 --~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 121 --RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred --CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999987543222 111223457889999988654 57889999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHH--hcCCc---------c----ccccc--chhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCF--ENGNL---------S----QLVED--EEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~---------~----~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
|+.||.......... ....... ....+ . ..... ..........+.+++.+||+.||++|||
T Consensus 198 g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 275 (285)
T cd07861 198 KKPLFHGDSEIDQLF--RIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS 275 (285)
T ss_pred CCCCCCCCCHHHHHH--HHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC
Confidence 999997653322111 0000000 00000 0 00000 0001112345678888999999999999
Q ss_pred HHHHHH
Q 038713 226 MKKVLL 231 (252)
Q Consensus 226 ~~~i~~ 231 (252)
+++++.
T Consensus 276 ~~~ll~ 281 (285)
T cd07861 276 AKKALN 281 (285)
T ss_pred HHHHhc
Confidence 999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=236.05 Aligned_cols=214 Identities=24% Similarity=0.357 Sum_probs=171.4
Q ss_pred hHHHHHHHHHHHhC-CCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 5 GEREFKTEMNAIGR-THHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 5 ~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
...++.+|+.++.+ ++||||+++++++.+.+..+++|||+++++|.+++.. ....++...++.++.|++.||.|||
T Consensus 51 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 130 (269)
T cd08528 51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130 (269)
T ss_pred HHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc
Confidence 34567889998875 6999999999999999999999999999999988733 3456899999999999999999999
Q ss_pred h-cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 81 D-ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 81 ~-~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
. . +++|+||+|.||+++.++.++++|||.+....... ......++..|++||.+.+..++.++|+||||+++|+
T Consensus 131 ~~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~ 205 (269)
T cd08528 131 KEK---RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQ 205 (269)
T ss_pred cCC---ceeecCCCHHHEEECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHH
Confidence 6 5 89999999999999999999999999987654332 2233457888999999998888999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
+++|..||........ . .....+....... ......+.+++.+||+.||++|||+.|+..++++
T Consensus 206 l~~g~~p~~~~~~~~~------~-~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 206 MCTLQPPFYSTNMLSL------A-TKIVEAVYEPLPE-----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HHhCCCcccccCHHHH------H-HHHhhccCCcCCc-----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 9999999975533221 1 1111222211111 1123457888889999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=250.41 Aligned_cols=218 Identities=21% Similarity=0.341 Sum_probs=171.1
Q ss_pred hHHHHHHHHHHHhCCC-CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC--------------------------
Q 038713 5 GEREFKTEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-------------------------- 57 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------- 57 (252)
..+.+.+|+.++.++. ||||+++++.+...+..++|+||+.+|+|.+++....
T Consensus 83 ~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (401)
T cd05107 83 EKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLS 162 (401)
T ss_pred HHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccc
Confidence 3457999999999996 9999999999999999999999999999999985421
Q ss_pred -----------------------------------------------------------------------CCCCHHHHH
Q 038713 58 -----------------------------------------------------------------------KQPNWVERM 66 (252)
Q Consensus 58 -----------------------------------------------------------------------~~~~~~~~~ 66 (252)
..+++..++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 242 (401)
T cd05107 163 QRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLV 242 (401)
T ss_pred ccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHH
Confidence 125666778
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCC
Q 038713 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPIT 145 (252)
Q Consensus 67 ~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~ 145 (252)
.++.|++.||.|||+. +++|+||||+||+++.++.++++|||.++....... .......++..|+|||.+.+..++
T Consensus 243 ~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 319 (401)
T cd05107 243 GFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT 319 (401)
T ss_pred HHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC
Confidence 8999999999999999 999999999999999999999999999876432221 111223456789999999888889
Q ss_pred CcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 146 VKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 146 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
.++|+||||+++|++++ |+.||......+. . ......+.... . +......+.+++.+||..+|.+||
T Consensus 320 ~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--~----~~~~~~~~~~~--~----p~~~~~~l~~li~~cl~~~P~~RP 387 (401)
T cd05107 320 TLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--F----YNAIKRGYRMA--K----PAHASDEIYEIMQKCWEEKFEIRP 387 (401)
T ss_pred cHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--H----HHHHHcCCCCC--C----CCCCCHHHHHHHHHHcCCChhHCc
Confidence 99999999999999998 8888865432221 1 11122221111 1 111234578888899999999999
Q ss_pred CHHHHHHHhhcCc
Q 038713 225 AMKKVLLMLEGTV 237 (252)
Q Consensus 225 s~~~i~~~l~~~~ 237 (252)
|+.+|++.|++.+
T Consensus 388 s~~ell~~L~~~~ 400 (401)
T cd05107 388 DFSQLVHLVGDLL 400 (401)
T ss_pred CHHHHHHHHHHHh
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=245.85 Aligned_cols=215 Identities=20% Similarity=0.184 Sum_probs=165.2
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.|.+|+.++..++|+||+++++.+.+.+..++||||+++|+|.+++.+....+++..+..++.|++.||.|||+.
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~--- 121 (332)
T cd05623 45 TACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL--- 121 (332)
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 45588999999999999999999999999999999999999999999976666789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-----CCCCCcccchhHHHHHHHH
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-----LPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l 160 (252)
+++||||||+||+++.++.++++|||.+...............|+..|+|||++.+ ..++.++|+||||+++|+|
T Consensus 122 ~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~el 201 (332)
T cd05623 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM 201 (332)
T ss_pred CeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHH
Confidence 99999999999999999999999999987543332222223468999999999863 3578899999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDE--PSLRRAMKKVLLM 232 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~--p~~Rps~~~i~~~ 232 (252)
++|+.||........ ................ .......+.+++.+|+..+ +..|++++++++.
T Consensus 202 l~g~~Pf~~~~~~~~------~~~i~~~~~~~~~p~~---~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 202 LYGETPFYAESLVET------YGKIMNHKERFQFPAQ---VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred hcCCCCCCCCCHHHH------HHHHhCCCccccCCCc---cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 999999976533221 1111111111111111 1122344667777887554 3447889888655
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=246.89 Aligned_cols=215 Identities=20% Similarity=0.185 Sum_probs=165.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|..++..++|+||+++++++.+.+..++||||+.||+|.+++......+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~-- 121 (331)
T cd05624 44 ETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL-- 121 (331)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 345688999999999999999999999999999999999999999999976566789999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-----CCCCCcccchhHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-----LPITVKADVYSFGVVLLE 159 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~ 159 (252)
+++|+||||+||+++.++.++++|||.+...............|+..|+|||++.+ ..++.++|+||||+++|+
T Consensus 122 -~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~e 200 (331)
T cd05624 122 -HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200 (331)
T ss_pred -CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhh
Confidence 99999999999999999999999999987654433322233458999999999875 357889999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSL--RRAMKKVLL 231 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~i~~ 231 (252)
|++|+.||........ ............... ........+.+++.+|+..+++. |++++++++
T Consensus 201 ll~g~~Pf~~~~~~~~------~~~i~~~~~~~~~p~---~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 201 MLYGETPFYAESLVET------YGKIMNHEERFQFPS---HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred hhhCCCCccCCCHHHH------HHHHHcCCCcccCCC---ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 9999999976543321 111111111111111 01112344667777988865543 467887765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=257.48 Aligned_cols=223 Identities=18% Similarity=0.236 Sum_probs=163.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC----CCCCHHHHHHHHHHHHHHHHHHh
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE----KQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
..+++.+|+.++++++||||+++++++.+.+..+++++++ +++|.+++.... .......+..++.||+.||.|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 3566889999999999999999999999999999999998 457777764321 22445667789999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+. +++||||||+|||++.++.++|+|||++...............|+..|+|||++.+..++.++||||||+++|+|
T Consensus 285 ~~---gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 361 (501)
T PHA03210 285 DK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361 (501)
T ss_pred hC---CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence 99 999999999999999999999999999987654333333345689999999999998999999999999999999
Q ss_pred HhCCcccc-ccchhhhHHHHHHHHHH-----------------HhcCCcccc---cccchhcHHHHHHHHHHHhhccCCC
Q 038713 161 VCLRRCLD-QNLLEDRAILQEWICQC-----------------FENGNLSQL---VEDEEVDQKQLQRMIKVGLRCILDE 219 (252)
Q Consensus 161 ~~g~~p~~-~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~ 219 (252)
++|+.++. .........+...+... +........ ....-.......++.+++.+||++|
T Consensus 362 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~D 441 (501)
T PHA03210 362 LSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD 441 (501)
T ss_pred HHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccC
Confidence 99886543 22222222222211100 000000000 0000000012234677788999999
Q ss_pred CCCCCCHHHHHH
Q 038713 220 PSLRRAMKKVLL 231 (252)
Q Consensus 220 p~~Rps~~~i~~ 231 (252)
|++|||+.|++.
T Consensus 442 P~~Rpsa~elL~ 453 (501)
T PHA03210 442 WHLRPGAAELLA 453 (501)
T ss_pred cccCcCHHHHhh
Confidence 999999999986
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=237.93 Aligned_cols=214 Identities=25% Similarity=0.369 Sum_probs=170.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+++.+|++++++++|+||+++++++.+.+..++|+||+++++|.+++.. .+.+++..++.++.|++.||.|||+.
T Consensus 46 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~-- 122 (268)
T cd06630 46 VVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHEN-- 122 (268)
T ss_pred HHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 357899999999999999999999999999999999999999999999854 34678899999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCC-ceEEcccCcccccCCCCCc---ccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKR-CAKISDFGLAKLMKPDQTR---TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||+|+||+++.++ .++++|||.+......... ......++..|+|||.+.+..++.++|+||+|++++++
T Consensus 123 -~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 201 (268)
T cd06630 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEM 201 (268)
T ss_pred -CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHH
Confidence 999999999999998776 5899999998766433211 11223567899999999888889999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||........... ......... ....+......+.+++.+||..+|++|||+.+++.
T Consensus 202 ~~g~~p~~~~~~~~~~~~---~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 202 ATAKPPWNAEKHSNHLAL---IFKIASATT------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HhCCCCCCCCCCcchHHH---HHHHhccCC------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 999999975433221111 111111111 11223344566888999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=241.67 Aligned_cols=210 Identities=20% Similarity=0.293 Sum_probs=168.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++.+.+|+.+++.++|||++++++++...+..++++||+++++|.+++.. ..+++..++.++.|++.||.|||+.
T Consensus 61 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~-- 136 (297)
T cd06659 61 RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQ-- 136 (297)
T ss_pred hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 456788999999999999999999999999999999999999999998743 4578999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||+++.++.++++|||.+......... .....++..|+|||++.+..++.++|+||||++++++++|.
T Consensus 137 -~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~ 214 (297)
T cd06659 137 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214 (297)
T ss_pred -CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999988654332221 12245788999999998888999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.||......... ............. .......+.+++.+||+.+|++|||++++++
T Consensus 215 ~p~~~~~~~~~~-------~~~~~~~~~~~~~----~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 215 PPYFSDSPVQAM-------KRLRDSPPPKLKN----AHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCCCCCCHHHHH-------HHHhccCCCCccc----cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 999755332211 1111111111111 1112234778888999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=238.88 Aligned_cols=218 Identities=24% Similarity=0.308 Sum_probs=169.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
+...++.+|++++++++||||+++++++.+ .+.+++||||+++++|.+++.. ....++...+..++.|++.||.|
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 120 (287)
T cd06621 41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120 (287)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 356779999999999999999999998864 4478999999999999888643 34557888999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
||+. +++|+|++|.||+++.++.++++|||.+........ ....++..|+|||.+.+..++.++|+||||+++|
T Consensus 121 lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~ 194 (287)
T cd06621 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLL 194 (287)
T ss_pred HHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHH
Confidence 9999 999999999999999999999999999865432221 1234677899999999888999999999999999
Q ss_pred HHHhCCccccccchh--hhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLE--DRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|++|..||...... ....... .......................+.+++.+||+.+|.+|||+.|+++
T Consensus 195 ~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 195 EVAQNRFPFPPEGEPPLGPIELLS----YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHhCCCCCCcccCCCCChHHHHH----HHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 999999999865321 1111111 11121111111111111123456888999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=240.64 Aligned_cols=225 Identities=22% Similarity=0.255 Sum_probs=170.4
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|++++++++|+||+++++++.+.+..++||||+ +|+|.+++......+++..++.++.||++||.|||+.
T Consensus 46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~--- 121 (298)
T cd07841 46 NFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN--- 121 (298)
T ss_pred hHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 456788999999999999999999999999999999999 8999999966555789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHhCC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+ ..++.++|+||||++++++++|.
T Consensus 122 ~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~ 200 (298)
T cd07841 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200 (298)
T ss_pred CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999876543321 1122345678999998865 35789999999999999999997
Q ss_pred ccccccchhhhHHHHHHHHHHHhc---------CCccccc---cc-----chhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFEN---------GNLSQLV---ED-----EEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~---~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
.+|......... ..+...... ....... .. ..........+.+++.+||+++|++|||++
T Consensus 201 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 277 (298)
T cd07841 201 PFLPGDSDIDQL---GKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITAR 277 (298)
T ss_pred ccccCCccHHHH---HHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHH
Confidence 777654332211 111110000 0000000 00 011122345688899999999999999999
Q ss_pred HHHHH--hhcCcC
Q 038713 228 KVLLM--LEGTVE 238 (252)
Q Consensus 228 ~i~~~--l~~~~~ 238 (252)
+++.. +++...
T Consensus 278 e~l~~~~~~~~~~ 290 (298)
T cd07841 278 QALEHPYFSNDPA 290 (298)
T ss_pred HHhhCccccCCCC
Confidence 99985 555333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=227.61 Aligned_cols=207 Identities=22% Similarity=0.302 Sum_probs=174.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT-PEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
-.+++.+|+++-+.|+||||+++|++|.+....|+++||+..|++...+.. ..+.+++...+.+..|++.|+.|+|..
T Consensus 65 v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k- 143 (281)
T KOG0580|consen 65 VEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK- 143 (281)
T ss_pred chhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC-
Confidence 357899999999999999999999999999999999999999999999974 345689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+|+|++..+..+++|||-+...+ ........||.-|.+||...+..++...|+|++|++.|+++.|
T Consensus 144 --~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg 218 (281)
T KOG0580|consen 144 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVG 218 (281)
T ss_pred --CcccCCCCHHHhccCCCCCeeccCCCceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhc
Confidence 99999999999999999999999999998754 2233446689999999999999999999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
..||......+ .. +.+..-+.+. +........++|.+|+..+|.+|.+..|+++
T Consensus 219 ~ppFes~~~~e--tY-----krI~k~~~~~-------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 219 LPPFESQSHSE--TY-----KRIRKVDLKF-------PSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred CCchhhhhhHH--HH-----HHHHHccccC-------CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 99998776332 11 1111112211 1222333667777999999999999999875
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=245.46 Aligned_cols=220 Identities=21% Similarity=0.218 Sum_probs=164.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecC------CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDV------SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
...+.+.+|+.+++.++||||+++++++... ...++||||+++ +|.+.+.. .++...++.++.|++.||.
T Consensus 65 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~ 140 (364)
T cd07875 65 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIK 140 (364)
T ss_pred hhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999987643 457999999965 78777742 4778889999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 157 (252)
|||+. +++||||||+||+++.++.++++|||.++...... ......++..|+|||++.+..++.++|+||||+++
T Consensus 141 ~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 215 (364)
T cd07875 141 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215 (364)
T ss_pred HHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHH
Confidence 99999 99999999999999999999999999997653322 12234578899999999998999999999999999
Q ss_pred HHHHhCCccccccchhhhHHHH----------------HHHHHHHhcCCcc------cccc----c--chhcHHHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQ----------------EWICQCFENGNLS------QLVE----D--EEVDQKQLQRMI 209 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~----------------~~~~~~~~~~~~~------~~~~----~--~~~~~~~~~~l~ 209 (252)
|+|++|+.||............ ..+.......... .... + ..........+.
T Consensus 216 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (364)
T cd07875 216 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR 295 (364)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHH
Confidence 9999999999765433221110 0000000000000 0000 0 000111234577
Q ss_pred HHHhhccCCCCCCCCCHHHHHHH
Q 038713 210 KVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 210 ~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
+++.+||+.||.+|||++|+++.
T Consensus 296 dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 296 DLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhcCcCcccCCCHHHHhcC
Confidence 88889999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=238.75 Aligned_cols=221 Identities=20% Similarity=0.254 Sum_probs=167.1
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|+.++++++|||++++++++......++||||+++++|..+... ...+++..++.++.|++.||.|||+.
T Consensus 44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~--- 119 (286)
T cd07847 44 KKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKH--- 119 (286)
T ss_pred cHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 45688999999999999999999999999999999999999888877643 44589999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHhCC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+ ..++.++|+||||+++|++++|+
T Consensus 120 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~ 198 (286)
T cd07847 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198 (286)
T ss_pred CceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCC
Confidence 999999999999999999999999999886543321 1122345778999999876 45789999999999999999999
Q ss_pred ccccccchhhhHHHHH-HHH-------HHHhcCCc-ccccccc--------hhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 165 RCLDQNLLEDRAILQE-WIC-------QCFENGNL-SQLVEDE--------EVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~-~~~-------~~~~~~~~-~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
.||......+...... ... ........ .....+. .........+.+++.+||+.+|++|||+.
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 278 (286)
T cd07847 199 PLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCE 278 (286)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHH
Confidence 9997654433211100 000 00000000 0000000 00112245678899999999999999999
Q ss_pred HHHH
Q 038713 228 KVLL 231 (252)
Q Consensus 228 ~i~~ 231 (252)
|++.
T Consensus 279 eil~ 282 (286)
T cd07847 279 ELLE 282 (286)
T ss_pred HHhc
Confidence 9875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=239.10 Aligned_cols=205 Identities=21% Similarity=0.231 Sum_probs=168.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... +.++...+..++.|++.||.|||+.
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~- 120 (290)
T cd05580 43 KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSL- 120 (290)
T ss_pred hHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34677899999999999999999999999999999999999999999999654 5688999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|.||+++.++.++++|||.+...... .....++..|+|||.+.+...+.++|+||||+++|+|++|
T Consensus 121 --~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 194 (290)
T cd05580 121 --DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194 (290)
T ss_pred --CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998765433 2223568899999999888889999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVL 230 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~ 230 (252)
..||....... . . .....+... .+......+.+++.+||..+|++|+ ++++++
T Consensus 195 ~~p~~~~~~~~---~---~-~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 195 YPPFFDDNPIQ---I---Y-EKILEGKVR-------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CCCCCCCCHHH---H---H-HHHhcCCcc-------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 99997654221 1 1 111122211 1111234577888899999999999 777766
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=240.77 Aligned_cols=224 Identities=21% Similarity=0.257 Sum_probs=169.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|++++++++|+||+++++++...+..++++||++++.+..+. .....++...++.++.|++.|+.|||+.
T Consensus 42 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~- 119 (288)
T cd07833 42 DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSH- 119 (288)
T ss_pred cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34678999999999999999999999999999999999999887666555 3445589999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+|++|+||+++.++.++++|||.+...............++..|+|||++.+. .++.++|+||||+++|++++
T Consensus 120 --~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 197 (288)
T cd07833 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197 (288)
T ss_pred --CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999887654432222334567789999999887 78999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHH--------HHH-hcCCc-----ccccccc----hhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 163 LRRCLDQNLLEDRAILQEWIC--------QCF-ENGNL-----SQLVEDE----EVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~--------~~~-~~~~~-----~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
|..||......+......... ... ..... ....... ..+......+.+++++||+.+|++||
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 277 (288)
T cd07833 198 GEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc
Confidence 999997553332111100000 000 00000 0000000 11112256688999999999999999
Q ss_pred CHHHHHH
Q 038713 225 AMKKVLL 231 (252)
Q Consensus 225 s~~~i~~ 231 (252)
|+++++.
T Consensus 278 s~~~il~ 284 (288)
T cd07833 278 TCDELLQ 284 (288)
T ss_pred cHHHHhc
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=243.69 Aligned_cols=204 Identities=22% Similarity=0.263 Sum_probs=162.5
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+..|..+++.+ +|++|+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~- 120 (323)
T cd05615 43 DVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRR- 120 (323)
T ss_pred HHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 346688899999888 4677888999999999999999999999999998543 4589999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.+........ ......|+..|+|||++.+..++.++|+||+|+++|+|++|
T Consensus 121 --~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 197 (323)
T cd05615 121 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197 (323)
T ss_pred --CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhC
Confidence 999999999999999999999999999875332221 12234578999999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
..||....... . ... ...+... .+......+.+++.+||+.+|.+|++..
T Consensus 198 ~~pf~~~~~~~---~---~~~-i~~~~~~-------~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 198 QPPFDGEDEDE---L---FQS-IMEHNVS-------YPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCCCCCCHHH---H---HHH-HHhCCCC-------CCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 99997654322 1 111 1111211 1112234577888899999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=246.80 Aligned_cols=220 Identities=22% Similarity=0.253 Sum_probs=164.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecC------CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDV------SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
...+++.+|+.+++.++||||+++++++... ...++||||+++ ++.+.+.. .++...++.++.|+++||.
T Consensus 58 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~ 133 (355)
T cd07874 58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIK 133 (355)
T ss_pred HHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999988643 357999999965 67776642 4788888999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 157 (252)
|||+. +++||||||+||+++.++.++++|||.++...... ......++..|+|||++.+..++.++|+||||+++
T Consensus 134 ~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il 208 (355)
T cd07874 134 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208 (355)
T ss_pred HHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHH
Confidence 99999 99999999999999999999999999997643221 12234578899999999998899999999999999
Q ss_pred HHHHhCCccccccchhhhHHHH----------------HHHHHHHhcCCc-cccc-----c------cchhcHHHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQ----------------EWICQCFENGNL-SQLV-----E------DEEVDQKQLQRMI 209 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~----------------~~~~~~~~~~~~-~~~~-----~------~~~~~~~~~~~l~ 209 (252)
|+|++|+.||............ ..+......... .... . ...........+.
T Consensus 209 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T cd07874 209 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 288 (355)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHH
Confidence 9999999999765433221100 000111111000 0000 0 0001111234577
Q ss_pred HHHhhccCCCCCCCCCHHHHHHH
Q 038713 210 KVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 210 ~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
+++.+||+.||++|||+.|+++.
T Consensus 289 ~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 289 DLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCchhcCCHHHHhcC
Confidence 88889999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=247.49 Aligned_cols=207 Identities=24% Similarity=0.205 Sum_probs=160.7
Q ss_pred HHHHHHHHHHhCC---CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 7 REFKTEMNAIGRT---HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 7 ~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+|..++... .||||+++++++.+.+..++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||+.
T Consensus 38 ~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~- 115 (330)
T cd05586 38 AHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKY- 115 (330)
T ss_pred HHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3456677777655 799999999999999999999999999999999854 44689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++.++++|||.+........ ......|+..|+|||++.+. .++.++|+||||+++|+|++
T Consensus 116 --~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ellt 192 (330)
T cd05586 116 --DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCC 192 (330)
T ss_pred --CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEecc
Confidence 999999999999999999999999999865322211 12234578999999998764 47899999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC----CHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR----AMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp----s~~~i~~ 231 (252)
|..||........ . .....+..... ... ....+.+++.+||+.||++|| ++.++++
T Consensus 193 G~~Pf~~~~~~~~------~-~~i~~~~~~~~--~~~----~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 193 GWSPFYAEDTQQM------Y-RNIAFGKVRFP--KNV----LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCCCCCCCHHHH------H-HHHHcCCCCCC--Ccc----CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 9999976543321 1 11222222111 111 223466778899999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=240.21 Aligned_cols=212 Identities=19% Similarity=0.210 Sum_probs=169.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|+++++.++||||+++++.+.+.+..+++|||+.+++|.+++... ...+++..++.++.|++.||.|||+.
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~- 122 (316)
T cd05574 44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL- 122 (316)
T ss_pred HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC-
Confidence 5567999999999999999999999999999999999999999999998653 35689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc----------------------------ccccccCCccccc
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR----------------------------TFTGIRGTRAYVA 135 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~a 135 (252)
+++|+||||+||+++.++.++++|||.+......... ......|+..|+|
T Consensus 123 --~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~a 200 (316)
T cd05574 123 --GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIA 200 (316)
T ss_pred --CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcC
Confidence 9999999999999999999999999988654321110 0112346778999
Q ss_pred cccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhc
Q 038713 136 AEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRC 215 (252)
Q Consensus 136 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 215 (252)
||++.+..++.++|+||||+++|++++|..||....... .+.. .. ...... . ........+.+++.+|
T Consensus 201 PE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~----~~-~~~~~~-~----~~~~~~~~~~~li~~~ 268 (316)
T cd05574 201 PEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE--TFSN----IL-KKEVTF-P----GSPPVSSSARDLIRKL 268 (316)
T ss_pred HHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH--HHHH----Hh-cCCccC-C----CccccCHHHHHHHHHH
Confidence 999998889999999999999999999999997654332 1111 11 111111 0 0111345688888899
Q ss_pred cCCCCCCCCC----HHHHHH
Q 038713 216 ILDEPSLRRA----MKKVLL 231 (252)
Q Consensus 216 l~~~p~~Rps----~~~i~~ 231 (252)
|..+|++||| ++++++
T Consensus 269 l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 269 LVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ccCCHhHCCCchhhHHHHHc
Confidence 9999999999 777777
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=236.47 Aligned_cols=212 Identities=21% Similarity=0.334 Sum_probs=170.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|++.+++++|+|++++++.+...+..++++||+++++|.+++......+++..++.++.|++.||.+||+.
T Consensus 58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-- 135 (286)
T cd06614 58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ-- 135 (286)
T ss_pred hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 356789999999999999999999999999999999999999999999976555789999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+|++|+||+++.++.++++|||.+........ ......++..|++||.+.+..++.++|+||||+++|++++|.
T Consensus 136 -gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~ 213 (286)
T cd06614 136 -NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213 (286)
T ss_pred -CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCC
Confidence 999999999999999999999999998765432221 112234677899999998888899999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.||.......... . ........... .......+.+++.+||+.+|.+|||+.+++.
T Consensus 214 ~p~~~~~~~~~~~------~-~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 214 PPYLREPPLRALF------L-ITTKGIPPLKN----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCCCCCHHHHHH------H-HHhcCCCCCcc----hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 9987543332111 1 11111111111 1112345778888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=239.74 Aligned_cols=224 Identities=17% Similarity=0.177 Sum_probs=169.9
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
.+..+.+.+|++++++++||||+++++++.+.+..+++|||+++|+|.+++... ...+++..+..++.|+++||.|||+
T Consensus 40 ~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~ 119 (314)
T cd08216 40 KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119 (314)
T ss_pred hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 455678999999999999999999999999999999999999999999999653 3457888899999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC------cccccccCCccccccccccC--CCCCCcccchhH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT------RTFTGIRGTRAYVAAEWHRN--LPITVKADVYSF 153 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~sl 153 (252)
. +++|+||+|+||+++.++.+++.||+.+........ .......++..|+|||++.+ ..++.++|+||+
T Consensus 120 ~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~ 196 (314)
T cd08216 120 K---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV 196 (314)
T ss_pred C---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHH
Confidence 9 999999999999999999999999998765432111 11122345678999999876 357899999999
Q ss_pred HHHHHHHHhCCccccccchhhhHHHHHHHHHHH----h-------cCCccc-----------ccccchhcHHHHHHHHHH
Q 038713 154 GVVLLEIVCLRRCLDQNLLEDRAILQEWICQCF----E-------NGNLSQ-----------LVEDEEVDQKQLQRMIKV 211 (252)
Q Consensus 154 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~-------~~~~~~-----------~~~~~~~~~~~~~~l~~l 211 (252)
|+++|++++|..||........ ..+...... . ...... ..............+.++
T Consensus 197 G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 274 (314)
T cd08216 197 GITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQF 274 (314)
T ss_pred HHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHH
Confidence 9999999999999986543321 111110000 0 000000 000001222334568889
Q ss_pred HhhccCCCCCCCCCHHHHHH
Q 038713 212 GLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 212 i~~cl~~~p~~Rps~~~i~~ 231 (252)
+.+||+.||++|||++++++
T Consensus 275 i~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 275 VELCLQRDPESRPSASQLLN 294 (314)
T ss_pred HHHHhhcCCCcCcCHHHHhc
Confidence 99999999999999999886
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=242.41 Aligned_cols=219 Identities=19% Similarity=0.207 Sum_probs=165.6
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
...+.+|+.++++++||||+++++++.+.+..++++||++ ++|.+++....+.+++..++.++.||++||.|||+.
T Consensus 43 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--- 118 (284)
T cd07839 43 PSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH--- 118 (284)
T ss_pred ccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 3567899999999999999999999999999999999996 588888866666789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhCC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|+
T Consensus 119 ~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~ 197 (284)
T cd07839 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 197 (284)
T ss_pred CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence 999999999999999999999999999875432221 12223467889999998764 4789999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhc------------CCcccccccc------hhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFEN------------GNLSQLVEDE------EVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
.|+........ .+. .+...... .......... .........+.+++.+||+.||.+|||+
T Consensus 198 ~p~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~ 275 (284)
T cd07839 198 RPLFPGNDVDD-QLK-RIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA 275 (284)
T ss_pred CCCcCCCCHHH-HHH-HHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH
Confidence 99754433221 111 11110000 0000000000 0111223557788889999999999999
Q ss_pred HHHHH
Q 038713 227 KKVLL 231 (252)
Q Consensus 227 ~~i~~ 231 (252)
+++++
T Consensus 276 ~~il~ 280 (284)
T cd07839 276 EEALQ 280 (284)
T ss_pred HHHhc
Confidence 99975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=236.98 Aligned_cols=211 Identities=21% Similarity=0.224 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|++++++++|+|++++.+.+...+..++++||+.+++|.+++... ...+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-- 121 (285)
T cd05632 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-- 121 (285)
T ss_pred HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 456789999999999999999999999999999999999999999888543 34689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||++++++.++++|||.+....... ......|+..|+|||.+.+..++.++|+||||+++|++++|.
T Consensus 122 -~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 198 (285)
T cd05632 122 -NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198 (285)
T ss_pred -CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence 99999999999999999999999999886543221 122346789999999998888999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-----MKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~i~~ 231 (252)
.||......... .. +......+... .+......+.+++.+||+.||++||| +++++.
T Consensus 199 ~P~~~~~~~~~~--~~-~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 199 SPFRGRKEKVKR--EE-VDRRVLETEEV-------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CCCCCCCHHHHH--HH-HHHhhhccccc-------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 999765332211 11 11111111111 11122334677888999999999999 667665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=235.02 Aligned_cols=211 Identities=24% Similarity=0.326 Sum_probs=164.8
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecC------CcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDV------SNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l 76 (252)
....+.+|+.+++++ +|||++++++++... ...+++|||+.+|+|.+++... ...+++..+..++.|++.|+
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l 124 (272)
T cd06637 45 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124 (272)
T ss_pred cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence 456789999999998 799999999998753 4578999999999999998753 34588999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-----CCCCCcccch
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-----LPITVKADVY 151 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~ 151 (252)
+|||+. +++|+|++|+||+++.++.++++|||.+........ ......|+..|+|||++.+ ..++.++|+|
T Consensus 125 ~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~ 200 (272)
T cd06637 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 200 (272)
T ss_pred HHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHH
Confidence 999999 999999999999999999999999999876433221 2223457889999999863 3578899999
Q ss_pred hHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 152 SFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 152 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|+|+++|+|++|+.||........... .......... .......+.+++.+||..+|.+|||+.+++.
T Consensus 201 slGv~l~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 201 SLGITAIEMAEGAPPLCDMHPMRALFL-------IPRNPAPRLK-----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHHHHHHhCCCCccccCHHHHHHH-------HhcCCCCCCC-----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 999999999999999965433221110 1111111111 1122345788888999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=237.41 Aligned_cols=211 Identities=20% Similarity=0.294 Sum_probs=167.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhh-
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP--EKQPNWVERMGIARDIARGIRYLHD- 81 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lh~- 81 (252)
..+++.+|++++++++||||+++++.+...+..++|+||+++++|.+++... ...+++..+..++.|++.||.|||+
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 121 (286)
T cd06622 42 KFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121 (286)
T ss_pred HHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 3567999999999999999999999999999999999999999999988653 3468999999999999999999996
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC------CCCcccchhHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP------ITVKADVYSFGV 155 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~------~~~~~Di~slG~ 155 (252)
. +++|+||+|+||+++.++.++++|||.+........ ....++..|+|||.+.+.. ++.++|+||||+
T Consensus 122 ~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 195 (286)
T cd06622 122 H---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGL 195 (286)
T ss_pred C---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHH
Confidence 5 899999999999999999999999999875432221 1234677899999986543 478999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|++++|..||........... .... ..+.... .+......+.+++.+||+.+|++||+++++++
T Consensus 196 il~~l~~g~~pf~~~~~~~~~~~---~~~~-~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 196 SILEMALGRYPYPPETYANIFAQ---LSAI-VDGDPPT------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHhCCCCCCCcchhhHHHH---HHHH-hhcCCCC------CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 99999999999975433221111 1111 1111111 12234556788888999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=231.92 Aligned_cols=214 Identities=25% Similarity=0.342 Sum_probs=169.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|+.+++.++|+||+++++++.+.+..++|+||+++++|.+++... ..+++..++.++.|++.|+.|||+.
T Consensus 41 ~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~- 118 (264)
T cd06626 41 KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSH- 118 (264)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHC-
Confidence 46778999999999999999999999999999999999999999999999654 4578889999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc---cccccCCccccccccccCCC---CCCcccchhHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT---FTGIRGTRAYVAAEWHRNLP---ITVKADVYSFGVVL 157 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~~l 157 (252)
+++|+||+|+||+++.++.++++|||.+.......... .....++..|+|||.+.+.. .+.++|+||||+++
T Consensus 119 --~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il 196 (264)
T cd06626 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVV 196 (264)
T ss_pred --CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHH
Confidence 99999999999999999999999999988664333211 11245678999999988765 78999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+++++|+.||......... . . ....+....... .......+.+++.+||+.+|++|||+.+++.
T Consensus 197 ~~l~~g~~pf~~~~~~~~~-~----~-~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 197 LEMATGKRPWSELDNEFQI-M----F-HVGAGHKPPIPD----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHhCCCCccCCcchHHH-H----H-HHhcCCCCCCCc----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 9999999999755322111 0 0 111111111111 1111344678888999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=235.20 Aligned_cols=212 Identities=24% Similarity=0.297 Sum_probs=165.4
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCC------cEEEEEecCCCCCHHhhhcCC---CCCCCHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVS------NKILVYDYMSNGSLVDVLFTP---EKQPNWVERMGIARDIAR 74 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~ 74 (252)
..++|.+|+.+++++ .|+||+++++++.... ..++||||+++++|.+++... +..+++..++.++.|++.
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~ 124 (275)
T cd06608 45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124 (275)
T ss_pred hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHH
Confidence 356799999999999 7999999999997644 489999999999999988542 356899999999999999
Q ss_pred HHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-----CCCCccc
Q 038713 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-----PITVKAD 149 (252)
Q Consensus 75 ~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~D 149 (252)
||.|||+. +++|+||+|+||+++.++.++++|||.+........ ......++..|+|||++.+. .++.++|
T Consensus 125 al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 200 (275)
T cd06608 125 GLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSD 200 (275)
T ss_pred HHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecccchh-hhcCccccccccCHhHhcccccccCCcccccc
Confidence 99999999 999999999999999999999999999875433221 22234577889999987542 3678899
Q ss_pred chhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 150 VYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 150 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
+||||+++|++++|..||....... .. ... ..+...... .+......+.+++.+||..||++|||+.++
T Consensus 201 v~slG~il~~l~~g~~p~~~~~~~~--~~----~~~-~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l 269 (275)
T cd06608 201 VWSLGITAIELADGKPPLCDMHPMR--AL----FKI-PRNPPPTLK----SPENWSKKFNDFISECLIKNYEQRPFMEEL 269 (275)
T ss_pred HHHhHHHHHHHHhCCCCccccchHH--HH----HHh-hccCCCCCC----chhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 9999999999999999997542221 11 111 111111111 122234567888899999999999999999
Q ss_pred HH
Q 038713 230 LL 231 (252)
Q Consensus 230 ~~ 231 (252)
++
T Consensus 270 l~ 271 (275)
T cd06608 270 LE 271 (275)
T ss_pred hc
Confidence 75
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=241.43 Aligned_cols=216 Identities=25% Similarity=0.294 Sum_probs=161.8
Q ss_pred HHHHHHHhCCCCCCCcceeeeEecCC-----cEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 10 KTEMNAIGRTHHRNPVRLLGYSFDVS-----NKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 10 ~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
.+|+++|+++.|||||++.-+|.... -..+||||++. +|.+++.. .+...+...+.-+..||++||+|||+
T Consensus 65 nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~ 143 (364)
T KOG0658|consen 65 NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS 143 (364)
T ss_pred cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh
Confidence 38999999999999999988887422 23589999966 89988863 34456777777899999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCC-CceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEK-RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLE 159 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~ 159 (252)
. +||||||||.|+|++.+ |.+||+|||.++........ .....+..|+|||.+.|. .|+.+.||||.||++.|
T Consensus 144 ~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aE 218 (364)
T KOG0658|consen 144 H---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAE 218 (364)
T ss_pred c---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHH
Confidence 9 99999999999999965 88999999999977554433 223457789999998876 69999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHH-----HHhcCCcc-------ccccc---chhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQ-----CFENGNLS-------QLVED---EEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~-------~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
|+-|++-|.+....++...+-.+.. .+..-+.. ++... .-.......+.++++.++|..+|.+|.
T Consensus 219 Ll~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~ 298 (364)
T KOG0658|consen 219 LLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL 298 (364)
T ss_pred HhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC
Confidence 9999999988766654332211110 00000000 00000 012223345688888999999999999
Q ss_pred CHHHHHH
Q 038713 225 AMKKVLL 231 (252)
Q Consensus 225 s~~~i~~ 231 (252)
|+.|++.
T Consensus 299 ~~~~~l~ 305 (364)
T KOG0658|consen 299 SALEALA 305 (364)
T ss_pred CHHHHhc
Confidence 9999774
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=230.27 Aligned_cols=211 Identities=22% Similarity=0.359 Sum_probs=172.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+..+++++|||++++++.+...+..++++||+++++|.+++....+.+++..++.++.|++.||.+||+.
T Consensus 40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-- 117 (253)
T cd05122 40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN-- 117 (253)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC--
Confidence 567899999999999999999999999999999999999999999999976556789999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||++++++.++++|||.+........ .....++..|+|||.+.+...+.++|+||||++++++++|+
T Consensus 118 -~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~ 194 (253)
T cd05122 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194 (253)
T ss_pred -CEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999877654332 22345678899999998888899999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.||.......... . ........... .......+.+++.+||+.||++|||+.|++.
T Consensus 195 ~p~~~~~~~~~~~------~-~~~~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 195 PPYSELPPMKALF------K-IATNGPPGLRN----PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCCCCCchHHHHH------H-HHhcCCCCcCc----ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9997653222111 1 11111111111 1111345888888999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=240.22 Aligned_cols=219 Identities=22% Similarity=0.305 Sum_probs=172.2
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++||||+++++++......++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.
T Consensus 59 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~-- 134 (297)
T cd06656 59 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSN-- 134 (297)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 346688999999999999999999999999999999999999999999853 3478889999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||+++.++.++++|||.+......... .....++..|+|||...+..++.++|+||||+++|++++|.
T Consensus 135 -~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~ 212 (297)
T cd06656 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (297)
T ss_pred -CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999988765432221 12235678899999999888899999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCcCCC
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEGTVEIP 240 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~~~~~~ 240 (252)
.||.......... .....+ .... ..+......+.+++.+||+.+|++|||++++++ .++.+...+
T Consensus 213 ~pf~~~~~~~~~~------~~~~~~-~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 213 PPYLNENPLRALY------LIATNG-TPEL----QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred CCCCCCCcchhee------eeccCC-CCCC----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 9997543321100 001111 1011 112223344677888999999999999999998 555444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=237.67 Aligned_cols=212 Identities=23% Similarity=0.339 Sum_probs=178.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+..|+.+|+++..|++||+||.+.....+++|||||..|+..+.+...++.+++.++..++...++||.|||..
T Consensus 71 DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~-- 148 (502)
T KOG0574|consen 71 DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL-- 148 (502)
T ss_pred hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH--
Confidence 457789999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
.-+|||||+.|||++.+|..|++|||.+....+..... ..+.||+.|||||++..-.|+.++||||||++..+|.-|+
T Consensus 149 -~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR-NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~ 226 (502)
T KOG0574|consen 149 -KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR-NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGR 226 (502)
T ss_pred -HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh-CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCC
Confidence 99999999999999999999999999998766544333 3467999999999999999999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+||..-..-.-- -.+. ......-..+......+-+++++||-++|++|-|+.++++
T Consensus 227 PPYsDIHPMRAI-------FMIP----T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 227 PPYSDIHPMRAI-------FMIP----TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCccccccccee-------Eecc----CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 999744221100 0000 0001111335556677888899999999999999999876
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=243.78 Aligned_cols=219 Identities=25% Similarity=0.376 Sum_probs=169.0
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEec-CCcEEEEEecCCCCCHHhhhcCCC-------------------------
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFD-VSNKILVYDYMSNGSLVDVLFTPE------------------------- 57 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~------------------------- 57 (252)
..+.+.+|+.++.++ +||||+++++++.. ....+++|||+++|+|.+++....
T Consensus 53 ~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (343)
T cd05103 53 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISE 132 (343)
T ss_pred HHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhh
Confidence 456789999999999 78999999998865 456789999999999999985321
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCC
Q 038713 58 -----------------------------------------KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQN 96 (252)
Q Consensus 58 -----------------------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~n 96 (252)
..+++..+..++.|++.||.|||+. +++|+||||+|
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~N 209 (343)
T cd05103 133 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARN 209 (343)
T ss_pred hhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCe
Confidence 2357778888999999999999999 99999999999
Q ss_pred EEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-CCccccccchhh
Q 038713 97 ILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-LRRCLDQNLLED 174 (252)
Q Consensus 97 il~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 174 (252)
|+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|+||||+++|++++ |..||.......
T Consensus 210 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 289 (343)
T cd05103 210 ILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 289 (343)
T ss_pred EEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH
Confidence 9999999999999999876432221 11122334567999999988889999999999999999997 888886543221
Q ss_pred hHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 175 RAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
. + ......+..... +.. ....+.+++.+||+.+|++|||+.+|++.|+.+++
T Consensus 290 ~--~----~~~~~~~~~~~~--~~~----~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 290 E--F----CRRLKEGTRMRA--PDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred H--H----HHHHhccCCCCC--CCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 1 111222221111 111 12357888999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=233.57 Aligned_cols=212 Identities=22% Similarity=0.257 Sum_probs=170.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|+.+++.++||||+++++.+.+.+..++++||+++++|.+++.+. ..++...+..++.|++.||.|||+.
T Consensus 35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~- 112 (262)
T cd05572 35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNR- 112 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC-
Confidence 45678999999999999999999999999999999999999999999999654 4578899999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+....... ......++..|++||.+.+..++.++|+||+|+++|++++|
T Consensus 113 --~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g 188 (262)
T cd05572 113 --GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188 (262)
T ss_pred --CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhC
Confidence 99999999999999999999999999988664432 11223567889999999888889999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-----MKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~i~~ 231 (252)
..||......... . ...... +.... ..+......+.+++.+||+.+|++||+ ++|+++
T Consensus 189 ~~p~~~~~~~~~~-~---~~~~~~-~~~~~-----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 189 RPPFGEDDEDPME-I---YNDILK-GNGKL-----EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCcCCCCCCHHH-H---HHHHhc-cCCCC-----CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 9999766432111 1 111111 11111 111112456888888999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=273.04 Aligned_cols=218 Identities=28% Similarity=0.530 Sum_probs=172.0
Q ss_pred HHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 038713 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIH 89 (252)
Q Consensus 10 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h 89 (252)
.+|++.+++++||||+++++++.+.+..++||||+++|+|.+++. .+++..+.+++.|+++|++|||..++.+++|
T Consensus 731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 806 (968)
T PLN00113 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806 (968)
T ss_pred HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeec
Confidence 467899999999999999999999999999999999999999995 3788999999999999999999666669999
Q ss_pred eccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccc
Q 038713 90 GDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQ 169 (252)
Q Consensus 90 ~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 169 (252)
||+||+||+++.++..++. ++........ ....++..|+|||++.+..++.++||||||+++||+++|+.||+.
T Consensus 807 ~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 807 GNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred CCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 9999999999988877664 4443322111 112467899999999998899999999999999999999999964
Q ss_pred cchhhhHHHHHHHHHHHhcCCccccccc-----chhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 170 NLLEDRAILQEWICQCFENGNLSQLVED-----EEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
.... ...+.+|..............++ .....+....+.+++.+||+.+|++|||++|+++.|++...
T Consensus 881 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 881 EFGV-HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccCC-CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 3222 23344444433333222222221 12345666778899999999999999999999999998655
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=262.71 Aligned_cols=218 Identities=18% Similarity=0.267 Sum_probs=166.6
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTP---EKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
.....|.+|+.++++++||||+++++++.+ ...+++||||+++|+|.+++... ...+++..++.|+.||+.||.|
T Consensus 54 ~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaY 133 (1021)
T PTZ00266 54 REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133 (1021)
T ss_pred HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999998864 45689999999999999998542 3568999999999999999999
Q ss_pred HhhcC----CCCeeeeccCCCCEEecC-----------------CCceEEcccCcccccCCCCCcccccccCCccccccc
Q 038713 79 LHDEC----EAQIIHGDIKPQNILMDE-----------------KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAE 137 (252)
Q Consensus 79 lh~~~----~~~i~h~di~~~nil~~~-----------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE 137 (252)
||..+ ..+|+|+||||+|||++. .+.++|+|||++........ .....|++.|+|||
T Consensus 134 LHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPE 211 (1021)
T PTZ00266 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPE 211 (1021)
T ss_pred HHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHH
Confidence 99851 125999999999999964 23489999999876543221 12346799999999
Q ss_pred cccC--CCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhc
Q 038713 138 WHRN--LPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRC 215 (252)
Q Consensus 138 ~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 215 (252)
++.+ ..++.++|||||||++|+|++|..||....... ..+. .+..+..... ......+.++|.+|
T Consensus 212 vL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~-----qli~-~lk~~p~lpi-------~~~S~eL~dLI~~~ 278 (1021)
T PTZ00266 212 LLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS-----QLIS-ELKRGPDLPI-------KGKSKELNILIKNL 278 (1021)
T ss_pred HHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH-----HHHH-HHhcCCCCCc-------CCCCHHHHHHHHHH
Confidence 9864 347899999999999999999999997543222 1111 1122211110 11234578888899
Q ss_pred cCCCCCCCCCHHHHH--HHhhcC
Q 038713 216 ILDEPSLRRAMKKVL--LMLEGT 236 (252)
Q Consensus 216 l~~~p~~Rps~~~i~--~~l~~~ 236 (252)
|+.+|++|||+.|++ ..+...
T Consensus 279 L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 279 LNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred hcCChhHCcCHHHHhccHHHhhc
Confidence 999999999999998 455543
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=233.80 Aligned_cols=214 Identities=21% Similarity=0.318 Sum_probs=167.2
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|+.++++++|||++++++++...+..++|+||+++|+|.+++... +.++...+..++.|++.||.|||+.
T Consensus 52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~--- 127 (272)
T cd06629 52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSK--- 127 (272)
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---
Confidence 356889999999999999999999999999999999999999999999654 4688888999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCC--CCCcccchhHHHHHHHHHh
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLP--ITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.+......... ......++..|+|||.+.+.. ++.++|+||||+++|++++
T Consensus 128 ~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~ 207 (272)
T cd06629 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA 207 (272)
T ss_pred CeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh
Confidence 9999999999999999999999999998754322111 112245678899999987654 7899999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|..||....... ... ..... ...... +..........+.+++.+||.++|++|||++++++
T Consensus 208 g~~p~~~~~~~~-----~~~-~~~~~-~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 208 GRRPWSDEEAIA-----AMF-KLGNK-RSAPPI-PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCCCCcCcchHH-----HHH-Hhhcc-ccCCcC-CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 999996432221 111 11111 111111 11111223456788888999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=247.43 Aligned_cols=213 Identities=19% Similarity=0.236 Sum_probs=163.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|+.++.+++||||+++++.+.+.+..++||||++||+|.+++.+ .+.+++..+..++.|++.||.|||+.
T Consensus 43 ~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~- 120 (360)
T cd05627 43 EQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQL- 120 (360)
T ss_pred hhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3456788999999999999999999999999999999999999999999954 34588899999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC----------------------------------cccccccC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT----------------------------------RTFTGIRG 129 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----------------------------------~~~~~~~~ 129 (252)
+++||||||+||+++.++.++++|||++........ .......|
T Consensus 121 --givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 198 (360)
T cd05627 121 --GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVG 198 (360)
T ss_pred --CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCC
Confidence 999999999999999999999999998764421110 00112458
Q ss_pred CccccccccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHH
Q 038713 130 TRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMI 209 (252)
Q Consensus 130 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 209 (252)
+..|+|||++.+..++.++|+|||||++|+|++|..||......... ........... ..... .....+.
T Consensus 199 t~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~------~~i~~~~~~~~-~p~~~---~~s~~~~ 268 (360)
T cd05627 199 TPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY------RKVMNWKETLV-FPPEV---PISEKAK 268 (360)
T ss_pred CccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHH------HHHHcCCCcee-cCCCC---CCCHHHH
Confidence 89999999999989999999999999999999999999765443211 11111111001 11110 1123466
Q ss_pred HHHhhccCCCCCCCCC---HHHHHH
Q 038713 210 KVGLRCILDEPSLRRA---MKKVLL 231 (252)
Q Consensus 210 ~li~~cl~~~p~~Rps---~~~i~~ 231 (252)
+++.+|+ .+|.+|++ +.++++
T Consensus 269 ~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 269 DLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred HHHHHhc-cChhhcCCCCCHHHHhc
Confidence 6666776 49999996 455443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=238.28 Aligned_cols=216 Identities=21% Similarity=0.249 Sum_probs=161.6
Q ss_pred HHHHHHHHHHhCC---CCCCCcceeeeEec-----CCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHH
Q 038713 7 REFKTEMNAIGRT---HHRNPVRLLGYSFD-----VSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 7 ~~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ 77 (252)
..+.+|+.+++.+ +||||+++++++.. ....++++||+. ++|.+++... ...+++..+..++.|++.||.
T Consensus 44 ~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 122 (288)
T cd07863 44 LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122 (288)
T ss_pred hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 3566788877765 79999999998864 345789999996 4898888653 345899999999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 157 (252)
|||+. +++|+||||+||+++.++.++++|||.+....... ......++..|+|||++.+..++.++|+||+|+++
T Consensus 123 ~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l 197 (288)
T cd07863 123 FLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 197 (288)
T ss_pred HHHhC---CeecCCCCHHHEEECCCCCEEECccCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHH
Confidence 99999 99999999999999999999999999987654322 11234568899999999888899999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhc---CCccc-------cccc------chhcHHHHHHHHHHHhhccCCCCC
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFEN---GNLSQ-------LVED------EEVDQKQLQRMIKVGLRCILDEPS 221 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~-------~~~~------~~~~~~~~~~l~~li~~cl~~~p~ 221 (252)
|+|++|..||......... .... ..... ..+.. ...+ ..........+.+++.+||+.||+
T Consensus 198 ~~l~~g~~~f~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 274 (288)
T cd07863 198 AEMFRRKPLFCGNSEADQL--GKIF-DLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPH 274 (288)
T ss_pred HHHHhCCcCcCCCCHHHHH--HHHH-HHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcc
Confidence 9999999999765443221 1111 11000 00000 0000 011122345577889999999999
Q ss_pred CCCCHHHHHH
Q 038713 222 LRRAMKKVLL 231 (252)
Q Consensus 222 ~Rps~~~i~~ 231 (252)
+|||+.|++.
T Consensus 275 ~R~t~~~~l~ 284 (288)
T cd07863 275 KRISAFRALQ 284 (288)
T ss_pred cCCCHHHHhc
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=242.84 Aligned_cols=160 Identities=23% Similarity=0.316 Sum_probs=132.7
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcC--------CCCCCCHHHHHHHHHHHHHHH
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFT--------PEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~~~i~~~i~~~l 76 (252)
..+.+|++++++++||||+++++++.. +...++++||+. ++|.+++.. ....+++..++.++.|++.||
T Consensus 43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 121 (317)
T cd07867 43 MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121 (317)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHH
Confidence 467899999999999999999998853 567899999985 578777632 123478889999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEe----cCCCceEEcccCcccccCCCCC--cccccccCCccccccccccCC-CCCCccc
Q 038713 77 RYLHDECEAQIIHGDIKPQNILM----DEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNL-PITVKAD 149 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~D 149 (252)
.|||+. +++|+||||+||++ +.++.++++|||.++....... .......++..|+|||++.+. .++.++|
T Consensus 122 ~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 198 (317)
T cd07867 122 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAID 198 (317)
T ss_pred HHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHH
Confidence 999999 99999999999999 4567899999999986543322 122334578899999998764 5789999
Q ss_pred chhHHHHHHHHHhCCcccccc
Q 038713 150 VYSFGVVLLEIVCLRRCLDQN 170 (252)
Q Consensus 150 i~slG~~l~~l~~g~~p~~~~ 170 (252)
+||||+++|+|++|..||...
T Consensus 199 iwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 199 IWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred HHhHHHHHHHHHhCCCCcccc
Confidence 999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=232.90 Aligned_cols=210 Identities=24% Similarity=0.333 Sum_probs=169.4
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|+.+++.++||||+++++++.+....++++||+++++|.+++.+. +.+++..++.++.|++.|+.|||+.
T Consensus 44 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~- 121 (258)
T cd06632 44 EAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDR- 121 (258)
T ss_pred HHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 45678999999999999999999999999999999999999999999998543 4578899999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC-CCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP-ITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.+....... ......++..|++||.+.... ++.++|+||||+++|++++
T Consensus 122 --~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~ 197 (258)
T cd06632 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT 197 (258)
T ss_pred --CcccCCCCHHHEEECCCCCEEEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHh
Confidence 99999999999999999999999999987654332 122345778899999987665 8899999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|+.||........ . ........... .+......+.+++.+||+.+|++|||+.+++.
T Consensus 198 g~~pf~~~~~~~~--~----~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 198 GKPPWSQLEGVAA--V----FKIGRSKELPP------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCCCcccCcHHHH--H----HHHHhcccCCC------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 9999976542211 1 11111111111 12223355778888999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=229.91 Aligned_cols=214 Identities=20% Similarity=0.218 Sum_probs=168.4
Q ss_pred HHHHHHHHHHhCC-CCCCCcceeeeEec----CCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHh
Q 038713 7 REFKTEMNAIGRT-HHRNPVRLLGYSFD----VSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 7 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
....+|++.--+. .|||||.+++++++ ..-+.+|||+++||.|.+.+++.+ ..+++.++..|..||+.|++|||
T Consensus 99 ~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH 178 (400)
T KOG0604|consen 99 PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH 178 (400)
T ss_pred HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH
Confidence 3457888884444 89999999999885 344679999999999999997644 56999999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecC---CCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDE---KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 157 (252)
+. +|+|||+||+|+|... |..+|++|||+++..... .......-|+.|.|||++-.++|+..+|+||+|+++
T Consensus 179 ~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVim 253 (400)
T KOG0604|consen 179 SM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253 (400)
T ss_pred hc---chhhccCChhheeeecCCCCcceEecccccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHH
Confidence 99 9999999999999964 456899999999865432 222334468899999999999999999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|-|++|-+||+.+.... +..-.+..+..|....... ....-++...++|+.+|..+|.+|.|++++++
T Consensus 254 YIlLCGyPPFYS~hg~a---ispgMk~rI~~gqy~FP~p---EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 254 YILLCGYPPFYSNHGLA---ISPGMKRRIRTGQYEFPEP---EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred HHhhcCCCcccccCCcc---CChhHHhHhhccCccCCCh---hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 99999999998764432 1111233444555444333 34444555666677999999999999999875
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=234.73 Aligned_cols=210 Identities=22% Similarity=0.285 Sum_probs=163.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..+.+.+|+.++++++||||+++++++.+ ....++++||+++++|.+++... +.++....+.++.|++.||.|||+.
T Consensus 47 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~ 125 (266)
T cd06651 47 EVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSN 125 (266)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45678999999999999999999998875 45678999999999999999543 3578888999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--cccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+|++|+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|+||+|+++|++
T Consensus 126 ---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el 202 (266)
T cd06651 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEM 202 (266)
T ss_pred ---CeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHH
Confidence 999999999999999999999999999875432111 111223467889999999988899999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|+.||........ +......... ...+......+.+++ +||..+|++|||++||++
T Consensus 203 ~~g~~pf~~~~~~~~------~~~~~~~~~~------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 203 LTEKPPWAEYEAMAA------IFKIATQPTN------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHCCCCccccchHHH------HHHHhcCCCC------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 999999975532211 1111111110 111222334455555 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=234.96 Aligned_cols=212 Identities=19% Similarity=0.242 Sum_probs=163.6
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEe-----cCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSF-----DVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l 76 (252)
..++.+|+.+++++ +||||+++++++. +.+..++||||+++++|.+++.. ....+++..++.++.|++.||
T Consensus 58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l 137 (286)
T cd06638 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137 (286)
T ss_pred HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHH
Confidence 35688999999999 7999999999874 34568999999999999998742 334678889999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-----CCCCCcccch
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-----LPITVKADVY 151 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~ 151 (252)
.|||+. +++|+|++|+||+++.++.++++|||.+........ ......|+..|+|||++.+ ..++.++|+|
T Consensus 138 ~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~ 213 (286)
T cd06638 138 QHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVW 213 (286)
T ss_pred HHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhh
Confidence 999999 999999999999999999999999999876543221 1122357889999998753 3478899999
Q ss_pred hHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 152 SFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 152 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|+|+++|++++|+.||......... ... ..+....... +......+.+++.+||+.+|++|||+.++++
T Consensus 214 slGvi~~el~~g~~p~~~~~~~~~~------~~~-~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 214 SLGITAIELGDGDPPLADLHPMRAL------FKI-PRNPPPTLHQ----PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred hHHHHHHHHhcCCCCCCCCchhHHH------hhc-cccCCCcccC----CCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 9999999999999999755332211 011 1111111111 1112345888899999999999999999986
Q ss_pred H
Q 038713 232 M 232 (252)
Q Consensus 232 ~ 232 (252)
.
T Consensus 283 ~ 283 (286)
T cd06638 283 H 283 (286)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=235.40 Aligned_cols=210 Identities=26% Similarity=0.255 Sum_probs=171.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|++++++++||||+++++.+.+....++|+||+.+++|.+++... ..++...+..++.|+++||.|||..
T Consensus 42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~- 119 (258)
T cd05578 42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK- 119 (258)
T ss_pred hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC-
Confidence 45678999999999999999999999999999999999999999999999654 5688999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||++++++.++++|||.+....... ......++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus 120 --~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g 195 (258)
T cd05578 120 --GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195 (258)
T ss_pred --CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhC
Confidence 99999999999999999999999999987654332 12234567789999999888899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM--KKVL 230 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~--~~i~ 230 (252)
..||..........+.. ....... ..+......+.+++.+||+.+|.+||++ .|++
T Consensus 196 ~~p~~~~~~~~~~~~~~----~~~~~~~-------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 196 KRPYRGHSRTIRDQIRA----KQETADV-------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CCCCCCCCccHHHHHHH----Hhccccc-------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 99998765432222211 1111111 1122233668888899999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=232.70 Aligned_cols=217 Identities=22% Similarity=0.320 Sum_probs=167.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCC------cEEEEEecCCCCCHHhhhcCC-----CCCCCHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVS------NKILVYDYMSNGSLVDVLFTP-----EKQPNWVERMGIARDI 72 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i 72 (252)
...+++.+|++++++++||||+++++++.... -.+++++|+.+|+|.+++... ...++...++.++.|+
T Consensus 43 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i 122 (273)
T cd05074 43 SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122 (273)
T ss_pred HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Confidence 45667899999999999999999999886532 247889999999998887421 2247888899999999
Q ss_pred HHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccch
Q 038713 73 ARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVY 151 (252)
Q Consensus 73 ~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 151 (252)
+.||+|||+. +++|+||||+||+++.++.++++|||.++........ ......++..|++||...+..++.++|+|
T Consensus 123 ~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~ 199 (273)
T cd05074 123 ASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVW 199 (273)
T ss_pred HHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhH
Confidence 9999999999 9999999999999999999999999998765332211 11122345679999999888889999999
Q ss_pred hHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 152 SFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 152 slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
|||+++|++++ |..||......+ +..+ ...+.... . +......+.+++.+||+.+|++|||+.+++
T Consensus 200 slG~il~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~~--~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~ 266 (273)
T cd05074 200 AFGVTMWEIMTRGQTPYAGVENSE---IYNY----LIKGNRLK--Q----PPDCLEDVYELMCQCWSPEPKCRPSFQHLR 266 (273)
T ss_pred HHHHHHHHHhhCCCCCCCCCCHHH---HHHH----HHcCCcCC--C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 99999999999 778876443221 1111 11111111 1 112334688899999999999999999999
Q ss_pred HHhhcC
Q 038713 231 LMLEGT 236 (252)
Q Consensus 231 ~~l~~~ 236 (252)
+.|+++
T Consensus 267 ~~l~~~ 272 (273)
T cd05074 267 DQLELI 272 (273)
T ss_pred HHHHhh
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=237.66 Aligned_cols=218 Identities=18% Similarity=0.246 Sum_probs=163.9
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
..+.+|++++++++||||+++++++.+.+..++||||+. ++|.+++......+++..++.++.|+++||.|||+. +
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~ 123 (291)
T cd07844 48 FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---R 123 (291)
T ss_pred hhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 457789999999999999999999999999999999997 499999876666789999999999999999999999 9
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHhCCc
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
++|+||+|+||+++.++.++++|||.++....... ......++..|+|||++.+ ..++.++|+||+|+++|+|++|..
T Consensus 124 i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~ 202 (291)
T cd07844 124 VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRP 202 (291)
T ss_pred eecccCCHHHEEEcCCCCEEECccccccccCCCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999865432111 1112235778999999876 457899999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcC---Cccc-------------ccccch---h--cHHHHHHHHHHHhhccCCCCCCCC
Q 038713 166 CLDQNLLEDRAILQEWICQCFENG---NLSQ-------------LVEDEE---V--DQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~---~~~~-------------~~~~~~---~--~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
||.......+ .+.. +....... .+.. ...... . .......+.+++.+||+.+|++||
T Consensus 203 ~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rp 280 (291)
T cd07844 203 LFPGSTDVED-QLHK-IFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI 280 (291)
T ss_pred CCCCCccHHH-HHHH-HHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccccc
Confidence 9975542211 1100 00100000 0000 000000 0 001125677889999999999999
Q ss_pred CHHHHHH
Q 038713 225 AMKKVLL 231 (252)
Q Consensus 225 s~~~i~~ 231 (252)
|+.+++.
T Consensus 281 s~~e~l~ 287 (291)
T cd07844 281 SAAEAMK 287 (291)
T ss_pred CHHHHhc
Confidence 9999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=242.00 Aligned_cols=215 Identities=21% Similarity=0.300 Sum_probs=161.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecC------CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDV------SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
..+.+.+|+.++++++||||+++++++... ...+++++++ +++|.+++.. +.++...++.++.||+.||.|
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~ 133 (343)
T cd07878 57 HARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKY 133 (343)
T ss_pred HHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence 346688999999999999999999987642 4578999988 7899888743 358999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVL 157 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l 157 (252)
||+. +++|+||||+||+++.++.++++|||.+....... ....++..|+|||++.+ ..++.++||||||+++
T Consensus 134 LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 206 (343)
T cd07878 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206 (343)
T ss_pred HHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHH
Confidence 9999 99999999999999999999999999987654322 23457889999999877 4688999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCC------------------ccccccc--chhcHHHHHHHHHHHhhccC
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGN------------------LSQLVED--EEVDQKQLQRMIKVGLRCIL 217 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~--~~~~~~~~~~l~~li~~cl~ 217 (252)
|+|++|..||.......... ... ....... ....... ..........+.+++.+||+
T Consensus 207 ~el~~g~~pf~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 283 (343)
T cd07878 207 AELLKGKALFPGNDYIDQLK--RIM-EVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLV 283 (343)
T ss_pred HHHHHCCCCCCCCCHHHHHH--HHH-HHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcC
Confidence 99999999997653322111 100 0000000 0000000 00000112346788889999
Q ss_pred CCCCCCCCHHHHHHH
Q 038713 218 DEPSLRRAMKKVLLM 232 (252)
Q Consensus 218 ~~p~~Rps~~~i~~~ 232 (252)
.||++|||+.|+++.
T Consensus 284 ~dp~~R~s~~ell~h 298 (343)
T cd07878 284 LDSDKRISASEALAH 298 (343)
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=231.64 Aligned_cols=209 Identities=23% Similarity=0.358 Sum_probs=172.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
.....+.+|+.++++++||||+++.+++.+....++|+||+++++|.+++.. ....+++..++.++.|++.||.+||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh 120 (256)
T cd08530 41 KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120 (256)
T ss_pred HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 4566788999999999999999999999999999999999999999999854 2346788999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+. +++|+||+|.||+++.++.++++|||.+........ ....++..|++||.+.+..++.++|+||||++++++
T Consensus 121 ~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~---~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l 194 (256)
T cd08530 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA---KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEM 194 (256)
T ss_pred hC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCCc---ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHH
Confidence 99 999999999999999999999999999877654421 223467899999999988889999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||....... + ......+..... +......+.+++.+||+.+|++|||+.++++
T Consensus 195 ~~g~~p~~~~~~~~---~----~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 195 ATFAPPFEARSMQD---L----RYKVQRGKYPPI------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HhCCCCCCCCCHHH---H----HHHHhcCCCCCC------chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 99999997654332 1 111222222221 2244566889999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=231.67 Aligned_cols=214 Identities=25% Similarity=0.343 Sum_probs=173.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-c
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD-E 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~ 82 (252)
...+.+.+|+..+++++|+|++++++++...+..++++||+++++|.+++... ..+++..++.++.|++.|+.|||+ .
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ 119 (264)
T cd06623 41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKR 119 (264)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccC
Confidence 34678999999999999999999999999999999999999999999999654 568999999999999999999999 9
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+|++|+||+++.++.++++|||.+.......... ....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 120 ---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~t 195 (264)
T cd06623 120 ---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECAL 195 (264)
T ss_pred ---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999987654333221 22346788999999988888999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQK-QLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
|..||............ .... ...... .+.. ....+.+++.+||+++|++|||+.++++.
T Consensus 196 g~~p~~~~~~~~~~~~~---~~~~-~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 196 GKFPFLPPGQPSFFELM---QAIC-DGPPPS------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCccccccCHHHHH---HHHh-cCCCCC------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 99999766432211121 1111 111111 1112 34568888889999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=235.33 Aligned_cols=208 Identities=25% Similarity=0.327 Sum_probs=166.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+++.+|+++++.++|||++++++++.+.+..++|+||+. |++.+.+....+.+++..+..++.|++.||.|||+.
T Consensus 57 ~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~- 134 (307)
T cd06607 57 EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH- 134 (307)
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 445679999999999999999999999999999999999996 578787765556789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc---CCCCCCcccchhHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR---NLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||+|+||+++.++.++++|||.+....... ...++..|+|||++. ...++.++|+||||+++|++
T Consensus 135 --~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el 207 (307)
T cd06607 135 --ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (307)
T ss_pred --CceecCCCcccEEECCCCCEEEeecCcceecCCCC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHH
Confidence 99999999999999999999999999887543221 234677899999874 34578899999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
++|..||........ ... ......... ........+.+++.+||+.+|++|||+.+++..
T Consensus 208 ~tg~~p~~~~~~~~~------~~~-~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 208 AERKPPLFNMNAMSA------LYH-IAQNDSPTL-----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HcCCCCCCCccHHHH------HHH-HhcCCCCCC-----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 999999875533221 111 111111111 112234568888999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=233.49 Aligned_cols=216 Identities=24% Similarity=0.276 Sum_probs=172.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|++++++++||||+++++.+...+..++++||+++++|.+++.... .+++..++.++.|++.||.|||+.
T Consensus 35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~- 112 (265)
T cd05579 35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSN- 112 (265)
T ss_pred hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc-
Confidence 456789999999999999999999999999999999999999999999996544 689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-------ccccccCCccccccccccCCCCCCcccchhHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-------TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVV 156 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~ 156 (252)
+++|+||+|+||+++.++.++++|||.+......... ......++..|++||...+...+.++|+||||++
T Consensus 113 --~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~ 190 (265)
T cd05579 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCI 190 (265)
T ss_pred --CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHH
Confidence 9999999999999999999999999988754332110 1122346778999999988888999999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
++++++|..||........ . .....+...... .......+.+++.+||+.+|++|||+..+.+.|+.
T Consensus 191 ~~~l~~g~~p~~~~~~~~~------~-~~~~~~~~~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 191 LYEFLVGIPPFHGETPEEI------F-QNILNGKIEWPE-----DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred HHHHHhCCCCCCCCCHHHH------H-HHHhcCCcCCCc-----cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 9999999999976543321 1 111222221111 10124557888889999999999999777666664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=235.68 Aligned_cols=220 Identities=21% Similarity=0.269 Sum_probs=169.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecC--CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDV--SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..+.+.+|++++++++|||++++++++.+. +..++|+||++ ++|.+++......+++..++.++.|++.||+|||..
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~ 119 (287)
T cd07840 41 FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119 (287)
T ss_pred chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 346788999999999999999999999987 89999999996 489999876656789999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||+|+||++++++.++++|||.+...............++..|+|||.+.+. .++.++|+||||+++|+++
T Consensus 120 ---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~ 196 (287)
T cd07840 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF 196 (287)
T ss_pred ---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999886654432222334567789999987653 5789999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhc---CCcccccc---------cc-------h-hcHHHHHHHHHHHhhccCCCCC
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFEN---GNLSQLVE---------DE-------E-VDQKQLQRMIKVGLRCILDEPS 221 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---------~~-------~-~~~~~~~~l~~li~~cl~~~p~ 221 (252)
+|..||.......... . +...... ..+..... .. . ........+.+++.+||+.+|.
T Consensus 197 t~~~p~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 273 (287)
T cd07840 197 LGKPIFQGSTELEQLE--K-IFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPK 273 (287)
T ss_pred hCCCCCCCCChHHHHH--H-HHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChh
Confidence 9999997654322111 1 1111000 00000000 00 0 0011256688999999999999
Q ss_pred CCCCHHHHHH
Q 038713 222 LRRAMKKVLL 231 (252)
Q Consensus 222 ~Rps~~~i~~ 231 (252)
+|||+++++.
T Consensus 274 ~Rp~~~~~l~ 283 (287)
T cd07840 274 KRISADQALQ 283 (287)
T ss_pred hCcCHHHHhh
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=237.50 Aligned_cols=222 Identities=22% Similarity=0.285 Sum_probs=166.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+++++.++||||+++++++...+..++|+||+++++|.++.... ..+++..++.++.|++.||.|||+.
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~-- 119 (286)
T cd07846 43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSH-- 119 (286)
T ss_pred hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4567899999999999999999999999999999999999998888876443 3489999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+|++|+||++++++.++++|||.+........ ......++..|+|||++.+. .++.++|+||||++++++++|
T Consensus 120 -~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g 197 (286)
T cd07846 120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197 (286)
T ss_pred -CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcC
Confidence 999999999999999999999999999876543322 12223467889999998753 467899999999999999999
Q ss_pred CccccccchhhhHHHHHHH--------HHHHhcCCc------ccccc---cchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 164 RRCLDQNLLEDRAILQEWI--------CQCFENGNL------SQLVE---DEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~------~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
..||......+...-...+ ......... ..... ...........+.+++.+||+.+|++|||+
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~ 277 (286)
T cd07846 198 EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS 277 (286)
T ss_pred CCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhH
Confidence 9998654332211100000 000000000 00000 001112234568889999999999999999
Q ss_pred HHHHH
Q 038713 227 KKVLL 231 (252)
Q Consensus 227 ~~i~~ 231 (252)
.++++
T Consensus 278 ~~il~ 282 (286)
T cd07846 278 SQLLH 282 (286)
T ss_pred HHHhc
Confidence 99875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=249.65 Aligned_cols=215 Identities=20% Similarity=0.244 Sum_probs=158.1
Q ss_pred HHHHHHHHHhCCCCCCCcceeeeEecC--------CcEEEEEecCCCCCHHhhhc---CCCCCCCHHHHHHHHHHHHHHH
Q 038713 8 EFKTEMNAIGRTHHRNPVRLLGYSFDV--------SNKILVYDYMSNGSLVDVLF---TPEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l 76 (252)
...+|+.+++.++||||+++++++... ..+++||||+++ +|.+++. .....+++..++.++.||+.||
T Consensus 105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL 183 (440)
T PTZ00036 105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183 (440)
T ss_pred hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence 346799999999999999999877531 236799999965 6776663 2455689999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCC-ceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHH
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKR-CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFG 154 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG 154 (252)
.|||+. +++||||||+||+++.++ .++|+|||+++....... .....++..|+|||++.+. .++.++|+||||
T Consensus 184 ~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG 258 (440)
T PTZ00036 184 AYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLG 258 (440)
T ss_pred HHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHH
Confidence 999999 999999999999998665 699999999986543221 1234568899999998764 689999999999
Q ss_pred HHHHHHHhCCccccccchhhhHHHHHHHHHHHhc----------CCcccc----cccc----hhcHHHHHHHHHHHhhcc
Q 038713 155 VVLLEIVCLRRCLDQNLLEDRAILQEWICQCFEN----------GNLSQL----VEDE----EVDQKQLQRMIKVGLRCI 216 (252)
Q Consensus 155 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~----~~~~----~~~~~~~~~l~~li~~cl 216 (252)
|++|+|++|..||......+. +...+. .... ...... .... ..+...+..+.+++.+||
T Consensus 259 vil~elltG~~pf~~~~~~~~--~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L 335 (440)
T PTZ00036 259 CIIAEMILGYPIFSGQSSVDQ--LVRIIQ-VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFL 335 (440)
T ss_pred HHHHHHHhCCCCCCCCChHHH--HHHHHH-HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHC
Confidence 999999999999976543322 111111 0000 000000 0000 011122356788899999
Q ss_pred CCCCCCCCCHHHHHH
Q 038713 217 LDEPSLRRAMKKVLL 231 (252)
Q Consensus 217 ~~~p~~Rps~~~i~~ 231 (252)
.+||.+|||+.|+++
T Consensus 336 ~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 336 KYEPLKRLNPIEALA 350 (440)
T ss_pred CCChhHCcCHHHHhC
Confidence 999999999999873
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=239.89 Aligned_cols=212 Identities=21% Similarity=0.337 Sum_probs=167.0
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
+...-|.+|+..|.+| .|.+||++++|-..++.+||||||- ..||..+|++.....+...+.-++.|++.|+.+.|.+
T Consensus 401 qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~ 479 (677)
T KOG0596|consen 401 QTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH 479 (677)
T ss_pred HHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh
Confidence 4567799999999999 7999999999999999999999975 5599999987776666457778999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCccc-ccccCCccccccccccCCC-----------CCCcccc
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF-TGIRGTRAYVAAEWHRNLP-----------ITVKADV 150 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~-----------~~~~~Di 150 (252)
||+|.|+||.|+++ -.|.+||+|||.+..+..+.+... ....||..||+||.+.... ...++||
T Consensus 480 ---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDv 555 (677)
T KOG0596|consen 480 ---GIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDV 555 (677)
T ss_pred ---ceeecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccch
Confidence 99999999999987 457899999999998887766433 3467999999999876322 4578999
Q ss_pred hhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCc-ccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 151 YSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNL-SQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 151 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
|||||++|+|+.|+.||+.-... +.+...-..+ ..+..+. .+.. ..++++++.||..||++|||..++
T Consensus 556 WSLGCILYqMvYgktPf~~~~n~--------~aKl~aI~~P~~~Iefp~-~~~~--~~li~~mK~CL~rdPkkR~si~eL 624 (677)
T KOG0596|consen 556 WSLGCILYQMVYGKTPFGQIINQ--------IAKLHAITDPNHEIEFPD-IPEN--DELIDVMKCCLARDPKKRWSIPEL 624 (677)
T ss_pred hhhhhHHHHHHhcCCchHHHHHH--------HHHHHhhcCCCccccccC-CCCc--hHHHHHHHHHHhcCcccCCCcHHH
Confidence 99999999999999999754221 1121111111 2111111 1111 118999999999999999999999
Q ss_pred HH
Q 038713 230 LL 231 (252)
Q Consensus 230 ~~ 231 (252)
++
T Consensus 625 Lq 626 (677)
T KOG0596|consen 625 LQ 626 (677)
T ss_pred hc
Confidence 86
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=231.00 Aligned_cols=216 Identities=25% Similarity=0.378 Sum_probs=170.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP--EKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..+.+.+|++.++.++|+|++++++.+...+..++++|++++++|.+++... ...+++..++.++.|++.|+.+||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~ 121 (267)
T cd06610 42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4678999999999999999999999999999999999999999999999653 24689999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc---ccccccCCccccccccccCC-CCCCcccchhHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR---TFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLL 158 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~ 158 (252)
+++|+|++|+||++++++.++++|||.+......... ......++..|+|||.+... .++.++|+||||++++
T Consensus 122 ---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~ 198 (267)
T cd06610 122 ---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAI 198 (267)
T ss_pred ---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHH
Confidence 9999999999999999999999999998765433221 11223577889999998776 6899999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|++|..||....... .. ...... ..... ............+.+++.+||+.||++|||+++++.
T Consensus 199 ~l~~g~~p~~~~~~~~--~~----~~~~~~-~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 199 ELATGAAPYSKYPPMK--VL----MLTLQN-DPPSL-ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHhCCCCccccChhh--hH----HHHhcC-CCCCc-CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 9999999997553321 11 111111 11111 110111133455788888999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=231.30 Aligned_cols=211 Identities=22% Similarity=0.348 Sum_probs=169.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
...+.+.+|++++++++|+|++++++.+.+....++++||+.+++|.+++.... ..+++..++.++.|+++||.|||+.
T Consensus 41 ~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (257)
T cd08225 41 KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120 (257)
T ss_pred hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678899999999999999999999999999999999999999999996543 3478999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCc-eEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRC-AKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+|++|+||++++++. ++++|||.+........ ......|+..|+|||+..+..++.++|+||||+++++++
T Consensus 121 ---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~ 196 (257)
T cd08225 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELC 196 (257)
T ss_pred ---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999998764 69999998876543221 122235788899999998888899999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||....... .+.... .+..... .......+.+++.+||..+|++|||+.++++
T Consensus 197 ~g~~p~~~~~~~~------~~~~~~-~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 197 TLKHPFEGNNLHQ------LVLKIC-QGYFAPI------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred hCCCCCCCccHHH------HHHHHh-cccCCCC------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 9999997553322 111111 1111111 1122345778888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=232.69 Aligned_cols=211 Identities=21% Similarity=0.287 Sum_probs=163.7
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEecC-----CcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFDV-----SNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l 76 (252)
...+.+|+.+++++ +|||++++++++... +..++|+||+++|+|.+++.. ..+.+++..++.++.|++.||
T Consensus 62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 141 (291)
T cd06639 62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141 (291)
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Confidence 45678899999999 899999999998753 358999999999999998853 345689999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-----CCCCcccch
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-----PITVKADVY 151 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~ 151 (252)
.+||+. +++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+... .++.++|+|
T Consensus 142 ~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 217 (291)
T cd06639 142 QHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVW 217 (291)
T ss_pred HHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchH
Confidence 999999 9999999999999999999999999998765432211 1223567889999987643 267899999
Q ss_pred hHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 152 SFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 152 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|||+++|++++|+.||........ + .. ...+.......+ ......+.++|.+||+.+|++|||+.++++
T Consensus 218 slGvi~~el~~g~~p~~~~~~~~~--~----~~-~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 218 SLGITAIELGDGDPPLFDMHPVKT--L----FK-IPRNPPPTLLHP----EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHHHHHhhCCCCCCCCcHHHH--H----HH-HhcCCCCCCCcc----cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 999999999999999975533211 1 11 111111111111 122345888899999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=235.26 Aligned_cols=218 Identities=19% Similarity=0.216 Sum_probs=165.6
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecC--CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDV--SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+|+.++++++||||+++++++... +..++|+||+. ++|.+++......+++..++.++.|++.||.|||+.
T Consensus 49 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 125 (293)
T cd07843 49 ITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN-- 125 (293)
T ss_pred hhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4678899999999999999999998876 89999999996 599998876566789999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC-CCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP-ITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+.. ++.++|+||+|++++++++|
T Consensus 126 -~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 203 (293)
T cd07843 126 -WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203 (293)
T ss_pred -CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999886554321 122234677899999987654 68899999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHH--------------H--hcCCccccccc---chhcHH-HHHHHHHHHhhccCCCCCCC
Q 038713 164 RRCLDQNLLEDRAILQEWICQC--------------F--ENGNLSQLVED---EEVDQK-QLQRMIKVGLRCILDEPSLR 223 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~--------------~--~~~~~~~~~~~---~~~~~~-~~~~l~~li~~cl~~~p~~R 223 (252)
..||.......... ...... . ........... ...+.. ....+.+++.+||+.+|++|
T Consensus 204 ~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 281 (293)
T cd07843 204 KPLFPGKSEIDQLN--KIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKR 281 (293)
T ss_pred CCCCCCCChHHHHH--HHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCcccc
Confidence 99997654332111 100000 0 00000000000 001111 24557788889999999999
Q ss_pred CCHHHHHH
Q 038713 224 RAMKKVLL 231 (252)
Q Consensus 224 ps~~~i~~ 231 (252)
||++|++.
T Consensus 282 ~t~~ell~ 289 (293)
T cd07843 282 ISAEDALK 289 (293)
T ss_pred CCHHHHhc
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=228.77 Aligned_cols=211 Identities=21% Similarity=0.368 Sum_probs=173.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP---EKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
+..+.+.+|+++++.++|||++++.+.+......++++|++++++|.+++... ...+++..++.++.+++.||.+||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 120 (258)
T cd08215 41 KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120 (258)
T ss_pred HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999999999999999999999999999999999999664 367899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+. +++|+|++|+||+++.++.++++|||.+........ ......++..|+|||...+..++.++|+||+|++++++
T Consensus 121 ~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l 196 (258)
T cd08215 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYEL 196 (258)
T ss_pred hC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHH
Confidence 99 999999999999999999999999999876544331 22224567789999999888899999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||....... .... ........+ +......+.+++.+||..+|++|||+.+++.
T Consensus 197 ~~g~~p~~~~~~~~------~~~~-~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 197 CTLKHPFEGENLLE------LALK-ILKGQYPPI------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HcCCCCCCCCcHHH------HHHH-HhcCCCCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 99999996553221 1111 222222221 1133455788888999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=234.64 Aligned_cols=219 Identities=19% Similarity=0.281 Sum_probs=171.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
....+.+|+.++++++|+||+++++++.+.+..++++||+++ +|.+++......+++..++.++.|++.||.|||+.
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-- 117 (283)
T cd05118 41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH-- 117 (283)
T ss_pred hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 456788999999999999999999999999999999999965 89988876666789999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+....... .......++..|+|||.+.+. .++.++|+||||+++|++++|
T Consensus 118 -~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg 195 (283)
T cd05118 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195 (283)
T ss_pred -CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999987665433 112223467789999998876 689999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCc---ccc----------------cccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNL---SQL----------------VEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
+.||......+.... +......... ... .............+.+++.+||++||.+||
T Consensus 196 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 272 (283)
T cd05118 196 RPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI 272 (283)
T ss_pred CCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCc
Confidence 999976544322111 1111110000 000 000112233456788999999999999999
Q ss_pred CHHHHHH
Q 038713 225 AMKKVLL 231 (252)
Q Consensus 225 s~~~i~~ 231 (252)
++.+++.
T Consensus 273 ~~~~ll~ 279 (283)
T cd05118 273 TAEQALA 279 (283)
T ss_pred CHHHHhh
Confidence 9999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=232.69 Aligned_cols=212 Identities=23% Similarity=0.246 Sum_probs=167.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|++++++++|||++++++++...+..|+||||+++++|.+++.... ..+++..++.++.|++.||.|||+.
T Consensus 36 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~- 114 (277)
T cd05577 36 GEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR- 114 (277)
T ss_pred hhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 35567899999999999999999999999999999999999999999986544 3588999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||++++++.++++|||.+....... ......++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus 115 --~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g 190 (277)
T cd05577 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190 (277)
T ss_pred --CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhC
Confidence 99999999999999999999999999887654311 12223567789999999888889999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
+.||........... +.... ... ....+......+.+++.+||+.+|.+|| ++.++++
T Consensus 191 ~~p~~~~~~~~~~~~---~~~~~----~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 191 RSPFRQRKEKVEKEE---LKRRT----LEM---AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCCCCCCcccccHHH---HHhcc----ccc---cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 999976543211110 10111 100 0111222344577888899999999999 6666754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=227.99 Aligned_cols=241 Identities=22% Similarity=0.291 Sum_probs=187.9
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..|.+..+|++++.++ .|+||+.++++|+++.+.|+|||-+.||.|.++|. .++.+++.++.++..+|+.||.|||.+
T Consensus 117 HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~-~~~~F~E~EAs~vvkdia~aLdFlH~k 195 (463)
T KOG0607|consen 117 HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQ-KRKHFNEREASRVVKDIASALDFLHTK 195 (463)
T ss_pred hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHH-HhhhccHHHHHHHHHHHHHHHHHHhhc
Confidence 4688899999999999 79999999999999999999999999999999995 455799999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCc---eEEcccCcccccC--CCCC----cccccccCCcccccccccc-----CCCCCCcc
Q 038713 83 CEAQIIHGDIKPQNILMDEKRC---AKISDFGLAKLMK--PDQT----RTFTGIRGTRAYVAAEWHR-----NLPITVKA 148 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~---~~l~d~~~~~~~~--~~~~----~~~~~~~~~~~~~aPE~~~-----~~~~~~~~ 148 (252)
||.|||+||+|||-..... +||+||.+..-.. .+-+ .......|+-.|||||+.. ...|+.++
T Consensus 196 ---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrC 272 (463)
T KOG0607|consen 196 ---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRC 272 (463)
T ss_pred ---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccc
Confidence 9999999999999876554 7999997765332 1111 1222345777899999753 34689999
Q ss_pred cchhHHHHHHHHHhCCccccccchhh------h--HHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCC
Q 038713 149 DVYSFGVVLLEIVCLRRCLDQNLLED------R--AILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEP 220 (252)
Q Consensus 149 Di~slG~~l~~l~~g~~p~~~~~~~~------~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 220 (252)
|.||||+++|-|++|-.||.+....+ + ..=++.+.+.+++|....+.......+.+.+++++ ..+-.++
T Consensus 273 DlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlis---nLlvrda 349 (463)
T KOG0607|consen 273 DLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLIS---NLLVRDA 349 (463)
T ss_pred cHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHH---HHHhccH
Confidence 99999999999999999997653321 1 11233344566777776655554445555555555 7777999
Q ss_pred CCCCCHHHHHH-----HhhcCcCCCCCCCCCCCCCC
Q 038713 221 SLRRAMKKVLL-----MLEGTVEIPIPQNPTSFLST 251 (252)
Q Consensus 221 ~~Rps~~~i~~-----~l~~~~~~~~~~~~~~~~~~ 251 (252)
.+|.++.++++ +......+|+|.+-.+-.+|
T Consensus 350 ~~rlsa~~vlnhPw~~~~~~ekalptp~v~~r~~s~ 385 (463)
T KOG0607|consen 350 KQRLSAAQVLNHPWVQRCAPEKALPTPQVLQRNSST 385 (463)
T ss_pred HhhhhhhhccCCccccccchhccCCCCcccccCccc
Confidence 99999999887 34445678888887776654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=245.33 Aligned_cols=162 Identities=25% Similarity=0.359 Sum_probs=138.1
Q ss_pred HHHHHHHHHHHhCCC-CC-----CCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRTH-HR-----NPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~ 78 (252)
..+-..|+.+|..++ |. |+|+++++|...+++|+|+|.+ ..+|.++++.++ ..++...+..++.||+.||.+
T Consensus 226 ~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~ 304 (586)
T KOG0667|consen 226 LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLF 304 (586)
T ss_pred HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence 456678999999996 43 7999999999999999999999 569999997755 458999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCC--CceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEK--RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVV 156 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~ 156 (252)
||+. +|+|+|+||+|||+... ..+|++|||.++......- ...-+..|+|||++.|..|+.+.|+|||||+
T Consensus 305 L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCI 377 (586)
T KOG0667|consen 305 LHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCI 377 (586)
T ss_pred HHhC---CeeeccCChhheeeccCCcCceeEEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhh
Confidence 9999 99999999999999754 3699999999987543332 2233668999999999999999999999999
Q ss_pred HHHHHhCCccccccchhhh
Q 038713 157 LLEIVCLRRCLDQNLLEDR 175 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~ 175 (252)
+.||++|.+.|.+....++
T Consensus 378 lAEL~tG~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 378 LAELFTGEPLFPGDNEYDQ 396 (586)
T ss_pred HHhHhcCccccCCCCHHHH
Confidence 9999999777766554443
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=231.08 Aligned_cols=209 Identities=22% Similarity=0.355 Sum_probs=168.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.|.+|+.++++++||||+++++++..+...++|+||+++++|.+++.. ..+++..+..++.|++.|+.+||+.
T Consensus 45 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~-- 120 (277)
T cd06641 45 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE-- 120 (277)
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccC--
Confidence 456799999999999999999999999999999999999999999999853 3578999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+|++|+||+++.++.++++|||.+........ ......++..|+|||.+.+...+.++|+||||+++|++++|.
T Consensus 121 -~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 198 (277)
T cd06641 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198 (277)
T ss_pred -CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999998875543221 112235677899999998888899999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
.||....... . ... ...+.... ........+.+++.+||+.+|.+||++.+++..
T Consensus 199 ~p~~~~~~~~---~---~~~-~~~~~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 199 PPHSELHPMK---V---LFL-IPKNNPPT------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCccchHH---H---HHH-HhcCCCCC------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9996543221 1 111 11111111 112233457788889999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=234.45 Aligned_cols=212 Identities=24% Similarity=0.310 Sum_probs=163.4
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEec------CCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFD------VSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARG 75 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~ 75 (252)
....++..|+.+++++ +|||++++++++.. ....+++|||+.+|+|.+++.... ..+++..++.++.|++.|
T Consensus 54 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~a 133 (282)
T cd06636 54 DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133 (282)
T ss_pred HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHH
Confidence 3456788999999998 79999999998853 457899999999999999986533 447888888999999999
Q ss_pred HHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc-----CCCCCCcccc
Q 038713 76 IRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-----NLPITVKADV 150 (252)
Q Consensus 76 l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di 150 (252)
+.|||+. +++|+|++|+||+++.++.++++|||.+........ ......++..|+|||.+. +..++.++|+
T Consensus 134 l~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dv 209 (282)
T cd06636 134 LAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDI 209 (282)
T ss_pred HHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccch
Confidence 9999999 999999999999999999999999999875432211 122245788899999876 3457889999
Q ss_pred hhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 151 YSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 151 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
||||+++|++++|..||.......... ......... .. .......+.+++.+||+.||.+|||+.||+
T Consensus 210 wslG~~l~el~~g~~p~~~~~~~~~~~------~~~~~~~~~--~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 210 WSLGITAIEMAEGAPPLCDMHPMRALF------LIPRNPPPK--LK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred hHHHHHHHHHHhCCCCccccCHHhhhh------hHhhCCCCC--Cc----ccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 999999999999999996543222111 111111111 11 112234588889999999999999999987
Q ss_pred H
Q 038713 231 L 231 (252)
Q Consensus 231 ~ 231 (252)
+
T Consensus 278 ~ 278 (282)
T cd06636 278 K 278 (282)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=231.10 Aligned_cols=210 Identities=21% Similarity=0.240 Sum_probs=164.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..+.+.+|+.++++++||||+++++++.+ ...+++++||+++++|.+++... +.++....+.++.|++.||.|||+.
T Consensus 47 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (265)
T cd06652 47 EVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSN 125 (265)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45678999999999999999999998876 35678999999999999998643 4578888999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--cccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||+|+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|+||||+++|++
T Consensus 126 ---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 202 (265)
T cd06652 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEM 202 (265)
T ss_pred ---CEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHH
Confidence 999999999999999999999999998875432211 111223477899999999888889999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|+.||........ ..... ...... ..+......+.+++.+|+ .+|++|||++++++
T Consensus 203 ~~g~~p~~~~~~~~~------~~~~~-~~~~~~-----~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 203 LTEKPPWAEFEAMAA------IFKIA-TQPTNP-----VLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred hhCCCCCCccchHHH------HHHHh-cCCCCC-----CCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 999999975422211 11111 111111 123333455777788998 49999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=231.06 Aligned_cols=210 Identities=20% Similarity=0.305 Sum_probs=167.1
Q ss_pred HhHHHHHHHHHHHhCCC---CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 4 EGEREFKTEMNAIGRTH---HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
...+++.+|+.++++++ |||++++++++.+....+++|||+++++|.+++.. +.+++..++.++.|++.||.|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh 118 (277)
T cd06917 41 DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIH 118 (277)
T ss_pred hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999996 99999999999999999999999999999999854 36889999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLE 159 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~ 159 (252)
+. +++|+||+|+||+++.++.++++|||.+......... .....|+..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 119 ~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ 194 (277)
T cd06917 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYE 194 (277)
T ss_pred hC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHH
Confidence 99 9999999999999999999999999998765443321 222357788999998865 457899999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|++|..||........ . ........... . .......+.+++.+||+.||++|||+.+++.
T Consensus 195 ll~g~~p~~~~~~~~~------~-~~~~~~~~~~~-~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 195 MATGNPPYSDVDAFRA------M-MLIPKSKPPRL-E----DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHhCCCCCCCCChhhh------h-hccccCCCCCC-C----cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 9999999975432211 0 01111111111 0 1113345788888999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=235.27 Aligned_cols=219 Identities=18% Similarity=0.159 Sum_probs=165.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
+..+.+.+|+.+++.++||||+++++++...+..++|+||+.+|+|.+++.... ..+++..+..++.|++.||.|||+.
T Consensus 41 ~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~ 120 (328)
T cd08226 41 EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN 120 (328)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 345788999999999999999999999999999999999999999999986532 3578888999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cc-----cccccCCccccccccccCC--CCCCcccchhHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RT-----FTGIRGTRAYVAAEWHRNL--PITVKADVYSFG 154 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~-----~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG 154 (252)
+++|+||||+||+++.++.+++.||+.......... .. .....++..|+|||++.+. .++.++|+||+|
T Consensus 121 ---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG 197 (328)
T cd08226 121 ---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVG 197 (328)
T ss_pred ---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHH
Confidence 999999999999999999999999875432211110 00 0111245579999998763 478999999999
Q ss_pred HHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcc------------------------------------cccc--
Q 038713 155 VVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLS------------------------------------QLVE-- 196 (252)
Q Consensus 155 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~-- 196 (252)
+++|++++|..||......... .. ........ ....
T Consensus 198 ~~l~el~~g~~p~~~~~~~~~~--~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (328)
T cd08226 198 ITACELATGRVPFQDMLRTQML--LQ----KLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSER 271 (328)
T ss_pred HHHHHHHhCCCCCCCcChHHHH--HH----HhcCCCCCCccccccchhhhhhccchhhhhcccccchhcccccccccccc
Confidence 9999999999999765432211 00 00000000 0000
Q ss_pred -cchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 197 -DEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 197 -~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
...........+.+++.+||+.||++|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 272 LRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00112334567899999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=226.92 Aligned_cols=213 Identities=25% Similarity=0.324 Sum_probs=173.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecC--CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDV--SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
...+.+.+|+.++++++||||+++++.+.+. +..++++||+++++|.+++.... .+++..++.++.|++.||.|||+
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~ 119 (260)
T cd06606 41 EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS 119 (260)
T ss_pred HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence 4577899999999999999999999999988 88999999999999999996544 78999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
. +++|+|++|+||+++.++.++++|||.+......... ......++..|+|||...+...+.++|+||||++++++
T Consensus 120 ~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l 196 (260)
T cd06606 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEM 196 (260)
T ss_pred C---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHH
Confidence 9 9999999999999999999999999998876543321 12234577899999999888899999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||........ ........+... ..+......+.+++.+|++.+|++|||+.++++
T Consensus 197 ~~g~~p~~~~~~~~~-----~~~~~~~~~~~~------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 197 ATGKPPWSELGNPMA-----ALYKIGSSGEPP------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HhCCCCCCCCCchHH-----HHHhccccCCCc------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 999999986652211 011111111111 122223566888889999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=231.78 Aligned_cols=211 Identities=19% Similarity=0.287 Sum_probs=167.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..++.+.+|+.+++.++|+|++++++.+...+..+++|||+++++|.+++.. ..+++..++.++.|++.|++|||+.
T Consensus 59 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~- 135 (292)
T cd06657 59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQ- 135 (292)
T ss_pred hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3466799999999999999999999999999999999999999999998743 3478899999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+..++.++|+||+|+++|++++|
T Consensus 136 --givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg 212 (292)
T cd06657 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212 (292)
T ss_pred --CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999998765433221 11224567889999999887889999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
..||......... ..+ ..+........ ......+.+++.+||+.+|.+||++++++.
T Consensus 213 ~~p~~~~~~~~~~---~~~----~~~~~~~~~~~----~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 213 EPPYFNEPPLKAM---KMI----RDNLPPKLKNL----HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCCCCCCCHHHHH---HHH----HhhCCcccCCc----ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 9999754332211 111 11111111111 112234677788999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=234.89 Aligned_cols=222 Identities=18% Similarity=0.233 Sum_probs=163.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCC--------cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVS--------NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
...+.+|++++++++||||+++++++.... ..++|+||+. ++|.+++......+++.+++.++.|++.||.
T Consensus 55 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~ 133 (310)
T cd07865 55 PITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLY 133 (310)
T ss_pred hhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999987543 4599999995 5898888766667899999999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc---ccccccCCccccccccccCC-CCCCcccchhH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR---TFTGIRGTRAYVAAEWHRNL-PITVKADVYSF 153 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~sl 153 (252)
|||+. +++|+||+|+||+++.++.++++|||.+......... ......++..|+|||.+.+. .++.++|+|||
T Consensus 134 ~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 210 (310)
T cd07865 134 YIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGA 210 (310)
T ss_pred HHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHH
Confidence 99999 9999999999999999999999999998765432211 11223467789999988764 36889999999
Q ss_pred HHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCccc---------ccccch---------hcHHHHHHHHHHHhhc
Q 038713 154 GVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQ---------LVEDEE---------VDQKQLQRMIKVGLRC 215 (252)
Q Consensus 154 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~---------~~~~~~~~l~~li~~c 215 (252)
|+++|++++|..||..............+........+.. ...+.. ........+.++|.+|
T Consensus 211 G~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~ 290 (310)
T cd07865 211 GCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKL 290 (310)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHH
Confidence 9999999999999976644332222111100000000000 000000 0001123467889999
Q ss_pred cCCCCCCCCCHHHHHH
Q 038713 216 ILDEPSLRRAMKKVLL 231 (252)
Q Consensus 216 l~~~p~~Rps~~~i~~ 231 (252)
|..||++|||++++++
T Consensus 291 l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 291 LVLDPAKRIDADTALN 306 (310)
T ss_pred hcCChhhccCHHHHhc
Confidence 9999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=248.70 Aligned_cols=227 Identities=24% Similarity=0.305 Sum_probs=183.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP--NWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~lh~ 81 (252)
+..+-+..|+.+-++++|.|||+++|.+-+++..-+.||-.+||+|.+.+....+++ ++.++--.-.||++||.|||+
T Consensus 614 r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe 693 (1226)
T KOG4279|consen 614 REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE 693 (1226)
T ss_pred hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh
Confidence 345567899999999999999999999999999999999999999999998888876 778877788999999999999
Q ss_pred cCCCCeeeeccCCCCEEec-CCCceEEcccCcccccCCCCCcccccccCCccccccccccCC--CCCCcccchhHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL--PITVKADVYSFGVVLL 158 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~ 158 (252)
. .|||||||-.|++++ -+|.+||.|||-++....-... -....||..|||||++... +|..++|||||||++.
T Consensus 694 n---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~v 769 (1226)
T KOG4279|consen 694 N---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMV 769 (1226)
T ss_pred c---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc-ccccccchhhhChHhhccCCcCCCchhhhhhccceeE
Confidence 9 999999999999998 6789999999998765322111 1234589999999999754 5899999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcC
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEGT 236 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~~ 236 (252)
||.||++||....... ....+-|..+.. .+.+.+..+....+|++|+.++|.+|||+.+++. +|+--
T Consensus 770 EMATGrPPF~Elgspq--------AAMFkVGmyKvH---P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 770 EMATGRPPFVELGSPQ--------AAMFKVGMYKVH---PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred eeccCCCCeeecCChh--------HhhhhhcceecC---CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 9999999997543332 122333443332 3567788888999999999999999999999985 45555
Q ss_pred cCCCCCCCC
Q 038713 237 VEIPIPQNP 245 (252)
Q Consensus 237 ~~~~~~~~~ 245 (252)
...+.|..+
T Consensus 839 ~kk~r~~ls 847 (1226)
T KOG4279|consen 839 NKKPRPKLS 847 (1226)
T ss_pred CCCCCCCCC
Confidence 445555444
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=232.22 Aligned_cols=219 Identities=20% Similarity=0.244 Sum_probs=164.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|++++++++||||+++++++.+.+..++||||+. ++|.+++... ...+++..++.++.|++.||+|||+.
T Consensus 43 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-- 119 (284)
T cd07860 43 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH-- 119 (284)
T ss_pred chHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4678999999999999999999999999999999999995 6898888543 35689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC-CCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP-ITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+.. ++.++|+||||+++|+++||
T Consensus 120 -~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 197 (284)
T cd07860 120 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197 (284)
T ss_pred -CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 999999999999999999999999999875432221 112233577899999887644 58889999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhc---------------CCccccccc--chhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFEN---------------GNLSQLVED--EEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
+.||........ ........-.. ......... ..........+.+++.+||+.||++|||+
T Consensus 198 ~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 275 (284)
T cd07860 198 RALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA 275 (284)
T ss_pred CCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH
Confidence 999976533221 11111100000 000000000 00011123446788999999999999999
Q ss_pred HHHHH
Q 038713 227 KKVLL 231 (252)
Q Consensus 227 ~~i~~ 231 (252)
++++.
T Consensus 276 ~~~l~ 280 (284)
T cd07860 276 KAALA 280 (284)
T ss_pred HHHhc
Confidence 99875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=244.99 Aligned_cols=213 Identities=18% Similarity=0.297 Sum_probs=174.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..++|+-|++||..+.||+||++++.|+..+.++++.|||.||-+...+..-++.+.+..+.-+++|++.||.|||++
T Consensus 71 EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~- 149 (1187)
T KOG0579|consen 71 EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ- 149 (1187)
T ss_pred hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc-
Confidence 4567899999999999999999999999999999999999999999999888888899999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc-----CCCCCCcccchhHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-----NLPITVKADVYSFGVVLL 158 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~ 158 (252)
+|+|||+|+.|||++-+|.++++|||++....... .......||+.|||||+.. ...|+.++||||||+++.
T Consensus 150 --~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLI 226 (1187)
T KOG0579|consen 150 --NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLI 226 (1187)
T ss_pred --chhhhhccccceEEEecCcEeeecccccccchhHH-hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHH
Confidence 99999999999999999999999999987543221 1223356899999999854 457899999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..+.+|......- ..+.+..... +..+. .++.....+.+++.+||.+||..||++.++++
T Consensus 227 EMAqiEPPHhelnpM------RVllKiaKSe-PPTLl----qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 227 EMAQIEPPHHELNPM------RVLLKIAKSE-PPTLL----QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHhccCCCccccchH------HHHHHHhhcC-CCccc----CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 999999887543221 1112222222 22222 24555566778888999999999999999875
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=232.80 Aligned_cols=211 Identities=23% Similarity=0.312 Sum_probs=168.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++|||++++++++...+..++|+||+++++|.+++.+. .++...+..++.|++.||.|||+.
T Consensus 59 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~-- 134 (293)
T cd06647 59 KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN-- 134 (293)
T ss_pred HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 3467899999999999999999999999999999999999999999998543 468888999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+|++|+||+++.++.++++|||.+........ ......++..|++||.+.+..++.++|+||||+++|++++|.
T Consensus 135 -gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~ 212 (293)
T cd06647 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (293)
T ss_pred -CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998765443222 112235677899999998878899999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
.||.......... .....+.. .. ..+......+.+++.+||..+|++||++.+++..
T Consensus 213 ~pf~~~~~~~~~~------~~~~~~~~-~~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 213 PPYLNENPLRALY------LIATNGTP-EL----QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCCChhhhee------ehhcCCCC-CC----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9997653322110 00111111 11 1111223457788889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=233.70 Aligned_cols=217 Identities=22% Similarity=0.244 Sum_probs=163.9
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecC--CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDV--SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+|+.++++++|+|++++++++.+. +..++||||+. ++|.+++......+++..++.++.|++.||.|||+.
T Consensus 51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-- 127 (309)
T cd07845 51 ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN-- 127 (309)
T ss_pred chhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 3567899999999999999999998764 56899999996 489888876566789999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+ ..++.++|+||||+++|++++|
T Consensus 128 -~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g 205 (309)
T cd07845 128 -FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205 (309)
T ss_pred -CeecCCCCHHHEEECCCCCEEECccceeeecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999886543321 1122334678999999875 4578999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcC---------------Ccccccccc----hhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENG---------------NLSQLVEDE----EVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
..||........... +....... ......... .........+.++|.+||++||++||
T Consensus 206 ~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~ 282 (309)
T cd07845 206 KPLLPGKSEIEQLDL---IIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRA 282 (309)
T ss_pred CCCCCCCCHHHHHHH---HHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCc
Confidence 999976544332111 11111000 000000000 00011245567888899999999999
Q ss_pred CHHHHHH
Q 038713 225 AMKKVLL 231 (252)
Q Consensus 225 s~~~i~~ 231 (252)
|++++++
T Consensus 283 t~~~il~ 289 (309)
T cd07845 283 TAEEALE 289 (309)
T ss_pred CHHHHhc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=228.07 Aligned_cols=213 Identities=20% Similarity=0.216 Sum_probs=171.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT-PEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
....+...|-+||+.+.||.+..+|..++.+...|++||||.||+|....++ +.+.+++..+.=.+.+|+.||.|||-.
T Consensus 119 kKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml 198 (459)
T KOG0610|consen 119 KKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML 198 (459)
T ss_pred hHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh
Confidence 3456678899999999999999999999999999999999999999999875 456789998888999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCC---------------------------------C-CC-------
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP---------------------------------D-QT------- 121 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~---------------------------------~-~~------- 121 (252)
||++||+||+||||-++|++.|.||.++....- . ..
T Consensus 199 ---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~ 275 (459)
T KOG0610|consen 199 ---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDES 275 (459)
T ss_pred ---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccc
Confidence 999999999999999999999999987743210 0 00
Q ss_pred --------------cccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHh
Q 038713 122 --------------RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFE 187 (252)
Q Consensus 122 --------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 187 (252)
......+||..|+|||++.|...+.+.|-|+||+++|||+.|..||.+...++. +.+. +
T Consensus 276 ~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~NI----v- 348 (459)
T KOG0610|consen 276 ASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--LRNI----V- 348 (459)
T ss_pred ccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--HHHH----h-
Confidence 011124588899999999999999999999999999999999999988766542 2211 1
Q ss_pred cCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 038713 188 NGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA----MKKVLL 231 (252)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~~i~~ 231 (252)
........ .......+.+||++.|-+||.+|.- ++||-+
T Consensus 349 ~~~l~Fp~-----~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 349 GQPLKFPE-----EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cCCCcCCC-----CCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 11222111 1133455788888999999999999 777643
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=231.91 Aligned_cols=218 Identities=17% Similarity=0.205 Sum_probs=162.7
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
..+.+|+++++.++|+||+++++++.+....++|+||+. +++.+++......+++..+..++.|++.||.|||+. +
T Consensus 48 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ 123 (291)
T cd07870 48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---H 123 (291)
T ss_pred HHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 467899999999999999999999999999999999995 688887765555678888889999999999999999 9
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhCCc
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
++|+||+|+||+++.++.++++|||.++........ .....++..|+|||.+.+. .++.++|+||||+++|++++|..
T Consensus 124 i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 202 (291)
T cd07870 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202 (291)
T ss_pred cccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999988754322211 1223457889999998764 57889999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhc------------CCccc----ccccch-----hcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 166 CLDQNLLEDRAILQEWICQCFEN------------GNLSQ----LVEDEE-----VDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~----~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
||.......+ .+.+.. ..... ..... ...+.. ........+.+++.+|+..||++||
T Consensus 203 ~f~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~ 280 (291)
T cd07870 203 AFPGVSDVFE-QLEKIW-TVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI 280 (291)
T ss_pred CCCCchhHHH-HHHHHH-HHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCc
Confidence 9976543221 111110 00000 00000 000000 0001134567888899999999999
Q ss_pred CHHHHHH
Q 038713 225 AMKKVLL 231 (252)
Q Consensus 225 s~~~i~~ 231 (252)
|+.|++.
T Consensus 281 t~~~~l~ 287 (291)
T cd07870 281 SAQDALL 287 (291)
T ss_pred CHHHHhc
Confidence 9999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=232.62 Aligned_cols=219 Identities=21% Similarity=0.265 Sum_probs=165.4
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|+++++.++|||++++++++.+.+..++++||++ ++|.+++.... ..+++..++.++.|++.||.|||+.
T Consensus 42 ~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-- 118 (283)
T cd07835 42 PSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH-- 118 (283)
T ss_pred hhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4568899999999999999999999999999999999995 68999886543 4689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+|++|+||+++.++.++++|||.+........ ......++..|+|||++.+. .++.++|+||||+++|++++|
T Consensus 119 -~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 196 (283)
T cd07835 119 -RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR 196 (283)
T ss_pred -CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999875432211 11222457789999988664 468899999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcC---------------Cccc--ccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENG---------------NLSQ--LVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
..||........ ............ .... ..............+.+++.+||+.+|++|||+
T Consensus 197 ~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 274 (283)
T cd07835 197 RPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA 274 (283)
T ss_pred CCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 999976543221 111111000000 0000 000001112223557889999999999999999
Q ss_pred HHHHH
Q 038713 227 KKVLL 231 (252)
Q Consensus 227 ~~i~~ 231 (252)
+|+++
T Consensus 275 ~~il~ 279 (283)
T cd07835 275 KAALQ 279 (283)
T ss_pred HHHhc
Confidence 99975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=268.28 Aligned_cols=213 Identities=25% Similarity=0.331 Sum_probs=166.8
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+...+|..++..+.|||+|+++|+-.+....+|.||||++|+|.+.+. .++-.++.-...+-.|++.|++|||++
T Consensus 1278 ~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~--- 1353 (1509)
T KOG4645|consen 1278 FKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEH--- 1353 (1509)
T ss_pred CcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhc---
Confidence 3456789999999999999999999999999999999999999999884 332233333344568999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCC---cccccccCCccccccccccCCC---CCCcccchhHHHHHHH
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT---RTFTGIRGTRAYVAAEWHRNLP---ITVKADVYSFGVVLLE 159 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~~l~~ 159 (252)
|||||||||.||+++.+|.+|++|||.+..+..... .......||+.|||||++.+.. ...+.|||||||++.|
T Consensus 1354 gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlE 1433 (1509)
T KOG4645|consen 1354 GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLE 1433 (1509)
T ss_pred CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEE
Confidence 999999999999999999999999999987765432 2334567999999999998754 5678999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
|+||++||...+.+-. +--.+..|...++.+. ....-.+++.+||+.||++|.++.|+++.=-
T Consensus 1434 M~tGkrPW~~~dne~a------IMy~V~~gh~Pq~P~~------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1434 MATGKRPWAELDNEWA------IMYHVAAGHKPQIPER------LSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred eecCCCchhhccchhH------HHhHHhccCCCCCchh------hhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 9999999986644421 1123344444443322 2233344555999999999999998876543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=237.65 Aligned_cols=208 Identities=19% Similarity=0.183 Sum_probs=164.9
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
.++.+-...|-++|....+|.|||++-.|++...+|+||||++|||+..+|... +.+++..+.-.+.+++.||..+|+.
T Consensus 182 ~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~ 260 (550)
T KOG0605|consen 182 KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQL 260 (550)
T ss_pred hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHc
Confidence 345666788999999999999999999999999999999999999999999654 4688888888999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCC----------------------CCCc------------------
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP----------------------DQTR------------------ 122 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~----------------------~~~~------------------ 122 (252)
|++||||||+|+|++..|++||.|||++.-... ....
T Consensus 261 ---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w 337 (550)
T KOG0605|consen 261 ---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTW 337 (550)
T ss_pred ---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHH
Confidence 999999999999999999999999999853210 0000
Q ss_pred ------ccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccc
Q 038713 123 ------TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVE 196 (252)
Q Consensus 123 ------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (252)
......||+-|+|||++.+.+|+..+|.|||||++|||+.|-+||......+...-+..... .+..+.+
T Consensus 338 ~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-----~l~fP~~ 412 (550)
T KOG0605|consen 338 KRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE-----TLKFPEE 412 (550)
T ss_pred HhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-----hccCCCc
Confidence 00123499999999999999999999999999999999999999998766654322111111 1111111
Q ss_pred cchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 197 DEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 197 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
. ... ....++|.+|+. ||++|.-
T Consensus 413 ~--~~s---~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 413 V--DLS---DEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred C--ccc---HHHHHHHHHHhc-CHHHhcC
Confidence 1 111 345667779998 9999987
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=237.32 Aligned_cols=222 Identities=20% Similarity=0.261 Sum_probs=165.2
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEec----CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFD----VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
..+.+.+|+.++++++||||+++++++.. ....++|+||+. |+|.+++... +.+++..++.++.|++.||.|||
T Consensus 47 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH 124 (334)
T cd07855 47 LAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIH 124 (334)
T ss_pred chHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999998763 456899999995 6899988544 45899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc---ccccccCCccccccccccC-CCCCCcccchhHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR---TFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVV 156 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~ 156 (252)
+. +++|+||+|+||+++.++.++++|||.+......... ......++..|+|||.+.+ ..++.++|+||||++
T Consensus 125 ~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~ 201 (334)
T cd07855 125 SA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCI 201 (334)
T ss_pred HC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHH
Confidence 99 9999999999999999999999999998765432221 1123457888999998765 457899999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHH-----------------HHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCC
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQE-----------------WICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDE 219 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 219 (252)
+|+|++|+.||............. .+......-.......-..........+.+++.+||+.+
T Consensus 202 l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 281 (334)
T cd07855 202 FAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFD 281 (334)
T ss_pred HHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCC
Confidence 999999999997553322111100 000000000000000000111223566889999999999
Q ss_pred CCCCCCHHHHHH
Q 038713 220 PSLRRAMKKVLL 231 (252)
Q Consensus 220 p~~Rps~~~i~~ 231 (252)
|++|||+++++.
T Consensus 282 P~~Rpt~~~~l~ 293 (334)
T cd07855 282 PEERITVEQALQ 293 (334)
T ss_pred hhhCcCHHHHHh
Confidence 999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=244.90 Aligned_cols=204 Identities=20% Similarity=0.242 Sum_probs=170.8
Q ss_pred hHhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 3 AEGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
.+..+..+.|..++... +||.++.++..|+...++|+||||+.||++..+. ..+.+++..+.=++..|+.||+|||+
T Consensus 409 ~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~ 486 (694)
T KOG0694|consen 409 RDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHE 486 (694)
T ss_pred cccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHh
Confidence 45677889999999887 6999999999999999999999999999944333 44568888888899999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+ +|+|||+|.+|||++..|.+||+|||+.+....... .-+...||+.|+|||++.+..|+...|-||||+++|+|+
T Consensus 487 ~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML 562 (694)
T KOG0694|consen 487 N---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEML 562 (694)
T ss_pred c---CceeeecchhheEEcccCcEEecccccccccCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHH
Confidence 9 999999999999999999999999999986442222 334567999999999999999999999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
.|+.||.+.+.++... . +. .+...++...+...+.+++++|..||++|.-.
T Consensus 563 ~Gq~PF~gddEee~Fd--s-----I~-------~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 563 VGESPFPGDDEEEVFD--S-----IV-------NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cCCCCCCCCCHHHHHH--H-----Hh-------cCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 9999998765553211 1 11 12224566666778899999999999999887
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=244.06 Aligned_cols=210 Identities=23% Similarity=0.327 Sum_probs=173.7
Q ss_pred chHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 2 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
+...++.+.+|+++|..++||||||++++......+|+||||+.+|.+.+++.+.+.. .+..+..++.|+++|++|||+
T Consensus 95 n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~-~e~~ar~~F~q~vsaveYcH~ 173 (596)
T KOG0586|consen 95 NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRM-KEKEARAKFRQIVSAVEYCHS 173 (596)
T ss_pred ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccc-hhhhhhhhhHHHHHHHHHHhh
Confidence 3455677999999999999999999999999999999999999999999999766554 448889999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCC-CCcccchhHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-TVKADVYSFGVVLLEI 160 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l 160 (252)
+ .++|||+|++|+|++.+..++|+|||++..+.... ......|++.|.|||++.|..+ .+++|+||+|+++|.+
T Consensus 174 k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~L 248 (596)
T KOG0586|consen 174 K---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYAL 248 (596)
T ss_pred c---ceeccccchhhcccccccceeeeccccceeecccc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheee
Confidence 9 99999999999999999999999999998876322 3344568999999999999876 5899999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||++.....- ......|++ ..+.....++-++++++|-.+|.+|++.+|+..
T Consensus 249 V~GsLPFDG~~lk~L-------r~rvl~gk~-------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 249 VEGSLPFDGQNLKEL-------RPRVLRGKY-------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eecccccCCcccccc-------cchheeeee-------cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 999999987643321 111111222 223333445777888999999999999999754
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=224.37 Aligned_cols=210 Identities=20% Similarity=0.308 Sum_probs=170.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|++++++++|||++++++++.+.+..++++||+++++|.+++... ..+++..++.++.|++.|+.+||+.
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~- 118 (254)
T cd06627 41 EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQ- 118 (254)
T ss_pred HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhC-
Confidence 45678999999999999999999999999999999999999999999998654 5689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+......... .....++..|+|||...+..++.++|+||+|++++++++|
T Consensus 119 --~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g 195 (254)
T cd06627 119 --GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195 (254)
T ss_pred --CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999876543322 2234568889999998887789999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
..||........ . .... ...... .+......+.+++.+||..+|++|||+.+++.
T Consensus 196 ~~p~~~~~~~~~--~----~~~~-~~~~~~------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 196 NPPYYDLNPMAA--L----FRIV-QDDHPP------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCccHHHH--H----HHHh-ccCCCC------CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 999975542211 1 0111 111111 11122345778888999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=235.09 Aligned_cols=219 Identities=21% Similarity=0.228 Sum_probs=163.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecC------CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDV------SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
..+.+.+|+.++++++||||+++++++... ...++||||+. ++|.+.+... ++...+..++.|++.||.|
T Consensus 58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~ 133 (353)
T cd07850 58 HAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKH 133 (353)
T ss_pred HHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999988643 35799999995 5888887533 7888899999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
||+. +++|+||||+||+++.++.++++|||.+........ .....++..|+|||.+.+..++.++|+||||+++|
T Consensus 134 LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 208 (353)
T cd07850 134 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 208 (353)
T ss_pred HHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHH
Confidence 9999 999999999999999999999999999976543221 12234677899999999988999999999999999
Q ss_pred HHHhCCccccccchhhhHHHH----------------HHHHHHHhcCCcc------cccccc-------hhcHHHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQ----------------EWICQCFENGNLS------QLVEDE-------EVDQKQLQRMI 209 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~----------------~~~~~~~~~~~~~------~~~~~~-------~~~~~~~~~l~ 209 (252)
+|++|+.||............ ............. ...... .........+.
T Consensus 209 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
T cd07850 209 EMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQAR 288 (353)
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHH
Confidence 999999999755332211100 0000011100000 000000 00112345577
Q ss_pred HHHhhccCCCCCCCCCHHHHHHH
Q 038713 210 KVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 210 ~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
+++.+||+.||++|||+.|+++.
T Consensus 289 ~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 289 DLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHHcCCChhhCcCHHHHhcC
Confidence 88999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=230.78 Aligned_cols=210 Identities=25% Similarity=0.312 Sum_probs=166.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+++.+|++++++++|||++++++++.+....++||||+. |+|.+.+......+++..+..++.|++.|+.|||+.
T Consensus 68 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-- 144 (317)
T cd06635 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH-- 144 (317)
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 44678999999999999999999999999999999999996 588888766566789999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc---CCCCCCcccchhHHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR---NLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||+|+||+++.++.++++|||.+...... ....++..|+|||.+. +..++.++|+||||+++|+|+
T Consensus 145 -~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~ 218 (317)
T cd06635 145 -NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 218 (317)
T ss_pred -CcccCCCCcccEEECCCCCEEEecCCCccccCCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHH
Confidence 9999999999999999999999999987654321 1234677899999874 345789999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
+|+.||........ . ......+.. .. ........+.+++.+||+.+|.+|||+.++++.+-.
T Consensus 219 ~g~~p~~~~~~~~~--~----~~~~~~~~~-~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 219 ERKPPLFNMNAMSA--L----YHIAQNESP-TL-----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred hCCCCCCCccHHHH--H----HHHHhccCC-CC-----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 99999875432211 1 111111111 10 111223447788889999999999999999986544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=251.44 Aligned_cols=218 Identities=22% Similarity=0.319 Sum_probs=179.5
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------------CCCCHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------------KQPNWVERMG 67 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~ 67 (252)
..++.++.|+++|+.+ .|+||+.++|.+...+.+++|.||+..|+|.+++...+ ..++....+.
T Consensus 343 ~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLls 422 (609)
T KOG0200|consen 343 SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLS 422 (609)
T ss_pred HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHH
Confidence 4678999999999999 89999999999999999999999999999999996655 2488889999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCccccccc--CCccccccccccCCCCC
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIR--GTRAYVAAEWHRNLPIT 145 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~--~~~~~~aPE~~~~~~~~ 145 (252)
++.||+.|+.||++. .++|||+-++|||++.+..+|++|||+++...+.......... -...|||||.+....++
T Consensus 423 fa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft 499 (609)
T KOG0200|consen 423 FAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFT 499 (609)
T ss_pred HHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccc
Confidence 999999999999999 9999999999999999999999999999865444333322222 24469999999999999
Q ss_pred CcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 146 VKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 146 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
.++||||+|+++||++| |..||.+..... . +.+.++.|..... +..+...+.++++.||+.+|++||
T Consensus 500 ~kSDVWSfGI~L~EifsLG~~PYp~~~~~~--~----l~~~l~~G~r~~~------P~~c~~eiY~iM~~CW~~~p~~RP 567 (609)
T KOG0200|consen 500 SKSDVWSFGILLWEIFTLGGTPYPGIPPTE--E----LLEFLKEGNRMEQ------PEHCSDEIYDLMKSCWNADPEDRP 567 (609)
T ss_pred ccchhhHHHHHHHHHhhCCCCCCCCCCcHH--H----HHHHHhcCCCCCC------CCCCCHHHHHHHHHHhCCCcccCC
Confidence 99999999999999997 556665422111 1 1234555555332 444456688999999999999999
Q ss_pred CHHHHHHHhhcC
Q 038713 225 AMKKVLLMLEGT 236 (252)
Q Consensus 225 s~~~i~~~l~~~ 236 (252)
++.++.+.+++.
T Consensus 568 ~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 568 TFSECVEFFEKH 579 (609)
T ss_pred CHHHHHHHHHHH
Confidence 999999999884
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=243.06 Aligned_cols=207 Identities=25% Similarity=0.308 Sum_probs=170.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+.=+++..|+.+|+++.|||+|.+-|.|....+.++||||| -|+-.+.+.-..+++.+.++..|+.+.+.||+|||+.
T Consensus 68 EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~- 145 (948)
T KOG0577|consen 68 EKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH- 145 (948)
T ss_pred HHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh-
Confidence 44578999999999999999999999999999999999999 5688888766677889999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC---CCCCCcccchhHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN---LPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l 160 (252)
+.+|||||+.|||+++.|.||++|||.+....+. ....||+.|||||++.. ..|+.+.||||||++..++
T Consensus 146 --~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIEL 218 (948)
T KOG0577|consen 146 --NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 218 (948)
T ss_pred --hHHhhhccccceEecCCCeeeeccccchhhcCch-----hcccCCccccchhHheeccccccCCccceeeccchhhhh
Confidence 9999999999999999999999999999875443 33678999999999864 3589999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.-+++|+.....-. .....-.+..+. -...+....+..++..||++-|.+|||.++++.
T Consensus 219 AERkPPlFnMNAMS------ALYHIAQNesPt------Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 219 AERKPPLFNMNAMS------ALYHIAQNESPT------LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred hhcCCCccCchHHH------HHHHHHhcCCCC------CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 99998876442111 111111222111 114445566777888999999999999999876
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=230.06 Aligned_cols=210 Identities=23% Similarity=0.290 Sum_probs=166.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+++.+|+++++.++|+|++++.+++......++|+||+. |++.+.+......++...++.++.|++.|+.|||+.
T Consensus 58 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-- 134 (308)
T cd06634 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-- 134 (308)
T ss_pred HHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 45678899999999999999999999999999999999996 688887765556688999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc---CCCCCCcccchhHHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR---NLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||+|+||+++.++.++++|||.+....... ...++..|+|||.+. ...++.++|+||||+++|+++
T Consensus 135 -~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 208 (308)
T cd06634 135 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208 (308)
T ss_pred -CcccCCCCHHhEEECCCCcEEECCcccceeecCcc-----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHH
Confidence 99999999999999999999999999887543221 234677899999874 345788999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
+|..||......... .. ...+..... ........+.+++.+||+.+|++||++++++..--.
T Consensus 209 ~g~~p~~~~~~~~~~------~~-~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 209 ERKPPLFNMNAMSAL------YH-IAQNESPAL-----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred cCCCCCccccHHHHH------HH-HhhcCCCCc-----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 999998654322111 11 111111111 111233457788889999999999999999876443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=232.61 Aligned_cols=219 Identities=23% Similarity=0.263 Sum_probs=164.5
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCC----------cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVS----------NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARG 75 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~ 75 (252)
...+.+|++++++++|||++++++++.+.. ..++++||+++ ++.+.+......+++..++.++.|++.|
T Consensus 50 ~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~a 128 (302)
T cd07864 50 PITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEG 128 (302)
T ss_pred hHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence 356788999999999999999999887654 78999999975 7878776655578999999999999999
Q ss_pred HHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHH
Q 038713 76 IRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFG 154 (252)
Q Consensus 76 l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG 154 (252)
|+|||+. +++|+|++|+||++++++.++++|||.+...............++..|+|||.+.+. .++.++|+||||
T Consensus 129 L~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG 205 (302)
T cd07864 129 LNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 205 (302)
T ss_pred HHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHH
Confidence 9999999 999999999999999999999999999876543332222223356789999988653 578999999999
Q ss_pred HHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCc---cccccc----------------chhcHHHHHHHHHHHhhc
Q 038713 155 VVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNL---SQLVED----------------EEVDQKQLQRMIKVGLRC 215 (252)
Q Consensus 155 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~----------------~~~~~~~~~~l~~li~~c 215 (252)
++++++++|+.||......... ..+......... ..+... .......+..+.+++.+|
T Consensus 206 ~~~~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 282 (302)
T cd07864 206 CILGELFTKKPIFQANQELAQL---ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHM 282 (302)
T ss_pred HHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHH
Confidence 9999999999999765432211 111111111100 000000 000111245688889999
Q ss_pred cCCCCCCCCCHHHHHH
Q 038713 216 ILDEPSLRRAMKKVLL 231 (252)
Q Consensus 216 l~~~p~~Rps~~~i~~ 231 (252)
|+.+|.+|||+++++.
T Consensus 283 l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 283 LTLDPSKRCTAEEALN 298 (302)
T ss_pred ccCChhhCCCHHHHhc
Confidence 9999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=225.77 Aligned_cols=210 Identities=20% Similarity=0.197 Sum_probs=164.0
Q ss_pred HHHHHHHHHHh-CCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 7 REFKTEMNAIG-RTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 7 ~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
..+..|..++. ..+|+|++++++++...+..++++||+++++|.+++... +.+++..+..++.|++.||.|||+.
T Consensus 41 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~--- 116 (260)
T cd05611 41 TNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQR--- 116 (260)
T ss_pred HHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 34555655544 459999999999999999999999999999999999543 4578999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
+++|+||+|+||+++.++.++++|||.+..... .....++..|+|||...+..++.++|+||||+++|++++|..
T Consensus 117 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~ 191 (260)
T cd05611 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191 (260)
T ss_pred CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCC
Confidence 999999999999999999999999998875432 122346778999999988778999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
||........ . .....+...... .........+.+++.+||+.+|++|||+.++.+.|..
T Consensus 192 p~~~~~~~~~--~-----~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 192 PFHAETPDAV--F-----DNILSRRINWPE---EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred CCCCCCHHHH--H-----HHHHhcccCCCC---cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 9976543321 1 111112211110 1111234558888889999999999988777666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=229.71 Aligned_cols=215 Identities=22% Similarity=0.322 Sum_probs=162.9
Q ss_pred HhHHHHHHHHHHHhCCC-CCCCcceeeeEecCCcEEEEEecCCCCCHHhhh---cC-CCCCCCHHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL---FT-PEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
.....+.+|+.++.++. ||||+++++++...+..+++|||+.. ++.++. .. ....+++..+..++.|++.||+|
T Consensus 44 ~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 122 (288)
T cd06616 44 KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122 (288)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence 34667899999999995 99999999999999999999999854 554433 22 33568999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC---CCCCcccchhHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL---PITVKADVYSFGV 155 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~ 155 (252)
||+. .+++|+||+|+||+++.++.++++|||.+......... ....++..|+|||++.+. .++.++|+||+|+
T Consensus 123 lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~ 198 (288)
T cd06616 123 LKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGI 198 (288)
T ss_pred Hhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc--ccccCccCccCHHHhccccccCCcchhhhhHHHH
Confidence 9973 28999999999999999999999999998754332211 223467889999998775 6889999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|++++|+.||..... ..+.+..... +...... ..........+.+++.+||+.+|++|||+++|+.
T Consensus 199 il~el~~g~~p~~~~~~-----~~~~~~~~~~-~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 199 TLYEVATGKFPYPKWNS-----VFDQLTQVVK-GDPPILS--NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHHHHhCCCCchhcch-----HHHHHhhhcC-CCCCcCC--CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999975431 1111111111 1111111 1111223445788888999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=229.29 Aligned_cols=208 Identities=21% Similarity=0.189 Sum_probs=161.3
Q ss_pred HHHHHHHHHHhC---CCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 7 REFKTEMNAIGR---THHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 7 ~~~~~E~~~l~~---l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+|..+++. .+|||++++++++...+..++||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.
T Consensus 39 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~- 116 (279)
T cd05633 39 TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNR- 116 (279)
T ss_pred HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 345556554443 4799999999999999999999999999999998854 44689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc-CCCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-NLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||||+||+++.++.++++|||.+........ ....|+..|+|||.+. +..++.++|+||+|+++|++++
T Consensus 117 --~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 191 (279)
T cd05633 117 --FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191 (279)
T ss_pred --CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHh
Confidence 999999999999999999999999999865432221 2235788999999986 4568899999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLLM 232 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~~ 232 (252)
|..||..........+. ........ ..+......+.+++.+||+.||++|| |++++++.
T Consensus 192 g~~pf~~~~~~~~~~~~----~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 192 GHSPFRQHKTKDKHEID----RMTLTVNV-------ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCCCcCCCCCcCHHHHH----HHhhcCCc-------CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 99999765433221111 11111111 11222334577888899999999999 59998873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=233.85 Aligned_cols=223 Identities=21% Similarity=0.242 Sum_probs=164.3
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
.....+.+|+.+++++ +||||+++++++.. ....++||||+. ++|.+++... .+++..++.++.|++.||.|||
T Consensus 48 ~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH 124 (337)
T cd07852 48 TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH 124 (337)
T ss_pred hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Confidence 3456688999999999 99999999998864 346899999996 5999988544 6788888899999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC----cccccccCCccccccccccC-CCCCCcccchhHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT----RTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGV 155 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~ 155 (252)
+. +++|+||+|+||+++.++.++++|||.+........ .......++..|+|||.+.+ ..++.++|+||||+
T Consensus 125 ~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~ 201 (337)
T cd07852 125 SG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGC 201 (337)
T ss_pred HC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHH
Confidence 99 999999999999999999999999999876543221 11222356888999998765 45788999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHH-----------------HHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCC
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEW-----------------ICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILD 218 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 218 (252)
++|++++|+.||.............. .......-..................+.+++.+||+.
T Consensus 202 ~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 281 (337)
T cd07852 202 ILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVF 281 (337)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccC
Confidence 99999999999975543322111000 0000000000000000011111345688899999999
Q ss_pred CCCCCCCHHHHHHH
Q 038713 219 EPSLRRAMKKVLLM 232 (252)
Q Consensus 219 ~p~~Rps~~~i~~~ 232 (252)
+|++|||+.++++.
T Consensus 282 ~P~~Rps~~~il~~ 295 (337)
T cd07852 282 NPNKRLTAEEALEH 295 (337)
T ss_pred CcccccCHHHHhhC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=243.16 Aligned_cols=200 Identities=21% Similarity=0.237 Sum_probs=162.0
Q ss_pred HHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 8 EFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 8 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
+-.+|+.++... +||||+++.+++.+..+.|+|||.+.|+-+.+.+..... +. .++..|+.+|+.|+.|||++ |
T Consensus 361 ~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~---g 435 (612)
T KOG0603|consen 361 DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQ---G 435 (612)
T ss_pred ccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhc---C
Confidence 345677777666 899999999999999999999999999988887754332 33 77788999999999999999 9
Q ss_pred eeeeccCCCCEEe-cCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 87 IIHGDIKPQNILM-DEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 87 i~h~di~~~nil~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
++|||+||+|||+ +..++++++|||.++..... .....-|..|.|||+.....++.++|+||||+++|+|++|+.
T Consensus 436 vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~t 511 (612)
T KOG0603|consen 436 VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRT 511 (612)
T ss_pred eeecCCChhheeecCCCCcEEEEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCC
Confidence 9999999999999 68899999999999876554 222234778999999999999999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||....... .+...+..+... ...++. ..+|+.+||+.||.+||++.++..
T Consensus 512 p~~~~P~~~------ei~~~i~~~~~s------~~vS~~---AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 512 LFAAHPAGI------EIHTRIQMPKFS------ECVSDE---AKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccccCCchH------HHHHhhcCCccc------cccCHH---HHHHHHHhccCChhhCcChhhhcc
Confidence 998876661 122333444333 223333 455555999999999999999875
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=228.87 Aligned_cols=216 Identities=19% Similarity=0.182 Sum_probs=169.6
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|++++.++ +||||+++++.+......++||||+.+|+|.+++... ..+++..+..++.|++.||.|||+.
T Consensus 48 ~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~-- 124 (288)
T cd05583 48 AEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQL-- 124 (288)
T ss_pred HHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHC--
Confidence 45688999999999 6999999999999999999999999999999998543 4578889999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC--CCCcccchhHHHHHHHHHh
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP--ITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+|++|.||+++.++.++++|||.+...............++..|+|||...+.. .+.++|+||||+++|++++
T Consensus 125 -~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t 203 (288)
T cd05583 125 -GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203 (288)
T ss_pred -CeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh
Confidence 9999999999999999999999999998765433322222345788999999987654 7889999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
|..||....... ...+......... . ..+......+.+++.+||+.+|++|||+.++...|+-
T Consensus 204 g~~p~~~~~~~~--~~~~~~~~~~~~~-~-------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 204 GASPFTVDGEQN--SQSEISRRILKSK-P-------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCCcccCcccc--hHHHHHHHHHccC-C-------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 999996432211 1111111211111 1 1111223447788889999999999999988887766
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=244.35 Aligned_cols=208 Identities=21% Similarity=0.322 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT-PEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
-.+|.+|+.+|.+|+|||++++||+..+ ....+|||++++|+|.+.|.+ ....+....+.+++.||+.|+.||..+
T Consensus 155 mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk-- 231 (1039)
T KOG0199|consen 155 MDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK-- 231 (1039)
T ss_pred HHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh--
Confidence 4689999999999999999999999998 778899999999999999977 445577788889999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-ccc-ccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTF-TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~-~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|||+-.+|+++.....+||+|||+.+-...... ... ....-...|+|||-+....++.++|+|++|+++|||++
T Consensus 232 -rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFt 310 (1039)
T KOG0199|consen 232 -RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFT 310 (1039)
T ss_pred -hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhc
Confidence 999999999999999999999999999987653322 111 12334567999999999999999999999999999996
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
|..||.+..... +.+.+..+.. + ..+..+..++++++++||..+|++|||+..|.
T Consensus 311 yGEePW~G~~g~q-------IL~~iD~~er---L---pRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 311 YGEEPWVGCRGIQ-------ILKNIDAGER---L---PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred cCCCCCCCCCHHH-------HHHhcccccc---C---CCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 667887664442 1122222222 1 23555677899999999999999999999996
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=230.22 Aligned_cols=218 Identities=23% Similarity=0.256 Sum_probs=162.0
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|++++++++||||+++++++.+....++||||++ ++|.+++.... ...++..++.++.||+.||.|||+.
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-- 121 (294)
T PLN00009 45 PSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-- 121 (294)
T ss_pred hHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4678899999999999999999999999999999999995 57888775433 3367888889999999999999999
Q ss_pred CCeeeeccCCCCEEecC-CCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHh
Q 038713 85 AQIIHGDIKPQNILMDE-KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++. ++.++++|||.+........ ......++..|+|||.+.+. .++.++|+||+|+++|++++
T Consensus 122 -~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~t 199 (294)
T PLN00009 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199 (294)
T ss_pred -CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 9999999999999985 55789999999875433211 11223457789999988764 57899999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcC---Ccc---------c------ccccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENG---NLS---------Q------LVEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~---------~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
|..||......+. +.... ...... .+. . ..............+.+++.+|++.+|++||
T Consensus 200 g~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 276 (294)
T PLN00009 200 QKPLFPGDSEIDE--LFKIF-RILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI 276 (294)
T ss_pred CCCCCCCCCHHHH--HHHHH-HHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc
Confidence 9999976533221 11110 000000 000 0 0000011112234578888999999999999
Q ss_pred CHHHHHH
Q 038713 225 AMKKVLL 231 (252)
Q Consensus 225 s~~~i~~ 231 (252)
++.+++.
T Consensus 277 s~~~~l~ 283 (294)
T PLN00009 277 TARAALE 283 (294)
T ss_pred CHHHHhc
Confidence 9999886
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=229.69 Aligned_cols=219 Identities=21% Similarity=0.283 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE--KQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.
T Consensus 42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~- 119 (284)
T cd07836 42 PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN- 119 (284)
T ss_pred hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC-
Confidence 46778999999999999999999999999999999999975 8988885543 4589999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||++++++.++++|||.+........ ......++..|++||.+.+. .++.++|+||||+++|++++
T Consensus 120 --~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (284)
T cd07836 120 --RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196 (284)
T ss_pred --CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999875433221 11223457789999988664 56889999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHH----------HHhc-CCccccccc------chhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQ----------CFEN-GNLSQLVED------EEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~----------~~~~-~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
|..||......+... ..... .+.. ......... ..........+.+++.+|++.||++|||
T Consensus 197 g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 274 (284)
T cd07836 197 GRPLFPGTNNEDQLL--KIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS 274 (284)
T ss_pred CCCCCCCCCcHHHHH--HHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC
Confidence 999997654332111 10000 0000 000000000 0111123455778899999999999999
Q ss_pred HHHHHH
Q 038713 226 MKKVLL 231 (252)
Q Consensus 226 ~~~i~~ 231 (252)
+.++++
T Consensus 275 ~~~~l~ 280 (284)
T cd07836 275 AHDALQ 280 (284)
T ss_pred HHHHhc
Confidence 999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=225.55 Aligned_cols=209 Identities=20% Similarity=0.326 Sum_probs=167.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
...++.+|+.+++.++||||+++++++.+....++++||+++++|.+++.. ....+++..++.++.|++.|+.|||+
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 124 (260)
T cd08222 45 ETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124 (260)
T ss_pred hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 345677899999999999999999999999999999999999999988853 34568999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
. +++|+|++|+||+++. +.++++|||.+........ ......++..|+|||...+..++.++|+||||+++|+++
T Consensus 125 ~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~ 199 (260)
T cd08222 125 R---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMC 199 (260)
T ss_pred c---CccccCCChhheEeec-CCEeecccCceeecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 9 9999999999999975 5699999999876543221 222345678899999998888899999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||....... .... ...+.... .+......+.+++.+||+.+|++||++.++++
T Consensus 200 ~~~~~~~~~~~~~------~~~~-~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 200 CLAHAFEGQNFLS------VVLR-IVEGPTPS------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred hCCCCCCCccHHH------HHHH-HHcCCCCC------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 9999986442211 1111 11222211 12333456788899999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=226.76 Aligned_cols=217 Identities=21% Similarity=0.258 Sum_probs=162.8
Q ss_pred HHHHHHHHHhCC-CCCCCcceeeeEecC--CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 8 EFKTEMNAIGRT-HHRNPVRLLGYSFDV--SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 8 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
...+|+.++.++ .|||++++++++.+. +..++|+||++ |+|.+.+......+++..++.++.|++.||.|||+.
T Consensus 43 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-- 119 (282)
T cd07831 43 NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN-- 119 (282)
T ss_pred hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 456899999988 599999999999987 88999999996 588888866556789999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++. +.++++|||.+......... ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|
T Consensus 120 -~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~ 195 (282)
T cd07831 120 -GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSL 195 (282)
T ss_pred -CceecccCHHHEEEcC-CCeEEEecccccccccCCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcC
Confidence 9999999999999999 99999999998765432221 22346788999997654 4578899999999999999999
Q ss_pred CccccccchhhhHHH-HHH-------HHHHHhcCCcccccccc-------hhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 164 RRCLDQNLLEDRAIL-QEW-------ICQCFENGNLSQLVEDE-------EVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
..||......+.... ... +..............+. .........+.+++.+||+++|++|||+++
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 275 (282)
T cd07831 196 FPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQ 275 (282)
T ss_pred CcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHH
Confidence 999976533221110 000 00011111100000000 111233567899999999999999999999
Q ss_pred HHH
Q 038713 229 VLL 231 (252)
Q Consensus 229 i~~ 231 (252)
+++
T Consensus 276 ~l~ 278 (282)
T cd07831 276 ALR 278 (282)
T ss_pred Hhh
Confidence 875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=242.65 Aligned_cols=221 Identities=17% Similarity=0.204 Sum_probs=159.6
Q ss_pred HHHHHHHHHHHhCCCC------CCCcceeeeEecC-CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRTHH------RNPVRLLGYSFDV-SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
.+.+..|+++++.++| .+++++++++... +..|+||+++ +++|.+++.+. +.+++..+..++.||+.||.|
T Consensus 169 ~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~y 246 (467)
T PTZ00284 169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDY 246 (467)
T ss_pred HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence 3445667777776654 4588888888764 5788999988 77899988543 468999999999999999999
Q ss_pred Hhh-cCCCCeeeeccCCCCEEecCCC----------------ceEEcccCcccccCCCCCcccccccCCccccccccccC
Q 038713 79 LHD-ECEAQIIHGDIKPQNILMDEKR----------------CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN 141 (252)
Q Consensus 79 lh~-~~~~~i~h~di~~~nil~~~~~----------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 141 (252)
||+ . +|+||||||+|||++.++ .++|+|||.+..... ......|+..|+|||++.+
T Consensus 247 LH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~ 319 (467)
T PTZ00284 247 FHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLG 319 (467)
T ss_pred HHhcC---CeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhc
Confidence 997 6 999999999999998665 489999998754221 1223567899999999999
Q ss_pred CCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHH-----------------HHHh-cCCcccccccc-----
Q 038713 142 LPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWIC-----------------QCFE-NGNLSQLVEDE----- 198 (252)
Q Consensus 142 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~-~~~~~~~~~~~----- 198 (252)
..++.++|||||||++|+|++|+.||......+......... .... .+.......+.
T Consensus 320 ~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (467)
T PTZ00284 320 LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARI 399 (467)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhh
Confidence 899999999999999999999999998665433222211100 0000 00000000000
Q ss_pred -----hhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 038713 199 -----EVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEG 235 (252)
Q Consensus 199 -----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~ 235 (252)
.........+.++|.+||++||++|||++|+++ .+.+
T Consensus 400 ~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 400 ARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred hcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 000011345778999999999999999999997 5555
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=234.06 Aligned_cols=225 Identities=24% Similarity=0.284 Sum_probs=171.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCC-----cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVS-----NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
...+.+.+|+.+++.++||||+++++++.... ..+++|+|+. ++|.+++.... .+++..++.++.|++.||.+
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~ 118 (330)
T cd07834 41 IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKY 118 (330)
T ss_pred hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHH
Confidence 34578999999999999999999999988765 7899999996 58999885544 78999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--cccccccCCccccccccccCC-CCCCcccchhHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGV 155 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~ 155 (252)
||+. +++|+||||.||+++.++.++++|||.+........ .......++..|+|||.+.+. .++.++|+||||+
T Consensus 119 LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~ 195 (330)
T cd07834 119 LHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGC 195 (330)
T ss_pred HHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHH
Confidence 9999 999999999999999999999999999987654431 122334567789999999887 7899999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHHHHHHhcC--------------------CcccccccchhcHHHHHHHHHHHhhc
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWICQCFENG--------------------NLSQLVEDEEVDQKQLQRMIKVGLRC 215 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~l~~li~~c 215 (252)
++|++++|..||........... +....... ..................+.+++.+|
T Consensus 196 il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 272 (330)
T cd07834 196 IFAELLTRKPLFPGRDYIDQLNL---IVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKM 272 (330)
T ss_pred HHHHHHcCCCCcCCCCHHHHHHH---HHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHH
Confidence 99999999999976643321110 00000000 00000000011112345678899999
Q ss_pred cCCCCCCCCCHHHHHHH--hhcC
Q 038713 216 ILDEPSLRRAMKKVLLM--LEGT 236 (252)
Q Consensus 216 l~~~p~~Rps~~~i~~~--l~~~ 236 (252)
|+++|++|||++++++. +++.
T Consensus 273 l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 273 LVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred ccCChhhCCCHHHHHhCccHHhh
Confidence 99999999999999873 5553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=230.99 Aligned_cols=222 Identities=20% Similarity=0.258 Sum_probs=163.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecC--CcEEEEEecCCCCCHHhhhcCC----CCCCCHHHHHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDV--SNKILVYDYMSNGSLVDVLFTP----EKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
.+.+.+|+.++++++||||+++++++.+. ...++||||+++ +|.+.+... ...+++..++.++.|++.||.||
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 124 (316)
T cd07842 46 SQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124 (316)
T ss_pred cHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999999987 789999999964 777766431 23678999999999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecC----CCceEEcccCcccccCCCCC--cccccccCCccccccccccCC-CCCCcccchh
Q 038713 80 HDECEAQIIHGDIKPQNILMDE----KRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNL-PITVKADVYS 152 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~----~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s 152 (252)
|+. +++|+||+|+||+++. ++.++++|||.+........ .......++..|+|||++.+. .++.++|+||
T Consensus 125 H~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 201 (316)
T cd07842 125 HSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWA 201 (316)
T ss_pred HhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHH
Confidence 999 9999999999999999 89999999999886543222 112234567889999988764 5789999999
Q ss_pred HHHHHHHHHhCCccccccchhh-------hHHHHHHHHHHH--------------hc-----CCcccccccchh----cH
Q 038713 153 FGVVLLEIVCLRRCLDQNLLED-------RAILQEWICQCF--------------EN-----GNLSQLVEDEEV----DQ 202 (252)
Q Consensus 153 lG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~--------------~~-----~~~~~~~~~~~~----~~ 202 (252)
||++++++++|..||....... ...+...+.... .. ............ ..
T Consensus 202 lG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (316)
T cd07842 202 IGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEK 281 (316)
T ss_pred HHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHh
Confidence 9999999999999997553322 011111110000 00 000000000000 00
Q ss_pred --HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 203 --KQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 203 --~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.....+.+++.+||+.||++|||+.++++
T Consensus 282 ~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 282 HKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred ccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 22345888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=226.11 Aligned_cols=193 Identities=21% Similarity=0.301 Sum_probs=155.1
Q ss_pred CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEe
Q 038713 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILM 99 (252)
Q Consensus 20 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~ 99 (252)
+|||++++++.+...+..++||||+++|+|.+++.... .+++..++.++.|+++||.+||+. +++|+||+|+||++
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~ 142 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLY 142 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEE
Confidence 79999999999999999999999999999999996544 789999999999999999999999 99999999999999
Q ss_pred cCCC-ceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHH
Q 038713 100 DEKR-CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAIL 178 (252)
Q Consensus 100 ~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 178 (252)
+.++ .++++|||.+....... ...++..|+|||++.+..++.++|+||+|+++|++++|+.||....... ...
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~ 216 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDL 216 (267)
T ss_pred eCCCCeEEEecCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhH
Confidence 9888 99999999887553222 2346889999999998889999999999999999999999998443221 112
Q ss_pred HHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 038713 179 QEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-MKKVLL 231 (252)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~i~~ 231 (252)
..+.... .... .........+.+++.+||+.+|.+||+ ++++++
T Consensus 217 ~~~~~~~--~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 217 ESLLKRQ--QKKL-------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHhh--cccC-------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1211111 1111 111133445788888999999999996 588874
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=233.05 Aligned_cols=225 Identities=20% Similarity=0.242 Sum_probs=166.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecC-----CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDV-----SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
....+.+|+.+++.++||||+++++++... ...++++||+. ++|.+++... +.+++..++.++.|++.||.||
T Consensus 47 ~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~L 124 (337)
T cd07858 47 DAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYI 124 (337)
T ss_pred hhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHH
Confidence 455778999999999999999999988653 35899999995 6899988544 4689999999999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLL 158 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~ 158 (252)
|+. +++|+||+|+||+++.++.++++|||.+....... .......++..|+|||.+.. ..++.++|+||||+++|
T Consensus 125 H~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 200 (337)
T cd07858 125 HSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA 200 (337)
T ss_pred HhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHH
Confidence 999 99999999999999999999999999987654322 11222346778999998764 45889999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHH-----------------HHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCC
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEW-----------------ICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPS 221 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 221 (252)
++++|..||.............. ..........................+.+++.+||+.+|+
T Consensus 201 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 280 (337)
T cd07858 201 ELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPS 280 (337)
T ss_pred HHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChh
Confidence 99999999975533221111000 0000000000000000011122345678999999999999
Q ss_pred CCCCHHHHHHH--hhc
Q 038713 222 LRRAMKKVLLM--LEG 235 (252)
Q Consensus 222 ~Rps~~~i~~~--l~~ 235 (252)
+|||++++++. ++.
T Consensus 281 ~Rps~~ell~h~~~~~ 296 (337)
T cd07858 281 KRITVEEALAHPYLAS 296 (337)
T ss_pred hccCHHHHHcCcchhh
Confidence 99999998876 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=221.96 Aligned_cols=205 Identities=23% Similarity=0.246 Sum_probs=167.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
....+.+|+.++++++|||++++++.+...+..+++|||+++++|.+++.... .+++..++.++.|++.|+.|||+.
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~-- 112 (250)
T cd05123 36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSL-- 112 (250)
T ss_pred HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 45678999999999999999999999999999999999999999999996543 589999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||+++.++.++++|||.+....... .......++..|++||...+...+.++|+||||+++|++++|.
T Consensus 113 -~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~ 190 (250)
T cd05123 113 -GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190 (250)
T ss_pred -CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999987654332 1122345677899999998888899999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
.||....... . ...... +... .+......+.+++.+||..||++|||+.+
T Consensus 191 ~p~~~~~~~~---~---~~~~~~-~~~~-------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 191 PPFYAEDRKE---I---YEKILK-DPLR-------FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCCHHH---H---HHHHhc-CCCC-------CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 9997654321 1 111111 1111 11122455788888999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=228.00 Aligned_cols=220 Identities=20% Similarity=0.257 Sum_probs=173.2
Q ss_pred HhHHHHHHHHHHHhCCC-C-CC----CcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTH-H-RN----PVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGI 76 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~-h-~~----iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l 76 (252)
..++..+-|+++++++. + |+ +|.+.++|+..++.|+|+|.+ |-|+.+++.+++ ..++...+..|+.|+++++
T Consensus 127 kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv 205 (415)
T KOG0671|consen 127 KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESV 205 (415)
T ss_pred HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHH
Confidence 45777888999999993 2 22 677888899999999999988 669999997644 5688899999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecC--------------------CCceEEcccCcccccCCCCCcccccccCCcccccc
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDE--------------------KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAA 136 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~--------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP 136 (252)
+|||+. +++|.|+||+||++.+ +..++++|||.++...... .....|.+|+||
T Consensus 206 ~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAP 278 (415)
T KOG0671|consen 206 AFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAP 278 (415)
T ss_pred HHHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCc
Confidence 999999 9999999999999822 3458999999998765444 334568899999
Q ss_pred ccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHH--------------HHHhcCCccccc-------
Q 038713 137 EWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWIC--------------QCFENGNLSQLV------- 195 (252)
Q Consensus 137 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~------- 195 (252)
|++.+.+++..+||||+||+++|+.+|...|+...+.+.....+.+. +....+.+....
T Consensus 279 EViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~ 358 (415)
T KOG0671|consen 279 EVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKS 358 (415)
T ss_pred hheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccc
Confidence 99999999999999999999999999999999888666544333221 122222111100
Q ss_pred -------cc----chhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 196 -------ED----EEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 196 -------~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.+ ......+...|++|+++||.+||.+|+|+.|++.
T Consensus 359 k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 359 KYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred hhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 00 0224456677999999999999999999999875
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=227.60 Aligned_cols=218 Identities=23% Similarity=0.282 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|+.++++++|+|++++++++.+....++|+||++ ++|.+++......+++..++.++.|++.||.+||+.
T Consensus 42 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--- 117 (282)
T cd07829 42 PSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH--- 117 (282)
T ss_pred cHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 4568899999999999999999999999999999999997 589999976545789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhCC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||++++++.++++|||.+........ ......++..|+|||.+.+. .++.++|+||||++++++++|.
T Consensus 118 ~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~ 196 (282)
T cd07829 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196 (282)
T ss_pred CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999876543322 11223346689999998766 7899999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHh----------------cCCcccccccc--hhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFE----------------NGNLSQLVEDE--EVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
.||.......... . +..... ........... .........+.+++.+||+.+|++||++
T Consensus 197 ~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 273 (282)
T cd07829 197 PLFPGDSEIDQLF--K-IFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA 273 (282)
T ss_pred CCCCCccHHHHHH--H-HHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCH
Confidence 9997654322111 0 000000 00000000000 1111124568899999999999999999
Q ss_pred HHHHH
Q 038713 227 KKVLL 231 (252)
Q Consensus 227 ~~i~~ 231 (252)
.+++.
T Consensus 274 ~~~l~ 278 (282)
T cd07829 274 KEALK 278 (282)
T ss_pred HHHhh
Confidence 99875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=228.49 Aligned_cols=218 Identities=18% Similarity=0.198 Sum_probs=161.2
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEecCCc-----EEEEEecCCCCCHHhhhcCC----CCCCCHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFDVSN-----KILVYDYMSNGSLVDVLFTP----EKQPNWVERMGIARDIARG 75 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~ 75 (252)
...+.+|+.+++.+ +||||+++++++..... .+++|||+++ +|.+++... ...+++..++.++.||+.|
T Consensus 44 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~ 122 (295)
T cd07837 44 PPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122 (295)
T ss_pred chHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence 35688999999999 56999999999887665 8999999975 898888542 3457999999999999999
Q ss_pred HHHHhhcCCCCeeeeccCCCCEEecC-CCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhH
Q 038713 76 IRYLHDECEAQIIHGDIKPQNILMDE-KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSF 153 (252)
Q Consensus 76 l~~lh~~~~~~i~h~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~sl 153 (252)
|.|||+. +++|+||+|+||+++. ++.++++|||.+........ ......++..|+|||.+.+ ..++.++|+|||
T Consensus 123 L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 198 (295)
T cd07837 123 VAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSV 198 (295)
T ss_pred HHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHH
Confidence 9999999 9999999999999998 88999999999875432221 1112245778999998865 357899999999
Q ss_pred HHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccc-----------------cccchhcHHHHHHHHHHHhhcc
Q 038713 154 GVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQL-----------------VEDEEVDQKQLQRMIKVGLRCI 216 (252)
Q Consensus 154 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~l~~li~~cl 216 (252)
|+++|+|++|..||........ ...... .......... .............+.++|.+||
T Consensus 199 G~~l~~l~~g~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 275 (295)
T cd07837 199 GCIFAEMSRKQPLFPGDSELQQ--LLHIFK-LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKML 275 (295)
T ss_pred HHHHHHHHcCCCCCCCCCHHHH--HHHHHH-HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHc
Confidence 9999999999999975433221 111110 0000000000 0000111123455788999999
Q ss_pred CCCCCCCCCHHHHHH
Q 038713 217 LDEPSLRRAMKKVLL 231 (252)
Q Consensus 217 ~~~p~~Rps~~~i~~ 231 (252)
.+||++|||+++++.
T Consensus 276 ~~~P~~R~~~~eil~ 290 (295)
T cd07837 276 RYDPAKRISAKAALT 290 (295)
T ss_pred cCChhhcCCHHHHhc
Confidence 999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=226.56 Aligned_cols=209 Identities=22% Similarity=0.324 Sum_probs=169.1
Q ss_pred hHHHHHHHHHHHhCCC-CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|++++++++ ||||+++++++.+.+..+++||++++++|.+++.+. +.+++..++.++.|++.||.+||+.
T Consensus 44 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~- 121 (280)
T cd05581 44 KVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSK- 121 (280)
T ss_pred HHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3567889999999998 999999999999999999999999999999999654 3689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-------------------cccccccCCccccccccccCCCC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-------------------RTFTGIRGTRAYVAAEWHRNLPI 144 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-------------------~~~~~~~~~~~~~aPE~~~~~~~ 144 (252)
+++|+|++|+||+++.++.++++|||.+........ .......++..|+|||...+..+
T Consensus 122 --~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 199 (280)
T cd05581 122 --GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA 199 (280)
T ss_pred --CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC
Confidence 999999999999999999999999999876543321 11222346788999999888888
Q ss_pred CCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 145 TVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 145 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
+.++|+||||++++++++|+.||....... .+ .... .... ..+......+.+++.+||+.+|.+||
T Consensus 200 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~----~~~~-~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~ 265 (280)
T cd05581 200 GKSSDLWALGCIIYQMLTGKPPFRGSNEYL--TF----QKIL-KLEY-------SFPPNFPPDAKDLIEKLLVLDPQDRL 265 (280)
T ss_pred ChhhhHHHHHHHHHHHHhCCCCCCCccHHH--HH----HHHH-hcCC-------CCCCccCHHHHHHHHHHhcCCHhhCC
Confidence 999999999999999999999998664221 11 1111 1111 11122245578888899999999999
Q ss_pred CH----HHHHH
Q 038713 225 AM----KKVLL 231 (252)
Q Consensus 225 s~----~~i~~ 231 (252)
|+ +++++
T Consensus 266 ~~~~~~~~ll~ 276 (280)
T cd05581 266 GVNEGYDELKA 276 (280)
T ss_pred CcccCHHHHhc
Confidence 99 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=225.75 Aligned_cols=212 Identities=20% Similarity=0.297 Sum_probs=162.9
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-c
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD-E 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~ 82 (252)
....+.+|+.++.+. .||||+++++++.+....+++|||+ ++++.+.+......+++..+..++.|++.|++|||+ .
T Consensus 56 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 134 (296)
T cd06618 56 ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134 (296)
T ss_pred HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 455677788877777 5999999999999999999999998 457888776655678999999999999999999997 5
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC----CCCcccchhHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP----ITVKADVYSFGVVLL 158 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~~l~ 158 (252)
+++|+||+|+||++++++.++++|||.+......... ....++..|+|||.+.+.. ++.++|+||||+++|
T Consensus 135 ---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 209 (296)
T cd06618 135 ---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLV 209 (296)
T ss_pred ---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHH
Confidence 8999999999999999999999999998765432221 2234677899999987654 788999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
++++|+.||.......+ . ........ ........ .....+.+++.+||+.+|++|||++++++.
T Consensus 210 el~~g~~p~~~~~~~~~-~----~~~~~~~~-~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 210 ELATGQFPYKNCKTEFE-V----LTKILQEE-PPSLPPNE----GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHhCCCCCCcchhHHH-H----HHHHhcCC-CCCCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99999999975422211 1 11112211 11111111 123447888889999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=226.40 Aligned_cols=207 Identities=25% Similarity=0.305 Sum_probs=164.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+++++.++|||++++++++.+....++||||+. |++.+++......+++..++.++.|++.|+.|||+.
T Consensus 64 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~-- 140 (313)
T cd06633 64 KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH-- 140 (313)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 34678899999999999999999999999999999999995 588888866666789999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc---CCCCCCcccchhHHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR---NLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+|++|+||+++.++.++++|||.+...... ....++..|+|||.+. +..++.++|+||||+++|+++
T Consensus 141 -gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~ 214 (313)
T cd06633 141 -NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 214 (313)
T ss_pred -CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999987643211 2245678899999974 345788999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
+|..||......... ...... ...... .......+.+++.+||+.+|.+|||+.+++..
T Consensus 215 ~g~~p~~~~~~~~~~------~~~~~~-~~~~~~-----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 215 ERKPPLFNMNAMSAL------YHIAQN-DSPTLQ-----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred hCCCCCCCCChHHHH------HHHHhc-CCCCCC-----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999998765332211 111111 111111 11112346778889999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=231.47 Aligned_cols=227 Identities=22% Similarity=0.260 Sum_probs=164.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecC-----CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDV-----SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
...++.+|+.++++++||||+++++++... ...++++||+. ++|.+++.. +.+++..++.++.|++.||.+|
T Consensus 46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~L 122 (336)
T cd07849 46 FCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYI 122 (336)
T ss_pred hHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 456688999999999999999999987643 35799999995 588888743 4588999999999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--cccccccCCccccccccccC-CCCCCcccchhHHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVV 156 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~ 156 (252)
|+. +++|+||+|+||+++.++.++++|||.+........ .......++..|+|||.+.+ ..++.++|+||+|++
T Consensus 123 H~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvi 199 (336)
T cd07849 123 HSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCI 199 (336)
T ss_pred HhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHH
Confidence 999 999999999999999999999999999876533221 11123457888999998754 457899999999999
Q ss_pred HHHHHhCCccccccchhhhHHHH-H--------HH--------HHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCC
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQ-E--------WI--------CQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDE 219 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~-~--------~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 219 (252)
+|+|++|+.||............ . .. .........................+.+++.+||+.+
T Consensus 200 l~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 279 (336)
T cd07849 200 LAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFN 279 (336)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCC
Confidence 99999999999755332211100 0 00 0000000000000000001112455788999999999
Q ss_pred CCCCCCHHHHHHH--hhcCc
Q 038713 220 PSLRRAMKKVLLM--LEGTV 237 (252)
Q Consensus 220 p~~Rps~~~i~~~--l~~~~ 237 (252)
|++|||+.++++. ++...
T Consensus 280 P~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 280 PHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhCcCHHHHhcCccccccC
Confidence 9999999999886 55543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=229.65 Aligned_cols=218 Identities=24% Similarity=0.278 Sum_probs=161.6
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCC--------cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVS--------NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
..+.+|++++++++||||+++++++.... .+++|+||+. +++...+......+++..++.++.|+++||.|
T Consensus 52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~ 130 (311)
T cd07866 52 ITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINY 130 (311)
T ss_pred hhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHH
Confidence 46789999999999999999999875433 4699999995 47888876666679999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc----------ccccccCCccccccccccCC-CCCCc
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR----------TFTGIRGTRAYVAAEWHRNL-PITVK 147 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~~-~~~~~ 147 (252)
||+. +++|+|++|+||++++++.++++|||.+......... ......++..|+|||.+.+. .++.+
T Consensus 131 lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 207 (311)
T cd07866 131 LHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA 207 (311)
T ss_pred HHhC---CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCch
Confidence 9999 9999999999999999999999999998765432211 11123457789999987654 57899
Q ss_pred ccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcC---Cc------cc--------ccccc--hhcHHHHHHH
Q 038713 148 ADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENG---NL------SQ--------LVEDE--EVDQKQLQRM 208 (252)
Q Consensus 148 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~------~~--------~~~~~--~~~~~~~~~l 208 (252)
+|+||||+++|+|++|..||........... +......- .+ .. ...+. .........+
T Consensus 208 ~Dv~slG~il~el~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (311)
T cd07866 208 VDIWGIGCVFAEMFTRRPILQGKSDIDQLHL---IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEG 284 (311)
T ss_pred hHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhH
Confidence 9999999999999999999975544322111 11100000 00 00 00000 0011122567
Q ss_pred HHHHhhccCCCCCCCCCHHHHHH
Q 038713 209 IKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 209 ~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.+++.+||+.+|++|||+.+++.
T Consensus 285 ~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 285 LDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHcccCcccCcCHHHHhc
Confidence 88999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=217.57 Aligned_cols=215 Identities=19% Similarity=0.278 Sum_probs=171.2
Q ss_pred chHhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 2 LAEGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 2 ~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
+++.-++++..++++.+. ..|+||+.+|+|..+..+.+.||.+ +..+...+..-.+.+++..+=++...+++||.||.
T Consensus 130 Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK 208 (391)
T KOG0983|consen 130 NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLK 208 (391)
T ss_pred CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH
Confidence 356678888899998776 4899999999999999999999998 44667777666777888888889999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC---CCCCCcccchhHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN---LPITVKADVYSFGVVL 157 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l 157 (252)
+++ +++|||+||+|||++..|.+|++|||.+....+.... ....|-+.|||||.+.- .+|+.++||||||+++
T Consensus 209 eKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITl 284 (391)
T KOG0983|consen 209 EKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITL 284 (391)
T ss_pred Hhc--ceeecccCccceEEccCCCEEeecccccceeeccccc--ccccCCccccCccccCCCCCCccchhhhhhhhccch
Confidence 874 9999999999999999999999999999876554432 23457889999998763 4689999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+++.||+.||..+..+-+. .-+.+.+.. ..+..... ...++.+++..||.+|+.+||...++++
T Consensus 285 veLaTg~yPy~~c~tdFe~-----ltkvln~eP-P~L~~~~g----FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 285 VELATGQYPYKGCKTDFEV-----LTKVLNEEP-PLLPGHMG----FSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred hhhhcccCCCCCCCccHHH-----HHHHHhcCC-CCCCcccC----cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 9999999999886554321 112233222 22211111 4566888888999999999999998875
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=222.71 Aligned_cols=211 Identities=21% Similarity=0.267 Sum_probs=160.4
Q ss_pred hHHHHHHHHHH-HhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 5 GEREFKTEMNA-IGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 5 ~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
...++..|+.. ++.++||||+++++++..++..+++|||++ |+|.+++.. ....+++..++.++.|++.||.|||
T Consensus 42 ~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 120 (283)
T cd06617 42 EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120 (283)
T ss_pred HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 34567777776 566699999999999999999999999996 578777643 3356899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC----CCCCCcccchhHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN----LPITVKADVYSFGVV 156 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~~ 156 (252)
++ .+++|+||+|+||+++.++.++++|||.+........ .....++..|+|||.+.+ ..++.++|+||||++
T Consensus 121 ~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~ 196 (283)
T cd06617 121 SK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGIT 196 (283)
T ss_pred hc--CCeecCCCCHHHEEECCCCCEEEeecccccccccccc--cccccCCccccChhhcCCcccccccCccccchhhHHH
Confidence 84 2899999999999999999999999999876533221 122346788999998865 346889999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|++++|+.||........ ....... +...... . ...+..+.+++.+||..+|++|||+.+++.
T Consensus 197 l~~l~~g~~p~~~~~~~~~-----~~~~~~~-~~~~~~~-~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 197 MIELATGRFPYDSWKTPFQ-----QLKQVVE-EPSPQLP-A----EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHhCCCCCCccccCHH-----HHHHHHh-cCCCCCC-c----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999964322211 1111111 1111111 1 112345788888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=220.01 Aligned_cols=211 Identities=20% Similarity=0.234 Sum_probs=164.4
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecC--CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDV--SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
+..+.|.+|++++++++||||+++++.+.+. +.+++++||+++++|.+++... +.++....+.++.|++.||.|||+
T Consensus 46 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~ 124 (264)
T cd06653 46 KEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHS 124 (264)
T ss_pred HHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456889999999999999999999998763 4688999999999999998543 347888899999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--cccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
. +++|+|++|+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|+||||+++|+
T Consensus 125 ~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 201 (264)
T cd06653 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVE 201 (264)
T ss_pred C---CEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHH
Confidence 9 999999999999999999999999999876532111 11122457788999999998888999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+++|+.||....... .+ ...... .... ..+......+.+++.+||. +|..|||+.+++.
T Consensus 202 l~~g~~p~~~~~~~~--~~----~~~~~~-~~~~-----~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 202 MLTEKPPWAEYEAMA--AI----FKIATQ-PTKP-----MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHhCCCCCCccCHHH--HH----HHHHcC-CCCC-----CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 999999997542221 11 111111 1111 1223333457777779998 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=230.34 Aligned_cols=216 Identities=21% Similarity=0.212 Sum_probs=164.8
Q ss_pred HHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 038713 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQI 87 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i 87 (252)
.+.+|++++++++||||+++++++......+++|||+. |+|.+++.. ...++......++.|++.||.+||+. ++
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~---~i 140 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKW---YF 140 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 57899999999999999999999999999999999996 689998854 44589999999999999999999999 99
Q ss_pred eeeccCCCCEEecCCCceEEcccCcccccCCCC-------------CcccccccCCccccccccccCC-CCCCcccchhH
Q 038713 88 IHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ-------------TRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSF 153 (252)
Q Consensus 88 ~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~sl 153 (252)
+|+||+|+||+++.++.++++|||.+....... ........++..|+|||.+.+. .++.++|+|||
T Consensus 141 ~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 220 (335)
T PTZ00024 141 MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220 (335)
T ss_pred ecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHH
Confidence 999999999999999999999999987654111 1111123357789999998764 46899999999
Q ss_pred HHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcc---cc------------ccc--chhcHHHHHHHHHHHhhcc
Q 038713 154 GVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLS---QL------------VED--EEVDQKQLQRMIKVGLRCI 216 (252)
Q Consensus 154 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~------------~~~--~~~~~~~~~~l~~li~~cl 216 (252)
|+++|++++|..||......... ..+.......... .. ... ..........+.+++.+||
T Consensus 221 G~~l~el~tg~~p~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 297 (335)
T PTZ00024 221 GCIFAELLTGKPLFPGENEIDQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLL 297 (335)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHc
Confidence 99999999999999766443221 1111111111000 00 000 0111122455788999999
Q ss_pred CCCCCCCCCHHHHHH
Q 038713 217 LDEPSLRRAMKKVLL 231 (252)
Q Consensus 217 ~~~p~~Rps~~~i~~ 231 (252)
+.+|++|||++|++.
T Consensus 298 ~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 298 KLNPLERISAKEALK 312 (335)
T ss_pred CCCchhccCHHHHhc
Confidence 999999999999986
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=229.83 Aligned_cols=230 Identities=20% Similarity=0.261 Sum_probs=166.5
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecC------CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDV------SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
.+.+.+|+.++++++||||+++++++... ...++|+||+. ++|.++.. ..+++..++.++.|++.||+||
T Consensus 58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~L 133 (342)
T cd07879 58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYI 133 (342)
T ss_pred hhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHH
Confidence 45688999999999999999999998754 34689999995 47777652 3578899999999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLL 158 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~ 158 (252)
|+. +++|+||+|+||+++.++.++++|||.+...... .....++..|+|||.+.+ ..++.++|+||||+++|
T Consensus 134 H~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~ 206 (342)
T cd07879 134 HSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206 (342)
T ss_pred HHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHH
Confidence 999 9999999999999999999999999998754321 122345778999999876 45889999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHH----------HHHhcCCcc------cccccc---hhcHHHHHHHHHHHhhccCCC
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWIC----------QCFENGNLS------QLVEDE---EVDQKQLQRMIKVGLRCILDE 219 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~----------~~~~~~~~~------~~~~~~---~~~~~~~~~l~~li~~cl~~~ 219 (252)
++++|+.||.......... .... ......... ...... .........+.+++.+||++|
T Consensus 207 el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 284 (342)
T cd07879 207 EMLTGKTLFKGKDYLDQLT--QILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELD 284 (342)
T ss_pred HHHhCCCCCCCCCHHHHHH--HHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCC
Confidence 9999999998653322111 0000 000000000 000000 000112345778899999999
Q ss_pred CCCCCCHHHHHH--HhhcCcCCCCCCCCCCC
Q 038713 220 PSLRRAMKKVLL--MLEGTVEIPIPQNPTSF 248 (252)
Q Consensus 220 p~~Rps~~~i~~--~l~~~~~~~~~~~~~~~ 248 (252)
|++|||+.+++. .+++.......+.|..+
T Consensus 285 P~~R~~~~e~l~h~~f~~~~~~~~~~~~~~~ 315 (342)
T cd07879 285 VDKRLTATEALEHPYFDSFRDADEETEQQPY 315 (342)
T ss_pred hhhCcCHHHHhcCcchhhcccccccCCCCcc
Confidence 999999999994 47776555444444333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=224.34 Aligned_cols=212 Identities=21% Similarity=0.209 Sum_probs=164.9
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|+++++++ +|+||+++++.+..+...++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.
T Consensus 48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~-- 124 (290)
T cd05613 48 TEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKL-- 124 (290)
T ss_pred HHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 46688999999999 6999999999999999999999999999999999643 4578888899999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC--CCCCcccchhHHHHHHHHHh
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL--PITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.+...............++..|+|||...+. .++.++|+||||+++|++++
T Consensus 125 -~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~ 203 (290)
T cd05613 125 -GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203 (290)
T ss_pred -CeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhc
Confidence 999999999999999999999999999876543322222234578899999998753 46789999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
|..||....... ............... .+......+.+++.+||+.+|++|| ++++++.
T Consensus 204 g~~p~~~~~~~~--~~~~~~~~~~~~~~~--------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 204 GASPFTVDGEKN--SQAEISRRILKSEPP--------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCCCCCcCCccc--cHHHHHHHhhccCCC--------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 999996432211 111112222111111 1112234577888899999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=221.60 Aligned_cols=218 Identities=22% Similarity=0.239 Sum_probs=164.1
Q ss_pred HHHHHHHHHHHhCC---CCCCCcceeeeEecCCc-----EEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRT---HHRNPVRLLGYSFDVSN-----KILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGI 76 (252)
Q Consensus 6 ~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l 76 (252)
...+.+|+.+++++ .|||++++++++..... .+++|||+. ++|.+++.... ..+++..++.++.|++.||
T Consensus 42 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al 120 (287)
T cd07838 42 PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120 (287)
T ss_pred hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHH
Confidence 34567788877665 69999999999988766 999999996 48988886533 3589999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHH
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVV 156 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~ 156 (252)
.+||+. +++|+|++|+||+++.++.++++|||.+........ .....++..|+|||++.+..++.++|+||||++
T Consensus 121 ~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~ 195 (287)
T cd07838 121 DFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCI 195 (287)
T ss_pred HHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHH
Confidence 999999 999999999999999999999999999876543321 122346778999999998889999999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcc-------------ccc--ccchhcHHHHHHHHHHHhhccCCCCC
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLS-------------QLV--EDEEVDQKQLQRMIKVGLRCILDEPS 221 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~--~~~~~~~~~~~~l~~li~~cl~~~p~ 221 (252)
+|+|++|..||......+ ....+.......+... ... ............+.+++.+||+.||+
T Consensus 196 l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 273 (287)
T cd07838 196 FAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPH 273 (287)
T ss_pred HHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCc
Confidence 999999999987654332 1111111110000000 000 00111223346678899999999999
Q ss_pred CCCCHHHHHH
Q 038713 222 LRRAMKKVLL 231 (252)
Q Consensus 222 ~Rps~~~i~~ 231 (252)
+||++.+++.
T Consensus 274 ~Rp~~~~il~ 283 (287)
T cd07838 274 KRISAFEALQ 283 (287)
T ss_pred cCCCHHHHhc
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=224.07 Aligned_cols=219 Identities=21% Similarity=0.284 Sum_probs=165.0
Q ss_pred HHHHHHHHHHhCCC-CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 7 REFKTEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 7 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
....+|+..+++++ |||++++++++.+++..++||||+ +|+|.+++.... ..+++..++.++.|++.+|.|||+.
T Consensus 42 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~-- 118 (283)
T cd07830 42 CMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH-- 118 (283)
T ss_pred HHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 34567999999998 999999999999999999999999 889999886544 4689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+........ .....++..|+|||++.+ ..++.++|+||||++++++++|
T Consensus 119 -~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g 195 (283)
T cd07830 119 -GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL 195 (283)
T ss_pred -CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhC
Confidence 999999999999999999999999999876543221 122346778999998754 4578999999999999999999
Q ss_pred CccccccchhhhHHHHH----------HHHHHHhcCCcccccc----c--chhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 164 RRCLDQNLLEDRAILQE----------WICQCFENGNLSQLVE----D--EEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~----~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
+.||......+...... |............... . ..........+.+++.+||+.+|++|||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ 275 (283)
T cd07830 196 RPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTAS 275 (283)
T ss_pred CCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHH
Confidence 99986553332211000 0000000000000000 0 011111135688999999999999999999
Q ss_pred HHHH
Q 038713 228 KVLL 231 (252)
Q Consensus 228 ~i~~ 231 (252)
|++.
T Consensus 276 ei~~ 279 (283)
T cd07830 276 QALQ 279 (283)
T ss_pred HHhh
Confidence 9875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=217.40 Aligned_cols=233 Identities=22% Similarity=0.279 Sum_probs=170.5
Q ss_pred HHHHHHHHHhCCCCCCCcceeeeEec-CCcEEEEEecCCCCCHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 8 EFKTEMNAIGRTHHRNPVRLLGYSFD-VSNKILVYDYMSNGSLVDVLFT----PEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..-||+.+++.++|||++.+..++.. +..+++++||++. +|.+.|+- ..+.++...+..++.||+.|+.|||+.
T Consensus 73 SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N 151 (438)
T KOG0666|consen 73 SACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN 151 (438)
T ss_pred HHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh
Confidence 35689999999999999999999887 8889999999977 89988832 336789999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCC----CceEEcccCcccccCCCCCc--ccccccCCccccccccccCCC-CCCcccchhHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEK----RCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLP-ITVKADVYSFGV 155 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~----~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~ 155 (252)
=++|||+||.||++..+ |.+||+|+|+++.+...-.. ....++.|.+|+|||.+.|.+ |+.+.|+|++||
T Consensus 152 ---WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGC 228 (438)
T KOG0666|consen 152 ---WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGC 228 (438)
T ss_pred ---heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHH
Confidence 89999999999999876 89999999999988654332 233466799999999999875 899999999999
Q ss_pred HHHHHHhCCccccccchhhh----HHH--HHHHHHHHhc---CCcccccccchh------------cH-------H----
Q 038713 156 VLLEIVCLRRCLDQNLLEDR----AIL--QEWICQCFEN---GNLSQLVEDEEV------------DQ-------K---- 203 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~----~~~--~~~~~~~~~~---~~~~~~~~~~~~------------~~-------~---- 203 (252)
++.||+|..+.|.+...... ... ...+.+.+.. ..|..+..-.+. +. .
T Consensus 229 IfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~ 308 (438)
T KOG0666|consen 229 IFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKV 308 (438)
T ss_pred HHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcC
Confidence 99999999988865422211 111 0111111111 111111100000 00 0
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCCCCCCCC
Q 038713 204 QLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIPIPQNP 245 (252)
Q Consensus 204 ~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~~~~~~~ 245 (252)
....-++|+.++|..||.+|.|++|.++-.- ..+.+.|+.|
T Consensus 309 k~~~a~~LL~klL~yDP~kRIta~qAleh~y-F~~d~lpp~p 349 (438)
T KOG0666|consen 309 KDPSALDLLQKLLTYDPIKRITAEQALEHPY-FTEDPLPPLP 349 (438)
T ss_pred CCchHHHHHHHHhccCchhhccHHHHhcccc-cccCCCCCCc
Confidence 0122678888999999999999999876432 2334444333
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=221.79 Aligned_cols=206 Identities=19% Similarity=0.177 Sum_probs=160.7
Q ss_pred HHHHHHHH---HhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 8 EFKTEMNA---IGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 8 ~~~~E~~~---l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+..|..+ ++...||+|+++++++......++|+||+.||+|.+++.. .+.+++..+..++.|++.|+.|||+.
T Consensus 40 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~-- 116 (278)
T cd05606 40 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNR-- 116 (278)
T ss_pred HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 34455444 4445899999999999999999999999999999998854 45689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+........ ....|+..|+|||.+.+. .++.++|+||+|+++|++++|
T Consensus 117 -~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g 192 (278)
T cd05606 117 -FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192 (278)
T ss_pred -CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhC
Confidence 999999999999999999999999999875432221 223578899999998743 688999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
..||............ ......... .+......+.+++.+||..+|.+|| ++.++++
T Consensus 193 ~~p~~~~~~~~~~~~~----~~~~~~~~~-------~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 193 HSPFRQHKTKDKHEID----RMTLTMAVE-------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCCCCCccchHHHH----HHhhccCCC-------CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 9999765333221111 111111111 1112245578888899999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=225.12 Aligned_cols=212 Identities=17% Similarity=0.198 Sum_probs=155.9
Q ss_pred HHHHHHHHhCCCCCCCcceeeeEecCC----cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 9 FKTEMNAIGRTHHRNPVRLLGYSFDVS----NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 9 ~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
...+...+..+.|+|++++++.+.... ..+++++++ ..++.+.+.. ....++..++.++.|++.||.|||+.
T Consensus 70 ~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-- 145 (294)
T PHA02882 70 KIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEH-- 145 (294)
T ss_pred HHHHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 344555677789999999998765432 346778876 3467666643 33457788889999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC------cccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT------RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
+++||||||+||+++.++.++++|||+++....... .......|+..|+|||++.+..++.++||||||+++|
T Consensus 146 -~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~ 224 (294)
T PHA02882 146 -GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCML 224 (294)
T ss_pred -CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHH
Confidence 999999999999999999999999999876532211 1112235889999999999989999999999999999
Q ss_pred HHHhCCccccccchhhhHH---HHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 159 EIVCLRRCLDQNLLEDRAI---LQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
+|++|+.||.......... ..++... ...+... .....+.+.+++..|++.+|++||+++++.+.|.
T Consensus 225 el~~g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 225 KWAGIKLPWKGFGHNGNLIHAAKCDFIKR-LHEGKIK--------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhCCCCCCccccchHHHHHhHHHHHHH-hhhhhhc--------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 9999999997653222111 1111111 1111111 1112355778888999999999999999998763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=214.99 Aligned_cols=210 Identities=27% Similarity=0.345 Sum_probs=170.9
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|++.+++++|+|++++++.+......++++|++.+++|.+++..... ++...++.++.+++.++.+||+.
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~--- 106 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR-LSEDEARFYARQILSALEYLHSN--- 106 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHHc---
Confidence 67899999999999999999999999999999999999999999999865443 88999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
+++|+||+|.||+++.++.++++|||.+....... ......++..|++||...+..++.++|+||+|++++++++|..
T Consensus 107 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~ 184 (244)
T smart00220 107 GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKP 184 (244)
T ss_pred CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999998765432 2223456778999999988888999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||....... .. ......+........ ......+.+++.+||..+|++||++.++++
T Consensus 185 p~~~~~~~~--~~----~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 185 PFPGDDQLL--EL----FKKIGKPKPPFPPPE----WKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCCCcHH--HH----HHHHhccCCCCcccc----ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 997632221 11 112222222211110 003345888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=225.06 Aligned_cols=218 Identities=22% Similarity=0.269 Sum_probs=162.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEec-CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFD-VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|++++++++||||+++.+++.. ....++++||+ +++|.+++.. ..++...+..++.|+++||.|||+.
T Consensus 52 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~- 127 (328)
T cd07856 52 LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSA- 127 (328)
T ss_pred hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 45678899999999999999999998875 56789999998 6689888853 3467788888999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+|++|+||+++.++.++++|||.+....... ....++..|+|||.+.+ ..++.++|+||||+++|++++
T Consensus 128 --~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t 201 (328)
T cd07856 128 --GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLE 201 (328)
T ss_pred --CcccCCCCHHHEeECCCCCEEeCccccccccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999987543211 22345778999998765 568999999999999999999
Q ss_pred CCccccccchhhhHHHHH---------HHHH--------HHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 163 LRRCLDQNLLEDRAILQE---------WICQ--------CFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~---------~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
|..||............. +... .......................+.++|.+||+.+|++|||
T Consensus 202 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t 281 (328)
T cd07856 202 GKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS 281 (328)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC
Confidence 999997654322111100 0000 00000000000000111112356888899999999999999
Q ss_pred HHHHHHH
Q 038713 226 MKKVLLM 232 (252)
Q Consensus 226 ~~~i~~~ 232 (252)
+++++..
T Consensus 282 ~~ell~~ 288 (328)
T cd07856 282 AAEALAH 288 (328)
T ss_pred HHHHhcC
Confidence 9998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=226.45 Aligned_cols=209 Identities=23% Similarity=0.256 Sum_probs=172.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
++..-.++|-.+|++++.+.||.+--.|+..+.+|+|+..|+||||.-+|.+.+ ..+++..+.=.+.+|++||.+||.+
T Consensus 227 ~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~ 306 (591)
T KOG0986|consen 227 KGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR 306 (591)
T ss_pred hhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc
Confidence 445567899999999999999999888899999999999999999999997644 4588888888999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+||+||+||+|||+++.|+++|.|+|++..+..... ..+..||.+|||||++.+..|+...|-|||||++|+|+.
T Consensus 307 ---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~ 381 (591)
T KOG0986|consen 307 ---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIA 381 (591)
T ss_pred ---ceeeccCChhheeeccCCCeEeeccceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHc
Confidence 999999999999999999999999999998765443 334589999999999999999999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
|+.||......... +.+.... +.++..++...+....++....|..||.+|.--.
T Consensus 382 G~sPFr~~KeKvk~---eEvdrr~-------~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 382 GHSPFRQRKEKVKR---EEVDRRT-------LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ccCchhhhhhhhhH---HHHHHHH-------hcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 99999866433211 0111111 1233345555666677777799999999997543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=225.98 Aligned_cols=221 Identities=19% Similarity=0.228 Sum_probs=160.4
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEec----CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFD----VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
.+.+.+|+.+++++ +||||+++++.+.. ....+++++++. ++|.+++.. ...+++..++.++.||+.||.|||
T Consensus 45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH 122 (332)
T cd07857 45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIH 122 (332)
T ss_pred HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999 69999999987543 245789999985 689998854 456889999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc---ccccccCCccccccccccC-CCCCCcccchhHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR---TFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVV 156 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~ 156 (252)
+. +++|+||||+||+++.++.++++|||.+......... ......|+..|+|||...+ ..++.++|+||+|++
T Consensus 123 ~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~ 199 (332)
T cd07857 123 SA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCI 199 (332)
T ss_pred hC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHH
Confidence 99 9999999999999999999999999998765432211 1123457889999998765 468899999999999
Q ss_pred HHHHHhCCccccccchhhhHH-------------HHHHHH----HHHhcCCcccccccchhcHHHHHHHHHHHhhccCCC
Q 038713 157 LLEIVCLRRCLDQNLLEDRAI-------------LQEWIC----QCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDE 219 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~-------------~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 219 (252)
+|++++|..||.......... +..+.. .............-..........+.+++.+||+.|
T Consensus 200 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 279 (332)
T cd07857 200 LAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFD 279 (332)
T ss_pred HHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCC
Confidence 999999999997654321100 000000 000000000000000001112356788899999999
Q ss_pred CCCCCCHHHHHH
Q 038713 220 PSLRRAMKKVLL 231 (252)
Q Consensus 220 p~~Rps~~~i~~ 231 (252)
|++|||+.+++.
T Consensus 280 P~~R~t~~~ll~ 291 (332)
T cd07857 280 PTKRISVEEALE 291 (332)
T ss_pred cccCCCHHHHhc
Confidence 999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=218.60 Aligned_cols=192 Identities=18% Similarity=0.157 Sum_probs=152.8
Q ss_pred HHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 038713 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQII 88 (252)
Q Consensus 9 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~ 88 (252)
+.+|...+....||||+++++++.+....+++|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++
T Consensus 32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~ 107 (237)
T cd05576 32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHRE---GIV 107 (237)
T ss_pred hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 445666666668999999999999999999999999999999998643 3588999999999999999999999 999
Q ss_pred eeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCcccc
Q 038713 89 HGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLD 168 (252)
Q Consensus 89 h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 168 (252)
|+||||+||+++.++.++++|||.+....... ....++..|+|||...+..++.++|+||+|+++|++++|..|+.
T Consensus 108 H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 108 CRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred ccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 99999999999999999999999876543221 12234667999999988888999999999999999999998875
Q ss_pred ccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 169 QNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
...... .. .... ..+......+.+++.+||+.||++|||+
T Consensus 184 ~~~~~~------------~~--~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 184 CHPSGI------------NT--HTTL----NIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cCchhc------------cc--cccc----CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 432110 00 0000 1112223457778889999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-32 Score=225.11 Aligned_cols=222 Identities=22% Similarity=0.262 Sum_probs=164.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCC------cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVS------NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
..+.+.+|++++++++||||+++++++.... ..++|+||+ +++|.+++.. ..+++..++.++.|++.||.|
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~ 133 (343)
T cd07880 57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKY 133 (343)
T ss_pred HHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999987644 358999999 7799988853 458899999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVL 157 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l 157 (252)
||+. +++|+||+|+||+++.++.++++|||.+....... ....++..|+|||.+.+ ..++.++|+||||+++
T Consensus 134 LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll 206 (343)
T cd07880 134 IHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIM 206 (343)
T ss_pred HHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 9999 99999999999999999999999999987543221 22345778999998876 3578999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHH----------HHHhcCCcc-------ccc--ccchhcHHHHHHHHHHHhhccCC
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWIC----------QCFENGNLS-------QLV--EDEEVDQKQLQRMIKVGLRCILD 218 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~----------~~~~~~~~~-------~~~--~~~~~~~~~~~~l~~li~~cl~~ 218 (252)
|++++|..||........ ...... ..+...... ... ............+.+++.+|++.
T Consensus 207 ~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 284 (343)
T cd07880 207 AEMLTGKPLFKGHDHLDQ--LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVL 284 (343)
T ss_pred HHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCC
Confidence 999999999975533211 110000 000000000 000 00001112234578899999999
Q ss_pred CCCCCCCHHHHH--HHhhcCcC
Q 038713 219 EPSLRRAMKKVL--LMLEGTVE 238 (252)
Q Consensus 219 ~p~~Rps~~~i~--~~l~~~~~ 238 (252)
||++|||+.+++ ..++...+
T Consensus 285 dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 285 DAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred ChhhCCCHHHHhcCccHhhhcC
Confidence 999999999998 55555433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=228.25 Aligned_cols=213 Identities=24% Similarity=0.304 Sum_probs=162.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCc------EEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSN------KILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
..+.+.+|+.++++++|||++++.+++..... .++|+||+ +++|.+++.. ..+++..++.++.|++.||.|
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~ 133 (343)
T cd07851 57 HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKY 133 (343)
T ss_pred HHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999998776544 89999999 6799998854 458999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVL 157 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l 157 (252)
||+. +++|+||+|+||+++.++.++++|||.+...... .....++..|+|||...+ ..++.++|+||||+++
T Consensus 134 LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l 206 (343)
T cd07851 134 IHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206 (343)
T ss_pred HHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHH
Confidence 9999 9999999999999999999999999998765332 122346778999998765 3678999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCccc----------------c--ccc---chhcHHHHHHHHHHHhhcc
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQ----------------L--VED---EEVDQKQLQRMIKVGLRCI 216 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~--~~~---~~~~~~~~~~l~~li~~cl 216 (252)
|++++|+.||.......... . +..... ..... . ... ..........+.+++.+||
T Consensus 207 ~elltg~~pf~~~~~~~~~~--~-i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l 282 (343)
T cd07851 207 AELLTGKTLFPGSDHIDQLK--R-IMNLVG-TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKML 282 (343)
T ss_pred HHHHhCCCCCCCCChHHHHH--H-HHHhcC-CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhC
Confidence 99999999997553322111 0 000000 00000 0 000 0001112456889999999
Q ss_pred CCCCCCCCCHHHHHH
Q 038713 217 LDEPSLRRAMKKVLL 231 (252)
Q Consensus 217 ~~~p~~Rps~~~i~~ 231 (252)
+.+|++|||+.+|+.
T Consensus 283 ~~~P~~Rpt~~ell~ 297 (343)
T cd07851 283 VLDPDKRITAAEALA 297 (343)
T ss_pred CCChhhCCCHHHHhc
Confidence 999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=213.92 Aligned_cols=238 Identities=18% Similarity=0.235 Sum_probs=179.7
Q ss_pred HHHHHHHHHhCCCCCCCcceeeeEec--------CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 8 EFKTEMNAIGRTHHRNPVRLLGYSFD--------VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
...+|+++|+.+.|+|++.++++|.. ...+|+||.+|+. +|...+......++..++.++..++..||.|+
T Consensus 62 talreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i 140 (376)
T KOG0669|consen 62 TALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI 140 (376)
T ss_pred HHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHH
Confidence 35699999999999999999998863 3458999999976 89999987777899999999999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC---cccccccCCccccccccccCC-CCCCcccchhHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT---RTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGV 155 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~ 155 (252)
|+. .|+|||+|+.|++++.+|.++++|||+++.+..... ........|.+|++||.+.|. .++++.|+|+.||
T Consensus 141 Hr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgC 217 (376)
T KOG0669|consen 141 HRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGC 217 (376)
T ss_pred HHh---hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHH
Confidence 999 999999999999999999999999999975532221 223334568899999999986 5899999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccc---------------------hhcHHHHHHHHHHHhh
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDE---------------------EVDQKQLQRMIKVGLR 214 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~l~~li~~ 214 (252)
++.+|+++.+-++++....+..++..........-|.....-. ..+........+++.+
T Consensus 218 imaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ 297 (376)
T KOG0669|consen 218 IMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEK 297 (376)
T ss_pred HHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHH
Confidence 9999999999999887776666554433222211111111000 0011111245677779
Q ss_pred ccCCCCCCCCCHHHHHHHhhcCcCCCCC-CCCCCCCC
Q 038713 215 CILDEPSLRRAMKKVLLMLEGTVEIPIP-QNPTSFLS 250 (252)
Q Consensus 215 cl~~~p~~Rps~~~i~~~l~~~~~~~~~-~~~~~~~~ 250 (252)
++..||++|+++.++++.---.. .|+| ++-...+|
T Consensus 298 ll~~DP~kR~~ad~alnh~~F~k-dp~pqanl~~ml~ 333 (376)
T KOG0669|consen 298 LLKLDPTKRIDADQALNHDFFWK-DPMPQANLQDMLS 333 (376)
T ss_pred HhccCcccCcchHhhhchhhhhc-CCcchhhHHHHHH
Confidence 99999999999999987654433 3444 44443333
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=227.97 Aligned_cols=221 Identities=19% Similarity=0.235 Sum_probs=158.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecC--------------CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDV--------------SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIAR 70 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~ 70 (252)
..+.+.+|++++++++||||+++++++... ...++|+||+. ++|.+++.. ..+++..++.++.
T Consensus 45 ~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~ 121 (342)
T cd07854 45 SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMY 121 (342)
T ss_pred hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHH
Confidence 456788999999999999999999876643 35789999996 589888843 3578899999999
Q ss_pred HHHHHHHHHhhcCCCCeeeeccCCCCEEec-CCCceEEcccCcccccCCCCC--cccccccCCccccccccccC-CCCCC
Q 038713 71 DIARGIRYLHDECEAQIIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRN-LPITV 146 (252)
Q Consensus 71 ~i~~~l~~lh~~~~~~i~h~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~ 146 (252)
||+.||.|||+. +++|+||||+||+++ .++.++++|||.+........ .......++..|+|||.+.+ ..++.
T Consensus 122 qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 198 (342)
T cd07854 122 QLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTK 198 (342)
T ss_pred HHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCc
Confidence 999999999999 999999999999997 456789999999876532211 11122346778999997654 45788
Q ss_pred cccchhHHHHHHHHHhCCccccccchhhhHHHHH-------------H---HHHHHhcCCcccccccchhcHHHHHHHHH
Q 038713 147 KADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQE-------------W---ICQCFENGNLSQLVEDEEVDQKQLQRMIK 210 (252)
Q Consensus 147 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------------~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 210 (252)
++|+||||+++|++++|+.||............. . ..........................+.+
T Consensus 199 ~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (342)
T cd07854 199 AIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALD 278 (342)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHH
Confidence 9999999999999999999997554322111000 0 00000000000000000111122355778
Q ss_pred HHhhccCCCCCCCCCHHHHHH
Q 038713 211 VGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 211 li~~cl~~~p~~Rps~~~i~~ 231 (252)
++.+||..||++|||+.+++.
T Consensus 279 li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 279 FLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHhCCCchhccCHHHHhC
Confidence 899999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-33 Score=240.03 Aligned_cols=220 Identities=25% Similarity=0.363 Sum_probs=187.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
++-+.+++|+.+|.++.|||++|+++++..+. +-+|++|+++|+|.+|+...+..+.....+.|+.||++|+.|||++
T Consensus 740 ~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q- 817 (1177)
T KOG1025|consen 740 KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ- 817 (1177)
T ss_pred hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc-
Confidence 45678999999999999999999999999876 8899999999999999988888899999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||-.+|+||.....+|+.|||+++...++... ...+..-.+.|+|-|.+....++.++||||+|+++||++|
T Consensus 818 --rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmT 895 (1177)
T KOG1025|consen 818 --RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMT 895 (1177)
T ss_pred --chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHh
Confidence 9999999999999999999999999999987655442 2223334567999999999999999999999999999996
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCCC
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIP 240 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 240 (252)
|..|++....++ +...++.|.. ...++-+..++.-++.+||..|++.||+++++...+.+....|
T Consensus 896 FGa~Py~gi~~~e-------I~dlle~geR------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 896 FGAKPYDGIPAEE-------IPDLLEKGER------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred cCCCccCCCCHHH-------hhHHHhcccc------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 778887765554 3333444433 1346667778999999999999999999999999988854443
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=222.86 Aligned_cols=216 Identities=22% Similarity=0.281 Sum_probs=159.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecC------CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDV------SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
..+.+.+|+.++++++||||+++++++... +..+++++++ +++|.+++.. +.+++..++.++.|++.||.|
T Consensus 59 ~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~ 135 (345)
T cd07877 59 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKY 135 (345)
T ss_pred HHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999988642 4578888887 7899888743 348899999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVL 157 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l 157 (252)
||+. +++|+||+|+||+++.++.++++|||.+...... .....++..|+|||.+.+ ..++.++|+||||+++
T Consensus 136 LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il 208 (345)
T cd07877 136 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 208 (345)
T ss_pred HHHC---CeeecCCChHHEEEcCCCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHH
Confidence 9999 9999999999999999999999999998754322 122456788999998876 4678899999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHH----------HhcC-------Ccccccccc--hhcHHHHHHHHHHHhhccCC
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQC----------FENG-------NLSQLVEDE--EVDQKQLQRMIKVGLRCILD 218 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~-------~~~~~~~~~--~~~~~~~~~l~~li~~cl~~ 218 (252)
|++++|+.||.......... ...... .... ......... .........+.+++.+|++.
T Consensus 209 ~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 286 (345)
T cd07877 209 AELLTGRTLFPGTDHIDQLK--LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL 286 (345)
T ss_pred HHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCC
Confidence 99999999996543322111 000000 0000 000000000 00001234577888899999
Q ss_pred CCCCCCCHHHHHHH
Q 038713 219 EPSLRRAMKKVLLM 232 (252)
Q Consensus 219 ~p~~Rps~~~i~~~ 232 (252)
+|.+|||+.++++.
T Consensus 287 dp~~R~t~~e~l~h 300 (345)
T cd07877 287 DSDKRITAAQALAH 300 (345)
T ss_pred ChhhcCCHHHHhcC
Confidence 99999999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=231.72 Aligned_cols=225 Identities=24% Similarity=0.315 Sum_probs=169.4
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCC------cEEEEEecCCCCCHHhhhcCCC--CCCCHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVS------NKILVYDYMSNGSLVDVLFTPE--KQPNWVERMGIARDIARG 75 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~ 75 (252)
..++.-.+|+++|++++|||||+++++-++.. ...++||||.||||...+.++. ..+++.+.+.++.+++.|
T Consensus 53 r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~a 132 (732)
T KOG4250|consen 53 RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSA 132 (732)
T ss_pred chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHH
Confidence 34667789999999999999999999877644 5679999999999999997754 458999999999999999
Q ss_pred HHHHhhcCCCCeeeeccCCCCEEecCC--C--ceEEcccCcccccCCCCCcccccccCCcccccccccc-CCCCCCcccc
Q 038713 76 IRYLHDECEAQIIHGDIKPQNILMDEK--R--CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-NLPITVKADV 150 (252)
Q Consensus 76 l~~lh~~~~~~i~h~di~~~nil~~~~--~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di 150 (252)
+.|||+. +|+||||||.||++... | ..|++|||.++...+.. .+....||..|++||+.. ...|+..+|.
T Consensus 133 l~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDL 207 (732)
T KOG4250|consen 133 LRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDL 207 (732)
T ss_pred HHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeeh
Confidence 9999999 99999999999998533 3 36999999999876555 556688999999999988 4688999999
Q ss_pred hhHHHHHHHHHhCCccccccchhhhHHHHHHHHH------------HHhcCCccc---ccccchhcHHHHHHHHHHHhhc
Q 038713 151 YSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQ------------CFENGNLSQ---LVEDEEVDQKQLQRMIKVGLRC 215 (252)
Q Consensus 151 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~c 215 (252)
||||+++|+++||..||..........-.-|... ...+|+... +..+..........+-+++..+
T Consensus 208 WS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~ 287 (732)
T KOG4250|consen 208 WSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASM 287 (732)
T ss_pred hhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHH
Confidence 9999999999999999975533321110111100 111111111 0111133445556677778888
Q ss_pred cCCCCCCCC--CHHHHHHHh
Q 038713 216 ILDEPSLRR--AMKKVLLML 233 (252)
Q Consensus 216 l~~~p~~Rp--s~~~i~~~l 233 (252)
|..+|++|- ...+.-..+
T Consensus 288 L~~~~~~~~~~~~~~~Fa~~ 307 (732)
T KOG4250|consen 288 LEWNPRKRGHEGFDRFFAEV 307 (732)
T ss_pred HhhhHHHhCCCCcchHHHHH
Confidence 999999998 444443333
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=219.14 Aligned_cols=235 Identities=24% Similarity=0.336 Sum_probs=176.2
Q ss_pred hHhHHHHHHHHHHHhCC--CCCCCcceeeeEecCC----cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRT--HHRNPVRLLGYSFDVS----NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l 76 (252)
.+.++.|.+|-++.+.. .|+||+++++.-.... .+++|++|.+.|+|.+||+. ..++|.+..+++..++.||
T Consensus 243 ~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGL 320 (534)
T KOG3653|consen 243 EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGL 320 (534)
T ss_pred HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHH
Confidence 46788899999998754 9999999999877554 78999999999999999953 3589999999999999999
Q ss_pred HHHhhc------CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCC-CC---
Q 038713 77 RYLHDE------CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLP-IT--- 145 (252)
Q Consensus 77 ~~lh~~------~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~-~~--- 145 (252)
+|||+. .++.|+|||||.+||||.+++++.|+|||++..+.+... ....+.+||.+|||||++.|.- ..
T Consensus 321 a~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~ 400 (534)
T KOG3653|consen 321 AHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRD 400 (534)
T ss_pred HHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHH
Confidence 999986 367899999999999999999999999999998765443 2233478999999999988753 22
Q ss_pred --CcccchhHHHHHHHHHhCCccccc-------cchh----hhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHH
Q 038713 146 --VKADVYSFGVVLLEIVCLRRCLDQ-------NLLE----DRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVG 212 (252)
Q Consensus 146 --~~~Di~slG~~l~~l~~g~~p~~~-------~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 212 (252)
.+.||||+|.++||++++-.-++. ...+ ..-.+.+....++.......+.+.. ........+.+.+
T Consensus 401 Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W-~~h~~~~~l~et~ 479 (534)
T KOG3653|consen 401 AFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAW-RKHAGMAVLCETI 479 (534)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhh-hcCccHHHHHHHH
Confidence 468999999999999986433321 0011 0111222222222222222222221 1224566688889
Q ss_pred hhccCCCCCCCCCHHHHHHHhhcCcCCC
Q 038713 213 LRCILDEPSLRRAMKKVLLMLEGTVEIP 240 (252)
Q Consensus 213 ~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 240 (252)
..||+.||+-|.|+.=+.+++.+..-..
T Consensus 480 EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 480 EECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 9999999999999999999988854443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=214.10 Aligned_cols=232 Identities=25% Similarity=0.287 Sum_probs=181.4
Q ss_pred hHhHHHHHHHHHHHhCC--CCCCCcceeeeEecCC----cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRT--HHRNPVRLLGYSFDVS----NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l 76 (252)
+..++.+.+|.++++.+ +|+||+.+++.-..++ .+++|++|.+.|||.|||.. ..++.+..++++..+++||
T Consensus 244 srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGL 321 (513)
T KOG2052|consen 244 SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGL 321 (513)
T ss_pred ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhH
Confidence 44567889999999865 9999999998765433 57999999999999999965 5588999999999999999
Q ss_pred HHHhhc-----CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc---ccccccCCccccccccccCCC-----
Q 038713 77 RYLHDE-----CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR---TFTGIRGTRAYVAAEWHRNLP----- 143 (252)
Q Consensus 77 ~~lh~~-----~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~----- 143 (252)
++||-. .++.|+|||||..||+|.+++.+.|+|+|++......... ......||.+|||||++...-
T Consensus 322 aHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~F 401 (513)
T KOG2052|consen 322 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHF 401 (513)
T ss_pred HHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhh
Confidence 999986 3688999999999999999999999999999876544321 223467999999999987532
Q ss_pred -CCCcccchhHHHHHHHHHhC----------CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHH
Q 038713 144 -ITVKADVYSFGVVLLEIVCL----------RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVG 212 (252)
Q Consensus 144 -~~~~~Di~slG~~l~~l~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 212 (252)
--..+||||||+++||++-+ +.||...-+.+. .+ +...+.+-..+.+..+++.-.+.+....+.++|
T Consensus 402 esyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP-s~-eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klM 479 (513)
T KOG2052|consen 402 ESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP-SF-EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLM 479 (513)
T ss_pred hhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC-CH-HHHhcceeecccCCCCCcccccCHHHHHHHHHH
Confidence 12568999999999999642 246654322221 11 123344444555555555555667788899999
Q ss_pred hhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 213 LRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 213 ~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
+-||..||.-|.|+-.|-..|.+..+
T Consensus 480 keCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 480 KECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 99999999999999999999988664
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=228.84 Aligned_cols=106 Identities=26% Similarity=0.384 Sum_probs=98.2
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++||||+++++.+......|+||||+.+++|.+++.. .+.+++..++.++.||+.||.|||..
T Consensus 47 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~-- 123 (669)
T cd05610 47 MVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRH-- 123 (669)
T ss_pred HHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 457889999999999999999999999999999999999999999999954 34578888999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAK 114 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~ 114 (252)
+|+|+||||+|||++.++.++|+|||+++
T Consensus 124 -gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 124 -GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred -CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=203.75 Aligned_cols=201 Identities=22% Similarity=0.209 Sum_probs=160.5
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
..--..|-++|+..+||.+..+--.|+.+..+|+||||+.||.|.-+++. .+.+++....=....|+.||.|||++
T Consensus 212 VAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~--- 287 (516)
T KOG0690|consen 212 VAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSR--- 287 (516)
T ss_pred hhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhC---
Confidence 33446788999999999999888889999999999999999999999955 44577777777889999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
+|++||+|.+|.+++.+|++|+.|||+.+...... ...+...||+.|+|||++....|..+.|-|.+|+++|+|++|+.
T Consensus 288 ~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRL 366 (516)
T KOG0690|consen 288 NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRL 366 (516)
T ss_pred CeeeeechhhhheeccCCceEeeecccchhccccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccC
Confidence 99999999999999999999999999987543222 33345679999999999999999999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
||...+-+.-..+ +..+.++ .++...+ ....|+.-.|.+||++|.-
T Consensus 367 PFyn~dh~kLFeL-------Il~ed~k---FPr~ls~----eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 367 PFYNKDHEKLFEL-------ILMEDLK---FPRTLSP----EAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred cccccchhHHHHH-------HHhhhcc---CCccCCH----HHHHHHHHHhhcChHhhcC
Confidence 9987644432211 1122221 1222222 2455555889999999973
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=205.25 Aligned_cols=220 Identities=23% Similarity=0.262 Sum_probs=168.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEec------CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFD------VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
...++.++|...+..++|+||+++++++.- -.+.|+|||++ .++|.+.+. ..++-+++..++.|+++|++
T Consensus 57 ~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik 132 (369)
T KOG0665|consen 57 THAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIK 132 (369)
T ss_pred ccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHH
Confidence 345677899999999999999999999984 34679999999 558999886 34677888899999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 157 (252)
+||+. +|+|||+||+||.++.+..+|+.|||.++..... ........+.-|+|||++.+..+....||||+||++
T Consensus 133 ~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~ 207 (369)
T KOG0665|consen 133 HLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 207 (369)
T ss_pred HHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHH
Confidence 99999 9999999999999999999999999999865443 345566778899999999999999999999999999
Q ss_pred HHHHhCCccccccchhhhHHH----------------HHHHHHHHh------cCCcccccccc------hhcHHHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRAIL----------------QEWICQCFE------NGNLSQLVEDE------EVDQKQLQRMI 209 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~----------------~~~~~~~~~------~~~~~~~~~~~------~~~~~~~~~l~ 209 (252)
.+|++|..-|.+.+--++... ...+..+.. .-.......+. +.+........
T Consensus 208 gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ar 287 (369)
T KOG0665|consen 208 GELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLAR 287 (369)
T ss_pred HHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHH
Confidence 999999998875533332221 111111111 01111111111 11112233455
Q ss_pred HHHhhccCCCCCCCCCHHHHHHH
Q 038713 210 KVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 210 ~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
+++.+||-.||++|.|++++++-
T Consensus 288 dll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 288 DLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhccChhhcccHHHHhcC
Confidence 66669999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=226.58 Aligned_cols=211 Identities=26% Similarity=0.324 Sum_probs=162.3
Q ss_pred hHhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCC---CCHHHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQ---PNWVERMGIARDIARGIRY 78 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~i~~~i~~~l~~ 78 (252)
.+-.....+|+..|+.- .|||||++++.-.+.+.+|+..|.|. .+|.+++...... ......+.+..|+++||++
T Consensus 543 ~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaH 621 (903)
T KOG1027|consen 543 EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAH 621 (903)
T ss_pred hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHH
Confidence 34455678999999998 89999999999999999999999994 5999999663111 1113446788999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecC---C--CceEEcccCcccccCCCCC--cccccccCCccccccccccCCCCCCcccch
Q 038713 79 LHDECEAQIIHGDIKPQNILMDE---K--RCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNLPITVKADVY 151 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~---~--~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 151 (252)
||+. +|+|||+||.|||+.. + ..++|.|||+++.+..... ....+..|+.+|+|||++.....+.+.|||
T Consensus 622 LHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiF 698 (903)
T KOG1027|consen 622 LHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIF 698 (903)
T ss_pred HHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchh
Confidence 9998 9999999999999975 2 3578999999998765433 344567899999999999998888999999
Q ss_pred hHHHHHHHHHhC-CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 152 SFGVVLLEIVCL-RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 152 slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
|+||++|+.++| ..||+....++...+ ..+.....+... ...+ ..+||.+|++++|..||+|.+|+
T Consensus 699 slGCvfyYvltgG~HpFGd~~~R~~NIl-------~~~~~L~~L~~~---~d~e---A~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 699 SLGCVFYYVLTGGSHPFGDSLERQANIL-------TGNYTLVHLEPL---PDCE---AKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred hcCceEEEEecCCccCCCchHHhhhhhh-------cCccceeeeccC---chHH---HHHHHHHhcCCCcccCCCHHHHh
Confidence 999999999987 789987755532111 111122222111 1113 45556699999999999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=222.00 Aligned_cols=215 Identities=22% Similarity=0.280 Sum_probs=174.3
Q ss_pred chHhHHHHHHHHHHHhCC-CCCCCcceeeeEe-----cCCcEEEEEecCCCCCHHhhhcC-CCCCCCHHHHHHHHHHHHH
Q 038713 2 LAEGEREFKTEMNAIGRT-HHRNPVRLLGYSF-----DVSNKILVYDYMSNGSLVDVLFT-PEKQPNWVERMGIARDIAR 74 (252)
Q Consensus 2 ~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~ 74 (252)
+.+..+.+..|.++++.. .|||++++++++. .++.+++|||||.|||..++++. .+....+..+..|+..++.
T Consensus 55 ~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lr 134 (953)
T KOG0587|consen 55 TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILR 134 (953)
T ss_pred CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHH
Confidence 345567788899999988 8999999999987 36789999999999999999965 3556888888999999999
Q ss_pred HHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-----CCCCccc
Q 038713 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-----PITVKAD 149 (252)
Q Consensus 75 ~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~D 149 (252)
|+.+||.. .++|||||-.|||++.++.+|++|||++.......... ....||+.|||||++... .|+.++|
T Consensus 135 gl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grR-nT~iGtP~WMAPEViac~e~~d~tyd~R~D 210 (953)
T KOG0587|consen 135 GLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRR-NTFIGTPYWMAPEVIACDESPDATYDYRSD 210 (953)
T ss_pred HHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecccccc-cCcCCCcccccceeeecccCCCCCcccccc
Confidence 99999999 99999999999999999999999999998766544333 336789999999998753 3678999
Q ss_pred chhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 150 VYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 150 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
+||||++..||.-|.+|+-....-.-. ... .+.+......+....+.+.++|..||.+|...||+..++
T Consensus 211 ~WsLGITaIEladG~PPl~DmHPmraL------F~I-----pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~l 279 (953)
T KOG0587|consen 211 LWSLGITAIEMAEGAPPLCDMHPMRAL------FLI-----PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEEL 279 (953)
T ss_pred hhhccceeehhcCCCCCccCcchhhhh------ccC-----CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence 999999999999999998655433210 000 111111123466677889999999999999999999988
Q ss_pred HH
Q 038713 230 LL 231 (252)
Q Consensus 230 ~~ 231 (252)
++
T Consensus 280 l~ 281 (953)
T KOG0587|consen 280 LK 281 (953)
T ss_pred cc
Confidence 75
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=187.47 Aligned_cols=219 Identities=18% Similarity=0.211 Sum_probs=168.0
Q ss_pred HHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 038713 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQI 87 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i 87 (252)
...+|+-+++.+.|.|||+++++...++.+-+|+|||+. +|..+..+-++.++.+.+...+.|++.|+.|+|++ ++
T Consensus 47 salreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nv 122 (292)
T KOG0662|consen 47 SALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NV 122 (292)
T ss_pred HHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hh
Confidence 467999999999999999999999999999999999955 89999988888899999999999999999999999 99
Q ss_pred eeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC-CCCcccchhHHHHHHHHHhCCcc
Q 038713 88 IHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP-ITVKADVYSFGVVLLEIVCLRRC 166 (252)
Q Consensus 88 ~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p 166 (252)
.|||+||.|.+++.+|..|++|||+++-+.-+.. ..+....|.+|++|.++.|.+ |+...|+||.||++.|+...++|
T Consensus 123 lhrdlkpqnllin~ngelkladfglarafgipvr-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 123 LHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred hhccCCcceEEeccCCcEEecccchhhhcCCceE-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence 9999999999999999999999999987654332 233445688999999998875 89999999999999999865555
Q ss_pred c-cccchhhhHHHHHHHHHHHhcCCcccccccc---------------hhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 167 L-DQNLLEDRAILQEWICQCFENGNLSQLVEDE---------------EVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 167 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
. .+++..++...+-++.....+..+..+..-. ...+.....=.+++.+.+.-+|..|.|++..+
T Consensus 202 lfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 202 LFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred CCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 4 4444443333322222222222222211111 11112223344566688888999999999876
Q ss_pred H
Q 038713 231 L 231 (252)
Q Consensus 231 ~ 231 (252)
+
T Consensus 282 q 282 (292)
T KOG0662|consen 282 Q 282 (292)
T ss_pred c
Confidence 5
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=207.35 Aligned_cols=217 Identities=24% Similarity=0.275 Sum_probs=167.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEe-cCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+-..+|.++-+.|.||.||++|+++. +...+|-|.|||+|.+|.-|++ ..+..++.++..|+.||+.||.||.+.
T Consensus 510 YhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEi- 587 (775)
T KOG1151|consen 510 YHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEI- 587 (775)
T ss_pred HHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhcc-
Confidence 3456679999999999999999999986 5678899999999999999994 556789999999999999999999986
Q ss_pred CCCeeeeccCCCCEEecC---CCceEEcccCcccccCCCCCc------ccccccCCccccccccccC----CCCCCcccc
Q 038713 84 EAQIIHGDIKPQNILMDE---KRCAKISDFGLAKLMKPDQTR------TFTGIRGTRAYVAAEWHRN----LPITVKADV 150 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~----~~~~~~~Di 150 (252)
+..|+|-|+||.|||+.+ .|.+||.|||+++.+..+... .-+...||.+|++||.|.- .+.+.+.||
T Consensus 588 kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDV 667 (775)
T KOG1151|consen 588 KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDV 667 (775)
T ss_pred CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceee
Confidence 789999999999999854 477999999999988654432 2234569999999998753 247899999
Q ss_pred hhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 151 YSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 151 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
||+|+++|.++.|+-||+.+....+-.-.+ ..+....... .+........ ..+|++||.+.-++|.+..++.
T Consensus 668 WSvGVIFyQClYGrKPFGhnqsQQdILqeN---TIlkAtEVqF--P~KPvVsseA---kaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 668 WSVGVIFYQCLYGRKPFGHNQSQQDILQEN---TILKATEVQF--PPKPVVSSEA---KAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred EeeehhhhhhhccCCCCCCchhHHHHHhhh---chhcceeccC--CCCCccCHHH---HHHHHHHHHhhhhhhhhHHHHc
Confidence 999999999999999999875553211111 1122222221 1222333334 4455599999999998887765
Q ss_pred H
Q 038713 231 L 231 (252)
Q Consensus 231 ~ 231 (252)
.
T Consensus 740 ~ 740 (775)
T KOG1151|consen 740 C 740 (775)
T ss_pred c
Confidence 3
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=216.55 Aligned_cols=209 Identities=20% Similarity=0.269 Sum_probs=168.5
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL-FTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
+.+..++.+|+.+|+++.||.||.+.-.|+.....++|||-+. |+...+| ....+.++++.-.=++.||+.||+|||.
T Consensus 604 ~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~ 682 (888)
T KOG4236|consen 604 TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHF 682 (888)
T ss_pred CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh
Confidence 3456889999999999999999999999999999999999995 4665555 4556778888777788999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCC---CceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEK---RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
+ +|+|+|+||+|+|+.+. ..+|++|||+++.+...... ....||+.|+|||++....|+..-|+||.|+++|
T Consensus 683 k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR--rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiY 757 (888)
T KOG4236|consen 683 K---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR--RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIY 757 (888)
T ss_pred c---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh--hhhcCCccccCHHHHhhccccccccceeeeEEEE
Confidence 9 99999999999999754 46899999999988755433 3478999999999999999999999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
.-++|..||....+-. ..+++..+....++ ..+.....+++|...|+..-.+|-|.+.-
T Consensus 758 VsLSGTFPFNEdEdIn---------dQIQNAaFMyPp~P---W~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 758 VSLSGTFPFNEDEDIN---------DQIQNAAFMYPPNP---WSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred EEecccccCCCccchh---------HHhhccccccCCCc---hhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 9999999997653332 22333333333333 33334446777778888888888887764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=200.01 Aligned_cols=216 Identities=19% Similarity=0.261 Sum_probs=175.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEe-cCCcEEEEEecCCCCCHHhhhc-----CCC--CCCCHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLF-----TPE--KQPNWVERMGIARDIARGI 76 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~-----~~~--~~~~~~~~~~i~~~i~~~l 76 (252)
+...+..|.-.+..++|||+..+.+++. +....++++.+..-|+|..++. +.. +..+..+...++.|++.|+
T Consensus 330 Qv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am 409 (563)
T KOG1024|consen 330 QVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAM 409 (563)
T ss_pred HHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999876 4667889999998899999996 222 3467778889999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccc-cccCCccccccccccCCCCCCcccchhHHH
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT-GIRGTRAYVAAEWHRNLPITVKADVYSFGV 155 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 155 (252)
.|||++ +++|.||..+|+.+++.-++|++|-.+++..-+..-...+ ....+..||+||.+....++.++|+||||+
T Consensus 410 ~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGV 486 (563)
T KOG1024|consen 410 EHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGV 486 (563)
T ss_pred HHHHhc---CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHH
Confidence 999999 9999999999999999999999999888855433322211 233566899999999999999999999999
Q ss_pred HHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 156 VLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 156 ~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
++||++| |+.|+..-++.+ ...+++.|..-. .+..++..++.++.-||...|++|||++|+...|+
T Consensus 487 llWELmtlg~~PyaeIDPfE-------m~~ylkdGyRla------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 487 LLWELMTLGKLPYAEIDPFE-------MEHYLKDGYRLA------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred HHHHHHhcCCCCccccCHHH-------HHHHHhccceec------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 9999987 677876655544 334455555433 24455667999999999999999999999999998
Q ss_pred cC
Q 038713 235 GT 236 (252)
Q Consensus 235 ~~ 236 (252)
+.
T Consensus 554 eF 555 (563)
T KOG1024|consen 554 EF 555 (563)
T ss_pred HH
Confidence 73
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=234.10 Aligned_cols=197 Identities=18% Similarity=0.198 Sum_probs=140.6
Q ss_pred HhCCCC-CCCcceeeeEe-------cCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 038713 16 IGRTHH-RNPVRLLGYSF-------DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQI 87 (252)
Q Consensus 16 l~~l~h-~~iv~~~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i 87 (252)
.+.++| +||+++++++. +......++|++ +++|.+++......+++.+++.++.||++||.|||++ +|
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 455677 68888999872 334567788987 6699999976666789999999999999999999999 99
Q ss_pred eeeccCCCCEEecCCC-------------------ceEEcccCcccccCCCCC---------------cccccccCCccc
Q 038713 88 IHGDIKPQNILMDEKR-------------------CAKISDFGLAKLMKPDQT---------------RTFTGIRGTRAY 133 (252)
Q Consensus 88 ~h~di~~~nil~~~~~-------------------~~~l~d~~~~~~~~~~~~---------------~~~~~~~~~~~~ 133 (252)
+||||||+|||++..+ .++++|||.++....... .......|++.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 455666666543211000 000113467889
Q ss_pred cccccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHh
Q 038713 134 VAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGL 213 (252)
Q Consensus 134 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 213 (252)
+|||++.+..++.++|||||||++|||++|..|+...... ..... .... .+ ...........++.
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~~-----~~~~----~~--~~~~~~~~~~~~~~ 246 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSLR-----HRVL----PP--QILLNWPKEASFCL 246 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHHH-----Hhhc----Ch--hhhhcCHHHHHHHH
Confidence 9999999989999999999999999999988876432111 11110 0000 00 00111223457778
Q ss_pred hccCCCCCCCCCHHHHHH
Q 038713 214 RCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 214 ~cl~~~p~~Rps~~~i~~ 231 (252)
+||+++|.+|||+.|+++
T Consensus 247 ~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HhCCCChhhCcChHHHhh
Confidence 999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=188.15 Aligned_cols=167 Identities=23% Similarity=0.223 Sum_probs=126.5
Q ss_pred CCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCccccc
Q 038713 47 GSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG 126 (252)
Q Consensus 47 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 126 (252)
|+|.+++...++.+++..++.++.|++.||.|||+. + ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 689999976666799999999999999999999998 6 999999999999998 99887654322
Q ss_pred ccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHH-
Q 038713 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQL- 205 (252)
Q Consensus 127 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 205 (252)
..|+..|+|||++.+..++.++||||||+++|+|++|+.||....... ..+... ... ................
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~----~~~-~~~~~~~~~~~~~~~~~ 137 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEIL----LNG-MPADDPRDRSNLESVSA 137 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHH----HHH-hccCCccccccHHHHHh
Confidence 246889999999999999999999999999999999999996543221 111111 111 1111000001111222
Q ss_pred -HHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 206 -QRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 206 -~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
..+.+++.+||+.+|++|||+.++++.+...
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2588899999999999999999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=225.60 Aligned_cols=180 Identities=27% Similarity=0.427 Sum_probs=136.7
Q ss_pred EEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCccccc
Q 038713 37 KILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116 (252)
Q Consensus 37 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~ 116 (252)
+||=||||+...+.+++..+...-.....|+++.+|++||+|+|++ |++||||||.|||+++++.|||+|||++...
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDL 747 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhh
Confidence 5788999999777777755443336788999999999999999999 9999999999999999999999999999862
Q ss_pred C----------C-------CCCcccccccCCccccccccccCCC---CCCcccchhHHHHHHHHHhCCccccccchhhhH
Q 038713 117 K----------P-------DQTRTFTGIRGTRAYVAAEWHRNLP---ITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRA 176 (252)
Q Consensus 117 ~----------~-------~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 176 (252)
. . .......+..||.-|+|||++.+.. |+.|+|+||||+++|||+ .||.....+.
T Consensus 748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa-- 822 (1351)
T KOG1035|consen 748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERA-- 822 (1351)
T ss_pred hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHH--
Confidence 1 0 0111334567899999999988765 999999999999999997 4476654442
Q ss_pred HHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 177 ILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
. +...++.+.+... .....+....-.++|++|++.||.+||||.|+++
T Consensus 823 ---~-iL~~LR~g~iP~~---~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 823 ---S-ILTNLRKGSIPEP---ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ---H-HHHhcccCCCCCC---cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 1 2223344444333 2223333344567788999999999999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=211.16 Aligned_cols=204 Identities=20% Similarity=0.212 Sum_probs=167.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.+.+-...|-++|..+++|.||++|--|.+++.+|++||-|-||.|+..+.. ++.++..+..=++..+++|+.|||++
T Consensus 462 kQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k- 539 (732)
T KOG0614|consen 462 KQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRK- 539 (732)
T ss_pred hHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhc-
Confidence 4555678999999999999999999999999999999999999999999954 44567677777888999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+|++||+||+|.+++.+|-+|+.|||+++.+...... ....||+.|+|||++.....+.+.|.||||+++||+++|
T Consensus 540 --~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT--wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G 615 (732)
T KOG0614|consen 540 --GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT--WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTG 615 (732)
T ss_pred --CceeccCChhheeeccCCceEEeehhhHHHhccCCce--eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcC
Confidence 9999999999999999999999999999987644332 235689999999999999999999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
.+||...+.-... +.+.+-+..-. .+....+...++|++....+|.+|.-
T Consensus 616 ~pPFs~~dpmktY---n~ILkGid~i~---------~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 616 SPPFSGVDPMKTY---NLILKGIDKIE---------FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred CCCCCCCchHHHH---HHHHhhhhhhh---------cccccchhHHHHHHHHHhcCcHhhhc
Confidence 9999876444322 22222222211 23333445667777888899999986
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=199.59 Aligned_cols=215 Identities=23% Similarity=0.294 Sum_probs=166.0
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT----PEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
..++|..|.++..+- +.||||++||.....+..++.||.|+- ||..+-+. .+..+++..+-.+..-.+.||.||
T Consensus 105 eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yL 183 (361)
T KOG1006|consen 105 EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYL 183 (361)
T ss_pred HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHH
Confidence 456788898886665 889999999999999999999999954 66554422 345578888778888889999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC--CCCCcccchhHHHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL--PITVKADVYSFGVVL 157 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l 157 (252)
.+. ..++|||+||+|||++..|.+|++|||......+.... ....|-.+|+|||.+... .|+-++|+||||+++
T Consensus 184 K~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk--T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL 259 (361)
T KOG1006|consen 184 KEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK--TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITL 259 (361)
T ss_pred HHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh--hhccCCccccChhccCCccCCcchhhhhhhhcceE
Confidence 987 58999999999999999999999999998755433221 223467789999988643 589999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|+.||+.|+......- +-+.. +-.|....+..+.+ ..+....+..+|..|+.+|-.+||+..++..
T Consensus 260 ~EvAtG~fPyr~w~svf-----eql~~-Vv~gdpp~l~~~~~-~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 260 YEVATGNFPYRKWDSVF-----EQLCQ-VVIGDPPILLFDKE-CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred eeeecCCCCcchHHHHH-----HHHHH-HHcCCCCeecCccc-ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 99999999998775532 11222 33444444443322 2334455888888999999999999998865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=187.07 Aligned_cols=178 Identities=34% Similarity=0.510 Sum_probs=156.9
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|+..++.++|++++++++++......++++|++.+++|.+++......++...++.++.+++.++.+||+.
T Consensus 35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--- 111 (215)
T cd00180 35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN--- 111 (215)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 57899999999999999999999999999999999999999999999966545689999999999999999999999
Q ss_pred CeeeeccCCCCEEecC-CCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhC
Q 038713 86 QIIHGDIKPQNILMDE-KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 86 ~i~h~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+|++|.||+++. ++.++++||+.+........ ......+...|.+||..... ..+.+.|+|++|++++++
T Consensus 112 ~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--- 187 (215)
T cd00180 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--- 187 (215)
T ss_pred CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---
Confidence 9999999999999999 89999999999886544321 12223467789999998887 788999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 347788889999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=220.73 Aligned_cols=210 Identities=21% Similarity=0.207 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
...|+.|-++|..-+.+=|+.+.-.|++.+++|+||||++||||...+.+-. .+++.-+.=+...|+-||.-+|+.
T Consensus 119 tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m--- 194 (1317)
T KOG0612|consen 119 TACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM--- 194 (1317)
T ss_pred HHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc---
Confidence 4568888999988888899999999999999999999999999999997666 688887777889999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-----CCCCCcccchhHHHHHHHH
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-----LPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l 160 (252)
|+|||||||.|||++..|+++++|||....+..+..-.....+|||-|++||++.. ..|...+|-||+|+++|+|
T Consensus 195 gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEM 274 (1317)
T KOG0612|consen 195 GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEM 274 (1317)
T ss_pred cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHH
Confidence 99999999999999999999999999998887666666677889999999999762 4588999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC---HHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA---MKKVL 230 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~i~ 230 (252)
+.|..||+.....+... +..-....+..+ +..+ .++. ..+||.+.+ -+|+.|.. ++++-
T Consensus 275 lyG~TPFYadslveTY~-----KIm~hk~~l~FP-~~~~-VSee---akdLI~~ll-~~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 275 LYGETPFYADSLVETYG-----KIMNHKESLSFP-DETD-VSEE---AKDLIEALL-CDREVRLGRNGIEDIK 336 (1317)
T ss_pred HcCCCcchHHHHHHHHH-----HHhchhhhcCCC-cccc-cCHH---HHHHHHHHh-cChhhhcccccHHHHH
Confidence 99999998654433221 111111112111 1112 2333 444454655 57889988 66664
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=197.58 Aligned_cols=199 Identities=23% Similarity=0.270 Sum_probs=157.0
Q ss_pred HHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 8 EFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 8 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
.-+.|-++|... .-|.++.+...|+.-+.+|+||||+.||+|-.++++-++ +-+..+.=.+..|+-||-|||++ +
T Consensus 395 ctm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~k---g 470 (683)
T KOG0696|consen 395 CTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSK---G 470 (683)
T ss_pred ceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcC---C
Confidence 345677777666 667888999999999999999999999999999976655 44444555889999999999999 9
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCcc
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRC 166 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 166 (252)
|++||+|..|++++..|++||.|||....---... .-....||+-|+|||++....|....|-||+|+++|||+.|+.|
T Consensus 471 IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpP 549 (683)
T KOG0696|consen 471 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 549 (683)
T ss_pred eeeeeccccceEeccCCceEeeecccccccccCCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999999874322222 22335689999999999999999999999999999999999999
Q ss_pred ccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 167 LDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
|++.+.++- +.. +.+.+. .++-..++..++++...|.+.|.+|.-
T Consensus 550 FdGeDE~el--F~a-----I~ehnv-------syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 550 FDGEDEDEL--FQA-----IMEHNV-------SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred CCCCCHHHH--HHH-----HHHccC-------cCcccccHHHHHHHHHHhhcCCccccC
Confidence 998755532 211 222222 234444555677777888899998854
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-29 Score=193.96 Aligned_cols=224 Identities=19% Similarity=0.238 Sum_probs=172.3
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecC-----CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDV-----SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
+-+++.+|+++|.-++|.|++..+++..-. ...|+++|.+ ..+|...+-+.+ .++...+.-.++||+.||.||
T Consensus 95 s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYL 172 (449)
T KOG0664|consen 95 SCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYL 172 (449)
T ss_pred HHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-HhhhhheeccCC-CCCcchhhhhHHHHHhhhHHH
Confidence 346789999999999999999998877642 3568899988 558888885544 577788888899999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLL 158 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~ 158 (252)
|+. +|+||||||.|.+++.|-..|++|||+++....+..........|.-|+|||++.|. .|+.+.||||.||++.
T Consensus 173 HsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFa 249 (449)
T KOG0664|consen 173 HTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFA 249 (449)
T ss_pred hhc---chhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHH
Confidence 999 999999999999999999999999999998877766666666678889999999986 4899999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHH----------------HHHHHhcCCcccccccc----hhcHHHHHHHHHHHhhccCC
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEW----------------ICQCFENGNLSQLVEDE----EVDQKQLQRMIKVGLRCILD 218 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~ 218 (252)
|++.++..|+......+..++.. .+.....+..+...... ..+......-+.+.++++.+
T Consensus 250 ELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~ 329 (449)
T KOG0664|consen 250 ELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHF 329 (449)
T ss_pred HHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCC
Confidence 99999999986655554433211 11222222222221111 11112334456777899999
Q ss_pred CCCCCCCHHHHHHHh
Q 038713 219 EPSLRRAMKKVLLML 233 (252)
Q Consensus 219 ~p~~Rps~~~i~~~l 233 (252)
+|++|.+-++.+..+
T Consensus 330 d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 330 DPDKRISVEEALQHR 344 (449)
T ss_pred CCcccccHhhhcccc
Confidence 999999999887654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=196.16 Aligned_cols=93 Identities=24% Similarity=0.386 Sum_probs=81.4
Q ss_pred HhHHHHHHHHHHHhCCC-----CC---CCcceeeeEec----CCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTH-----HR---NPVRLLGYSFD----VSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIAR 70 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~-----h~---~iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~ 70 (252)
...+..+.|+++|++++ |+ .||++++.|.. ..++|||+|++ |.+|..+|... -+.++...+..|+.
T Consensus 116 hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~ 194 (590)
T KOG1290|consen 116 HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICR 194 (590)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHH
Confidence 35677889999999982 33 59999999985 56899999999 77999999764 45689999999999
Q ss_pred HHHHHHHHHhhcCCCCeeeeccCCCCEEe
Q 038713 71 DIARGIRYLHDECEAQIIHGDIKPQNILM 99 (252)
Q Consensus 71 ~i~~~l~~lh~~~~~~i~h~di~~~nil~ 99 (252)
||+.||.|||.+| +|+|.||||+|||+
T Consensus 195 qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 195 QVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred HHHHHHHHHHHhc--CccccCCCcceeee
Confidence 9999999999998 99999999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=211.37 Aligned_cols=196 Identities=23% Similarity=0.203 Sum_probs=128.5
Q ss_pred ecCCcEEEEEecCCCCCHHhhhcCCCCC-------------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeeeecc
Q 038713 32 FDVSNKILVYDYMSNGSLVDVLFTPEKQ-------------------PNWVERMGIARDIARGIRYLHDECEAQIIHGDI 92 (252)
Q Consensus 32 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di 92 (252)
.+....++|+||+.+++|.+++...... .....+..++.|++.||.|||+. +++||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 4566789999999999999998643211 11234567899999999999999 9999999
Q ss_pred CCCCEEecC-CCceEEcccCcccccCCCCCcccccccCCccccccccccCC----------------------CCCCccc
Q 038713 93 KPQNILMDE-KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL----------------------PITVKAD 149 (252)
Q Consensus 93 ~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------------------~~~~~~D 149 (252)
||+|||++. ++.++++|||+++..............+++.|+|||.+... .+..++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 67899999999976543332233345678899999965322 2345679
Q ss_pred chhHHHHHHHHHhCCccccccchhhhHH-------HHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCC
Q 038713 150 VYSFGVVLLEIVCLRRCLDQNLLEDRAI-------LQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSL 222 (252)
Q Consensus 150 i~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 222 (252)
|||+||++|+|+++..++......-... ...|.... ............+..........+++.+||+.||++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV-EPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh-ccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999998776644221110000 01110000 000000000000000001123457888999999999
Q ss_pred CCCHHHHHH
Q 038713 223 RRAMKKVLL 231 (252)
Q Consensus 223 Rps~~~i~~ 231 (252)
|||++|+++
T Consensus 441 R~ta~e~L~ 449 (566)
T PLN03225 441 RISAKAALA 449 (566)
T ss_pred CCCHHHHhC
Confidence 999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=179.58 Aligned_cols=167 Identities=24% Similarity=0.346 Sum_probs=140.3
Q ss_pred chHhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhc---CCCCCCCHHHHHHHHHHHHHHHH
Q 038713 2 LAEGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLF---TPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 2 ~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
+.+..++..+|+++..+. ..|.+|.+||........++.||.++. ||..+-. ..++.+++.-+=+++..++.||.
T Consensus 84 n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~ 162 (282)
T KOG0984|consen 84 NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALE 162 (282)
T ss_pred ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHH
Confidence 356677888999997766 899999999999999999999999954 7766543 35667888888899999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC----CCCCCcccchhH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN----LPITVKADVYSF 153 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~sl 153 (252)
|||++ ..++|||+||+|||++..|++|++|||.+....+...... ..|-..|+|||.+.. ..|+-++|||||
T Consensus 163 ~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~--daGCkpYmaPEri~~e~n~~gY~vksDvWSL 238 (282)
T KOG0984|consen 163 FLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTM--DAGCKPYMAPERINPELNQKGYSVKSDVWSL 238 (282)
T ss_pred HHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHH--hcCCCccCChhhcCcccCcccceeehhhhhh
Confidence 99998 5999999999999999999999999999977654433221 346678999998753 358899999999
Q ss_pred HHHHHHHHhCCccccccchh
Q 038713 154 GVVLLEIVCLRRCLDQNLLE 173 (252)
Q Consensus 154 G~~l~~l~~g~~p~~~~~~~ 173 (252)
|+++.||.+++.||......
T Consensus 239 GItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 239 GITMIEMAILRFPYESWGTP 258 (282)
T ss_pred hhhhhhhhhccccccccCCH
Confidence 99999999999999877444
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-27 Score=197.76 Aligned_cols=168 Identities=25% Similarity=0.298 Sum_probs=141.4
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
+++..-...|-+||..-.++-|||+|-.|.++.++|+||+|++||++-++|.+.+ -+.++.+.=++..+.+|+.+.|+.
T Consensus 670 rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkm 748 (1034)
T KOG0608|consen 670 RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKM 748 (1034)
T ss_pred hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhc
Confidence 4555566788999999999999999999999999999999999999999996544 466666666788999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCccccc--CCCCC---------------------------------------
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM--KPDQT--------------------------------------- 121 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~--~~~~~--------------------------------------- 121 (252)
|++||||||.|||++.+|++||.|||+..-+ .+...
T Consensus 749 ---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r 825 (1034)
T KOG0608|consen 749 ---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQR 825 (1034)
T ss_pred ---cceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhh
Confidence 9999999999999999999999999987522 11000
Q ss_pred cccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccccchhh
Q 038713 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLED 174 (252)
Q Consensus 122 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 174 (252)
......+||+.|+|||++....++..+|-||.|++||+|+.|+.||......+
T Consensus 826 ~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 826 ILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred hhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 00012458999999999999999999999999999999999999998765554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=199.65 Aligned_cols=214 Identities=21% Similarity=0.198 Sum_probs=144.4
Q ss_pred HHHHHHHHHhCCCCCCC-----cceeeeEec--------CCcEEEEEecCCCCCHHhhhcCCC-----------------
Q 038713 8 EFKTEMNAIGRTHHRNP-----VRLLGYSFD--------VSNKILVYDYMSNGSLVDVLFTPE----------------- 57 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------- 57 (252)
.+..|+.++.+++|.++ +++++++.. .+..++|+||+.+|+|.+++....
T Consensus 218 ~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l 297 (507)
T PLN03224 218 TGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKI 297 (507)
T ss_pred hhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCch
Confidence 34457777777866654 677777653 356899999999999999885421
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCc
Q 038713 58 ------KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131 (252)
Q Consensus 58 ------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 131 (252)
...++..++.++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+...............+++
T Consensus 298 ~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp 374 (507)
T PLN03224 298 PDNMPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDP 374 (507)
T ss_pred hhhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCc
Confidence 1235667888999999999999999 9999999999999999999999999998754332221111223477
Q ss_pred cccccccccCCCC----------------------CCcccchhHHHHHHHHHhCCc-cccccchhh------hHHHHHHH
Q 038713 132 AYVAAEWHRNLPI----------------------TVKADVYSFGVVLLEIVCLRR-CLDQNLLED------RAILQEWI 182 (252)
Q Consensus 132 ~~~aPE~~~~~~~----------------------~~~~Di~slG~~l~~l~~g~~-p~~~~~~~~------~~~~~~~~ 182 (252)
.|+|||.+..... ..+.|+||+|+++++|+++.. |+.....-. ......|.
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r 454 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR 454 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence 9999998754221 134699999999999999875 664321111 11111111
Q ss_pred HHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 038713 183 CQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEP---SLRRAMKKVLL 231 (252)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~Rps~~~i~~ 231 (252)
. ...+... ... .........+++.+||..+| .+|+|++|+++
T Consensus 455 ~--~~~~~~~--~~~---~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 455 M--YKGQKYD--FSL---LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred h--hcccCCC--ccc---ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1 1111111 111 11123446667779998765 78999999985
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-28 Score=199.39 Aligned_cols=218 Identities=20% Similarity=0.271 Sum_probs=164.6
Q ss_pred HHHHHHHHHHhCCCC------CCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCC--CCHHHHHHHHHHHHHHHHH
Q 038713 7 REFKTEMNAIGRTHH------RNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQ--PNWVERMGIARDIARGIRY 78 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~i~~~i~~~l~~ 78 (252)
+.=+.|+++|++|+- -|+++++-.|.+.+++|+|||.+ .-+|..+|++-++. +....+..++.|+.-||..
T Consensus 473 KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALkl 551 (752)
T KOG0670|consen 473 KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKL 551 (752)
T ss_pred hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHH
Confidence 444689999999953 27899999999999999999988 56999999775543 5666778899999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCC-ceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKR-CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 157 (252)
|... +++|+||||.||||+++. .+||||||.+....... ..+...+..|+|||++.|..|+...|+||.||+|
T Consensus 552 LK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctL 625 (752)
T KOG0670|consen 552 LKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTL 625 (752)
T ss_pred HHhc---CeeecccCccceEeccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceee
Confidence 9998 999999999999999664 57999999997654333 2334446689999999999999999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHH-----HHHHhcCCccc-------------------------cc--cc-c------
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWI-----CQCFENGNLSQ-------------------------LV--ED-E------ 198 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-------------------------~~--~~-~------ 198 (252)
||+.||+..|.+.....-..+--.+ .+.+..|.+.. +. .+ .
T Consensus 626 YElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l 705 (752)
T KOG0670|consen 626 YELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSEL 705 (752)
T ss_pred EEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHH
Confidence 9999999999876554422211000 01111111110 00 00 0
Q ss_pred -------hhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 199 -------EVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 199 -------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+........|.+|+.+|+..||++|.|..|++.
T Consensus 706 ~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 706 IAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred hccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 112334567888899999999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=176.77 Aligned_cols=219 Identities=16% Similarity=0.269 Sum_probs=160.8
Q ss_pred hHhHHHHHHHHHHHhCCC-CCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTH-HRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
+-..+.+.+|+.+|+.+. ||||++++++..+ +....+|+||.++.+....-. .++...+.-.+.++++||.|+
T Consensus 73 PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyC 148 (338)
T KOG0668|consen 73 PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYC 148 (338)
T ss_pred hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHH
Confidence 345678999999999995 9999999999986 667889999999988877652 355566777899999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecC-CCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDE-KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVL 157 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l 157 (252)
|+. ||.|||+||.|++++. ....+++|+|++.+..+...... ...+.-|.-||.+... .|+..-|+|||||++
T Consensus 149 HS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~Gcml 223 (338)
T KOG0668|consen 149 HSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCML 223 (338)
T ss_pred Hhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHH
Confidence 999 9999999999999984 45689999999988765544222 2345567889987754 588999999999999
Q ss_pred HHHHhCCccccccchhhhHH-----------HHHHHHHHH--------------hcCCcccccccchhcHHHHHHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRAI-----------LQEWICQCF--------------ENGNLSQLVEDEEVDQKQLQRMIKVG 212 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~-----------~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li 212 (252)
..|+..+.||..+.+..+.. +..++.+.. ....+....... ...-.....++++
T Consensus 224 A~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~-n~hl~~peaiDll 302 (338)
T KOG0668|consen 224 ASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSE-NQHLVSPEAIDLL 302 (338)
T ss_pred HHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcc-ccccCChHHHHHH
Confidence 99999999997765543322 111221110 001111111110 0001123466777
Q ss_pred hhccCCCCCCCCCHHHHHH
Q 038713 213 LRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 213 ~~cl~~~p~~Rps~~~i~~ 231 (252)
.+.|..|..+|||+.|...
T Consensus 303 dklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 303 DKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHhhccccccchHHHhc
Confidence 7999999999999999764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=200.88 Aligned_cols=152 Identities=26% Similarity=0.345 Sum_probs=136.3
Q ss_pred HHHHHHhCCC---CCCCcceeeeEecCCcEEEEEecC-CCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 11 TEMNAIGRTH---HRNPVRLLGYSFDVSNKILVYDYM-SNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 11 ~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
-|+.+|..++ |+||+|++++|++++.+|++||.. +|.+|.+++. .....++.++..|+.||+.|+++||++ +
T Consensus 615 ~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~---~ 690 (772)
T KOG1152|consen 615 SEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQ---G 690 (772)
T ss_pred hhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhcccccccc---C
Confidence 6899999996 999999999999999999999987 4569999994 455688999999999999999999999 9
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCC-CcccchhHHHHHHHHHhCCc
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPIT-VKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~ 165 (252)
|+|||||-+|+.++.+|.++++|||.+........+. ..||..|.|||++.|.+|- ...|||++|+++|.++....
T Consensus 691 ivhrdikdenvivd~~g~~klidfgsaa~~ksgpfd~---f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 691 IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPFDV---FVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred ceecccccccEEEecCCeEEEeeccchhhhcCCCcce---eeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 9999999999999999999999999998876555444 4689999999999999875 55899999999999999999
Q ss_pred cccc
Q 038713 166 CLDQ 169 (252)
Q Consensus 166 p~~~ 169 (252)
||+.
T Consensus 768 pyyn 771 (772)
T KOG1152|consen 768 PYYN 771 (772)
T ss_pred CCcC
Confidence 9863
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=181.81 Aligned_cols=203 Identities=20% Similarity=0.265 Sum_probs=155.9
Q ss_pred HHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 038713 11 TEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIH 89 (252)
Q Consensus 11 ~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h 89 (252)
.|-.+..+- +||.+|-+...|+....+++|.||.+||+|--++++ ++.++++.+.-....|+-||.|||++ ||++
T Consensus 299 tek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~r---giiy 374 (593)
T KOG0695|consen 299 TEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHER---GIIY 374 (593)
T ss_pred hhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhc---Ceee
Confidence 444455544 899999999999999999999999999999888854 44578888877889999999999999 9999
Q ss_pred eccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccc
Q 038713 90 GDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQ 169 (252)
Q Consensus 90 ~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 169 (252)
||+|..|++++..|++|+.|+|..+..-.+. +.-+...||+.|.|||++.|..|....|-|+||+++++|+.|+.||+.
T Consensus 375 rdlkldnvlldaeghikltdygmcke~l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 375 RDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred eeccccceEEccCCceeecccchhhcCCCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 9999999999999999999999987543222 233456789999999999999999999999999999999999999973
Q ss_pred c-chhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 170 N-LLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 170 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
. ....+..-..+..+.+.+..++ .+...+.+.-.+++..|++||++|.-
T Consensus 454 vgm~n~d~ntedylfqvilekqir-------iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 454 VGMDNPDMNTEDYLFQVILEKQIR-------IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ecCCCcccchhHHHHHHHhhhccc-------ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 3 1112222222333333322222 12233334455666888899999853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=176.41 Aligned_cols=162 Identities=30% Similarity=0.435 Sum_probs=142.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|++.+++++|+|++++++++......++++|++++++|.+++......+++..++.++.+++.++.+||+.
T Consensus 40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-- 117 (225)
T smart00221 40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL-- 117 (225)
T ss_pred HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 578899999999999999999999999999999999999999999999965443378899999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccc-cCCCCCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWH-RNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+|+++.||+++.++.++++|||.+...............+...|++||.. ....++.++|+|+||++++++++|
T Consensus 118 -~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g 196 (225)
T smart00221 118 -GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWG 196 (225)
T ss_pred -CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999999999999999999887654431122233467789999998 666778899999999999999999
Q ss_pred Cccccc
Q 038713 164 RRCLDQ 169 (252)
Q Consensus 164 ~~p~~~ 169 (252)
+.||..
T Consensus 197 ~~pf~~ 202 (225)
T smart00221 197 PEPFSG 202 (225)
T ss_pred CCCccc
Confidence 999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=178.18 Aligned_cols=215 Identities=14% Similarity=0.188 Sum_probs=154.6
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeee-EecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGY-SFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..++|.+|..---.| .|.||+..|++ |+..+-+.+++||++.|+|.+.+... .+.+....+++.|+++||.|+|++
T Consensus 63 t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsk 140 (378)
T KOG1345|consen 63 TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSK 140 (378)
T ss_pred hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhcc
Confidence 357899998775555 79999998885 45566667999999999999988543 367888889999999999999999
Q ss_pred CCCCeeeeccCCCCEEecC--CCceEEcccCcccccCCCCCcccccccCCccccccccccC---CC--CCCcccchhHHH
Q 038713 83 CEAQIIHGDIKPQNILMDE--KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN---LP--ITVKADVYSFGV 155 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~--~~~~~Di~slG~ 155 (252)
++||||||.+|||+.. ...+|++|||..+...... ....-+..|.+||+... ++ -.+.+|+|.||+
T Consensus 141 ---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGI 213 (378)
T KOG1345|consen 141 ---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGI 213 (378)
T ss_pred ---chhhcccccceEEEecCCccEEEeeecccccccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheee
Confidence 9999999999999964 3469999999987643222 22223557889987542 22 367899999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
++|.++||..||+..... +....+|. .+..+....+...-..-++ .+.++.++-+.++|++|-...++.++..
T Consensus 214 i~f~cltG~~PWQka~~~-d~~Y~~~~--~w~~rk~~~~P~~F~~fs~---~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 214 IFFYCLTGKFPWQKASIM-DKPYWEWE--QWLKRKNPALPKKFNPFSE---KALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred eeeeeecCCCcchhhhcc-CchHHHHH--HHhcccCccCchhhcccCH---HHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 999999999999944333 23333332 3344444333332222333 3445555999999999966666555443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-25 Score=188.50 Aligned_cols=211 Identities=20% Similarity=0.272 Sum_probs=165.0
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
+-..+|+-+++..+||||+.+++.+.....+++.||||.||+|.+.-+ ..+.+++.++..++.+.++|++|||+. +
T Consensus 57 ~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~---g 132 (829)
T KOG0576|consen 57 SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQ---G 132 (829)
T ss_pred cccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcC---C
Confidence 345688899999999999999999999999999999999999988653 445788889999999999999999999 9
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc---CCCCCCcccchhHHHHHHHHHhC
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR---NLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g 163 (252)
-.|||||-.||++++.|.+++.|||.+..+..... ......||+-|||||+.. ...|...+|+|++|++..++.-.
T Consensus 133 k~hRdiKGanilltd~gDvklaDfgvsaqitati~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eL 211 (829)
T KOG0576|consen 133 KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGEL 211 (829)
T ss_pred cccccccccceeecccCceeecccCchhhhhhhhh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhc
Confidence 99999999999999999999999999886654332 334567999999999854 44689999999999999999888
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+.|......-.-.. -..+.+.-.... +........+-++++.|+-.+|++|||++-++.
T Consensus 212 qpplfdlhpmr~l~------LmTkS~~qpp~l---kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 212 QPPLFDLHPMRALF------LMTKSGFQPPTL---KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcccccchHHHHH------HhhccCCCCCcc---cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 87765443322111 111122111111 223333445777777999999999999987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-25 Score=194.57 Aligned_cols=213 Identities=19% Similarity=0.257 Sum_probs=170.1
Q ss_pred HHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 038713 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQII 88 (252)
Q Consensus 9 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~ 88 (252)
+..|.-+-..++|||++..+..+.+....+-.||||++ +|...+... ..++..++..++.|++.|++|+|+. |+.
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~---Gia 442 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSM---GLA 442 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhc---Cce
Confidence 55677777788999999888888776665556999999 999999654 4578888889999999999999999 999
Q ss_pred eeccCCCCEEecCCCceEEcccCcccccCCCCC---cccccccCCccccccccccCCCCCC-cccchhHHHHHHHHHhCC
Q 038713 89 HGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT---RTFTGIRGTRAYVAAEWHRNLPITV-KADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 89 h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~ 164 (252)
|||+|++|+++..+|.++++|||.+........ ....+..|..+|+|||+..+..|++ ..||||.|+++..|.+|+
T Consensus 443 hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 443 HRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred eccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 999999999999999999999999987654333 3445677899999999999988875 589999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.||......++... .....+.......+.......+.....++.+||+++|.+|.|+++|++
T Consensus 523 ~~Wk~a~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 523 FPWKVAKKSDNSFK-----TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred Cccccccccccchh-----hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 99987766654321 111122222233333455566666778888999999999999999976
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=168.57 Aligned_cols=218 Identities=22% Similarity=0.245 Sum_probs=159.5
Q ss_pred HHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 7 REFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 7 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.++.+|++.|..+ -+.||+++.+.+..++++.+|+||.+.....++... ++...+...++.++.||.++|+.
T Consensus 79 ~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~--- 151 (418)
T KOG1167|consen 79 SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKN--- 151 (418)
T ss_pred hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhcc---
Confidence 4578999999999 799999999999999999999999999998888753 55778888999999999999999
Q ss_pred CeeeeccCCCCEEecC-CCceEEcccCcccccCCC---------------C----------------C------------
Q 038713 86 QIIHGDIKPQNILMDE-KRCAKISDFGLAKLMKPD---------------Q----------------T------------ 121 (252)
Q Consensus 86 ~i~h~di~~~nil~~~-~~~~~l~d~~~~~~~~~~---------------~----------------~------------ 121 (252)
||+||||||+|++.+. .+.-.|+|||++...... . .
T Consensus 152 GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~ 231 (418)
T KOG1167|consen 152 GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRP 231 (418)
T ss_pred CccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCcc
Confidence 9999999999999985 456789999998621100 0 0
Q ss_pred cccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHhCCccccccchhhhHHH--HH------HHHHHHhcCC--
Q 038713 122 RTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAIL--QE------WICQCFENGN-- 190 (252)
Q Consensus 122 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~------~~~~~~~~~~-- 190 (252)
.......||++|+|||++.. ...+.+.||||.|+++..+++++.||....++.+... .. ..+-...-|.
T Consensus 232 ~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~ 311 (418)
T KOG1167|consen 232 SERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRIL 311 (418)
T ss_pred ceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCcee
Confidence 00012348999999998765 4678999999999999999999999976544432211 00 0010111111
Q ss_pred ccc----------------c----ccc--------chhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 191 LSQ----------------L----VED--------EEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 191 ~~~----------------~----~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+.+ + ... .....-....+++++.+|++.||.+|.|+++.+.
T Consensus 312 l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 312 LWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred eeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 000 0 000 0000111235788888999999999999999874
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=169.50 Aligned_cols=216 Identities=26% Similarity=0.433 Sum_probs=164.4
Q ss_pred HhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe-eeeccCC
Q 038713 16 IGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQI-IHGDIKP 94 (252)
Q Consensus 16 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i-~h~di~~ 94 (252)
|+.+.|.|+.+++|.+.+....++|.+||..|+|.+.+.......++.-...+..+++.|+.|+|.. .+ .|+.++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 4678999999999999999999999999999999999987677788888889999999999999998 55 9999999
Q ss_pred CCEEecCCCceEEcccCcccccCCCC-CcccccccCCccccccccccCCC-------CCCcccchhHHHHHHHHHhCCcc
Q 038713 95 QNILMDEKRCAKISDFGLAKLMKPDQ-TRTFTGIRGTRAYVAAEWHRNLP-------ITVKADVYSFGVVLLEIVCLRRC 166 (252)
Q Consensus 95 ~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~Di~slG~~l~~l~~g~~p 166 (252)
.|++++.+..+|+.|||+........ ...........-|.|||.+.+.. .+.+.|+||+|++++++++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987664210 01111122345689999987642 36779999999999999999999
Q ss_pred ccccchhhh-HHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 167 LDQNLLEDR-AILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 167 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
|.......+ ..+...++. .+............ +....+..++.+||..+|.+||++++|-..++....
T Consensus 158 ~~~~~~~~~~~eii~~~~~---~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK---GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHh---cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 987544432 222222222 12211111111111 334468889999999999999999999988887544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-20 Score=150.38 Aligned_cols=221 Identities=24% Similarity=0.286 Sum_probs=168.2
Q ss_pred hHHHHHHHHHHHhCCCCC-CCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 5 GEREFKTEMNAIGRTHHR-NPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE--KQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
....|.+|+.+++.+.|+ +++++.+.+......+++++++.++++.+++.... ..........+..|++.++.++|+
T Consensus 40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~ 119 (384)
T COG0515 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119 (384)
T ss_pred HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 467899999999999888 79999999987777899999999999997775544 268889999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCC-ceEEcccCcccccCCCCCc-----ccccccCCccccccccccC---CCCCCcccchh
Q 038713 82 ECEAQIIHGDIKPQNILMDEKR-CAKISDFGLAKLMKPDQTR-----TFTGIRGTRAYVAAEWHRN---LPITVKADVYS 152 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~s 152 (252)
. +++|||+||+||+++..+ .++++|||.+......... ......++..|++||...+ .......|+|+
T Consensus 120 ~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s 196 (384)
T COG0515 120 K---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS 196 (384)
T ss_pred C---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHH
Confidence 9 999999999999999888 7999999999855443321 2345678999999999987 57889999999
Q ss_pred HHHHHHHHHhCCccccccchh-hhHHHHHHHHHHHhcCCcc--cccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 153 FGVVLLEIVCLRRCLDQNLLE-DRAILQEWICQCFENGNLS--QLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 153 lG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
+|++++++++|..||...... ...... ......... ...............+.+++..|+..+|..|.+..+.
T Consensus 197 ~g~~~~~~~~~~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~ 272 (384)
T COG0515 197 LGITLYELLTGLPPFEGEKNSSATSQTL----KIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272 (384)
T ss_pred HHHHHHHHHhCCCCCCCCCccccHHHHH----HHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHH
Confidence 999999999999997655431 001111 111111111 0000000012223456777779999999999999987
Q ss_pred HHH
Q 038713 230 LLM 232 (252)
Q Consensus 230 ~~~ 232 (252)
...
T Consensus 273 ~~~ 275 (384)
T COG0515 273 LSH 275 (384)
T ss_pred hhc
Confidence 764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.6e-21 Score=149.87 Aligned_cols=211 Identities=23% Similarity=0.322 Sum_probs=157.6
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEK-QPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
-++|..|.-.|+.++||||..+++.|....++.++..|++.|+|...+..... ..+..++.+.+.+++.|++|||+. .
T Consensus 231 srdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-e 309 (448)
T KOG0195|consen 231 SRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-E 309 (448)
T ss_pred cchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-c
Confidence 35788999999999999999999999999999999999999999999976543 467788899999999999999996 2
Q ss_pred CCeeeeccCCCCEEecCCCceEE--cccCcccccCCCCCcccccccCCccccccccccCCC---CCCcccchhHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKI--SDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP---ITVKADVYSFGVVLLE 159 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l--~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~~l~~ 159 (252)
.-+.---++...++++++-+.++ +|--++. ...+..-.+.|++||.++... .-.++|+|||++++||
T Consensus 310 p~ipr~~lns~hvmidedltarismad~kfsf--------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwe 381 (448)
T KOG0195|consen 310 PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWE 381 (448)
T ss_pred hhhhhhhcccceEEecchhhhheecccceeee--------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHH
Confidence 22334457788899988766554 3322211 111223467899999987643 3367999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
+.|+..||.....-+-.- +...+|-.. ..++.....+.+++.-|+..||.+||.+++|+-.|++..
T Consensus 382 l~trevpfadlspmecgm------kialeglrv------~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 382 LNTREVPFADLSPMECGM------KIALEGLRV------HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhccccccccCCchhhhh------hhhhccccc------cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 999999997654432110 111122221 223444445777888999999999999999999998753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-19 Score=149.68 Aligned_cols=219 Identities=18% Similarity=0.156 Sum_probs=161.9
Q ss_pred HHHHHHHHHhCCCC----CCCcceeeeE-ecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 8 EFKTEMNAIGRTHH----RNPVRLLGYS-FDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 8 ~~~~E~~~l~~l~h----~~iv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
.+..|..++..++. +++.++++.. .....-++||+.+ |.+|.++.... .+.++..+.++++.|++.+|.++|+
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~ 140 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS 140 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence 57788899888863 5888999988 4677789999988 88999988544 4789999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCC-----CceEEcccCccc--ccCCCCCc------c-cccccCCccccccccccCCCCCCc
Q 038713 82 ECEAQIIHGDIKPQNILMDEK-----RCAKISDFGLAK--LMKPDQTR------T-FTGIRGTRAYVAAEWHRNLPITVK 147 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~-----~~~~l~d~~~~~--~~~~~~~~------~-~~~~~~~~~~~aPE~~~~~~~~~~ 147 (252)
. |++||||||.|+.+... ..+.+.|||+++ ........ . .....||..|.++....+...+.+
T Consensus 141 ~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~ 217 (322)
T KOG1164|consen 141 K---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR 217 (322)
T ss_pred c---CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc
Confidence 9 99999999999999855 358999999998 32222111 1 123458999999999999999999
Q ss_pred ccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 148 ADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 148 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
.|+||++.++.++..|..||........... ............ .....+.. +.++...+-+.+...+|...
T Consensus 218 DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~ 288 (322)
T KOG1164|consen 218 DDLESLFYMLLELLKGSLPWEALEMTDLKSK---FEKDPRKLLTDR---FGDLKPEE---FAKILEYIDSLDYEDKPDYE 288 (322)
T ss_pred hhhhhHHHHHHHHhcCCCCCccccccchHHH---HHHHhhhhcccc---ccCCChHH---HHHHHHHhhccCCcCCCCHH
Confidence 9999999999999999999976543322111 111111101100 11123333 33333345558999999999
Q ss_pred HHHHHhhcCcCC
Q 038713 228 KVLLMLEGTVEI 239 (252)
Q Consensus 228 ~i~~~l~~~~~~ 239 (252)
.+...|++....
T Consensus 289 ~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 289 KLAELLKDVFDS 300 (322)
T ss_pred HHHHHHHHHHHh
Confidence 999998875444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=146.78 Aligned_cols=197 Identities=19% Similarity=0.243 Sum_probs=138.5
Q ss_pred CCCCCcceeeeEe---------------------------cCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHH
Q 038713 20 HHRNPVRLLGYSF---------------------------DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDI 72 (252)
Q Consensus 20 ~h~~iv~~~~~~~---------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i 72 (252)
.|||||++++.|. +..++|+||.-.+. +|..++..+. .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 6999999998775 23567999987755 8999996554 4667777899999
Q ss_pred HHHHHHHhhcCCCCeeeeccCCCCEEec--CCC--ceEEcccCcccccCCCCC-----cccccccCCccccccccccCCC
Q 038713 73 ARGIRYLHDECEAQIIHGDIKPQNILMD--EKR--CAKISDFGLAKLMKPDQT-----RTFTGIRGTRAYVAAEWHRNLP 143 (252)
Q Consensus 73 ~~~l~~lh~~~~~~i~h~di~~~nil~~--~~~--~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~ 143 (252)
++|+.|||++ ++.|||+|.+||++. +++ ...+.|||...--..... ...-...|.-..+|||+.....
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999 999999999999995 333 357899987643221110 1111233556789999987532
Q ss_pred ------CCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccC
Q 038713 144 ------ITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCIL 217 (252)
Q Consensus 144 ------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 217 (252)
.-.++|.|+.|.+.||+++...||+....- .+... . +++..+. ..+...+..+..++...|+
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~~r--~-Yqe~qLP------alp~~vpp~~rqlV~~lL~ 495 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLDTR--T-YQESQLP------ALPSRVPPVARQLVFDLLK 495 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchh---eechh--h-hhhhhCC------CCcccCChHHHHHHHHHhc
Confidence 247899999999999999999999863111 11000 0 1111111 1233334456777889999
Q ss_pred CCCCCCCCHHHHHHHhh
Q 038713 218 DEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 218 ~~p~~Rps~~~i~~~l~ 234 (252)
.||.+|+|.+=..+.|+
T Consensus 496 r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANVLN 512 (598)
T ss_pred CCccccCCccHHHhHHH
Confidence 99999999887666664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.9e-19 Score=146.15 Aligned_cols=122 Identities=24% Similarity=0.249 Sum_probs=96.3
Q ss_pred hHHHHHHHHHHHhCCCCCCCcc-eeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVR-LLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.++.|.+|+++|++++|+|++. +++ .+..++||||++|++|.. .. ..+ ...++.++++||.|||+.
T Consensus 64 ~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~-~~-~~~------~~~~~~~i~~aL~~lH~~- 130 (365)
T PRK09188 64 ARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHL-AR-PHG------DPAWFRSAHRALRDLHRA- 130 (365)
T ss_pred HHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHH-hC-ccc------hHHHHHHHHHHHHHHHHC-
Confidence 4677999999999999999985 443 246899999999999973 21 111 146789999999999999
Q ss_pred CCCeeeecc-CCCCEEecCCCceEEcccCcccccCCCCCc-------ccccccCCccccccccccC
Q 038713 84 EAQIIHGDI-KPQNILMDEKRCAKISDFGLAKLMKPDQTR-------TFTGIRGTRAYVAAEWHRN 141 (252)
Q Consensus 84 ~~~i~h~di-~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~ 141 (252)
+++|||| ||+||+++.++.++++|||+++........ ......++..|.|||.+.-
T Consensus 131 --gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 131 --GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred --CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999 999999998999999999999876543221 1123456778999998764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.5e-20 Score=164.88 Aligned_cols=204 Identities=25% Similarity=0.297 Sum_probs=144.7
Q ss_pred HHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 038713 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIH 89 (252)
Q Consensus 10 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h 89 (252)
..|++ ....+|||.+.+.-+-..++-.|+|-+|... +|.|.+.. +..+..-++.=++.|++.||..+|+. |++|
T Consensus 70 L~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~---gVcH 143 (1431)
T KOG1240|consen 70 LEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKL---GVCH 143 (1431)
T ss_pred HHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHc---Cccc
Confidence 34444 4456999999988887778888999999955 89999954 33566666666889999999999999 9999
Q ss_pred eccCCCCEEecCCCceEEcccCccccc--CCCCCccc----ccccCCccccccccccCC-----------CCCCcccchh
Q 038713 90 GDIKPQNILMDEKRCAKISDFGLAKLM--KPDQTRTF----TGIRGTRAYVAAEWHRNL-----------PITVKADVYS 152 (252)
Q Consensus 90 ~di~~~nil~~~~~~~~l~d~~~~~~~--~~~~~~~~----~~~~~~~~~~aPE~~~~~-----------~~~~~~Di~s 152 (252)
+|||.+|||++.-+-+.+.||..-+.. +++....+ -....-.+|.|||.|... ..+++-||||
T Consensus 144 GDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS 223 (1431)
T KOG1240|consen 144 GDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFS 223 (1431)
T ss_pred cccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhh
Confidence 999999999999999999999876532 32222211 112234589999987531 1567889999
Q ss_pred HHHHHHHHHhC-CccccccchhhhHHHHHHHHHHHhcCC---cccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 153 FGVVLLEIVCL-RRCLDQNLLEDRAILQEWICQCFENGN---LSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 153 lG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
+||++.|+++- +++|... .+. .++.+. ...+.+. -+...+..++..|++.||.+|.|+++
T Consensus 224 ~GCViaELf~Eg~PlF~LS------QL~-----aYr~~~~~~~e~~Le~-----Ied~~~Rnlil~Mi~rdPs~RlSAed 287 (1431)
T KOG1240|consen 224 AGCVIAELFLEGRPLFTLS------QLL-----AYRSGNADDPEQLLEK-----IEDVSLRNLILSMIQRDPSKRLSAED 287 (1431)
T ss_pred hhHHHHHHHhcCCCcccHH------HHH-----hHhccCccCHHHHHHh-----CcCccHHHHHHHHHccCchhccCHHH
Confidence 99999999875 5566422 000 011111 0000000 00124778889999999999999999
Q ss_pred HHHHhhc
Q 038713 229 VLLMLEG 235 (252)
Q Consensus 229 i~~~l~~ 235 (252)
.++--++
T Consensus 288 yL~~yrG 294 (1431)
T KOG1240|consen 288 YLQKYRG 294 (1431)
T ss_pred HHHhhhc
Confidence 9887443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.6e-18 Score=135.14 Aligned_cols=221 Identities=17% Similarity=0.174 Sum_probs=165.5
Q ss_pred HHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 7 REFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 7 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
-++..|....+.| ..+.|..++-+......=.+|+|.+ |-||.++..--++.++..++..++.|++.-+.++|++
T Consensus 68 PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k--- 143 (449)
T KOG1165|consen 68 PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK--- 143 (449)
T ss_pred chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---
Confidence 3577888888888 6788988887777777778999988 8899998877778899999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCC-----ceEEcccCcccccCCCCCcc------cccccCCccccccccccCCCCCCcccchhHH
Q 038713 86 QIIHGDIKPQNILMDEKR-----CAKISDFGLAKLMKPDQTRT------FTGIRGTRAYVAAEWHRNLPITVKADVYSFG 154 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~-----~~~l~d~~~~~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 154 (252)
.+++|||||+|+|+...+ .+.++|||+++.+.++.+.. .+...||-+||+=....|...+.+.|+-|||
T Consensus 144 ~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLG 223 (449)
T KOG1165|consen 144 DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALG 223 (449)
T ss_pred ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhh
Confidence 999999999999997433 47899999999887665532 2446699999999999999999999999999
Q ss_pred HHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 155 VVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 155 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
-++++.+-|..||++......-..++.+ |..+............+..+..-+.-.-+.+-.+-|+.+=+...+.
T Consensus 224 HvFmYFLRGsLPWQGLKA~tnK~kYeKI------Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~ 297 (449)
T KOG1165|consen 224 HVFMYFLRGSLPWQGLKADTNKEKYEKI------GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFD 297 (449)
T ss_pred hhhhhhccCCCccccccCcchHHHHHHh------ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 9999999999999877544432222222 2222222222222223333333333444466677787766655555
Q ss_pred cCc
Q 038713 235 GTV 237 (252)
Q Consensus 235 ~~~ 237 (252)
+++
T Consensus 298 dvl 300 (449)
T KOG1165|consen 298 DVL 300 (449)
T ss_pred HHH
Confidence 433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.1e-19 Score=149.48 Aligned_cols=170 Identities=22% Similarity=0.324 Sum_probs=126.2
Q ss_pred cEEEEEecCCCCCHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcc
Q 038713 36 NKILVYDYMSNGSLVDVLFT--PEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA 113 (252)
Q Consensus 36 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~ 113 (252)
.+|+.|++|..++|.+++.. .....++.....++.|++.|+.| + +.+|+|+||.||+...+..++++|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 47899999999999999953 33457888899999999999999 6 9999999999999999999999999999
Q ss_pred cccCCCC-----CcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHh
Q 038713 114 KLMKPDQ-----TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFE 187 (252)
Q Consensus 114 ~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 187 (252)
....... ........|+..|++||.+.+..|+.++|||+||+++++++. -...+..... ..-++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t----------~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT----------LTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh----------hhhhh
Confidence 8765444 234445679999999999999999999999999999999985 2222221100 01122
Q ss_pred cCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 188 NGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
.+.+.... ..+..+ =..++.+++...|.+||++.
T Consensus 474 ~g~ip~~~---~~d~p~---e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 474 DGIIPPEF---LQDYPE---EYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred cCCCChHH---hhcCcH---HHHHHHHhcCCCcccCchHH
Confidence 22222100 011111 23555699999999999433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-18 Score=134.42 Aligned_cols=127 Identities=15% Similarity=0.231 Sum_probs=99.3
Q ss_pred HHHHHHHHhCCCCCCCcceeeeEecC--------CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 9 FKTEMNAIGRTHHRNPVRLLGYSFDV--------SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 9 ~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
|.+|++.+.+++||+|..+.+++... +..+++|||++|.+|.++.. .+. ....+++.++..+|
T Consensus 82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH 152 (232)
T PRK10359 82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH 152 (232)
T ss_pred HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH
Confidence 68999999999999999998886632 46889999999999988742 222 24569999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+. |++|+|++|+||+++++| ++++|||............ .+.....+..++|+||||+++..+
T Consensus 153 ~~---gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 153 QH---GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred Hc---CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHH
Confidence 99 999999999999999888 9999999876543222111 022333456789999999997655
Q ss_pred H
Q 038713 161 V 161 (252)
Q Consensus 161 ~ 161 (252)
.
T Consensus 216 ~ 216 (232)
T PRK10359 216 K 216 (232)
T ss_pred H
Confidence 3
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=126.66 Aligned_cols=149 Identities=19% Similarity=0.168 Sum_probs=111.7
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.|.+|+++|+++ +|+++.+++++ +..+++|+|+.|.+|.+.+.. . ...++.|++.+|.++|+.
T Consensus 45 ~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~--~------~~~~~~qi~~~L~~lH~~-- 110 (218)
T PRK12274 45 WWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR--G------DLAYFRAARRLLQQLHRC-- 110 (218)
T ss_pred HHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh--h------hHHHHHHHHHHHHHHHHC--
Confidence 34688999999999 55889999886 457999999999998765421 1 134678999999999999
Q ss_pred CCeeeecc-CCCCEEecCCCceEEcccCcccccCCCCCc----c---c-----ccccCCccccccccccCC-CCC-Cccc
Q 038713 85 AQIIHGDI-KPQNILMDEKRCAKISDFGLAKLMKPDQTR----T---F-----TGIRGTRAYVAAEWHRNL-PIT-VKAD 149 (252)
Q Consensus 85 ~~i~h~di-~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~---~-----~~~~~~~~~~aPE~~~~~-~~~-~~~D 149 (252)
|++|+|| ||.||+++.++.++++|||.+......... . . .-...++.+++|+...-. ..+ ...+
T Consensus 111 -GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~ 189 (218)
T PRK12274 111 -GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIREL 189 (218)
T ss_pred -cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHH
Confidence 9999999 799999999999999999999865433310 0 0 001245566777643322 222 5567
Q ss_pred chhHHHHHHHHHhCCccccc
Q 038713 150 VYSFGVVLLEIVCLRRCLDQ 169 (252)
Q Consensus 150 i~slG~~l~~l~~g~~p~~~ 169 (252)
-++-|.-+|.++|++.+...
T Consensus 190 w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 190 WFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHhcchHHHHHhccCCccc
Confidence 78999999999999988754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.4e-18 Score=145.94 Aligned_cols=189 Identities=21% Similarity=0.193 Sum_probs=150.4
Q ss_pred HHHHHHHHhCCC-CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 038713 9 FKTEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQI 87 (252)
Q Consensus 9 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i 87 (252)
...|..++..++ ||.++++.-.++.+..++++.++..||+|...+.... .+++....-....++-++.++|+. ++
T Consensus 43 t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l---~i 118 (612)
T KOG0603|consen 43 TKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKL---GI 118 (612)
T ss_pred cccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchh---HH
Confidence 346777888885 9999999999999999999999999999999886544 456666666778899999999999 99
Q ss_pred eeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccc
Q 038713 88 IHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCL 167 (252)
Q Consensus 88 ~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 167 (252)
+|+|+|++||++..+|++++.|||.++..-..... .|+.-|||||++. .....+|-||+|++.|++++|-.||
T Consensus 119 iyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf 191 (612)
T KOG0603|consen 119 AYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPF 191 (612)
T ss_pred HHhcccccceeecccCccccCCchhhhHhHhhhhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCC
Confidence 99999999999999999999999999865433322 6789999999999 4688999999999999999999999
Q ss_pred cccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 168 DQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
... . .....+.. + ..+........+++.+++..+|..|.-.
T Consensus 192 ~~~--~--------~~~Il~~~----~----~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 192 GGD--T--------MKRILKAE----L----EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chH--H--------HHHHhhhc----c----CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 871 0 11111111 1 2244444556666668888888888766
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-18 Score=138.54 Aligned_cols=162 Identities=20% Similarity=0.281 Sum_probs=104.2
Q ss_pred cEEEEEecCCCCCHHhhhcC---CC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcc
Q 038713 36 NKILVYDYMSNGSLVDVLFT---PE---KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISD 109 (252)
Q Consensus 36 ~~~lv~e~~~~g~L~~~l~~---~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d 109 (252)
+.+++|+-+ .+||.+++.. .. .......++.+-.|+++.+++||.. |++|+||+|+|++++.+|.+.++|
T Consensus 113 n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~ 188 (288)
T PF14531_consen 113 NRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFLLDQDGGVFLGD 188 (288)
T ss_dssp SEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEE-TTS-EEE--
T ss_pred hhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEEEcCCCCEEEcC
Confidence 346777777 5688887632 11 1233334455668999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCccccccccccC--------CCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHH
Q 038713 110 FGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN--------LPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEW 181 (252)
Q Consensus 110 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 181 (252)
|+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|+|+..||+..........
T Consensus 189 F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--- 261 (288)
T PF14531_consen 189 FSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--- 261 (288)
T ss_dssp GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---
T ss_pred hHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---
Confidence 9887654322211 233467889997643 2468899999999999999999999986644421100
Q ss_pred HHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCC
Q 038713 182 ICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLR 223 (252)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 223 (252)
. .. ... +.+..+..+|..+|+.||.+|
T Consensus 262 -----------~-f~--~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 -----------D-FS--RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -----------G-GT--TSS----HHHHHHHHHHT-SSGGGS
T ss_pred -----------c-ch--hcC-CcCHHHHHHHHHHccCCcccC
Confidence 1 11 122 555667778889999999987
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.4e-17 Score=123.91 Aligned_cols=175 Identities=23% Similarity=0.231 Sum_probs=142.8
Q ss_pred HHHHHHHHHHhCCCC-CCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 7 REFKTEMNAIGRTHH-RNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
-++..|..+.+.+++ ..|..+..+..+...-.+||+.+ |-+|.+..+--.+.++..+++-++.|++.-+.|+|.+
T Consensus 55 pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r--- 130 (341)
T KOG1163|consen 55 PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR--- 130 (341)
T ss_pred cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---
Confidence 356789999999865 56777777888888888999988 8899998876677789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCC---CceEEcccCcccccCCCCCc------ccccccCCccccccccccCCCCCCcccchhHHHH
Q 038713 86 QIIHGDIKPQNILMDEK---RCAKISDFGLAKLMKPDQTR------TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVV 156 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~ 156 (252)
+++||||||+|+++.-+ ..+.++|||+++..-+..+. ......||.+|.+-....+...+.+.|+-|+|.+
T Consensus 131 ~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYv 210 (341)
T KOG1163|consen 131 NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYV 210 (341)
T ss_pred ccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcce
Confidence 99999999999999754 45789999999876543332 1223458888988888888788899999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHHH
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQC 185 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 185 (252)
+.++--|..||++-........++.+.+.
T Consensus 211 LmYfnrG~LPWQglka~tk~QKyEkI~Ek 239 (341)
T KOG1163|consen 211 LMYFNRGSLPWQGLKAATKKQKYEKISEK 239 (341)
T ss_pred eeeeecCCCcccccchhhHHHHHHHHHHh
Confidence 99999999999988666655555554443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=121.98 Aligned_cols=102 Identities=21% Similarity=0.295 Sum_probs=82.0
Q ss_pred hHHHHHHHHHHHhCC-----CCCCCcceeeeEecCC---cEE-EEEec--CCCCCHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRT-----HHRNPVRLLGYSFDVS---NKI-LVYDY--MSNGSLVDVLFTPEKQPNWVERMGIARDIA 73 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~---~~~-lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~ 73 (252)
..+++.+|+.+++.+ .||||++++++++++. .++ +|+|| +.+|+|.+++.+. .+++. ..++.+++
T Consensus 39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L 114 (210)
T PRK10345 39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLL 114 (210)
T ss_pred hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHH
Confidence 467899999999999 5799999999999863 334 78999 5579999999553 34444 35678888
Q ss_pred HHH-HHHhhcCCCCeeeeccCCCCEEecC----CCceEEccc-Ccc
Q 038713 74 RGI-RYLHDECEAQIIHGDIKPQNILMDE----KRCAKISDF-GLA 113 (252)
Q Consensus 74 ~~l-~~lh~~~~~~i~h~di~~~nil~~~----~~~~~l~d~-~~~ 113 (252)
.++ .|||++ +|+||||||+||+++. ++.++|+|+ |..
T Consensus 115 ~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 115 KKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred HHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 777 999999 9999999999999974 337999994 543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.3e-16 Score=119.38 Aligned_cols=101 Identities=14% Similarity=0.170 Sum_probs=81.0
Q ss_pred HHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCee
Q 038713 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL-HDECEAQII 88 (252)
Q Consensus 10 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~~i~ 88 (252)
.+|++++.++.++++.....+.. ...++||||++|+++...... ...++......++.|++.+|.++ |+. +++
T Consensus 67 ~~E~~~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~---gii 140 (190)
T cd05147 67 EKEMRNLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDC---RLV 140 (190)
T ss_pred HHHHHHHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 45999999998888754443322 233899999988877655422 34688899999999999999999 688 999
Q ss_pred eeccCCCCEEecCCCceEEcccCcccccC
Q 038713 89 HGDIKPQNILMDEKRCAKISDFGLAKLMK 117 (252)
Q Consensus 89 h~di~~~nil~~~~~~~~l~d~~~~~~~~ 117 (252)
|+|+||+||+++ ++.++++|||.+....
T Consensus 141 HrDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 141 HADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred cCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 999999999998 4789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-15 Score=116.70 Aligned_cols=104 Identities=15% Similarity=0.164 Sum_probs=83.5
Q ss_pred HHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCC
Q 038713 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD-ECEAQ 86 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~ 86 (252)
.+.+|...+.++.|+++.....+... ..++||||++|+++..... .....+......++.|++.++.++|+ . |
T Consensus 65 ~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~---g 138 (190)
T cd05145 65 WAEKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEA---G 138 (190)
T ss_pred HHHHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhC---C
Confidence 34689999999999988655444433 2489999998875544322 23456788889999999999999999 8 9
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccccCC
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKP 118 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~ 118 (252)
++|+||||+||+++ ++.++++|||.+.....
T Consensus 139 ivHrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 139 LVHGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 99999999999998 78999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.1e-16 Score=123.13 Aligned_cols=198 Identities=22% Similarity=0.292 Sum_probs=137.8
Q ss_pred HHHhCCCCCCCcceeeeEecC-----CcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 14 NAIGRTHHRNPVRLLGYSFDV-----SNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 14 ~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.-+-++-|.|++++..|+.+. ....++.||+..|++.++|++ .++.+......+|+.||+.||.|||+ |.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 334456789999999998763 346789999999999999965 45567888888999999999999999 588
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCC----cccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT----RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
.++|+++....|++..+|-++++--.- ........ .......+.++|.+||.-...+.+..+|||+||++..+|.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 999999999999999999888764221 11111110 0111123567899999888778889999999999999998
Q ss_pred hCCccccccchhh--hHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLED--RAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.+..--....... +..+.. . +..+.++ . -...+.+|++..|..||++.+++.
T Consensus 277 ilEiq~tnseS~~~~ee~ia~----~-----i~~len~------l---qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIAN----V-----IIGLENG------L---QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehhhhhhh----h-----eeeccCc------c---ccCcCcccccCCCCCCcchhhhhc
Confidence 7764422221110 000000 0 0000000 0 123455999999999999998764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.7e-15 Score=133.37 Aligned_cols=202 Identities=18% Similarity=0.181 Sum_probs=145.1
Q ss_pred HHHHhCCC---CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 038713 13 MNAIGRTH---HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIH 89 (252)
Q Consensus 13 ~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h 89 (252)
.+++.+|. -+-|..+...+.-.+..++|+||.+.|+|.++++ ..+..++...+-+..|++..+..||.. +|+|
T Consensus 742 ~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~---~IIH 817 (974)
T KOG1166|consen 742 LQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIH 817 (974)
T ss_pred HHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhc---ceec
Confidence 34445554 1244555555556778899999999999999996 666789999999999999999999999 9999
Q ss_pred eccCCCCEEec-------CCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 90 GDIKPQNILMD-------EKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 90 ~di~~~nil~~-------~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+||||+|+++. ++..++|+|||.+.-+..... ..+.+.+++-.+-.+|...|..|+...|.|+|+.+++-|+
T Consensus 818 gDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mL 897 (974)
T KOG1166|consen 818 GDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVML 897 (974)
T ss_pred ccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHH
Confidence 99999999994 234589999999976543332 4667778899999999999999999999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
.|++.= ...++.+.....-+.+... .-.-++...+|..+=..=|.+.++...|++++
T Consensus 898 FG~y~q-----------------~~~g~~~~~~~~~~Ry~~~--~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 898 FGKYME-----------------VKNGSSWMVKTNFPRYWKR--DMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred HHHHHH-----------------hcCCcceeccccchhhhhH--HHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 887331 1111122111110111111 11233344556566666677788877777643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.4e-16 Score=139.50 Aligned_cols=208 Identities=24% Similarity=0.321 Sum_probs=156.9
Q ss_pred HHHHHHhCCC-CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCe
Q 038713 11 TEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLF-TPEKQPNWVERMGIARDIARGIRYLH-DECEAQI 87 (252)
Q Consensus 11 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~i 87 (252)
.|..+=..+. |+|+++.++...+....++++++.+||++.+-+. ......+....-..+.|+..++.|+| .. ++
T Consensus 69 ~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~ 145 (601)
T KOG0590|consen 69 TETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GV 145 (601)
T ss_pred ccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---cc
Confidence 4566666665 9999999999999999999999999999999883 33324555667778999999999999 87 99
Q ss_pred eeeccCCCCEEecCCC-ceEEcccCcccccCC--CCCcccccccC-CccccccccccCC-CCCCcccchhHHHHHHHHHh
Q 038713 88 IHGDIKPQNILMDEKR-CAKISDFGLAKLMKP--DQTRTFTGIRG-TRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 88 ~h~di~~~nil~~~~~-~~~l~d~~~~~~~~~--~~~~~~~~~~~-~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~ 162 (252)
.|+|++|+|.+++.++ ..+..|||.+..... ..........| ++.|.|||...+. ......|+||.|+++..+++
T Consensus 146 ~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~ 225 (601)
T KOG0590|consen 146 THRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLT 225 (601)
T ss_pred ccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccccccc
Confidence 9999999999999999 999999999987765 22334444567 9999999999985 45678999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
|..||......... ...|.... +... . ...........++..+++..+|..|.+.+++-
T Consensus 226 g~~p~~~~~~~~~~-~~~~~~~~---~~~~--~---~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 226 GELPWDFPSRKDGR-YSSWKSNK---GRFT--Q---LPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred CCCCcccccccccc-ceeecccc---cccc--c---CccccCChhhhhcccccccCCchhcccccccc
Confidence 99999876554421 11111111 0000 0 11112223355666689999999999998864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-14 Score=112.61 Aligned_cols=101 Identities=27% Similarity=0.440 Sum_probs=89.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
+.++.+|+.++..+.|+++.....++.+....+++|||++|++|.+.+.... . ....++.+++.+|.++|..
T Consensus 43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~--- 114 (211)
T PRK14879 43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA--- 114 (211)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---
Confidence 3568899999999999999888888777888999999999999999985422 1 7788999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
+++|+|++|.||+++ ++.++++|||.+..
T Consensus 115 ~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 115 GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999999999 78899999998765
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.8e-14 Score=126.16 Aligned_cols=97 Identities=24% Similarity=0.405 Sum_probs=87.4
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+++.+|++++++++|++++....+..+....++||||++|++|.+++. ....++.+++.+|.+||+.
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~--- 447 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA--- 447 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---
Confidence 4678999999999999999988877777778899999999999999884 3567899999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
+++|+|+||+||++ .++.++++|||.++.
T Consensus 448 giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 448 GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999 678899999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-14 Score=131.11 Aligned_cols=148 Identities=22% Similarity=0.257 Sum_probs=108.6
Q ss_pred HHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--------------cccccccCCcccccc
Q 038713 71 DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--------------RTFTGIRGTRAYVAA 136 (252)
Q Consensus 71 ~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--------------~~~~~~~~~~~~~aP 136 (252)
+++.++.|||+. +|+|||+||.|.+++.-|++|+.|||+++....... ...+++.||+.|+||
T Consensus 151 dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 151 DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence 347899999999 999999999999999999999999999875422111 122345799999999
Q ss_pred ccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhcc
Q 038713 137 EWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCI 216 (252)
Q Consensus 137 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 216 (252)
|++.-..|....|.|++|+++|+.+.|..||.+...++-.. .+-...+.........+ .+..+++.+.|
T Consensus 228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg-------~visd~i~wpE~dea~p----~Ea~dli~~LL 296 (1205)
T KOG0606|consen 228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG-------QVISDDIEWPEEDEALP----PEAQDLIEQLL 296 (1205)
T ss_pred hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh-------hhhhhhccccccCcCCC----HHHHHHHHHHH
Confidence 99999999999999999999999999999999876654211 11112222222222222 23555666999
Q ss_pred CCCCCCCCCHHHHHHH
Q 038713 217 LDEPSLRRAMKKVLLM 232 (252)
Q Consensus 217 ~~~p~~Rps~~~i~~~ 232 (252)
+++|.+|.-....+++
T Consensus 297 ~qnp~~Rlgt~ga~ev 312 (1205)
T KOG0606|consen 297 RQNPLCRLGTGGALEV 312 (1205)
T ss_pred HhChHhhcccchhhhh
Confidence 9999999755544433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.5e-14 Score=109.20 Aligned_cols=98 Identities=28% Similarity=0.460 Sum_probs=83.7
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
..++.+|++++..++|+++....-++......+++|||++|++|.+.+..... .++.+++.+|.++|+.
T Consensus 41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~--- 109 (199)
T TIGR03724 41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKA--- 109 (199)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHC---
Confidence 35678999999999988776666666667778999999999999998743221 6889999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
+++|+|++|.||+++ ++.++++|||.+..
T Consensus 110 gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 110 GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999999999 78999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=109.52 Aligned_cols=101 Identities=20% Similarity=0.309 Sum_probs=79.6
Q ss_pred HHHHHHHHHHhCCCCCC--CcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 7 REFKTEMNAIGRTHHRN--PVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+|+.++.++.+.. +.++++. ...++||||++|++|...... ...........++.|++.++.+||+.
T Consensus 95 ~~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-- 167 (237)
T smart00090 95 LWAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKE-- 167 (237)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhc--
Confidence 44678999999997532 3344432 235899999999888765532 23455666788999999999999999
Q ss_pred CC-eeeeccCCCCEEecCCCceEEcccCccccc
Q 038713 85 AQ-IIHGDIKPQNILMDEKRCAKISDFGLAKLM 116 (252)
Q Consensus 85 ~~-i~h~di~~~nil~~~~~~~~l~d~~~~~~~ 116 (252)
+ ++|+|+||+||+++ ++.++++|||.+...
T Consensus 168 -g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 168 -GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9 99999999999999 788999999988754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-13 Score=108.90 Aligned_cols=103 Identities=17% Similarity=0.179 Sum_probs=82.5
Q ss_pred hHHHHHHHHHHHhCCCCCCC--cceeeeEecCC----cEEEEEecCCC-CCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNP--VRLLGYSFDVS----NKILVYDYMSN-GSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
.+.++.+|+.++.+++|+++ ++.+++..... ..++|+|+++| .+|.+++... .++.. .+.+++.+|.
T Consensus 83 ~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~ 156 (239)
T PRK01723 83 ERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIA 156 (239)
T ss_pred hhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHH
Confidence 34678899999999988875 67777654322 23599999997 6899888542 34433 3578999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCccccc
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~ 116 (252)
+||+. |++|+|+||.|||++.++.++++|||.+...
T Consensus 157 ~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 157 RFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred HHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 99999 9999999999999999889999999988753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=8.6e-13 Score=114.23 Aligned_cols=147 Identities=16% Similarity=0.172 Sum_probs=111.6
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.....+-++-|+.++||||+++++.++..+..|+|+|-+. -|..++++.. .....--+.||+.||.|||..|
T Consensus 53 ~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~~Gl~qIl~AL~FL~~d~-- 124 (690)
T KOG1243|consen 53 TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVCLGLFQILAALSFLNDDC-- 124 (690)
T ss_pred hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHHHHHHHHHHHHHHHhccC--
Confidence 4556788889999999999999999999999999999873 4666665433 3444456789999999998664
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|++++-..+||+..|..+|++|........... .......-..|..|+.+.... ...|.|.||+++++++.|
T Consensus 125 ~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 125 NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 999999999999999999999999987754332221 111112223456666554322 557999999999999988
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=2e-12 Score=99.95 Aligned_cols=97 Identities=20% Similarity=0.221 Sum_probs=78.5
Q ss_pred HHHHHHHHHHhCCCCCC--CcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 7 REFKTEMNAIGRTHHRN--PVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+|..++..+.|++ +.+.++ ....++||||++|++|.+.... .....++.+++.++.++|..
T Consensus 78 ~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~-- 144 (198)
T cd05144 78 LAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH-- 144 (198)
T ss_pred HHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC--
Confidence 35778999999997774 444443 2456899999999998775421 23456889999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~ 117 (252)
+++|+||+|.||+++.++.++++|||.+....
T Consensus 145 -gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 145 -GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred -CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=9e-13 Score=112.72 Aligned_cols=204 Identities=21% Similarity=0.223 Sum_probs=156.2
Q ss_pred HHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCC
Q 038713 10 KTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIAR----GIRYLHDECE 84 (252)
Q Consensus 10 ~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~lh~~~~ 84 (252)
++|+..-+.+ .|+|.++.+..++..+..++=+|+| +.+|..+.......++...++..+.+..+ |+.++|..
T Consensus 165 ~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~-- 241 (524)
T KOG0601|consen 165 LREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN-- 241 (524)
T ss_pred cchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC--
Confidence 4667777777 7999999999999999999999999 57899988777777788888888888888 99999999
Q ss_pred CCeeeeccCCCCEEecCC-CceEEcccCcccccCCCCCccc----ccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEK-RCAKISDFGLAKLMKPDQTRTF----TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
+++|.|++|.||+...+ ..++++|||+...+........ ....|...|++||...+ .++...|++++|.++.+
T Consensus 242 -~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~ 319 (524)
T KOG0601|consen 242 -NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILE 319 (524)
T ss_pred -cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHh
Confidence 99999999999999998 8899999999987765442211 22246678999999988 57899999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
-.++......+....... .+++. .+.++.......+..++.+|++.+|..|++...+.+
T Consensus 320 ~~l~~~~~~~g~~~~W~~--------~r~~~-----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 320 AILGSHLPSVGKNSSWSQ--------LRQGY-----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hHhhcccccCCCCCCccc--------ccccc-----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 988887765543332110 11111 111222223334555888999999999998876543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.7e-12 Score=94.22 Aligned_cols=102 Identities=22% Similarity=0.270 Sum_probs=86.9
Q ss_pred HHHHHHHHHHHhCCCC--CCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 6 EREFKTEMNAIGRTHH--RNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+|+.+++.++| .++.+++.+....+..++++||++++.+..+ +......++.+++++++.+|...
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~ 106 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLP 106 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCC
Confidence 3578999999999966 5899999988888889999999988877654 44556678899999999999963
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
..+++|+|++|.||++++.+.++++||+.+..
T Consensus 107 ~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 34799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.2e-10 Score=85.94 Aligned_cols=104 Identities=13% Similarity=0.162 Sum_probs=76.5
Q ss_pred HHHHH----HHHHHHhCCCC--CCCcceeeeEecCCcEEEEEecCCCCCHHh-hhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 6 EREFK----TEMNAIGRTHH--RNPVRLLGYSFDVSNKILVYDYMSNGSLVD-VLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 6 ~~~~~----~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
++.+. +|+..|+++.. -++.+++++ ..-++||||+.++.+.. .+.. ..++......+..+++.++..
T Consensus 66 ~~~~~~wa~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~ 139 (197)
T cd05146 66 RKIIRMWAEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQ 139 (197)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHH
Confidence 44455 89999999843 456666654 56789999997643322 2211 124445566778999999999
Q ss_pred H-hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCC
Q 038713 79 L-HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD 119 (252)
Q Consensus 79 l-h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~ 119 (252)
+ |+. +++|+|+++.||++. ++.+.++|||.+....++
T Consensus 140 l~H~~---glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 140 LYKEC---NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred HHHhC---CeecCCCCHHHEEEE-CCcEEEEECCCceeCCCC
Confidence 8 888 999999999999997 467999999998766543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=3e-10 Score=86.86 Aligned_cols=98 Identities=18% Similarity=0.237 Sum_probs=70.2
Q ss_pred HHHHHHHhCCCCCC--CcceeeeEecCCcEEEEEecCCCCCHHhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCC
Q 038713 10 KTEMNAIGRTHHRN--PVRLLGYSFDVSNKILVYDYMSNGSLVDV-LFTPEKQPNWVERMGIARDIARGIRYLHD-ECEA 85 (252)
Q Consensus 10 ~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~ 85 (252)
..|...+..+.+.. +.+.++. ...+++|||++++.+... +..... . .....++.+++.++.++|. .
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~--~-~~~~~~~~~~~~~l~~lh~~~--- 134 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL--L-EDPEELYDQILELMRKLYREA--- 134 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhh--c-ccHHHHHHHHHHHHHHHhhcc---
Confidence 35666666664432 4444443 346899999998543221 111110 1 5577899999999999999 8
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP 118 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~ 118 (252)
+++|+|++|+||+++ ++.++++|||.+.....
T Consensus 135 ~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 135 GLVHGDLSEYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcCcCCCChhhEEEE-CCcEEEEECcccccccC
Confidence 999999999999999 88999999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.1e-09 Score=81.51 Aligned_cols=99 Identities=25% Similarity=0.453 Sum_probs=81.0
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
+.+-.+|+.++.++.--.|.-..=+..+..+..++|||++|..|.+.+... ...++..+-.-+.-||..
T Consensus 43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~--- 111 (204)
T COG3642 43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKA--- 111 (204)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---
Confidence 455678999999886666665566667778889999999999999999655 134667777788999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCccccc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~ 116 (252)
+++|+|+.++||.++..+ +.++|||++...
T Consensus 112 givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 112 GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999999999998766 999999998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.9e-10 Score=97.13 Aligned_cols=104 Identities=18% Similarity=0.304 Sum_probs=75.9
Q ss_pred HHHHHHHHHhCCC----CCCCcceeeeEe-cCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHhh
Q 038713 8 EFKTEMNAIGRTH----HRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIAR-GIRYLHD 81 (252)
Q Consensus 8 ~~~~E~~~l~~l~----h~~iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~lh~ 81 (252)
+|.+|+..+.++. |.+-+.+-.++. ..+..++||||++|++|.+.........+ ...++..++. .+..+|.
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh
Confidence 5778888877762 333344444443 35567999999999999887643222222 2345566655 4678898
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccC
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~ 117 (252)
. |++|+|++|.||++..++.++++|||.+....
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 99999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=5e-09 Score=87.08 Aligned_cols=129 Identities=14% Similarity=0.259 Sum_probs=97.7
Q ss_pred EEEEEecCCCCCHHhhhcCC----C--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEccc
Q 038713 37 KILVYDYMSNGSLVDVLFTP----E--KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDF 110 (252)
Q Consensus 37 ~~lv~e~~~~g~L~~~l~~~----~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~ 110 (252)
..++|..+.|-.-...+.+. + ...+|...++++.+++.+.+.||.. |.+.+|++++|++|++.+.+.+.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence 56788877664332333221 1 2378899999999999999999999 9999999999999999999999885
Q ss_pred CcccccCCCCCcccccccCCccccccccc-----cCCCCCCcccchhHHHHHHHHHhC-Ccccccc
Q 038713 111 GLAKLMKPDQTRTFTGIRGTRAYVAAEWH-----RNLPITVKADVYSFGVVLLEIVCL-RRCLDQN 170 (252)
Q Consensus 111 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~-----~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~ 170 (252)
.....- ..........|...|.+||.- .+..-+...|.|.||+++|+++.| +.||.+-
T Consensus 162 Dsfqi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 162 DSFQIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cceeec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 443322 222333445688899999964 355567889999999999999877 7888643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.4e-10 Score=99.66 Aligned_cols=155 Identities=16% Similarity=0.220 Sum_probs=103.4
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--------cccccccCCcccccc
Q 038713 65 RMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--------RTFTGIRGTRAYVAA 136 (252)
Q Consensus 65 ~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~~aP 136 (252)
...=+.+++.|+.|+|.. +++||++|.|++|.++.++.+|+++|+.......... ....-.....-|.||
T Consensus 101 ~f~nl~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 101 GFANLGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred hhhhhhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence 334456777899999997 7999999999999999999999999988765443111 111112234579999
Q ss_pred ccccCCCCCCcccchhHHHHHHHHH-hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhc
Q 038713 137 EWHRNLPITVKADVYSFGVVLLEIV-CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRC 215 (252)
Q Consensus 137 E~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 215 (252)
|++.+.-.+.++|+||+|+.+|.+. +|+.-+..........+. ...............+.+ +.+=+.++
T Consensus 179 E~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~------~~~~~~~~~~~s~~~p~e----l~~~l~k~ 248 (700)
T KOG2137|consen 179 EYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS------RNLLNAGAFGYSNNLPSE----LRESLKKL 248 (700)
T ss_pred hhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh------hcccccccccccccCcHH----HHHHHHHH
Confidence 9999877889999999999999998 555544433222111110 111111111111233444 55666688
Q ss_pred cCCCCCCCCCHHHHHH
Q 038713 216 ILDEPSLRRAMKKVLL 231 (252)
Q Consensus 216 l~~~p~~Rps~~~i~~ 231 (252)
+..++..||++..+..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999998777654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3e-10 Score=103.08 Aligned_cols=193 Identities=21% Similarity=0.200 Sum_probs=133.7
Q ss_pred CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEe
Q 038713 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILM 99 (252)
Q Consensus 20 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~ 99 (252)
+||.+++..--+.-....+++++|..+++|...+.... ..+.+........+..++.+||.. .+.|+|.+|.|.+.
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~ 937 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLI 937 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccc---hhhcccccccchhh
Confidence 44555555444455678899999999999999886544 334444444567788999999998 79999999999999
Q ss_pred cCCCceEEcccCcccccC---C------------------C-C-----C---cccccccCCccccccccccCCCCCCccc
Q 038713 100 DEKRCAKISDFGLAKLMK---P------------------D-Q-----T---RTFTGIRGTRAYVAAEWHRNLPITVKAD 149 (252)
Q Consensus 100 ~~~~~~~l~d~~~~~~~~---~------------------~-~-----~---~~~~~~~~~~~~~aPE~~~~~~~~~~~D 149 (252)
..++...+.+|+...... + . . . .......+++.|.+||...+......+|
T Consensus 938 ~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad 1017 (1205)
T KOG0606|consen 938 AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD 1017 (1205)
T ss_pred cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch
Confidence 999999999986222110 0 0 0 0 1112345788999999999999999999
Q ss_pred chhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 150 VYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 150 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
.|++|+++++.++|..||......... .....+.......+....+ . ..+++...+..+|.+|..+.
T Consensus 1018 ~~~~g~~l~e~l~g~pp~na~tpq~~f-------~ni~~~~~~~p~g~~~~s~-~---aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1018 WWSSGVCLFEVLTGIPPFNAETPQQIF-------ENILNRDIPWPEGPEEGSY-E---AQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhhhhhcCCCCCCCcchhhhh-------hccccCCCCCCCCccccCh-h---hhhhhhhhhccCchhccCcc
Confidence 999999999999999999876544311 1222223322222222222 2 44445577778888887776
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.9e-08 Score=85.53 Aligned_cols=133 Identities=19% Similarity=0.275 Sum_probs=107.5
Q ss_pred HHHHHHhCCCCCCCcceeeeEe----cCCcEEEEEecCCC-CCHHhhhcCC--------------CCCCCHHHHHHHHHH
Q 038713 11 TEMNAIGRTHHRNPVRLLGYSF----DVSNKILVYDYMSN-GSLVDVLFTP--------------EKQPNWVERMGIARD 71 (252)
Q Consensus 11 ~E~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-g~L~~~l~~~--------------~~~~~~~~~~~i~~~ 71 (252)
.-++.++++.|+|+|++.+++. ++..+++|++|.++ ++|.++...+ +...++..+|.++.|
T Consensus 322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q 401 (655)
T KOG3741|consen 322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ 401 (655)
T ss_pred HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence 4478899999999999999887 46678999999877 6787765321 224678899999999
Q ss_pred HHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccch
Q 038713 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVY 151 (252)
Q Consensus 72 i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 151 (252)
+..||.++|+. |+..+-+.+.+|++..+.++++..+|.......+.... +. ...+.|.-
T Consensus 402 LtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~~---------------le---~~Qq~D~~ 460 (655)
T KOG3741|consen 402 LTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTEP---------------LE---SQQQNDLR 460 (655)
T ss_pred HHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCCCCcc---------------hh---HHhhhhHH
Confidence 99999999999 99999999999999998899999988877655444111 11 12456889
Q ss_pred hHHHHHHHHHhCC
Q 038713 152 SFGVVLLEIVCLR 164 (252)
Q Consensus 152 slG~~l~~l~~g~ 164 (252)
.||.+++.+.||.
T Consensus 461 ~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 461 DLGLLLLALATGT 473 (655)
T ss_pred HHHHHHHHHhhcc
Confidence 9999999999995
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.5e-09 Score=81.52 Aligned_cols=96 Identities=17% Similarity=0.199 Sum_probs=70.2
Q ss_pred HHHHHHHHHHhCCCCCCC-cceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--
Q 038713 7 REFKTEMNAIGRTHHRNP-VRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC-- 83 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-- 83 (252)
.++.+|+.+++.+.+.++ .+++... ....++|||+++|.++.+.- . .....+.+++.+++.||...
T Consensus 37 ~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~~-----~----~~~~~~~~l~~~l~~LH~~~~~ 105 (170)
T cd05151 37 INRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTED-----F----SDPENLEKIAKLLKKLHSSPLP 105 (170)
T ss_pred cCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccccc-----c----cCHHHHHHHHHHHHHHhCCCCC
Confidence 356789999998865554 3555443 33458999999998876430 0 11235678999999999981
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCccc
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~ 114 (252)
..+++|+|++|.||+++ ++.++++||+.+.
T Consensus 106 ~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 106 DLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 11259999999999998 6679999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=5.8e-09 Score=77.48 Aligned_cols=109 Identities=22% Similarity=0.320 Sum_probs=84.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCC-CCHHhhhcCCCCCCCHHHH-HHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSN-GSLVDVLFTPEKQPNWVER-MGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~-~~i~~~i~~~l~~lh~~ 82 (252)
.+++-.+|++++.++.--.|.-..=++.+.+.-.++|||.+| .++.+++...-........ ...+..|-+.+.-||..
T Consensus 53 tr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n 132 (229)
T KOG3087|consen 53 TRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN 132 (229)
T ss_pred HHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC
Confidence 466778999999998766666666677777888899999977 4788888553322222333 67888999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCc---eEEcccCccccc
Q 038713 83 CEAQIIHGDIKPQNILMDEKRC---AKISDFGLAKLM 116 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~---~~l~d~~~~~~~ 116 (252)
+++|+|+..+||++...+. +.++|||++...
T Consensus 133 ---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 133 ---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9999999999999975543 489999998654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=8.8e-09 Score=82.88 Aligned_cols=104 Identities=17% Similarity=0.153 Sum_probs=80.9
Q ss_pred HHHHHHHHHhCCCCCCC--cceeeeEec-----CCcEEEEEecCCCC-CHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHH
Q 038713 8 EFKTEMNAIGRTHHRNP--VRLLGYSFD-----VSNKILVYDYMSNG-SLVDVLFTP-EKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~i--v~~~~~~~~-----~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
.+.+|...+.++...+| .+++.+.+. ....++|+|++++. +|.+++..- ....+......++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 47899999988854444 344555543 23578999999876 899888431 2345666777899999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecC-------CCceEEcccCccc
Q 038713 79 LHDECEAQIIHGDIKPQNILMDE-------KRCAKISDFGLAK 114 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~-------~~~~~l~d~~~~~ 114 (252)
||.. |++|+|++++|||+.. +..+.++||+.+.
T Consensus 154 LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999 9999999999999975 4578999999875
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.1e-08 Score=77.90 Aligned_cols=107 Identities=25% Similarity=0.332 Sum_probs=84.2
Q ss_pred HHHHHHHHHHHhCCCCCC--CcceeeeEecCC----cEEEEEecCCCC-CHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRTHHRN--PVRLLGYSFDVS----NKILVYDYMSNG-SLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
+..+.+|...+..+.... ..+.+++.+... ..++|+|++++. +|.+++..... .+......++.+++..++-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 446788888888874443 456677666522 457999999884 89998854222 5566677899999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCC---ceEEcccCccccc
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKR---CAKISDFGLAKLM 116 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~---~~~l~d~~~~~~~ 116 (252)
||.. |++|+|+++.|||+..++ .+.++||+.++..
T Consensus 134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 999999999999999887 7899999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.2e-09 Score=92.24 Aligned_cols=198 Identities=17% Similarity=0.165 Sum_probs=136.3
Q ss_pred HHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 038713 10 KTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQII 88 (252)
Q Consensus 10 ~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~ 88 (252)
+.|+.+...+ .|.++++.+..+....+.++--|||+++++...+... ...++...+++..|++.++.++|+. ..+
T Consensus 313 l~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~s~---~~~ 388 (524)
T KOG0601|consen 313 LGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIHSK---LFV 388 (524)
T ss_pred hhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhccccccch---hhh
Confidence 4566665555 7889999988888888888999999999887766322 2467778899999999999999999 999
Q ss_pred eeccCCCCEEecCC-CceEEcccCcccccCCCCCcccccccCCcccc--ccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 89 HGDIKPQNILMDEK-RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYV--AAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 89 h~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~--aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
|+|++|+||++..+ +..+++||+....+.-.... ....-++. ++.......+..+.|++|||..+.+.+++..
T Consensus 389 ~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 389 HLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGV----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cccccccceeeccchhhhhccccccccccceeccc----ccccccccccchhhccccccccccccccccccccccccCcc
Confidence 99999999999986 66788999887642211111 11122334 4445555568899999999999999987764
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
.-.....- ..+..+..... +.. ...+..+...++..++..||++.++...
T Consensus 465 ls~~~~~~----------~~i~~~~~p~~------~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 465 LSESGVQS----------LTIRSGDTPNL------PGL-KLQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred cCcccccc----------eeeecccccCC------Cch-HHhhhhhhhhhcCCccccchhhhhhccc
Confidence 33221000 01112222111 111 1345555568888999999998876544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.1e-08 Score=77.78 Aligned_cols=101 Identities=25% Similarity=0.298 Sum_probs=66.7
Q ss_pred HHHHHHHHHHHhCCCCC--CCcceeeeEecCCcEEEEEecCC--CCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH-Hh
Q 038713 6 EREFKTEMNAIGRTHHR--NPVRLLGYSFDVSNKILVYDYMS--NGSLVDVLFTPEKQPNWVERMGIARDIARGIRY-LH 80 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-lh 80 (252)
+....+|++.|.++... ++.+++++. .-.+||||++ |..+........ +......++.+++..+.. +|
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~~---~~~~~~~~~~~il~~~~~~~~ 124 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVDL---SPEEPKELLEEILEEIIKMLH 124 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCGG---GGSTHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhccc---cchhHHHHHHHHHHHHHHHHH
Confidence 45678999999999766 456666543 3479999997 544444332221 122345567788875555 57
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccC
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~ 117 (252)
.. |++|+|+++.||+++++ .+.++|||.+....
T Consensus 125 ~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 125 KA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp CT---TEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred hc---CceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 88 99999999999999887 89999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.5e-08 Score=87.42 Aligned_cols=102 Identities=15% Similarity=0.174 Sum_probs=69.1
Q ss_pred HHHHHHHHHHhCCC----CCCCcceeeeEec-CCcEEEEEecCCCCCHHhhh--cCCCC---CCCHHHHHHHHHHHHHHH
Q 038713 7 REFKTEMNAIGRTH----HRNPVRLLGYSFD-VSNKILVYDYMSNGSLVDVL--FTPEK---QPNWVERMGIARDIARGI 76 (252)
Q Consensus 7 ~~~~~E~~~l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~---~~~~~~~~~i~~~i~~~l 76 (252)
-+|.+|+..+.++. +.+.+.+-.++.+ .+..++||||++|+.+.+.- ...+. .+....+..++.|+
T Consensus 201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi---- 276 (537)
T PRK04750 201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV---- 276 (537)
T ss_pred hCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH----
Confidence 34667776666652 4455666565554 56788999999999998753 21111 12222222333333
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCC----ceEEcccCcccccCC
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKR----CAKISDFGLAKLMKP 118 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~----~~~l~d~~~~~~~~~ 118 (252)
... |++|+|++|.||+++.+| .++++|||.......
T Consensus 277 ---f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ---FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ---HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 446 999999999999999887 899999999987654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.7e-07 Score=73.33 Aligned_cols=108 Identities=22% Similarity=0.309 Sum_probs=82.7
Q ss_pred HHHHHHHHHHHhCCCCC--CCcceeeeEecC---CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 6 EREFKTEMNAIGRTHHR--NPVRLLGYSFDV---SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
..++.+|+++++.+.+. ++.+++.+.... +..++||||++|.++.+.+.. ..++......++.+++++|..||
T Consensus 39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH 116 (223)
T cd05154 39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALH 116 (223)
T ss_pred cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHh
Confidence 45788999999999653 457777776654 367899999999888776532 34666777778888888888888
Q ss_pred hcC-----------------------------------------------------CCCeeeeccCCCCEEecC--CCce
Q 038713 81 DEC-----------------------------------------------------EAQIIHGDIKPQNILMDE--KRCA 105 (252)
Q Consensus 81 ~~~-----------------------------------------------------~~~i~h~di~~~nil~~~--~~~~ 105 (252)
+.. ...++|+|+++.||+++. ++.+
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~ 196 (223)
T cd05154 117 SVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVV 196 (223)
T ss_pred CCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEE
Confidence 531 245799999999999998 5668
Q ss_pred EEcccCcccc
Q 038713 106 KISDFGLAKL 115 (252)
Q Consensus 106 ~l~d~~~~~~ 115 (252)
.++||+.+..
T Consensus 197 ~iID~e~~~~ 206 (223)
T cd05154 197 AVLDWELATL 206 (223)
T ss_pred EEEecccccc
Confidence 8999988764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.9e-07 Score=73.75 Aligned_cols=100 Identities=19% Similarity=0.236 Sum_probs=73.3
Q ss_pred hHHHHHHHHHHHhCCCCC--CCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRTHHR--NPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
++....+|.++|++|... .+.+.++ .+...+|||+++|--|...-. +....-.++..|++-+..+-..
T Consensus 152 sRl~A~rEf~~L~~L~~~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~ 221 (304)
T COG0478 152 SRLAAEREFEALQRLYPEGVKVPKPIA----WNRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRR 221 (304)
T ss_pred HHHHHHHHHHHHHHhhhcCCCCCCccc----cccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHc
Confidence 467788999999999655 6666665 456789999998866654331 1222333445555555555566
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccC
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~ 117 (252)
|++|+|+++-||+++++|.+.++||..+....
T Consensus 222 ---GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 222 ---GIVHGDLSEFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred ---CccccCCchheEEEecCCCEEEEeCcccccCC
Confidence 99999999999999999999999998876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=5.3e-07 Score=69.32 Aligned_cols=109 Identities=15% Similarity=0.124 Sum_probs=83.1
Q ss_pred hHhHHHHHHHHHHHhCCCCCC--CcceeeeEe-c----CCcEEEEEecCCC-CCHHhhhcCC-CCCCCHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRN--PVRLLGYSF-D----VSNKILVYDYMSN-GSLVDVLFTP-EKQPNWVERMGIARDIA 73 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~-~----~~~~~lv~e~~~~-g~L~~~l~~~-~~~~~~~~~~~i~~~i~ 73 (252)
+-++..|.+|...++++..-+ +.++. ++. . .....+|+|-++| -+|.+++.+. ....+...+..++.+++
T Consensus 60 P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va 138 (216)
T PRK09902 60 PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVA 138 (216)
T ss_pred CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHH
Confidence 446788999999999984332 44444 332 1 2246799997754 5898888542 33567777888999999
Q ss_pred HHHHHHhhcCCCCeeeeccCCCCEEecCCCc--eEEcccCcccc
Q 038713 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRC--AKISDFGLAKL 115 (252)
Q Consensus 74 ~~l~~lh~~~~~~i~h~di~~~nil~~~~~~--~~l~d~~~~~~ 115 (252)
..++-||.. |+.|+|+.+.||+++..+. +.++||.-++.
T Consensus 139 ~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 139 LAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999999999 9999999999999986666 89999876653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.1e-06 Score=63.98 Aligned_cols=102 Identities=20% Similarity=0.216 Sum_probs=81.4
Q ss_pred HHHHHHHhCCCC-CCCcceeeeEecCCcEEEEEecCCCCCHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 10 KTEMNAIGRTHH-RNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLF--TPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 10 ~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
..|.-+++.+++ +++.+++|+|- ..++.||...+++...-. ......+|..+.+++.++++.+.+++......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468888988966 69999999995 367899998776643210 11224789999999999999999999965446
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
+..+|++++|+-+++++.++++|......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 99999999999999999999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.4e-06 Score=64.62 Aligned_cols=68 Identities=26% Similarity=0.413 Sum_probs=53.1
Q ss_pred CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCccc
Q 038713 35 SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114 (252)
Q Consensus 35 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~ 114 (252)
....++|||++|..|.+... ++. .+...+.+++.-+|+. |+.|+|++|+|+++++++ ++++|++..+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 34568999999988876542 221 2446677889999999 999999999999998655 8999997655
Q ss_pred c
Q 038713 115 L 115 (252)
Q Consensus 115 ~ 115 (252)
.
T Consensus 183 ~ 183 (229)
T PF06176_consen 183 M 183 (229)
T ss_pred c
Confidence 3
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.6e-06 Score=75.90 Aligned_cols=149 Identities=19% Similarity=0.101 Sum_probs=105.1
Q ss_pred HHHHHHHHHhCCCCCC-CcceeeeEecCCcEEEEEecCCCC-CHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 8 EFKTEMNAIGRTHHRN-PVRLLGYSFDVSNKILVYDYMSNG-SLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
...-++++|.+++||| .++.++-++......+.++++.++ +...-.....-.+.+......+..-..+++++|+.
T Consensus 279 ~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~--- 355 (829)
T KOG0576|consen 279 SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS--- 355 (829)
T ss_pred hhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccc---
Confidence 3456789999999999 777777777788889999999877 32222211222233333344556666789999987
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
.-+|+| ||+.++ +..+.++|+......... ......+++.++|||+.....+..+.|.|++|.-..++.-|..
T Consensus 356 ~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~p 428 (829)
T KOG0576|consen 356 YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLP 428 (829)
T ss_pred cccCcc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCC
Confidence 668887 666544 678999998887655433 2233457889999999999899999999999976555555554
Q ss_pred c
Q 038713 166 C 166 (252)
Q Consensus 166 p 166 (252)
|
T Consensus 429 P 429 (829)
T KOG0576|consen 429 P 429 (829)
T ss_pred C
Confidence 4
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.1e-05 Score=70.63 Aligned_cols=107 Identities=19% Similarity=0.307 Sum_probs=74.0
Q ss_pred HHHHHHHHHHHhCC----CCCCCcceeeeEec-CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHH-HHHHH
Q 038713 6 EREFKTEMNAIGRT----HHRNPVRLLGYSFD-VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIAR-GIRYL 79 (252)
Q Consensus 6 ~~~~~~E~~~l~~l----~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~l 79 (252)
+-+|.+|+..+.++ +...-+++-.++.+ .+...++|||++|..+.+.........+...+. ..++. .+..+
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia---~~~~~~f~~q~ 281 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELA---ELLVRAFLRQL 281 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHH---HHHHHHHHHHH
Confidence 45678888888776 23333455555544 677889999999988888753333334533333 32322 22333
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCC
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP 118 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~ 118 (252)
-.. |+.|+|.+|.||++..+|.+.+.|||......+
T Consensus 282 ~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 282 LRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred Hhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 345 999999999999999999999999999887654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.8e-05 Score=69.18 Aligned_cols=107 Identities=17% Similarity=0.238 Sum_probs=68.8
Q ss_pred HHHHHHHHHHHhCC----CCCC---CcceeeeEec-CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRT----HHRN---PVRLLGYSFD-VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 6 ~~~~~~E~~~l~~l----~h~~---iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
+=+|.+|++...++ .|-+ -|++-.++.+ .....++|||++|..+.+.-.-....++...+. ..+.++..
T Consensus 238 ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~---~~l~~~~~ 314 (538)
T KOG1235|consen 238 ELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDIL---NKLVEAYL 314 (538)
T ss_pred hcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHH---HHHHHHHH
Confidence 33566777766655 3444 2334444444 567889999999987766543233345655444 33333222
Q ss_pred H-HhhcCCCCeeeeccCCCCEEecC----CCceEEcccCcccccCC
Q 038713 78 Y-LHDECEAQIIHGDIKPQNILMDE----KRCAKISDFGLAKLMKP 118 (252)
Q Consensus 78 ~-lh~~~~~~i~h~di~~~nil~~~----~~~~~l~d~~~~~~~~~ 118 (252)
. +-.. |++|+|-+|.||++.. ++.+.+.|||+.....+
T Consensus 315 ~qIf~~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 315 EQIFKT---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHhc---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2 2223 8999999999999984 56789999999876543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00011 Score=57.99 Aligned_cols=107 Identities=13% Similarity=0.186 Sum_probs=64.0
Q ss_pred HHHHHHHHHHhCCCCCC--CcceeeeEecCCcEEEEEecCCCCC-HHhhh---------------------cCC-CCCCC
Q 038713 7 REFKTEMNAIGRTHHRN--PVRLLGYSFDVSNKILVYDYMSNGS-LVDVL---------------------FTP-EKQPN 61 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~g~-L~~~l---------------------~~~-~~~~~ 61 (252)
....+|.++++.+..-. +.+++++..+.+...+|||+++|.. +...+ ..- .....
T Consensus 37 ~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~ 116 (226)
T TIGR02172 37 ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTST 116 (226)
T ss_pred HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 45688999999885433 5788888888888899999998863 21111 110 00111
Q ss_pred HHHHHH-HHHH----------HHH-HHHHHhhc-CCCCeeeeccCCCCEEecCCCceEEcccCccc
Q 038713 62 WVERMG-IARD----------IAR-GIRYLHDE-CEAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114 (252)
Q Consensus 62 ~~~~~~-i~~~----------i~~-~l~~lh~~-~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~ 114 (252)
...... +..+ +.. ...+|... ....++|+|+.|.|+++++++ +.++||+.+.
T Consensus 117 l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 117 FQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 111110 1000 111 11222211 124679999999999999888 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00011 Score=68.91 Aligned_cols=198 Identities=14% Similarity=0.153 Sum_probs=127.6
Q ss_pred HHHHHHHHhCCCCCCCcceeeeEecCCcE----EEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNK----ILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 9 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..-|...+.+..|+|++.++.|....... .+..+++..-++.+.+.. -...+....+.+..+..+|+.++|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~-- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSL-- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHh--
Confidence 33456667788999999999988764433 355678888888887743 34678888888999999999999998
Q ss_pred CCeeeeccCCC---CEEecCCCceEEc--ccCcccccCCCCCcccccccCCccccccccccCCCC--CCcccchhHHHHH
Q 038713 85 AQIIHGDIKPQ---NILMDEKRCAKIS--DFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI--TVKADVYSFGVVL 157 (252)
Q Consensus 85 ~~i~h~di~~~---nil~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~Di~slG~~l 157 (252)
...|.-+..+ +.-++..+.+... ||+.+........... ..-..-+.++|....... ....|+|++|...
T Consensus 306 -~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 -SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 6666655554 3333444555555 7777665443222111 112334566666554333 3447999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
..+..|..+-...... ..+.+. ...........+|+..++++|+++.+++...-.
T Consensus 383 ~~~~~~~~i~~~~~~~------------------~~~l~~-----~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVP------------------VSLLDV-----LSTSELLDALPKCLDEDSEERLSALELLTHPFL 437 (1351)
T ss_pred hhhhhcCcccccccch------------------hhhhcc-----ccchhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence 9998777553322111 001110 000124555669999999999999999876554
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0001 Score=57.92 Aligned_cols=101 Identities=22% Similarity=0.309 Sum_probs=66.6
Q ss_pred HHHHHHhCCC--CCCCcceeeeEecCCcEEEEEecCCCC-CHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 038713 11 TEMNAIGRTH--HRNPVRLLGYSFDVSNKILVYDYMSNG-SLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQI 87 (252)
Q Consensus 11 ~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i 87 (252)
+|+..|+++. +-.+.+.+.+. +-.+||||+... .-.-.|+ .-.+...+...+..++++.+.-|-.. +++
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~--a~L 188 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKE--AGL 188 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHh--cCc
Confidence 6667777663 22334444433 236899998442 1111121 12233335667788888888887773 399
Q ss_pred eeeccCCCCEEecCCCceEEcccCcccccCCCC
Q 038713 88 IHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120 (252)
Q Consensus 88 ~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~ 120 (252)
||+|++..|||+. .+.+.++|++.+....++.
T Consensus 189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp~ 220 (268)
T COG1718 189 VHGDLSEYNILVH-DGEPYIIDVSQAVTIDHPN 220 (268)
T ss_pred ccccchhhheEEE-CCeEEEEECccccccCCCc
Confidence 9999999999999 8889999999987655433
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0002 Score=57.05 Aligned_cols=46 Identities=11% Similarity=0.091 Sum_probs=34.8
Q ss_pred HHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhh
Q 038713 7 REFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDV 52 (252)
Q Consensus 7 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 52 (252)
.++.+|+++++.+ ++--+.+++++....+..++||++++|.++...
T Consensus 36 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 36 YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 3567899999888 344456788877776778999999998777643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0016 Score=61.19 Aligned_cols=43 Identities=9% Similarity=0.230 Sum_probs=33.9
Q ss_pred HHHHHHHHHHHhCCC-CCCC--cceeeeEecC---CcEEEEEecCCCCC
Q 038713 6 EREFKTEMNAIGRTH-HRNP--VRLLGYSFDV---SNKILVYDYMSNGS 48 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv~e~~~~g~ 48 (252)
...+.+|+++++.+. |+++ .+++.++.+. +..++||||++|..
T Consensus 82 ~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 82 AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence 457889999999995 6665 7888887764 46789999998854
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0011 Score=52.58 Aligned_cols=31 Identities=32% Similarity=0.651 Sum_probs=25.5
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
..++|+|+.+.|++++.++..-++||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998765567999998653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0041 Score=47.87 Aligned_cols=100 Identities=21% Similarity=0.255 Sum_probs=69.9
Q ss_pred HHHHHHHHHHHhCCC------CCCCcceeeeEecCCcEEEEEecCCC------CCHHhhhcCCCCCCCHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRTH------HRNPVRLLGYSFDVSNKILVYDYMSN------GSLVDVLFTPEKQPNWVERMGIARDIA 73 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~i~~~i~ 73 (252)
.+++.+|+.-...+. +.+|.+++|+.+++....+|+|.+.. -+|.+++... .++. ... ..+-
T Consensus 55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~---~~L~ 128 (199)
T PF10707_consen 55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELR---QALD 128 (199)
T ss_pred hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHH---HHHH
Confidence 466677777766665 78899999999999999999998632 3677777433 2444 333 3333
Q ss_pred HHHHHHhhcCCCCeeeeccCCCCEEecCCC----ceEEcc-cCccc
Q 038713 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKR----CAKISD-FGLAK 114 (252)
Q Consensus 74 ~~l~~lh~~~~~~i~h~di~~~nil~~~~~----~~~l~d-~~~~~ 114 (252)
+-..+|-+. +|+.+|++|.||++..++ .+.++| ||...
T Consensus 129 ~f~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 129 EFKRYLLDH---HIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred HHHHHHHHc---CCeecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence 456677777 999999999999996332 356666 45443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0034 Score=49.22 Aligned_cols=110 Identities=21% Similarity=0.260 Sum_probs=58.6
Q ss_pred hHHHHHHHHHHHhCCCCC--CCcceeeeEe---cCCcEEEEEecCCCCCHHh----------------hh---cC---CC
Q 038713 5 GEREFKTEMNAIGRTHHR--NPVRLLGYSF---DVSNKILVYDYMSNGSLVD----------------VL---FT---PE 57 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~--~iv~~~~~~~---~~~~~~lv~e~~~~g~L~~----------------~l---~~---~~ 57 (252)
....+.+|..+++.+... .+.+++.... .....+++|++++|..+.. .+ .. ..
T Consensus 33 ~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~ 112 (239)
T PF01636_consen 33 AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPF 112 (239)
T ss_dssp HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTC
T ss_pred CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccc
Confidence 456788999999888433 3456666443 2445789999999987777 11 00 11
Q ss_pred CCCCHHHH---------HHH------------HHHHHH-HHHHHhhc----CCCCeeeeccCCCCEEec-CCCceEEccc
Q 038713 58 KQPNWVER---------MGI------------ARDIAR-GIRYLHDE----CEAQIIHGDIKPQNILMD-EKRCAKISDF 110 (252)
Q Consensus 58 ~~~~~~~~---------~~i------------~~~i~~-~l~~lh~~----~~~~i~h~di~~~nil~~-~~~~~~l~d~ 110 (252)
........ ... ...+.. .+..++.. ....++|+|+.+.||+++ .++.+.++||
T Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~ 192 (239)
T PF01636_consen 113 SPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDF 192 (239)
T ss_dssp CCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--G
T ss_pred cccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEec
Confidence 11111100 000 011122 23333321 224799999999999999 5666679999
Q ss_pred Cccc
Q 038713 111 GLAK 114 (252)
Q Consensus 111 ~~~~ 114 (252)
+.+.
T Consensus 193 e~a~ 196 (239)
T PF01636_consen 193 EDAG 196 (239)
T ss_dssp TT-E
T ss_pred ccce
Confidence 8764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0024 Score=52.48 Aligned_cols=100 Identities=15% Similarity=0.141 Sum_probs=71.1
Q ss_pred HHHHHHHHHHHhCCC-CCC-CcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 6 EREFKTEMNAIGRTH-HRN-PVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~-h~~-iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
|-...+|+..|+.|. |-. +.+.++ .+..++|||+++|-.|.+.-.-. + .-.+...+..-|--|..+
T Consensus 154 Rlaa~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~----d---~~~ly~~lm~~Iv~la~~- 221 (465)
T KOG2268|consen 154 RLAATKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHVE----D---PPTLYDDLMGLIVRLANH- 221 (465)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeecC----C---hHHHHHHHHHHHHHHHHc-
Confidence 445678899998883 322 334443 45679999999887776654221 1 223455566666777788
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD 119 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~ 119 (252)
|++|+|++--||++.+++.++++||..-....++
T Consensus 222 --GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~sh~ 255 (465)
T KOG2268|consen 222 --GLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTSHP 255 (465)
T ss_pred --CceecccchheeEEecCCCEEEeechHhhccCCC
Confidence 9999999999999999999999999766554443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.005 Score=49.41 Aligned_cols=30 Identities=20% Similarity=0.305 Sum_probs=25.7
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
..++|+|+.|.||++++++ +.++||..+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 3689999999999999877 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.00017 Score=69.57 Aligned_cols=156 Identities=10% Similarity=0.021 Sum_probs=111.0
Q ss_pred HHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCC---CCCHHHHHHHHHHH-HHHHHHHhhcC-
Q 038713 11 TEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEK---QPNWVERMGIARDI-ARGIRYLHDEC- 83 (252)
Q Consensus 11 ~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~~i-~~~l~~lh~~~- 83 (252)
.|.+-++...|+++...+.-... +...+.+++|+.+|++.+.+.+... ..+..-+. ..+++ +.+..-+|+..
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~-~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVH-LRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHH-HHHHHHHhccchhhhccc
Confidence 44445555688888777665543 5567899999999999999965322 22222222 33343 55556666653
Q ss_pred -CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 84 -EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 -~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+..-+|+++++-|.++..+-.++++++|+.+... ......+...+++-|+.|+......++.++|+|..|+-+|..-.
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 3457899999999999999999999999988333 23333444556777899999888888888999999999998877
Q ss_pred CCcccc
Q 038713 163 LRRCLD 168 (252)
Q Consensus 163 g~~p~~ 168 (252)
|..+|-
T Consensus 1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred ccHHHH
Confidence 766653
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.012 Score=51.27 Aligned_cols=162 Identities=19% Similarity=0.257 Sum_probs=89.5
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecC-CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDV-SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+....+..++.++|+|.-.++++.... .+.-+|+|++ +.||.+.+.... .-. .++ + ..
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~--------~s~---~----~~--- 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKD--------ESL---L----AH--- 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cch--------hhh---c----cc---
Confidence 4567788999999999999999988763 4466889999 669999885433 110 000 0 11
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
++.|-++ + +..| ..... ... ...+|+||||+|.++.++.-|..
T Consensus 87 ~~~~~~~-----~-------~~td-~~~t~-------~~~-----------------~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 87 GVLHLNI-----I-------YITD-HFLTK-------YPS-----------------PIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred ccceehh-----h-------hccc-ccccc-------CCC-----------------CCCcchhhhhHHHHHHHHHHhhH
Confidence 3333222 2 2222 11000 000 01149999999999999987765
Q ss_pred cccccchhhhHHHHHHHHHHH-hcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCF-ENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
-+......+.. +.+.+.. ..+......-....-.+..+.+..+..+|+-..|..||...+
T Consensus 130 l~~~~~~s~~l---~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 130 LEAELTESEYL---EILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred HHHHHHHHHHH---HHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 55433222111 1111111 111111110001233445566788888999999998885444
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.045 Score=45.30 Aligned_cols=106 Identities=21% Similarity=0.271 Sum_probs=68.0
Q ss_pred HHHHHHHHHHHhCCCC--CCCcceeeeEecCC--cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHH-HHHHHHHHHHh
Q 038713 6 EREFKTEMNAIGRTHH--RNPVRLLGYSFDVS--NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIA-RDIARGIRYLH 80 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~-~~i~~~l~~lh 80 (252)
..+-.+|..+++.+.- --+.+.+++|.+.. ..+.||++++|..+.+....... . .+.+ ..++..|+-||
T Consensus 65 ~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~--~----~~~~~~~l~~~La~LH 138 (321)
T COG3173 65 AHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESL--G----RQFALDALADFLAELH 138 (321)
T ss_pred hhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccc--h----HHHHHHHHHHHHHHHh
Confidence 4455677777777632 23446677777655 78999999988544433311110 0 0111 24444445555
Q ss_pred h--------------------------------------------------c-----CCCCeeeeccCCCCEEecCCCce
Q 038713 81 D--------------------------------------------------E-----CEAQIIHGDIKPQNILMDEKRCA 105 (252)
Q Consensus 81 ~--------------------------------------------------~-----~~~~i~h~di~~~nil~~~~~~~ 105 (252)
+ . ....++|+|+++.|+++.+.+-+
T Consensus 139 ~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~ 218 (321)
T COG3173 139 SIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPT 218 (321)
T ss_pred CCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCee
Confidence 4 1 13569999999999999998888
Q ss_pred EEcccCcccccC
Q 038713 106 KISDFGLAKLMK 117 (252)
Q Consensus 106 ~l~d~~~~~~~~ 117 (252)
=++||+.+....
T Consensus 219 gVlDwe~~~lGD 230 (321)
T COG3173 219 GVLDWELATLGD 230 (321)
T ss_pred EEEeccccccCC
Confidence 999999987644
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.023 Score=46.55 Aligned_cols=31 Identities=29% Similarity=0.445 Sum_probs=26.8
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
.+++|+|++|.|+++++++.+.++||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999877778999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.039 Score=41.46 Aligned_cols=96 Identities=16% Similarity=0.174 Sum_probs=65.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCc-ceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPV-RLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.+..+..|+++|..+.-.++. +++.|..+. +.|||++|-.|....... +..+ ...+++.-.-|...
T Consensus 58 ~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~L~~~~~~~----~rk~----l~~vlE~a~~LD~~- 124 (201)
T COG2112 58 PRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRPLGKLEIGG----DRKH----LLRVLEKAYKLDRL- 124 (201)
T ss_pred chhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcchhhhhhcc----cHHH----HHHHHHHHHHHHHh-
Confidence 467899999999998766654 555554443 349999998887765321 2222 34556666667777
Q ss_pred CCCeeeeccCC-CCEEecCCCceEEcccCcccc
Q 038713 84 EAQIIHGDIKP-QNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 84 ~~~i~h~di~~-~nil~~~~~~~~l~d~~~~~~ 115 (252)
||-|+.++- ....+.+++.+.++||..++.
T Consensus 125 --GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 125 --GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred --ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 999999984 444444444899999998873
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.041 Score=46.19 Aligned_cols=72 Identities=18% Similarity=0.196 Sum_probs=56.9
Q ss_pred cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 36 NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 36 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
..|++|++. |+++.. -+.....++..++.+.+..++-+.+. ...-||++...||+++ +|.+.++||-+++.
T Consensus 300 y~yl~~kdh-gt~is~-----ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPISI-----IKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-Cceeee-----eecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeec
Confidence 446777776 545432 22456778888999999888888887 6889999999999999 99999999999884
Q ss_pred c
Q 038713 116 M 116 (252)
Q Consensus 116 ~ 116 (252)
.
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 3
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.046 Score=46.01 Aligned_cols=103 Identities=16% Similarity=0.181 Sum_probs=69.1
Q ss_pred HHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeee
Q 038713 11 TEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHG 90 (252)
Q Consensus 11 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~ 90 (252)
.|+..|.+++...|.-. .... -.+..+||+++ |.+-+-.-.-..-.++...+..+-.+++.-+.-|.+.| ++||.
T Consensus 215 KE~RNLkRl~~aGIP~P-ePIl-Lk~hVLVM~Fl-Grdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHA 289 (520)
T KOG2270|consen 215 KEMRNLKRLNNAGIPCP-EPIL-LKNHVLVMEFL-GRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHA 289 (520)
T ss_pred HHHHHHHHHHhcCCCCC-Ccee-eecceEeeeec-cCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceecc
Confidence 56666777655543211 1111 13456899999 44433332223445677778888888888888888876 99999
Q ss_pred ccCCCCEEecCCCceEEcccCcccccCCC
Q 038713 91 DIKPQNILMDEKRCAKISDFGLAKLMKPD 119 (252)
Q Consensus 91 di~~~nil~~~~~~~~l~d~~~~~~~~~~ 119 (252)
|++--|+|+. .|.+.++|.+.+....++
T Consensus 290 DLSEfN~Lyh-dG~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 290 DLSEFNLLYH-DGKLYIIDVSQSVEHDHP 317 (520)
T ss_pred chhhhhheEE-CCEEEEEEccccccCCCh
Confidence 9999999975 467999998887654443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.072 Score=44.56 Aligned_cols=30 Identities=20% Similarity=0.365 Sum_probs=25.7
Q ss_pred CeeeeccCCCCEEecC-CCceEEcccCcccc
Q 038713 86 QIIHGDIKPQNILMDE-KRCAKISDFGLAKL 115 (252)
Q Consensus 86 ~i~h~di~~~nil~~~-~~~~~l~d~~~~~~ 115 (252)
-.+|+|+.+.||++++ ++.++++||..+..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 4899999999999975 46899999988754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.096 Score=44.08 Aligned_cols=30 Identities=33% Similarity=0.546 Sum_probs=25.9
Q ss_pred CCeeeeccCCCCEEecC-CCceEEcccCccc
Q 038713 85 AQIIHGDIKPQNILMDE-KRCAKISDFGLAK 114 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~-~~~~~l~d~~~~~ 114 (252)
..++|+|+++.||++++ ++.+.++||..+.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 47899999999999986 4679999998765
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.82 E-value=0.18 Score=41.49 Aligned_cols=31 Identities=26% Similarity=0.369 Sum_probs=27.1
Q ss_pred CCCeeeeccCCCCEEecCC----CceEEcccCccc
Q 038713 84 EAQIIHGDIKPQNILMDEK----RCAKISDFGLAK 114 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~----~~~~l~d~~~~~ 114 (252)
...++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 3579999999999999875 789999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.24 E-value=0.33 Score=41.46 Aligned_cols=29 Identities=28% Similarity=0.247 Sum_probs=24.0
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAK 114 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~ 114 (252)
...+|.|+.+.||+..+ +.+.++||..+.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 47899999999998754 459999997764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.15 Score=40.17 Aligned_cols=30 Identities=30% Similarity=0.461 Sum_probs=26.3
Q ss_pred CCeeeeccCCCCEEecC-CCceEEcccCccc
Q 038713 85 AQIIHGDIKPQNILMDE-KRCAKISDFGLAK 114 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~-~~~~~l~d~~~~~ 114 (252)
..++|+|+++.||+++. ++.+.++||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 37999999999999997 5779999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.13 E-value=0.36 Score=38.09 Aligned_cols=47 Identities=17% Similarity=0.270 Sum_probs=37.1
Q ss_pred HhHHHHHHHHHHHhCCCC---CCCcceeeeEecCCcEEEEEecCCCCCHH
Q 038713 4 EGEREFKTEMNAIGRTHH---RNPVRLLGYSFDVSNKILVYDYMSNGSLV 50 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~lv~e~~~~g~L~ 50 (252)
+...-|..|+.-|..+.- -++.+++.+....++.|+|+||++.|.+.
T Consensus 50 ~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 50 EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 445778899998888733 45778888888999999999999876554
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.87 E-value=0.084 Score=40.18 Aligned_cols=30 Identities=17% Similarity=0.257 Sum_probs=26.0
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
...+|+|+.|.|+++++++ ++++|++.+..
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 3679999999999998877 88999998764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=92.87 E-value=0.18 Score=41.68 Aligned_cols=31 Identities=32% Similarity=0.538 Sum_probs=26.9
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCccc
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~ 114 (252)
..+++|+|+++.|++++.++...++||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3589999999999999988767899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.76 E-value=0.56 Score=38.62 Aligned_cols=70 Identities=10% Similarity=0.022 Sum_probs=51.8
Q ss_pred HHHHHHHHHHhCCCC---CCCcceeeeEec---CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 7 REFKTEMNAIGRTHH---RNPVRLLGYSFD---VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
..|.+|++.|+.+.- -.+.++++++.. .+..++|||+++|+++.+. ..+......+..+++++++-||
T Consensus 52 ~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH 125 (297)
T PRK10593 52 GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWH 125 (297)
T ss_pred hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHh
Confidence 478999999998843 357788887764 4668999999999887651 1233344556678889999999
Q ss_pred hc
Q 038713 81 DE 82 (252)
Q Consensus 81 ~~ 82 (252)
+.
T Consensus 126 ~~ 127 (297)
T PRK10593 126 RI 127 (297)
T ss_pred CC
Confidence 85
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.55 E-value=0.29 Score=40.06 Aligned_cols=43 Identities=12% Similarity=0.275 Sum_probs=27.3
Q ss_pred hHHHHHHHHHHHhCCC---CCCCcceeeeEecCCcEEEEEecCCCC
Q 038713 5 GEREFKTEMNAIGRTH---HRNPVRLLGYSFDVSNKILVYDYMSNG 47 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~g 47 (252)
....|..|++-|+.|. --.+.+++++....+..++|+||++.+
T Consensus 52 ~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 52 GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 3456889999998883 234678899888777789999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.48 E-value=0.26 Score=39.90 Aligned_cols=30 Identities=30% Similarity=0.464 Sum_probs=27.6
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
-.||+|+.|.|++.++.+.+.++||..+..
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 599999999999999999999999988764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.42 E-value=0.15 Score=40.04 Aligned_cols=86 Identities=19% Similarity=0.235 Sum_probs=53.3
Q ss_pred HHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 038713 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQI 87 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i 87 (252)
-|.++..++.+++ .|+++.+= +.-.+.++.|.|.... ..... ...-=+.+|.-.|+. +.+.
T Consensus 104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----------i~~~N---~i~agi~~L~~fH~~-~~~~ 164 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----------INFSN---FITAGIKDLMDFHSE-NQHC 164 (308)
T ss_pred hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----------cchhH---HHHHhHHHHHHhhcc-CCCe
Confidence 3455566665543 34555421 3445668888884321 11111 111113567777854 4689
Q ss_pred eeeccCCCCEEecCCCceEEcccCc
Q 038713 88 IHGDIKPQNILMDEKRCAKISDFGL 112 (252)
Q Consensus 88 ~h~di~~~nil~~~~~~~~l~d~~~ 112 (252)
+|+|.+|+||+-+..|-+|+.|-+.
T Consensus 165 lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 165 LHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ecCCCChhheeecCCCCEEecChhh
Confidence 9999999999999999999999543
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.20 E-value=0.36 Score=39.76 Aligned_cols=29 Identities=24% Similarity=0.367 Sum_probs=25.1
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAK 114 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~ 114 (252)
.+++|+|+++.|++++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 48999999999999987 668899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.18 E-value=0.099 Score=40.59 Aligned_cols=30 Identities=33% Similarity=0.561 Sum_probs=21.5
Q ss_pred CeeeeccCCCCEEe-cCCCceEEcccCcccc
Q 038713 86 QIIHGDIKPQNILM-DEKRCAKISDFGLAKL 115 (252)
Q Consensus 86 ~i~h~di~~~nil~-~~~~~~~l~d~~~~~~ 115 (252)
.++|+|+.+.||++ ..++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 79999999999999 7889999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=92.06 E-value=1 Score=34.84 Aligned_cols=85 Identities=25% Similarity=0.404 Sum_probs=58.5
Q ss_pred HHHHHHHHHHhCCC---CCCC--cceeeeEecC------------------CcEEEEEecCCCCCHHhhhcCCCCCCCHH
Q 038713 7 REFKTEMNAIGRTH---HRNP--VRLLGYSFDV------------------SNKILVYDYMSNGSLVDVLFTPEKQPNWV 63 (252)
Q Consensus 7 ~~~~~E~~~l~~l~---h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 63 (252)
.-|..|.++..+|+ +.++ |+++|+..-. ....||.||.+... ..+..
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~ 168 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR 168 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh
Confidence 45888999988773 4455 8999987421 12356777765533 12222
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcc
Q 038713 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA 113 (252)
Q Consensus 64 ~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~ 113 (252)
-+.+|.+-+..+|+. ||+-+|+++.|.. + =+++|||.+
T Consensus 169 ----~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 169 ----DIPQMLRDLKILHKL---GIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred ----HHHHHHHHHHHHHHC---CeeeccCcccccc---C--CEEEecccC
Confidence 345677778889999 9999999999987 2 388888764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.66 E-value=0.12 Score=42.76 Aligned_cols=30 Identities=30% Similarity=0.476 Sum_probs=25.7
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAK 114 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~ 114 (252)
.+++|+|+++.||+++.+...-++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999866556799998865
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=91.64 E-value=3 Score=36.05 Aligned_cols=30 Identities=17% Similarity=0.424 Sum_probs=24.1
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCccc
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~ 114 (252)
...++|+|+.+.||+++.++ .+++|...+.
T Consensus 229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~ 258 (418)
T PLN02756 229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAF 258 (418)
T ss_pred ccceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence 45899999999999999876 7778755443
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.03 E-value=1.9 Score=36.08 Aligned_cols=85 Identities=19% Similarity=0.226 Sum_probs=60.0
Q ss_pred CCCCCcceeeeEecCCcEEEEEecCCC-CCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEE
Q 038713 20 HHRNPVRLLGYSFDVSNKILVYDYMSN-GSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNIL 98 (252)
Q Consensus 20 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil 98 (252)
..|-+|++- ...+||.|+.. +.-.-.+ +.-.++..++...-.|+..+++-|...| -+||.|++-.|+|
T Consensus 348 pcP~vV~lk-------khvLVMsFiGd~~~aAPkL--K~v~l~d~E~~~aY~q~~~~M~~lY~Ec--~LVHADlSEyN~L 416 (531)
T KOG2269|consen 348 PCPQVVKLK-------KHVLVMSFIGDQGLAAPKL--KNVELTDDERRNAYDQVQSIMCRLYKEC--LLVHADLSEYNLL 416 (531)
T ss_pred CCCceeeee-------cceEEEEeecCCCCCCccc--cccccChHHHHHHHHHHHHHHHHHHHhh--heeecchhhhhhe
Confidence 456666653 45678888733 2211222 2233777777778889999998887775 8999999999999
Q ss_pred ecCCCceEEcccCccccc
Q 038713 99 MDEKRCAKISDFGLAKLM 116 (252)
Q Consensus 99 ~~~~~~~~l~d~~~~~~~ 116 (252)
.... .+.++|...+..-
T Consensus 417 w~~g-Kvw~IDVsQsvep 433 (531)
T KOG2269|consen 417 WTPG-KVWVIDVSQSVEP 433 (531)
T ss_pred ecCC-ceEEEechhccCC
Confidence 9876 8999997766543
|
|
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=90.55 E-value=3 Score=35.08 Aligned_cols=122 Identities=13% Similarity=0.129 Sum_probs=72.5
Q ss_pred HHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCC-CHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeee
Q 038713 12 EMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNG-SLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHG 90 (252)
Q Consensus 12 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~ 90 (252)
+++++.+ ..|++++-+. .+.....+-++..... ++.+ + +.......++++.+.+..|.-+-. .-.|-
T Consensus 41 ~~~lld~-~~~f~~~eit--~~~Ds~vIsy~i~~~~~~F~~-~----k~~~k~~Klr~a~~~I~~l~e~~~----tr~~~ 108 (434)
T COG4499 41 LAELLDK-SPPFIVAEIT--EDNDSFVISYPIPEAAKSFAS-A----KRKEKTRKLRLALQNIATLSELNN----TRYTF 108 (434)
T ss_pred HHHHhcc-CCCccceeec--ccCceeEEEecCccccchHHH-H----HHHHHHHHHHHHHHHHHHHHHhhc----cceeE
Confidence 4555665 4455544432 2334444445544322 2222 1 124556678878888777776554 45667
Q ss_pred ccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCcccc
Q 038713 91 DIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLD 168 (252)
Q Consensus 91 di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 168 (252)
=+.|+||+++.++.+.+..+|+-..+++.. +.||.+.. .+-+++..++.|..+|.
T Consensus 109 ~laPeNilf~~~l~p~~vH~Glk~~lpPye-------------~tee~f~~----------~ykA~~~~~fn~k~~Fe 163 (434)
T COG4499 109 FLAPENILFDGGLTPFFVHRGLKNSLPPYE-------------MTEERFLK----------EYKALAIYAFNGKFSFE 163 (434)
T ss_pred EecchheEEcCCCceEEEecchhccCCCCC-------------CCHHHHHH----------HHHHHHHHHHcCCccHH
Confidence 788999999999999999999865543322 33443332 44556666667777764
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=89.73 E-value=0.3 Score=37.48 Aligned_cols=31 Identities=26% Similarity=0.430 Sum_probs=25.3
Q ss_pred CCeeeeccCCCCEEecCCC-----ceEEcccCcccc
Q 038713 85 AQIIHGDIKPQNILMDEKR-----CAKISDFGLAKL 115 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~-----~~~l~d~~~~~~ 115 (252)
..++|+|+.+.|+++..++ .+.++||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 3799999999999997543 588999987653
|
subfamily of choline kinases |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.18 E-value=1 Score=37.69 Aligned_cols=46 Identities=28% Similarity=0.445 Sum_probs=33.5
Q ss_pred HHHHHHHHHHHhhcC----C-CC--eeeeccCCCCEEecCCCc-eEEcccCccc
Q 038713 69 ARDIARGIRYLHDEC----E-AQ--IIHGDIKPQNILMDEKRC-AKISDFGLAK 114 (252)
Q Consensus 69 ~~~i~~~l~~lh~~~----~-~~--i~h~di~~~nil~~~~~~-~~l~d~~~~~ 114 (252)
..++...+..+.+.. . .+ ++|+|+.|.||+++.... .-++||+-+.
T Consensus 174 ~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 174 RAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 345555555555542 2 23 999999999999998875 7899998765
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.05 E-value=1.3 Score=37.11 Aligned_cols=42 Identities=26% Similarity=0.192 Sum_probs=28.6
Q ss_pred HHHHHHHHHHHHHHHHH-hhcCCCCeeeeccCCCCEEecCCCc
Q 038713 63 VERMGIARDIARGIRYL-HDECEAQIIHGDIKPQNILMDEKRC 104 (252)
Q Consensus 63 ~~~~~i~~~i~~~l~~l-h~~~~~~i~h~di~~~nil~~~~~~ 104 (252)
+-+.-++.||+--.-.. .-.|-.+.+|.|+||.|||+.++..
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~ 321 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDE 321 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCC
Confidence 34455778887544223 3333458999999999999976653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=87.60 E-value=1 Score=37.21 Aligned_cols=32 Identities=25% Similarity=0.468 Sum_probs=28.0
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
..+++|+|+.+.|++++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 35899999999999999988899999987653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=87.20 E-value=0.45 Score=38.73 Aligned_cols=31 Identities=35% Similarity=0.670 Sum_probs=25.3
Q ss_pred CCeeeeccCCCCEEecCCCc-eEEcccCcccc
Q 038713 85 AQIIHGDIKPQNILMDEKRC-AKISDFGLAKL 115 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~-~~l~d~~~~~~ 115 (252)
..++|+|+++.||++++++. .-++||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 45999988754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 252 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-39 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-30 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-30 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 6e-91
Identities = 88/239 (36%), Positives = 134/239 (56%), Gaps = 8/239 (3%)
Query: 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP---N 61
GE +F+TE+ I HRN +RL G+ + ++LVY YM+NGS+ L + +
Sbjct: 70 GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 129
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
W +R IA ARG+ YLHD C+ +IIH D+K NIL+DE+ A + DFGLAKLM T
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLL--EDRAILQ 179
T +RGT ++A E+ + K DV+ +GV+LLE++ +R D L +D +L
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 180 EWICQCFENGNLSQLVE---DEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235
+W+ + L LV+ ++++++I+V L C P R M +V+ MLEG
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 2e-84
Identities = 83/242 (34%), Positives = 131/242 (54%), Gaps = 10/242 (4%)
Query: 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP---N 61
G EF+TE+ + H + V L+G+ + + IL+Y YM NG+L L+ + +
Sbjct: 78 GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM-KPDQ 120
W +R+ I ARG+ YLH IIH D+K NIL+DE KI+DFG++K + DQ
Sbjct: 138 WEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQE 180
T T ++GT Y+ E+ +T K+DVYSFGVVL E++C R + Q+L + L E
Sbjct: 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254
Query: 181 WICQCFENGNLSQLVE---DEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237
W + NG L Q+V+ +++ + L++ ++C+ R +M VL LE +
Sbjct: 255 WAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314
Query: 238 EI 239
+
Sbjct: 315 RL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-81
Identities = 88/238 (36%), Positives = 128/238 (53%), Gaps = 14/238 (5%)
Query: 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP--NW 62
+++F E+ + + H N V LLG+S D + LVY YM NGSL+D L + P +W
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM-KPDQT 121
R IA+ A GI +LH+ IH DIK NIL+DE AKISDFGLA+ K QT
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEW 181
+ I GT AY+A E R IT K+D+YSFGVVLLEI+ +D++ +L +
Sbjct: 190 VMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLDI 246
Query: 182 ICQCF-ENGNLSQLVED---EEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235
+ E + + D + D ++ M V +C+ ++ + R +KKV +L+
Sbjct: 247 KEEIEDEEKTIEDYI-DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 6e-53
Identities = 57/253 (22%), Positives = 103/253 (40%), Gaps = 28/253 (11%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSN----KILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ + E+ ++ H N ++ +G ++ L+ + GSL D L +W
Sbjct: 64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWN 121
Query: 64 ERMGIARDIARGIRYLHDECEAQ-------IIHGDIKPQNILMDEKRCAKISDFGLAKLM 116
E IA +ARG+ YLH++ I H DIK +N+L+ A I+DFGLA
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 117 KPDQTRTFT-GIRGTRAYVAAE-----WHRNLPITVKADVYSFGVVLLEIVCLRRCLDQN 170
+ ++ T G GTR Y+A E + ++ D+Y+ G+VL E+ D
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 171 LLEDRAILQEWICQCFENGNLSQLVEDEEVD---------QKQLQRMIKVGLRCILDEPS 221
+ E +E I Q ++ ++V ++ + + + C +
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 222 LRRAMKKVLLMLE 234
R + V +
Sbjct: 302 ARLSAGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-46
Identities = 58/164 (35%), Positives = 89/164 (54%), Gaps = 4/164 (2%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE--KQP 60
AE EF E+ + R H N V +G N +V +Y+S GSL +L +Q
Sbjct: 75 AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQL 134
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
+ R+ +A D+A+G+ YLH I+H ++K N+L+D+K K+ DFGL++L K
Sbjct: 135 DERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KAST 192
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
+ GT ++A E R+ P K+DVYSFGV+L E+ L+
Sbjct: 193 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-46
Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 9/163 (5%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP--NWV 63
+ F E+ + R +H N V+L G + LV +Y GSL +VL E P
Sbjct: 45 RKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAA 102
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEK-RCAKISDFGLAKLMKPDQTR 122
M ++G+ YLH +IH D+KP N+L+ KI DFG A D
Sbjct: 103 HAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQT 158
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
T +G+ A++A E + K DV+S+G++L E++ R+
Sbjct: 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-43
Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 14/171 (8%)
Query: 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPN 61
+ E +EF+ E+ + +H N V+L G + +V +++ G L L
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIK 120
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEK-----RCAKISDFGLAKLM 116
W ++ + DIA GI Y+ + I+H D++ NI + CAK++DFGL++
Sbjct: 121 WSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-- 177
Query: 117 KPDQTRTFTGIRGTRAYVAAE--WHRNLPITVKADVYSFGVVLLEIVCLRR 165
+ +G+ G ++A E T KAD YSF ++L I+
Sbjct: 178 --QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-42
Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
++ + E H N + L G N LV ++ G L VL K+
Sbjct: 47 SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPP 104
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEK--------RCAKISDFGLAK 114
+ A IARG+ YLHDE IIH D+K NIL+ +K + KI+DFGLA+
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 115 LMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
+ G A++A E R + +DV+S+GV+L E++
Sbjct: 165 EWHRTTKMSAA---GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-41
Identities = 38/175 (21%), Positives = 72/175 (41%), Gaps = 17/175 (9%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ + FK E+ A +T H N V +G + ++ +L V+ + +
Sbjct: 70 EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDV 129
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK----P 118
+ IA++I +G+ YLH + I+H D+K +N+ D + I+DFGL +
Sbjct: 130 NKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAG 185
Query: 119 DQTRTFTGIRGTRAYVAAE---------WHRNLPITVKADVYSFGVVLLEIVCLR 164
+ G ++A E LP + +DV++ G + E+
Sbjct: 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-41
Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 8/168 (4%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+ + FK E+ + +T H N + +GYS +V + SL L E +
Sbjct: 59 PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKF 117
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
+ + IAR ARG+ YLH + IIH D+K NI + E KI DFGLA
Sbjct: 118 EMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174
Query: 121 -TRTFTGIRGTRAYVAAEWHRN---LPITVKADVYSFGVVLLEIVCLR 164
+ F + G+ ++A E R P + ++DVY+FG+VL E++ +
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-40
Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
E +R F E+ + H N ++ +G + + +Y+ G+L ++ + + Q W
Sbjct: 48 EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPW 107
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM------ 116
+R+ A+DIA G+ YLH IIH D+ N L+ E + ++DFGLA+LM
Sbjct: 108 SQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164
Query: 117 -------KPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
K + + G ++A E K DV+SFG+VL EI+
Sbjct: 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-40
Identities = 54/275 (19%), Positives = 96/275 (34%), Gaps = 45/275 (16%)
Query: 1 MLAEGEREFKTE--MNAIGRTHHRNPVRLLGYSFDVS-----NKILVYDYMSNGSLVDVL 53
+ F E + + H N R + V+ +LV +Y NGSL L
Sbjct: 44 FSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL 103
Query: 54 FTPEKQPNWVERMGIARDIARGIRYLHDE------CEAQIIHGDIKPQNILMDEKRCAKI 107
+WV +A + RG+ YLH E + I H D+ +N+L+ I
Sbjct: 104 S--LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161
Query: 108 SDFGLAKLMKPD-------QTRTFTGIRGTRAYVAAE-------WHRNLPITVKADVYSF 153
SDFGL+ + + + GT Y+A E + D+Y+
Sbjct: 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221
Query: 154 GVVLLEIVCLRRCLD----QNLLEDRAILQEWICQCFENGNLSQLV----------EDEE 199
G++ EI RC D +++ E + Q + ++ LV E +
Sbjct: 222 GLIYWEI--FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK 279
Query: 200 VDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
+ ++ + + C + R + +
Sbjct: 280 ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-40
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 13/168 (7%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQP 60
R+F E + H N + +LG + L+ +M GSL +VL
Sbjct: 48 TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV 107
Query: 61 -NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD 119
+ + + A D+ARG+ +LH E I + +++++DE A+IS +
Sbjct: 108 VDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF----- 161
Query: 120 QTRTFTGIRGTRAYVAAEWHRNLP---ITVKADVYSFGVVLLEIVCLR 164
+ G A+VA E + P AD++SF V+L E+V
Sbjct: 162 -SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-39
Identities = 48/189 (25%), Positives = 77/189 (40%), Gaps = 22/189 (11%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI----LVYDYMSNGSLVDVLFTPEKQ 59
E +TE+ H N + + + L+ DY NGSL D L
Sbjct: 73 EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTT 130
Query: 60 PNWVERMGIARDIARGIRYLHDECEAQ-----IIHGDIKPQNILMDEKRCAKISDFGLAK 114
+ + +A G+ +LH E + I H D+K +NIL+ + I+D GLA
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190
Query: 115 LMKPDQTRTF---TGIRGTRAYVAAE------WHRNLPITVKADVYSFGVVLLEIVCLRR 165
D GT+ Y+ E + + AD+YSFG++L E+ RR
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARR 248
Query: 166 CLDQNLLED 174
C+ ++E+
Sbjct: 249 CVSGGIVEE 257
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-36
Identities = 49/197 (24%), Positives = 75/197 (38%), Gaps = 24/197 (12%)
Query: 1 MLAEGEREFKTE--MNAIGRTHHRNPVRLLGYSFDVSNKI----LVYDYMSNGSLVDVLF 54
+ ER + E + H N + + + LV DY +GSL D L
Sbjct: 73 FSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 132
Query: 55 TPEKQPNWVERMGIARDIARGIRYLHDECEAQ-----IIHGDIKPQNILMDEKRCAKISD 109
+ +A A G+ +LH E I H D+K +NIL+ + I+D
Sbjct: 133 R--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190
Query: 110 FGLAKLMKPDQTRTF---TGIRGTRAYVAAE------WHRNLPITVKADVYSFGVVLLEI 160
GLA GT+ Y+A E ++ +AD+Y+ G+V EI
Sbjct: 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250
Query: 161 VCLRRCLDQNLLEDRAI 177
RRC + ED +
Sbjct: 251 --ARRCSIGGIHEDYQL 265
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-36
Identities = 47/189 (24%), Positives = 76/189 (40%), Gaps = 24/189 (12%)
Query: 6 EREFK--TEMNAIGRTHHRNPVRLLGYSFDVSNKI----LVYDYMSNGSLVDVLFTPEKQ 59
E+ + TE+ H N + + + L+ Y GSL D L
Sbjct: 44 EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTT 101
Query: 60 PNWVERMGIARDIARGIRYLHDECEAQ-----IIHGDIKPQNILMDEKRCAKISDFGLAK 114
+ V + I IA G+ +LH E I H D+K +NIL+ + I+D GLA
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161
Query: 115 LMKPDQTR---TFTGIRGTRAYVAAEWHRNLPITV------KADVYSFGVVLLEIVCLRR 165
+ + GT+ Y+A E + D+++FG+VL E+ RR
Sbjct: 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARR 219
Query: 166 CLDQNLLED 174
+ ++ED
Sbjct: 220 MVSNGIVED 228
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-28
Identities = 41/174 (23%), Positives = 71/174 (40%), Gaps = 28/174 (16%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+ + + +F E + + H N VRL+G +V + + G + L T +
Sbjct: 151 LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARL 210
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
+ + D A G+ YL IH D+ +N L+ EK KISDFG+++
Sbjct: 211 RVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
Y A+ R +P+ + ++DV+SFG++L E
Sbjct: 268 ------------YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 4/157 (2%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP-NWVE 64
EF E + H N V+LLG ++ ++M+ G+L+D L +Q + V
Sbjct: 260 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 319
Query: 65 RMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF 124
+ +A I+ + YL + IH ++ +N L+ E K++DFGL++LM D
Sbjct: 320 LLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376
Query: 125 TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
G + + A E ++K+DV++FGV+L EI
Sbjct: 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 413
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-26
Identities = 46/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 1 MLAEG---EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE 57
+ EG E +F E + + H V+L G + + LV ++M +G L D L T
Sbjct: 39 TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR 98
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
+G+ D+ G+ YL + +IH D+ +N L+ E + K+SDFG+ + +
Sbjct: 99 GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
DQ + TG + P+ + K+DV+SFGV++ E+
Sbjct: 156 DDQYTSSTGTK-------------FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 199
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 34/169 (20%), Positives = 61/169 (36%), Gaps = 19/169 (11%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL----FTPEKQPNWVER 65
M + + ++ + +LV + S G+L++ + TPEK
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILM-----------DEKRCAKISDFGLAK 114
+ A + I +H + +IIHGDIKP N ++ D + D G +
Sbjct: 175 ISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 115 LMKP-DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
MK + FT T + E N P + D + + ++
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-26
Identities = 41/177 (23%), Positives = 80/177 (45%), Gaps = 32/177 (18%)
Query: 1 MLAEG---EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE 57
M+ EG E EF E + H V+L G ++ +YM+NG L++ L
Sbjct: 55 MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR 114
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
+ + + + +D+ + YL + Q +H D+ +N L++++ K+SDFGL++ +
Sbjct: 115 HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
D+ + G + P+ + K+D+++FGV++ EI
Sbjct: 172 DDEYTSSVGSK-------------FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-26
Identities = 41/170 (24%), Positives = 78/170 (45%), Gaps = 29/170 (17%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLG--YSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVE 64
+ K E+ + +H N V+ G + L+ +++ +GSL + L + + N +
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 65 RMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF 124
++ A I +G+ YL Q +H D+ +N+L++ + KI DFGL K ++ D+
Sbjct: 128 QLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE--- 181
Query: 125 TGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
Y + R+ P+ + +DV+SFGV L E++
Sbjct: 182 -------YYTVKD-DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-26
Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 29/173 (16%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK--ILVYDYMSNGSLVDVLFTPEKQPN 61
+ +R+F+ E+ + H V+ G S+ + LV +Y+ +G L D L + +
Sbjct: 66 DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD 125
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
+ + I +G+ YL + +H D+ +NIL++ + KI+DFGLAKL+ D+
Sbjct: 126 ASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182
Query: 122 RTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
YV E PI + ++DV+SFGVVL E+
Sbjct: 183 ----------YYVVRE-PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-26
Identities = 35/153 (22%), Positives = 63/153 (41%), Gaps = 14/153 (9%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79
H N +R D + + + + +L + + + +E + + + G+ +L
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 80 HDECEAQIIHGDIKPQNILMDEK-----RCAKISDFGLAKLMKPDQ--TRTFTGIRGTRA 132
H I+H D+KP NIL+ A ISDFGL K + + +G+ GT
Sbjct: 135 H---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 133 YVAAE---WHRNLPITVKADVYSFGVVLLEIVC 162
++A E T D++S G V ++
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 9/162 (5%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK--ILVYDYMSNGSLVDVLFTPE-KQ 59
F E + + H V+L VS + +V +YMS GSL+D L K
Sbjct: 303 TMSPEAFLQEAQVMKKLRHEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGETGKY 359
Query: 60 PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD 119
+ + +A IA G+ Y+ +H D++ NIL+ E K++DFGLA+L++ +
Sbjct: 360 LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416
Query: 120 QTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+ G + + A E T+K+DV+SFG++L E+
Sbjct: 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 9/162 (5%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK--ILVYDYMSNGSLVDVLFTPE-KQ 59
F E + + H V+L VS + +V +YMS GSL+D L K
Sbjct: 220 TMSPEAFLQEAQVMKKLRHEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGETGKY 276
Query: 60 PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD 119
+ + +A IA G+ Y+ +H D++ NIL+ E K++DFGLA+L++ +
Sbjct: 277 LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333
Query: 120 QTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+ G + + A E T+K+DV+SFG++L E+
Sbjct: 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 29/170 (17%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLG--YSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVE 64
R+F+ E+ + H N V+ G YS N L+ +Y+ GSL D L +++ + ++
Sbjct: 56 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 115
Query: 65 RMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF 124
+ I +G+ YL + IH D+ +NIL++ + KI DFGL K++ D+
Sbjct: 116 LLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--- 169
Query: 125 TGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
+ E PI +V +DV+SFGVVL E+
Sbjct: 170 -------FFKVKE-PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-25
Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 32/177 (18%)
Query: 1 MLAEG---EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE 57
M+ EG E EF E + + H V+ G +V +Y+SNG L++ L +
Sbjct: 39 MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG 98
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
K + + + D+ G+ +L Q IH D+ +N L+D C K+SDFG+ + +
Sbjct: 99 KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
DQ + G + P+ + K+DV++FG+++ E+
Sbjct: 156 DDQYVSSVGTK-------------FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-25
Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 29/170 (17%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLG--YSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVE 64
R+F+ E+ + H N V+ G YS N L+ +Y+ GSL D L +++ + ++
Sbjct: 87 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 146
Query: 65 RMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF 124
+ I +G+ YL + + IH D+ +NIL++ + KI DFGL K++ D+
Sbjct: 147 LLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--- 200
Query: 125 TGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
Y E PI +V +DV+SFGVVL E+
Sbjct: 201 -------YYKVKE-PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 17/166 (10%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK--ILVYDYMSNGSLVDVLFTPEKQP 60
+ F E N + H V+L V+ + ++ ++M+ GSL+D L + E
Sbjct: 224 SMSVEAFLAEANVMKTLQHDKLVKLHAV---VTKEPIYIITEFMAKGSLLDFLKSDEGSK 280
Query: 61 -NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD 119
+ + + IA G+ ++ + IH D++ NIL+ KI+DFGLA++++ +
Sbjct: 281 QPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337
Query: 120 QTRTFTG----IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+ G I+ T A E T+K+DV+SFG++L+EIV
Sbjct: 338 EYTAREGAKFPIKWT----APEAINFGSFTIKSDVWSFGILLMEIV 379
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-25
Identities = 39/169 (23%), Positives = 74/169 (43%), Gaps = 29/169 (17%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
+E E + + + RLLG + ++ + M G L+D + +
Sbjct: 61 NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+ IA+G+ YL + +++H D+ +N+L+ + KI+DFGLAKL+ ++
Sbjct: 120 LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----- 171
Query: 126 GIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
AE +PI T ++DV+S+GV + E++
Sbjct: 172 ------KEYHAE-GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-25
Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 19/177 (10%)
Query: 2 LAEGEREF-KTEMNAIGRTHHRNPVRLLGYSFDVSNKIL--VYDYMSNGSLVDVL----- 53
+ E E++ +E+N + H N VR D +N L V +Y G L V+
Sbjct: 44 MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK 103
Query: 54 ---FTPEKQPNWVERMGIARDIARGIRYLHDECEA--QIIHGDIKPQNILMDEKRCAKIS 108
+ E+ + + + ++ H + ++H D+KP N+ +D K+ K+
Sbjct: 104 ERQYLDEEFV-----LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158
Query: 109 DFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
DFGLA+++ D + T + GT Y++ E + K+D++S G +L E+ L
Sbjct: 159 DFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-24
Identities = 39/177 (22%), Positives = 71/177 (40%), Gaps = 21/177 (11%)
Query: 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK--ILVYDYMSNGSLVDVLFTPEKQ 59
E + + +H+N V+L + + + +L+ ++ GSL VL P
Sbjct: 47 FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA 106
Query: 60 PNWVERMG--IARDIARGIRYLHDECEAQIIHGDIKPQNILM----DEKRCAKISDFGLA 113
E + RD+ G+ +L + I+H +IKP NI+ D + K++DFG A
Sbjct: 107 YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
Query: 114 KLMKPDQTRTFTGIRGTRAYVAAE--------WHRNLPITVKADVYSFGVVLLEIVC 162
+ ++ D+ F + GT Y+ + D++S GV
Sbjct: 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-24
Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 27/170 (15%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKIL-VYDYMSNGSLVDVLFTPEKQPNWVE 64
+F TE + H N + LLG L V YM +G L + + P +
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 129
Query: 65 RMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF 124
+G +A+G++YL + +H D+ +N ++DEK K++DFGLA+ M + +
Sbjct: 130 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 186
Query: 125 TGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
G + LP+ T K+DV+SFGV+L E++
Sbjct: 187 HNKTGAK----------LPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-24
Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 27/171 (15%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
R+F +E + +G+ H N +RL G ++V +YM NGSL L T + Q +
Sbjct: 92 RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM 151
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
+ +G+ R + G+RYL + +H D+ +N+L+D K+SDFGL+++++ D
Sbjct: 152 QLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208
Query: 124 FTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
+T G +PI + +DV+SFGVV+ E++
Sbjct: 209 YTTTGG-----------KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-24
Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 31/170 (18%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLG--YSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVE 64
+K E++ + +H + ++ G ++ LV +Y+ GSL D L P +
Sbjct: 78 SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQ 135
Query: 65 RMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF 124
+ A+ I G+ YLH + IH D+ +N+L+D R KI DFGLAK +
Sbjct: 136 LLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE--- 189
Query: 125 TGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
Y E + P+ +DV+SFGV L E++
Sbjct: 190 -------YYRVRE-DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-24
Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 19/169 (11%)
Query: 1 MLAEG--EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPE 57
+ + F E + + + H N V+LLG + + +V +YM+ GSLVD L +
Sbjct: 223 CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 282
Query: 58 KQP-NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116
+ + + D+ + YL +H D+ +N+L+ E AK+SDFGL K
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-- 337
Query: 117 KPDQTRTFTG----IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+ + T ++ T A E R + K+DV+SFG++L EI
Sbjct: 338 --EASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIY 380
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-24
Identities = 46/169 (27%), Positives = 84/169 (49%), Gaps = 27/169 (15%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
+F E +G+ H N +RL G +++ +YM NG+L L + + + ++
Sbjct: 90 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL 149
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+G+ R IA G++YL +H D+ +NIL++ K+SDFGL+++++ D T+T
Sbjct: 150 VGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 126 GIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
G + +PI T +DV+SFG+V+ E++
Sbjct: 207 T-SGGK----------IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 244
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-24
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 1 MLAEG---EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE 57
L E EF E + H N V+LLG ++ ++M+ G+L+D L
Sbjct: 45 TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 104
Query: 58 KQP-NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116
+Q + V + +A I+ + YL + IH D+ +N L+ E K++DFGL++LM
Sbjct: 105 RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 161
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
D G + PI ++K+DV++FGV+L EI
Sbjct: 162 TGDTYTAHAGAK-------------FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-24
Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 27/170 (15%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKIL-VYDYMSNGSLVDVLFTPEKQPNWVE 64
+F TE + H N + LLG L V YM +G L + + P +
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 193
Query: 65 RMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF 124
+G +A+G+++L + +H D+ +N ++DEK K++DFGLA+ M + +
Sbjct: 194 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250
Query: 125 TGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
G + LP+ T K+DV+SFGV+L E++
Sbjct: 251 HNKTGAK----------LPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 7e-24
Identities = 55/180 (30%), Positives = 87/180 (48%), Gaps = 38/180 (21%)
Query: 1 MLAEG---EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK--ILVYDYMSNGSLVDVLFT 55
L +G F E N + + H+ VRL V+ + ++ +YM NGSLVD L T
Sbjct: 44 SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV---VTQEPIYIITEYMENGSLVDFLKT 100
Query: 56 PE-KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114
P + + + +A IA G+ ++ + IH D++ NIL+ + KI+DFGLA+
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 115 LMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
L++ ++ Y A E PI T+K+DV+SFG++L EIV
Sbjct: 158 LIEDNE------------YTARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-24
Identities = 44/163 (26%), Positives = 66/163 (40%), Gaps = 11/163 (6%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK----ILVYDYMSNGSLVDVLFTPEKQ 59
+ FK E + H N VR +LV + M++G+L L K
Sbjct: 67 SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKV 125
Query: 60 PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKR-CAKISDFGLAKLMKP 118
R I +G+++LH IIH D+K NI + KI D GLA L +
Sbjct: 126 MKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+ GT ++A E + DVY+FG+ +LE+
Sbjct: 185 SFAKAV---IGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA 223
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-24
Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 29/169 (17%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
+ M AIG H + VRLLG S ++ V Y+ GSL+D +
Sbjct: 59 FQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLL 117
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+ IA+G+ YL E ++H ++ +N+L+ +++DFG+A L+ PD
Sbjct: 118 LNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD----- 169
Query: 126 GIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
+ PI T ++DV+S+GV + E++
Sbjct: 170 ------KQLLYS-EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-23
Identities = 43/170 (25%), Positives = 75/170 (44%), Gaps = 29/170 (17%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKIL-VYDYMSNGSLVDVLFTPEKQPNWVER 65
F E + +H N + L+G + YM +G L+ + +P++ P +
Sbjct: 67 EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL 126
Query: 66 MGIARDIARGIRYLHDECEAQ-IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF 124
+ +ARG+ YL Q +H D+ +N ++DE K++DFGLA+ + + +
Sbjct: 127 ISFGLQVARGMEYL----AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182
Query: 125 TGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
R R LP+ T K+DV+SFGV+L E++
Sbjct: 183 QQHRHAR----------LPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-23
Identities = 46/172 (26%), Positives = 70/172 (40%), Gaps = 28/172 (16%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
E +F E+NA+ HRN +RL G K+ V + GSL+D L +
Sbjct: 62 PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLL 120
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
A +A G+ YL + IH D+ +N+L+ + KI DFGL + + +
Sbjct: 121 GTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD- 176
Query: 123 TFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
YV E HR +P + +D + FGV L E+
Sbjct: 177 ---------HYVMQE-HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 2e-23
Identities = 28/178 (15%), Positives = 65/178 (36%), Gaps = 26/178 (14%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYM--SNGSLVDVLF---T 55
A+ F + + + +R+ D V ++ +Y M + + +VL +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 56 PEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115
K R+ + + R + LH ++H ++P +I++D++ ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 116 MKPDQTRTFTGIRGTRAYVAAEW-----------HRNLPITVKADVYSFGVVLLEIVC 162
+ + +R + E R +T D ++ G+V+ I C
Sbjct: 255 -RDGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-23
Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 34/172 (19%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK---ILVYDYMSNGSLVDVLFTPEKQPNW 62
E E + + + VRL+G V +LV + G L L ++
Sbjct: 54 TEEMMREAQIMHQLDNPYIVRLIG----VCQAEALMLVMEMAGGGPLHKFLVGKREEIPV 109
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
+ ++ G++YL E +H D+ +N+L+ + AKISDFGL+K + D +
Sbjct: 110 SNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS- 165
Query: 123 TFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
Y A P+ + ++DV+S+GV + E +
Sbjct: 166 ---------YYTARS-AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 207
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 2e-23
Identities = 39/169 (23%), Positives = 71/169 (42%), Gaps = 21/169 (12%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNK--ILVYDYMSNGSLVDVLFTPEKQPNWVERMG 67
E + + +H+N V+L + + + +L+ ++ GSL VL P E
Sbjct: 55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 68 --IARDIARGIRYLHDECEAQIIHGDIKPQNILM----DEKRCAKISDFGLAKLMKPDQT 121
+ RD+ G+ +L + I+H +IKP NI+ D + K++DFG A+ ++ D+
Sbjct: 115 LIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE- 170
Query: 122 RTFTGIRGTRAYVAAE--------WHRNLPITVKADVYSFGVVLLEIVC 162
F + GT Y+ + D++S GV
Sbjct: 171 -QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-23
Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 27/169 (15%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
R+F E + +G+ H N +RL G ++V +YM NGSL L + Q ++
Sbjct: 90 RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+G+ R IA G++YL D +H D+ +NIL++ K+SDFGL ++++ D +T
Sbjct: 150 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 126 GIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
RG + +PI T +DV+S+G+VL E++
Sbjct: 207 T-RGGK----------IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-23
Identities = 37/154 (24%), Positives = 67/154 (43%), Gaps = 18/154 (11%)
Query: 20 HHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVL--------FTPEKQPNWVERMGIAR 70
+ + G +++ ++Y+YM N S++ P V + I +
Sbjct: 101 KNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-CIIK 158
Query: 71 DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGT 130
+ Y+H+E I H D+KP NILMD+ K+SDFG ++ M + + RGT
Sbjct: 159 SVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RGT 213
Query: 131 RAYVAAE--WHRNLPITVKADVYSFGVVLLEIVC 162
++ E + + K D++S G+ L +
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-23
Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 37/178 (20%)
Query: 1 MLAEG--EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPE 57
+ + F E + + + H N V+LLG + + +V +YM+ GSLVD L +
Sbjct: 51 CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 110
Query: 58 KQP-NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116
+ + + D+ + YL +H D+ +N+L+ E AK+SDFGL K
Sbjct: 111 RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-- 165
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
+ + T + LP+ + K+DV+SFG++L EI
Sbjct: 166 --EASSTQDTGK-------------LPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 208
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-23
Identities = 38/170 (22%), Positives = 74/170 (43%), Gaps = 31/170 (18%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
+E E + + + RLLG + ++ + M G L+D + +
Sbjct: 61 NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ-TRTF 124
+ IA+G+ YL + +++H D+ +N+L+ + KI+DFGLAKL+ ++
Sbjct: 120 LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 125 TGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
G + +PI T ++DV+S+GV + E++
Sbjct: 177 EGGK-------------VPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 97.1 bits (241), Expect = 4e-23
Identities = 44/164 (26%), Positives = 67/164 (40%), Gaps = 16/164 (9%)
Query: 10 KTEMNAIGRTHHRNPVRLL------GYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
E+ + + +H N V +L +Y G L L E
Sbjct: 60 CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 64 ERM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILMD---EKRCAKISDFGLAKLMKP 118
E + DI+ +RYLH+ +IIH D+KP+NI++ ++ KI D G AK +
Sbjct: 120 EGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
+ T GT Y+A E TV D +SFG + E +
Sbjct: 177 GEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-23
Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 2 LAEGEREF-KTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVL------ 53
++ ERE + E+ + H N V+ SF+ + + +V DY G L +
Sbjct: 62 MSSKEREESRREVAVLANMKHPNIVQYRE-SFEENGSLYIVMDYCEGGDLFKRINAQKGV 120
Query: 54 FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA 113
E Q + I ++++HD +I+H DIK QNI + + ++ DFG+A
Sbjct: 121 LFQEDQI-----LDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIA 172
Query: 114 KLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
+++ I GT Y++ E N P K+D+++ G VL E+ L+
Sbjct: 173 RVLNSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-23
Identities = 40/157 (25%), Positives = 65/157 (41%), Gaps = 7/157 (4%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
E + + E+ H N +RL GY D + L+ +Y G++ L K
Sbjct: 53 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 112
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
++A + Y H ++IH DIKP+N+L+ KI+DFG + +
Sbjct: 113 T-YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC 168
Query: 126 GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
GT Y+ E K D++S GV+ E +
Sbjct: 169 ---GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 7e-23
Identities = 38/174 (21%), Positives = 69/174 (39%), Gaps = 34/174 (19%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK---ILVYDYMSNGSLVDVLFTPEKQP 60
E E + + + VRL+G V +LV + G L L ++
Sbjct: 378 ADTEEMMREAQIMHQLDNPYIVRLIG----VCQAEALMLVMEMAGGGPLHKFLVGKREEI 433
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
+ ++ G++YL E +H ++ +N+L+ + AKISDFGL+K + D
Sbjct: 434 PVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
+ Y A P+ + ++DV+S+GV + E +
Sbjct: 491 S----------YYTARS-AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-23
Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 6/154 (3%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGI 68
F+ E++ + H+N V ++ + LV +Y+ +L + + + +
Sbjct: 58 FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINF 116
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG-I 127
I GI++ H + +I+H DIKPQNIL+D + KI DFG+AK + + + T T +
Sbjct: 117 TNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHV 172
Query: 128 RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
GT Y + E + D+YS G+VL E++
Sbjct: 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-23
Identities = 40/182 (21%), Positives = 70/182 (38%), Gaps = 28/182 (15%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFD---------VSNKILVY---DYMSNGSLVDVL 53
+ E+ A+ + H VR + S K+ +Y +L D +
Sbjct: 47 REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM 106
Query: 54 FT--PEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFG 111
++ + I IA + +LH + ++H D+KP NI K+ DFG
Sbjct: 107 NGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG 163
Query: 112 LAKLMKPDQTR-----------TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
L M D+ TG GT+ Y++ E + K D++S G++L E+
Sbjct: 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
Query: 161 VC 162
+
Sbjct: 224 LY 225
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-22
Identities = 36/171 (21%), Positives = 67/171 (39%), Gaps = 34/171 (19%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK--ILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ +F +E + H + V+L+G + + ++ + G L L + +
Sbjct: 57 KEKFMSEAVIMKNLDHPHIVKLIGI---IEEEPTWIIMELYPYGELGHYLERNKNSLKVL 113
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
+ + I + + YL +H DI +NIL+ C K+ DFGL++ ++ +
Sbjct: 114 TLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED--- 167
Query: 124 FTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
Y A LPI T +DV+ F V + EI+
Sbjct: 168 ---------YYKAS-VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEIL 208
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-22
Identities = 41/157 (26%), Positives = 65/157 (41%), Gaps = 7/157 (4%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
E + + E+ H N +R+ Y D L+ ++ G L L +
Sbjct: 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 117
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
++A + Y H E ++IH DIKP+N+LM K KI+DFG + + RT
Sbjct: 118 T-FMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC 173
Query: 126 GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
GT Y+ E K D++ GV+ E +
Sbjct: 174 ---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-22
Identities = 37/173 (21%), Positives = 68/173 (39%), Gaps = 34/173 (19%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK--ILVYDYMSNGSLVDVLFTPEKQPN 61
+F E + + H + V+L+G ++ ++ + + G L L + +
Sbjct: 58 SVREKFLQEALTMRQFDHPHIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLD 114
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
+ A ++ + YL + +H DI +N+L+ C K+ DFGL++ M+
Sbjct: 115 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-- 169
Query: 122 RTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
Y A LPI T +DV+ FGV + EI+
Sbjct: 170 ----------TYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 94.4 bits (234), Expect = 1e-22
Identities = 26/172 (15%), Positives = 59/172 (34%), Gaps = 15/172 (8%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYM--SNGSLVDVLF---T 55
A+ F + + + +R+ D V ++ +Y M + + +VL +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 56 PEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115
K R+ + + R + LH ++H ++P +I++D++ ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 116 MKPDQTRTFTGIRGTRAYVAAEW-----HRNLPITVKADVYSFGVVLLEIVC 162
A H +T D ++ G+ + I C
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 3e-22
Identities = 23/195 (11%), Positives = 46/195 (23%), Gaps = 40/195 (20%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGY--------------------------SFDVSN 36
A R +P + V+N
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162
Query: 37 KILVYDYMS-----NGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGD 91
+L+ S S +D ++ + + + R L ++HG
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGH 219
Query: 92 IKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEW--HRNLPITVKAD 149
P N+ + + D K + Y E+ T +
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASS--VPVTYAPREFLNASTATFTHALN 275
Query: 150 VYSFGVVLLEIVCLR 164
+ G+ + + CL
Sbjct: 276 AWQLGLSIYRVWCLF 290
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 3e-22
Identities = 41/156 (26%), Positives = 82/156 (52%), Gaps = 12/156 (7%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERM--GI 68
E+ + + V G +F +I + ++M GSL VL + P E++ +
Sbjct: 81 ELQVLHECNSPYIVGFYG-AFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKV 136
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIR 128
+ + +G+ YL ++ +I+H D+KP NIL++ + K+ DFG++ + +F
Sbjct: 137 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 191
Query: 129 GTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
GTR+Y++ E + +V++D++S G+ L+E+ R
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-22
Identities = 39/184 (21%), Positives = 70/184 (38%), Gaps = 31/184 (16%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK----ILVYDYMSNGSLVDVL------ 53
+ E + E + +H N +RL+ Y L+ + G+L + +
Sbjct: 68 QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK 127
Query: 54 --FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFG 111
F E Q + + I RG+ +H + H D+KP NIL+ ++ + D G
Sbjct: 128 GNFLTEDQI-----LWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLG 179
Query: 112 LAKLMK--PDQTRTFTGI------RGTRAYVAAE-WH--RNLPITVKADVYSFGVVLLEI 160
+ +R + R T +Y A E + + I + DV+S G VL +
Sbjct: 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239
Query: 161 VCLR 164
+
Sbjct: 240 MFGE 243
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-22
Identities = 38/167 (22%), Positives = 67/167 (40%), Gaps = 17/167 (10%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
F + + + H++ V G ILV +++ GSL L + N +
Sbjct: 54 NYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL 113
Query: 64 ERMGIARDIARGIRYLHDECEAQ-IIHGDIKPQNILMD--------EKRCAKISDFGLAK 114
++ +A+ +A + +L E +IHG++ +NIL+ K+SD G++
Sbjct: 114 WKLEVAKQLAAAMHFL----EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
Query: 115 LMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+ P I E +NL + D +SFG L EI
Sbjct: 170 TVLPKDILQER-IPWV-PPECIENPKNL--NLATDKWSFGTTLWEIC 212
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-22
Identities = 46/187 (24%), Positives = 72/187 (38%), Gaps = 36/187 (19%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-------------LVYDYMSNGSLVDV 52
+E+ + +H+ VR + N + + +Y NG+L D+
Sbjct: 46 LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL 105
Query: 53 LFTPEKQPNWVERMGIA---RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISD 109
+ + +R R I + Y+H + IIH D+KP NI +DE R KI D
Sbjct: 106 I---HSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159
Query: 110 FGLAKLMKPDQTRTFTGIR-------------GTRAYVAAEWHRNLPI-TVKADVYSFGV 155
FGLAK + + GT YVA E K D+YS G+
Sbjct: 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219
Query: 156 VLLEIVC 162
+ E++
Sbjct: 220 IFFEMIY 226
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-22
Identities = 37/169 (21%), Positives = 75/169 (44%), Gaps = 9/169 (5%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVY-DYMSNGSLVDVLFTPEKQ 59
M A+ + E++ + + +H N ++ SF N++ + + G L ++ +KQ
Sbjct: 71 MDAKARADCIKEIDLLKQLNHPNVIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQ 129
Query: 60 PNWV-ER--MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116
+ ER + + ++H +++H DIKP N+ + K+ D GL +
Sbjct: 130 KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
T + + GT Y++ E K+D++S G +L E+ L+
Sbjct: 187 SSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-22
Identities = 39/174 (22%), Positives = 74/174 (42%), Gaps = 28/174 (16%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKI----------------LVYDYMSNGSLVDVLFT 55
E+ A+ + H N V G + ++ G+L +
Sbjct: 54 EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-- 111
Query: 56 PEKQPNWV----ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFG 111
EK+ + + I +G+ Y+H + ++I+ D+KP NI + + + KI DFG
Sbjct: 112 -EKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFG 167
Query: 112 LAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
L +K D R T +GT Y++ E + + D+Y+ G++L E++ +
Sbjct: 168 LVTSLKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-22
Identities = 41/178 (23%), Positives = 73/178 (41%), Gaps = 37/178 (20%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK---ILVYDYMSNGSLVDVLFTPE 57
+ E E N + + + VR++G + +LV + G L L
Sbjct: 57 NDPALKDELLAEANVMQQLDNPYIVRMIG----ICEAESWMLVMEMAELGPLNKYLQQ-N 111
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQ-IIHGDIKPQNILMDEKRCAKISDFGLAKLM 116
+ + + ++ G++YL E +H D+ +N+L+ + AKISDFGL+K +
Sbjct: 112 RHVKDKNIIELVHQVSMGMKYL----EESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
+ D+ Y A H P+ + K+DV+SFGV++ E
Sbjct: 168 RADEN----------YYKAQT-HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-22
Identities = 34/159 (21%), Positives = 72/159 (45%), Gaps = 11/159 (6%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ K E++ + HRN + L + +++++++S + + +
Sbjct: 42 GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFEL 99
Query: 63 VER--MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA--KISDFGLAKLMKP 118
ER + + +++LH I H DI+P+NI+ +R + KI +FG A+ +KP
Sbjct: 100 NEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
F + Y A E H++ ++ D++S G ++
Sbjct: 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-22
Identities = 39/165 (23%), Positives = 63/165 (38%), Gaps = 22/165 (13%)
Query: 6 EREFKTEMNAIGR-THHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVL-----FTPEK 58
E+ + + H VRL +++ + L + SL PE
Sbjct: 100 RARKLAEVGSHEKVGQHPCCVRLEQ-AWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEA 157
Query: 59 QPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM-K 117
Q G RD + +LH + ++H D+KP NI + + K+ DFGL +
Sbjct: 158 Q-----VWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
G Y+A E + ADV+S G+ +LE+ C
Sbjct: 210 AGAGEVQE---GDPRYMAPELLQG-SYGTAADVFSLGLTILEVAC 250
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-21
Identities = 38/157 (24%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ + E+ + H V L D + +++Y++MS G L + + + +
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 254
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA--KISDFGLAKLMKPDQ 120
E + R + +G+ ++H+ +H D+KP+NI+ KR K+ DFGL + P Q
Sbjct: 255 DEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
+ GT + A E P+ D++S GV+
Sbjct: 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 36/163 (22%), Positives = 68/163 (41%), Gaps = 18/163 (11%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK---ILVYDYMSNGSLVDVLFTPEKQPNW 62
+F E + + H + V+L+G V + ++ + + G L L + +
Sbjct: 435 REKFLQEALTMRQFDHPHIVKLIG----VITENPVWIIMELCTLGELRSFLQVRKFSLDL 490
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
+ A ++ + YL + +H DI +N+L+ C K+ DFGL++ M+
Sbjct: 491 ASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547
Query: 123 TFTG----IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+ I+ A E T +DV+ FGV + EI+
Sbjct: 548 KASKGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEIL 586
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-21
Identities = 54/195 (27%), Positives = 81/195 (41%), Gaps = 52/195 (26%)
Query: 1 MLAEG-----EREFKTEMNAIGR-THHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL- 53
+ E R+F E+ + + HH N + LLG L +Y +G+L+D L
Sbjct: 59 RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 118
Query: 54 --------------FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILM 99
+ + + + A D+ARG+ YL + Q IH D+ +NIL+
Sbjct: 119 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILV 175
Query: 100 DEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TV 146
E AKI+DFGL+ RG YV LP+ T
Sbjct: 176 GENYVAKIADFGLS--------------RGQEVYVKKT-MGRLPVRWMAIESLNYSVYTT 220
Query: 147 KADVYSFGVVLLEIV 161
+DV+S+GV+L EIV
Sbjct: 221 NSDVWSYGVLLWEIV 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-21
Identities = 39/155 (25%), Positives = 62/155 (40%), Gaps = 18/155 (11%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79
H +RL Y +V + N L L +K + ER +++ + +
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF-TGIRGTRAYVAAE- 137
H I+H D+KP N L+ + K+ DFG+A M+PD T GT Y+ E
Sbjct: 125 HQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 138 ----------WHRNLPITVKADVYSFGVVLLEIVC 162
I+ K+DV+S G +L +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-21
Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 11/158 (6%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ K E++ + + HH + L D +L+ +++S G L D + +
Sbjct: 90 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMS 147
Query: 64 ER--MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA--KISDFGLAKLMKPD 119
E + R G++++H+ I+H DIKP+NI+ + K+ + KI DFGLA + PD
Sbjct: 148 EAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204
Query: 120 QTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
+ T + A E P+ D+++ GV+
Sbjct: 205 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-21
Identities = 42/172 (24%), Positives = 62/172 (36%), Gaps = 33/172 (19%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL----FTPEKQPNWVER--MGIARDIA 73
H N +R + + N +L D++ + E E + + R IA
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRC-------------AKISDFGLAKLMKPDQ 120
G+ +LH +IIH D+KPQNIL+ ISDFGL K + Q
Sbjct: 126 SGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 121 ---TRTFTGIRGTRAYVAAE-------WHRNLPITVKADVYSFGVVLLEIVC 162
GT + A E +T D++S G V I+
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 4e-21
Identities = 36/155 (23%), Positives = 58/155 (37%), Gaps = 18/155 (11%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79
H +RL Y I + N L L + W + +++ + +
Sbjct: 114 HSDKIIRLYDY-EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTI 171
Query: 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF-TGIRGTRAYVAAE- 137
H I+H D+KP N L+ + K+ DFG+A M+PD T G Y+ E
Sbjct: 172 HQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 138 ----------WHRNLPITVKADVYSFGVVLLEIVC 162
I+ K+DV+S G +L +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-21
Identities = 39/168 (23%), Positives = 68/168 (40%), Gaps = 20/168 (11%)
Query: 9 FKTEMNAIGRTHHRNP--VRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM 66
++ E+ + + + +RL Y +V + N L L +K + ER
Sbjct: 73 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERK 130
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF-T 125
+++ + +H I+H D+KP N L+ + K+ DFG+A M+PD T
Sbjct: 131 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKD 186
Query: 126 GIRGTRAYVAAE-----------WHRNLPITVKADVYSFGVVLLEIVC 162
GT Y+ E I+ K+DV+S G +L +
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 4e-21
Identities = 32/133 (24%), Positives = 53/133 (39%), Gaps = 16/133 (12%)
Query: 43 YMSNGSLVDVL--FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMD 100
+L D + + + I IA + +LH + ++H D+KP NI
Sbjct: 142 LCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFT 198
Query: 101 EKRCAKISDFGLAKLMK-----------PDQTRTFTGIRGTRAYVAAEWHRNLPITVKAD 149
K+ DFGL M T TG GT+ Y++ E + K D
Sbjct: 199 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258
Query: 150 VYSFGVVLLEIVC 162
++S G++L E++
Sbjct: 259 IFSLGLILFELLY 271
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 5e-21
Identities = 32/95 (33%), Positives = 44/95 (46%), Gaps = 5/95 (5%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG- 126
I R I + H A H D+KP+NIL+ A + DFG+A D+ T G
Sbjct: 139 IVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGN 194
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
GT Y+A E T +AD+Y+ VL E +
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-21
Identities = 46/201 (22%), Positives = 76/201 (37%), Gaps = 55/201 (27%)
Query: 1 MLAEG-----EREFKTE---MNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDV 52
ML +E ++ +G H N V LLG +++ +Y G L++
Sbjct: 60 MLKPSAHLTEREALMSELKVLSYLGN--HMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 117
Query: 53 L-----------------FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQ 95
L E + + + + +A+G+ +L IH D+ +
Sbjct: 118 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR 174
Query: 96 NILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI----------- 144
NIL+ R KI DFGLA+ I+ YV R LP+
Sbjct: 175 NILLTHGRITKICDFGLARD-----------IKNDSNYVVKGNAR-LPVKWMAPESIFNC 222
Query: 145 --TVKADVYSFGVVLLEIVCL 163
T ++DV+S+G+ L E+ L
Sbjct: 223 VYTFESDVWSYGIFLWELFSL 243
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 8e-21
Identities = 44/195 (22%), Positives = 73/195 (37%), Gaps = 48/195 (24%)
Query: 1 MLAEG----EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL--- 53
L E ++F+ E + H++ VR G + ++V++YM +G L L
Sbjct: 78 ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137
Query: 54 -----------FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEK 102
+ + +A +A G+ YL +H D+ +N L+ +
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQG 194
Query: 103 RCAKISDFGLAK-LMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKA 148
KI DFG+++ + D R LPI T ++
Sbjct: 195 LVVKIGDFGMSRDIYSTDYYRVGGRTM-------------LPIRWMPPESILYRKFTTES 241
Query: 149 DVYSFGVVLLEIVCL 163
DV+SFGVVL EI
Sbjct: 242 DVWSFGVVLWEIFTY 256
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-21
Identities = 41/178 (23%), Positives = 67/178 (37%), Gaps = 38/178 (21%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFD-----VSNKILVYDYMSNGSLVDVL-----FTP 56
EF +E + H N +RLLG + + +++ +M G L L T
Sbjct: 81 EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140
Query: 57 EKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116
K + DIA G+ YL +H D+ +N ++ + ++DFGL+K
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK- 196
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
I Y +P+ T K+DV++FGV + EI
Sbjct: 197 ----------IYSGDYYRQGR-IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 9e-21
Identities = 39/163 (23%), Positives = 71/163 (43%), Gaps = 10/163 (6%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKI----LVYDYMSNGSLVDVLFTPEKQPNWVE 64
F+ E +H V + + +V +Y+ +L D++ E
Sbjct: 59 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKR 117
Query: 65 RMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD-QTRT 123
+ + D + + + H + IIH D+KP NI++ K+ DFG+A+ + + T
Sbjct: 118 AIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 124 FTG-IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
T + GT Y++ E R + ++DVYS G VL E++
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 1e-20
Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL-----FTPEKQPNW 62
E + E+N + H N + L + ++ +L+ + +S G L D L T E
Sbjct: 54 EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT-ED---- 108
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA----KISDFGLAKLMKP 118
E + I G+ YLH + +I H D+KP+NI++ +K K+ DFG+A ++
Sbjct: 109 -EATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
F I GT +VA E P+ ++AD++S GV+
Sbjct: 165 GN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-20
Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 20/159 (12%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL-----FTPEKQPNW 62
E + E++ + + H N + L + ++ +L+ + +S G L D L + E+
Sbjct: 61 EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS-EE---- 115
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA----KISDFGLAKLMKP 118
E + I G+ YLH + +I H D+KP+NI++ +K K+ DFGLA ++
Sbjct: 116 -EATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
F I GT +VA E P+ ++AD++S GV+
Sbjct: 172 GV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-20
Identities = 44/195 (22%), Positives = 73/195 (37%), Gaps = 50/195 (25%)
Query: 1 MLAEG-----EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL-- 53
L + EF+ E R H N V LLG +++ Y S+G L + L
Sbjct: 46 TLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM 105
Query: 54 -------------FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMD 100
T + + + + IA G+ YL ++H D+ +N+L+
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVY 162
Query: 101 EKRCAKISDFGLA-KLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TV 146
+K KISD GL ++ D + LPI ++
Sbjct: 163 DKLNVKISDLGLFREVYAADYYKLLGNSL-------------LPIRWMAPEAIMYGKFSI 209
Query: 147 KADVYSFGVVLLEIV 161
+D++S+GVVL E+
Sbjct: 210 DSDIWSYGVVLWEVF 224
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-20
Identities = 44/178 (24%), Positives = 71/178 (39%), Gaps = 37/178 (20%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL---------FTP 56
EF E + + + + VRLLG +++ + M+ G L L
Sbjct: 72 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 57 EKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116
P+ + + +A +IA G+ YL+ + +H D+ +N ++ E KI DFG+ +
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD- 187
Query: 117 KPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
I T Y LP+ T +DV+SFGVVL EI
Sbjct: 188 ----------IYETDYYRKGG-KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-20
Identities = 44/159 (27%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ + E K E++ + + H N ++L ++ +LV +Y+ G L D + ++ N
Sbjct: 127 MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII--DESYNL 184
Query: 63 VER--MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA--KISDFGLAKLMKP 118
E + + I GIR++H I+H D+KP+NIL + KI DFGLA+ KP
Sbjct: 185 TELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
+ GT ++A E ++ D++S GV+
Sbjct: 242 RE--KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-20
Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 39/179 (21%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL------FTPEKQ 59
E +F E I + +H+N VR +G S + ++ + M+ G L L +
Sbjct: 77 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 60 PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMD---EKRCAKISDFGLAK-L 115
++ + +ARDIA G +YL E IH DI +N L+ R AKI DFG+A+ +
Sbjct: 137 LAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193
Query: 116 MKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
+ R +G A LP+ T K D +SFGV+L EI
Sbjct: 194 YRASYYR-----KGGCAM--------LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-20
Identities = 53/200 (26%), Positives = 79/200 (39%), Gaps = 54/200 (27%)
Query: 1 MLAEG-----EREFKTE---MNAIGRTHHRNPVRLLGYSFDVSNKILV-YDYMSNGSLVD 51
ML EG R +E + IG H N V LLG ++V ++ G+L
Sbjct: 64 MLKEGATHSEHRALMSELKILIHIGH--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 52 VL---------------FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQN 96
L + + + +A+G+ +L + IH D+ +N
Sbjct: 122 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN 178
Query: 97 ILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI------------ 144
IL+ EK KI DFGLA+ + D YV R LP+
Sbjct: 179 ILLSEKNVVKICDFGLARDIYKDPD-----------YVRKGDAR-LPLKWMAPETIFDRV 226
Query: 145 -TVKADVYSFGVVLLEIVCL 163
T+++DV+SFGV+L EI L
Sbjct: 227 YTIQSDVWSFGVLLWEIFSL 246
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-20
Identities = 39/185 (21%), Positives = 72/185 (38%), Gaps = 25/185 (13%)
Query: 4 EGEREFKTEMNAIGR-THHRNPVRLLGYSFDVSNK-------ILVYDYMSNGSLVDVLFT 55
E R E+ + + + H N V+ + + L+ + G LV+ L
Sbjct: 67 EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKK 126
Query: 56 PEKQPNWVER--MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA 113
E + + I R ++++H + IIH D+K +N+L+ + K+ DFG A
Sbjct: 127 MESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185
Query: 114 KLMK--PDQTRTFTGI---------RGTRAYVAAE---WHRNLPITVKADVYSFGVVLLE 159
+ PD + + T Y E + N PI K D+++ G +L
Sbjct: 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
Query: 160 IVCLR 164
+ +
Sbjct: 246 LCFRQ 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-20
Identities = 45/194 (23%), Positives = 73/194 (37%), Gaps = 49/194 (25%)
Query: 1 MLAEG----EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL--- 53
L + ++F+ E + H + V+ G D I+V++YM +G L L
Sbjct: 52 ALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 111
Query: 54 ------------FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDE 101
+ + + + IA IA G+ YL +H D+ +N L+
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGA 168
Query: 102 KRCAKISDFGLAK-LMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVK 147
KI DFG+++ + D R LPI T +
Sbjct: 169 NLLVKIGDFGMSRDVYSTDYYRVGGHTM-------------LPIRWMPPESIMYRKFTTE 215
Query: 148 ADVYSFGVVLLEIV 161
+DV+SFGV+L EI
Sbjct: 216 SDVWSFGVILWEIF 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-20
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 20/159 (12%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL-----FTPEKQPNW 62
E + E++ + + H N + L + ++ +L+ + +S G L D L + E+
Sbjct: 61 EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS-EE---- 115
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA----KISDFGLAKLMKP 118
E + I G+ YLH +I H D+KP+NI++ +K K+ DFGLA ++
Sbjct: 116 -EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
F I GT +VA E P+ ++AD++S GV+
Sbjct: 172 GV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-20
Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 5/143 (3%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79
H++ V G+ D +V + SL+++ + R R I G +YL
Sbjct: 99 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYL 157
Query: 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWH 139
H ++IH D+K N+ ++E KI DFGLA ++ D R + GT Y+A E
Sbjct: 158 HRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL 213
Query: 140 RNLPITVKADVYSFGVVLLEIVC 162
+ + DV+S G ++ ++
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLV 236
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-20
Identities = 45/197 (22%), Positives = 78/197 (39%), Gaps = 51/197 (25%)
Query: 1 MLAEG-----EREFKTE---MNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDV 52
ML + +E M+ +G H N V LLG +++ +Y G L++
Sbjct: 83 MLKSTAHADEKEALMSELKIMSHLG--QHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 140
Query: 53 L-------------FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILM 99
L + + + + +A+G+ +L IH D+ +N+L+
Sbjct: 141 LRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL 197
Query: 100 DEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TV 146
AKI DFGLA+ + D Y+ + LP+ TV
Sbjct: 198 TNGHVAKIGDFGLARDIMNDS-----------NYIVKG-NARLPVKWMAPESIFDCVYTV 245
Query: 147 KADVYSFGVVLLEIVCL 163
++DV+S+G++L EI L
Sbjct: 246 QSDVWSYGILLWEIFSL 262
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-20
Identities = 35/169 (20%), Positives = 63/169 (37%), Gaps = 33/169 (19%)
Query: 20 HHRNPVRLLGYSFDVSNKILVY-DYMSNGSLVDVLFTPEKQPNWV---ERMGIARDIARG 75
H + VR ++ + +L+ +Y + GSL D + + ++ E + + RG
Sbjct: 69 QHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 76 IRYLHDECEAQIIHGDIKPQNILMDE-------------------KRCAKISDFGLAKLM 116
+RY+H ++H DIKP NI + K KI D G +
Sbjct: 128 LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 117 KPDQTRTFTGIRGTRAYVAAE-WHRNLPITVKADVYSFGVVLLEIVCLR 164
Q G ++A E N KAD+++ + ++
Sbjct: 185 SSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-20
Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 39/181 (21%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL------FTPEKQ 59
E +F E I + +H+N VR +G S + ++ + M+ G L L +
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 60 PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMD---EKRCAKISDFGLAK-L 115
++ + +ARDIA G +YL E IH DI +N L+ R AKI DFG+A+ +
Sbjct: 178 LAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234
Query: 116 MKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIVC 162
+ R +G A LP+ T K D +SFGV+L EI
Sbjct: 235 YRAGYYR-----KGGCAM--------LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
Query: 163 L 163
L
Sbjct: 282 L 282
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-20
Identities = 48/187 (25%), Positives = 78/187 (41%), Gaps = 48/187 (25%)
Query: 6 EREFKTE---MNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL--------- 53
+ +E M IG+ H+N + LLG ++ +Y S G+L + L
Sbjct: 84 LSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 54 ------FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKI 107
PE+Q + + + +ARG+ YL + IH D+ +N+L+ E KI
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKI 198
Query: 108 SDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFG 154
+DFGLA+ I Y + LP+ T ++DV+SFG
Sbjct: 199 ADFGLARD-----------INNIDYYKKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 155 VVLLEIV 161
V++ EI
Sbjct: 247 VLMWEIF 253
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-20
Identities = 36/156 (23%), Positives = 62/156 (39%), Gaps = 15/156 (9%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKILVY-DYMSNGSLVDVL--FTPEKQPNWVERMGI 68
E+ A V L G + + ++ + + GSL ++ + +
Sbjct: 100 ELVACAGLSSPRIVPLYG-AVREGPWVNIFMELLEGGSLGQLIKQMGCLPED---RALYY 155
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEK-RCAKISDFGLAKLMKPDQTRTFTG- 126
G+ YLH +I+HGD+K N+L+ A + DFG A ++PD
Sbjct: 156 LGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 127 ---IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
I GT ++A E P K D++S ++L
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 7e-20
Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 5/143 (3%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79
H++ V G+ D +V + SL+++ + R R I G +YL
Sbjct: 73 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYL 131
Query: 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWH 139
H ++IH D+K N+ ++E KI DFGLA ++ D R + GT Y+A E
Sbjct: 132 HRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL 187
Query: 140 RNLPITVKADVYSFGVVLLEIVC 162
+ + DV+S G ++ ++
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLV 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-20
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL-----FTPEKQPNW 62
+ + E++ + H N + L + ++ IL+ + ++ G L D L T E+
Sbjct: 60 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT-EE---- 114
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA----KISDFGLAKLMKP 118
E + I G+ YLH QI H D+KP+NI++ ++ KI DFGLA +
Sbjct: 115 -EATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
F I GT +VA E P+ ++AD++S GV+
Sbjct: 171 GN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 8e-20
Identities = 38/143 (26%), Positives = 63/143 (44%), Gaps = 4/143 (2%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79
H + + L Y D + LV + NG + L K + E I G+ YL
Sbjct: 69 KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWH 139
H I+H D+ N+L+ KI+DFGLA +K + +T + GT Y++ E
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIA 184
Query: 140 RNLPITVKADVYSFGVVLLEIVC 162
+++DV+S G + ++
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLI 207
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 9e-20
Identities = 53/199 (26%), Positives = 82/199 (41%), Gaps = 53/199 (26%)
Query: 1 MLAEG-----EREFKTE---MNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDV 52
ML + +E M IG+ H+N + LLG ++ +Y S G+L +
Sbjct: 108 MLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREY 165
Query: 53 L---------------FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNI 97
L PE+Q + + + A +ARG+ YL + IH D+ +N+
Sbjct: 166 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 222
Query: 98 LMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI------------- 144
L+ E KI+DFGLA+ + T R LP+
Sbjct: 223 LVTEDNVMKIADFGLARDIHHIDYYKKTT--NGR----------LPVKWMAPEALFDRIY 270
Query: 145 TVKADVYSFGVVLLEIVCL 163
T ++DV+SFGV+L EI L
Sbjct: 271 THQSDVWSFGVLLWEIFTL 289
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 9e-20
Identities = 51/199 (25%), Positives = 82/199 (41%), Gaps = 53/199 (26%)
Query: 1 MLAEG-----EREFKTE---MNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDV 52
ML + + +E M IG+ H+N + LLG ++ +Y S G+L +
Sbjct: 120 MLKDDATEKDLSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREY 177
Query: 53 L---------------FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNI 97
L PE+Q + + + +ARG+ YL + IH D+ +N+
Sbjct: 178 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 234
Query: 98 LMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI------------- 144
L+ E KI+DFGLA+ I Y + LP+
Sbjct: 235 LVTENNVMKIADFGLARD-----------INNIDYYKKTT-NGRLPVKWMAPEALFDRVY 282
Query: 145 TVKADVYSFGVVLLEIVCL 163
T ++DV+SFGV++ EI L
Sbjct: 283 THQSDVWSFGVLMWEIFTL 301
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 47/206 (22%), Positives = 76/206 (36%), Gaps = 60/206 (29%)
Query: 1 MLAEG-----EREFKTEMN---AIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDV 52
ML E +E+ +G H N V LLG L+++Y G L++
Sbjct: 82 MLKEKADSSEREALMSELKMMTQLGS--HENIVNLLGACTLSGPIYLIFEYCCYGDLLNY 139
Query: 53 L----------------------FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHG 90
L + + + A +A+G+ +L +H
Sbjct: 140 LRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR 196
Query: 91 DIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI------ 144
D+ +N+L+ + KI DFGLA+ I YV R LP+
Sbjct: 197 DLAARNVLVTHGKVVKICDFGLARD-----------IMSDSNYVVRGNAR-LPVKWMAPE 244
Query: 145 -------TVKADVYSFGVVLLEIVCL 163
T+K+DV+S+G++L EI L
Sbjct: 245 SLFEGIYTIKSDVWSYGILLWEIFSL 270
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-19
Identities = 39/179 (21%), Positives = 65/179 (36%), Gaps = 39/179 (21%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFD------VSNKILVYDYMSNGSLVDVL-----FT 55
EF E + H + +L+G S + +++ +M +G L L
Sbjct: 70 EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 56 PEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115
+ DIA G+ YL IH D+ +N ++ E ++DFGL++
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRK 186
Query: 116 MKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIV 161
I Y LP+ TV +DV++FGV + EI+
Sbjct: 187 -----------IYSGDYYRQGC-ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-19
Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVD-VLFTPEKQP 60
+ + E+ + H N +++ D N +V + G L++ ++ +
Sbjct: 60 SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK 119
Query: 61 NWVERM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILM---DEKRCAKISDFGLAKL 115
E + + + + Y H + ++H D+KP+NIL KI DFGLA+L
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 116 MKPDQTRTFTGIRGTRAYVAAE-WHRNLPITVKADVYSFGVVL 157
K D+ T GT Y+A E + R++ T K D++S GVV+
Sbjct: 177 FKSDE--HSTNAAGTALYMAPEVFKRDV--TFKCDIWSAGVVM 215
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-19
Identities = 34/163 (20%), Positives = 65/163 (39%), Gaps = 19/163 (11%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWV-E 64
+ M V G + + + + M + SL + + E
Sbjct: 54 MDLDISMRT---VDCPFTVTFYG-ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPE 108
Query: 65 RM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL-AKLMKPDQT 121
+ IA I + + +LH + +IH D+KP N+L++ K+ DFG+ L+
Sbjct: 109 DILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166
Query: 122 RTFTGIRGTRAYVAAE----WHRNLPITVKADVYSFGVVLLEI 160
G + Y+A E +VK+D++S G+ ++E+
Sbjct: 167 DIDA---GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-19
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 56/204 (27%)
Query: 1 MLAEG-----EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL-- 53
ML E R+ +E N + + +H + ++L G +L+ +Y GSL L
Sbjct: 60 MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRE 119
Query: 54 ---------------------FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDI 92
E+ + + A I++G++YL E +++H D+
Sbjct: 120 SRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDL 176
Query: 93 KPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------- 144
+NIL+ E R KISDFGL++ + + + YV R +P+
Sbjct: 177 AARNILVAEGRKMKISDFGLSRDVYEEDS-----------YVKRSQGR-IPVKWMAIESL 224
Query: 145 -----TVKADVYSFGVVLLEIVCL 163
T ++DV+SFGV+L EIV L
Sbjct: 225 FDHIYTTQSDVWSFGVLLWEIVTL 248
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-19
Identities = 39/143 (27%), Positives = 63/143 (44%), Gaps = 11/143 (7%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER--MGIARDIARGIR 77
+ L + S IL+ +Y + G + + PE E + + + I G+
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVY 145
Query: 78 YLHDECEAQIIHGDIKPQNILMDEKRCA---KISDFGLAKLMKPDQTRTFTGIRGTRAYV 134
YLH I+H D+KPQNIL+ KI DFG+++ + I GT Y+
Sbjct: 146 YLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYL 200
Query: 135 AAEWHRNLPITVKADVYSFGVVL 157
A E PIT D+++ G++
Sbjct: 201 APEILNYDPITTATDMWNIGIIA 223
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 14/165 (8%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ E+ + + H N ++L + D LV + + G L D + + +
Sbjct: 67 KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRF 123
Query: 63 VERM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILM---DEKRCAKISDFGLAKLMK 117
E I R + GI Y+H + +I+H D+KP+N+L+ + +I DFGL+ +
Sbjct: 124 SEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
+ GT Y+A E K DV+S GV+L ++
Sbjct: 181 ASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS 222
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-19
Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 9/162 (5%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ + E+ H+N V+ LG + + + + GSL +L +
Sbjct: 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD 119
Query: 63 VER--MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKR-CAKISDFGLAKLMKPD 119
E+ + I G++YLHD QI+H DIK N+L++ KISDFG +K +
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176
Query: 120 QTRTFTGIRGTRAYVAAE--WHRNLPITVKADVYSFGVVLLE 159
T T GT Y+A E AD++S G ++E
Sbjct: 177 NPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ E E++ + H N ++L D LV ++ G L + + + +
Sbjct: 88 KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFD 144
Query: 64 ERM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKR---CAKISDFGLAKLMKP 118
E I + I GI YLH + I+H DIKP+NIL++ K KI DFGL+
Sbjct: 145 ECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 119 DQTRTFTGIRGTRAYVAAE-WHRNLPITVKADVYSFGVVLLEIVC 162
D GT Y+A E + K DV+S GV++ ++C
Sbjct: 202 DY--KLRDRLGTAYYIAPEVLKKK--YNEKCDVWSCGVIMYILLC 242
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-19
Identities = 38/159 (23%), Positives = 72/159 (45%), Gaps = 19/159 (11%)
Query: 12 EMNAIGRTH-HRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERM--G 67
+++ + ++H V+ G +F + + + + M + P ER+
Sbjct: 73 DLDVVLKSHDCPYIVQCFG-TFITNTDVFIAMELMGTCAEKLKKRMQGPIP---ERILGK 128
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGL-AKLMKPDQTRTFTG 126
+ I + + YL ++ +IH D+KP NIL+DE+ K+ DFG+ +L+
Sbjct: 129 MTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA- 185
Query: 127 IRGTRAYVAAE-----WHRNLPITVKADVYSFGVVLLEI 160
G AY+A E ++ADV+S G+ L+E+
Sbjct: 186 --GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-19
Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 17/163 (10%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
A+ +TE+ + + +H +++ + FD + +V + M G L D + ++
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLK-- 237
Query: 63 VERM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILM---DEKRCAKISDFGLAKLMK 117
E + ++YLH+ IIH D+KP+N+L+ +E KI+DFG +K++
Sbjct: 238 -EATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293
Query: 118 PDQTRTFTGIRGTRAYVAAE---WHRNLPITVKADVYSFGVVL 157
+ GT Y+A E D +S GV+L
Sbjct: 294 ETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-19
Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 24/149 (16%)
Query: 21 HRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVL-----FTPEKQPNWVERMGIARDIAR 74
H N ++L ++ + LV+D M G L D L + EK E I R +
Sbjct: 83 HPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVTLS-EK-----ETRKIMRALLE 135
Query: 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYV 134
I LH I+H D+KP+NIL+D+ K++DFG + + P + + GT +Y+
Sbjct: 136 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYL 190
Query: 135 AAE------WHRNLPITVKADVYSFGVVL 157
A E + + D++S GV++
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 5e-19
Identities = 35/168 (20%), Positives = 66/168 (39%), Gaps = 18/168 (10%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-----LVYDYMSNGSLVDVLFTPE 57
AE + E + H + V++ + +V +Y+ SL
Sbjct: 120 AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---G 176
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
++ E + +I + YLH +++ D+KP+NI++ E++ K+ D G +
Sbjct: 177 QKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI- 231
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
+ + GT + A E R P TV D+Y+ G L +
Sbjct: 232 -NSFGY---LYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLP 274
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-19
Identities = 36/163 (22%), Positives = 65/163 (39%), Gaps = 18/163 (11%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVL-FTPEKQPNWV- 63
+ M + + V+ G + + + M + S + + +
Sbjct: 69 MDLDVVMRS---SDCPYIVQFYG-ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIP 123
Query: 64 ERM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
E + I + + +L + +IIH DIKP NIL+D K+ DFG++ +
Sbjct: 124 EEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181
Query: 122 RTFTGIRGTRAYVAAE----WHRNLPITVKADVYSFGVVLLEI 160
+T G R Y+A E V++DV+S G+ L E+
Sbjct: 182 KTRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 7e-19
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 14/167 (8%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+ + E+ + H N ++L + D N LV + G L D + +
Sbjct: 75 VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI---IHRM 131
Query: 61 NWVERM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILM---DEKRCAKISDFGLAKL 115
+ E I + + G+ YLH + I+H D+KP+N+L+ ++ KI DFGL+ +
Sbjct: 132 KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188
Query: 116 MKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
+ + GT Y+A E R K DV+S GV+L ++
Sbjct: 189 FENQK--KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLA 232
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-18
Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 25/163 (15%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDV---SNKI-LVYDYMSNGSLVDVLFT----PEKQPN 61
E+ + +H N V+L F+V + L+ +Y S G + D L EK
Sbjct: 62 FREVRIMKILNHPNIVKL----FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK--- 114
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
E R I ++Y H + I+H D+K +N+L+D KI+DFG +
Sbjct: 115 --EARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169
Query: 122 -RTFTGIRGTRAYVAAEWHRNLPIT-VKADVYSFGVVLLEIVC 162
F G Y A E + + DV+S GV+L +V
Sbjct: 170 LDAFC---GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-18
Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 24/149 (16%)
Query: 21 HRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVD-----VLFTPEKQPNWVERMGIARDIAR 74
H + + L+ ++ S+ + LV+D M G L D V + EK E I R +
Sbjct: 159 HPHIITLIDS-YESSSFMFLVFDLMRKGELFDYLTEKVALS-EK-----ETRSIMRSLLE 211
Query: 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYV 134
+ +LH I+H D+KP+NIL+D+ ++SDFG + ++P + + GT Y+
Sbjct: 212 AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYL 266
Query: 135 AAE------WHRNLPITVKADVYSFGVVL 157
A E + + D+++ GV+L
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-18
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 20 HHRNPVRLLGYSFDV-----SNKI-LVYDYMSNGSLVDVLFTPEKQP-NWVERMGIARDI 72
H N V+L +V + + +V++ ++ G +++V P +P + + +D+
Sbjct: 94 DHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPLSEDQARFYFQDL 146
Query: 73 ARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRA 132
+GI YLH + +IIH DIKP N+L+ E KI+DFG++ K GT A
Sbjct: 147 IKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN-TVGTPA 202
Query: 133 YVAAEWHRNLPITV---KADVYSFGVVLLEIVC 162
++A E DV++ GV L V
Sbjct: 203 FMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-18
Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVE 64
++ +TE+ + R H N ++L F+ +I LV + ++ G L D + ++ + E
Sbjct: 92 KKIVRTEIGVLLRLSHPNIIKLKEI-FETPTEISLVLELVTGGELFDRIV---EKGYYSE 147
Query: 65 RM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILM---DEKRCAKISDFGLAKLMKPD 119
R + I + YLH E I+H D+KP+N+L KI+DFGL+K+++
Sbjct: 148 RDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
Query: 120 QTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
+ GT Y A E R + D++S G++
Sbjct: 205 V--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-18
Identities = 44/168 (26%), Positives = 74/168 (44%), Gaps = 16/168 (9%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+ E+ + + H N ++L D S+ +V + + G L D + K+
Sbjct: 60 AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRK 116
Query: 61 NWVERM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKR---CAKISDFGLAKL 115
+ E I + + GI Y+H + I+H D+KP+NIL++ K KI DFGL+
Sbjct: 117 RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 116 MKPDQTRTFTGIRGTRAYVAAE-WHRNLPITVKADVYSFGVVLLEIVC 162
+ + GT Y+A E K DV+S GV+L ++
Sbjct: 174 FQQNT--KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLS 217
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-18
Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 23/166 (13%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVD-----VLFTPE 57
A+ +TE+ + + +H +++ + FD + +V + M G L D E
Sbjct: 56 ADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLK-E 113
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKR---CAKISDFGLAK 114
+ ++YLH+ IIH D+KP+N+L+ + KI+DFG +K
Sbjct: 114 A-----TCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165
Query: 115 LMKPDQTRTFTGIRGTRAYVAAE---WHRNLPITVKADVYSFGVVL 157
++ + GT Y+A E D +S GV+L
Sbjct: 166 ILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 6e-18
Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 6/159 (3%)
Query: 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQP 60
+ +E E++ + + + V+ G S+ + + +V +Y GS+ D++ K
Sbjct: 64 VESDLQEIIKEISIMQQCDSPHVVKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL 122
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
E I + +G+ YLH + IH DIK NIL++ + AK++DFG+A +
Sbjct: 123 TEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
+ T I GT ++A E + + AD++S G+ +E
Sbjct: 180 AKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 6e-18
Identities = 41/162 (25%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+ A ++ + E + H N VRL + S LV+D ++ G L + + ++
Sbjct: 44 LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--ARE- 100
Query: 61 NWVERM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKR---CAKISDFGLAKL 115
+ E + I I Y H I+H ++KP+N+L+ K K++DFGLA
Sbjct: 101 FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157
Query: 116 MKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
+ + + G GT Y++ E + P + D+++ GV+L
Sbjct: 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 8e-18
Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 14/162 (8%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+ E+ + + H N ++L D S+ +V + + G L D + K+
Sbjct: 60 AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRK 116
Query: 61 NWVERM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILM---DEKRCAKISDFGLAKL 115
+ E I + + GI Y+H I+H D+KP+NIL+ ++ KI DFGL+
Sbjct: 117 RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 116 MKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
+ + GT Y+A E R K DV+S GV+L
Sbjct: 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-17
Identities = 40/159 (25%), Positives = 65/159 (40%), Gaps = 14/159 (8%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
E FK E+ + H N +RL D ++ LV + + G L + + + +
Sbjct: 48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV---HKRVFR 104
Query: 64 ERM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILM---DEKRCAKISDFGLAKLMKP 118
E I +D+ + Y H + H D+KP+N L K+ DFGLA KP
Sbjct: 105 ESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
+ GT YV+ + + D +S GV++
Sbjct: 162 GK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMM 197
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-17
Identities = 36/163 (22%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPN 61
+ E+ + H N V + S+ V ++ ++ +++ G+L D++
Sbjct: 83 QQRRELLFNEVVIMRDYQHFNVVEMYK-SYLVGEELWVLMEFLQGGALTDIV-----SQV 136
Query: 62 WVERMGIA---RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP 118
+ IA + + + YLH + +IH DIK +IL+ K+SDFG +
Sbjct: 137 RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
D + + + GT ++A E + D++S G++++E+V
Sbjct: 194 DVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV 235
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-17
Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 26/167 (15%)
Query: 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVL-----FT 55
A + + E+ + + H N V L ++ + LV +S G L D + +T
Sbjct: 46 PAFRDSSLENEIAVLKKIKHENIVTLEDI-YESTTHYYLVMQLVSGGELFDRILERGVYT 104
Query: 56 PEKQPNWVERM--GIARDIARGIRYLHDECEAQIIHGDIKPQNIL---MDEKRCAKISDF 110
E+ + + + ++YLH+ I+H D+KP+N+L +E I+DF
Sbjct: 105 --------EKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDF 153
Query: 111 GLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
GL+K+ + T GT YVA E P + D +S GV+
Sbjct: 154 GLSKMEQNGIMSTAC---GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-17
Identities = 43/163 (26%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPN 61
+ E+ + + N V L S+ V +++ +V +Y++ GSL DV+
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLD-SYLVGDELWVVMEYLAGGSLTDVV-----TET 111
Query: 62 WVERMGIA---RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP 118
++ IA R+ + + +LH Q+IH DIK NIL+ K++DFG + P
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168
Query: 119 DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+Q++ T + GT ++A E K D++S G++ +E++
Sbjct: 169 EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-17
Identities = 41/162 (25%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
+ A ++ + E + H N VRL + S LV+D ++ G L + + ++
Sbjct: 67 LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--ARE- 123
Query: 61 NWVERM--GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA---KISDFGLAKL 115
+ E + I I Y H I+H ++KP+N+L+ K K++DFGLA
Sbjct: 124 FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180
Query: 116 MKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
+ + + G GT Y++ E + P + D+++ GV+L
Sbjct: 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-17
Identities = 39/155 (25%), Positives = 60/155 (38%), Gaps = 10/155 (6%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW-VERM- 66
K E + H + V LL +V+++M L + E +
Sbjct: 73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 67 -GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA---KISDFGLAKLMKPDQTR 122
R I +RY HD IIH D+KP +L+ K + K+ FG+A +
Sbjct: 133 SHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
G GT ++A E + P DV+ GV+L
Sbjct: 190 -AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-17
Identities = 48/205 (23%), Positives = 79/205 (38%), Gaps = 58/205 (28%)
Query: 1 MLAEG-----EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL-- 53
ML E + +F+ E + + N V+LLG L+++YM+ G L + L
Sbjct: 84 MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 143
Query: 54 ---------------------FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDI 92
+ E++ IAR +A G+ YL E + +H D+
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL 200
Query: 93 KPQNILMDEKRCAKISDFGLA-KLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI------- 144
+N L+ E KI+DFGL+ + D + +PI
Sbjct: 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYK-----ADGNDA--------IPIRWMPPES 247
Query: 145 ------TVKADVYSFGVVLLEIVCL 163
T ++DV+++GVVL EI
Sbjct: 248 IFYNRYTTESDVWAYGVVLWEIFSY 272
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-17
Identities = 40/155 (25%), Positives = 66/155 (42%), Gaps = 14/155 (9%)
Query: 10 KTEMNAIGR-THHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM-- 66
E+ + R H N + L D +V + M G L+D + +Q + ER
Sbjct: 63 TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREAS 119
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKR----CAKISDFGLAKLMKPDQTR 122
+ I + + YLH + ++H D+KP NIL ++ +I DFG AK ++ +
Sbjct: 120 AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-G 175
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
T +VA E D++S GV+L
Sbjct: 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 8e-17
Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 9/137 (6%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86
+ Y+F +K+ + D M+ G L L R A +I G+ ++H+
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMHNR---F 312
Query: 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAE-WHRNLPIT 145
+++ D+KP NIL+DE +ISD GLA + GT Y+A E + +
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYD 369
Query: 146 VKADVYSFGVVLLEIVC 162
AD +S G +L +++
Sbjct: 370 SSADWFSLGCMLFKLLR 386
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-16
Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 12/143 (8%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM--GIARDIARGIR 77
H N V+L D + LV + ++ G L + + +K+ ++ E I R + +
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI---KKKKHFSETEASYIMRKLVSAVS 120
Query: 78 YLHDECEAQIIHGDIKPQNILM---DEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYV 134
++HD ++H D+KP+N+L ++ KI DFG A+L PD + T Y
Sbjct: 121 HMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYA 176
Query: 135 AAEWHRNLPITVKADVYSFGVVL 157
A E D++S GV+L
Sbjct: 177 APELLNQNGYDESCDLWSLGVIL 199
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-16
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 17/166 (10%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVL----FTPEKQPNW 62
E E+ A+ + HH N V SF V +++ LV +S GS++D++ E +
Sbjct: 59 ELLKEIQAMSQCHHPNIVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117
Query: 63 VERMGIA---RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD 119
++ IA R++ G+ YLH IH D+K NIL+ E +I+DFG++ +
Sbjct: 118 LDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174
Query: 120 QTRTFTGIR----GTRAYVAAE-WHRNLPITVKADVYSFGVVLLEI 160
T +R GT ++A E + KAD++SFG+ +E+
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 8/97 (8%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRC-AKISDFGLAKLMKPDQTRTFTG 126
+ +R+ H+ ++H DIK +NIL+D R K+ DFG L+K F
Sbjct: 154 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD- 209
Query: 127 IRGTRAYVAAEWHRNLPIT-VKADVYSFGVVLLEIVC 162
GTR Y EW R A V+S G++L ++VC
Sbjct: 210 --GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 1e-16
Identities = 30/161 (18%), Positives = 60/161 (37%), Gaps = 18/161 (11%)
Query: 12 EMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIA- 69
E++ +H N V +F N++ +V +M+ GS D++ + + + IA
Sbjct: 76 ELHVSKLFNHPNIVPYRA-TFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAY 132
Query: 70 --RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
+ + + + Y+H +H +K +IL+ +S M R
Sbjct: 133 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 128 RGTRAYV------AAE--WHRNLPITVKADVYSFGVVLLEI 160
+ V + E K+D+YS G+ E+
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-16
Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 8/97 (8%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA-KISDFGLAKLMKPDQTRTFTG 126
+ I++ H ++H DIK +NIL+D +R K+ DFG L+ + F
Sbjct: 144 FFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 127 IRGTRAYVAAEWHRNLPIT-VKADVYSFGVVLLEIVC 162
GTR Y EW + A V+S G++L ++VC
Sbjct: 200 --GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-16
Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 9/156 (5%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI 68
E + + R H V+L ++F K+ Y NG L+ + R
Sbjct: 78 TRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 136
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP--DQTRTFTG 126
A +I + YLH + IIH D+KP+NIL++E +I+DFG AK++ P Q R +
Sbjct: 137 A-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS- 191
Query: 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
GT YV+ E +D+++ G ++ ++V
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-16
Identities = 44/157 (28%), Positives = 81/157 (51%), Gaps = 14/157 (8%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERM 66
+ + E+ + + + G S+ K+ ++ +Y+ GS +D+L +P ++
Sbjct: 66 DIQQEITVLSQCDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDET 119
Query: 67 GIA---RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
IA R+I +G+ YLH E + IH DIK N+L+ E K++DFG+A + Q +
Sbjct: 120 QIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
T + GT ++A E + KAD++S G+ +E+
Sbjct: 177 NTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 212
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-16
Identities = 36/159 (22%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERM 66
++ E+ + H V+LLG ++ K+ ++ ++ G++ ++ ++ +
Sbjct: 62 DYIVEIEILATCDHPYIVKLLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG 126
+ R + + +LH + +IIH D+K N+LM + +++DFG++ + +
Sbjct: 121 VVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF 177
Query: 127 IRGTRAY------VAAEWHRNLPITVKADVYSFGVVLLE 159
I GT Y V E ++ P KAD++S G+ L+E
Sbjct: 178 I-GT-PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 37/154 (24%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM-- 66
+ E H N VRL + + L++D ++ G L + + + + E
Sbjct: 57 LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADAS 113
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA---KISDFGLAKLMKPDQTRT 123
+ I + + H ++H ++KP+N+L+ K K++DFGLA ++ +Q +
Sbjct: 114 HCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QA 169
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
+ G GT Y++ E R P D+++ GV+L
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 8e-16
Identities = 49/206 (23%), Positives = 68/206 (33%), Gaps = 49/206 (23%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ KTE+ + + HH N RL D LV + G L+D L
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 63 VERMG---------------------------------------IARDIARGIRYLHDEC 83
M I R I + YLH++
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ- 187
Query: 84 EAQIIHGDIKPQNILMDEKRCA--KISDFGLAKLM---KPDQTRTFTGIRGTRAYVAAE- 137
I H DIKP+N L + K+ DFGL+K + T GT +VA E
Sbjct: 188 --GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245
Query: 138 -WHRNLPITVKADVYSFGVVLLEIVC 162
N K D +S GV+L ++
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLM 271
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-15
Identities = 40/186 (21%), Positives = 72/186 (38%), Gaps = 44/186 (23%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNK-------ILVYDYMSNGSLVDVL--FTPE 57
RE + M + HH N V+L Y + + + +V +Y+ + +L +
Sbjct: 65 RELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR 122
Query: 58 KQPNWVERMGIARD--------IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA-KIS 108
+ + R I LH + H DIKP N+L++E K+
Sbjct: 123 QVA-------PPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLC 174
Query: 109 DFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-------TVKADVYSFGVVLLEIV 161
DFG AK + P + AY+ + ++R + T D++S G + E++
Sbjct: 175 DFGSAKKLSPSEPNV--------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226
Query: 162 CLRRCL 167
L +
Sbjct: 227 -LGEPI 231
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 16/159 (10%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI 68
E + + + R V L Y+++ + + LV M+ G D+ F
Sbjct: 232 LNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGG---DLKFHIYHMGQAGFPEAR 287
Query: 69 AR----DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ-TRT 123
A +I G+ LH E +I++ D+KP+NIL+D+ +ISD GLA + Q +
Sbjct: 288 AVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
GT Y+A E +N T D ++ G +L E++
Sbjct: 345 RV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 9/157 (5%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSL-VDVLFTPEKQPNWVERMG 67
E + + H R V L Y+F+ + LV M+ G + + E P + E
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 68 I--ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
I I G+ +LH II+ D+KP+N+L+D+ +ISD GLA +K QT+T
Sbjct: 292 IFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
Query: 126 GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
GT ++A E D ++ GV L E++
Sbjct: 349 YA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 12/143 (8%)
Query: 28 LGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86
L YSF D + +V D + G L L ++ I ++ + YL ++ +
Sbjct: 80 LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQ---R 135
Query: 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ-TRTFTGIRGTRAYVAAE---WHRNL 142
IIH D+KP NIL+DE I+DF +A ++ + T GT+ Y+A E +
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMFSSRKGA 192
Query: 143 PITVKADVYSFGVVLLEIVCLRR 165
+ D +S GV E++ RR
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRR 215
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-15
Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 33/167 (19%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDV---SNKI-LVYDYMSNGSLVDVLFTPEKQPNWVER 65
K E+ + H + ++L + V +V +Y+S G L D + +
Sbjct: 59 KREIQNLKLFRHPHIIKL----YQVISTPTDFFMVMEYVSGGELFDYI---------CKH 105
Query: 66 MGIARDIAR--------GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
+ AR + Y H ++H D+KP+N+L+D AKI+DFGL+ +M
Sbjct: 106 GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162
Query: 118 PDQT-RTFTGIRGTRAYVAAEWHRNLPIT-VKADVYSFGVVLLEIVC 162
+ RT G+ Y A E + D++S GV+L ++C
Sbjct: 163 DGEFLRTSC---GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-15
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 16/159 (10%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGS-LVDVLFTPEKQPNWVERMG 67
E+ + R H N +++L F+ LV + +G L + ++ P E +
Sbjct: 77 TLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFI---DRHPRLDEPLA 132
Query: 68 --IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTF 124
I R + + YL + IIH DIK +NI++ E K+ DFG A ++ + TF
Sbjct: 133 SYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF 189
Query: 125 TGIRGTRAYVAAEWHRNLP-ITVKADVYSFGVVLLEIVC 162
GT Y A E P + +++S GV L +V
Sbjct: 190 C---GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 6e-15
Identities = 46/157 (29%), Positives = 67/157 (42%), Gaps = 30/157 (19%)
Query: 20 HHRNPVRLLGYSFDV---SNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIAR- 74
+H N V+ + N L +Y S G L D + +G+ A+
Sbjct: 63 NHENVVKF----YGHRREGNIQYLFLEYCSGGELFDRI---------EPDIGMPEPDAQR 109
Query: 75 -------GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
G+ YLH I H DIKP+N+L+DE+ KISDFGLA + + +
Sbjct: 110 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 128 R-GTRAYVAAEWHRNLPIT-VKADVYSFGVVLLEIVC 162
GT YVA E + DV+S G+VL ++
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 8e-15
Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 33/167 (19%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDV---SNKI-LVYDYMSNGSLVDVLFTPEKQPNWVER 65
+ E+ + H + ++L + V + I +V +Y+S G L D + +
Sbjct: 64 RREIQNLKLFRHPHIIKL----YQVISTPSDIFMVMEYVSGGELFDYI---------CKN 110
Query: 66 MGIARDIAR--------GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
+ +R G+ Y H ++H D+KP+N+L+D AKI+DFGL+ +M
Sbjct: 111 GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167
Query: 118 PDQT-RTFTGIRGTRAYVAAEWHRNLP-ITVKADVYSFGVVLLEIVC 162
+ RT G+ Y A E + D++S GV+L ++C
Sbjct: 168 DGEFLRTSC---GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC 211
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-15
Identities = 39/154 (25%), Positives = 62/154 (40%), Gaps = 30/154 (19%)
Query: 20 HHRNPVRLLGYSFDVSNKI----LVYDYMSNGSLVD-------VLFTPEKQPNWVERM-- 66
+ V +L ++ + ++ + M G L FT ER
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT--------EREAA 131
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILM---DEKRCAKISDFGLAKLMKPDQTRT 123
I RDI I++LH I H D+KP+N+L ++ K++DFG AK + +T
Sbjct: 132 EIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT 188
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
T YVA E D++S GV++
Sbjct: 189 PC---YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-14
Identities = 46/157 (29%), Positives = 67/157 (42%), Gaps = 30/157 (19%)
Query: 20 HHRNPVRLLGYSFDV---SNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIAR- 74
+H N V+ + N L +Y S G L D + +G+ A+
Sbjct: 63 NHENVVKF----YGHRREGNIQYLFLEYCSGGELFDRI---------EPDIGMPEPDAQR 109
Query: 75 -------GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
G+ YLH I H DIKP+N+L+DE+ KISDFGLA + + +
Sbjct: 110 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 128 R-GTRAYVAAEWHRNLPIT-VKADVYSFGVVLLEIVC 162
GT YVA E + DV+S G+VL ++
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-14
Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 20/104 (19%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA-KISDFGLAKLMKPDQTRTFTGIRGT 130
+ R + ++H I H DIKPQN+L++ K K+ DFG AK + P +
Sbjct: 150 LFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV------- 199
Query: 131 RAYVAAEWHRNLPI-------TVKADVYSFGVVLLEIVCLRRCL 167
AY+ + ++R + T D++S G V E+ L + L
Sbjct: 200 -AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL-ILGKPL 241
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-14
Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 22/154 (14%)
Query: 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM--GIARDIARGIR 77
HRN + L+ + + LV++ M GS++ + K+ ++ E + +D+A +
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI---HKRRHFNELEASVVVQDVASALD 125
Query: 78 YLHDECEAQIIHGDIKPQNILM---DEKRCAKISDFGLAKLMKPDQTRTFTGIR------ 128
+LH++ I H D+KP+NIL ++ KI DF L +K + +
Sbjct: 126 FLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 129 GTRAYVAAE-----WHRNLPITVKADVYSFGVVL 157
G+ Y+A E + D++S GV+L
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-14
Identities = 38/155 (24%), Positives = 59/155 (38%), Gaps = 29/155 (18%)
Query: 19 THHRNPVRLLGY---SFDVSNKI-LVYDYMSNGSLVD-------VLFTPEKQPNWVERM- 66
+ + VR++ + + +V + + G L FT ER
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT--------EREA 163
Query: 67 -GIARDIARGIRYLHDECEAQIIHGDIKPQNILM---DEKRCAKISDFGLAKLMKPDQTR 122
I + I I+YLH I H D+KP+N+L K++DFG AK
Sbjct: 164 SEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-- 218
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157
+ T T YVA E D++S GV++
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-14
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 20/155 (12%)
Query: 20 HHRNPVRLLG-----YSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIA---R 70
HHRN G + +++ LV ++ GS+ D++ + ++ IA R
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT--LKEEWIAYICR 136
Query: 71 DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGT 130
+I RG+ +LH ++IH DIK QN+L+ E K+ DFG++ + R T I GT
Sbjct: 137 EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GT 192
Query: 131 RAY-----VAAEWHRNLPITVKADVYSFGVVLLEI 160
+ +A + + + K+D++S G+ +E+
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-14
Identities = 48/182 (26%), Positives = 73/182 (40%), Gaps = 40/182 (21%)
Query: 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDV-----SNKI-LVYDYMSNGS--LVDVL 53
+ GE K E+ + R H+N ++L DV K+ +V +Y G ++D
Sbjct: 46 IPNGEANVKKEIQLLRRLRHKNVIQL----VDVLYNEEKQKMYMVMEYCVCGMQEMLD-- 99
Query: 54 FTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA 113
PEK+ + G + G+ YLH + I+H DIKP N+L+ KIS G+A
Sbjct: 100 SVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156
Query: 114 KLMKPDQT----RTFTG---------IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+ + P RT G G + K D++S GV L I
Sbjct: 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGF----------KVDIWSAGVTLYNI 206
Query: 161 VC 162
Sbjct: 207 TT 208
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 5e-14
Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 13/170 (7%)
Query: 1 MLAEGERE-FKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEK 58
ML E F+ E + + + L Y+F N + LV DY G L+ +L E
Sbjct: 112 MLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFED 170
Query: 59 Q-PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
+ P + R +A ++ I +H +H DIKP NILMD +++DFG +
Sbjct: 171 RLPEEMARFYLA-EMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226
Query: 118 PDQTRTFTGIRGTRAYVAAE-----WHRNLPITVKADVYSFGVVLLEIVC 162
D T + GT Y++ E + D +S GV + E++
Sbjct: 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-14
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDV---SNKI-LVYDYMSNGSLVDVLFTPEKQPNWVER 65
+ E++ + H + ++L +DV I +V +Y + G L D + ++ R
Sbjct: 57 EREISYLKLLRHPHIIKL----YDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR 111
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTF 124
+ I I Y H I+H D+KP+N+L+D+ KI+DFGL+ +M +T
Sbjct: 112 R-FFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167
Query: 125 TGIRGTRAYVAAEWHRNLPIT-VKADVYSFGVVLLEIVC 162
G+ Y A E + DV+S G+VL ++
Sbjct: 168 C---GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV 203
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-14
Identities = 42/159 (26%), Positives = 61/159 (38%), Gaps = 35/159 (22%)
Query: 20 HHRNPVRLLGYSFDV---SNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIAR- 74
H N VR +V + ++ +Y S G L + + + D AR
Sbjct: 74 RHPNIVRF----KEVILTPTHLAIIMEYASGGELYERI---------CNAGRFSEDEARF 120
Query: 75 -------GIRYLHDECEAQIIHGDIKPQNILMDEKRCA--KISDFGLAKLMKPDQT-RTF 124
G+ Y H QI H D+K +N L+D KI DFG +K ++
Sbjct: 121 FFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177
Query: 125 TGIRGTRAYVAAEWHRNLPIT-VKADVYSFGVVLLEIVC 162
GT AY+A E ADV+S GV L ++
Sbjct: 178 V---GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 34/111 (30%), Positives = 52/111 (46%), Gaps = 28/111 (25%)
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+ + +A+G+ +L + IH D+ +NIL+ EK KI DFGLA+ + D
Sbjct: 196 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD---- 248
Query: 126 GIRGTRAYVAAEWHRNLPI-------------TVKADVYSFGVVLLEIVCL 163
YV LP+ T+++DV+SFGV+L EI L
Sbjct: 249 -------YVRKG-DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 291
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI 68
TE + + H L YSF +++ V +Y + G ++ F ++ + E
Sbjct: 196 LTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDR-- 249
Query: 69 AR----DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK--LMKPDQTR 122
AR +I + YLH E +++ D+K +N+++D+ KI+DFGL K + +
Sbjct: 250 ARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 307
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
TF GT Y+A E + D + GVV+ E++C
Sbjct: 308 TFC---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 344
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-13
Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 23/162 (14%)
Query: 10 KTEMNAIGRTHHRNP--VRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERM 66
TE + T H P L Y+F +++ V +Y + G ++ F ++ + E
Sbjct: 53 VTESRVLQNTRH--PFLTALK-YAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEER 106
Query: 67 GIAR----DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL-MKP-DQ 120
AR +I + YLH +++ DIK +N+++D+ KI+DFGL K +
Sbjct: 107 --ARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
+TF GT Y+A E + D + GVV+ E++C
Sbjct: 162 MKTFC---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-13
Identities = 22/159 (13%), Positives = 47/159 (29%), Gaps = 34/159 (21%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ +E + + R R+L + ++V +++ GSL +V + P+
Sbjct: 72 DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSP 128
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
V + + +A H A + P + +S G L
Sbjct: 129 VGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVR--------VSIDGDVVL------- 170
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
A + + D+ G L ++
Sbjct: 171 ------AYPATMP-------DANPQDDIRGIGASLYALL 196
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 14/161 (8%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNW 62
E ++ E+ + + H N ++ G + + LV +Y GS D+L +K
Sbjct: 96 EKWQDIIKEVRFLQKLRHPNTIQYRG-CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE 153
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
VE + +G+ YLH +IH D+K NIL+ E K+ DFG A +M
Sbjct: 154 VEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM--APAN 208
Query: 123 TFTGIRGTRAYVAAE---WHRNLPITVKADVYSFGVVLLEI 160
+F GT ++A E K DV+S G+ +E+
Sbjct: 209 SFV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 3e-13
Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 13/115 (11%)
Query: 7 REFKTEMNAIGRTHHRNPVRLL----GYSFDVSNKI-LVYDYMSN--GSLVDVLFTPEKQ 59
RE + + H N VRL+ D K+ LV++++ + +D P
Sbjct: 60 REVAL-LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLP 118
Query: 60 PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114
++ + R RG+ +LH I+H D+KP+NIL+ K++DFGLA+
Sbjct: 119 AETIKD--LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-13
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 10/154 (6%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGI 68
E + + V+L +SF D SN +V +Y++ G + L + R
Sbjct: 89 LNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIR 128
A I YLH +I+ D+KP+N+L+D++ +++DFG AK + +T T
Sbjct: 148 A-QIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWTL---C 199
Query: 129 GTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
GT +A E + D ++ GV++ E+
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 4e-13
Identities = 31/115 (26%), Positives = 54/115 (46%), Gaps = 13/115 (11%)
Query: 7 REFKTEMNAIGRTHHRNPVRLL----GYSFDVSNKI-LVYDYMSN--GSLVDVLFTPEKQ 59
RE + + H N VRL D K+ LV++++ + +D + P
Sbjct: 60 REVAV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVP 118
Query: 60 PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114
++ + + RG+ +LH ++H D+KPQNIL+ K++DFGLA+
Sbjct: 119 TETIKD--MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-13
Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 29/168 (17%)
Query: 9 FKTEMNAIGRTHHRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMG 67
F E + + + V+L Y+F D +V +YM G LV+++
Sbjct: 116 FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM----------SNYD 164
Query: 68 IARDIAR--------GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD 119
+ AR + +H IH D+KP N+L+D+ K++DFG M +
Sbjct: 165 VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221
Query: 120 -QTRTFTGIRGTRAYVAAEWHRNLPITVK----ADVYSFGVVLLEIVC 162
R T + GT Y++ E ++ D +S GV L E++
Sbjct: 222 GMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 6e-13
Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 17/173 (9%)
Query: 1 MLAEGERE-FKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEK 58
ML GE F+ E + + R +L ++F N + LV +Y G L+ +L +
Sbjct: 99 MLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGE 157
Query: 59 Q-PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
+ P + R +A +I I +H +H DIKP NIL+D +++DFG ++
Sbjct: 158 RIPAEMARFYLA-EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213
Query: 118 PD-QTRTFTGIRGTRAYVAAE-------WHRNLPITVKADVYSFGVVLLEIVC 162
D R+ + GT Y++ E + D ++ GV E+
Sbjct: 214 ADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 9e-13
Identities = 30/112 (26%), Positives = 56/112 (50%), Gaps = 16/112 (14%)
Query: 20 HHRNPVRLLGYSFDV---SNKI-LVYDYMSN--GSLVDVLFTPEKQPNWVERMGIARDIA 73
+H N V+LL DV NK+ LV++++ +D ++ +
Sbjct: 60 NHPNIVKLL----DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLL 113
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+G+ + H +++H D+KPQN+L++ + K++DFGLA+ RT+T
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYT 161
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 9e-13
Identities = 39/142 (27%), Positives = 71/142 (50%), Gaps = 18/142 (12%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIAR----DIARGIRYLHDE 82
L F +++ V +Y++ G D+++ ++ + E A +IA G+ +L +
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPH--AVFYAAEIAIGLFFLQSK 140
Query: 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL-MKP-DQTRTFTGIRGTRAYVAAEWHR 140
II+ D+K N+++D + KI+DFG+ K + T+TF GT Y+A E
Sbjct: 141 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPDYIAPEIIA 194
Query: 141 NLPITVKADVYSFGVVLLEIVC 162
P D ++FGV+L E++
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLA 216
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-12
Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 16/114 (14%)
Query: 20 HHRNPVRLLGYSFDV---SNKI-LVYDYMSN--GSLVDVLFTPEKQPNWVERM--GIARD 71
H N VRL DV NK+ LV+++M N +D +
Sbjct: 61 KHENIVRLY----DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+ +G+ + H+ +I+H D+KPQN+L++++ K+ DFGLA+ TF+
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA-FGIPVNTFS 166
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 39/140 (27%), Positives = 72/140 (51%), Gaps = 14/140 (10%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI--ARDIARGIRYLHDECE 84
L F +++ V +Y++ G D+++ ++ + E + A +IA G+ +L +
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK-- 461
Query: 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKL-MKP-DQTRTFTGIRGTRAYVAAEWHRNL 142
II+ D+K N+++D + KI+DFG+ K + T+TF GT Y+A E
Sbjct: 462 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPDYIAPEIIAYQ 517
Query: 143 PITVKADVYSFGVVLLEIVC 162
P D ++FGV+L E++
Sbjct: 518 PYGKSVDWWAFGVLLYEMLA 537
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-12
Identities = 43/172 (25%), Positives = 70/172 (40%), Gaps = 44/172 (25%)
Query: 20 HHRNPVRLLGYSFDVSNKI------LVYDYMSNGSLVDVL--FTPEKQPNWVERMGIARD 71
H N VRL + + K LV DY+ ++ V ++ KQ +
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQT-------LPVI 156
Query: 72 --------IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA-KISDFGLAKLMKPDQTR 122
+ R + Y+H I H DIKPQN+L+D K+ DFG AK + +
Sbjct: 157 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 123 TFTGIRGTRAYVAAEWHRNLPI-------TVKADVYSFGVVLLEIVCLRRCL 167
+Y+ + ++R + T DV+S G VL E++ L + +
Sbjct: 214 V--------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPI 256
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-12
Identities = 29/125 (23%), Positives = 54/125 (43%), Gaps = 19/125 (15%)
Query: 20 HHRNPVRLLGYSFDV---SNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARG 75
H N V LL +V ++ LV++Y + +++ L ++ I +
Sbjct: 60 KHPNLVNLL----EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQA 114
Query: 76 IRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVA 135
+ + H + IH D+KP+NIL+ + K+ DFG A+ + + + VA
Sbjct: 115 VNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDYYD------DEVA 164
Query: 136 AEWHR 140
W+R
Sbjct: 165 TRWYR 169
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 41/142 (28%), Positives = 73/142 (51%), Gaps = 18/142 (12%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIAR----DIARGIRYLHDE 82
L F +++ V +Y++ G D++F ++Q E AR +I+ + YLH+
Sbjct: 75 LHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEH--ARFYSAEISLALNYLHER 129
Query: 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL-MKP-DQTRTFTGIRGTRAYVAAEWHR 140
II+ D+K N+L+D + K++D+G+ K ++P D T TF GT Y+A E R
Sbjct: 130 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEILR 183
Query: 141 NLPITVKADVYSFGVVLLEIVC 162
D ++ GV++ E++
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMA 205
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-12
Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 28/147 (19%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI-----AR----DIARGIR 77
L Y+F K+ L+ +Y+S G L F +ER GI A +I+ +
Sbjct: 86 LIYAFQTGGKLYLILEYLSGGEL----FM------QLEREGIFMEDTACFYLAEISMALG 135
Query: 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL-MKPDQ-TRTFTGIRGTRAYVA 135
+LH + II+ D+KP+NI+++ + K++DFGL K + T TF GT Y+A
Sbjct: 136 HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIEYMA 189
Query: 136 AEWHRNLPITVKADVYSFGVVLLEIVC 162
E D +S G ++ +++
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLT 216
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 3e-12
Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 28/147 (19%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSL-----VDVLFTPEKQPNWVERMGIAR----DIARGIR 77
L Y+F K+ L+ D++ G L +V+FT E + ++A +
Sbjct: 91 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED----------VKFYLAELALALD 140
Query: 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL-MKPDQ-TRTFTGIRGTRAYVA 135
+LH II+ D+KP+NIL+DE+ K++DFGL+K + ++ +F GT Y+A
Sbjct: 141 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---GTVEYMA 194
Query: 136 AEWHRNLPITVKADVYSFGVVLLEIVC 162
E T AD +SFGV++ E++
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLT 221
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-12
Identities = 28/108 (25%), Positives = 48/108 (44%), Gaps = 28/108 (25%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA-KISDFGLAKLMKPDQTRTFTGIRGT 130
+ R + Y+H I H DIKPQN+L+D K+ DFG AK++ +
Sbjct: 150 LLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV------- 199
Query: 131 RAYVAAEWHR-----------NLPITVKADVYSFGVVLLEIVCLRRCL 167
+Y+ + ++R I D++S G V+ E++ + L
Sbjct: 200 -SYICSRYYRAPELIFGATNYTTNI----DIWSTGCVMAELM-QGQPL 241
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-12
Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 28/147 (19%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI-----AR----DIARGIR 77
L +SF ++K+ V DY++ G L F ++R AR +IA +
Sbjct: 104 LHFSFQTADKLYFVLDYINGGEL----FY------HLQRERCFLEPRARFYAAEIASALG 153
Query: 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL-MKPDQ-TRTFTGIRGTRAYVA 135
YLH I++ D+KP+NIL+D + ++DFGL K ++ + T TF GT Y+A
Sbjct: 154 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---GTPEYLA 207
Query: 136 AEWHRNLPITVKADVYSFGVVLLEIVC 162
E P D + G VL E++
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLY 234
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 3e-12
Identities = 26/110 (23%), Positives = 49/110 (44%), Gaps = 13/110 (11%)
Query: 20 HHRNPVRLLGYSFDV---SNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARG 75
H+N VRL DV K+ LV+++ L + + + +G
Sbjct: 59 KHKNIVRLH----DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 76 IRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+ + H ++H D+KPQN+L++ K+++FGLA+ R ++
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYS 159
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-12
Identities = 21/100 (21%), Positives = 43/100 (43%), Gaps = 27/100 (27%)
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCA-KISDFGLAKLMKPDQTRTFTGIRGTRA 132
+ + Y H I+H D+KP N+++D + ++ D+GLA+ P Q
Sbjct: 141 KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN--------V 189
Query: 133 YVAAEWHR-----------NLPITVKADVYSFGVVLLEIV 161
VA+ + + + + D++S G +L ++
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSL----DMWSLGCMLASMI 225
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-12
Identities = 41/142 (28%), Positives = 73/142 (51%), Gaps = 18/142 (12%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIAR----DIARGIRYLHDE 82
L F +++ V +Y++ G D++F ++Q E AR +I+ + YLH+
Sbjct: 118 LHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEH--ARFYSAEISLALNYLHER 172
Query: 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL-MKP-DQTRTFTGIRGTRAYVAAEWHR 140
II+ D+K N+L+D + K++D+G+ K ++P D T TF GT Y+A E R
Sbjct: 173 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEILR 226
Query: 141 NLPITVKADVYSFGVVLLEIVC 162
D ++ GV++ E++
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMA 248
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 5e-12
Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 13/110 (11%)
Query: 20 HHRNPVRLLGYSFDV---SNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARG 75
H N V+L DV ++ LV++++ L +L E V + G
Sbjct: 58 KHSNIVKLY----DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 76 IRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
I Y HD +++H D+KPQN+L++ + KI+DFGLA+ R +T
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYT 158
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-12
Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 13/110 (11%)
Query: 20 HHRNPVRLLGYSFDV---SNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARG 75
H N V L D+ + LV++Y+ L L N + RG
Sbjct: 58 KHANIVTLH----DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRG 112
Query: 76 IRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+ Y H +++H D+KPQN+L++E+ K++DFGLA+ K T+T+
Sbjct: 113 LAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYD 158
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-12
Identities = 35/128 (27%), Positives = 54/128 (42%), Gaps = 25/128 (19%)
Query: 20 HHRNPVRLLGYSFDV---SNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI---ARDI 72
H N V LL +V + LV++++ + +L E PN ++ + I
Sbjct: 82 RHENLVNLL----EVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQI 133
Query: 73 ARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRA 132
GI + H IIH DIKP+NIL+ + K+ DFG A+ +
Sbjct: 134 INGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYD------D 183
Query: 133 YVAAEWHR 140
VA W+R
Sbjct: 184 EVATRWYR 191
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-12
Identities = 31/112 (27%), Positives = 54/112 (48%), Gaps = 17/112 (15%)
Query: 20 HHRNPVRLLGYSFDV---SNKI-LVYDYMSN--GSLVDVLFTPEKQPNWVERMGIARDIA 73
HH N V L+ DV + LV+++M ++D T + + +
Sbjct: 77 HHPNIVSLI----DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDS---QIKIYLYQLL 129
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
RG+ + H +I+H D+KPQN+L++ K++DFGLA+ R++T
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYT 177
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 8e-12
Identities = 41/138 (29%), Positives = 67/138 (48%), Gaps = 10/138 (7%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86
+ +F + V +Y++ G L+ + + K A +I G+++LH +
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQFLHSK---G 138
Query: 87 IIHGDIKPQNILMDEKRCAKISDFGLAKL-MKPDQ-TRTFTGIRGTRAYVAAEWHRNLPI 144
I++ D+K NIL+D+ KI+DFG+ K M D T TF GT Y+A E
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC---GTPDYIAPEILLGQKY 195
Query: 145 TVKADVYSFGVVLLEIVC 162
D +SFGV+L E++
Sbjct: 196 NHSVDWWSFGVLLYEMLI 213
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 8e-12
Identities = 48/154 (31%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 10 KTEMNAIGRTHHRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGI 68
E + H +R+ +F D ++ DY+ G L +L ++ PN V +
Sbjct: 54 NDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA 112
Query: 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIR 128
A ++ + YLH + II+ D+KP+NIL+D+ KI+DFG AK + PD T T
Sbjct: 113 A-EVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTYTL---C 164
Query: 129 GTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
GT Y+A E P D +SFG+++ E++
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 8e-12
Identities = 40/142 (28%), Positives = 72/142 (50%), Gaps = 18/142 (12%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIAR----DIARGIRYLHDE 82
L F +++ V ++++ G D++F +K + E AR +I + +LHD+
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEAR--ARFYAAEIISALMFLHDK 143
Query: 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL-MKPDQ-TRTFTGIRGTRAYVAAEWHR 140
II+ D+K N+L+D + K++DFG+ K + T TF GT Y+A E +
Sbjct: 144 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC---GTPDYIAPEILQ 197
Query: 141 NLPITVKADVYSFGVVLLEIVC 162
+ D ++ GV+L E++C
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLC 219
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-12
Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 12/100 (12%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA------KISDFGLAKLMKPDQT 121
I++ + G+ Y+H C IIH DIKP+N+LM+ KI+D G A
Sbjct: 136 ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYD 189
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
+T TR Y + E P AD++S ++ E++
Sbjct: 190 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 30/93 (32%), Positives = 44/93 (47%), Gaps = 5/93 (5%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+ GI++LH A IIH D+KP NI++ KI DFGLA+ T TR
Sbjct: 136 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTR 190
Query: 132 AYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
Y A E + D++S G ++ E++
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-11
Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 23/115 (20%)
Query: 20 HHRNPVRLLGYSFDV---SNKI-LVYDYMSN--GSLVD---VLFTPEKQPNWVERMGIAR 70
H N + LL D + I LV+D+M ++ ++ TP ++
Sbjct: 70 SHPNIIGLL----DAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM------L 119
Query: 71 DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+G+ YLH I+H D+KP N+L+DE K++DFGLAK R +T
Sbjct: 120 MTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYT 170
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-11
Identities = 31/90 (34%), Positives = 44/90 (48%), Gaps = 5/90 (5%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+ GI++LH A IIH D+KP NI++ KI DFGLA+ T TR
Sbjct: 173 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTR 227
Query: 132 AYVAAEWHRNLPITVKADVYSFGVVLLEIV 161
Y A E + D++S G ++ E+V
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 257
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-11
Identities = 25/100 (25%), Positives = 51/100 (51%), Gaps = 19/100 (19%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA-KISDFGLAKLMKPDQTRT--FTGIR 128
+ RG++Y+H A ++H D+KP N+ ++ + KI DFGLA++M P + +
Sbjct: 129 LLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE-- 183
Query: 129 GTRAYVAAEWHRNLPI-------TVKADVYSFGVVLLEIV 161
+ +W+R+ + T D+++ G + E++
Sbjct: 184 ----GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-11
Identities = 30/97 (30%), Positives = 48/97 (49%), Gaps = 20/97 (20%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+ +G+RY+H A IIH D+KP N+ ++E KI DFGLA+ + T
Sbjct: 137 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---------- 183
Query: 132 AYVAAEWHRNLPI-------TVKADVYSFGVVLLEIV 161
YV W+R + T D++S G ++ E++
Sbjct: 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 7e-11
Identities = 29/117 (24%), Positives = 49/117 (41%), Gaps = 15/117 (12%)
Query: 20 HHRNPVRLLG-------YSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGIARD 71
H N V L+ I LV+D+ + L +L + E + +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM---KPDQTRTFT 125
+ G+ Y+H +I+H D+K N+L+ K++DFGLA+ K Q +T
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-11
Identities = 26/97 (26%), Positives = 47/97 (48%), Gaps = 20/97 (20%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+ +G++Y+H A ++H D+KP N+ ++E KI DFGLA+ + T
Sbjct: 135 MLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT---------- 181
Query: 132 AYVAAEWHRNLPI-------TVKADVYSFGVVLLEIV 161
YV W+R + D++S G ++ E++
Sbjct: 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-11
Identities = 38/148 (25%), Positives = 67/148 (45%), Gaps = 27/148 (18%)
Query: 28 LGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERMGI-----AR----DIARGIR 77
L Y+F K+ L+ DY++ G L FT + + + +I +
Sbjct: 124 LHYAFQTETKLHLILDYINGGEL----FT------HLSQRERFTEHEVQIYVGEIVLALE 173
Query: 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKL-MKPDQTRTFTGIRGTRAYVAA 136
+LH + II+ DIK +NIL+D ++DFGL+K + + R + GT Y+A
Sbjct: 174 HLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAP 229
Query: 137 E--WHRNLPITVKADVYSFGVVLLEIVC 162
+ + D +S GV++ E++
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLT 257
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 28/71 (39%), Positives = 40/71 (56%), Gaps = 11/71 (15%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF--TGIRG 129
I RG++Y+H A ++H D+KP N+L++ KI DFGLA++ PD T T
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE--- 190
Query: 130 TRAYVAAEWHR 140
YVA W+R
Sbjct: 191 ---YVATRWYR 198
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 28/97 (28%), Positives = 43/97 (44%), Gaps = 18/97 (18%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
I G+ LH+ A ++H D+ P NIL+ + I DF LA+ D +T
Sbjct: 143 ILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT-------- 191
Query: 132 AYVAAEWHRNLPI-------TVKADVYSFGVVLLEIV 161
YV W+R + T D++S G V+ E+
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 20/97 (20%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
I RG++Y+H A IIH D+KP N+ ++E KI DFGLA+ + T
Sbjct: 141 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT---------- 187
Query: 132 AYVAAEWHRNLPI-------TVKADVYSFGVVLLEIV 161
YVA W+R I D++S G ++ E++
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 20/72 (27%), Positives = 34/72 (47%), Gaps = 6/72 (8%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
R ++ LH + +IH D+KP N+L++ K+ DFGLA+++
Sbjct: 121 TLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 132 A---YVAAEWHR 140
+VA W+R
Sbjct: 178 GMVEFVATRWYR 189
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-10
Identities = 31/117 (26%), Positives = 53/117 (45%), Gaps = 23/117 (19%)
Query: 20 HHRNPVRLLGYSFDV---SNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERM--GIARDIA 73
HRN + L V ++++ L+++Y N L + +K P+ R+ +
Sbjct: 91 QHRNIIELK----SVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLI 142
Query: 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCA-----KISDFGLAKLMKPDQTRTFT 125
G+ + H + +H D+KPQN+L+ + KI DFGLA+ R FT
Sbjct: 143 NGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQFT 195
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 9e-10
Identities = 29/118 (24%), Positives = 47/118 (39%), Gaps = 17/118 (14%)
Query: 20 HHRNPVRLLG-YSFDVSNKI-LVYDYMSN--GSLVDVLFTPEKQPNWV-----ERMGIAR 70
H N + L + K+ L++DY + ++ + V +
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 71 DIARGIRYLHDECEAQIIHGDIKPQNILM----DEKRCAKISDFGLAKLM-KPDQTRT 123
I GI YLH ++H D+KP NIL+ E+ KI+D G A+L P +
Sbjct: 136 QILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 21/95 (22%), Positives = 43/95 (45%), Gaps = 11/95 (11%)
Query: 76 IRYLHDECEAQIIHGDIKPQNILMDEKRCAKI--SDFGLAKLMKPDQT------RTFTGI 127
+ Y+H E + +HGDIK N+L++ K ++ D+GLA P+
Sbjct: 165 LEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCH 221
Query: 128 RGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
GT + + + H + + + D+ G +++ +
Sbjct: 222 DGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT 256
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 9/95 (9%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILM-DEKRCA-KISDFGLAKLMKPDQTRTFT 125
A I + + LH +IIH D+KP+NIL+ + R K+ DFG + + +
Sbjct: 205 FAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC----YEHQRVY 257
Query: 126 GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160
+R Y A E + D++S G +L E+
Sbjct: 258 TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 20/84 (23%), Positives = 35/84 (41%), Gaps = 18/84 (21%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+ G ++H E+ IIH D+KP N L+++ K+ DFGLA+ + ++
Sbjct: 138 LLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 132 A---------------YVAAEWHR 140
+V W+R
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYR 218
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 24/103 (23%), Positives = 49/103 (47%), Gaps = 11/103 (10%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKI--SDFGLAKLMKPDQT---- 121
+ + + Y+H E + +HGDIK N+L+ K ++ +D+GL+ P+
Sbjct: 156 LGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 122 --RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
G GT + + + H+ + ++ ++DV G +L +C
Sbjct: 213 QENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLC 255
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILM-DEKRCA-KISDFGLAKLMKPDQTRTFT 125
A+ + + +L E IIH D+KP+NIL+ + KR A KI DFG + +
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC----QLGQRIY 216
Query: 126 GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
+R Y + E +P + D++S G +L+E
Sbjct: 217 QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-09
Identities = 17/42 (40%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLA 113
+ G++Y+H A I+H D+KP N L+++ K+ DFGLA
Sbjct: 165 LLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-09
Identities = 22/83 (26%), Positives = 37/83 (44%), Gaps = 17/83 (20%)
Query: 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131
+ + I+YLH ++H D+KP NIL++ + K++DFGL++ + T
Sbjct: 118 LIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 132 A--------------YVAAEWHR 140
YVA W+R
Sbjct: 175 ENTENFDDDQPILTDYVATRWYR 197
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-08
Identities = 26/105 (24%), Positives = 44/105 (41%), Gaps = 13/105 (12%)
Query: 19 THHRNPVRLLGY---SFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNWVERM--GIARDI 72
+ + VR++ + + +V + + G L + + ER I + I
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSI 126
Query: 73 ARGIRYLHDECEAQIIHGDIKPQNILM---DEKRCAKISDFGLAK 114
I+YLH I H D+KP+N+L K++DFG AK
Sbjct: 127 GEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-08
Identities = 18/103 (17%), Positives = 48/103 (46%), Gaps = 11/103 (10%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKI--SDFGLAKLMKPDQT---- 121
+A + + +LH E + +HG++ +NI +D + +++ + +G A P
Sbjct: 164 VACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 122 --RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162
+ + G +++ + H+ + ++D+ S G +L+ +
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY 263
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 5e-08
Identities = 35/168 (20%), Positives = 54/168 (32%), Gaps = 59/168 (35%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILM---------------------------- 99
I + + +G+ YLH +C +IIH DIKP+NIL+
Sbjct: 151 IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 100 ---------------------DEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEW 138
EK KI+D G A + + FT TR Y + E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH----KHFTEDIQTRQYRSLEV 264
Query: 139 HRNLPITVKADVYSFGVVLLEIVCLRRCLD----QNLLEDRAILQEWI 182
AD++S + E+ + + D + I
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 312
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 23/103 (22%), Positives = 45/103 (43%), Gaps = 14/103 (13%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILM---DEKRCAKIS--DFGLAKLMKPDQT- 121
A+ + ++ +H++ +++ DIKP N L+ + K I DFG+ K + T
Sbjct: 111 AAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
Query: 122 -----RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
R + GT Y++ H + + D+ + G V +
Sbjct: 168 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMY 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 12/101 (11%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAK---ISDFGLAKLMKPDQT--- 121
+A + I Y+H + IH D+KP N LM + I DFGLAK + +T
Sbjct: 110 LADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166
Query: 122 ---RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
R + GT Y + H + + + D+ S G VL+
Sbjct: 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 207
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 3e-07
Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 12/101 (11%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAK---ISDFGLAKLMKPDQT--- 121
+A + + ++H + +H DIKP N LM R A I DFGLAK + T
Sbjct: 108 LADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
Query: 122 ---RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
R + GT Y + H + + + D+ S G VL+
Sbjct: 165 IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMY 205
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-07
Identities = 25/103 (24%), Positives = 44/103 (42%), Gaps = 14/103 (13%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILM---DEKRCAKI--SDFGLAKLMKPDQT- 121
IA + + Y+H + +I+ D+KP+N L+ K I DF LAK +T
Sbjct: 110 IAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
Query: 122 -----RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
R + GT Y++ H + + D+ + G + +
Sbjct: 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMY 209
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 9e-07
Identities = 12/87 (13%), Positives = 25/87 (28%), Gaps = 4/87 (4%)
Query: 31 SFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHG 90
F +V ++ G D+ K + I + + + H
Sbjct: 131 FFKDDQLFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHR 186
Query: 91 DIKPQNILMDEKRCAKISDFGLAKLMK 117
D+ N+L+ + K+ K
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 22/85 (25%), Positives = 37/85 (43%), Gaps = 14/85 (16%)
Query: 30 YSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIH 89
+ D+ NK ++ Y++ DV+ + + IA I + LH + +IH
Sbjct: 407 FDVDLDNKRIMMSYINGKLAKDVI---------EDNLDIAYKIGEIVGKLH---KNDVIH 454
Query: 90 GDIKPQNILMDEKRCAKISDFGLAK 114
D+ N + D+ I DFGL K
Sbjct: 455 NDLTTSNFIFDK-DLYII-DFGLGK 477
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 33/117 (28%), Positives = 47/117 (40%), Gaps = 32/117 (27%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDE------------------------KR 103
+I + + YL + H D+KP+NIL+D+ K
Sbjct: 142 YCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 104 CA-KISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
K+ DFG A ++ I TR Y A E NL V +D++SFG VL E
Sbjct: 199 TGIKLIDFGCAT----FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 30/111 (27%), Positives = 44/111 (39%), Gaps = 26/111 (23%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDE------------------KRCA-KIS 108
+A + +R+LH+ Q+ H D+KP+NIL K + +++
Sbjct: 128 MAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 109 DFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
DFG A T I TR Y E L DV+S G +L E
Sbjct: 185 DFGSAT----FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 8e-05
Identities = 27/110 (24%), Positives = 47/110 (42%), Gaps = 24/110 (21%)
Query: 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGI 127
+A I + + +LH ++ H D+KP+NIL + + + K+ + ++T I
Sbjct: 123 MAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYN---PKIKRDERTLINPDI 176
Query: 128 R----G--------------TRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
+ G TR Y A E L + DV+S G +L+E
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 252 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.53 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.8 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.78 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.61 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.21 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.15 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.03 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.03 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.65 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.59 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.72 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.58 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.31 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.98 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.52 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.3 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 93.61 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.27 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.98 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 90.88 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 89.97 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 88.97 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 88.21 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 86.39 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 86.17 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 85.14 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.05 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 81.72 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 81.06 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-53 Score=343.38 Aligned_cols=223 Identities=26% Similarity=0.380 Sum_probs=177.0
Q ss_pred chHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 2 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
+.+..++|.+|+.++++++|||||++++++.+ +.+++|||||+||+|.+++......+++..++.++.||+.||.|||+
T Consensus 72 ~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~ 150 (307)
T 3omv_A 72 TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA 150 (307)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35677899999999999999999999998865 56899999999999999998777789999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCC---CCCCcccchhHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNL---PITVKADVYSFGVVL 157 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~~l 157 (252)
+ +|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+. .++.++||||||+++
T Consensus 151 ~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl 227 (307)
T 3omv_A 151 K---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVL 227 (307)
T ss_dssp T---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHH
T ss_pred C---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHH
Confidence 9 999999999999999999999999999986543322 233445799999999998643 589999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
|||+||+.||........ +......+...... ...+...+..+.+++.+||+.||++|||+.||++.|+..
T Consensus 228 ~Elltg~~Pf~~~~~~~~------~~~~~~~~~~~p~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 228 YELMTGELPYSHINNRDQ------IIFMVGRGYASPDL--SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp HHHHHSSCTTTTCCCHHH------HHHHHHTTCCCCCS--TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred HHHHHCCCCCCCCChHHH------HHHHHhcCCCCCCc--ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 999999999976543321 11222222221111 112233445588889999999999999999999988753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=346.09 Aligned_cols=222 Identities=23% Similarity=0.351 Sum_probs=177.4
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC--------------CCCCCHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP--------------EKQPNWVERMGI 68 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~i 68 (252)
.+.+++|.+|+++|++++|||||++++++.+.+..++|||||++|+|.+++... ...+++..++.+
T Consensus 84 ~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 163 (329)
T 4aoj_A 84 ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163 (329)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHH
Confidence 456788999999999999999999999999999999999999999999999653 235899999999
Q ss_pred HHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCc
Q 038713 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVK 147 (252)
Q Consensus 69 ~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~ 147 (252)
+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.+
T Consensus 164 ~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~ 240 (329)
T 4aoj_A 164 ASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE 240 (329)
T ss_dssp HHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHH
T ss_pred HHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc
Confidence 99999999999999 999999999999999999999999999986543322 22234568999999999999999999
Q ss_pred ccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 148 ADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 148 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
+||||||+++|||+| |+.||......+ + + ..+..+.... . +...+..+.+++.+||+.||++|||+
T Consensus 241 sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~---~-~~i~~g~~~~--~----p~~~~~~~~~li~~cl~~dP~~RPs~ 307 (329)
T 4aoj_A 241 SDVWSFGVVLWEIFTYGKQPWYQLSNTE---A---I-DCITQGRELE--R----PRACPPEVYAIMRGCWQREPQQRHSI 307 (329)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTCSSCHHH---H---H-HHHHHTCCCC--C----CTTCCHHHHHHHHHHCCSSTTTSCCH
T ss_pred ccccchHHHHHHHHcCCCCCCCCCCHHH---H---H-HHHHcCCCCC--C----cccccHHHHHHHHHHcCcChhHCcCH
Confidence 999999999999999 899998654432 1 1 1222232111 1 22233458888999999999999999
Q ss_pred HHHHHHhhcCcCCC
Q 038713 227 KKVLLMLEGTVEIP 240 (252)
Q Consensus 227 ~~i~~~l~~~~~~~ 240 (252)
.||++.|+.+.+.|
T Consensus 308 ~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 308 KDVHARLQALAQAP 321 (329)
T ss_dssp HHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHhhCC
Confidence 99999999977653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=346.00 Aligned_cols=220 Identities=24% Similarity=0.377 Sum_probs=183.5
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC------------CCCCCHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP------------EKQPNWVERMGIAR 70 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~~i~~ 70 (252)
.+.+++|.+|+++|++++|||||++++++.+.+..++|||||++|+|.+++... ...+++..++.++.
T Consensus 56 ~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 135 (299)
T 4asz_A 56 DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135 (299)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999999542 34689999999999
Q ss_pred HHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCccc
Q 038713 71 DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKAD 149 (252)
Q Consensus 71 ~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~D 149 (252)
||+.||.|||++ +++||||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|
T Consensus 136 qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~D 212 (299)
T 4asz_A 136 QIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 212 (299)
T ss_dssp HHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhh
Confidence 999999999999 9999999999999999999999999999865433322 222345899999999999999999999
Q ss_pred chhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 150 VYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 150 i~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
|||||+++|||+| |+.||......+ + ...+..+..... +...+..+.+++.+||+.||++|||+.+
T Consensus 213 VwS~Gvvl~Ellt~G~~Pf~~~~~~~---~----~~~i~~~~~~~~------p~~~~~~~~~li~~cl~~dP~~RPs~~~ 279 (299)
T 4asz_A 213 VWSLGVVLWEIFTYGKQPWYQLSNNE---V----IECITQGRVLQR------PRTCPQEVYELMLGCWQREPHMRKNIKG 279 (299)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSCHHH---H----HHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHcCCCCCC------CccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999999998 899998654332 1 122233332221 2223345888899999999999999999
Q ss_pred HHHHhhcCcC
Q 038713 229 VLLMLEGTVE 238 (252)
Q Consensus 229 i~~~l~~~~~ 238 (252)
|++.|++..+
T Consensus 280 i~~~L~~~~~ 289 (299)
T 4asz_A 280 IHTLLQNLAK 289 (299)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 9999998654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=339.91 Aligned_cols=218 Identities=22% Similarity=0.283 Sum_probs=181.4
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC---------------CCCCCHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP---------------EKQPNWVERMGI 68 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i 68 (252)
+.+++|.+|+.++++++|||||+++|++.+.+.+++|||||++|+|.++|... ...+++..++.+
T Consensus 71 ~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 150 (308)
T 4gt4_A 71 PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150 (308)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHH
Confidence 34678999999999999999999999999999999999999999999999542 235899999999
Q ss_pred HHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCc
Q 038713 69 ARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVK 147 (252)
Q Consensus 69 ~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~ 147 (252)
+.||+.||.|||++ +++||||||+|||+++++.+||+|||+++....... .......||+.|+|||++.+..++.+
T Consensus 151 ~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k 227 (308)
T 4gt4_A 151 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID 227 (308)
T ss_dssp HHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc
Confidence 99999999999999 999999999999999999999999999986543222 22334568999999999999999999
Q ss_pred ccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 148 ADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 148 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
+||||||+++|||+| |..||......+ + ...+..+..... +...+..+.+++.+||+.||++|||+
T Consensus 228 sDVwSfGvvl~El~t~g~~Pf~~~~~~~---~----~~~i~~~~~~~~------p~~~~~~~~~li~~C~~~dP~~RPs~ 294 (308)
T 4gt4_A 228 SDIWSYGVVLWEVFSYGLQPYCGYSNQD---V----VEMIRNRQVLPC------PDDCPAWVYALMIECWNEFPSRRPRF 294 (308)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTCCHHH---H----HHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred chhhhHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCCCC------cccchHHHHHHHHHHcCCChhHCcCH
Confidence 999999999999998 889997654332 1 122333333221 22334558889999999999999999
Q ss_pred HHHHHHhhcCc
Q 038713 227 KKVLLMLEGTV 237 (252)
Q Consensus 227 ~~i~~~l~~~~ 237 (252)
.||++.|+...
T Consensus 295 ~ei~~~L~a~~ 305 (308)
T 4gt4_A 295 KDIHSRLRAWG 305 (308)
T ss_dssp HHHHHHHHTSC
T ss_pred HHHHHHHHhcc
Confidence 99999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=341.46 Aligned_cols=212 Identities=20% Similarity=0.334 Sum_probs=176.6
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
...++.|.+|+++|++++|||||++++++++.+.+|+|||||+||+|.+++... ...+++..++.++.||+.||.|||+
T Consensus 64 ~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~ 143 (350)
T 4b9d_A 64 SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143 (350)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999999644 4457899999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+ +|+||||||+|||++.+|.+||+|||+++...... .......||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 144 ~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyeml 219 (350)
T 4b9d_A 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELC 219 (350)
T ss_dssp T---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred C---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence 9 99999999999999999999999999998654221 1223456999999999999999999999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|+.||......+. ..... .+..... +...+..+.++|.+||+.||++|||++|+++
T Consensus 220 tG~~PF~~~~~~~~------~~~i~-~~~~~~~------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 220 TLKHAFEAGSMKNL------VLKII-SGSFPPV------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HSSCSCCCSSHHHH------HHHHH-HTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HCCCCCCCcCHHHH------HHHHH-cCCCCCC------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999986643321 11222 2222211 1122345778888999999999999999985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=336.15 Aligned_cols=214 Identities=19% Similarity=0.277 Sum_probs=176.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++.+.+|+.+|++++|||||++++++.+.+.+|+|||||+||+|.+++.. +.+++..+..++.||+.||.|||++
T Consensus 114 ~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~-- 189 (346)
T 4fih_A 114 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ-- 189 (346)
T ss_dssp SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 346689999999999999999999999999999999999999999999954 4589999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+|+||||||+|||++.+|.+||+|||+++....... ......||+.|+|||++.+..|+.++|||||||++|+|++|.
T Consensus 190 -~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~ 267 (346)
T 4fih_A 190 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 267 (346)
T ss_dssp -TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 999999999999999999999999999987654332 233467999999999999999999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEG 235 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~ 235 (252)
.||......... ..+..+.......... ....+.++|.+||+.||++|||++|+++ .+++
T Consensus 268 ~PF~~~~~~~~~-------~~i~~~~~~~~~~~~~----~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 268 PPYFNEPPLKAM-------KMIRDNLPPRLKNLHK----VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp CTTTTSCHHHHH-------HHHHHSSCCCCSCGGG----SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCCCCcCHHHHH-------HHHHcCCCCCCCcccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 999765433211 1122222212211112 2344778888999999999999999987 3444
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=324.76 Aligned_cols=211 Identities=25% Similarity=0.339 Sum_probs=170.0
Q ss_pred chHhHHHHHHHHHHHhCCCCCCCcceeeeEec----CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFD----VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 2 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
....+++|.+|+.+|++++|||||++++++.+ .+.+|+|||||+||+|.+++.+ .+.+++..+..++.||+.||.
T Consensus 65 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ 143 (290)
T 3fpq_A 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQ 143 (290)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999875 3458999999999999999964 456899999999999999999
Q ss_pred HHhhcCCCC--eeeeccCCCCEEec-CCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHH
Q 038713 78 YLHDECEAQ--IIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFG 154 (252)
Q Consensus 78 ~lh~~~~~~--i~h~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 154 (252)
|||++ + |+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++.+ .++.++||||||
T Consensus 144 ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlG 216 (290)
T 3fpq_A 144 FLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFG 216 (290)
T ss_dssp HHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHH
T ss_pred HHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHH
Confidence 99998 7 99999999999997 4789999999999864332 2234679999999999876 699999999999
Q ss_pred HHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 155 VVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 155 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|++|+|+||+.||........ +......+...... +......+.++|.+||+.||++|||++|+++
T Consensus 217 vilyelltg~~Pf~~~~~~~~------~~~~i~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 217 MCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPASF-----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCGGG-----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHCCCCCCCCCcHHH------HHHHHHcCCCCCCC-----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999999999999975433321 11222222221111 1111234778888999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=332.67 Aligned_cols=212 Identities=20% Similarity=0.190 Sum_probs=171.9
Q ss_pred HHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 038713 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIH 89 (252)
Q Consensus 10 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h 89 (252)
.+|+.++++++|||||++++++.+.+.+|+|||||+||+|.+++.+ .+.+++..+..++.||+.||.|||++ +|+|
T Consensus 98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiH 173 (336)
T 4g3f_A 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTR---RILH 173 (336)
T ss_dssp THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTT---TEEC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---Ccee
Confidence 5799999999999999999999999999999999999999999964 34689999999999999999999999 9999
Q ss_pred eccCCCCEEecCCC-ceEEcccCcccccCCCCCc----ccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 90 GDIKPQNILMDEKR-CAKISDFGLAKLMKPDQTR----TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 90 ~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
|||||+|||++.+| .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 174 RDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~ 253 (336)
T 4g3f_A 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253 (336)
T ss_dssp SCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCc
Confidence 99999999999887 6999999999876543221 122346999999999999999999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
.||......... ..... +.... ...+...+..+.++|.+||+.||++|||+.|+++.|...
T Consensus 254 ~Pf~~~~~~~~~------~~i~~-~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 254 HPWTQYFRGPLC------LKIAS-EPPPI----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp CSSTTTCCSCCH------HHHHH-SCCGG----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHH------HHHHc-CCCCc----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 999765433211 11111 22111 112223345577888899999999999999999887664
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=330.48 Aligned_cols=209 Identities=20% Similarity=0.258 Sum_probs=175.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|+++|++++|||||++++++++.+.+|+|||||+||+|.+++.+ .+.+++..+..++.||+.||.|||++
T Consensus 74 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~- 151 (311)
T 4aw0_A 74 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGK- 151 (311)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3467899999999999999999999999999999999999999999999964 45689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|+||+||++|+|++
T Consensus 152 --~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~ 229 (311)
T 4aw0_A 152 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229 (311)
T ss_dssp --TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred --CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999987654332 23345679999999999999999999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
|..||....... + . .....+.+.. +... ...+.++|.+||+.||++|||++|++
T Consensus 230 G~~PF~~~~~~~---~---~-~~i~~~~~~~---p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 230 GLPPFRAGNEGL---I---F-AKIIKLEYDF---PEKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp SSCSSCCSSHHH---H---H-HHHHHTCCCC---CTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCCCCCCCHHH---H---H-HHHHcCCCCC---Cccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 999997654332 1 1 1122233221 1122 23477788899999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=336.74 Aligned_cols=214 Identities=19% Similarity=0.285 Sum_probs=176.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++.+.+|+.+|++++|||||++++++.+.+.+|+|||||+||+|.+++.. +.+++..+..++.||+.||.|||++
T Consensus 191 ~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~-- 266 (423)
T 4fie_A 191 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ-- 266 (423)
T ss_dssp SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 356789999999999999999999999999999999999999999999953 3589999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+|+||||||+|||++.+|.+||+|||+++....... ......||+.|+|||++.+..|+.++|||||||++|+|++|.
T Consensus 267 -~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~ 344 (423)
T 4fie_A 267 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344 (423)
T ss_dssp -TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 999999999999999999999999999987654332 233467899999999999999999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEG 235 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~ 235 (252)
.||......... ..+..+........... ...+.++|.+||..||++|||++|+++ .|++
T Consensus 345 ~PF~~~~~~~~~-------~~i~~~~~~~~~~~~~~----s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 345 PPYFNEPPLKAM-------KMIRDNLPPRLKNLHKV----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp CTTTTSCHHHHH-------HHHHHSCCCCCSCTTSS----CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCCCCcCHHHHH-------HHHHcCCCCCCcccccC----CHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 999765433211 11222222121111122 334778888999999999999999987 3554
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=319.31 Aligned_cols=207 Identities=23% Similarity=0.358 Sum_probs=163.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+.++++.+|++++++++|||||++++++.+.+.+|+||||+ +|+|.+++.+. +.+++..+..++.||+.||.|||++
T Consensus 55 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~- 131 (275)
T 3hyh_A 55 DMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRH- 131 (275)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34678999999999999999999999999999999999999 68999999644 4699999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCC-CCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-TVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~ 162 (252)
+|+||||||+|||++.++.+|++|||+++...... ......||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus 132 --~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~llt 207 (275)
T 3hyh_A 132 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC 207 (275)
T ss_dssp --TCCCCCCCTTTEEECTTCCEEECCSSCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHH
T ss_pred --CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHH
Confidence 99999999999999999999999999998654332 2234579999999999998876 579999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|+.||....... + . .....+.... +.. .+..+.+++.+||+.||++|||++|+++
T Consensus 208 g~~PF~~~~~~~---~---~-~~i~~~~~~~---p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 208 RRLPFDDESIPV---L---F-KNISNGVYTL---PKF----LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp SSCSSCCSSHHH---H---H-HHHHHTCCCC---CTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHH---H---H-HHHHcCCCCC---CCC----CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 999997653332 1 1 1222233221 111 2344778888999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=331.55 Aligned_cols=221 Identities=24% Similarity=0.350 Sum_probs=180.0
Q ss_pred HhHHHHHHHHHHHhCCC-CCCCcceeeeEec-CCcEEEEEecCCCCCHHhhhcCC---------------CCCCCHHHHH
Q 038713 4 EGEREFKTEMNAIGRTH-HRNPVRLLGYSFD-VSNKILVYDYMSNGSLVDVLFTP---------------EKQPNWVERM 66 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~ 66 (252)
...++|.+|+++|+++. |||||+++++|.+ ++.+++|||||++|+|.++|... ...+++..++
T Consensus 109 ~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 188 (353)
T 4ase_A 109 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188 (353)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHH
Confidence 45678999999999995 5999999999976 45789999999999999999542 2348999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCC
Q 038713 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPIT 145 (252)
Q Consensus 67 ~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~ 145 (252)
.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++
T Consensus 189 ~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~ 265 (353)
T 4ase_A 189 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 265 (353)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC
Confidence 9999999999999999 999999999999999999999999999987654333 223345689999999999999999
Q ss_pred CcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 146 VKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 146 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
.++|||||||++|||+| |+.||........ +...+..+..... +...+..+.+++.+||+.||++||
T Consensus 266 ~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~------~~~~i~~g~~~~~------p~~~~~~~~~li~~c~~~dP~~RP 333 (353)
T 4ase_A 266 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRA------PDYTTPEMYQTMLDCWHGEPSQRP 333 (353)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CcccEeehHHHHHHHHhCCCCCCCCCCHHHH------HHHHHHcCCCCCC------CccCCHHHHHHHHHHcCcChhHCc
Confidence 99999999999999998 8999976543321 1222333332221 112234578888999999999999
Q ss_pred CHHHHHHHhhcCcCC
Q 038713 225 AMKKVLLMLEGTVEI 239 (252)
Q Consensus 225 s~~~i~~~l~~~~~~ 239 (252)
|+.||++.|+++++.
T Consensus 334 t~~eil~~L~~llq~ 348 (353)
T 4ase_A 334 TFSELVEHLGNLLQA 348 (353)
T ss_dssp CHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHH
Confidence 999999999987653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=326.87 Aligned_cols=207 Identities=22% Similarity=0.220 Sum_probs=164.5
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
+.++.+|+++|++++|||||++++++++.+.+|+|||||+||+|.+++.+ .+.+++..+..++.||+.||.|||++
T Consensus 70 ~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~--- 145 (304)
T 3ubd_A 70 RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSL--- 145 (304)
T ss_dssp CC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 44688999999999999999999999999999999999999999999964 44689999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
+|+||||||+|||++.+|.+||+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|+.
T Consensus 146 ~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 224 (304)
T 3ubd_A 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224 (304)
T ss_dssp TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCC
Confidence 999999999999999999999999999986543222 2234679999999999999999999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM-----KKVLL 231 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~i~~ 231 (252)
||......+. ... ...+.... +.. .+..+.+++.+||+.||++|||+ +|+++
T Consensus 225 PF~~~~~~~~------~~~-i~~~~~~~---p~~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 225 PFQGKDRKET------MTM-ILKAKLGM---PQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp SSCCSSHHHH------HHH-HHHCCCCC---CTT----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCCcCHHHH------HHH-HHcCCCCC---CCc----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 9986544321 111 22222211 112 23447788889999999999995 56653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=316.84 Aligned_cols=232 Identities=22% Similarity=0.237 Sum_probs=172.9
Q ss_pred HhHHHHHHHH--HHHhCCCCCCCcceeeeEecCC----cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEM--NAIGRTHHRNPVRLLGYSFDVS----NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~--~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
+..+.+.+|. ..+.+++|||||++++++.+.+ .+++|||||++|+|.+++.. ..+++..+++++.|++.||+
T Consensus 37 ~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ 114 (303)
T 3hmm_A 37 REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLA 114 (303)
T ss_dssp GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHH
T ss_pred cchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHH
Confidence 3444555554 4556789999999999998643 57999999999999999964 35899999999999999999
Q ss_pred HHhhcC-----CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc---ccccccCCccccccccccCC------C
Q 038713 78 YLHDEC-----EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR---TFTGIRGTRAYVAAEWHRNL------P 143 (252)
Q Consensus 78 ~lh~~~-----~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~------~ 143 (252)
|||+++ ..+|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+. .
T Consensus 115 ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~ 194 (303)
T 3hmm_A 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 194 (303)
T ss_dssp HHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHH
T ss_pred HHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCc
Confidence 999762 348999999999999999999999999999876543321 22235689999999998764 3
Q ss_pred CCCcccchhHHHHHHHHHhCCccccccchhh---------hHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhh
Q 038713 144 ITVKADVYSFGVVLLEIVCLRRCLDQNLLED---------RAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLR 214 (252)
Q Consensus 144 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 214 (252)
++.++||||||+++|||+||..||....... ...... +......+...........+.+....+.+++.+
T Consensus 195 ~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~ 273 (303)
T 3hmm_A 195 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE-MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE 273 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH-HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHT
T ss_pred cChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH-HHHHHhcccCCCCCCccccchHHHHHHHHHHHH
Confidence 5679999999999999999988775332110 001111 222233333332233333345566778999999
Q ss_pred ccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 215 CILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 215 cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
||+.||++|||+.||++.|+++.+
T Consensus 274 cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 274 CWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcccCHhHCcCHHHHHHHHHHHHH
Confidence 999999999999999999987543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=308.80 Aligned_cols=210 Identities=19% Similarity=0.293 Sum_probs=159.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCC------------cEEEEEecCCCCCHHhhhcCCCC--CCCHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVS------------NKILVYDYMSNGSLVDVLFTPEK--QPNWVERMGIA 69 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~ 69 (252)
..++++.+|+++|++++|||||++++++.+.+ .+|+|||||+||+|.+++..... ..+...++.++
T Consensus 45 ~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~ 124 (299)
T 4g31_A 45 LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHH
Confidence 45678999999999999999999999987544 36899999999999999975432 34566788999
Q ss_pred HHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-----------ccccccCCcccccccc
Q 038713 70 RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-----------TFTGIRGTRAYVAAEW 138 (252)
Q Consensus 70 ~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-----------~~~~~~~~~~~~aPE~ 138 (252)
.||++||.|||++ +|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||+
T Consensus 125 ~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~ 201 (299)
T 4g31_A 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ 201 (299)
T ss_dssp HHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHH
T ss_pred HHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHH
Confidence 9999999999999 9999999999999999999999999999876543221 1223469999999999
Q ss_pred ccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCC
Q 038713 139 HRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILD 218 (252)
Q Consensus 139 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 218 (252)
+.+..++.++|||||||++|+|++ ||....... ..+ ......... .........+.+++.+||+.
T Consensus 202 ~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~-----~~~-~~~~~~~~p------~~~~~~~~~~~~li~~~L~~ 266 (299)
T 4g31_A 202 IHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV-----RTL-TDVRNLKFP------PLFTQKYPCEYVMVQDMLSP 266 (299)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-----HHH-HHHHTTCCC------HHHHHHCHHHHHHHHHHTCS
T ss_pred HcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH-----HHH-HHHhcCCCC------CCCcccCHHHHHHHHHHcCC
Confidence 999999999999999999999996 775432111 111 111222221 11223334466788899999
Q ss_pred CCCCCCCHHHHHH
Q 038713 219 EPSLRRAMKKVLL 231 (252)
Q Consensus 219 ~p~~Rps~~~i~~ 231 (252)
||++|||+.|+++
T Consensus 267 dP~~Rps~~eil~ 279 (299)
T 4g31_A 267 SPMERPEAINIIE 279 (299)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=308.22 Aligned_cols=221 Identities=22% Similarity=0.284 Sum_probs=170.1
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEec------CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFD------VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l 76 (252)
....+.+.+|+++|++++|||||++++++.. .+.+|+|||||+ |+|.+++.. .+.+++..+..++.||+.||
T Consensus 94 ~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al 171 (398)
T 4b99_A 94 VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGL 171 (398)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999998763 468999999995 689999954 45799999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCC---CcccccccCCccccccccccCC-CCCCcccchh
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ---TRTFTGIRGTRAYVAAEWHRNL-PITVKADVYS 152 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s 152 (252)
.|||++ +|+||||||+|||++.++.+|++|||+++...... ........||+.|+|||++.+. .++.++||||
T Consensus 172 ~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWS 248 (398)
T 4b99_A 172 KYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWS 248 (398)
T ss_dssp HHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHH
T ss_pred HHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheeh
Confidence 999999 99999999999999999999999999998654322 1223446799999999998875 4689999999
Q ss_pred HHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccc---------------cccc-----hhcHHHHHHHHHHH
Q 038713 153 FGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQL---------------VEDE-----EVDQKQLQRMIKVG 212 (252)
Q Consensus 153 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~-----~~~~~~~~~l~~li 212 (252)
+||++|+|++|+.||.+....+.... +............ .... .........+.+++
T Consensus 249 lG~il~ell~G~~pF~g~~~~~~l~~---I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 325 (398)
T 4b99_A 249 VGCIFGEMLARRQLFPGKNYVHQLQL---IMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLL 325 (398)
T ss_dssp HHHHHHHHHHTSCSSCCSSHHHHHHH---HHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHH
T ss_pred hHHHHHHHHHCCCCCCCCCHHHHHHH---HHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHH
Confidence 99999999999999987654433222 1111111000000 0000 01111234577888
Q ss_pred hhccCCCCCCCCCHHHHHH
Q 038713 213 LRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 213 ~~cl~~~p~~Rps~~~i~~ 231 (252)
.+||..||++|||++|+++
T Consensus 326 ~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 326 GRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHSCSSTTTSCCHHHHTT
T ss_pred HHHCcCChhHCcCHHHHhc
Confidence 8999999999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=315.20 Aligned_cols=213 Identities=19% Similarity=0.304 Sum_probs=177.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|+.+|+.++|||||++++++.+.+.+|+|||||+||+|.+++....+.+++..+..++.||+.||.|||++
T Consensus 196 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~- 274 (573)
T 3uto_A 196 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN- 274 (573)
T ss_dssp HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3467789999999999999999999999999999999999999999999977777899999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCC--CceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEK--RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+|+||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 275 --~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml 350 (573)
T 3uto_A 275 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 350 (573)
T ss_dssp --TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred --CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999854 889999999998765432 233457899999999999999999999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||......+.. ..+..+....... ........+.++|.+||+.||++|||+.|+++
T Consensus 351 ~G~~Pf~~~~~~~~~-------~~i~~~~~~~~~~---~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 351 SGLSPFGGENDDETL-------RNVKSCDWNMDDS---AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HSCCSSCCSSHHHHH-------HHHHTTCCCCCSG---GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HCCCCCCCcCHHHHH-------HHHHhCCCCCCcc---cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999999876444311 1222222221111 11122344678888999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=298.74 Aligned_cols=162 Identities=19% Similarity=0.283 Sum_probs=140.2
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...++.+|+++|+.+ +||||+++++++.+.+.+|+||||++||+|.+++. .+++.++..++.||+.||.|||++
T Consensus 62 ~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~- 136 (361)
T 4f9c_A 62 HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQF- 136 (361)
T ss_dssp CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 356788999999988 79999999999999999999999999999999994 489999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCC-CceEEcccCcccccCCCCCc---------------------------ccccccCCccccc
Q 038713 84 EAQIIHGDIKPQNILMDEK-RCAKISDFGLAKLMKPDQTR---------------------------TFTGIRGTRAYVA 135 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~a 135 (252)
+|+||||||+|||++.+ +.+|++|||+++........ ......||+.|+|
T Consensus 137 --gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 214 (361)
T 4f9c_A 137 --GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRA 214 (361)
T ss_dssp --TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCC
T ss_pred --CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccC
Confidence 99999999999999876 79999999999765432211 1123468999999
Q ss_pred cccccCC-CCCCcccchhHHHHHHHHHhCCccccccchh
Q 038713 136 AEWHRNL-PITVKADVYSFGVVLLEIVCLRRCLDQNLLE 173 (252)
Q Consensus 136 PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 173 (252)
||++.+. .++.++||||+||++|+|++|+.||....+.
T Consensus 215 PE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 215 PEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp HHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred HHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 9999875 5899999999999999999999999765443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=289.96 Aligned_cols=228 Identities=28% Similarity=0.417 Sum_probs=173.2
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEK--QPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lh 80 (252)
.+..+.|.+|++++++++||||+++++++.+.+..++||||+++|+|.+++..... .+++..++.++.|++.||.|||
T Consensus 75 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 154 (309)
T 3p86_A 75 AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154 (309)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999999976442 3899999999999999999999
Q ss_pred hcCCCC--eeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 81 DECEAQ--IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 81 ~~~~~~--i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
+. + ++|+||||+||+++.++.++|+|||.++....... ......|+..|+|||++.+..++.++||||||+++|
T Consensus 155 ~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 230 (309)
T 3p86_A 155 NR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230 (309)
T ss_dssp TS---SSCCCCTTCCGGGEEECTTCCEEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHH
Confidence 99 8 99999999999999999999999999975433221 223356899999999999988999999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
+|++|+.||.......... .......... .+......+.+++.+||+.||++|||+.++++.|+.+++
T Consensus 231 elltg~~Pf~~~~~~~~~~------~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 231 ELATLQQPWGNLNPAQVVA------AVGFKCKRLE------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHCCCTTTTSCHHHHHH------HHHHSCCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHhCCCCCCCCCHHHHHH------HHHhcCCCCC------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999999998664432111 1111111111 111223447888889999999999999999999999887
Q ss_pred CCCCCCCC
Q 038713 239 IPIPQNPT 246 (252)
Q Consensus 239 ~~~~~~~~ 246 (252)
...|+.++
T Consensus 299 ~~~p~~~~ 306 (309)
T 3p86_A 299 SAVPPPNR 306 (309)
T ss_dssp --------
T ss_pred hCCCCCCc
Confidence 66665544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=291.63 Aligned_cols=234 Identities=34% Similarity=0.603 Sum_probs=194.4
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---KQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
+..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||
T Consensus 77 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 156 (321)
T 2qkw_B 77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156 (321)
T ss_dssp SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc
Confidence 456789999999999999999999999999999999999999999999996543 35899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
+. +++|+||||+||+++.++.++++|||.+........ .......|+..|+|||++.+..++.++||||||+++|+
T Consensus 157 ~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 233 (321)
T 2qkw_B 157 TR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233 (321)
T ss_dssp HT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHH
T ss_pred CC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHH
Confidence 99 999999999999999999999999999986543222 22233457889999999988889999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccc---hhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDE---EVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
|++|+.||.............+.......+......++. .........+.+++.+||+.||++|||+.|+++.|++.
T Consensus 234 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp HHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 999999998765544444444444444444444443322 44677788899999999999999999999999999987
Q ss_pred cCCC
Q 038713 237 VEIP 240 (252)
Q Consensus 237 ~~~~ 240 (252)
+...
T Consensus 314 l~~~ 317 (321)
T 2qkw_B 314 LRLQ 317 (321)
T ss_dssp HHSS
T ss_pred hhcc
Confidence 6543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=293.31 Aligned_cols=228 Identities=27% Similarity=0.392 Sum_probs=182.6
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
...++.|.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 91 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 170 (325)
T 3kul_A 91 ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170 (325)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45678899999999999999999999999999999999999999999999977777899999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--ccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||||+||+++.++.++|+|||.++........ ......++..|+|||++.+..++.++||||||+++|+|
T Consensus 171 ---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 247 (325)
T 3kul_A 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV 247 (325)
T ss_dssp ---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred ---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999876543322 22223456789999999988899999999999999999
Q ss_pred Hh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCC
Q 038713 161 VC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 161 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~ 239 (252)
++ |..||......... .....+.... . +......+.+++.+||+.||++|||+.++++.|+.++..
T Consensus 248 l~~g~~p~~~~~~~~~~-------~~~~~~~~~~--~----~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 248 LAYGERPYWNMTNRDVI-------SSVEEGYRLP--A----PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HTTSCCTTTTSCHHHHH-------HHHHTTCCCC--C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HcCCCCCcccCCHHHHH-------HHHHcCCCCC--C----CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 99 99999765444311 1122221111 1 112234588888899999999999999999999998776
Q ss_pred CCCCCCC
Q 038713 240 PIPQNPT 246 (252)
Q Consensus 240 ~~~~~~~ 246 (252)
+....+.
T Consensus 315 ~~~~~~~ 321 (325)
T 3kul_A 315 PESLRAT 321 (325)
T ss_dssp CC-----
T ss_pred ccccccc
Confidence 6554433
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=289.62 Aligned_cols=229 Identities=38% Similarity=0.644 Sum_probs=190.7
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---KQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.+|.+|++++++++||||+++++++.+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+
T Consensus 72 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 151 (326)
T 3uim_A 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151 (326)
T ss_dssp CHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 368999999999999999999999999999999999999999999997643 34899999999999999999999987
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
..+++|+||||+||+++.++.++|+|||.+...............|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 152 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 231 (326)
T 3uim_A 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231 (326)
T ss_dssp SSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred CCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence 77999999999999999999999999999987665444444455689999999999888899999999999999999999
Q ss_pred Cccccccch--hhhHHHHHHHHHHHhcCCccccccc---chhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 164 RRCLDQNLL--EDRAILQEWICQCFENGNLSQLVED---EEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 164 ~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
..||..... ........++.............+. ...+......+.+++.+||+.||++|||+.++++.|++
T Consensus 232 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 232 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred CCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 999963321 1112233334333334333333332 24567778889999999999999999999999999997
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=288.07 Aligned_cols=221 Identities=26% Similarity=0.417 Sum_probs=178.5
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
.+..+.|.+|++++++++||||+++++++.+.+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 48 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 127 (310)
T 3s95_A 48 EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127 (310)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45678899999999999999999999999999999999999999999999987677899999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc-------------cccccCCccccccccccCCCCCCccc
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT-------------FTGIRGTRAYVAAEWHRNLPITVKAD 149 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~D 149 (252)
+++|+||||+||+++.++.++++|||.+.......... .....|+..|+|||++.+..++.++|
T Consensus 128 ---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 204 (310)
T 3s95_A 128 ---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVD 204 (310)
T ss_dssp ---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHH
T ss_pred ---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHH
Confidence 99999999999999999999999999998664332211 11346899999999999989999999
Q ss_pred chhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 150 VYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 150 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
|||||+++|+|++|..|+............. ........ .+...+..+.+++.+||+.||++|||+.++
T Consensus 205 i~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 273 (310)
T 3s95_A 205 VFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRGFLDRY----------CPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273 (310)
T ss_dssp HHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHHHHHHT----------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhcccccc----------CCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9999999999999999986542221100000 00001100 011122347888899999999999999999
Q ss_pred HHHhhcCc
Q 038713 230 LLMLEGTV 237 (252)
Q Consensus 230 ~~~l~~~~ 237 (252)
++.|+++.
T Consensus 274 ~~~L~~l~ 281 (310)
T 3s95_A 274 EHWLETLR 281 (310)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=307.30 Aligned_cols=203 Identities=19% Similarity=0.196 Sum_probs=165.2
Q ss_pred HHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeee
Q 038713 11 TEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHG 90 (252)
Q Consensus 11 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~ 90 (252)
+++.+++.++|||||++++++++.+.+|+|||||+||+|.+++.+ .+.+++..+..++.||+.||.|||++ +|+||
T Consensus 241 ~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHR 316 (689)
T 3v5w_A 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR---FVVYR 316 (689)
T ss_dssp HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECC
T ss_pred HHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---Ccccc
Confidence 446777888999999999999999999999999999999999964 45689999999999999999999999 99999
Q ss_pred ccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc-CCCCCCcccchhHHHHHHHHHhCCccccc
Q 038713 91 DIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-NLPITVKADVYSFGVVLLEIVCLRRCLDQ 169 (252)
Q Consensus 91 di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 169 (252)
||||+|||++.+|.+||+|||+++....... ....||+.|+|||++. +..|+.++|+|||||++|+|++|..||..
T Consensus 317 DLKPeNILld~~G~vKL~DFGlA~~~~~~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 317 DLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECSSCCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred CCchHHeEEeCCCCEEecccceeeecCCCCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654332 3357999999999996 45799999999999999999999999976
Q ss_pred cchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038713 170 NLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-----MKKVLL 231 (252)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~i~~ 231 (252)
....+...+. .......... +......+.++|.+||+.||++|++ ++||.+
T Consensus 394 ~~~~~~~~i~----~~i~~~~~~~-------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 394 HKTKDKHEID----RMTLTMAVEL-------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp GGCCCHHHHH----HHHHHCCCCC-------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CChHHHHHHH----HhhcCCCCCC-------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 5443322221 1112222211 1122344778888999999999998 577653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=283.13 Aligned_cols=229 Identities=22% Similarity=0.316 Sum_probs=180.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..++|.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 53 ~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~- 130 (294)
T 4eqm_A 53 ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDM- 130 (294)
T ss_dssp HHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 45678999999999999999999999999999999999999999999999543 4689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||||+||+++.++.++++|||.+...............|++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 131 --~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g 208 (294)
T 4eqm_A 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208 (294)
T ss_dssp --TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred --CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999987654433333445689999999999998899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhhcCcCCCCC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-AMKKVLLMLEGTVEIPIP 242 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~i~~~l~~~~~~~~~ 242 (252)
..||........ .......... .. ........+..+.+++.+||+.||++|| ++.++.+.|+.++.....
T Consensus 209 ~~pf~~~~~~~~------~~~~~~~~~~-~~--~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 209 EPPFNGETAVSI------AIKHIQDSVP-NV--TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp SCSSCSSCHHHH------HHHHHSSCCC-CH--HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred CCCCCCCChHHH------HHHHhhccCC-Cc--chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 999986644321 1111222111 11 0111222345588888899999999999 999999999998776655
Q ss_pred CCC
Q 038713 243 QNP 245 (252)
Q Consensus 243 ~~~ 245 (252)
..+
T Consensus 280 ~~~ 282 (294)
T 4eqm_A 280 NED 282 (294)
T ss_dssp TCC
T ss_pred Ccc
Confidence 443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=281.98 Aligned_cols=218 Identities=24% Similarity=0.391 Sum_probs=180.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+++.+|++++++++||||+++++++.+.+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 48 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-- 125 (269)
T 4hcu_A 48 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-- 125 (269)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC--
Confidence 457799999999999999999999999999999999999999999999987777899999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-C
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-L 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 163 (252)
+++|+||||+||+++.++.++++|||.+...............++..|+|||++.+..++.++|+||||+++|+|++ |
T Consensus 126 -~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g 204 (269)
T 4hcu_A 126 -CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 204 (269)
T ss_dssp -TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -CeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCC
Confidence 99999999999999999999999999998654433223334456778999999998889999999999999999999 8
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
..||........ . .....+.. ...+... ...+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 205 ~~p~~~~~~~~~------~-~~~~~~~~--~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 205 KIPYENRSNSEV------V-EDISTGFR--LYKPRLA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCTTTTCCHHHH------H-HHHHTTCC--CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHH------H-HHHhcCcc--CCCCCcC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 999976544321 1 11122211 1111122 3447788889999999999999999999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=280.11 Aligned_cols=219 Identities=23% Similarity=0.358 Sum_probs=181.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+++.+|++++++++||||+++++++.+.+..++||||+++|+|.+++....+.+++..++.++.|++.||.|||+.
T Consensus 46 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-- 123 (268)
T 3sxs_A 46 SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH-- 123 (268)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 457799999999999999999999999999999999999999999999976666799999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-C
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-L 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 163 (252)
+++|+||||+||+++.++.++++|||.+...............++..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus 124 -~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 202 (268)
T 3sxs_A 124 -QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLG 202 (268)
T ss_dssp -TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTT
T ss_pred -CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCC
Confidence 99999999999999999999999999998765544434344556778999999998889999999999999999999 9
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~ 239 (252)
..||......... .....+.... .+... ...+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 203 ~~p~~~~~~~~~~-------~~~~~~~~~~--~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 203 KMPYDLYTNSEVV-------LKVSQGHRLY--RPHLA----SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCTTTTSCHHHHH-------HHHHTTCCCC--CCTTS----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCccccChHHHH-------HHHHcCCCCC--CCCcC----hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 9999765444311 1112222111 11112 23477888899999999999999999999987653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=289.91 Aligned_cols=219 Identities=24% Similarity=0.337 Sum_probs=180.0
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------------CCCCHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------------KQPNWVERMG 67 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~ 67 (252)
...+++.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++.... ..+++..++.
T Consensus 128 ~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (370)
T 2psq_A 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207 (370)
T ss_dssp HHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHH
Confidence 4567899999999999 89999999999999999999999999999999996432 3578999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCC
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITV 146 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~ 146 (252)
++.||+.||.|||+. +++||||||+||+++.++.++|+|||.++....... .......++..|+|||++.+..++.
T Consensus 208 i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 284 (370)
T 2psq_A 208 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 284 (370)
T ss_dssp HHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCH
T ss_pred HHHHHHHHHHHHHhC---CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCc
Confidence 999999999999999 999999999999999999999999999986543322 1223345678899999999988999
Q ss_pred cccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 147 KADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 147 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
++||||||+++|+|++ |..||......... .....+..... +......+.+++.+||+.||++|||
T Consensus 285 ~~DvwslG~il~ellt~g~~p~~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rpt 351 (370)
T 2psq_A 285 QSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-------KLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPT 351 (370)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HHHHTTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHhcCCCCCC------CCCCCHHHHHHHHHHcCCChhhCcC
Confidence 9999999999999999 99999765443311 12222222111 1223345888888999999999999
Q ss_pred HHHHHHHhhcCcC
Q 038713 226 MKKVLLMLEGTVE 238 (252)
Q Consensus 226 ~~~i~~~l~~~~~ 238 (252)
+.|+++.|++++.
T Consensus 352 ~~ell~~L~~il~ 364 (370)
T 2psq_A 352 FKQLVEDLDRILT 364 (370)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=279.17 Aligned_cols=210 Identities=22% Similarity=0.307 Sum_probs=173.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++||||+++++++...+..++||||+++|+|.+++... .+++..++.++.|++.||.|||+.
T Consensus 60 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~-- 135 (297)
T 3fxz_A 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN-- 135 (297)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 4567899999999999999999999999999999999999999999999643 589999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||||+||+++.++.++++|||.+........ ......|+..|+|||++.+..++.++||||||+++|+|++|.
T Consensus 136 -~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 213 (297)
T 3fxz_A 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (297)
T ss_dssp -TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999886654333 223456899999999999989999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.||.......... .....+.. ....+ ......+.+++.+||+.||++|||+.|+++
T Consensus 214 ~pf~~~~~~~~~~------~~~~~~~~-~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 214 PPYLNENPLRALY------LIATNGTP-ELQNP----EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CTTTTSCHHHHHH------HHHHHCSC-CCSCG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCHHHHHH------HHHhCCCC-CCCCc----cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 9997654432211 11111111 11111 122344778888999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=291.34 Aligned_cols=221 Identities=25% Similarity=0.397 Sum_probs=171.2
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
...+++|.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++......+++..++.++.||+.||.|||+.
T Consensus 87 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 166 (373)
T 2qol_A 87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166 (373)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34577899999999999999999999999999999999999999999999987777899999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc--cccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT--FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||||+||+++.++.++++|||.++......... .....++..|+|||++.+..++.++||||||+++|++
T Consensus 167 ---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~el 243 (373)
T 2qol_A 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243 (373)
T ss_dssp ---TCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHH
Confidence 99999999999999999999999999998765432211 1122346689999999988899999999999999999
Q ss_pred Hh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCC
Q 038713 161 VC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 161 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~ 239 (252)
++ |..||....... .. .....+.... . +......+.+++.+||+.||++|||+.++++.|++++..
T Consensus 244 lt~g~~P~~~~~~~~---~~----~~i~~~~~~~--~----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 244 MSYGERPYWEMSNQD---VI----KAVDEGYRLP--P----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HTTC-CTTTTCCHHH---HH----HHHHTTEECC--C----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhCCCCCCCCCCHHH---HH----HHHHcCCCCC--C----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 97 999997654332 11 1122221111 1 112334588889999999999999999999999886543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=281.11 Aligned_cols=218 Identities=20% Similarity=0.288 Sum_probs=168.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..++.|.+|+.++++++||||+++++++. .+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 58 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~- 135 (281)
T 1mp8_A 58 SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 135 (281)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 45678999999999999999999999985 5678999999999999999976666799999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++|+||||+||+++.++.++++|||.+...............++..|+|||++.+..++.++|+||||+++|++++
T Consensus 136 --~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~ 213 (281)
T 1mp8_A 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 213 (281)
T ss_dssp --TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred --CeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhc
Confidence 99999999999999999999999999998765433333333456778999999998889999999999999999996
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
|..||......+.. .....+..... +...+..+.+++.+||+.||++|||+.++++.|+++++
T Consensus 214 g~~pf~~~~~~~~~-------~~i~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 214 GVKPFQGVKNNDVI-------GRIENGERLPM------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp SCCTTTTCCGGGHH-------HHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHH-------HHHHcCCCCCC------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 88999765444311 11222222111 12223457888889999999999999999999988653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=284.05 Aligned_cols=209 Identities=22% Similarity=0.314 Sum_probs=173.9
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
....+++.+|+.+++.++||||+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 55 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~ 133 (328)
T 3fe3_A 55 PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQK 133 (328)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678999999999999999999999999999999999999999999999544 4589999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCC-CcccchhHHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPIT-VKADVYSFGVVLLEIV 161 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~ 161 (252)
+++||||||+||+++.++.++++|||.+....... ......|++.|+|||++.+..++ .++||||||+++|+|+
T Consensus 134 ---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 208 (328)
T 3fe3_A 134 ---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208 (328)
T ss_dssp ---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHH
T ss_pred ---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHH
Confidence 99999999999999999999999999997654332 23345689999999999987765 7899999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||........ ......+.... +......+.+++.+||..||++|||++|+++
T Consensus 209 ~g~~pf~~~~~~~~-------~~~i~~~~~~~-------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 209 SGSLPFDGQNLKEL-------RERVLRGKYRI-------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HSSCSSCCSSHHHH-------HHHHHHCCCCC-------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred hCCCCCCCCCHHHH-------HHHHHhCCCCC-------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999987644321 11222232221 1112344778888999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=280.12 Aligned_cols=218 Identities=20% Similarity=0.342 Sum_probs=180.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+++.+|++++++++||||+++++++.+.+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 62 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-- 139 (283)
T 3gen_A 62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-- 139 (283)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 457799999999999999999999999999999999999999999999987666799999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-C
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-L 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 163 (252)
+++|+||||+||+++.++.++++|||.+...............++..|+|||++.+..++.++|+||||+++|+|++ |
T Consensus 140 -~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g 218 (283)
T 3gen_A 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 218 (283)
T ss_dssp -TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTT
T ss_pred -CccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999998654433223333456778999999998889999999999999999998 9
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
..||......... .....+.... .+... ...+.+++.+||+.+|++|||+.++++.|+++++
T Consensus 219 ~~p~~~~~~~~~~-------~~~~~~~~~~--~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 219 KMPYERFTNSETA-------EHIAQGLRLY--RPHLA----SEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCTTTTSCHHHHH-------HHHHTTCCCC--CCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccccChhHHH-------HHHhcccCCC--CCCcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 9999766443211 1122221111 11111 2447788889999999999999999999988653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=293.30 Aligned_cols=218 Identities=21% Similarity=0.260 Sum_probs=177.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..++|.+|++++++++||||+++++++.+.+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 154 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~- 232 (377)
T 3cbl_A 154 DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK- 232 (377)
T ss_dssp HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4566799999999999999999999999999999999999999999999976666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCccc-ccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTF-TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++.++++|||.++.......... ....++..|+|||.+.+..++.++||||||+++|++++
T Consensus 233 --~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t 310 (377)
T 3cbl_A 233 --CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310 (377)
T ss_dssp --TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred --CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999876433221111 11224567999999988889999999999999999998
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
|..||........ ......+..... +...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 311 ~g~~p~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 311 LGASPYPNLSNQQT-------REFVEKGGRLPC------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp TSCCSSTTSCHHHH-------HHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHH-------HHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 8999876544321 122222221111 1112345778888999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=284.38 Aligned_cols=220 Identities=23% Similarity=0.317 Sum_probs=179.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-----------------------CCC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-----------------------KQP 60 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~ 60 (252)
+..+.|.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.... ..+
T Consensus 92 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (343)
T 1luf_A 92 DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171 (343)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCC
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCC
Confidence 456789999999999999999999999999999999999999999999996431 568
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccc
Q 038713 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWH 139 (252)
Q Consensus 61 ~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~ 139 (252)
++..++.++.||+.||.|||+. +++|+||||+||+++.++.++++|||.+........ .......++..|+|||++
T Consensus 172 ~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 248 (343)
T 1luf_A 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 248 (343)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh
Confidence 9999999999999999999999 999999999999999999999999999976543221 122334568899999999
Q ss_pred cCCCCCCcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCC
Q 038713 140 RNLPITVKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILD 218 (252)
Q Consensus 140 ~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 218 (252)
.+..++.++|+||||+++|+|++ |..||....... +......+..... +......+.+++.+||+.
T Consensus 249 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~ 315 (343)
T 1luf_A 249 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-------VIYYVRDGNILAC------PENCPLELYNLMRLCWSK 315 (343)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCS
T ss_pred ccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH-------HHHHHhCCCcCCC------CCCCCHHHHHHHHHHccc
Confidence 98889999999999999999999 999997654332 1122233332221 112234578888899999
Q ss_pred CCCCCCCHHHHHHHhhcCcCC
Q 038713 219 EPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 219 ~p~~Rps~~~i~~~l~~~~~~ 239 (252)
||++|||+.++++.|+++.+.
T Consensus 316 ~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 316 LPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp SGGGSCCHHHHHHHHHHTTC-
T ss_pred CcccCCCHHHHHHHHHHHHhh
Confidence 999999999999999997764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=288.97 Aligned_cols=227 Identities=25% Similarity=0.334 Sum_probs=183.9
Q ss_pred hHhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------------CCCCHHHHH
Q 038713 3 AEGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------------KQPNWVERM 66 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~ 66 (252)
.+..+++.+|+++++++ +||||+++++++.+.+..++||||+++|+|.+++.... ..+++..++
T Consensus 115 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 194 (382)
T 3tt0_A 115 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194 (382)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHH
Confidence 34567899999999999 99999999999999999999999999999999996432 458999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCC
Q 038713 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPIT 145 (252)
Q Consensus 67 ~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~ 145 (252)
.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||.++....... .......++..|+|||++.+..++
T Consensus 195 ~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 271 (382)
T 3tt0_A 195 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271 (382)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC
T ss_pred HHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC
Confidence 9999999999999999 999999999999999999999999999986643322 222334567789999999998999
Q ss_pred CcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 146 VKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 146 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
.++||||||+++|+|++ |..||....... +......+..... +......+.+++.+||+.||++||
T Consensus 272 ~~~DiwslG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rp 338 (382)
T 3tt0_A 272 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LFKLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRP 338 (382)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHTTCCCCC------CSSCCHHHHHHHHHHTCSSGGGSC
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC------CccCCHHHHHHHHHHcCCChhhCc
Confidence 99999999999999999 999997654332 1122222222111 112234578888899999999999
Q ss_pred CHHHHHHHhhcCcCCCCCCCC
Q 038713 225 AMKKVLLMLEGTVEIPIPQNP 245 (252)
Q Consensus 225 s~~~i~~~l~~~~~~~~~~~~ 245 (252)
|+.|+++.|++++.....+..
T Consensus 339 s~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 339 TFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp CHHHHHHHHHHHHHHSCSCC-
T ss_pred CHHHHHHHHHHHHHHHhcCCC
Confidence 999999999997765544443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=283.96 Aligned_cols=218 Identities=21% Similarity=0.337 Sum_probs=177.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.|.+|+.++++++||||+++++++.+.. .++|++|+.+|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 59 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~- 136 (327)
T 3poz_A 59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136 (327)
T ss_dssp -CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC-
Confidence 45678999999999999999999999998754 7899999999999999987777899999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++.++++|||.++........ ......++..|+|||++.+..++.++||||||+++|++++
T Consensus 137 --~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 214 (327)
T 3poz_A 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214 (327)
T ss_dssp --TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred --CeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHh
Confidence 9999999999999999999999999999876543322 2233456779999999999899999999999999999999
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
|..||......... .....+.... . +......+.+++.+||+.||++|||+.++++.|++...
T Consensus 215 ~g~~p~~~~~~~~~~-------~~~~~~~~~~--~----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 215 FGSKPYDGIPASEIS-------SILEKGERLP--Q----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TSCCTTTTCCGGGHH-------HHHHTTCCCC--C----CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCCccCCCHHHHH-------HHHHcCCCCC--C----CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99999866544321 2222222111 1 11223457888899999999999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=278.64 Aligned_cols=213 Identities=20% Similarity=0.286 Sum_probs=175.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|+.+++.++||||+++++++.+.+..++||||++||+|.+++......+++..++.++.|++.||.|||+.
T Consensus 43 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~- 121 (321)
T 1tki_A 43 TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH- 121 (321)
T ss_dssp HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4566789999999999999999999999999999999999999999999977666799999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecC--CCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDE--KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||||+||+++. ++.++++|||.+....... ......|++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 122 --givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 197 (321)
T 1tki_A 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp --TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred --CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999987 7899999999998765332 223456899999999999888899999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||........ ... ...+..... ..........+.+++.+||..||++|||+.|+++
T Consensus 198 ~g~~pf~~~~~~~~------~~~-i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 198 SGINPFLAETNQQI------IEN-IMNAEYTFD---EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HSSCTTCCSSHHHH------HHH-HHHTCCCCC---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCCCCcCCCHHHH------HHH-HHcCCCCCC---hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99999976544321 111 122222111 1111122345788888999999999999999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=287.19 Aligned_cols=214 Identities=20% Similarity=0.270 Sum_probs=175.0
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
....+.+.+|+.++++++||||+++++++.+.+..++||||++||+|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 51 ~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~ 129 (444)
T 3soa_A 51 ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQM 129 (444)
T ss_dssp HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678999999999999999999999999999999999999999999999654 4689999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEec---CCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMD---EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
+++||||||+||+++ .++.++++|||.+........ ......|++.|+|||++.+..++.++||||||+++|+
T Consensus 130 ---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilye 205 (444)
T 3soa_A 130 ---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYI 205 (444)
T ss_dssp ---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred ---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHH
Confidence 999999999999998 467899999999976654332 2234568999999999999889999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|++|..||........ ......+........ .......+.+++.+||+.||++|||+.|+++
T Consensus 206 ll~G~~Pf~~~~~~~~-------~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 206 LLVGYPPFWDEDQHRL-------YQQIKAGAYDFPSPE---WDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHSSCSCCCSSHHHH-------HHHHHHTCCCCCTTT---TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCCCCCCccHHHH-------HHHHHhCCCCCCccc---cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999999976543321 122223332221111 1112344778888999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=287.40 Aligned_cols=231 Identities=23% Similarity=0.344 Sum_probs=174.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEec-CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFD-VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
...++|.+|+.++++++||||+++++++.. .+..++||||+++|+|.+++......+++..++.++.||+.||.|||+.
T Consensus 132 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 211 (373)
T 3c1x_A 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211 (373)
T ss_dssp HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 457889999999999999999999998754 5678999999999999999987777789999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc---ccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR---TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
+++||||||+||+++.++.++++|||.++........ ......++..|+|||++.+..++.++||||||+++|+
T Consensus 212 ---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~e 288 (373)
T 3c1x_A 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 288 (373)
T ss_dssp ---TCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ---CEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHH
Confidence 9999999999999999999999999999865432211 1223456778999999998899999999999999999
Q ss_pred HHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 160 IVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 160 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
|++ |..||......+.. .....+... ..+.. .+..+.+++.+||+.||++|||+.++++.|++++.
T Consensus 289 llt~~~~p~~~~~~~~~~-------~~~~~~~~~--~~p~~----~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 289 LMTRGAPPYPDVNTFDIT-------VYLLQGRRL--LQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp HHTTSCCSCTTSCSSCHH-------HHHHTTCCC--CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhCcCCCCCCCCHHHHH-------HHHHcCCCC--CCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 999 56666554333211 112222211 11112 23457888889999999999999999999999776
Q ss_pred CCCCCCCCCCCC
Q 038713 239 IPIPQNPTSFLS 250 (252)
Q Consensus 239 ~~~~~~~~~~~~ 250 (252)
.........+..
T Consensus 356 ~~~~~~~~~~~~ 367 (373)
T 3c1x_A 356 TFIGEHYVHVNA 367 (373)
T ss_dssp TCCSCCBCCCCT
T ss_pred hccccceeeccc
Confidence 555544444433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=274.36 Aligned_cols=210 Identities=19% Similarity=0.279 Sum_probs=173.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++||||+++++++...+..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.
T Consensus 85 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~-- 160 (321)
T 2c30_A 85 RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQ-- 160 (321)
T ss_dssp SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 467799999999999999999999999999999999999999999999853 3589999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||||+||+++.++.++++|||.+........ ......|+..|+|||++.+..++.++|+||||+++|+|++|+
T Consensus 161 -~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~ 238 (321)
T 2c30_A 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238 (321)
T ss_dssp -TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999886654322 223456899999999999888999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.||........ . ................. ...+.+++.+||+.||++|||+.++++
T Consensus 239 ~pf~~~~~~~~------~-~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 239 PPYFSDSPVQA------M-KRLRDSPPPKLKNSHKV----SPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp CTTTTSCHHHH------H-HHHHHSSCCCCTTGGGS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCCCHHHH------H-HHHhcCCCCCcCccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99976543321 1 11222222222111122 234778888999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=279.13 Aligned_cols=220 Identities=25% Similarity=0.347 Sum_probs=180.1
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-----------------------CC
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-----------------------KQ 59 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~ 59 (252)
.+..+++.+|++++++++||||+++++++.+.+..++||||+++|+|.+++.... ..
T Consensus 67 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (314)
T 2ivs_A 67 PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146 (314)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CE
T ss_pred HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccC
Confidence 3456789999999999999999999999999999999999999999999996532 23
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCcccccccc
Q 038713 60 PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEW 138 (252)
Q Consensus 60 ~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~ 138 (252)
+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++++|||.+......... ......++..|+|||.
T Consensus 147 ~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 223 (314)
T 2ivs_A 147 LTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES 223 (314)
T ss_dssp ECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhh
Confidence 78999999999999999999999 9999999999999999999999999999866443321 2223456778999999
Q ss_pred ccCCCCCCcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccC
Q 038713 139 HRNLPITVKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCIL 217 (252)
Q Consensus 139 ~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 217 (252)
+.+..++.++||||||+++|+|++ |..||......... .....+..... +......+.+++.+||+
T Consensus 224 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~~~li~~~l~ 290 (314)
T 2ivs_A 224 LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF-------NLLKTGHRMER------PDNCSEEMYRLMLQCWK 290 (314)
T ss_dssp HHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HHHHTTCCCCC------CTTCCHHHHHHHHHHTC
T ss_pred hcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHhhcCCcCCC------CccCCHHHHHHHHHHcc
Confidence 998889999999999999999999 99999766544311 12222221111 11223458888889999
Q ss_pred CCCCCCCCHHHHHHHhhcCcC
Q 038713 218 DEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 218 ~~p~~Rps~~~i~~~l~~~~~ 238 (252)
.||++|||+.++++.|++++.
T Consensus 291 ~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 291 QEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp SSGGGSCCHHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999998654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=275.30 Aligned_cols=218 Identities=24% Similarity=0.370 Sum_probs=179.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+++.+|+.++++++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.
T Consensus 46 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-- 123 (267)
T 3t9t_A 46 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-- 123 (267)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 457899999999999999999999999999999999999999999999977667789999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-C
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-L 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 163 (252)
+++|+||+|+||+++.++.++++|||.+...............++..|+|||++.+..++.++|+||||+++|+|++ |
T Consensus 124 -~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 202 (267)
T 3t9t_A 124 -CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 202 (267)
T ss_dssp -TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -CcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccC
Confidence 99999999999999999999999999998654322222233456778999999998889999999999999999999 8
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
..||........ . .....+... ..+.. ....+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 203 ~~p~~~~~~~~~------~-~~i~~~~~~--~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 203 KIPYENRSNSEV------V-EDISTGFRL--YKPRL----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTTTCCHHHH------H-HHHHTTCCC--CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHH------H-HHHhcCCcC--CCCcc----CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999876543321 1 112222111 11111 23447788889999999999999999999998654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=274.83 Aligned_cols=228 Identities=18% Similarity=0.188 Sum_probs=169.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++||||+++++++.+.+..++|+||+++++|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 77 ~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~-- 153 (309)
T 2h34_A 77 FRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAA-- 153 (309)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4578999999999999999999999999999999999999999999999643 4689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||+|+||+++.++.++++|||.+...............++..|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 154 -~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 232 (309)
T 2h34_A 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232 (309)
T ss_dssp -TCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSS
T ss_pred -cCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999998766544333334456889999999999888999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhhcCcCCCCCC
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-AMKKVLLMLEGTVEIPIPQ 243 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~i~~~l~~~~~~~~~~ 243 (252)
.||....... ............ ...+...+..+.+++.+||+.||++|| |++++++.|++.+....+.
T Consensus 233 ~pf~~~~~~~-------~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 233 PPYQGDQLSV-------MGAHINQAIPRP----STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp CSSCSCHHHH-------HHHHHHSCCCCG----GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred CCCCCchHHH-------HHHHhccCCCCc----cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 9998653321 111222211111 111222334477888899999999999 9999999999988776655
Q ss_pred CCCC
Q 038713 244 NPTS 247 (252)
Q Consensus 244 ~~~~ 247 (252)
...+
T Consensus 302 ~~~~ 305 (309)
T 2h34_A 302 RATD 305 (309)
T ss_dssp ----
T ss_pred chhh
Confidence 4443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=280.74 Aligned_cols=219 Identities=23% Similarity=0.392 Sum_probs=174.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+++|.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 88 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~- 166 (333)
T 1mqb_A 88 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM- 166 (333)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4567899999999999999999999999999999999999999999999977667799999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--ccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||||+||+++.++.++++|||.+......... ......++..|+|||++.+..++.++||||||+++|+++
T Consensus 167 --~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 244 (333)
T 1mqb_A 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 244 (333)
T ss_dssp --TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred --CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999999876433221 112234577899999999888999999999999999999
Q ss_pred h-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 162 C-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 162 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
+ |..||....... + . .....+.... . +......+.+++.+||+.||++|||+.++++.|++++.
T Consensus 245 t~g~~pf~~~~~~~---~---~-~~~~~~~~~~--~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 245 TYGERPYWELSNHE---V---M-KAINDGFRLP--T----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp TTSCCTTTTCCHHH---H---H-HHHHTTCCCC--C----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCCCCcccCCHHH---H---H-HHHHCCCcCC--C----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 8 999997654332 1 1 1222221111 1 11223457888889999999999999999999988543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=296.12 Aligned_cols=219 Identities=23% Similarity=0.325 Sum_probs=181.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT-PEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..++|.+|+.+|++++||||+++++++.+....++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++
T Consensus 259 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~- 337 (495)
T 1opk_A 259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK- 337 (495)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 467899999999999999999999999999999999999999999999965 345689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++||||||+||+++.++.++|+|||+++..............++..|+|||++.+..++.++||||||+++|+|++
T Consensus 338 --~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~ 415 (495)
T 1opk_A 338 --NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415 (495)
T ss_dssp --TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred --CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhC
Confidence 99999999999999999999999999998765433323333456778999999998889999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~ 239 (252)
|..||........ ...+..+.... .+......+.+++.+||+.||++|||+.+|++.|++.+..
T Consensus 416 g~~p~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 416 GMSPYPGIDLSQV-------YELLEKDYRME------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp SCCSSTTCCGGGH-------HHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCCHHHH-------HHHHHcCCCCC------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 8899876544331 11222221111 1122234578888999999999999999999999997654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=274.65 Aligned_cols=224 Identities=28% Similarity=0.452 Sum_probs=169.3
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
.+..+.|.+|+.++++++||||++++++. .....++||||+++++|.+++......+++..++.++.|++.||.|||+.
T Consensus 61 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~ 139 (289)
T 3og7_A 61 PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139 (289)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45568899999999999999999999965 55678999999999999999987777899999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCC-CcccccccCCcccccccccc---CCCCCCcccchhHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ-TRTFTGIRGTRAYVAAEWHR---NLPITVKADVYSFGVVLL 158 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~ 158 (252)
+++|+||||+||+++.++.++++|||.+....... ........|+..|+|||++. +..++.++||||||+++|
T Consensus 140 ---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 216 (289)
T 3og7_A 140 ---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLY 216 (289)
T ss_dssp ---TCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHH
T ss_pred ---CcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHH
Confidence 99999999999999999999999999987654322 22223456899999999986 556788999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
+|++|+.||........ +. .....+....... ......+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 217 el~~g~~p~~~~~~~~~--~~----~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 217 ELMTGQLPYSNINNRDQ--II----EMVGRGSLSPDLS--KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHSSCTTSSCCCHHH--HH----HHHHHTSCCCCTT--SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHCCCCccccchHHH--HH----HHhcccccCcchh--hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 99999999976544321 11 2222222222111 1122233558888889999999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=278.66 Aligned_cols=211 Identities=24% Similarity=0.353 Sum_probs=172.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++.+.+|+.++++++||||+++++++.+.+..++||||++||+|.+++.. .+.+++..++.++.||+.||.|||+.
T Consensus 58 ~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-- 134 (361)
T 2yab_A 58 CREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTK-- 134 (361)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 357899999999999999999999999999999999999999999999954 45689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCC----ceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKR----CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||||+||+++.++ .++++|||.+....... ......|++.|+|||++.+..++.++|+||||+++|+|
T Consensus 135 -givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~l 211 (361)
T 2yab_A 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211 (361)
T ss_dssp -TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred -CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHH
Confidence 999999999999998776 79999999998765432 22335689999999999998899999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||........ . ..+..+.... +..........+.++|.+||..||++|||+.|+++
T Consensus 212 l~g~~Pf~~~~~~~~------~-~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 212 LSGASPFLGDTKQET------L-ANITAVSYDF---DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHSCCSSCCSSHHHH------H-HHHHTTCCCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCCCCCCCCCHHHH------H-HHHHhcCCCC---CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 999999976543321 1 1122222111 11111122344778888999999999999999885
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=293.00 Aligned_cols=222 Identities=25% Similarity=0.356 Sum_probs=175.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..++|.+|+.++++++||||+++++++.+ +..++||||+++|+|.+++... .+.+++..++.++.|++.||.|||++
T Consensus 222 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~- 299 (452)
T 1fmk_A 222 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 299 (452)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 35789999999999999999999999876 7789999999999999999643 35689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++||||||+||+++.++.++|+|||.++..............++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 300 --~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~ 377 (452)
T 1fmk_A 300 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377 (452)
T ss_dssp --TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhC
Confidence 99999999999999999999999999998765433323333456788999999998889999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCCCCC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIPIP 242 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~~~~ 242 (252)
|..||......+. ......+.... .+...+..+.+++.+||+.||++|||++++++.|++......|
T Consensus 378 g~~P~~~~~~~~~-------~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 378 GRVPYPGMVNREV-------LDQVERGYRMP------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp TCCSSTTCCHHHH-------HHHHHTTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCCCCCHHHH-------HHHHHcCCCCC------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 8999976543321 11222222111 1122334578889999999999999999999999998766555
Q ss_pred C
Q 038713 243 Q 243 (252)
Q Consensus 243 ~ 243 (252)
+
T Consensus 445 ~ 445 (452)
T 1fmk_A 445 Q 445 (452)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=293.68 Aligned_cols=221 Identities=23% Similarity=0.364 Sum_probs=179.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..++|.+|+.++++++||||+++++++. .+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++
T Consensus 226 ~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~- 303 (454)
T 1qcf_A 226 SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR- 303 (454)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4678999999999999999999999987 567899999999999999997543 3578899999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++||||||+||+++.++.++|+|||+++..............++..|+|||++.+..++.++||||||+++|+|++
T Consensus 304 --~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~ 381 (454)
T 1qcf_A 304 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 381 (454)
T ss_dssp --TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhC
Confidence 99999999999999999999999999998754322222223345778999999998889999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCCCCC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIPIP 242 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~~~~ 242 (252)
|..||......+. . ..+..+.... . +...+..+.+++.+||+.||++|||+++|++.|++......+
T Consensus 382 g~~P~~~~~~~~~---~----~~i~~~~~~~--~----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 382 GRIPYPGMSNPEV---I----RALERGYRMP--R----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp SCCSSTTCCHHHH---H----HHHHHTCCCC--C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred CCCCCCCCCHHHH---H----HHHHcCCCCC--C----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 9999976543321 1 1122221111 1 112234588889999999999999999999999998765443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=278.69 Aligned_cols=227 Identities=22% Similarity=0.353 Sum_probs=175.3
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
.+..++|.+|+.++++++||||+++++++.. ....++||||+++|+|.+++......+++..++.++.|++.||.|||
T Consensus 52 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH 131 (295)
T 3ugc_A 52 EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131 (295)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh
Confidence 3456789999999999999999999999865 45689999999999999999776667999999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--cccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
+. +++|+||||+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++||||||+++|
T Consensus 132 ~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 208 (295)
T 3ugc_A 132 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208 (295)
T ss_dssp HT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred cC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHH
Confidence 99 999999999999999999999999999987643322 1122234566799999999889999999999999999
Q ss_pred HHHhCCccccccchhhh---------HHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 159 EIVCLRRCLDQNLLEDR---------AILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
++++|..|+........ .............+..... +...+..+.+++.+||+.||++|||+.|+
T Consensus 209 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~el 282 (295)
T 3ugc_A 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR------PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282 (295)
T ss_dssp HHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC------CTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCC------CcCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 99999999875432211 0111111122222221111 22233458888889999999999999999
Q ss_pred HHHhhcCcC
Q 038713 230 LLMLEGTVE 238 (252)
Q Consensus 230 ~~~l~~~~~ 238 (252)
++.|+++.+
T Consensus 283 ~~~L~~l~~ 291 (295)
T 3ugc_A 283 ALRVDQIRD 291 (295)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999988643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=280.33 Aligned_cols=231 Identities=24% Similarity=0.336 Sum_probs=181.6
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
.+.++.+.+|++++++++||||+++++++.+ ....++||||+++|+|.+++... .+++..++.++.|++.||.|||
T Consensus 74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH 151 (318)
T 3lxp_A 74 PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH 151 (318)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHH
Confidence 3557789999999999999999999999987 46789999999999999999643 3899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--ccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
+. +++|+||||+||+++.++.++++|||.+......... ......++..|+|||++.+..++.++||||||+++|
T Consensus 152 ~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 228 (318)
T 3lxp_A 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228 (318)
T ss_dssp HT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred hC---CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHH
Confidence 99 9999999999999999999999999999876543321 122345677899999999888899999999999999
Q ss_pred HHHhCCccccccchhh---------hHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 159 EIVCLRRCLDQNLLED---------RAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
+|++|..||....... ..... ........+..... +......+.+++.+||+.||++|||+.++
T Consensus 229 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~el 301 (318)
T 3lxp_A 229 ELLTHCDSSQSPPTKFLELIGIAQGQMTVL-RLTELLERGERLPR------PDKCPAEVYHLMKNCWETEASFRPTFENL 301 (318)
T ss_dssp HHHTTTCGGGSHHHHHHHHHCSCCHHHHHH-HHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHhCCCcccccchhhhhhhcccccchhHH-HHHHHHhcccCCCC------CccccHHHHHHHHHHcCCCcccCcCHHHH
Confidence 9999999997653321 11111 11222222222111 12223458888899999999999999999
Q ss_pred HHHhhcCcCCCCCCCC
Q 038713 230 LLMLEGTVEIPIPQNP 245 (252)
Q Consensus 230 ~~~l~~~~~~~~~~~~ 245 (252)
++.|+++.+...+++|
T Consensus 302 l~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 302 IPILKTVHEKYQGQAP 317 (318)
T ss_dssp HHHHHHHHHHHHC---
T ss_pred HHHHHHHHHhhccCCC
Confidence 9999998776666555
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=278.74 Aligned_cols=213 Identities=21% Similarity=0.302 Sum_probs=173.1
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
....+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.
T Consensus 69 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~ 147 (362)
T 2bdw_A 69 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSN 147 (362)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34567899999999999999999999999999999999999999999999954 45689999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCC---ceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKR---CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
+++|+||||+||+++.++ .++++|||.+....... ......|++.|+|||++.+..++.++||||||+++|+
T Consensus 148 ---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ 222 (362)
T 2bdw_A 148 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYI 222 (362)
T ss_dssp ---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred ---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence 999999999999998654 59999999998665332 2233568999999999999889999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|++|..||....... + ......+........ .......+.+++.+||+.||++|||+.|+++
T Consensus 223 ll~g~~Pf~~~~~~~---~----~~~i~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 223 LLVGYPPFWDEDQHR---L----YAQIKAGAYDYPSPE---WDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHHSSCSSCCSSHHH---H----HHHHHHTCCCCCTTG---GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCCCCCHHH---H----HHHHHhCCCCCCccc---ccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 999999997654332 1 112222322221111 1112344778888999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=274.96 Aligned_cols=217 Identities=19% Similarity=0.274 Sum_probs=174.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..++|.+|+.++++++||||+++++++.+ +..++||||+++++|.+++......+++..++.++.|++.||.|||+.
T Consensus 55 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~- 132 (281)
T 3cc6_A 55 DNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI- 132 (281)
T ss_dssp HHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 467889999999999999999999999875 457899999999999999977666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++|+||||+||+++.++.++++|||.+...............++..|+|||++.+..++.++|+||||+++|+|++
T Consensus 133 --~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~ 210 (281)
T 3cc6_A 133 --NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSF 210 (281)
T ss_dssp --TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --CcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhC
Confidence 99999999999999999999999999998765443333334456788999999998889999999999999999998
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
|+.||......... .....+.... .+.. ....+.+++.+||+.||++|||+.++++.|+++.
T Consensus 211 g~~p~~~~~~~~~~-------~~~~~~~~~~--~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 211 GKQPFFWLENKDVI-------GVLEKGDRLP--KPDL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp TCCTTTTSCGGGHH-------HHHHHTCCCC--CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccCChHHHH-------HHHhcCCCCC--CCCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 99999765444321 1112221111 1111 2344788888999999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=276.66 Aligned_cols=223 Identities=21% Similarity=0.339 Sum_probs=178.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecC--CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDV--SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..+.+.+|+.++++++||||+++++++.+. +..++||||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 66 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 145 (302)
T 4e5w_A 66 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145 (302)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC
Confidence 457899999999999999999999999876 678999999999999999976666799999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--cccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||||+||+++.++.++++|||.+........ .......++..|+|||++.+..++.++|+||||+++|+|
T Consensus 146 ---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 222 (302)
T 4e5w_A 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222 (302)
T ss_dssp ---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred ---CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHH
Confidence 999999999999999999999999999987654332 122334577789999999988889999999999999999
Q ss_pred HhCCccccccchh---------hhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLE---------DRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..|+...... ....... .......+..... +......+.+++.+||+.||.+|||+.++++
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 223 LTYCDSDSSPMALFLKMIGPTHGQMTVTR-LVNTLKEGKRLPC------PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTTCGGGSHHHHHHHHHCSCCGGGHHHH-HHHHHHTTCCCCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHccCCCcchhhHHhhccCCcccccCHHH-HHHHHhccCCCCC------CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9999987543211 1111111 1122222221111 1222345888888999999999999999999
Q ss_pred HhhcCc
Q 038713 232 MLEGTV 237 (252)
Q Consensus 232 ~l~~~~ 237 (252)
.|++++
T Consensus 296 ~L~~ll 301 (302)
T 4e5w_A 296 GFEALL 301 (302)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 999765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=273.64 Aligned_cols=224 Identities=15% Similarity=0.137 Sum_probs=181.1
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|+.+++++ +|+|++++++++.+....++||||+ +++|.+++....+.+++..++.++.|++.||.|||+.
T Consensus 49 ~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-- 125 (298)
T 1csn_A 49 APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK-- 125 (298)
T ss_dssp SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 45688999999999 8999999999999999999999999 9999999977666799999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCc-----eEEcccCcccccCCCCCc------ccccccCCccccccccccCCCCCCcccchhH
Q 038713 85 AQIIHGDIKPQNILMDEKRC-----AKISDFGLAKLMKPDQTR------TFTGIRGTRAYVAAEWHRNLPITVKADVYSF 153 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 153 (252)
+++|+||||+||+++.++. ++++|||.+......... ......|+..|+|||++.+..++.++|||||
T Consensus 126 -~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 204 (298)
T 1csn_A 126 -SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 204 (298)
T ss_dssp -TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred -CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHH
Confidence 9999999999999987765 999999999876543321 2234568999999999999889999999999
Q ss_pred HHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 038713 154 GVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233 (252)
Q Consensus 154 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l 233 (252)
|+++|+|++|+.||..............+.......... ......+..+.+++.+||+.||++|||+++|++.|
T Consensus 205 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l 278 (298)
T 1csn_A 205 GHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 278 (298)
T ss_dssp HHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred HHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 999999999999998754433322222222111111111 11112234588888899999999999999999999
Q ss_pred hcCcCC
Q 038713 234 EGTVEI 239 (252)
Q Consensus 234 ~~~~~~ 239 (252)
+++++.
T Consensus 279 ~~~~~~ 284 (298)
T 1csn_A 279 SKVLER 284 (298)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 986643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=274.28 Aligned_cols=208 Identities=23% Similarity=0.237 Sum_probs=171.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++||||+++++++.+.+..++||||++||+|.+++.. .+.+++..++.++.||+.||.|||++
T Consensus 48 ~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~-- 124 (337)
T 1o6l_A 48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR-- 124 (337)
T ss_dssp CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 456789999999999999999999999999999999999999999999954 34689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+||+++.+|.++|+|||+++....... ......|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 125 -~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 202 (337)
T 1o6l_A 125 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202 (337)
T ss_dssp -TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred -CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCC
Confidence 999999999999999999999999999875432221 223456899999999999989999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
.||....... .. .....+.... +......+.+++.+||+.||++|| +++|+++
T Consensus 203 ~Pf~~~~~~~---~~----~~i~~~~~~~-------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 203 LPFYNQDHER---LF----ELILMEEIRF-------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CSSCCSSHHH---HH----HHHHHCCCCC-------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCCHHH---HH----HHHHcCCCCC-------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 9997654332 11 1111222211 112234477888899999999999 8999865
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=287.36 Aligned_cols=220 Identities=24% Similarity=0.323 Sum_probs=177.0
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC------CCCCHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE------KQPNWVERMGIARDIARGI 76 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l 76 (252)
.+...++.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||
T Consensus 115 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 194 (367)
T 3l9p_A 115 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194 (367)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHH
Confidence 4566789999999999999999999999999999999999999999999995432 4589999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCC---ceEEcccCcccccCCCC-CcccccccCCccccccccccCCCCCCcccchh
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKR---CAKISDFGLAKLMKPDQ-TRTFTGIRGTRAYVAAEWHRNLPITVKADVYS 152 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 152 (252)
.|||+. +++||||||+||+++.++ .++|+|||.++...... ........++..|+|||++.+..++.++||||
T Consensus 195 ~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws 271 (367)
T 3l9p_A 195 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 271 (367)
T ss_dssp HHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHH
Confidence 999999 999999999999999555 49999999997543211 12223345688999999999888999999999
Q ss_pred HHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 153 FGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 153 lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||+++|+|++ |..||........ . .....+..... +......+.+++.+||+.||++|||+.+|++
T Consensus 272 lG~il~ellt~g~~pf~~~~~~~~------~-~~i~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~ 338 (367)
T 3l9p_A 272 FGVLLWEIFSLGYMPYPSKSNQEV------L-EFVTSGGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 338 (367)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHHHH------H-HHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHH------H-HHHHcCCCCCC------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999998 8899976644321 1 22222222111 1122334788888999999999999999999
Q ss_pred HhhcCcC
Q 038713 232 MLEGTVE 238 (252)
Q Consensus 232 ~l~~~~~ 238 (252)
.|+.+..
T Consensus 339 ~l~~~~~ 345 (367)
T 3l9p_A 339 RIEYCTQ 345 (367)
T ss_dssp HHHHHHH
T ss_pred HHHHHhh
Confidence 9987543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=279.25 Aligned_cols=230 Identities=23% Similarity=0.326 Sum_probs=176.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCC----cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVS----NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
....+.+|+.++++++||||+++++++.+.. ..++||||+++|+|.+++.. +.+++..++.++.|++.||.|||
T Consensus 61 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH 138 (322)
T 3soc_A 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLH 138 (322)
T ss_dssp HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH
Confidence 4556677999999999999999999998744 36999999999999999954 34899999999999999999999
Q ss_pred hcC-------CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCC-----CCCCc
Q 038713 81 DEC-------EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNL-----PITVK 147 (252)
Q Consensus 81 ~~~-------~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-----~~~~~ 147 (252)
+.+ +.+++|+||||+||+++.++.++|+|||.++....... .......|+..|+|||++.+. .++.+
T Consensus 139 ~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 218 (322)
T 3soc_A 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR 218 (322)
T ss_dssp CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHH
T ss_pred hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCcc
Confidence 852 23899999999999999999999999999986654332 222335689999999998873 35568
Q ss_pred ccchhHHHHHHHHHhCCccccccchhhhH----------HHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccC
Q 038713 148 ADVYSFGVVLLEIVCLRRCLDQNLLEDRA----------ILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCIL 217 (252)
Q Consensus 148 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 217 (252)
+||||||+++|+|++|+.||......... .... ..........................+.+++.+||+
T Consensus 219 ~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (322)
T 3soc_A 219 IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED-MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297 (322)
T ss_dssp HHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHH-HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTC
T ss_pred chhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhh-hhhhhhcccCCCCccccccccchHHHHHHHHHHHcc
Confidence 89999999999999999999754322110 0111 111222222222222222233455668899999999
Q ss_pred CCCCCCCCHHHHHHHhhcCc
Q 038713 218 DEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 218 ~~p~~Rps~~~i~~~l~~~~ 237 (252)
.||++|||+.++++.|+++.
T Consensus 298 ~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 298 HDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp SSGGGSCCHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHH
Confidence 99999999999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=273.07 Aligned_cols=218 Identities=19% Similarity=0.280 Sum_probs=179.3
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
....+++.+|++++++++||||+++++++ ..+..++||||+++++|.+++......+++..++.++.|++.||.|||+.
T Consensus 51 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 129 (287)
T 1u59_A 51 KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 129 (287)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34678899999999999999999999999 45679999999999999999977777799999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--ccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||+|+||+++.++.++++|||.+......... ......++..|+|||++.+..++.++|+||||+++|+|
T Consensus 130 ---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 206 (287)
T 1u59_A 130 ---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 206 (287)
T ss_dssp ---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred ---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999999999999876543321 12223457889999999888889999999999999999
Q ss_pred Hh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 161 VC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 161 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
++ |..||......... .....+..... +...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 207 lt~g~~p~~~~~~~~~~-------~~i~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 207 LSYGQKPYKKMKGPEVM-------AFIEQGKRMEC------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp HTTSCCTTTTCCTHHHH-------HHHHTTCCCCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCCcccCCHHHHH-------HHHhcCCcCCC------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 98 99999765443211 12222222111 1223345888888999999999999999999998853
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=275.19 Aligned_cols=216 Identities=20% Similarity=0.293 Sum_probs=173.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.|.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++......+++..++.++.||+.||.|||+.
T Consensus 54 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~- 132 (289)
T 4fvq_A 54 NYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN- 132 (289)
T ss_dssp GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC-
Confidence 4567899999999999999999999999999999999999999999999977666699999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCc--------eEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRC--------AKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFG 154 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG 154 (252)
+++|+||||+||+++.++. ++++|||.+...... ....++..|+|||++.+ ..++.++||||||
T Consensus 133 --~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 205 (289)
T 4fvq_A 133 --TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFG 205 (289)
T ss_dssp --TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHH
T ss_pred --CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHH
Confidence 9999999999999998876 999999998654221 22346888999999987 6689999999999
Q ss_pred HHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 155 VVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 155 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
+++|+|++|+.|+.......... . .......... .. ...+.+++.+||+.||++|||+.++++.|+
T Consensus 206 ~il~el~~g~~~~~~~~~~~~~~--~---~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 271 (289)
T 4fvq_A 206 TTLWEICSGGDKPLSALDSQRKL--Q---FYEDRHQLPA-----PK----AAELANLINNCMDYEPDHRPSFRAIIRDLN 271 (289)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHHH--H---HHHTTCCCCC-----CS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHcCCCCCccccchHHHH--H---HhhccCCCCC-----CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 99999999766655443332111 0 1111111111 11 233778888999999999999999999999
Q ss_pred cCcCCCC
Q 038713 235 GTVEIPI 241 (252)
Q Consensus 235 ~~~~~~~ 241 (252)
+++....
T Consensus 272 ~l~~p~~ 278 (289)
T 4fvq_A 272 SLFTPDL 278 (289)
T ss_dssp TCC----
T ss_pred HhcCCCC
Confidence 9776433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=280.28 Aligned_cols=219 Identities=21% Similarity=0.316 Sum_probs=173.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|+.++++++||||+++++++.... .+++++++.+|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 59 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~- 136 (327)
T 3lzb_A 59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136 (327)
T ss_dssp CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC-
Confidence 35678999999999999999999999998754 8899999999999999987777899999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 137 --~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 214 (327)
T 3lzb_A 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214 (327)
T ss_dssp --TCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred --CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999987643322 22233446778999999999899999999999999999999
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCC
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~ 239 (252)
|..||......... .....+..... +......+.+++.+||+.||++|||+.|+++.|++....
T Consensus 215 ~g~~p~~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 215 FGSKPYDGIPASEIS-------SILEKGERLPQ------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TSCCTTTTCCGGGHH-------HHHHTTCCCCC------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCCCCCCHHHHH-------HHHHcCCCCCC------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 99999876554321 12222221111 111233478888899999999999999999999986643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=274.57 Aligned_cols=218 Identities=24% Similarity=0.330 Sum_probs=181.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT-PEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
...+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.
T Consensus 51 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 130 (288)
T 3kfa_A 51 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130 (288)
T ss_dssp THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC
Confidence 3567899999999999999999999999999999999999999999999965 345689999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||||+||+++.++.++++|||.+...............++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 131 ---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~ 207 (288)
T 3kfa_A 131 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207 (288)
T ss_dssp ---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999998766554444444556788999999998889999999999999999999
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
|..||......... .....+.... . +...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 208 ~g~~p~~~~~~~~~~-------~~~~~~~~~~--~----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 208 YGMSPYPGIDLSQVY-------ELLEKDYRME--R----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp TSCCSSTTCCGGGHH-------HHHHTTCCCC--C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHH-------HHHhccCCCC--C----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 88998765444311 1111111111 1 1122345788888999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=280.26 Aligned_cols=230 Identities=22% Similarity=0.281 Sum_probs=179.4
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEe--cCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSF--DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
....+.+.+|++++++++||||+++++++. +.+..++||||+++|+|.+++......+++..++.++.|++.||.|||
T Consensus 65 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH 144 (327)
T 3lxl_A 65 PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 144 (327)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999887 456689999999999999999765567899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--ccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
+. +++|+||||+||+++.++.++++|||.+......... ......++..|+|||++.+..++.++||||||+++|
T Consensus 145 ~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 221 (327)
T 3lxl_A 145 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLY 221 (327)
T ss_dssp HT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred hC---CccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHH
Confidence 99 9999999999999999999999999999876543321 222345777899999999888899999999999999
Q ss_pred HHHhCCccccccchhhhHH--------HHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAI--------LQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
+|++|..||.......... ....+......+.... .+......+.+++.+||+.||++|||+.+++
T Consensus 222 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 295 (327)
T 3lxl_A 222 ELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLP------APPACPAEVHELMKLCWAPSPQDRPSFSALG 295 (327)
T ss_dssp HHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCC------CCCcccHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 9999999997553321100 0011112222222111 1222334588888899999999999999999
Q ss_pred HHhhcCcCCCC
Q 038713 231 LMLEGTVEIPI 241 (252)
Q Consensus 231 ~~l~~~~~~~~ 241 (252)
+.|+.+.....
T Consensus 296 ~~L~~~~~~~~ 306 (327)
T 3lxl_A 296 PQLDMLWSGSR 306 (327)
T ss_dssp HHHHHC-----
T ss_pred HHHHHHHhhhc
Confidence 99998765443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=278.85 Aligned_cols=222 Identities=21% Similarity=0.304 Sum_probs=169.7
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcE------EEEEecCCCCCHHhhhcCC-----CCCCCHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK------ILVYDYMSNGSLVDVLFTP-----EKQPNWVERMGIARD 71 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~ 71 (252)
....++|.+|+.++++++||||+++++++...... ++||||+++|+|.+++... ...+++..++.++.|
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~q 145 (323)
T 3qup_A 66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145 (323)
T ss_dssp CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHH
Confidence 34578899999999999999999999999876655 9999999999999998432 225899999999999
Q ss_pred HHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccc
Q 038713 72 IARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADV 150 (252)
Q Consensus 72 i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 150 (252)
++.||.|||+. +++|+||||+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++||
T Consensus 146 i~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 222 (323)
T 3qup_A 146 IACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDV 222 (323)
T ss_dssp HHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccch
Confidence 99999999999 999999999999999999999999999986543322 22223446778999999999889999999
Q ss_pred hhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 151 YSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 151 ~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
||||+++|+|++ |..||......... .....+..... +......+.+++.+||+.||++|||+.++
T Consensus 223 ~slG~il~ell~~g~~p~~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l 289 (323)
T 3qup_A 223 WAFGVTMWEIMTRGQTPYAGIENAEIY-------NYLIGGNRLKQ------PPECMEEVYDLMYQCWSADPKQRPSFTCL 289 (323)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCCCCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred hhHHHHHHHHHhCCCCCccccChHHHH-------HHHhcCCCCCC------CCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999999999 89999766544311 11222221111 11223457888889999999999999999
Q ss_pred HHHhhcCcCCC
Q 038713 230 LLMLEGTVEIP 240 (252)
Q Consensus 230 ~~~l~~~~~~~ 240 (252)
++.|+++++-+
T Consensus 290 ~~~l~~~l~~~ 300 (323)
T 3qup_A 290 RMELENILGHL 300 (323)
T ss_dssp HHHHHHHHHC-
T ss_pred HHHHHHHHHHh
Confidence 99999866544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=270.86 Aligned_cols=219 Identities=21% Similarity=0.240 Sum_probs=172.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++||||+++++++.+.+..++||||++ |+|.+++......+++..++.++.|++.||.|||+.
T Consensus 62 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-- 138 (311)
T 3niz_A 62 IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-- 138 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 35778999999999999999999999999999999999997 489998877777799999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||||+||+++.++.++++|||.+........ ......++..|+|||++.+ ..++.++||||||+++|+|++|
T Consensus 139 -~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 216 (311)
T 3niz_A 139 -RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216 (311)
T ss_dssp -TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred -CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhC
Confidence 999999999999999999999999999987543322 2233467899999999876 4589999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCccccc----------------cc---chhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLV----------------ED---EEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~---~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
+.||......+.... +............. .. ..........+.+++.+||+.||++||
T Consensus 217 ~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 293 (311)
T 3niz_A 217 KPLFPGVTDDDQLPK---IFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI 293 (311)
T ss_dssp SCSCCCSSTTTHHHH---HHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSC
T ss_pred CCCCCCCChHHHHHH---HHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCC
Confidence 999986654432211 11111111111000 00 011112234578888999999999999
Q ss_pred CHHHHHH
Q 038713 225 AMKKVLL 231 (252)
Q Consensus 225 s~~~i~~ 231 (252)
|++|+++
T Consensus 294 t~~ell~ 300 (311)
T 3niz_A 294 SARDAMN 300 (311)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=273.18 Aligned_cols=220 Identities=24% Similarity=0.376 Sum_probs=175.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEe-cCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
...+.+.+|+.++++++||||+++++++. ..+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 68 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~ 147 (298)
T 3f66_A 68 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147 (298)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45678999999999999999999999864 56688999999999999999987777789999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC---cccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT---RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
+++|+||||+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|+||||+++|+
T Consensus 148 ---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 224 (298)
T 3f66_A 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 224 (298)
T ss_dssp ---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ---CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHH
Confidence 999999999999999999999999999986543221 12233456778999999998889999999999999999
Q ss_pred HHhCCc-cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 160 IVCLRR-CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 160 l~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
+++|+. ||......... .....+.... .+... +..+.+++.+||+.||++|||+.++++.|++++.
T Consensus 225 l~~~~~~~~~~~~~~~~~-------~~~~~~~~~~--~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 225 LMTRGAPPYPDVNTFDIT-------VYLLQGRRLL--QPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp HHTTSCCSSTTSCTTTHH-------HHHHTTCCCC--CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhCCCCCCccCCHHHHH-------HHHhcCCCCC--CCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 999554 55443332211 1111222111 11112 2347888889999999999999999999998665
Q ss_pred C
Q 038713 239 I 239 (252)
Q Consensus 239 ~ 239 (252)
.
T Consensus 292 ~ 292 (298)
T 3f66_A 292 T 292 (298)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=276.51 Aligned_cols=212 Identities=21% Similarity=0.251 Sum_probs=171.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+
T Consensus 69 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 148 (351)
T 3c0i_A 69 STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148 (351)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 367899999999999999999999999999999999999999999988854 23458999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCc---eEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRC---AKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
. +++|+||||+||+++.++. ++++|||.+........ ......|++.|+|||++.+..++.++||||||+++|
T Consensus 149 ~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 224 (351)
T 3c0i_A 149 N---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224 (351)
T ss_dssp T---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred C---CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHH
Confidence 9 9999999999999986554 99999999987654322 223356899999999999988999999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|++|..||...... . . .....+..... ..........+.+++.+||+.||++|||+.|+++
T Consensus 225 ~ll~g~~pf~~~~~~----~---~-~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 225 ILLSGCLPFYGTKER----L---F-EGIIKGKYKMN---PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHSSCSSCSSHHH----H---H-HHHHHTCCCCC---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHCCCCCCCcHHH----H---H-HHHHcCCCCCC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 999999999864221 1 1 11112222111 0111122345788888999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=271.65 Aligned_cols=223 Identities=22% Similarity=0.367 Sum_probs=178.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcE-EEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK-ILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
+..+.|.+|+.++++++||||+++++++.+.+.. ++|+||+.+|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 64 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 143 (298)
T 3pls_A 64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143 (298)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4567899999999999999999999999876655 999999999999999988777899999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC---cccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT---RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
+++|+||||+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|+||||+++|+
T Consensus 144 ---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 220 (298)
T 3pls_A 144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWE 220 (298)
T ss_dssp ---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHH
Confidence 999999999999999999999999999976543221 12223456788999999999899999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCC
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~ 239 (252)
|++|+.|+........ .. .....+.... .+.. ....+.+++.+||+.||.+|||+.++++.|+++++.
T Consensus 221 l~~g~~~~~~~~~~~~--~~----~~~~~~~~~~--~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 221 LLTRGAPPYRHIDPFD--LT----HFLAQGRRLP--QPEY----CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp HHHTSCCTTTTSCGGG--HH----HHHHTTCCCC--CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhhCCCCCCccCCHHH--HH----HHhhcCCCCC--CCcc----chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 9997666554433321 11 1122222111 1111 224578888899999999999999999999986654
Q ss_pred CC
Q 038713 240 PI 241 (252)
Q Consensus 240 ~~ 241 (252)
-.
T Consensus 289 l~ 290 (298)
T 3pls_A 289 LL 290 (298)
T ss_dssp CC
T ss_pred Hh
Confidence 43
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=276.04 Aligned_cols=220 Identities=14% Similarity=0.106 Sum_probs=178.2
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+++.+|+.+++++ +||||+++++++...+..++||||+ +++|.+++....+.+++..++.++.|++.||.|||+.
T Consensus 48 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-- 124 (330)
T 2izr_A 48 APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK-- 124 (330)
T ss_dssp SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 34688999999999 9999999999999999999999999 9999999976667899999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCc-----eEEcccCcccccCCCCCc------ccccccCCccccccccccCCCCCCcccchhH
Q 038713 85 AQIIHGDIKPQNILMDEKRC-----AKISDFGLAKLMKPDQTR------TFTGIRGTRAYVAAEWHRNLPITVKADVYSF 153 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 153 (252)
+++||||||+||+++.++. ++|+|||.+......... ......|+..|+|||++.+..++.++|+|||
T Consensus 125 -~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 203 (330)
T 2izr_A 125 -NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEAL 203 (330)
T ss_dssp -TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred -CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHH
Confidence 9999999999999998887 999999999875443321 1234568999999999999899999999999
Q ss_pred HHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 038713 154 GVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233 (252)
Q Consensus 154 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l 233 (252)
|+++|+|++|..||..............+.......... ......+ .+.+++.+||+.||.+|||+++|.+.|
T Consensus 204 G~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l 276 (330)
T 2izr_A 204 GHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLF 276 (330)
T ss_dssp HHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred HHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHH
Confidence 999999999999998764443222222221111111110 0001112 688888899999999999999999999
Q ss_pred hcC
Q 038713 234 EGT 236 (252)
Q Consensus 234 ~~~ 236 (252)
++.
T Consensus 277 ~~~ 279 (330)
T 2izr_A 277 TDL 279 (330)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=273.62 Aligned_cols=226 Identities=22% Similarity=0.308 Sum_probs=173.5
Q ss_pred hHhHHHHHHHHHHHhC--CCCCCCcceeeeEec----CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGR--THHRNPVRLLGYSFD----VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l 76 (252)
.+..+.+.+|.+++.. ++||||+++++++.. ....++||||+++|+|.+++.. ..+++..++.++.|++.||
T Consensus 41 ~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l 118 (301)
T 3q4u_A 41 SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGL 118 (301)
T ss_dssp GGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHH
T ss_pred cccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHH
Confidence 3456677788888776 799999999998654 3458999999999999999943 4589999999999999999
Q ss_pred HHHh--------hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc---cccccCCccccccccccCC---
Q 038713 77 RYLH--------DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT---FTGIRGTRAYVAAEWHRNL--- 142 (252)
Q Consensus 77 ~~lh--------~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~--- 142 (252)
.||| +. +++|+||||+||+++.++.++|+|||.++......... .....|+..|+|||++.+.
T Consensus 119 ~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 195 (301)
T 3q4u_A 119 AHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195 (301)
T ss_dssp HHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCT
T ss_pred HHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCC
Confidence 9999 77 99999999999999999999999999997654433221 2234689999999999876
Q ss_pred ---CCCCcccchhHHHHHHHHHhC----------CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHH
Q 038713 143 ---PITVKADVYSFGVVLLEIVCL----------RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMI 209 (252)
Q Consensus 143 ---~~~~~~Di~slG~~l~~l~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 209 (252)
.++.++||||||+++|+|++| ..||......... ... ...................+......+.
T Consensus 196 ~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 273 (301)
T 3q4u_A 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS-FED-MRKVVCVDQQRPNIPNRWFSDPTLTSLA 273 (301)
T ss_dssp TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-HHH-HHHHHTTSCCCCCCCGGGGGSHHHHHHH
T ss_pred CcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc-hhh-hhHHHhccCCCCCCChhhccCccHHHHH
Confidence 345789999999999999999 7887654322211 111 1122222222222222233445667799
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 210 KVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 210 ~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
+++.+||+.||++|||+.++++.|++
T Consensus 274 ~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 274 KLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 99999999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=272.87 Aligned_cols=211 Identities=24% Similarity=0.350 Sum_probs=172.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.
T Consensus 57 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~-- 133 (326)
T 2y0a_A 57 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSL-- 133 (326)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHC--
Confidence 467899999999999999999999999999999999999999999999954 45689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCC----ceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKR----CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||||+||+++.++ .++++|||.+....... ......|++.|+|||++.+..++.++|+||||+++|+|
T Consensus 134 -~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 210 (326)
T 2y0a_A 134 -QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210 (326)
T ss_dssp -TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred -CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999998877 79999999998764332 22335689999999999988899999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||......... .. ........ ...........+.+++.+||+.||++|||+.|+++
T Consensus 211 l~g~~pf~~~~~~~~~------~~-~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 211 LSGASPFLGDTKQETL------AN-VSAVNYEF---EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHSCCSSCCSSHHHHH------HH-HHHTCCCC---CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHCcCCCCCCCHHHHH------HH-HHhcCCCc---CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999999765433211 11 11111111 11111122345778888999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=268.16 Aligned_cols=211 Identities=25% Similarity=0.400 Sum_probs=171.6
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
+.+.+|+.++++++||||+++++++.+.. ++||||+++|+|.+++......+++..++.++.|++.||.|||+. +
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~ 142 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---N 142 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---S
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 78999999999999999999999987655 799999999999999987777899999999999999999999999 8
Q ss_pred --eeeeccCCCCEEecCCCc-----eEEcccCcccccCCCCCcccccccCCcccccccccc--CCCCCCcccchhHHHHH
Q 038713 87 --IIHGDIKPQNILMDEKRC-----AKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR--NLPITVKADVYSFGVVL 157 (252)
Q Consensus 87 --i~h~di~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~slG~~l 157 (252)
++|+||||+||+++.++. ++++|||.+..... ......|+..|+|||++. +..++.++|+||||+++
T Consensus 143 ~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l 218 (287)
T 4f0f_A 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218 (287)
T ss_dssp SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHH
T ss_pred CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHH
Confidence 999999999999987776 99999999875432 233456899999999984 34578899999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
|+|++|..||........... ......+..... +......+.+++.+||+.||++|||++++++.|+++
T Consensus 219 ~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 219 YTILTGEGPFDEYSYGKIKFI----NMIREEGLRPTI------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHSSCTTTTCCCCHHHHH----HHHHHSCCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHcCCCCCccccccHHHHH----HHHhccCCCCCC------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 999999999976544432111 111122211111 112234578888899999999999999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=283.50 Aligned_cols=224 Identities=15% Similarity=0.194 Sum_probs=173.1
Q ss_pred HHHHHHHHHhCCCCCCCcceeeeEecC----CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 8 EFKTEMNAIGRTHHRNPVRLLGYSFDV----SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.+.+|+..++.++||||+++++++... ...++||||+ +++|.+++....+.+++..++.++.||+.||.|||+.
T Consensus 94 ~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~- 171 (364)
T 3op5_A 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH- 171 (364)
T ss_dssp HHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 455677788888999999999998764 4489999999 9999999977767899999999999999999999999
Q ss_pred CCCeeeeccCCCCEEec--CCCceEEcccCcccccCCCCCc------ccccccCCccccccccccCCCCCCcccchhHHH
Q 038713 84 EAQIIHGDIKPQNILMD--EKRCAKISDFGLAKLMKPDQTR------TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGV 155 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 155 (252)
+++||||||+||+++ .++.++|+|||.++........ ......|+..|+|||++.+..++.++||||||+
T Consensus 172 --~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 249 (364)
T 3op5_A 172 --EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGY 249 (364)
T ss_dssp --TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred --CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHH
Confidence 999999999999999 8899999999999765432211 112344899999999999989999999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
++|+|++|+.||.......... ......... ......+........+..+.+++.+||+.+|++|||+.+|++.|++
T Consensus 250 ~l~el~~g~~Pf~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 250 CMIQWLTGHLPWEDNLKDPKYV--RDSKIRYRE-NIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp HHHHHHHSCCTTGGGTTCHHHH--HHHHHHHHH-CHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHhCCCCccccccCHHHH--HHHHHHhhh-hHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 9999999999998643332211 111111111 1111110000001123457888889999999999999999999998
Q ss_pred CcC
Q 038713 236 TVE 238 (252)
Q Consensus 236 ~~~ 238 (252)
.++
T Consensus 327 ~~~ 329 (364)
T 3op5_A 327 GLK 329 (364)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=277.67 Aligned_cols=213 Identities=21% Similarity=0.290 Sum_probs=174.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.....+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++......+++..++.++.||+.||.|||+.
T Consensus 90 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 168 (387)
T 1kob_A 90 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH- 168 (387)
T ss_dssp HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3456799999999999999999999999999999999999999999999977766799999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecC--CCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDE--KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||||+||+++. .+.++|+|||.+........ .....|+..|+|||++.+..++.++||||||+++|+|+
T Consensus 169 --givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 244 (387)
T 1kob_A 169 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244 (387)
T ss_dssp --TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred --CeeecccchHHeEEecCCCCceEEEecccceecCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH
Confidence 9999999999999974 46799999999987654322 23346899999999999988999999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||........ + .. .....+.... .........+.+++.+||+.||++|||+.|+++
T Consensus 245 tg~~Pf~~~~~~~~--~----~~-i~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 245 SGLSPFAGEDDLET--L----QN-VKRCDWEFDE---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HSCCSSCCSSHHHH--H----HH-HHHCCCCCCS---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCCCHHHH--H----HH-HHhCCCCCCc---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 99999986543321 1 11 1122221111 111122344778888999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=282.22 Aligned_cols=219 Identities=25% Similarity=0.368 Sum_probs=176.1
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCc-EEEEEecCCCCCHHhhhcCCCC-----------------------
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSN-KILVYDYMSNGSLVDVLFTPEK----------------------- 58 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~----------------------- 58 (252)
...+.+.+|+++++++ +||||+++++++.+.+. .++||||+++|+|.+++.....
T Consensus 67 ~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (359)
T 3vhe_A 67 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146 (359)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------
T ss_pred HHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccc
Confidence 4567899999999999 89999999999987554 8999999999999999965432
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCC
Q 038713 59 ------------------------------------------QPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQN 96 (252)
Q Consensus 59 ------------------------------------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~n 96 (252)
.+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~N 223 (359)
T 3vhe_A 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 223 (359)
T ss_dssp -------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred hhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhh
Confidence 288999999999999999999999 99999999999
Q ss_pred EEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-CCccccccchhh
Q 038713 97 ILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-LRRCLDQNLLED 174 (252)
Q Consensus 97 il~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 174 (252)
|+++.++.++|+|||.+........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 224 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 303 (359)
T 3vhe_A 224 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303 (359)
T ss_dssp EEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred EEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH
Confidence 9999999999999999986543322 22234557889999999998889999999999999999998 999997654332
Q ss_pred hHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 175 RAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
. .......+..... +.. ....+.+++.+||+.||++|||+.|+++.|++++
T Consensus 304 ~------~~~~~~~~~~~~~--~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 304 E------FCRRLKEGTRMRA--PDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp H------HHHHHHHTCCCCC--CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H------HHHHHHcCCCCCC--CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1 1112222222111 111 2234788888999999999999999999999865
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.09 Aligned_cols=216 Identities=19% Similarity=0.282 Sum_probs=175.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...++|.+|+++|++++||||+++++++.+ +..++||||+++|+|.+++......+++..++.++.||+.||.|||+.
T Consensus 378 ~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~- 455 (613)
T 2ozo_A 378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK- 455 (613)
T ss_dssp TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 457889999999999999999999999986 569999999999999999977777799999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--ccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++||||||+||+++.++.++|+|||+++........ ......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 456 --~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ell 533 (613)
T 2ozo_A 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533 (613)
T ss_dssp --TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred --CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999876433221 112233567899999999889999999999999999999
Q ss_pred h-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 162 C-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 162 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
+ |..||......+ +...+..+..... +...+..+.++|.+||+.||++|||+.+|++.|++.
T Consensus 534 t~G~~Pf~~~~~~~-------~~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 534 SYGQKPYKKMKGPE-------VMAFIEQGKRMEC------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp TTSCCTTTTCCSHH-------HHHHHHTTCCCCC------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred HCCCCCCCCCCHHH-------HHHHHHcCCCCCC------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 8 999998664443 1122233322111 222334588899999999999999999999999984
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=271.03 Aligned_cols=228 Identities=36% Similarity=0.534 Sum_probs=182.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP--EKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
+..+.|.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+
T Consensus 72 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 151 (307)
T 2nru_A 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151 (307)
T ss_dssp THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 45778999999999999999999999999999999999999999999999643 3458999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
. +++|+||+|+||+++.++.++++|||.+......... ......|+..|+|||.+.+ .++.++|+||||+++|+|
T Consensus 152 ~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l 227 (307)
T 2nru_A 152 N---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEI 227 (307)
T ss_dssp T---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHH
T ss_pred C---CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHH
Confidence 9 9999999999999999999999999999865543322 2233468999999999876 478999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhc-CCccccccc--chhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFEN-GNLSQLVED--EEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
++|..||......... ..+....... ..+....+. ...+......+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 228 ~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 228 ITGLPAVDEHREPQLL--LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHCCCSBCTTBSSSBT--THHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHCCCCcccCcchHHH--HHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 9999999765432211 1111111111 111111111 1335566778999999999999999999999999999854
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=275.60 Aligned_cols=219 Identities=22% Similarity=0.312 Sum_probs=178.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC---------CCCCCHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP---------EKQPNWVERMGIARDIAR 74 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~~i~~ 74 (252)
+.++.|.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++... ...+++..++.++.|++.
T Consensus 70 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 149 (322)
T 1p4o_A 70 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149 (322)
T ss_dssp HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHH
Confidence 45677999999999999999999999999999999999999999999998542 145789999999999999
Q ss_pred HHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchhH
Q 038713 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYSF 153 (252)
Q Consensus 75 ~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 153 (252)
||.|||+. +++|+||||+||+++.++.++++|||.+........ .......++..|+|||++.+..++.++|+|||
T Consensus 150 ~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 226 (322)
T 1p4o_A 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226 (322)
T ss_dssp HHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHC---CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence 99999999 999999999999999999999999999876543222 12222345788999999998889999999999
Q ss_pred HHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 154 GVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 154 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
|+++|+|++ |..||........ ......+..... +......+.+++.+||+.||.+|||+.++++.
T Consensus 227 G~il~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 227 GVVLWEIATLAEQPYQGLSNEQV-------LRFVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHHHHTSCCTTTTSCHHHH-------HHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCccccCCHHHH-------HHHHHcCCcCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999 8888876543321 112222222111 11223447888889999999999999999999
Q ss_pred hhcCcC
Q 038713 233 LEGTVE 238 (252)
Q Consensus 233 l~~~~~ 238 (252)
|++.++
T Consensus 294 L~~~~~ 299 (322)
T 1p4o_A 294 IKEEME 299 (322)
T ss_dssp HGGGSC
T ss_pred HHHhhc
Confidence 998655
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=270.38 Aligned_cols=224 Identities=20% Similarity=0.278 Sum_probs=177.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCC--cEEEEEecCCCCCHHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHh
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVS--NKILVYDYMSNGSLVDVLFTPE--KQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
..+.+.+|++++++++||||+++++++.... ..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||
T Consensus 50 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH 129 (319)
T 4euu_A 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129 (319)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 4577899999999999999999999998755 7899999999999999997643 23899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEe----cCCCceEEcccCcccccCCCCCcccccccCCcccccccccc--------CCCCCCcc
Q 038713 81 DECEAQIIHGDIKPQNILM----DEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR--------NLPITVKA 148 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~ 148 (252)
+. +++|+||||+||++ +.++.++|+|||.++....... .....|+..|+|||++. +..++.++
T Consensus 130 ~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 204 (319)
T 4euu_A 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204 (319)
T ss_dssp HT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTH
T ss_pred HC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHH
Confidence 99 99999999999999 7777899999999987654332 22356899999999876 46788999
Q ss_pred cchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCc---c--------------cccccchhcHHHHHHHHHH
Q 038713 149 DVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNL---S--------------QLVEDEEVDQKQLQRMIKV 211 (252)
Q Consensus 149 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~--------------~~~~~~~~~~~~~~~l~~l 211 (252)
||||||+++|+|++|..||......... .+........... . ...............+.++
T Consensus 205 DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 282 (319)
T 4euu_A 205 DLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPV 282 (319)
T ss_dssp HHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHH
Confidence 9999999999999999999754332211 1111122221110 0 0111113456677788999
Q ss_pred HhhccCCCCCCCCCHHHHHHHhhc
Q 038713 212 GLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 212 i~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
+.+||+.||++|||++|+++..++
T Consensus 283 l~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 283 LANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HHHhccCChhhhccHHHhhhccHH
Confidence 999999999999999999999887
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=279.40 Aligned_cols=222 Identities=20% Similarity=0.300 Sum_probs=178.0
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCC----------------------CC
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEK----------------------QP 60 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~ 60 (252)
...+.+.+|+.+++++ +||||+++++++...+..++||||+++|+|.+++..... .+
T Consensus 90 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 169 (344)
T 1rjb_A 90 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169 (344)
T ss_dssp --CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------C
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccC
Confidence 3457899999999999 999999999999999999999999999999999976442 37
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccc
Q 038713 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWH 139 (252)
Q Consensus 61 ~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~ 139 (252)
++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||.+......... ......++..|+|||++
T Consensus 170 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 246 (344)
T 1rjb_A 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 246 (344)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh
Confidence 8999999999999999999999 9999999999999999999999999999866443322 22334567889999999
Q ss_pred cCCCCCCcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCC
Q 038713 140 RNLPITVKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILD 218 (252)
Q Consensus 140 ~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 218 (252)
.+..++.++||||||+++|+|++ |..||........ + ......+.... . +......+.+++.+||+.
T Consensus 247 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~----~~~~~~~~~~~--~----~~~~~~~l~~li~~~l~~ 314 (344)
T 1rjb_A 247 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN--F----YKLIQNGFKMD--Q----PFYATEEIYIIMQSCWAF 314 (344)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--H----HHHHHTTCCCC--C----CTTCCHHHHHHHHHHTCS
T ss_pred ccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH--H----HHHHhcCCCCC--C----CCCCCHHHHHHHHHHcCC
Confidence 88889999999999999999998 9999976643321 1 11222221111 1 112234578888899999
Q ss_pred CCCCCCCHHHHHHHhhcCcCCC
Q 038713 219 EPSLRRAMKKVLLMLEGTVEIP 240 (252)
Q Consensus 219 ~p~~Rps~~~i~~~l~~~~~~~ 240 (252)
||++|||+.++++.|+..+...
T Consensus 315 dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 315 DSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp SGGGSCCHHHHHHHHHHHC---
T ss_pred CchhCcCHHHHHHHHHHHHHHH
Confidence 9999999999999999976644
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=279.11 Aligned_cols=215 Identities=23% Similarity=0.334 Sum_probs=174.3
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
+.+.+|+.++++++||||+++++++. .+..++|+||+.+|+|.+++....+.+++..++.++.|++.||.|||+. +
T Consensus 60 ~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ 135 (325)
T 3kex_A 60 QAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---G 135 (325)
T ss_dssp CSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 45778999999999999999999886 4668999999999999999987666789999999999999999999999 9
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-CC
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC-LR 164 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~ 164 (252)
++||||||+||+++.++.++++|||.++........ ......++..|+|||++.+..++.++|+||||+++|++++ |.
T Consensus 136 ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~ 215 (325)
T 3kex_A 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA 215 (325)
T ss_dssp CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCC
Confidence 999999999999999999999999999876544322 2233456779999999998889999999999999999999 99
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
.||......... .....+..... +.. ....+.+++.+||+.||++|||+.++++.|+....
T Consensus 216 ~p~~~~~~~~~~-------~~~~~~~~~~~--~~~----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 216 EPYAGLRLAEVP-------DLLEKGERLAQ--PQI----CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CTTTTSCTTHHH-------HHHHTTCBCCC--CTT----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCccccCHHHHH-------HHHHcCCCCCC--CCc----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999876444311 12222221111 111 22247778889999999999999999999988654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=266.20 Aligned_cols=211 Identities=28% Similarity=0.334 Sum_probs=165.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+++++.++||||+++++++.+.+..++||||+++++|.+++. .+.+++..++.++.|++.||.|||+.
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~-- 124 (271)
T 3dtc_A 49 TIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDE-- 124 (271)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHS--
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 35789999999999999999999999999999999999999999999984 34689999999999999999999999
Q ss_pred CC---eeeeccCCCCEEecC--------CCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhH
Q 038713 85 AQ---IIHGDIKPQNILMDE--------KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSF 153 (252)
Q Consensus 85 ~~---i~h~di~~~nil~~~--------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 153 (252)
+ ++|+||||+||+++. ++.++++|||.+........ ....|+..|+|||.+.+..++.++|+|||
T Consensus 125 -~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (271)
T 3dtc_A 125 -AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSY 200 (271)
T ss_dssp -SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHH
T ss_pred -CCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHH
Confidence 7 999999999999985 67899999999976543322 23457899999999998889999999999
Q ss_pred HHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 038713 154 GVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233 (252)
Q Consensus 154 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l 233 (252)
|+++|++++|+.||......... ...... ..... .+......+.+++.+||+.||++|||+.|+++.|
T Consensus 201 G~~l~~l~~g~~p~~~~~~~~~~------~~~~~~-~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 201 GVLLWELLTGEVPFRGIDGLAVA------YGVAMN-KLALP-----IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp HHHHHHHHHCCCTTTTSCHHHHH------HHHHTS-CCCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHH------HhhhcC-CCCCC-----CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 99999999999999865433211 111111 11111 1122234578888899999999999999999999
Q ss_pred hc
Q 038713 234 EG 235 (252)
Q Consensus 234 ~~ 235 (252)
++
T Consensus 269 ~~ 270 (271)
T 3dtc_A 269 TT 270 (271)
T ss_dssp HC
T ss_pred hc
Confidence 86
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=277.83 Aligned_cols=223 Identities=23% Similarity=0.329 Sum_probs=180.2
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------------CCCCHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------------KQPNWVERMG 67 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~ 67 (252)
...+++.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++.... ..+++..++.
T Consensus 82 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (334)
T 2pvf_A 82 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161 (334)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHH
Confidence 4567899999999999 99999999999999999999999999999999996543 2488999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCC
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITV 146 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~ 146 (252)
++.||+.||.|||+. +++|+||||+||+++.++.++++|||.+......... ......++..|+|||++.+..++.
T Consensus 162 i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 238 (334)
T 2pvf_A 162 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238 (334)
T ss_dssp HHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH
T ss_pred HHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh
Confidence 999999999999999 9999999999999999999999999999866543321 122334677899999998888899
Q ss_pred cccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 147 KADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 147 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
++||||||+++|+|++ |..||........ ......+..... +......+.+++.+||+.||++|||
T Consensus 239 ~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps 305 (334)
T 2pvf_A 239 QSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-------FKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPT 305 (334)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------HHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-------HHHHhcCCCCCC------CccCCHHHHHHHHHHccCChhhCcC
Confidence 9999999999999999 9999976543321 111222221111 1122345788888999999999999
Q ss_pred HHHHHHHhhcCcCCCCC
Q 038713 226 MKKVLLMLEGTVEIPIP 242 (252)
Q Consensus 226 ~~~i~~~l~~~~~~~~~ 242 (252)
+.++++.|++++.....
T Consensus 306 ~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 306 FKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHHHhcccc
Confidence 99999999997654433
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=270.81 Aligned_cols=218 Identities=22% Similarity=0.269 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++ +|.+++....+.+++..++.++.|++.||.|||+.
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--- 119 (288)
T 1ob3_A 44 PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--- 119 (288)
T ss_dssp CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred chhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46789999999999999999999999999999999999975 99999977767799999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhCC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++|+||||+||+++.++.++++|||.+........ ......++..|+|||++.+. .++.++|+||||+++|+|++|.
T Consensus 120 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 198 (288)
T 1ob3_A 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (288)
T ss_dssp TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999976543221 22334578999999998764 5899999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCC---ccccc------------c---cchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGN---LSQLV------------E---DEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~------------~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
.||......+. +.... ....... +.... . ...........+.+++.+||+.||++|||+
T Consensus 199 ~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 275 (288)
T 1ob3_A 199 PLFPGVSEADQ--LMRIF-RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275 (288)
T ss_dssp CSCCCSSHHHH--HHHHH-HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred CCCCCCCHHHH--HHHHH-HHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH
Confidence 99986644322 11111 1111110 00000 0 000111223457788889999999999999
Q ss_pred HHHHH
Q 038713 227 KKVLL 231 (252)
Q Consensus 227 ~~i~~ 231 (252)
.|+++
T Consensus 276 ~e~l~ 280 (288)
T 1ob3_A 276 KQALE 280 (288)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=267.19 Aligned_cols=215 Identities=22% Similarity=0.297 Sum_probs=174.1
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecC--CcEEEEEecCCCCCHHhhhcCCCC-CCCHHHHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDV--SNKILVYDYMSNGSLVDVLFTPEK-QPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~l 79 (252)
.+..+.|.+|+.++++++||||+++++++.+. +..++||||+++|+|.+++....+ .+++..++.++.|++.||.||
T Consensus 48 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 127 (271)
T 3kmu_A 48 TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127 (271)
T ss_dssp HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 45567899999999999999999999999886 788999999999999999976543 589999999999999999999
Q ss_pred hhcCCCC--eeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCC---cccchhHH
Q 038713 80 HDECEAQ--IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITV---KADVYSFG 154 (252)
Q Consensus 80 h~~~~~~--i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~Di~slG 154 (252)
|+. + ++|+||||+||+++.++.+++.||+.+..... ....+++.|+|||.+.+..++. ++||||||
T Consensus 128 H~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG 198 (271)
T 3kmu_A 128 HTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFA 198 (271)
T ss_dssp TTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHH
T ss_pred hcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHH
Confidence 998 8 99999999999999999999998887654221 2245688999999998765444 79999999
Q ss_pred HHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 155 VVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 155 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
+++|+|++|+.||........ .......+..... +......+.+++.+||+.||++|||++++++.|+
T Consensus 199 ~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~ 266 (271)
T 3kmu_A 199 VLLWELVTREVPFADLSNMEI------GMKVALEGLRPTI------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266 (271)
T ss_dssp HHHHHHHHCSCTTTTSCHHHH------HHHHHHSCCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhCCCCccccChHHH------HHHHHhcCCCCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999976544321 1112222222111 1122344788888999999999999999999999
Q ss_pred cCcC
Q 038713 235 GTVE 238 (252)
Q Consensus 235 ~~~~ 238 (252)
++.+
T Consensus 267 ~l~~ 270 (271)
T 3kmu_A 267 KMQD 270 (271)
T ss_dssp HHCC
T ss_pred Hhhc
Confidence 8654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=274.74 Aligned_cols=232 Identities=19% Similarity=0.283 Sum_probs=173.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCc----EEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSN----KILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
+..+.|.+|+.++++++||||+++++++..... .++||||+++|+|.+++... +.+++..++.++.|++.||.||
T Consensus 54 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~l 132 (311)
T 3ork_A 54 SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFS 132 (311)
T ss_dssp HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 345689999999999999999999999886543 49999999999999999643 4689999999999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--cccccccCCccccccccccCCCCCCcccchhHHHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 157 (252)
|++ +++|+||||+||+++.++.++++|||.+........ .......|+..|+|||++.+..++.++||||||+++
T Consensus 133 H~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l 209 (311)
T 3ork_A 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209 (311)
T ss_dssp HHT---TCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred HHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHH
Confidence 999 999999999999999999999999999986543322 122234589999999999998999999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHH-HHHHhhcC
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKK-VLLMLEGT 236 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~-i~~~l~~~ 236 (252)
|+|++|+.||........ ............ ..........+.+++.+||+.||++||++.+ +...+...
T Consensus 210 ~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 210 YEVLTGEPPFTGDSPVSV------AYQHVREDPIPP----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHHSSCSCCCSSHHHH------HHHHHHCCCCCH----HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCChHHH------HHHHhcCCCCCc----ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 999999999976544321 111222222111 1111223345788888999999999996665 55666666
Q ss_pred cCCCCCCCCCCCC
Q 038713 237 VEIPIPQNPTSFL 249 (252)
Q Consensus 237 ~~~~~~~~~~~~~ 249 (252)
.....|..|..+.
T Consensus 280 ~~~~~~~~~~~~~ 292 (311)
T 3ork_A 280 HNGEPPEAPKVLT 292 (311)
T ss_dssp HTTCCCSSCCCCC
T ss_pred hcCCCCCCCcccc
Confidence 6556666555543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=274.19 Aligned_cols=212 Identities=25% Similarity=0.325 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.
T Consensus 49 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~--- 124 (323)
T 3tki_A 49 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI--- 124 (323)
T ss_dssp --CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46789999999999999999999999999999999999999999999954 44589999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCC-CCcccchhHHHHHHHHHhC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPI-TVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||||+||+++.++.++|+|||.+........ .......|+..|+|||++.+..+ +.++||||||+++|+|++|
T Consensus 125 givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (323)
T 3tki_A 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204 (323)
T ss_dssp TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999976532221 22234568999999999987664 7789999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
..||......... ... ........ ..... ....+.+++.+||+.||++|||+.|+++.
T Consensus 205 ~~pf~~~~~~~~~-~~~----~~~~~~~~--~~~~~----~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 205 ELPWDQPSDSCQE-YSD----WKEKKTYL--NPWKK----IDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp SCSCSSSCTTSHH-HHH----HHTTCTTS--TTGGG----SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCchHHHH-HHH----HhcccccC--Ccccc----CCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 9999866443221 111 11111111 11112 22346788889999999999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=285.52 Aligned_cols=213 Identities=26% Similarity=0.343 Sum_probs=174.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCC-cEEEEEecCCCCCHHhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVS-NKILVYDYMSNGSLVDVLFTPEK-QPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..+.|.+|+.++++++||||+++++++.+.. ..++||||+++|+|.+++..... .++...++.++.||+.||.|||++
T Consensus 229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 308 (450)
T 1k9a_A 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308 (450)
T ss_dssp TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4568999999999999999999999987654 79999999999999999976443 479999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++.++|+|||+++...... ....++..|+|||++.+..++.++||||||+++|+|++
T Consensus 309 ---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t 381 (450)
T 1k9a_A 309 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381 (450)
T ss_dssp ---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHT
T ss_pred ---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999998543221 12245778999999999899999999999999999998
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
|..||......+. ......+.... . +...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 382 ~g~~P~~~~~~~~~-------~~~i~~~~~~~--~----p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 382 FGRVPYPRIPLKDV-------VPRVEKGYKMD--A----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp TTCCSSTTSCTTTH-------HHHHHTTCCCC--C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHH-------HHHHHcCCCCC--C----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 9999976544431 11222332111 1 2223345888889999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=276.75 Aligned_cols=213 Identities=23% Similarity=0.306 Sum_probs=174.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.|.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++......+++..++.++.||+.||.|||+.
T Consensus 128 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 206 (373)
T 2x4f_A 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM- 206 (373)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4567899999999999999999999999999999999999999999999976666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEe--cCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILM--DEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||||+||++ +.++.++|+|||.++....... .....|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 207 --~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 282 (373)
T 2x4f_A 207 --YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282 (373)
T ss_dssp --TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHH
T ss_pred --CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHH
Confidence 99999999999999 5677899999999987654332 22345899999999999888999999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||........ + ..... ..+.... .........+.+++.+||+.||.+|||+.|+++
T Consensus 283 tg~~pf~~~~~~~~--~----~~i~~-~~~~~~~---~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 283 SGLSPFLGDNDAET--L----NNILA-CRWDLED---EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HSSCTTCCSSHHHH--H----HHHHH-TCCCSCS---GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCHHHH--H----HHHHh-ccCCCCh---hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999986644321 1 11111 1111111 111122345788888999999999999999987
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=279.06 Aligned_cols=225 Identities=16% Similarity=0.145 Sum_probs=170.9
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
.+..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+
T Consensus 67 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~ 146 (389)
T 3gni_B 67 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146 (389)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345678899999999999999999999999999999999999999999999653 3568999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC------cccccccCCccccccccccC--CCCCCcccchhH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT------RTFTGIRGTRAYVAAEWHRN--LPITVKADVYSF 153 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~sl 153 (252)
. +++||||||+||+++.++.++++|||.+........ .......|+..|+|||++.+ ..++.++|||||
T Consensus 147 ~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 223 (389)
T 3gni_B 147 M---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 223 (389)
T ss_dssp T---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHH
T ss_pred C---CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHH
Confidence 9 999999999999999999999999998765422111 11122357889999999987 578999999999
Q ss_pred HHHHHHHHhCCccccccchhhhHHHHHHHHHHH----hcC------------------Cccc------------ccccch
Q 038713 154 GVVLLEIVCLRRCLDQNLLEDRAILQEWICQCF----ENG------------------NLSQ------------LVEDEE 199 (252)
Q Consensus 154 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~------------------~~~~------------~~~~~~ 199 (252)
|+++|+|++|+.||.......... ....... ... .... ......
T Consensus 224 G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (389)
T 3gni_B 224 GITACELANGHVPFKDMPATQMLL--EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHP 301 (389)
T ss_dssp HHHHHHHHHSSCTTTTCCSTTHHH--HC----------------------------------------------------
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHH--HHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCc
Confidence 999999999999997653332111 0000000 000 0000 000001
Q ss_pred hcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 200 VDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 200 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
.+......+.+++.+||+.||++|||+.|+++.
T Consensus 302 ~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 302 YHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 122234558889999999999999999999853
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=275.07 Aligned_cols=221 Identities=22% Similarity=0.350 Sum_probs=179.9
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCC-----------------CCCHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEK-----------------QPNWVER 65 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~ 65 (252)
..++.+.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++..... .+++..+
T Consensus 68 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (313)
T 1t46_A 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147 (313)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred HHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHH
Confidence 4568899999999999 999999999999999999999999999999999965432 4899999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCC
Q 038713 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPI 144 (252)
Q Consensus 66 ~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~ 144 (252)
+.++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+......... ......++..|+|||++.+..+
T Consensus 148 ~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 224 (313)
T 1t46_A 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224 (313)
T ss_dssp HHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence 99999999999999999 9999999999999999999999999999876544332 2223446778999999988889
Q ss_pred CCcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCC
Q 038713 145 TVKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLR 223 (252)
Q Consensus 145 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 223 (252)
+.++||||||+++|+|++ |..||........ .. .....+... ..+ ......+.+++.+||+.||++|
T Consensus 225 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~----~~~~~~~~~--~~~----~~~~~~l~~li~~~l~~dp~~R 292 (313)
T 1t46_A 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--FY----KMIKEGFRM--LSP----EHAPAEMYDIMKTCWDADPLKR 292 (313)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--HH----HHHHHTCCC--CCC----TTSCHHHHHHHHHHTCSSGGGS
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--HH----HHhccCCCC--CCc----ccCCHHHHHHHHHHcCCCchhC
Confidence 999999999999999998 9999976543321 11 111221111 111 1123457888889999999999
Q ss_pred CCHHHHHHHhhcCcCC
Q 038713 224 RAMKKVLLMLEGTVEI 239 (252)
Q Consensus 224 ps~~~i~~~l~~~~~~ 239 (252)
||+.++++.|++.++.
T Consensus 293 ps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 293 PTFKQIVQLIEKQISE 308 (313)
T ss_dssp CCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHH
Confidence 9999999999986653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=265.92 Aligned_cols=208 Identities=22% Similarity=0.293 Sum_probs=152.8
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++....+.+++..++.++.|++.||.|||+.
T Consensus 55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--- 131 (278)
T 3cok_A 55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH--- 131 (278)
T ss_dssp HHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 47799999999999999999999999999999999999999999999987767899999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
+++|+||+|+||+++.++.++++|||.+......... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 132 ~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 210 (278)
T 3cok_A 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210 (278)
T ss_dssp TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSC
T ss_pred CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999999865432221 223457889999999998889999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||........ .......... .+......+.+++.+||+.||++|||++++++
T Consensus 211 p~~~~~~~~~----------~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 211 PFDTDTVKNT----------LNKVVLADYE----MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SSCCCSCC---------------CCSSCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCChhHHHH----------HHHHhhcccC----CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 9976543321 0000111111 11122345778888999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=271.17 Aligned_cols=219 Identities=28% Similarity=0.399 Sum_probs=177.2
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.|.+|++++++++||||+++++++.+ +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~- 128 (279)
T 1qpc_A 51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128 (279)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 46789999999999999999999999874 56899999999999999996533 3689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++|+||||+||+++.++.++++|||.+...............++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 129 --~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 206 (279)
T 1qpc_A 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206 (279)
T ss_dssp --TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred --CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhC
Confidence 99999999999999999999999999998765443333334456778999999988888999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCCC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIP 240 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~~ 240 (252)
|..||........ . .....+... .. +......+.+++.+||+.||++|||+.++++.|++.+...
T Consensus 207 g~~p~~~~~~~~~------~-~~~~~~~~~--~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 207 GRIPYPGMTNPEV------I-QNLERGYRM--VR----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp TCCSSTTCCHHHH------H-HHHHTTCCC--CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCcccCHHHH------H-HHHhcccCC--CC----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 8889876543321 1 112222111 11 1122345788888999999999999999999999865443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=270.82 Aligned_cols=216 Identities=22% Similarity=0.301 Sum_probs=175.6
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...++|.+|++++++++||||+++++++ ..+..++||||+++++|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 60 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~- 136 (291)
T 1xbb_A 60 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEES- 136 (291)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3467899999999999999999999999 567789999999999999999653 4589999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc--cccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT--FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||||+||+++.++.++++|||.+.......... .....++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 137 --~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 214 (291)
T 1xbb_A 137 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214 (291)
T ss_dssp --TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred --CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHH
Confidence 99999999999999999999999999998765433321 12233567899999998888899999999999999999
Q ss_pred h-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 162 C-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 162 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
+ |..||....... +......+..... +......+.+++.+||+.||++|||+.++++.|++.+
T Consensus 215 ~~g~~p~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 215 SYGQKPYRGMKGSE-------VTAMLEKGERMGC------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp TTTCCSSTTCCHHH-------HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred hcCCCCCCCCCHHH-------HHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9 999998654432 1122222222111 1222345888888999999999999999999999854
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=274.73 Aligned_cols=220 Identities=26% Similarity=0.349 Sum_probs=175.7
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------------CCCCHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------------KQPNWVERMG 67 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~ 67 (252)
+..+++.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++.... ..+++..++.
T Consensus 67 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (327)
T 1fvr_A 67 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146 (327)
T ss_dssp ---CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHH
Confidence 4566799999999999 99999999999999999999999999999999996543 4689999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCc
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVK 147 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 147 (252)
++.||+.||.|||+. +++|+||||+||+++.++.++++|||.+....... ......++..|+|||++.+..++.+
T Consensus 147 i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 221 (327)
T 1fvr_A 147 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTN 221 (327)
T ss_dssp HHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHH
T ss_pred HHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCch
Confidence 999999999999999 99999999999999999999999999987432211 1122345778999999988888999
Q ss_pred ccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 148 ADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 148 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
+|+||||+++|+|++ |..||........ . .....+.... . +......+.+++.+||+.||++|||+
T Consensus 222 ~Di~slG~il~ellt~g~~pf~~~~~~~~------~-~~~~~~~~~~--~----~~~~~~~l~~li~~~l~~dp~~Rps~ 288 (327)
T 1fvr_A 222 SDVWSYGVLLWEIVSLGGTPYCGMTCAEL------Y-EKLPQGYRLE--K----PLNCDDEVYDLMRQCWREKPYERPSF 288 (327)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHH------H-HHGGGTCCCC--C----CTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hcchHHHHHHHHHHcCCCCCCCCCcHHHH------H-HHhhcCCCCC--C----CCCCCHHHHHHHHHHccCChhhCcCH
Confidence 999999999999998 9999976644321 1 1222221111 1 11223457888889999999999999
Q ss_pred HHHHHHhhcCcCCCC
Q 038713 227 KKVLLMLEGTVEIPI 241 (252)
Q Consensus 227 ~~i~~~l~~~~~~~~ 241 (252)
.++++.|++.++...
T Consensus 289 ~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 289 AQILVSLNRMLEERK 303 (327)
T ss_dssp HHHHHHHHHHHHSSS
T ss_pred HHHHHHHHHHHHhhc
Confidence 999999998655443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=294.43 Aligned_cols=222 Identities=25% Similarity=0.354 Sum_probs=180.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..++|.+|+++|++++||||+++++++.+ +..++||||+++|+|.+++... .+.+++..++.++.||+.||.|||++
T Consensus 305 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~- 382 (535)
T 2h8h_A 305 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 382 (535)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 35789999999999999999999999876 7789999999999999999643 34589999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++||||||+|||++.++.++|+|||+++..............++..|+|||++.+..++.++||||||+++|+|++
T Consensus 383 --~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~ 460 (535)
T 2h8h_A 383 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 460 (535)
T ss_dssp --TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred --CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998654322112223445778999999998889999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCCCCC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIPIP 242 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~~~~ 242 (252)
|..||......+. ...+..+..... +......+.++|.+||+.||++|||+++|++.|++.+....|
T Consensus 461 g~~P~~~~~~~~~-------~~~i~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 461 GRVPYPGMVNREV-------LDQVERGYRMPC------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp TCCSSTTCCHHHH-------HHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCCCCCCCCHHHH-------HHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 8999976543321 112222221111 122334578888999999999999999999999998876655
Q ss_pred C
Q 038713 243 Q 243 (252)
Q Consensus 243 ~ 243 (252)
+
T Consensus 528 ~ 528 (535)
T 2h8h_A 528 Q 528 (535)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=281.23 Aligned_cols=211 Identities=22% Similarity=0.353 Sum_probs=174.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.
T Consensus 59 ~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-- 135 (476)
T 2y94_A 59 VVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRH-- 135 (476)
T ss_dssp THHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 356789999999999999999999999999999999999999999999964 45689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCC-CCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-TVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.+....... ......|++.|+|||++.+..+ +.++|+||||+++|+|++|
T Consensus 136 -givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG 212 (476)
T 2y94_A 136 -MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212 (476)
T ss_dssp -TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHS
T ss_pred -CCCcccccHHHEEEecCCCeEEEeccchhhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhC
Confidence 99999999999999999999999999998764332 2233468999999999998765 6899999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEG 235 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~ 235 (252)
..||........ . .....+.... +... ...+.+++.+||+.||++|||+.|+++ .+++
T Consensus 213 ~~Pf~~~~~~~~------~-~~i~~~~~~~---p~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 213 TLPFDDDHVPTL------F-KKICDGIFYT---PQYL----NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp SCSSCCSSSHHH------H-HHHHTTCCCC---CTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred CCCCCCCCHHHH------H-HHHhcCCcCC---CccC----CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 999986543321 1 1122222211 1112 234778888999999999999999997 4555
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=275.88 Aligned_cols=210 Identities=22% Similarity=0.280 Sum_probs=171.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++||||+++++++.+.+..++||||+.||+|.+++.. .+.+++..++.++.||+.||.|||+.
T Consensus 58 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~-- 134 (384)
T 4fr4_A 58 EVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQ-- 134 (384)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 457889999999999999999999999999999999999999999999965 44689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC---CCCCCcccchhHHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN---LPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~ 161 (252)
+++||||||+||+++.+|.++|+|||.+....... ......||+.|+|||++.+ ..++.++|+||||+++|+|+
T Consensus 135 -givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ell 211 (384)
T 4fr4_A 135 -RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211 (384)
T ss_dssp -TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHH
T ss_pred -CceeccCcHHHeEECCCCCEEEeccceeeeccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHH
Confidence 99999999999999999999999999998664332 2234568999999999874 35889999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-MKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~i~~ 231 (252)
+|..||..............+ ...... .+......+.+++.+||+.||++||+ ++++.+
T Consensus 212 tG~~Pf~~~~~~~~~~~~~~~----~~~~~~-------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 212 RGRRPYHIRSSTSSKEIVHTF----ETTVVT-------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HSSCSSCCCTTSCHHHHHHHH----HHCCCC-------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hCCCCCCCCCCccHHHHHHHH----hhcccC-------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 999999765444322222211 111111 11222345788888999999999999 676654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=269.24 Aligned_cols=218 Identities=27% Similarity=0.435 Sum_probs=167.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHhh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEK--QPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
..++.|.+|++++++++||||+++++++.+ ..++||||+++|+|.+++..... .++...++.++.|+++||.|||+
T Consensus 43 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~ 120 (307)
T 2eva_A 43 SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120 (307)
T ss_dssp THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHh
Confidence 456789999999999999999999998874 58999999999999999976543 47889999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCc-eEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRC-AKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
.+..+++|+||||+||+++.++. ++++|||.+....... ....|+..|+|||++.+..++.++||||||+++|+|
T Consensus 121 ~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 196 (307)
T 2eva_A 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEV 196 (307)
T ss_dssp CSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHH
T ss_pred CCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHH
Confidence 21129999999999999998886 7999999987543222 223578999999999998899999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
++|+.||........... .....+...... ......+.+++.+||+.||++|||++++++.|+....
T Consensus 197 ~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 197 ITRRKPFDEIGGPAFRIM-----WAVHNGTRPPLI------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HHTCCTTTTTCSSHHHHH-----HHHHTTCCCCCB------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred HHCCCCchhhCccHHHHH-----HHHhcCCCCCcc------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 999999975433221111 111222221111 1122347788889999999999999999999988543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=272.89 Aligned_cols=225 Identities=14% Similarity=0.178 Sum_probs=174.8
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEec----CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFD----VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
.+.+.+|+..++.++||||+++++++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||+
T Consensus 92 ~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~ 169 (345)
T 2v62_A 92 KKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHE 169 (345)
T ss_dssp CHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence 3457889999999999999999999987 77899999999 999999996544 78999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCC--ceEEcccCcccccCCCCC------cccccccCCccccccccccCCCCCCcccchhH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKR--CAKISDFGLAKLMKPDQT------RTFTGIRGTRAYVAAEWHRNLPITVKADVYSF 153 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~--~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 153 (252)
. +++|+||||+||+++.++ .++|+|||.++....... .......|+..|+|||++.+..++.++|||||
T Consensus 170 ~---~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 246 (345)
T 2v62_A 170 N---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEIL 246 (345)
T ss_dssp T---TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHH
T ss_pred C---CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHH
Confidence 9 999999999999998777 999999999986643221 11234568999999999999889999999999
Q ss_pred HHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 038713 154 GVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233 (252)
Q Consensus 154 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l 233 (252)
|+++|+|++|..||........... . .............. ........+..+.+++.+||+.||++|||+++|++.|
T Consensus 247 G~il~ell~g~~pf~~~~~~~~~~~-~-~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 323 (345)
T 2v62_A 247 GYCMLRWLCGKLPWEQNLKDPVAVQ-T-AKTNLLDELPQSVL-KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKIL 323 (345)
T ss_dssp HHHHHHHHHSSCTTGGGTTCHHHHH-H-HHHHHHHTTTHHHH-HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHHHHHhCCCCccccccccHHHH-H-HHHhhcccccHHHH-hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 9999999999999975433221111 1 11111111110000 0000002234588888899999999999999999999
Q ss_pred hcCcC
Q 038713 234 EGTVE 238 (252)
Q Consensus 234 ~~~~~ 238 (252)
++..-
T Consensus 324 ~~~~~ 328 (345)
T 2v62_A 324 NPHGI 328 (345)
T ss_dssp CTTCC
T ss_pred hccCC
Confidence 98543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=265.97 Aligned_cols=208 Identities=24% Similarity=0.333 Sum_probs=166.7
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.+++.+|++++++++||||+++++++.+ .+..++||||+++|+|.+++. .+.+++..++.++.|++.||.|||+.
T Consensus 80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~- 156 (298)
T 2zv2_A 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQ- 156 (298)
T ss_dssp -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4678999999999999999999999986 567899999999999988663 34689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC---CCCcccchhHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP---ITVKADVYSFGVVLLEI 160 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~~l~~l 160 (252)
+++|+||||+||+++.++.++|+|||.+........ ......|+..|+|||++.+.. ++.++|+||||+++|+|
T Consensus 157 --~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 157 --KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp --TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred --CeeccCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 999999999999999999999999999987654322 223456899999999998765 36789999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||....... .. .....+.... ...... ...+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~g~~pf~~~~~~~---~~----~~~~~~~~~~-~~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 234 VFGQCPFMDERIMC---LH----SKIKSQALEF-PDQPDI----AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHSSCSSCCSSHHH---HH----HHHHHCCCCC-CSSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHCCCCCCCccHHH---HH----HHHhcccCCC-CCcccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 99999997653322 11 1112222211 111122 234788888999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=275.43 Aligned_cols=221 Identities=23% Similarity=0.268 Sum_probs=156.0
Q ss_pred hHhHHHHHHHHHHHhCCC-CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 3 AEGEREFKTEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
++....+.+|+.+++.+. ||||+++++++.+....++||||+++|+|.+++... +.+++..++.++.|++.||.|||+
T Consensus 46 ~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~ 124 (325)
T 3kn6_A 46 KRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHD 124 (325)
T ss_dssp GGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999996 999999999999999999999999999999999654 568999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCC---ceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKR---CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
. +++|+||||+||+++.++ .++++|||.+........ ......|+..|+|||++.+..++.++||||||+++|
T Consensus 125 ~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 200 (325)
T 3kn6_A 125 V---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILY 200 (325)
T ss_dssp T---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------------------CCCCHHHHHHHHHHHHH
T ss_pred C---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHH
Confidence 9 999999999999998665 799999999986543322 223345789999999999989999999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|++|..||..............+......+...... .........+.+++.+||+.||++|||+.|+++
T Consensus 201 ~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 201 TMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG---EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS---HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc---ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 9999999997653321110011112223333322111 111223455788888999999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=265.39 Aligned_cols=221 Identities=18% Similarity=0.180 Sum_probs=171.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|+.++++++||||+++++++.+.+..++||||+++ ++.+.+....+.+++..++.++.|++.||.|||+.
T Consensus 43 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~- 120 (292)
T 3o0g_A 43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120 (292)
T ss_dssp THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3457889999999999999999999999999999999999965 67777766667799999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC-CCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP-ITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||||+||+++.++.++++|||.+........ ......++..|+|||++.+.. ++.++||||||+++|+|++
T Consensus 121 --~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 197 (292)
T 3o0g_A 121 --NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_dssp --TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT
T ss_pred --CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999986543322 223356789999999988765 7999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccc---c---------------ccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQL---V---------------EDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~---------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
|+.||........ .+.... ........... . ............+.+++.+||+.||++||
T Consensus 198 ~~~p~~~~~~~~~-~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 275 (292)
T 3o0g_A 198 AGRPLFPGNDVDD-QLKRIF-RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275 (292)
T ss_dssp TSCCSCCCSSHHH-HHHHHH-HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred cCCCCcCCCCHHH-HHHHHH-HHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCC
Confidence 9988755433321 121111 11111000000 0 00011122344577888899999999999
Q ss_pred CHHHHHH
Q 038713 225 AMKKVLL 231 (252)
Q Consensus 225 s~~~i~~ 231 (252)
|++|+++
T Consensus 276 t~~e~l~ 282 (292)
T 3o0g_A 276 SAEEALQ 282 (292)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=274.24 Aligned_cols=205 Identities=22% Similarity=0.329 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|+.+++.++||||+++++++.+.+..++||||+ +|+|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~--- 127 (336)
T 3h4j_B 53 HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRH--- 127 (336)
T ss_dssp SHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 457899999999999999999999999999999999999 78999988543 4689999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCC-CCcccchhHHHHHHHHHhCC
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-TVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+||+++.++.++++|||.+....... ......|++.|+|||++.+..+ +.++||||||+++|+|++|.
T Consensus 128 givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 205 (336)
T 3h4j_B 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205 (336)
T ss_dssp TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSS
T ss_pred CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCC
Confidence 99999999999999999999999999998654332 2233468999999999998765 68999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.||......... .....+. . ..+......+.+++.+||+.||++|||++|+++
T Consensus 206 ~Pf~~~~~~~~~-------~~i~~~~---~----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 206 LPFDDEFIPNLF-------KKVNSCV---Y----VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CSSBCSSSTTCB-------CCCCSSC---C----CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCCCccHHHHH-------HHHHcCC---C----CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 999765332200 0000000 0 112222345778888999999999999999976
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=268.74 Aligned_cols=219 Identities=23% Similarity=0.335 Sum_probs=169.4
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCC-----cEEEEEecCCCCCHHhhhc-----CCCCCCCHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVS-----NKILVYDYMSNGSLVDVLF-----TPEKQPNWVERMGIARDIA 73 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~i~~~i~ 73 (252)
+..+.+.+|+.++++++||||+++++++.+.+ ..++||||+++|+|.+++. ...+.+++..++.++.|++
T Consensus 78 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~ 157 (313)
T 3brb_A 78 REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157 (313)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHH
Confidence 45678999999999999999999999998754 3599999999999999983 2345689999999999999
Q ss_pred HHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchh
Q 038713 74 RGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYS 152 (252)
Q Consensus 74 ~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 152 (252)
.||.|||+. +++|+||||+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|+||
T Consensus 158 ~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 234 (313)
T 3brb_A 158 LGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWA 234 (313)
T ss_dssp HHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHH
T ss_pred HHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHH
Confidence 999999999 999999999999999999999999999976543322 1122344677899999999988999999999
Q ss_pred HHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 153 FGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 153 lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||+++|+|++ |..||......... .....+..... +......+.+++.+||+.||++|||+.++++
T Consensus 235 lG~il~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 235 FGVTMWEIATRGMTPYPGVQNHEMY-------DYLLHGHRLKQ------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp HHHHHHHHHTTSCCSSTTCCGGGHH-------HHHHTTCCCCC------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCCCCCccCCHHHHH-------HHHHcCCCCCC------CccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999 88888765444311 11122221111 1122345888888999999999999999999
Q ss_pred HhhcCcC
Q 038713 232 MLEGTVE 238 (252)
Q Consensus 232 ~l~~~~~ 238 (252)
.|++.++
T Consensus 302 ~L~~l~~ 308 (313)
T 3brb_A 302 QLEKLLE 308 (313)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=264.37 Aligned_cols=210 Identities=24% Similarity=0.353 Sum_probs=165.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
..+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+
T Consensus 63 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 142 (285)
T 3is5_A 63 PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142 (285)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 457899999999999999999999999999999999999999999999854 23668999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEe---cCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILM---DEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
. +++|+||||+||++ +.++.++++|||.+........ .....|+..|+|||++.+ .++.++|+||||+++|
T Consensus 143 ~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~ 216 (285)
T 3is5_A 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMY 216 (285)
T ss_dssp T---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHH
T ss_pred C---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc--CcCcccccCcCChHHhcc-CCCcccCeehHHHHHH
Confidence 9 99999999999999 4567899999999976543222 233457899999999865 6889999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|++|..||......... ................. ...+.+++.+||+.||++|||+.|+++
T Consensus 217 ~ll~g~~pf~~~~~~~~~-------~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 217 FLLTGCLPFTGTSLEEVQ-------QKATYKEPNYAVECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHSSCSSCCSSHHHHH-------HHHHHCCCCCCC--CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHhCCCCCCCCCHHHHH-------hhhccCCcccccccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999876443311 11111111111111112 234778888999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=268.82 Aligned_cols=228 Identities=19% Similarity=0.253 Sum_probs=176.1
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEe----cCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSF----DVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARG 75 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~ 75 (252)
.+..+.+.+|+.++++++||||+++++++. .....++|+||+++|+|.+++.. ....+++..++.++.|++.|
T Consensus 67 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~ 146 (317)
T 2buj_A 67 QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146 (317)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence 356778999999999999999999999987 34578999999999999999865 45678999999999999999
Q ss_pred HHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--------ccccccCCccccccccccCCC---C
Q 038713 76 IRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--------TFTGIRGTRAYVAAEWHRNLP---I 144 (252)
Q Consensus 76 l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~---~ 144 (252)
|.|||+. +++|+||||+||+++.++.++++|||.+......... ......|+..|+|||++.+.. +
T Consensus 147 L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 223 (317)
T 2buj_A 147 LEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVI 223 (317)
T ss_dssp HHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEE
T ss_pred HHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCC
Confidence 9999999 9999999999999999999999999988754321111 112234688999999987654 6
Q ss_pred CCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 145 TVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 145 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
+.++||||||+++|+|++|..||........... ...... . ..... ......+.+++.+||+.||++||
T Consensus 224 ~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-----~~~~~~-~-~~~~~----~~~~~~l~~li~~~l~~dp~~Rp 292 (317)
T 2buj_A 224 DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-----LAVQNQ-L-SIPQS----PRHSSALWQLLNSMMTVDPHQRP 292 (317)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH-----HHHHCC----CCCC----TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CchhhHHHHHHHHHHHHhCCCChhhhhcccchhh-----HHhhcc-C-CCCcc----ccCCHHHHHHHHHHhhcChhhCC
Confidence 8899999999999999999999965322211111 111111 1 11111 11234588888899999999999
Q ss_pred CHHHHHHHhhcCcCCCCCCC
Q 038713 225 AMKKVLLMLEGTVEIPIPQN 244 (252)
Q Consensus 225 s~~~i~~~l~~~~~~~~~~~ 244 (252)
|+.++++.|+.....++++.
T Consensus 293 s~~~ll~~L~~~~~~~~~~~ 312 (317)
T 2buj_A 293 HIPLLLSQLEALQPPAPGQH 312 (317)
T ss_dssp CHHHHHHHHHHTCCCCCC--
T ss_pred CHHHHHHHhhhcCCCCCCCC
Confidence 99999999998765544443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=272.45 Aligned_cols=205 Identities=19% Similarity=0.178 Sum_probs=171.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++||||+++++++.+.+..++||||++||+|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 84 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~-- 160 (350)
T 1rdq_E 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSL-- 160 (350)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4567899999999999999999999999999999999999999999999643 4589999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+||+++.++.++|+|||.++...... ....|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 161 -~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 235 (350)
T 1rdq_E 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235 (350)
T ss_dssp -TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -CcccccCccceEEECCCCCEEEcccccceeccCCc----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCC
Confidence 99999999999999999999999999998654322 2346799999999999989999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-----MKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~i~~ 231 (252)
.||....... . . ..+..+.... +......+.+++.+||+.||++||+ +++|++
T Consensus 236 ~Pf~~~~~~~---~---~-~~i~~~~~~~-------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 236 PPFFADQPIQ---I---Y-EKIVSGKVRF-------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CSSCCSSHHH---H---H-HHHHHCCCCC-------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHH---H---H-HHHHcCCCCC-------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 9998654332 1 1 1122222211 1122344778888999999999999 888764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=268.50 Aligned_cols=210 Identities=20% Similarity=0.304 Sum_probs=165.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCc-----------------------------------------------
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSN----------------------------------------------- 36 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----------------------------------------------- 36 (252)
...+.+.+|+.++++++||||+++++++.+...
T Consensus 46 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 125 (332)
T 3qd2_B 46 LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125 (332)
T ss_dssp THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccc
Confidence 356789999999999999999999999865432
Q ss_pred ----------EEEEEecCCCCCHHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCc
Q 038713 37 ----------KILVYDYMSNGSLVDVLFTPE--KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRC 104 (252)
Q Consensus 37 ----------~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~ 104 (252)
.++||||+++|+|.+++.... ...++..++.++.||+.||.|||+. +++|+||||+||+++.++.
T Consensus 126 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 202 (332)
T 3qd2_B 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDV 202 (332)
T ss_dssp ------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred cccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCC
Confidence 799999999999999997643 2356667899999999999999999 9999999999999999999
Q ss_pred eEEcccCcccccCCCCC-----------cccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccccchh
Q 038713 105 AKISDFGLAKLMKPDQT-----------RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLE 173 (252)
Q Consensus 105 ~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 173 (252)
++|+|||.+........ .......|+..|+|||++.+..++.++|+||||+++|+|++|..|+.....
T Consensus 203 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~- 281 (332)
T 3qd2_B 203 VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR- 281 (332)
T ss_dssp EEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-
T ss_pred EEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-
Confidence 99999999987654321 112334689999999999998999999999999999999998776532211
Q ss_pred hhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 174 DRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
. . .....+... .........+.+++.+||+.||++|||++|+++
T Consensus 282 ----~---~-~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 282 ----I---I-TDVRNLKFP------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ----H---H-HHHHTTCCC------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ----H---H-HHhhccCCC------cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 0 1 111122111 122333445678888999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=268.06 Aligned_cols=205 Identities=23% Similarity=0.287 Sum_probs=170.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++||||+++++++.+.+..++||||++||+|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 49 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~-- 125 (318)
T 1fot_A 49 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSK-- 125 (318)
T ss_dssp CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4567889999999999999999999999999999999999999999999643 4689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+||+++.+|.++|+|||.+....... ....|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 126 -~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 200 (318)
T 1fot_A 126 -DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200 (318)
T ss_dssp -TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred -CccccCCChheEEEcCCCCEEEeecCcceecCCcc----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCC
Confidence 99999999999999999999999999998654322 2346899999999999989999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
.||........ ...... +.... +......+.+++.+||+.||++|| +++++++
T Consensus 201 ~pf~~~~~~~~------~~~i~~-~~~~~-------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 201 TPFYDSNTMKT------YEKILN-AELRF-------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CTTCCSSHHHH------HHHHHH-CCCCC-------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHH------HHHHHh-CCCCC-------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 99976543321 111122 22211 111224477888899999999999 8898873
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=270.33 Aligned_cols=218 Identities=20% Similarity=0.289 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-----EKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
.+.+.+|+.++++++||||+++++++.+.+..++||||++ |+|.+++... ...+++..++.++.||+.||.|||
T Consensus 47 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH 125 (317)
T 2pmi_A 47 PSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125 (317)
T ss_dssp CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999999999999999999997 5999988532 245899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLE 159 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~ 159 (252)
+. +++|+||||+||+++.++.++|+|||.+........ ......++..|+|||++.+. .++.++||||||+++|+
T Consensus 126 ~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 201 (317)
T 2pmi_A 126 EN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201 (317)
T ss_dssp HT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred HC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHH
Confidence 99 999999999999999999999999999986543222 22334678999999998864 58999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCC---ccccc----------c--c--------chhcHHHHHHHHHHHhhcc
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGN---LSQLV----------E--D--------EEVDQKQLQRMIKVGLRCI 216 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~----------~--~--------~~~~~~~~~~l~~li~~cl 216 (252)
|++|+.||........... +........ +.... . . ..........+.+++.+||
T Consensus 202 l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 278 (317)
T 2pmi_A 202 MITGKPLFPGTNDEEQLKL---IFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLL 278 (317)
T ss_dssp HHHSSCSCCCSSHHHHHHH---HHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHS
T ss_pred HHhCCCCCCCCChHHHHHH---HHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHC
Confidence 9999999987654432211 111111000 00000 0 0 0000112345888888999
Q ss_pred CCCCCCCCCHHHHHH
Q 038713 217 LDEPSLRRAMKKVLL 231 (252)
Q Consensus 217 ~~~p~~Rps~~~i~~ 231 (252)
+.||++|||+.|+++
T Consensus 279 ~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 279 QLNPDMRLSAKQALH 293 (317)
T ss_dssp CSSGGGSCCHHHHTT
T ss_pred CCCcccCCCHHHHhC
Confidence 999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=269.57 Aligned_cols=223 Identities=17% Similarity=0.284 Sum_probs=170.3
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
...++++.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. ....+++..++.++.|++.||.||
T Consensus 73 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 152 (310)
T 2wqm_A 73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152 (310)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence 35678899999999999999999999999999999999999999999999854 355689999999999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
|+. +++|+||+|+||+++.++.++++|||.+........ ......++..|+|||++.+..++.++|+||||+++|+
T Consensus 153 H~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~ 228 (310)
T 2wqm_A 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228 (310)
T ss_dssp HHT---TCCCCCCCGGGEEECTTSCEEECCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred hhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHH
Confidence 999 999999999999999999999999999876543322 1223457889999999998889999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCC
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~ 239 (252)
|++|+.||........ .+ . .....+...... ... ....+.+++.+||+.||++|||+.++++.|+++...
T Consensus 229 l~~g~~p~~~~~~~~~-~~---~-~~~~~~~~~~~~-~~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 229 MAALQSPFYGDKMNLY-SL---C-KKIEQCDYPPLP-SDH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp HHHSSCTTC---CCHH-HH---H-HHHHTTCSCCCC-TTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhCCCCCcccchhHH-HH---H-HHhhcccCCCCc-ccc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 9999999975432211 11 1 122222222111 111 223477888899999999999999999999985443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=276.34 Aligned_cols=208 Identities=20% Similarity=0.265 Sum_probs=167.2
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|..+++.+ +||||+++++++.+.+.+++||||++||+|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 66 ~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~- 143 (353)
T 3txo_A 66 DVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDK- 143 (353)
T ss_dssp THHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 456788999999988 7999999999999999999999999999999999643 4689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++|+|||+++...... .......|++.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 144 --givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 220 (353)
T 3txo_A 144 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220 (353)
T ss_dssp --TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHS
T ss_pred --CCcccCCCHHHEEECCCCCEEEccccceeecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhC
Confidence 99999999999999999999999999987533222 122335689999999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM------KKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~------~~i~~ 231 (252)
..||......+. . .....+.... +......+.+++.+||+.||++||++ +++++
T Consensus 221 ~~Pf~~~~~~~~------~-~~i~~~~~~~-------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 221 HAPFEAENEDDL------F-EAILNDEVVY-------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp SCSSCCSSHHHH------H-HHHHHCCCCC-------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCCCHHHH------H-HHHHcCCCCC-------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 999986644321 1 1122222211 11123447788889999999999998 66654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=275.34 Aligned_cols=219 Identities=21% Similarity=0.352 Sum_probs=176.8
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-------------CCCCCHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-------------EKQPNWVERMGIA 69 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~ 69 (252)
+..+.+.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++... ...+++..++.++
T Consensus 91 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (333)
T 2i1m_A 91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170 (333)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHH
Confidence 4567899999999999 8999999999999999999999999999999998542 3457999999999
Q ss_pred HHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcc
Q 038713 70 RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKA 148 (252)
Q Consensus 70 ~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~ 148 (252)
.|++.||.|||+. +++|+||||+||+++.++.++++|||.+......... ......++..|+|||++.+..++.++
T Consensus 171 ~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 247 (333)
T 2i1m_A 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS 247 (333)
T ss_dssp HHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHhcC---CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHH
Confidence 9999999999999 9999999999999999999999999999865433322 22234467789999999888899999
Q ss_pred cchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 149 DVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 149 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
||||||+++|+|++ |..||........ .. .....+.... .+.. ....+.+++.+||+.||++|||+.
T Consensus 248 Di~slG~il~el~t~g~~p~~~~~~~~~--~~----~~~~~~~~~~--~~~~----~~~~l~~li~~~l~~~p~~Rps~~ 315 (333)
T 2i1m_A 248 DVWSYGILLWEIFSLGLNPYPGILVNSK--FY----KLVKDGYQMA--QPAF----APKNIYSIMQACWALEPTHRPTFQ 315 (333)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCSSHH--HH----HHHHHTCCCC--CCTT----CCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHHHHcCCCCCCcccchhHH--HH----HHHhcCCCCC--CCCC----CCHHHHHHHHHHhccChhhCcCHH
Confidence 99999999999998 8889876543321 11 1122221111 1111 134578888899999999999999
Q ss_pred HHHHHhhcCc
Q 038713 228 KVLLMLEGTV 237 (252)
Q Consensus 228 ~i~~~l~~~~ 237 (252)
++++.|++..
T Consensus 316 ~l~~~L~~~~ 325 (333)
T 2i1m_A 316 QICSFLQEQA 325 (333)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=271.51 Aligned_cols=225 Identities=23% Similarity=0.350 Sum_probs=177.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCC--cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVS--NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
+..+.|.+|+.++++++||||+++++++...+ ..++||||+++|+|.+++......+++..++.++.|++.||.+||+
T Consensus 84 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 163 (326)
T 2w1i_A 84 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163 (326)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45678999999999999999999999987643 7899999999999999997766679999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--ccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
. +++|+||||+||+++.++.++++|||.+......... ......++..|+|||.+.+..++.++||||||+++|+
T Consensus 164 ~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 240 (326)
T 2w1i_A 164 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 240 (326)
T ss_dssp T---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred C---CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHH
Confidence 9 9999999999999999999999999999876543321 1122345678999999988888999999999999999
Q ss_pred HHhCCccccccchhhh---------HHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 160 IVCLRRCLDQNLLEDR---------AILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
|++|..|+........ ......+......+..... +...+..+.+++.+||+.||++|||+.+++
T Consensus 241 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 314 (326)
T 2w1i_A 241 LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR------PDGCPDEIYMIMTECWNNNVNQRPSFRDLA 314 (326)
T ss_dssp HHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCC------CCcccHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 9999999875421110 1111111222222221111 122234588888899999999999999999
Q ss_pred HHhhcCc
Q 038713 231 LMLEGTV 237 (252)
Q Consensus 231 ~~l~~~~ 237 (252)
+.|+++.
T Consensus 315 ~~L~~l~ 321 (326)
T 2w1i_A 315 LRVDQIR 321 (326)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=264.60 Aligned_cols=211 Identities=21% Similarity=0.309 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 68 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--- 144 (314)
T 3com_A 68 LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM--- 144 (314)
T ss_dssp CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 46789999999999999999999999999999999999999999999975566789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
+++|+||+|+||+++.++.++++|||.+........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 145 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (314)
T 3com_A 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223 (314)
T ss_dssp TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999976543322 2233467889999999999889999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||......... .. ...........+.. ....+.+++.+||+.||.+|||+.++++
T Consensus 224 p~~~~~~~~~~------~~-~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 224 PYADIHPMRAI------FM-IPTNPPPTFRKPEL----WSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp TTTTSCHHHHH------HH-HHHSCCCCCSSGGG----SCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCChHHHH------HH-HhcCCCcccCCccc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99765433211 11 11111111111112 2344778888999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=274.22 Aligned_cols=212 Identities=21% Similarity=0.295 Sum_probs=157.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+.
T Consensus 91 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~-- 167 (349)
T 2w4o_A 91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHEN-- 167 (349)
T ss_dssp --------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 356788999999999999999999999999999999999999999999964 44689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecC---CCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDE---KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||||+||+++. ++.++++|||.+....... ......|+..|+|||++.+..++.++||||||+++|+|+
T Consensus 168 -~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 244 (349)
T 2w4o_A 168 -GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244 (349)
T ss_dssp -TCCCCCCCGGGEEESSSSTTCCEEECCCC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred -CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHH
Confidence 9999999999999975 8899999999988654322 122346799999999999988999999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||........ . . .....+...... .........+.+++.+||+.||++|||+.|+++
T Consensus 245 ~g~~pf~~~~~~~~--~---~-~~i~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 245 CGFEPFYDERGDQF--M---F-RRILNCEYYFIS---PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HSSCTTCCTTCHHH--H---H-HHHHTTCCCCCT---TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCcccHH--H---H-HHHHhCCCccCC---chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999976543321 1 1 112222221111 111122345778888999999999999999987
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=269.91 Aligned_cols=215 Identities=24% Similarity=0.208 Sum_probs=167.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC---------------------------
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP--------------------------- 56 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--------------------------- 56 (252)
+..+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.+++...
T Consensus 70 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (345)
T 3hko_A 70 KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149 (345)
T ss_dssp CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccc
Confidence 45678999999999999999999999999999999999999999999998420
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCC--ceEEcccCcccccCCCCC-
Q 038713 57 ------------EKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKR--CAKISDFGLAKLMKPDQT- 121 (252)
Q Consensus 57 ------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~--~~~l~d~~~~~~~~~~~~- 121 (252)
...+++..++.++.||+.||.|||+. +++|+||||+||+++.++ .++|+|||.+........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~ 226 (345)
T 3hko_A 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG 226 (345)
T ss_dssp HHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC
T ss_pred cccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCcc
Confidence 11235677888999999999999999 999999999999998776 899999999986543222
Q ss_pred --cccccccCCccccccccccC--CCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCccccccc
Q 038713 122 --RTFTGIRGTRAYVAAEWHRN--LPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVED 197 (252)
Q Consensus 122 --~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (252)
.......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||........ ..............
T Consensus 227 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~-- 298 (345)
T 3hko_A 227 EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKLCFENP-- 298 (345)
T ss_dssp --------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCCTTSG--
T ss_pred ccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcccccCCc--
Confidence 12234568999999999875 5688999999999999999999999976644321 11222222111111
Q ss_pred chhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 198 EEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 198 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
........+.+++.+||+.||++|||+.++++
T Consensus 299 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 299 --NYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp --GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11112344778888999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=294.31 Aligned_cols=216 Identities=22% Similarity=0.304 Sum_probs=174.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...++|.+|++++++++||||+++++++.+ +..++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.
T Consensus 412 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~- 488 (635)
T 4fl3_A 412 ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES- 488 (635)
T ss_dssp GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 446889999999999999999999999974 568999999999999999954 45689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--cccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++||||||+||+++.++.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 489 --~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ell 566 (635)
T 4fl3_A 489 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 566 (635)
T ss_dssp --TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred --CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999987654332 1222234577899999999989999999999999999999
Q ss_pred h-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 162 C-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 162 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
+ |..||....... +...+..+..... +...+..+.+++.+||+.||++|||+++|++.|++..
T Consensus 567 t~G~~Pf~~~~~~~-------~~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 567 SYGQKPYRGMKGSE-------VTAMLEKGERMGC------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp TTTCCSSTTCCHHH-------HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHH-------HHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 8 999997664443 1122333322211 1223355888999999999999999999999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=262.94 Aligned_cols=217 Identities=21% Similarity=0.284 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~--- 133 (284)
T 2vgo_A 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHER--- 133 (284)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 567999999999999999999999999999999999999999999999643 4589999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
+++|+||+|+||+++.++.++++|||.+....... .....|+..|+|||++.+..++.++|+||||+++|++++|..
T Consensus 134 ~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 210 (284)
T 2vgo_A 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210 (284)
T ss_dssp TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CceecCCCHHHEEEcCCCCEEEecccccccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCC
Confidence 99999999999999999999999999987654322 223457899999999999889999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCcCCCCCC
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEGTVEIPIPQ 243 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~~~~~~~~~ 243 (252)
||......... .......... +......+.+++.+||+.||++|||++++++ .++.......|+
T Consensus 211 pf~~~~~~~~~-------~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~ 276 (284)
T 2vgo_A 211 PFDSPSHTETH-------RRIVNVDLKF-------PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP 276 (284)
T ss_dssp TTCCSSHHHHH-------HHHHTTCCCC-------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred CCCCCCHhHHH-------HHHhccccCC-------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCC
Confidence 99865433211 1111222111 1112344778888999999999999999986 555544333333
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=261.21 Aligned_cols=213 Identities=21% Similarity=0.282 Sum_probs=172.7
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
.+..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~ 124 (284)
T 3kk8_A 46 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSN 124 (284)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678999999999999999999999999999999999999999999988543 4689999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCc---eEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRC---AKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
+++|+||||+||+++.++. ++++|||.+........ .....|+..|+|||++.+..++.++|+||||+++|+
T Consensus 125 ---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 199 (284)
T 3kk8_A 125 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYI 199 (284)
T ss_dssp ---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred ---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHH
Confidence 9999999999999986655 99999999976543322 233568999999999999889999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|++|..||......... .....+........ .......+.+++.+||+.||++|||+.|+++
T Consensus 200 l~~g~~pf~~~~~~~~~-------~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 200 LLVGYPPFWDEDQHRLY-------AQIKAGAYDYPSPE---WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHSSCSSCCSSHHHHH-------HHHHHTCCCCCTTT---TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHCCCCCCCCchhHHH-------HHHHhccccCCchh---hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 99999999765433211 11222222221111 1112234778888999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=265.46 Aligned_cols=211 Identities=24% Similarity=0.361 Sum_probs=172.9
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.
T Consensus 58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~-- 134 (321)
T 2a2a_A 58 SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTK-- 134 (321)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 367899999999999999999999999999999999999999999999965 44689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCC----ceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKR----CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||||+||+++.++ .++++|||.+........ .....|+..|+|||++.+..++.++|+||||+++|+|
T Consensus 135 -~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 211 (321)
T 2a2a_A 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211 (321)
T ss_dssp -TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred -CeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHH
Confidence 999999999999999887 799999999986654322 2334589999999999988899999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||........ . .....+.... +..........+.+++.+||+.||++|||+.|+++
T Consensus 212 ~~g~~pf~~~~~~~~------~-~~i~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 212 LSGASPFLGDTKQET------L-ANITSVSYDF---DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHSCCSSCCSSHHHH------H-HHHHTTCCCC---CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHCCCCCCCCCHHHH------H-HHHHhccccc---ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 999999976543321 1 1111111111 11111122345788888999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=263.13 Aligned_cols=205 Identities=23% Similarity=0.341 Sum_probs=167.8
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.
T Consensus 53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~--- 128 (279)
T 3fdn_A 53 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSK--- 128 (279)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 567899999999999999999999999999999999999999999999543 4589999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
+++|+||+|+||+++.++.++++|||.+....... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 129 ~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 205 (279)
T 3fdn_A 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205 (279)
T ss_dssp TCEECCCCGGGEEECTTSCEEECSCCEESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred CEecccCChHhEEEcCCCCEEEEeccccccCCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCC
Confidence 99999999999999999999999999886543322 223467899999999999889999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||.......... ......... +......+.+++.+||+.||++|||+.|+++
T Consensus 206 p~~~~~~~~~~~-------~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 206 PFEANTYQETYK-------RISRVEFTF-------PDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp TTCCSSHHHHHH-------HHHHTCCCC-------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCCcHHHHHH-------HHHhCCCCC-------CCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 998664443211 111111111 1112234778888999999999999999995
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=280.40 Aligned_cols=208 Identities=21% Similarity=0.214 Sum_probs=162.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD-EC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~ 83 (252)
..+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+ .
T Consensus 191 ~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~- 268 (446)
T 4ejn_A 191 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEK- 268 (446)
T ss_dssp ----------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcC-
Confidence 456788999999999999999999999999999999999999999999954 3468999999999999999999998 8
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++|+|||+++...... .......|++.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 269 --giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 345 (446)
T 4ejn_A 269 --NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345 (446)
T ss_dssp --CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred --CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhC
Confidence 99999999999999999999999999987543222 222345689999999999998999999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
+.||......... .....+.... +.. ....+.+++.+||+.||++|| |++|+++
T Consensus 346 ~~Pf~~~~~~~~~-------~~i~~~~~~~---p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 346 RLPFYNQDHEKLF-------ELILMEEIRF---PRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp SCSSCCSSHHHHH-------HHHHHCCCCC---CTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCCCHHHHH-------HHHHhCCCCC---Ccc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 9999765443211 1111122111 111 224477888899999999999 9999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=267.92 Aligned_cols=223 Identities=17% Similarity=0.184 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeE-ecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYS-FDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+++.+|+.+++.++|++++..+..+ .+.+..++||||+ +++|.+++....+.+++..++.++.|++.||.|||+.
T Consensus 48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-- 124 (296)
T 4hgt_A 48 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK-- 124 (296)
T ss_dssp CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 34688999999999888877776655 5677889999999 9999999976666799999999999999999999999
Q ss_pred CCeeeeccCCCCEEe---cCCCceEEcccCcccccCCCCC------cccccccCCccccccccccCCCCCCcccchhHHH
Q 038713 85 AQIIHGDIKPQNILM---DEKRCAKISDFGLAKLMKPDQT------RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGV 155 (252)
Q Consensus 85 ~~i~h~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 155 (252)
+++|+||||+||++ +.++.++++|||.+........ .......|+..|+|||.+.+..++.++||||||+
T Consensus 125 -~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 203 (296)
T 4hgt_A 125 -NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 203 (296)
T ss_dssp -TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred -CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHH
Confidence 99999999999999 7889999999999987654332 1223456899999999999989999999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
++|+|++|+.||..............+.......... ......+..+.+++.+||+.||++|||+.++++.|++
T Consensus 204 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 204 VLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred HHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 9999999999998653332211111111111111100 0111123458888889999999999999999999998
Q ss_pred CcC
Q 038713 236 TVE 238 (252)
Q Consensus 236 ~~~ 238 (252)
...
T Consensus 278 ~~~ 280 (296)
T 4hgt_A 278 LFH 280 (296)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=260.36 Aligned_cols=211 Identities=22% Similarity=0.289 Sum_probs=171.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~- 125 (277)
T 3f3z_A 48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKL- 125 (277)
T ss_dssp SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3467899999999999999999999999999999999999999999999854 34589999999999999999999999
Q ss_pred CCCeeeeccCCCCEEe---cCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILM---DEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 84 ~~~i~h~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||||+||++ +.++.++++|||.+....... ......++..|+|||++.+. ++.++|+||||+++|+|
T Consensus 126 --~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l 200 (277)
T 3f3z_A 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVL 200 (277)
T ss_dssp --TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHH
T ss_pred --CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHH
Confidence 99999999999999 788899999999998665333 22334689999999998774 89999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||........ ......+...... .........+.+++.+||+.||++|||+.++++
T Consensus 201 ~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 201 LCGYPPFSAPTDSEV-------MLKIREGTFTFPE---KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHSSCSSCCSSHHHH-------HHHHHHCCCCCCH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHCCCCCCCCCHHHH-------HHHHHhCCCCCCc---hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999987544321 1112222221111 111122345788888999999999999999985
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=270.53 Aligned_cols=211 Identities=21% Similarity=0.256 Sum_probs=167.3
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
+..+.+.+|..+++++ +||||+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 51 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~ 129 (345)
T 3a8x_A 51 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER 129 (345)
T ss_dssp HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4466789999999988 8999999999999999999999999999999999643 4689999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++.++|+|||.++...... .......|++.|+|||++.+..++.++|+||||+++|+|++
T Consensus 130 ---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 205 (345)
T 3a8x_A 130 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205 (345)
T ss_dssp ---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred ---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHh
Confidence 99999999999999999999999999987533222 22234568999999999999889999999999999999999
Q ss_pred CCccccccchhhh--HHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 163 LRRCLDQNLLEDR--AILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 163 g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
|..||........ ......+......+.... +......+.+++.+||+.||++||++
T Consensus 206 g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~-------p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 206 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI-------PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp SSCTTTTTTC-------CHHHHHHHHHHCCCCC-------CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCcCCcccccccccccHHHHHHHHHcCCCCC-------CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 9999975321110 011111222222222211 11223447788889999999999996
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=266.73 Aligned_cols=223 Identities=20% Similarity=0.226 Sum_probs=168.4
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.
T Consensus 44 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~- 121 (311)
T 4agu_A 44 VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKH- 121 (311)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4467889999999999999999999999999999999999999999988754 44689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||||+||+++.++.++++|||.+........ ......++..|+|||++.+ ..++.++|+||||+++|+|++
T Consensus 122 --~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 198 (311)
T 4agu_A 122 --NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198 (311)
T ss_dssp --TEECCCCSGGGEEECTTSCEEECCCTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred --CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHh
Confidence 999999999999999999999999999986543322 2233467889999999876 567999999999999999999
Q ss_pred CCccccccchhhhHHHHHHH--------HHHHhcC------Cccccccc---chhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 163 LRRCLDQNLLEDRAILQEWI--------CQCFENG------NLSQLVED---EEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~--------~~~~~~~------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
|..||......+........ ....... ........ ..........+.+++.+||+.||++|||
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 278 (311)
T 4agu_A 199 GVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT 278 (311)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC
T ss_pred CCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC
Confidence 99999876554432221110 0000000 00000000 0011123445788899999999999999
Q ss_pred HHHHHH
Q 038713 226 MKKVLL 231 (252)
Q Consensus 226 ~~~i~~ 231 (252)
++|+++
T Consensus 279 ~~ell~ 284 (311)
T 4agu_A 279 CEQLLH 284 (311)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=293.79 Aligned_cols=217 Identities=20% Similarity=0.280 Sum_probs=174.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+.++.|.+|+.++++++||||+++++++. .+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.
T Consensus 433 ~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 510 (656)
T 2j0j_A 433 SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK- 510 (656)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 45678999999999999999999999985 4668999999999999999976666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++||||||+||+++.++.++++|||.++..............++..|+|||++.+..++.++||||||+++|+|++
T Consensus 511 --givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~ 588 (656)
T 2j0j_A 511 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 588 (656)
T ss_dssp --TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --CccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHc
Confidence 99999999999999999999999999998765443333333456778999999998889999999999999999997
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
|..||......+. . .....+..... +...+..+.+++.+||+.||++|||+.++++.|++++
T Consensus 589 g~~Pf~~~~~~~~---~----~~i~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 589 GVKPFQGVKNNDV---I----GRIENGERLPM------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp SCCTTTTCCHHHH---H----HHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHH---H----HHHHcCCCCCC------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 8899976543321 1 11222221111 1222345788889999999999999999999998864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=266.58 Aligned_cols=216 Identities=19% Similarity=0.319 Sum_probs=172.7
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEe--cCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSF--DVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
...++.+.+|+.++++++||||+++++++. ..+..++||||+++|+|.+++.. ....+++..++.++.|++.||.
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~ 125 (279)
T 2w5a_A 46 EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125 (279)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999875 46788999999999999999964 2345899999999999999999
Q ss_pred HHhhcCCCC-----eeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchh
Q 038713 78 YLHDECEAQ-----IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYS 152 (252)
Q Consensus 78 ~lh~~~~~~-----i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 152 (252)
|||+. + ++|+||+|+||+++.++.++++|||.+........ ......|+..|+|||++.+..++.++|+||
T Consensus 126 ~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 201 (279)
T 2w5a_A 126 ECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWS 201 (279)
T ss_dssp HHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHH
T ss_pred HHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHH
Confidence 99999 8 99999999999999999999999999876543321 122345788999999999888999999999
Q ss_pred HHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 153 FGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 153 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
||+++|+|++|..||....... + ......+..... +......+.+++.+||+.||++|||+.|+++.
T Consensus 202 lG~il~~l~~g~~p~~~~~~~~---~----~~~i~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 202 LGCLLYELCALMPPFTAFSQKE---L----AGKIREGKFRRI------PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCCCcccCHHH---H----HHHHhhcccccC------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 9999999999999998664332 1 122223332221 11223457888889999999999999999986
Q ss_pred hhc
Q 038713 233 LEG 235 (252)
Q Consensus 233 l~~ 235 (252)
+..
T Consensus 269 ~~~ 271 (279)
T 2w5a_A 269 PLI 271 (279)
T ss_dssp TTC
T ss_pred hhh
Confidence 654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=270.17 Aligned_cols=220 Identities=25% Similarity=0.367 Sum_probs=176.6
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCC-cEEEEEecCCCCCHHhhhcCCCC---------------CCCHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVS-NKILVYDYMSNGSLVDVLFTPEK---------------QPNWVERM 66 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~ 66 (252)
...+.+.+|+.+++++ +||||+++++++...+ ..++||||+++|+|.+++..... .+++..++
T Consensus 72 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (316)
T 2xir_A 72 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151 (316)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHH
T ss_pred HHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHH
Confidence 3567899999999999 7999999999988754 58999999999999999976443 27899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCC
Q 038713 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPIT 145 (252)
Q Consensus 67 ~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~ 145 (252)
.++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+........ .......++..|+|||++.+..++
T Consensus 152 ~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 228 (316)
T 2xir_A 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 228 (316)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc
Confidence 9999999999999999 999999999999999999999999999986543332 222334567899999999988899
Q ss_pred CcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 146 VKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 146 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
.++|+||||+++|+|++ |..||........ + ......+..... +......+.+++.+||+.||++||
T Consensus 229 ~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~----~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rp 296 (316)
T 2xir_A 229 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F----CRRLKEGTRMRA------PDYTTPEMYQTMLDCWHGEPSQRP 296 (316)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--H----HHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred chhHHHHHHHHHHHHHhCCCCCCcccchhHH--H----HHHhccCccCCC------CCCCCHHHHHHHHHHcCCChhhCc
Confidence 99999999999999998 9999976543321 1 111222221111 111234478888899999999999
Q ss_pred CHHHHHHHhhcCcC
Q 038713 225 AMKKVLLMLEGTVE 238 (252)
Q Consensus 225 s~~~i~~~l~~~~~ 238 (252)
|+.++++.|++.++
T Consensus 297 s~~ell~~L~~~~~ 310 (316)
T 2xir_A 297 TFSELVEHLGNLLQ 310 (316)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHh
Confidence 99999999998653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=270.14 Aligned_cols=229 Identities=23% Similarity=0.267 Sum_probs=178.2
Q ss_pred hHhHHHHHHHHHHHhC--CCCCCCcceeeeEecCC----cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGR--THHRNPVRLLGYSFDVS----NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l 76 (252)
....+.+.+|++++.. ++||||+++++++.... ..++||||+++|+|.+++.. ..+++..++.++.|++.||
T Consensus 75 ~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l 152 (342)
T 1b6c_B 75 SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGL 152 (342)
T ss_dssp GGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHH
Confidence 3456778899999887 79999999999998765 78999999999999999954 3589999999999999999
Q ss_pred HHHh--------hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc---ccccccCCccccccccccCCC--
Q 038713 77 RYLH--------DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR---TFTGIRGTRAYVAAEWHRNLP-- 143 (252)
Q Consensus 77 ~~lh--------~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~-- 143 (252)
.||| +. +++|+||||+||+++.++.++|+|||.+......... ......|+..|+|||++.+..
T Consensus 153 ~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 229 (342)
T 1b6c_B 153 AHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229 (342)
T ss_dssp HHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT
T ss_pred HHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccc
Confidence 9999 77 9999999999999999999999999999866543321 123346889999999988752
Q ss_pred ----CCCcccchhHHHHHHHHHhC----------CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHH
Q 038713 144 ----ITVKADVYSFGVVLLEIVCL----------RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMI 209 (252)
Q Consensus 144 ----~~~~~Di~slG~~l~~l~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 209 (252)
++.++||||||+++|+|++| ..||......... ... .......+..................+.
T Consensus 230 ~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (342)
T 1b6c_B 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEE-MRKVVCEQKLRPNIPNRWQSCEALRVMA 307 (342)
T ss_dssp TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-HHH-HHHHHTTSCCCCCCCGGGGTSHHHHHHH
T ss_pred cccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc-HHH-HHHHHHHHHhCCCCcccccchhHHHHHH
Confidence 23689999999999999999 6787654322110 111 1122222222222222223445667789
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 210 KVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 210 ~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
+++.+||+.||++|||+.++++.|+++.+
T Consensus 308 ~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 308 KIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 99999999999999999999999998654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=269.29 Aligned_cols=208 Identities=21% Similarity=0.197 Sum_probs=161.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.
T Consensus 64 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~-- 140 (327)
T 3a62_A 64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQK-- 140 (327)
T ss_dssp -------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 355688999999999999999999999999999999999999999999954 34588999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+||+++.++.++|+|||.++....... ......|+..|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 141 -~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 218 (327)
T 3a62_A 141 -GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218 (327)
T ss_dssp -TCCCCCCCTTTEEECTTSCEEECCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred -CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCC
Confidence 999999999999999999999999999875432221 222346899999999999888999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
.||........ ...... +.... +......+.+++.+||+.||++|| +++++++
T Consensus 219 ~pf~~~~~~~~------~~~i~~-~~~~~-------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 219 PPFTGENRKKT------IDKILK-CKLNL-------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CSCCCSSHHHH------HHHHHH-TCCCC-------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCCCCCHHHH------HHHHHh-CCCCC-------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 99986543321 111111 11111 112234477888899999999999 7778765
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=270.42 Aligned_cols=220 Identities=25% Similarity=0.332 Sum_probs=175.4
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC------CCCCHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE------KQPNWVERMGIARDIARGI 76 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l 76 (252)
.+...++.+|+.++++++||||+++++++.+....++||||+++|+|.+++.... ..+++..++.++.|++.||
T Consensus 74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al 153 (327)
T 2yfx_A 74 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153 (327)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999996543 3488999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecC---CCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchh
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDE---KRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYS 152 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 152 (252)
.|||+. +++|+||||+||+++. +..++++|||.+........ .......++..|+|||++.+..++.++||||
T Consensus 154 ~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 230 (327)
T 2yfx_A 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 230 (327)
T ss_dssp HHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHhhC---CeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHH
Confidence 999999 9999999999999984 44699999999875432222 2223345688999999998888999999999
Q ss_pred HHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 153 FGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 153 lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
||+++|+|++ |..||....... . ......+..... +......+.+++.+||+.||++|||+.++++
T Consensus 231 lG~il~ellt~g~~p~~~~~~~~---~----~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 297 (327)
T 2yfx_A 231 FGVLLWEIFSLGYMPYPSKSNQE---V----LEFVTSGGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297 (327)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHHH---H----HHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCcCHHH---H----HHHHhcCCCCCC------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999998 889987654332 1 112222222111 1112345788888999999999999999999
Q ss_pred HhhcCcC
Q 038713 232 MLEGTVE 238 (252)
Q Consensus 232 ~l~~~~~ 238 (252)
.|+.+..
T Consensus 298 ~l~~~~~ 304 (327)
T 2yfx_A 298 RIEYCTQ 304 (327)
T ss_dssp HHHHHHH
T ss_pred HHHHHhc
Confidence 9987544
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=258.16 Aligned_cols=212 Identities=26% Similarity=0.367 Sum_probs=170.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.
T Consensus 48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-- 124 (276)
T 2yex_A 48 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI-- 124 (276)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 467899999999999999999999999999999999999999999999954 44689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCC-CCcccchhHHHHHHHHHh
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPI-TVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||+|+||+++.++.++++|||.+........ .......|+..|+|||++.+..+ +.++|+||||+++|+|++
T Consensus 125 -~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 203 (276)
T 2yex_A 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203 (276)
T ss_dssp -TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred -CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh
Confidence 999999999999999999999999999876532221 12233567889999999987664 778999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|..||......... ...+ ...... ....... ...+.+++.+||+.||++|||++|+++
T Consensus 204 g~~p~~~~~~~~~~-~~~~----~~~~~~--~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 204 GELPWDQPSDSCQE-YSDW----KEKKTY--LNPWKKI----DSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp SSCCCSCSCTTSHH-HHHH----HTTCTT--STTGGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCchHHHH-HHHh----hhcccc--cCchhhc----CHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 99999866443211 1111 111111 1111122 234778888999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=267.25 Aligned_cols=219 Identities=22% Similarity=0.280 Sum_probs=175.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+++.+|++++++++||||+++++++.+.. .++|+||+++|+|.+++....+.+++..++.++.|++.||.|||+.
T Consensus 63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~- 140 (291)
T 1u46_A 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 140 (291)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC-
Confidence 45678999999999999999999999998755 8999999999999999976666789999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--ccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||||+||+++.++.++++|||.+......... ......++..|+|||++.+..++.++|+||||+++|+|+
T Consensus 141 --~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 218 (291)
T 1u46_A 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218 (291)
T ss_dssp --TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred --CcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999999876543321 112234677899999998888899999999999999999
Q ss_pred h-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 162 C-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 162 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
+ |..||........ .......+... .. +......+.+++.+||+.||++|||+.++++.|++...
T Consensus 219 ~~g~~p~~~~~~~~~------~~~~~~~~~~~--~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 219 TYGQEPWIGLNGSQI------LHKIDKEGERL--PR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp TTSCCTTTTCCHHHH------HHHHHTSCCCC--CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred hCCCCCcccCCHHHH------HHHHHccCCCC--CC----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 9 9999976643321 11222222111 11 11223458888889999999999999999999998543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=259.84 Aligned_cols=210 Identities=24% Similarity=0.335 Sum_probs=168.5
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEec----CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFD----VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
...++.+.+|+.++++++||||+++++++.. ....++||||+++|+|.+++... +.+++..++.++.|++.||.|
T Consensus 66 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~ 144 (290)
T 1t4h_A 66 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQF 144 (290)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999875 45589999999999999999543 458999999999999999999
Q ss_pred HhhcCCCC--eeeeccCCCCEEec-CCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHH
Q 038713 79 LHDECEAQ--IIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGV 155 (252)
Q Consensus 79 lh~~~~~~--i~h~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 155 (252)
||+. + ++|+||||+||+++ .++.++++|||.+....... .....|+..|+|||++.+ .++.++|+||||+
T Consensus 145 lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~ 217 (290)
T 1t4h_A 145 LHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGM 217 (290)
T ss_dssp HHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHH
T ss_pred HHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHH
Confidence 9999 8 99999999999997 78999999999997544332 223457899999998875 5899999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|+|++|+.||......... . .....+..... .+......+.+++.+||+.||++|||+.|+++
T Consensus 218 ~l~~l~~g~~pf~~~~~~~~~-----~-~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 218 CMLEMATSEYPYSECQNAAQI-----Y-RRVTSGVKPAS-----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHSSCTTTTCSSHHHH-----H-HHHTTTCCCGG-----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCCCCCcCcHHHH-----H-HHHhccCCccc-----cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 999999999999765433211 1 11222211111 11111234788888999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=264.87 Aligned_cols=224 Identities=17% Similarity=0.173 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeE-ecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYS-FDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+++.+|+.+++.++|++++..+..+ ...+..++||||+ +++|.+++....+.+++..++.++.|++.||.|||+.
T Consensus 48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-- 124 (296)
T 3uzp_A 48 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK-- 124 (296)
T ss_dssp CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 35689999999999988877666655 5677789999999 9999999976667799999999999999999999999
Q ss_pred CCeeeeccCCCCEEec---CCCceEEcccCcccccCCCCCc------ccccccCCccccccccccCCCCCCcccchhHHH
Q 038713 85 AQIIHGDIKPQNILMD---EKRCAKISDFGLAKLMKPDQTR------TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGV 155 (252)
Q Consensus 85 ~~i~h~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 155 (252)
+++|+||||+||+++ .++.++++|||.+......... ......|+..|+|||++.+..++.++||||||+
T Consensus 125 -~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 203 (296)
T 3uzp_A 125 -NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 203 (296)
T ss_dssp -TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred -CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHH
Confidence 999999999999994 7889999999999876543321 123456899999999999988999999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
++|+|++|+.||..............+.......... ......+..+.+++.+||+.||++|||+.++++.|++
T Consensus 204 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 204 VLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 9999999999998643322111111111111111100 0111223458888899999999999999999999998
Q ss_pred CcCC
Q 038713 236 TVEI 239 (252)
Q Consensus 236 ~~~~ 239 (252)
....
T Consensus 278 ~~~~ 281 (296)
T 3uzp_A 278 LFHR 281 (296)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 6543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=276.13 Aligned_cols=212 Identities=21% Similarity=0.206 Sum_probs=171.8
Q ss_pred HHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 038713 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQI 87 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i 87 (252)
.+.+|..++..++||||+++++++.+.+.+++||||++||+|.+++....+.+++..++.++.||+.||.|||+. ++
T Consensus 120 ~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gi 196 (437)
T 4aw2_A 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HY 196 (437)
T ss_dssp CHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 488999999999999999999999999999999999999999999987667799999999999999999999999 99
Q ss_pred eeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc-----CCCCCCcccchhHHHHHHHHHh
Q 038713 88 IHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-----NLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 88 ~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+||||||+||+++.++.++|+|||+++..............||+.|+|||++. +..++.++|+||||+++|+|++
T Consensus 197 iHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ellt 276 (437)
T 4aw2_A 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276 (437)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHH
T ss_pred EecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHh
Confidence 99999999999999999999999999876544443334457899999999987 4468999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSL--RRAMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~i~~ 231 (252)
|+.||......+.. .... .....-.+.. ..... ...+.+++.+||..+|+. ||+++|+++
T Consensus 277 G~~Pf~~~~~~~~~--~~i~-~~~~~~~~p~--~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 277 GETPFYAESLVETY--GKIM-NHKERFQFPT--QVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp SSCTTCCSSHHHHH--HHHH-THHHHCCCCS--SCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CCCCCCCCChhHHH--Hhhh-hccccccCCc--ccccC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 99999865443321 1111 1111111111 00112 234777888999888888 999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=274.72 Aligned_cols=209 Identities=21% Similarity=0.252 Sum_probs=166.0
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|..++.++ +||||+++++++.+.+.+++||||++||+|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 96 ~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~-- 172 (396)
T 4dc2_A 96 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER-- 172 (396)
T ss_dssp CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 34578999999877 8999999999999999999999999999999999643 4689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+||+++.++.++|+|||+++...... .......||+.|+|||++.+..++.++|+||||+++|+|++|+
T Consensus 173 -givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~ 250 (396)
T 4dc2_A 173 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250 (396)
T ss_dssp -TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -CEEeccCCHHHEEECCCCCEEEeecceeeecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999997533222 2233456899999999999999999999999999999999999
Q ss_pred ccccccchhhh--HHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 165 RCLDQNLLEDR--AILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 165 ~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
.||........ ......+......+.... +......+.+++.+||+.||++||++
T Consensus 251 ~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~-------p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 251 SPFDIVGSSDNPDQNTEDYLFQVILEKQIRI-------PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CSSTTTTC------CCHHHHHHHHHHCCCCC-------CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCcccccccccchhhHHHHHHHHhccccCC-------CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 99964322111 001111222222222221 11223447788889999999999996
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=272.63 Aligned_cols=207 Identities=20% Similarity=0.253 Sum_probs=169.5
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|..+++.+ +||||+++++++.+.+..++||||++||+|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 60 ~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~- 137 (345)
T 1xjd_A 60 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSK- 137 (345)
T ss_dssp CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 456788999999876 9999999999999999999999999999999999643 4589999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.+|.++++|||.++....... ......|++.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 138 --~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 214 (345)
T 1xjd_A 138 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214 (345)
T ss_dssp --TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred --CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcC
Confidence 999999999999999999999999999875432221 22345689999999999998899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK-KVL 230 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~i~ 230 (252)
..||........ . .....+.... +......+.+++.+||..||++||++. ++.
T Consensus 215 ~~Pf~~~~~~~~------~-~~i~~~~~~~-------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 215 QSPFHGQDEEEL------F-HSIRMDNPFY-------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp SCSSCCSSHHHH------H-HHHHHCCCCC-------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCCCCCHHHH------H-HHHHhCCCCC-------CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 999986543321 1 1112222111 111234577888899999999999997 654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=263.17 Aligned_cols=209 Identities=21% Similarity=0.295 Sum_probs=173.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..++.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.
T Consensus 57 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~- 134 (294)
T 2rku_A 57 HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRN- 134 (294)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4678899999999999999999999999999999999999999999998854 34689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 135 --~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 211 (294)
T 2rku_A 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211 (294)
T ss_dssp --TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHS
T ss_pred --CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999986543222 22334678899999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
..||......+.. .....+.... +......+.+++.+||+.||++|||++|+++
T Consensus 212 ~~p~~~~~~~~~~-------~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 212 KPPFETSCLKETY-------LRIKKNEYSI-------PKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp SCTTCCSSHHHHH-------HHHHTTCCCC-------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCCCCCCHHHHH-------HHHhhccCCC-------ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 9999866443211 1111221111 1112234778888999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=268.38 Aligned_cols=221 Identities=18% Similarity=0.236 Sum_probs=168.3
Q ss_pred HHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 038713 8 EFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQI 87 (252)
Q Consensus 8 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i 87 (252)
.+.+|+.++++++||||+++++++.+.+..++||||++ |+|.+++......+++..++.++.|++.||.|||+. ++
T Consensus 46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i 121 (324)
T 3mtl_A 46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KV 121 (324)
T ss_dssp CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 45689999999999999999999999999999999996 599999977777799999999999999999999999 99
Q ss_pred eeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHHHHHhCCcc
Q 038713 88 IHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCLRRC 166 (252)
Q Consensus 88 ~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p 166 (252)
+|+||||+||+++.++.++++|||.+........ ......++..|+|||++.+ ..++.++||||||+++|+|++|+.|
T Consensus 122 vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 200 (324)
T 3mtl_A 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPL 200 (324)
T ss_dssp EESSCCGGGEEECTTCCEEECSSSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCcCHHHEEECCCCCEEEccCcccccccCCcc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543222 2233467899999999876 4689999999999999999999999
Q ss_pred ccccchhhhHHHHHHHHHHHhcC---Cccccccc----------------chhcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038713 167 LDQNLLEDRAILQEWICQCFENG---NLSQLVED----------------EEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227 (252)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~----------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 227 (252)
|......+.... +....... .+...... ..........+.+++.+||+.||++|||++
T Consensus 201 f~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 277 (324)
T 3mtl_A 201 FPGSTVEEQLHF---IFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAE 277 (324)
T ss_dssp CCCSSHHHHHHH---HHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCHHHHHHH---HHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHH
Confidence 987654432221 11111111 11110000 011112234578888899999999999999
Q ss_pred HHHH--HhhcC
Q 038713 228 KVLL--MLEGT 236 (252)
Q Consensus 228 ~i~~--~l~~~ 236 (252)
|+++ .+.+.
T Consensus 278 e~l~hp~f~~~ 288 (324)
T 3mtl_A 278 DAMKHPFFLSL 288 (324)
T ss_dssp HHTTSGGGGGG
T ss_pred HHhcChhhhhc
Confidence 9987 44443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=269.21 Aligned_cols=207 Identities=25% Similarity=0.328 Sum_probs=169.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+++.+|+.++++++||||+++++++.+.+..++||||+. |+|.+++....+.+++..++.++.|++.||.|||+.
T Consensus 96 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 173 (348)
T 1u5q_A 96 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH- 173 (348)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 345789999999999999999999999999999999999996 688888866666799999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc---CCCCCCcccchhHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR---NLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||||+||+++.++.++|+|||.+...... ....|++.|+|||++. +..++.++||||||+++|+|
T Consensus 174 --~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~el 246 (348)
T 1u5q_A 174 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246 (348)
T ss_dssp --TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHH
T ss_pred --CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999765432 2346899999999984 45688999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|+.||........ .......... .. .... ....+.+++.+||+.||++|||++++++
T Consensus 247 l~g~~p~~~~~~~~~------~~~~~~~~~~-~~-~~~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 247 AERKPPLFNMNAMSA------LYHIAQNESP-AL-QSGH----WSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHSSCTTTTSCHHHH------HHHHHHSCCC-CC-CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhCCCCCCCCChHHH------HHHHHhcCCC-CC-CCCC----CCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 999999976543321 1112222211 11 1111 2234778888999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=274.81 Aligned_cols=228 Identities=19% Similarity=0.267 Sum_probs=179.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCC--cEEEEEecCCCCCHHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHh
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVS--NKILVYDYMSNGSLVDVLFTPE--KQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
..+.+.+|++++++++||||+++++++.+.+ ..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||
T Consensus 50 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 129 (396)
T 4eut_A 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129 (396)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 4577899999999999999999999998754 7899999999999999996643 23899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEe----cCCCceEEcccCcccccCCCCCcccccccCCccccccccccC--------CCCCCcc
Q 038713 81 DECEAQIIHGDIKPQNILM----DEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN--------LPITVKA 148 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~ 148 (252)
+. +++|+||||+||++ +.++.++|+|||.++...... ......|+..|+|||++.+ ..++.++
T Consensus 130 ~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 204 (396)
T 4eut_A 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204 (396)
T ss_dssp HT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHH
T ss_pred HC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHH
Confidence 99 99999999999999 677789999999998654322 2233568999999999865 4567899
Q ss_pred cchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCccc-----------------ccccchhcHHHHHHHHHH
Q 038713 149 DVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQ-----------------LVEDEEVDQKQLQRMIKV 211 (252)
Q Consensus 149 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~l~~l 211 (252)
||||||+++|+|++|+.||......... .+............. ..............+.++
T Consensus 205 DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~l 282 (396)
T 4eut_A 205 DLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPV 282 (396)
T ss_dssp HHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHH
Confidence 9999999999999999999754322111 111222222211100 011113346677788899
Q ss_pred HhhccCCCCCCCCCHHHHHHHhhcCcCC
Q 038713 212 GLRCILDEPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 212 i~~cl~~~p~~Rps~~~i~~~l~~~~~~ 239 (252)
+.+||+.||++|||+.|+++.+++.++.
T Consensus 283 l~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 283 LANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 9999999999999999999999887654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=268.94 Aligned_cols=208 Identities=20% Similarity=0.239 Sum_probs=169.7
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|..++..+ +||||+++++++.+.+..|+||||++||+|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 63 ~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~- 140 (353)
T 2i0e_A 63 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK- 140 (353)
T ss_dssp CHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 456789999999988 8999999999999999999999999999999999643 4589999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.+|.++|+|||++........ ......|++.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 141 --givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 217 (353)
T 2i0e_A 141 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217 (353)
T ss_dssp --TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred --CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcC
Confidence 999999999999999999999999999875432221 22345689999999999998999999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-----MKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~i~~ 231 (252)
..||....... . ... +..+.... +......+.+++.+||+.||++||+ ++++++
T Consensus 218 ~~Pf~~~~~~~---~---~~~-i~~~~~~~-------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 218 QAPFEGEDEDE---L---FQS-IMEHNVAY-------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp SCSSCCSSHHH---H---HHH-HHHCCCCC-------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCCCCHHH---H---HHH-HHhCCCCC-------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 99998654332 1 111 12222211 1122345778888999999999995 466653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=268.38 Aligned_cols=213 Identities=21% Similarity=0.303 Sum_probs=175.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..++.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.
T Consensus 83 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~- 160 (335)
T 2owb_A 83 HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRN- 160 (335)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 5678899999999999999999999999999999999999999999998854 34689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+........ ......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 161 --~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 237 (335)
T 2owb_A 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237 (335)
T ss_dssp --TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHS
T ss_pred --CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999999999999999999986643322 22334678999999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEG 235 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~ 235 (252)
..||......... .....+.... +... ...+.+++.+||+.||++|||++|+++ .+.+
T Consensus 238 ~~pf~~~~~~~~~-------~~~~~~~~~~---~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 238 KPPFETSCLKETY-------LRIKKNEYSI---PKHI----NPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp SCTTCCSSHHHHH-------HHHHHTCCCC---CTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred cCCCCCCCHHHHH-------HHHhcCCCCC---CccC----CHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 9999865443211 1111111111 1112 234778888999999999999999987 4444
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=264.46 Aligned_cols=233 Identities=24% Similarity=0.276 Sum_probs=175.4
Q ss_pred HhHHHHHHHHHHHhCC--CCCCCcceeeeEecC----CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT--HHRNPVRLLGYSFDV----SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
.....+.+|.+++..+ +||||+++++++... ...++||||+++|+|.+++... .+++..++.++.|++.||.
T Consensus 71 ~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~ 148 (337)
T 3mdy_A 71 TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLC 148 (337)
T ss_dssp GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHH
T ss_pred cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHH
Confidence 3455667777777765 999999999999876 7889999999999999999543 5899999999999999999
Q ss_pred HHhhcC-----CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc---cccccCCccccccccccCCCCCCc--
Q 038713 78 YLHDEC-----EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT---FTGIRGTRAYVAAEWHRNLPITVK-- 147 (252)
Q Consensus 78 ~lh~~~-----~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~-- 147 (252)
|||+.+ ..+++|+||||+||+++.++.++|+|||.+.......... .....|+..|+|||++.+...+..
T Consensus 149 ~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 228 (337)
T 3mdy_A 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQ 228 (337)
T ss_dssp HHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTH
T ss_pred HHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCcccc
Confidence 999752 2389999999999999999999999999997654332221 123468999999999988766655
Q ss_pred ----ccchhHHHHHHHHHhC----------CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHh
Q 038713 148 ----ADVYSFGVVLLEIVCL----------RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGL 213 (252)
Q Consensus 148 ----~Di~slG~~l~~l~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 213 (252)
+||||||+++|+|++| ..||......... . ............................+.+++.
T Consensus 229 ~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 306 (337)
T 3mdy_A 229 SYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS-Y-EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT 306 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-H-HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHH
T ss_pred CccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc-h-hhhHHHHhhhccCccccccchhhHHHHHHHHHHH
Confidence 9999999999999999 6666543222111 0 1111222222222222222233466777999999
Q ss_pred hccCCCCCCCCCHHHHHHHhhcCcCCC
Q 038713 214 RCILDEPSLRRAMKKVLLMLEGTVEIP 240 (252)
Q Consensus 214 ~cl~~~p~~Rps~~~i~~~l~~~~~~~ 240 (252)
+||+.||++|||+.++++.|+++.+..
T Consensus 307 ~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 307 ECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp HHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 999999999999999999999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=269.55 Aligned_cols=236 Identities=21% Similarity=0.268 Sum_probs=171.7
Q ss_pred HhHHHHHHHHHHHh--CCCCCCCcceeeeEec-----CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIG--RTHHRNPVRLLGYSFD-----VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 4 ~~~~~~~~E~~~l~--~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l 76 (252)
...+.+..|.+++. .++||||+++++.+.. ....++||||+++|+|.+++.... .++..++.++.||+.||
T Consensus 47 ~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L 124 (336)
T 3g2f_A 47 ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGL 124 (336)
T ss_dssp GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHH
T ss_pred cchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHH
Confidence 34566666766654 4899999999986542 335789999999999999995433 48889999999999999
Q ss_pred HHHhhcC------CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-------cccccccCCccccccccccC--
Q 038713 77 RYLHDEC------EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-------RTFTGIRGTRAYVAAEWHRN-- 141 (252)
Q Consensus 77 ~~lh~~~------~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~-- 141 (252)
.|||+.+ ..+++||||||+||+++.++.++|+|||.+........ .......|+..|+|||++.+
T Consensus 125 ~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 204 (336)
T 3g2f_A 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAV 204 (336)
T ss_dssp HHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCC
T ss_pred HHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCc
Confidence 9999863 23899999999999999999999999999987643221 11223458999999999987
Q ss_pred -----CCCCCcccchhHHHHHHHHHhCCccccccchhhhH------------HHHHHHHHHHhcCCcccccccchhcHHH
Q 038713 142 -----LPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRA------------ILQEWICQCFENGNLSQLVEDEEVDQKQ 204 (252)
Q Consensus 142 -----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (252)
..++.++||||||+++|+|++|..||......... ............+...............
T Consensus 205 ~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (336)
T 3g2f_A 205 NLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLA 284 (336)
T ss_dssp CGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHH
T ss_pred ccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccch
Confidence 34567899999999999999998887543221100 0001111111112222222222333445
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCCCC
Q 038713 205 LQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIPI 241 (252)
Q Consensus 205 ~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~~~ 241 (252)
...+.+++.+||+.||++|||+.|+++.|+++++.-.
T Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 285 VRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 6678999999999999999999999999999665443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=268.82 Aligned_cols=219 Identities=24% Similarity=0.312 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.|.+|+.++++++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.
T Consensus 73 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~--- 149 (319)
T 2y4i_B 73 LKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--- 149 (319)
T ss_dssp CCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 35577899999999999999999999999999999999999999999977666799999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCC----CcccccccCCccccccccccC---------CCCCCcccchh
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ----TRTFTGIRGTRAYVAAEWHRN---------LPITVKADVYS 152 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~---------~~~~~~~Di~s 152 (252)
+++|+||||+||+++ ++.++++|||.+....... ........|+..|+|||++.+ ..++.++||||
T Consensus 150 ~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~s 228 (319)
T 2y4i_B 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228 (319)
T ss_dssp TCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHH
T ss_pred CccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHH
Confidence 999999999999998 6789999999987543211 112223457889999999875 34788999999
Q ss_pred HHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 153 FGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 153 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
||+++|+|++|..||........ . .....+....... ... ...+.+++.+||+.||++|||+.++++.
T Consensus 229 lG~il~el~~g~~p~~~~~~~~~------~-~~~~~~~~~~~~~-~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 229 LGTIWYELHAREWPFKTQPAEAI------I-WQMGTGMKPNLSQ-IGM----GKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHHHHHHHHHSSCSSSSCCHHHH------H-HHHHTTCCCCCCC-SSC----CTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHH------H-HHhccCCCCCCCc-CCC----CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999986644321 1 1122222211111 111 2337788889999999999999999999
Q ss_pred hhcCcCCC
Q 038713 233 LEGTVEIP 240 (252)
Q Consensus 233 l~~~~~~~ 240 (252)
|+++.+..
T Consensus 297 l~~l~~~~ 304 (319)
T 2y4i_B 297 LEKLPKRN 304 (319)
T ss_dssp HTTC----
T ss_pred HHHHHHhh
Confidence 99976553
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=265.09 Aligned_cols=212 Identities=17% Similarity=0.292 Sum_probs=168.1
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+++.+|+.++++++||||+++++++.+.+..++||||+++++|.+++....+.+++..++.++.|++.||.|||+.
T Consensus 59 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-- 136 (302)
T 2j7t_A 59 ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK-- 136 (302)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC--
Confidence 467899999999999999999999999999999999999999999999876666799999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccc-----cCCCCCCcccchhHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWH-----RNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~-----~~~~~~~~~Di~slG~~l~~ 159 (252)
+++|+||+|+||+++.++.++++|||.+....... .......|+..|+|||++ .+..++.++|+||||+++|+
T Consensus 137 -~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 214 (302)
T 2j7t_A 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214 (302)
T ss_dssp -TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHH
T ss_pred -CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHH
Confidence 99999999999999999999999999875321111 111224578899999988 35678899999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|++|..||........ ...... +.......+... ...+.+++.+||+.||++|||+.++++
T Consensus 215 l~~g~~p~~~~~~~~~------~~~~~~-~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 215 MAQIEPPHHELNPMRV------LLKIAK-SDPPTLLTPSKW----SVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHSSCTTTTSCHHHH------HHHHHH-SCCCCCSSGGGS----CHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HhcCCCCCccCCHHHH------HHHHhc-cCCcccCCcccc----CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 9999999986543321 111112 222122222222 344788888999999999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=269.57 Aligned_cols=213 Identities=22% Similarity=0.256 Sum_probs=159.8
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+.
T Consensus 60 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~--- 135 (361)
T 3uc3_A 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSM--- 135 (361)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 46788999999999999999999999999999999999999999999954 34589999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCc--eEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCc-ccchhHHHHHHHHHh
Q 038713 86 QIIHGDIKPQNILMDEKRC--AKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVK-ADVYSFGVVLLEIVC 162 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++. ++++|||.++...... ......|++.|+|||++.+..++.+ +||||||+++|+|++
T Consensus 136 ~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 213 (361)
T 3uc3_A 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213 (361)
T ss_dssp TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHH
T ss_pred CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHh
Confidence 9999999999999987765 9999999987432221 2233468999999999988777655 899999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
|+.||......... ...+..... ..... ...... ...+.+++.+||+.||++|||+.|+++.
T Consensus 214 g~~Pf~~~~~~~~~--~~~~~~~~~-~~~~~-~~~~~~----s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 214 GAYPFEDPEEPRDY--RKTIQRILS-VKYSI-PDDIRI----SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp SSCSCC----CCCH--HHHHHHHHT-TCCCC-CTTSCC----CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCCCccHHHH--HHHHHHHhc-CCCCC-CCcCCC----CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 99999765432211 111112211 11111 111112 2347788889999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=264.58 Aligned_cols=213 Identities=26% Similarity=0.351 Sum_probs=165.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEec-CCcEEEEEecCCCCCHHhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFD-VSNKILVYDYMSNGSLVDVLFTPEK-QPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..++|.+|+.++++++||||+++++++.+ .+..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+.
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 136 (278)
T 1byg_A 57 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136 (278)
T ss_dssp --HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 46789999999999999999999998765 4578999999999999999965332 378899999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||||+||+++.++.++++|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 137 ---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 209 (278)
T 1byg_A 137 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209 (278)
T ss_dssp ---TCCCSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---CccccCCCcceEEEeCCCcEEEeeccccccccccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHh
Confidence 99999999999999999999999999987544322 12345778999999998889999999999999999998
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
|..||......... .....+..... +......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 210 ~g~~p~~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 210 FGRVPYPRIPLKDVV-------PRVEKGYKMDA------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp TSCCSCTTSCGGGHH-------HHHTTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHH-------HHHhcCCCCCC------cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 99999765443311 11222211111 1122345788888999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=262.80 Aligned_cols=216 Identities=22% Similarity=0.250 Sum_probs=167.2
Q ss_pred HHHHHHHHHHhCC---CCCCCcceeeeEecCC-----cEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHH
Q 038713 7 REFKTEMNAIGRT---HHRNPVRLLGYSFDVS-----NKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 7 ~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ 77 (252)
..+.+|+.+++++ +||||+++++++.... ..++||||+. |+|.+++.... ..+++..++.++.|++.||.
T Consensus 56 ~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~ 134 (308)
T 3g33_A 56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134 (308)
T ss_dssp HHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence 4677888887776 4999999999998755 4799999996 59999997654 34899999999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 157 (252)
|||+. +++|+||||+||+++.++.++|+|||.+........ .....|+..|+|||++.+..++.++||||||+++
T Consensus 135 ~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 209 (308)
T 3g33_A 135 FLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 209 (308)
T ss_dssp HHHHT---TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHH
T ss_pred HHHHC---CcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHH
Confidence 99999 999999999999999999999999999986543322 2345679999999999988999999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccc-----------c-----chhcHHHHHHHHHHHhhccCCCCC
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVE-----------D-----EEVDQKQLQRMIKVGLRCILDEPS 221 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~-----~~~~~~~~~~l~~li~~cl~~~p~ 221 (252)
|+|++|..||......... .. +.............. . .....+....+.+++.+||+.||+
T Consensus 210 ~~l~~g~~pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 286 (308)
T 3g33_A 210 AEMFRRKPLFCGNSEADQL--GK-IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPH 286 (308)
T ss_dssp HHTTTSSCSCCCSSHHHHH--HH-HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTT
T ss_pred HHHHhCCCCCCCCCHHHHH--HH-HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCc
Confidence 9999999999876544321 11 111111100000000 0 011122345578888899999999
Q ss_pred CCCCHHHHHH
Q 038713 222 LRRAMKKVLL 231 (252)
Q Consensus 222 ~Rps~~~i~~ 231 (252)
+|||+.|+++
T Consensus 287 ~R~t~~e~l~ 296 (308)
T 3g33_A 287 KRISAFRALQ 296 (308)
T ss_dssp TSCCHHHHHT
T ss_pred cCCCHHHHhc
Confidence 9999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=265.36 Aligned_cols=206 Identities=22% Similarity=0.232 Sum_probs=164.5
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..+.++.+|+..+.++ +||||+++++++.+.+..++||||+ +++|.+++......+++..++.++.|++.||.|||+.
T Consensus 98 ~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 176 (311)
T 3p1a_A 98 KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176 (311)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3455666777766655 9999999999999999999999999 7799999877667799999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||||+||+++.++.++|+|||.+........ .....|+..|+|||++.+ .++.++||||||+++|+|++
T Consensus 177 ---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~ 250 (311)
T 3p1a_A 177 ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVAC 250 (311)
T ss_dssp ---TEECCCCSGGGEEECGGGCEEECCCTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHH
T ss_pred ---CEecCCCCHHHEEECCCCCEEEccceeeeecccCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999876543322 223458999999999987 78999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|..|+...... .....+... ...+......+.+++.+||+.||++|||++|+++
T Consensus 251 g~~~~~~~~~~----------~~~~~~~~~-----~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 251 NMELPHGGEGW----------QQLRQGYLP-----PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TCCCCSSHHHH----------HHHTTTCCC-----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCCCccHH----------HHHhccCCC-----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 97776543211 111122111 1112223455888899999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=279.06 Aligned_cols=211 Identities=24% Similarity=0.336 Sum_probs=172.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|+.++++++||||+++++++.+.+..++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 68 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~- 145 (484)
T 3nyv_A 68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKN- 145 (484)
T ss_dssp SCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34678999999999999999999999999999999999999999999999654 4689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEe---cCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILM---DEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 84 ~~~i~h~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++||||||+||++ +.++.++|+|||.+....... ......|++.|+|||++.+ .++.++||||||+++|+|
T Consensus 146 --~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l 220 (484)
T 3nyv_A 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYIL 220 (484)
T ss_dssp --TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHH
T ss_pred --CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHH
Confidence 99999999999999 567889999999998765433 2233568999999999987 689999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||........ ......+........ .......+.+++.+||+.||++|||+.|+++
T Consensus 221 l~g~~pf~~~~~~~~-------~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 221 LSGCPPFNGANEYDI-------LKKVEKGKYTFELPQ---WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHSSCSSCCSSHHHH-------HHHHHHCCCCCCSGG---GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHCCCCCCCCCHHHH-------HHHHHcCCCCCCCcc---cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 999999987644321 122223332221111 1122344778888999999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=277.60 Aligned_cols=213 Identities=20% Similarity=0.189 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
.+.+.+|..++..++||||+++++++.+.+.+|+||||++||+|.+++.+....+++..++.++.||+.||.|||+.
T Consensus 105 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--- 181 (412)
T 2vd5_A 105 VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL--- 181 (412)
T ss_dssp GCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 34588999999999999999999999999999999999999999999976556789999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc-------CCCCCCcccchhHHHHHH
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-------NLPITVKADVYSFGVVLL 158 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~~Di~slG~~l~ 158 (252)
+++||||||+||+++.++.++|+|||+++..............||+.|+|||++. +..++.++|+||||+++|
T Consensus 182 giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvily 261 (412)
T 2vd5_A 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAY 261 (412)
T ss_dssp TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHH
T ss_pred CeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHH
Confidence 9999999999999999999999999999876544433333457899999999987 346899999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLR---RAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---ps~~~i~~ 231 (252)
+|++|+.||......... ...+ .....-... ..+......+.++|.+||. +|.+| |+++|+++
T Consensus 262 elltG~~Pf~~~~~~~~~--~~i~-~~~~~~~~p------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 262 EMFYGQTPFYADSTAETY--GKIV-HYKEHLSLP------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHSSCTTCCSSHHHHH--HHHH-THHHHCCCC----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHhCCCCCCCCCHHHHH--HHHH-hcccCcCCC------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 999999999876443321 1111 100101110 0011223457788889999 99998 58998875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=268.96 Aligned_cols=218 Identities=24% Similarity=0.275 Sum_probs=171.6
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
+.+.+|+.++++++||||+++++++.+.+..++||||+++ +|.+++......+++..++.++.|++.||.|||+. +
T Consensus 57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ 132 (346)
T 1ua2_A 57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---W 132 (346)
T ss_dssp THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 4688999999999999999999999999999999999975 89999977777789999999999999999999999 9
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhCCc
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
++|+||||+||+++.++.++++|||.+........ ......++..|+|||++.+. .++.++||||||+++|+|++|..
T Consensus 133 ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 211 (346)
T 1ua2_A 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211 (346)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EECCCCCHHHEEEcCCCCEEEEecccceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999999999999999999999986543322 22335678999999998764 47899999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcC---Cccccccc--------------chhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENG---NLSQLVED--------------EEVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
||........ +..... ..... .+...... ..........+.+++.+||+.||++|||+.|
T Consensus 212 ~~~~~~~~~~--~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 288 (346)
T 1ua2_A 212 FLPGDSDLDQ--LTRIFE-TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 288 (346)
T ss_dssp SSCCSSHHHH--HHHHHH-HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred CCCCCCHHHH--HHHHHH-HcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHH
Confidence 9876644322 111111 11110 01000000 0011222356888899999999999999999
Q ss_pred HHHH
Q 038713 229 VLLM 232 (252)
Q Consensus 229 i~~~ 232 (252)
+++.
T Consensus 289 ll~h 292 (346)
T 1ua2_A 289 ALKM 292 (346)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9873
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=264.68 Aligned_cols=220 Identities=20% Similarity=0.266 Sum_probs=165.8
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.++.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 53 ~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~- 130 (316)
T 2ac3_A 53 IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNK- 130 (316)
T ss_dssp CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 467899999999985 8999999999999999999999999999999999643 4689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCc---eEEcccCcccccCCCCC------cccccccCCccccccccccC-----CCCCCccc
Q 038713 84 EAQIIHGDIKPQNILMDEKRC---AKISDFGLAKLMKPDQT------RTFTGIRGTRAYVAAEWHRN-----LPITVKAD 149 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~-----~~~~~~~D 149 (252)
+++|+||||+||+++.++. ++++|||.+........ .......|+..|+|||++.+ ..++.++|
T Consensus 131 --~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 208 (316)
T 2ac3_A 131 --GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCD 208 (316)
T ss_dssp --TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHH
T ss_pred --CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccc
Confidence 9999999999999998776 99999999875532211 11123458999999999875 45789999
Q ss_pred chhHHHHHHHHHhCCccccccchhhh--------HHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCC
Q 038713 150 VYSFGVVLLEIVCLRRCLDQNLLEDR--------AILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPS 221 (252)
Q Consensus 150 i~slG~~l~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 221 (252)
|||||+++|+|++|..||......+. .............+...... .........+.+++.+||+.||+
T Consensus 209 iwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~ 285 (316)
T 2ac3_A 209 LWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD---KDWAHISCAAKDLISKLLVRDAK 285 (316)
T ss_dssp HHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCH---HHHTTSCHHHHHHHHHHSCSSTT
T ss_pred cHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCc---hhcccCCHHHHHHHHHHhhCChh
Confidence 99999999999999999976532210 00001111222223221110 00111234578888899999999
Q ss_pred CCCCHHHHHH
Q 038713 222 LRRAMKKVLL 231 (252)
Q Consensus 222 ~Rps~~~i~~ 231 (252)
+|||+.|+++
T Consensus 286 ~Rps~~e~l~ 295 (316)
T 2ac3_A 286 QRLSAAQVLQ 295 (316)
T ss_dssp TSCCHHHHHH
T ss_pred hCCCHHHHhc
Confidence 9999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=274.49 Aligned_cols=220 Identities=22% Similarity=0.249 Sum_probs=163.9
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecC------CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDV------SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l 76 (252)
....+++.+|+.+++.++||||+++++++... ...|+||||+++ +|.+.+.. .+++..++.++.||+.||
T Consensus 102 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL 177 (464)
T 3ttj_A 102 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGI 177 (464)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHH
Confidence 34577899999999999999999999999754 457999999966 57777743 388999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHH
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVV 156 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~ 156 (252)
.|||+. +++||||||+||+++.++.++|+|||+++...... ......|+..|+|||++.+..++.++|||||||+
T Consensus 178 ~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 252 (464)
T 3ttj_A 178 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252 (464)
T ss_dssp HHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred HHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHH
Confidence 999999 99999999999999999999999999998654322 2234568999999999999999999999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHH----------------HHHHHhcCCc-cc-----ccc------cchhcHHHHHHH
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEW----------------ICQCFENGNL-SQ-----LVE------DEEVDQKQLQRM 208 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~-~~-----~~~------~~~~~~~~~~~l 208 (252)
+|+|++|+.||.+....+....... .......... .. ... ...........+
T Consensus 253 l~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 332 (464)
T 3ttj_A 253 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 332 (464)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHH
Confidence 9999999999987654432211100 0000000000 00 000 001111224568
Q ss_pred HHHHhhccCCCCCCCCCHHHHHH
Q 038713 209 IKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 209 ~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.+++.+||..||++|||++|+++
T Consensus 333 ~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 333 RDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCChhhCCCHHHHhc
Confidence 88999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=270.16 Aligned_cols=216 Identities=19% Similarity=0.321 Sum_probs=170.7
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD- 81 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~- 81 (252)
...++.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.|++.||.|||+
T Consensus 72 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~ 150 (360)
T 3eqc_A 72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK 150 (360)
T ss_dssp HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 455788999999999999999999999999999999999999999999999543 458999999999999999999998
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
. +++|+||||+||+++.++.++|+|||.+....... .....|+..|+|||++.+..++.++||||||+++|+|+
T Consensus 151 ~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 224 (360)
T 3eqc_A 151 H---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224 (360)
T ss_dssp H---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHH
T ss_pred C---CEEcCCccHHHEEECCCCCEEEEECCCCccccccc---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 5 89999999999999999999999999987543221 12346789999999999989999999999999999999
Q ss_pred hCCccccccchhhhHHHH------------------------------------HHHHHHHhcCCcccccccchhcHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQ------------------------------------EWICQCFENGNLSQLVEDEEVDQKQL 205 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (252)
+|..||............ +....... +..... . .....
T Consensus 225 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~----~~~~~ 298 (360)
T 3eqc_A 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVN-EPPPKL-P----SGVFS 298 (360)
T ss_dssp HTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHH-SCCCCC-C----TTTSC
T ss_pred hCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhc-cCCCCC-C----ccccc
Confidence 999999865444321111 00000111 111000 0 01123
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 206 QRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 206 ~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
..+.+++.+||+.||++|||++|+++
T Consensus 299 ~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 299 LEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 35788888999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=276.45 Aligned_cols=210 Identities=24% Similarity=0.324 Sum_probs=169.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++||||+++++++.+.+..++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 64 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-- 140 (486)
T 3mwu_A 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKH-- 140 (486)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4678999999999999999999999999999999999999999999988543 4689999999999999999999999
Q ss_pred CCeeeeccCCCCEEec---CCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMD---EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 85 ~~i~h~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++||||||+||+++ .++.++|+|||.+....... ......|++.|+|||++.+ .++.++||||||+++|+|+
T Consensus 141 -~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll 216 (486)
T 3mwu_A 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL 216 (486)
T ss_dssp -TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHH
T ss_pred -CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHH
Confidence 999999999999995 45679999999998654332 2233568999999999987 5899999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||........ . .....+........ .......+.+++.+||+.||++|||+.|+++
T Consensus 217 ~g~~pf~~~~~~~~------~-~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 217 SGTPPFYGKNEYDI------L-KRVETGKYAFDLPQ---WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HSSCSSCCSSHHHH------H-HHHHHTCCCSCSGG---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hCCCCCCCCCHHHH------H-HHHHhCCCCCCCcc---cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 99999976644321 1 12222332221111 1122344778888999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=261.71 Aligned_cols=209 Identities=23% Similarity=0.345 Sum_probs=172.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. +.+++..++.++.|++.||.|||+.
T Consensus 62 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~- 138 (303)
T 3a7i_A 62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE- 138 (303)
T ss_dssp TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3467899999999999999999999999999999999999999999999953 4689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+........ ......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 139 --~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 215 (303)
T 3a7i_A 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215 (303)
T ss_dssp --TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred --CCccCCCChheEEECCCCCEEEeecccceecCcccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccC
Confidence 999999999999999999999999999976654332 22335678899999999988899999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
..||......... .....+...... ... ...+.+++.+||+.||++|||+.++++
T Consensus 216 ~~p~~~~~~~~~~-------~~~~~~~~~~~~--~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 216 EPPHSELHPMKVL-------FLIPKNNPPTLE--GNY----SKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp SCTTTTSCHHHHH-------HHHHHSCCCCCC--SSC----CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCCCcCHHHHH-------HHhhcCCCCCCc--ccc----CHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 9999765433211 111112211111 112 234788888999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=266.64 Aligned_cols=218 Identities=18% Similarity=0.227 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEec--------CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFD--------VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
...+.+|+.++++++||||+++++++.. .+..++||||+++ +|.+.+......+++..++.++.|++.||.
T Consensus 60 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~ 138 (351)
T 3mi9_A 60 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138 (351)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence 4578899999999999999999999986 4468999999965 888888777777999999999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC---cccccccCCccccccccccCC-CCCCcccchhH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT---RTFTGIRGTRAYVAAEWHRNL-PITVKADVYSF 153 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~sl 153 (252)
|||+. +++|+||||+||+++.++.++|+|||.+........ .......|+..|+|||++.+. .++.++|||||
T Consensus 139 ~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 215 (351)
T 3mi9_A 139 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 215 (351)
T ss_dssp HHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHH
T ss_pred HHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHH
Confidence 99999 999999999999999999999999999986543221 222345678999999998764 57999999999
Q ss_pred HHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccc----------------hhcH------HHHHHHHHH
Q 038713 154 GVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDE----------------EVDQ------KQLQRMIKV 211 (252)
Q Consensus 154 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~------~~~~~l~~l 211 (252)
|+++|+|++|..||........... +......-.. ...... .... .....+.++
T Consensus 216 G~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 291 (351)
T 3mi9_A 216 GCIMAEMWTRSPIMQGNTEQHQLAL---ISQLCGSITP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 291 (351)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCT-TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCh-hhccccccchhhcccccccccccCHHHHhhhccCChHHHHH
Confidence 9999999999999987654433222 1111111110 000000 0000 012447788
Q ss_pred HhhccCCCCCCCCCHHHHHH
Q 038713 212 GLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 212 i~~cl~~~p~~Rps~~~i~~ 231 (252)
+.+||+.||++|||++|+++
T Consensus 292 i~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 292 IDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhcCChhhCCCHHHHhC
Confidence 99999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=270.88 Aligned_cols=226 Identities=14% Similarity=0.171 Sum_probs=175.3
Q ss_pred HHHHHHHHHHhCCCCCCCcc---------------eeeeEec-CCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHH
Q 038713 7 REFKTEMNAIGRTHHRNPVR---------------LLGYSFD-VSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIA 69 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~---------------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~ 69 (252)
+.+.+|++++++++||||++ +++++.. .+..++||||+ +++|.+++... ...+++..++.++
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~ 165 (352)
T 2jii_A 87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA 165 (352)
T ss_dssp STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHH
Confidence 45889999999999999887 6677765 77889999999 99999999754 3679999999999
Q ss_pred HHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCC--ceEEcccCcccccCCCCC------cccccccCCccccccccccC
Q 038713 70 RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKR--CAKISDFGLAKLMKPDQT------RTFTGIRGTRAYVAAEWHRN 141 (252)
Q Consensus 70 ~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~--~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~ 141 (252)
.||+.||.|||+. +++|+||||+||+++.++ .++|+|||.++....... .......|+..|+|||++.+
T Consensus 166 ~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 166 CRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp HHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 9999999999999 999999999999999988 899999999976543221 11133468999999999999
Q ss_pred CCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCC
Q 038713 142 LPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPS 221 (252)
Q Consensus 142 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 221 (252)
..++.++||||||+++|+|++|+.||......... +......... ..................+.+++.+||+.||+
T Consensus 243 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 319 (352)
T 2jii_A 243 CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED-IMKQKQKFVD--KPGPFVGPCGHWIRPSETLQKYLKVVMALTYE 319 (352)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH-HHHHHHHHHH--SCCCEECTTSCEECCCHHHHHHHHHHHTCCTT
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH-HHHHHHhccC--ChhhhhhhccccCCCcHHHHHHHHHHHhCChh
Confidence 88999999999999999999999999876433222 2121111111 11111111100111124478888899999999
Q ss_pred CCCCHHHHHHHhhcCcCC
Q 038713 222 LRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 222 ~Rps~~~i~~~l~~~~~~ 239 (252)
+|||+.++++.|+++++.
T Consensus 320 ~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 320 EKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp CCCCHHHHHHHHHHHHHH
T ss_pred hCCCHHHHHHHHHHHHHh
Confidence 999999999999986543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=277.05 Aligned_cols=210 Identities=23% Similarity=0.344 Sum_probs=169.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.
T Consensus 79 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~-- 155 (494)
T 3lij_A 79 SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKH-- 155 (494)
T ss_dssp TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4567899999999999999999999999999999999999999999988543 4589999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCC---CceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEK---RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++||||||+||+++.. +.++++|||.+....... ......|++.|+|||++.+ .++.++||||+|+++|+|+
T Consensus 156 -~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll 231 (494)
T 3lij_A 156 -NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILL 231 (494)
T ss_dssp -TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHH
T ss_pred -CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHH
Confidence 99999999999999764 459999999998765332 2233568999999999875 6899999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||........ . .....+........ .......+.+++.+||+.||++|||+.|+++
T Consensus 232 ~g~~pf~~~~~~~~------~-~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 232 AGYPPFGGQTDQEI------L-RKVEKGKYTFDSPE---WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HSSCSSCCSSHHHH------H-HHHHHTCCCCCSGG---GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCCCCCCCHHHH------H-HHHHhCCCCCCchh---cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 99999987644321 1 12222222211111 1122344778888999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=273.86 Aligned_cols=210 Identities=19% Similarity=0.239 Sum_probs=169.6
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
+.+.+|+.+++.++||||+++++++.+.+.+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||+. +
T Consensus 114 ~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~---g 188 (410)
T 3v8s_A 114 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM---G 188 (410)
T ss_dssp STHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 4478999999999999999999999999999999999999999999954 3589999999999999999999999 9
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC----CCCcccchhHHHHHHHHHh
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP----ITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~~l~~l~~ 162 (252)
++||||||+||+++.++.++|+|||.++..............||+.|+|||++.+.. ++.++|+||||+++|+|++
T Consensus 189 ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~ 268 (410)
T 3v8s_A 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268 (410)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH
T ss_pred eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh
Confidence 999999999999999999999999999876544333334567899999999998765 7889999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSL--RRAMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~i~~ 231 (252)
|..||........ .. ................. ...+.++|.+||..+|++ ||+++||++
T Consensus 269 G~~Pf~~~~~~~~--~~----~i~~~~~~~~~p~~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 269 GDTPFYADSLVGT--YS----KIMNHKNSLTFPDDNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp SSCTTCCSSHHHH--HH----HHHTHHHHCCCCTTCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred CCCCCCCCChhhH--HH----HHHhccccccCCCcccc----cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 9999986543321 11 11111000001111112 234777888999999988 999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=265.87 Aligned_cols=214 Identities=21% Similarity=0.310 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhh------hcCC-CCCCCHHHHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDV------LFTP-EKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
.+.|.+|+.++++++||||+++++++.+.+..++||||+++|+|.++ +... ...+++..++.++.|++.||.|
T Consensus 87 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 166 (348)
T 2pml_X 87 YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSY 166 (348)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHH
Confidence 38899999999999999999999999999999999999999999998 6442 5679999999999999999999
Q ss_pred Hhh-cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCC-cccchhHHH
Q 038713 79 LHD-ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITV-KADVYSFGV 155 (252)
Q Consensus 79 lh~-~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~Di~slG~ 155 (252)
||+ . +++|+||+|+||+++.++.++++|||.+...... ......++..|+|||++.+. .++. ++|+||||+
T Consensus 167 lH~~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 240 (348)
T 2pml_X 167 IHNEK---NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240 (348)
T ss_dssp HHHTS---CEECCCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHH
T ss_pred HhccC---CEeecCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHH
Confidence 999 8 9999999999999999999999999999865433 23345688999999999887 5655 999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccc------------hhcHHHHHHHHHHHhhccCCCCCCC
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDE------------EVDQKQLQRMIKVGLRCILDEPSLR 223 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~l~~li~~cl~~~p~~R 223 (252)
++|+|++|..||........ .......+......... .........+.+++.+||+.||.+|
T Consensus 241 il~~l~~g~~pf~~~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 314 (348)
T 2pml_X 241 CLYVMFYNVVPFSLKISLVE------LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314 (348)
T ss_dssp HHHHHHHSSCSSCCSSCSHH------HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHHhCCCCCCCCCcHHH------HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhC
Confidence 99999999999986654211 11122222222111000 0012234557888889999999999
Q ss_pred CCHHHHHH
Q 038713 224 RAMKKVLL 231 (252)
Q Consensus 224 ps~~~i~~ 231 (252)
||+.|+++
T Consensus 315 ps~~e~l~ 322 (348)
T 2pml_X 315 ITSEDALK 322 (348)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999987
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=268.74 Aligned_cols=212 Identities=21% Similarity=0.260 Sum_probs=168.0
Q ss_pred HHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 8 EFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 8 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
.+.+|++++.++ +||||+++++++.+.+..++||||++||+|.+++... +.+++..++.++.||+.||.|||+. +
T Consensus 61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~---g 136 (342)
T 2qr7_A 61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQ---G 136 (342)
T ss_dssp CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 356789998888 8999999999999999999999999999999999654 4689999999999999999999999 9
Q ss_pred eeeeccCCCCEEecCC----CceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 87 IIHGDIKPQNILMDEK----RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 87 i~h~di~~~nil~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
++||||||+||++... +.++++|||.+........ ......|+..|+|||++.+..++.++|+||||+++|+|++
T Consensus 137 ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 215 (342)
T 2qr7_A 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT 215 (342)
T ss_dssp EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhc
Confidence 9999999999998543 3599999999986544322 2233567899999999988778999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|..||..........+. ..+..+...... .........+.+++.+||+.||++|||+.++++
T Consensus 216 g~~Pf~~~~~~~~~~~~----~~i~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 216 GYTPFANGPDDTPEEIL----ARIGSGKFSLSG---GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp SSCSSCSSTTSCHHHHH----HHHHHCCCCCCS---TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCCcCCHHHHH----HHHccCCcccCc---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999865333222222 222333332211 111222344778888999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.68 Aligned_cols=154 Identities=24% Similarity=0.377 Sum_probs=130.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEec-----CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFD-----VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
...+++.+|+.+|++++||||+++++++.. ...+|+||||+ +|+|.+++.. ...+++..++.++.||+.||.|
T Consensus 94 ~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~ 171 (458)
T 3rp9_A 94 IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKY 171 (458)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999843 46799999998 5799999964 4568999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--------------------------cccccccCCcc
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--------------------------RTFTGIRGTRA 132 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--------------------------~~~~~~~~~~~ 132 (252)
||+. +++||||||+|||++.++.++|+|||+++....... .......||..
T Consensus 172 LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 248 (458)
T 3rp9_A 172 VHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW 248 (458)
T ss_dssp HHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCT
T ss_pred HHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCccccc
Confidence 9999 999999999999999999999999999987643221 12234567999
Q ss_pred ccccccc-cCCCCCCcccchhHHHHHHHHHh
Q 038713 133 YVAAEWH-RNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 133 ~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
|+|||++ .+..++.++|||||||++|+|++
T Consensus 249 Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 249 YRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 9999986 45579999999999999999998
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=267.14 Aligned_cols=223 Identities=22% Similarity=0.287 Sum_probs=168.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..++.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.
T Consensus 66 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~- 143 (331)
T 4aaa_A 66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSH- 143 (331)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4467789999999999999999999999999999999999999988887754 34589999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||||+||+++.++.++|+|||.+........ ......++..|+|||++.+. .++.++||||||+++|+|++
T Consensus 144 --~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 220 (331)
T 4aaa_A 144 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220 (331)
T ss_dssp --TCCCCCCCGGGEEECTTSCEEECCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred --CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999976543222 22334578899999998875 68999999999999999999
Q ss_pred CCccccccchhhhHHHHHHH--------HHHHhc------CCccccccc---chhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 163 LRRCLDQNLLEDRAILQEWI--------CQCFEN------GNLSQLVED---EEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~--------~~~~~~------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
|+.||............... ...... ......... ..........+.+++.+||+.||++|||
T Consensus 221 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 300 (331)
T 4aaa_A 221 GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300 (331)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC
Confidence 99999876544322111000 000000 001111000 0111223456888999999999999999
Q ss_pred HHHHHH
Q 038713 226 MKKVLL 231 (252)
Q Consensus 226 ~~~i~~ 231 (252)
+.|+++
T Consensus 301 ~~ell~ 306 (331)
T 4aaa_A 301 CAELLH 306 (331)
T ss_dssp GGGGGG
T ss_pred HHHHhc
Confidence 999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=260.09 Aligned_cols=213 Identities=21% Similarity=0.336 Sum_probs=171.7
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEec----------------CCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHH
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFD----------------VSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIA 69 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~ 69 (252)
+.+.+|++++++++||||+++++++.. ....++||||+++|+|.+++... ...+++..++.++
T Consensus 49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~ 128 (284)
T 2a19_B 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128 (284)
T ss_dssp GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHH
Confidence 457899999999999999999998864 44579999999999999999643 3568999999999
Q ss_pred HHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCccc
Q 038713 70 RDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKAD 149 (252)
Q Consensus 70 ~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 149 (252)
.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+........ .....++..|+|||++.+..++.++|
T Consensus 129 ~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~D 203 (284)
T 2a19_B 129 EQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVD 203 (284)
T ss_dssp HHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHH
T ss_pred HHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhh
Confidence 9999999999999 999999999999999999999999999887654332 22345789999999999988999999
Q ss_pred chhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 150 VYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 150 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
+||||+++|+|++|..|+..... . . .....+.... ..+ ..+.+++.+||+.||++|||+.|+
T Consensus 204 i~slG~il~~l~~~~~~~~~~~~-----~---~-~~~~~~~~~~-----~~~----~~~~~li~~~l~~dp~~Rps~~e~ 265 (284)
T 2a19_B 204 LYALGLILAELLHVCDTAFETSK-----F---F-TDLRDGIISD-----IFD----KKEKTLLQKLLSKKPEDRPNTSEI 265 (284)
T ss_dssp HHHHHHHHHHHHSCCSSHHHHHH-----H---H-HHHHTTCCCT-----TSC----HHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hHHHHHHHHHHHhcCCcchhHHH-----H---H-HHhhcccccc-----cCC----HHHHHHHHHHccCChhhCcCHHHH
Confidence 99999999999999988753211 1 1 1122222211 112 346788889999999999999999
Q ss_pred HHHhhcCcCCCCC
Q 038713 230 LLMLEGTVEIPIP 242 (252)
Q Consensus 230 ~~~l~~~~~~~~~ 242 (252)
++.|+.....+..
T Consensus 266 l~~l~~~~~~~~~ 278 (284)
T 2a19_B 266 LRTLTVWKKSPEK 278 (284)
T ss_dssp HHHHHHHTC----
T ss_pred HHHHHHHhhCCCc
Confidence 9999987665543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=266.88 Aligned_cols=201 Identities=21% Similarity=0.241 Sum_probs=167.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCC-CHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNG-SLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|+.++++++||||+++++++.+.+..++||||+.+| +|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 73 ~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~-- 149 (335)
T 3dls_A 73 LGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLK-- 149 (335)
T ss_dssp TEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 446778999999999999999999999999999999998776 999999654 4589999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCC-CCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-TVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||||+||+++.++.++|+|||.+........ .....|+..|+|||++.+..+ +.++||||||+++|+|++|
T Consensus 150 -~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 226 (335)
T 3dls_A 150 -DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226 (335)
T ss_dssp -TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHS
T ss_pred -CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhC
Confidence 999999999999999999999999999987654322 233568999999999988776 7899999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
..||....... .... ..+.. ....+.+++.+||+.||++|||++++++.
T Consensus 227 ~~pf~~~~~~~-------------~~~~---~~~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 227 ENPFCELEETV-------------EAAI---HPPYL----VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SCSCSSGGGGT-------------TTCC---CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CCchhhHHHHH-------------hhcc---CCCcc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99997532211 0011 11111 22347788889999999999999999884
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=257.32 Aligned_cols=211 Identities=25% Similarity=0.364 Sum_probs=169.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-- 127 (283)
T 3bhy_A 51 SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSK-- 127 (283)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 367899999999999999999999999999999999999999999999954 34689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCC----ceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKR----CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++|+||+|+||+++.++ .++++|||.+........ .....++..|+|||++.+..++.++|+||||+++|+|
T Consensus 128 -~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 204 (283)
T 3bhy_A 128 -RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 204 (283)
T ss_dssp -TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred -CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHH
Confidence 999999999999998777 799999999986543222 2234578899999999988899999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||......... .......... +..........+.+++.+||+.||++|||+.++++
T Consensus 205 ~~g~~p~~~~~~~~~~-------~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 205 LSGASPFLGETKQETL-------TNISAVNYDF---DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHSSCTTCCSSHHHHH-------HHHHTTCCCC---CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHCCCCCCCcchHHHH-------HHhHhcccCC---cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 9999999865433211 1111111111 11111122345788888999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=272.83 Aligned_cols=221 Identities=22% Similarity=0.274 Sum_probs=166.9
Q ss_pred hHhHHHHHHHHHHHhCCC-CCCCcceeeeEecC--CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTH-HRNPVRLLGYSFDV--SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
....+++.+|+.+++.+. ||||+++++++... ...|+||||++ |+|.+++.. +.+++..+..++.||+.||.||
T Consensus 49 ~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~L 125 (388)
T 3oz6_A 49 STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYL 125 (388)
T ss_dssp HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 345677899999999996 99999999999754 47899999996 589998854 4689999999999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCC--------------------CcccccccCCccccccccc
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ--------------------TRTFTGIRGTRAYVAAEWH 139 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--------------------~~~~~~~~~~~~~~aPE~~ 139 (252)
|+. +++||||||+||+++.++.++++|||+++...... ........||..|+|||++
T Consensus 126 H~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (388)
T 3oz6_A 126 HSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL 202 (388)
T ss_dssp HHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHH
T ss_pred HhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHh
Confidence 999 99999999999999999999999999998653211 1112334689999999999
Q ss_pred cC-CCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCC----------------------------
Q 038713 140 RN-LPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGN---------------------------- 190 (252)
Q Consensus 140 ~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------- 190 (252)
.+ ..++.++|||||||++|+|++|+.||........... .. .......
T Consensus 203 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~--i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (388)
T 3oz6_A 203 LGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER--II-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQS 279 (388)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC----
T ss_pred cCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCC
Confidence 87 5689999999999999999999999987654432211 11 1110000
Q ss_pred -cccccccc-------hhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 191 -LSQLVEDE-------EVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 191 -~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
........ .........+.+++.+||+.||++|||++|+++.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 280 NKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp -CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 00000000 0000123457888889999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=277.09 Aligned_cols=210 Identities=24% Similarity=0.327 Sum_probs=171.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 89 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~-- 165 (504)
T 3q5i_A 89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKH-- 165 (504)
T ss_dssp THHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4678999999999999999999999999999999999999999999998543 4689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCC---ceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKR---CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++||||||+||+++.++ .++++|||.+....... ......|++.|+|||++.+ .++.++||||+|+++|+|+
T Consensus 166 -~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll 241 (504)
T 3q5i_A 166 -NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILL 241 (504)
T ss_dssp -TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHH
T ss_pred -CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHH
Confidence 999999999999998776 69999999998765432 2233568999999999875 6899999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||........ ......+....... ........+.+++.+||+.||.+|||++|+++
T Consensus 242 ~g~~pf~~~~~~~~-------~~~i~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 242 CGYPPFGGQNDQDI-------IKKVEKGKYYFDFN---DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HSSCSSCCSSHHHH-------HHHHHHCCCCCCHH---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCCCCCCCHHHH-------HHHHHcCCCCCCcc---ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999987644321 12222232221111 11112345788888999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=270.96 Aligned_cols=206 Identities=23% Similarity=0.241 Sum_probs=159.3
Q ss_pred hHHHHHHHHHH-HhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNA-IGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|..+ ++.++||||+++++++.+.+.+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||+.
T Consensus 81 ~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~- 158 (373)
T 2r5t_A 81 EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSL- 158 (373)
T ss_dssp ----------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 45567788887 5678999999999999999999999999999999999964 34688999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.+|.++|+|||+++....... ......|++.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 159 --givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 235 (373)
T 2r5t_A 159 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235 (373)
T ss_dssp --TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred --CceecCCCHHHEEECCCCCEEEeeCccccccccCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcC
Confidence 999999999999999999999999999976432221 22345689999999999998999999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKV 229 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i 229 (252)
..||........ ..... .+.... +.. ....+.+++.+||+.||++||++.+.
T Consensus 236 ~~Pf~~~~~~~~------~~~i~-~~~~~~---~~~----~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 236 LPPFYSRNTAEM------YDNIL-NKPLQL---KPN----ITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp SCTTCCSBHHHH------HHHHH-HSCCCC---CSS----SCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred CCCCCCCCHHHH------HHHHH-hcccCC---CCC----CCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 999976543321 11111 222211 111 22347788889999999999998643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=256.10 Aligned_cols=214 Identities=23% Similarity=0.365 Sum_probs=168.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEe--cCCcEEEEEecCCCCCHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSF--DVSNKILVYDYMSNGSLVDVLFT-PEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
+..+.+.+|+.++++++||||+++++++. +.+..++||||++++ |.+++.. ..+.+++..++.++.|++.||.|||
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH 126 (305)
T 2wtk_C 48 NGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126 (305)
T ss_dssp THHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999999984 456889999999876 7676643 4556899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCC--CCCcccchhHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLP--ITVKADVYSFGVVL 157 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l 157 (252)
+. +++|+||||+||+++.++.++++|||.+........ .......|+..|+|||++.+.. .+.++|+||||+++
T Consensus 127 ~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 203 (305)
T 2wtk_C 127 SQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203 (305)
T ss_dssp HT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHH
T ss_pred HC---CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHH
Confidence 99 999999999999999999999999999987643222 2233456899999999988654 37799999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEG 235 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~ 235 (252)
|+|++|..||........ ...+..+.... +......+.+++.+||+.||++|||+.|+++ .+++
T Consensus 204 ~~l~~g~~p~~~~~~~~~-------~~~i~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 204 YNITTGLYPFEGDNIYKL-------FENIGKGSYAI-------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp HHHHHSSCSCCCSSHHHH-------HHHHHHCCCCC-------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred HHHHhCCCCCCCchHHHH-------HHHHhcCCCCC-------CCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 999999999986543321 11222222211 1112234778888999999999999999996 4555
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=264.51 Aligned_cols=220 Identities=20% Similarity=0.236 Sum_probs=170.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecC------CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDV------SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
...+++.+|+.+++.++||||+++++++... ...++||||+ +++|.+++.. ..+++..+..++.||+.||.
T Consensus 66 ~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~ 142 (367)
T 1cm8_A 66 LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLR 142 (367)
T ss_dssp HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHH
Confidence 3467899999999999999999999999865 3469999999 8899999864 45899999999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVV 156 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~ 156 (252)
|||+. +++||||||+||+++.++.++++|||.++..... .....++..|+|||++.+ ..++.++|+||+||+
T Consensus 143 ~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 215 (367)
T 1cm8_A 143 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCI 215 (367)
T ss_dssp HHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHH
T ss_pred HHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHH
Confidence 99999 9999999999999999999999999999875432 233467899999999887 578999999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHH-------------------HHhcCCcccccccchhcHHHHHHHHHHHhhccC
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQ-------------------CFENGNLSQLVEDEEVDQKQLQRMIKVGLRCIL 217 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 217 (252)
+|+|++|+.||......+.... .... ....-.......-..........+.+++.+||.
T Consensus 216 l~ell~g~~pf~~~~~~~~l~~--i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~ 293 (367)
T 1cm8_A 216 MAEMITGKTLFKGSDHLDQLKE--IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV 293 (367)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHH--HHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSC
T ss_pred HHHHHhCCCCCCCCCHHHHHHH--HHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHcc
Confidence 9999999999986644332111 1100 000000000000001111223457888889999
Q ss_pred CCCCCCCCHHHHHH--Hhhc
Q 038713 218 DEPSLRRAMKKVLL--MLEG 235 (252)
Q Consensus 218 ~~p~~Rps~~~i~~--~l~~ 235 (252)
.||++|||++|+++ .+++
T Consensus 294 ~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 294 LDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp SSTTTSCCHHHHHHSGGGTT
T ss_pred CChhHCCCHHHHhcChHHHh
Confidence 99999999999988 4554
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=257.02 Aligned_cols=207 Identities=22% Similarity=0.357 Sum_probs=163.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 54 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~-- 130 (276)
T 2h6d_A 54 VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRH-- 130 (276)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3568899999999999999999999999999999999999999999999543 4589999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCC-CCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-TVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||+|+||+++.++.++++|||.+........ .....++..|+|||.+.+..+ +.++|+||||+++|+|++|
T Consensus 131 -~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 207 (276)
T 2h6d_A 131 -MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207 (276)
T ss_dssp -CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHS
T ss_pred -CCccCCCChhhEEECCCCCEEEeecccccccCCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhC
Confidence 999999999999999999999999999886543221 223457889999999988765 6899999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
..||....... . . .....+.... +.. ....+.+++.+||+.||++|||+.++++
T Consensus 208 ~~p~~~~~~~~---~---~-~~~~~~~~~~---~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 208 TLPFDDEHVPT---L---F-KKIRGGVFYI---PEY----LNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp SCSSCCSSHHH---H---H-HHHHHCCCCC---CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcHHH---H---H-HHhhcCcccC---chh----cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 99997654332 1 1 1122222111 111 2234778888999999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=269.74 Aligned_cols=213 Identities=20% Similarity=0.230 Sum_probs=162.0
Q ss_pred HHHHHHHHHHh-CCCCCCCcceeeeEec----CCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHh
Q 038713 7 REFKTEMNAIG-RTHHRNPVRLLGYSFD----VSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 7 ~~~~~E~~~l~-~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
..+.+|+.++. ..+||||+++++++.. .+.+++||||++||+|.+++.... ..+++..++.++.||+.||.|||
T Consensus 99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH 178 (400)
T 1nxk_A 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178 (400)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45778999874 4599999999999875 567899999999999999997643 46899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecC---CCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDE---KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 157 (252)
+. +++||||||+||+++. ++.++|+|||+++...... ......|+..|+|||++.+..++.++||||||+++
T Consensus 179 ~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 253 (400)
T 1nxk_A 179 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253 (400)
T ss_dssp HT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHH
T ss_pred HC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHH
Confidence 99 9999999999999997 7889999999998654322 22335678999999999998999999999999999
Q ss_pred HHHHhCCccccccchhhhH-HHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRA-ILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|+|++|..||......... .. ......+........ .......+.+++.+||+.||++|||+.|+++
T Consensus 254 ~ell~g~~pf~~~~~~~~~~~~----~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 254 YILLCGYPPFYSNHGLAISPGM----KTRIRMGQYEFPNPE---WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp HHHHHSSCSCCCCTTCSSCCSH----HHHHHHTCCCCCTTT---TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCCccccccHHH----HHHHHcCcccCCCcc---cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999999999765332110 01 111122222211111 1122344778888999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=267.03 Aligned_cols=218 Identities=18% Similarity=0.199 Sum_probs=160.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++||||+++++++.+.+..++||||++ |+|.+++... ..+++..++.++.||+.||.|||+.
T Consensus 76 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~-- 151 (329)
T 3gbz_A 76 VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSR-- 151 (329)
T ss_dssp ----CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred cchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 35678899999999999999999999999999999999997 5999999644 3589999999999999999999999
Q ss_pred CCeeeeccCCCCEEec-----CCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHH
Q 038713 85 AQIIHGDIKPQNILMD-----EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLL 158 (252)
Q Consensus 85 ~~i~h~di~~~nil~~-----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~ 158 (252)
+++|+||||+||+++ ..+.++|+|||.+........ ......++..|+|||++.+. .++.++||||||+++|
T Consensus 152 -~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 229 (329)
T 3gbz_A 152 -RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWA 229 (329)
T ss_dssp -TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred -CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHH
Confidence 999999999999994 445599999999986543322 22334578899999999875 4899999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcc------------ccccc-c------hhcHHHHHHHHHHHhhccCCC
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLS------------QLVED-E------EVDQKQLQRMIKVGLRCILDE 219 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~-~------~~~~~~~~~l~~li~~cl~~~ 219 (252)
+|++|..||......+. +..... ........ ..... . .........+.+++.+||+.|
T Consensus 230 ell~g~~pf~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 306 (329)
T 3gbz_A 230 EMLMKTPLFPGDSEIDQ--LFKIFE-VLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMD 306 (329)
T ss_dssp HHHHSSCSSCCSSHHHH--HHHHHH-HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSS
T ss_pred HHHHCCCCcCCCCHHHH--HHHHHH-HhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCC
Confidence 99999999987644332 111111 11100000 00000 0 001112355788888999999
Q ss_pred CCCCCCHHHHHH
Q 038713 220 PSLRRAMKKVLL 231 (252)
Q Consensus 220 p~~Rps~~~i~~ 231 (252)
|++|||++|+++
T Consensus 307 P~~R~t~~e~l~ 318 (329)
T 3gbz_A 307 PVKRISAKNALE 318 (329)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhC
Confidence 999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=264.47 Aligned_cols=218 Identities=23% Similarity=0.339 Sum_probs=160.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC-------CCCCCCHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT-------PEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l 76 (252)
...+++.+|+.++++++||||+++++++...+..++||||+++|+|.+++.. ....+++..++.++.|++.||
T Consensus 55 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 134 (303)
T 2vwi_A 55 TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134 (303)
T ss_dssp -----------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999853 345689999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC----cccccccCCccccccccccC-CCCCCcccch
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT----RTFTGIRGTRAYVAAEWHRN-LPITVKADVY 151 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~ 151 (252)
.|||+. +++|+||+|+||+++.++.++++|||.+........ .......|+..|+|||++.+ ..++.++|+|
T Consensus 135 ~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 211 (303)
T 2vwi_A 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 211 (303)
T ss_dssp HHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHH
T ss_pred HHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHH
Confidence 999999 999999999999999999999999999876543221 11223457889999999876 4689999999
Q ss_pred hHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccc---cchhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 152 SFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVE---DEEVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 152 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
|||+++|+|++|..||.......... .... +....... ...........+.+++.+||+.||++|||+.+
T Consensus 212 slG~il~~l~~g~~pf~~~~~~~~~~------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 284 (303)
T 2vwi_A 212 SFGITAIELATGAAPYHKYPPMKVLM------LTLQ-NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284 (303)
T ss_dssp HHHHHHHHHHHSSCTTTTSCGGGHHH------HHHT-SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHHHHHHhCCCCCccCchhhHHH------HHhc-cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999999999998764443211 1111 11111110 00111122345788888999999999999999
Q ss_pred HHH
Q 038713 229 VLL 231 (252)
Q Consensus 229 i~~ 231 (252)
+++
T Consensus 285 ll~ 287 (303)
T 2vwi_A 285 LLR 287 (303)
T ss_dssp HHT
T ss_pred Hhh
Confidence 986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=263.50 Aligned_cols=220 Identities=22% Similarity=0.286 Sum_probs=169.7
Q ss_pred HhHHHHHHHHHHHhCCC-----CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTH-----HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ 77 (252)
...+.+.+|+.+++.++ ||||+++++++...+..++||||+ +++|.+++.... ..+++..++.++.||+.||.
T Consensus 73 ~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 151 (360)
T 3llt_A 73 KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151 (360)
T ss_dssp HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 44667889999999986 999999999999999999999999 999999996543 45899999999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecC-------------------------CCceEEcccCcccccCCCCCcccccccCCcc
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDE-------------------------KRCAKISDFGLAKLMKPDQTRTFTGIRGTRA 132 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~-------------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 132 (252)
|||+. +++||||||+||+++. ++.++|+|||.+....... ....|+..
T Consensus 152 ~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~ 224 (360)
T 3llt_A 152 YLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQ 224 (360)
T ss_dssp HHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGG
T ss_pred HHHHC---CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCccc
Confidence 99999 9999999999999975 7889999999998644322 23467999
Q ss_pred ccccccccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHH---------HHHHhcC--------Cccccc
Q 038713 133 YVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWI---------CQCFENG--------NLSQLV 195 (252)
Q Consensus 133 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~--------~~~~~~ 195 (252)
|+|||++.+..++.++||||||+++|+|++|+.||......+........ ....... ......
T Consensus 225 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (360)
T 3llt_A 225 YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAW 304 (360)
T ss_dssp GCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECT
T ss_pred ccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecC
Confidence 99999999999999999999999999999999999876444322211110 0000000 000000
Q ss_pred ccch---------------hcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 196 EDEE---------------VDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 196 ~~~~---------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.... ........+.+++.+||+.||++|||++|+++
T Consensus 305 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 305 PENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp TTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00001145778999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=259.23 Aligned_cols=214 Identities=22% Similarity=0.333 Sum_probs=171.2
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~-- 125 (304)
T 2jam_A 49 RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHEN-- 125 (304)
T ss_dssp ---HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3467899999999999999999999999999999999999999999998543 4589999999999999999999999
Q ss_pred CCeeeeccCCCCEEe---cCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILM---DEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 85 ~~i~h~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||+|+||++ +.++.++++|||.+...... ......|+..|+|||++.+..++.++|+||||+++|+|+
T Consensus 126 -~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 201 (304)
T 2jam_A 126 -GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201 (304)
T ss_dssp -TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHH
T ss_pred -CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999 67889999999998754322 222345789999999999988999999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEG 235 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~ 235 (252)
+|..||....... .. .....+...... .........+.+++.+||+.||++|||+.|+++ .+++
T Consensus 202 ~g~~pf~~~~~~~---~~----~~i~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 202 CGYPPFYEETESK---LF----EKIKEGYYEFES---PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp HSSCTTTTSCHHH---HH----HHHHHCCCCCCT---TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred HCCCCCCCCCHHH---HH----HHHHcCCCCCCc---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 9999997654332 11 112222221111 111122345788888999999999999999986 4544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=260.94 Aligned_cols=213 Identities=21% Similarity=0.289 Sum_probs=169.7
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
.++.+.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++... .+.+++..++.++.|++.||.|||+.
T Consensus 71 ~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~ 150 (327)
T 3lm5_A 71 CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150 (327)
T ss_dssp CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 467899999999999 6799999999999999999999999999999998653 46689999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecC---CCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDE---KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~ 159 (252)
+++|+||||+||+++. ++.++|+|||.+........ .....|++.|+|||++.+..++.++|+||||+++|+
T Consensus 151 ---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ 225 (327)
T 3lm5_A 151 ---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYM 225 (327)
T ss_dssp ---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred ---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHH
Confidence 9999999999999987 78999999999987643322 233568999999999999899999999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
|++|..||........... .......... .........+.+++.+||+.||++|||++++++.
T Consensus 226 ll~g~~pf~~~~~~~~~~~-------i~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 226 LLTHTSPFVGEDNQETYLN-------ISQVNVDYSE---ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHSSCSSCCSSHHHHHHH-------HHHTCCCCCT---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHhCCCCCCCCCchHHHHH-------HHhcccccCc---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 9999999977644432111 1111111111 1111223447788889999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=273.29 Aligned_cols=159 Identities=22% Similarity=0.310 Sum_probs=133.6
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecC-----CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDV-----SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
...+++.+|+.++++++||||+++++++... +..|+||||++ |+|.+++.. ...+++..++.++.||+.||.|
T Consensus 67 ~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~ 144 (432)
T 3n9x_A 67 IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENF 144 (432)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999999765 67999999995 599999964 4468999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc---------------------ccccccCCccccccc
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR---------------------TFTGIRGTRAYVAAE 137 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---------------------~~~~~~~~~~~~aPE 137 (252)
||+. +++||||||+||+++.++.++|+|||+++........ ......||..|+|||
T Consensus 145 LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 221 (432)
T 3n9x_A 145 IHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE 221 (432)
T ss_dssp HHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHH
T ss_pred HHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHH
Confidence 9999 9999999999999999999999999999876433211 124456899999999
Q ss_pred cc-cCCCCCCcccchhHHHHHHHHHhCCccc
Q 038713 138 WH-RNLPITVKADVYSFGVVLLEIVCLRRCL 167 (252)
Q Consensus 138 ~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~ 167 (252)
++ .+..++.++|||||||++|+|++|..||
T Consensus 222 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 222 LILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred HHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 86 4556999999999999999999854444
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=278.14 Aligned_cols=211 Identities=24% Similarity=0.273 Sum_probs=172.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|+.++++++||||+++++++.+.+..++||||++||+|.+++.... ..+++..++.++.||+.||.|||+.
T Consensus 227 ~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~- 305 (576)
T 2acx_A 227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE- 305 (576)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 45678999999999999999999999999999999999999999999996643 4589999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.+|.++|+|||++........ .....|++.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 306 --gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG 381 (576)
T 2acx_A 306 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381 (576)
T ss_dssp --TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHS
T ss_pred --CEeccCCchheEEEeCCCCeEEEecccceecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhC
Confidence 999999999999999999999999999987643322 2335689999999999998899999999999999999999
Q ss_pred Cccccccchhh-hHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 164 RRCLDQNLLED-RAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
..||....... ...+. ......... .+......+.+++.+||+.||++|| +++|+++
T Consensus 382 ~~PF~~~~~~~~~~~i~----~~i~~~~~~-------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 382 QSPFQQRKKKIKREEVE----RLVKEVPEE-------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp SCSSSCSSSCCCHHHHH----HHHHHCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CCCCcccccchhHHHHH----HHhhccccc-------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 99998654321 11111 112222111 1112234578888899999999999 7888874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=257.96 Aligned_cols=213 Identities=23% Similarity=0.277 Sum_probs=166.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE--KQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
...+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++.... ...++..++.++.|++.||.|||+
T Consensus 61 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 140 (295)
T 2clq_A 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140 (295)
T ss_dssp ---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh
Confidence 346789999999999999999999999999999999999999999999996543 346788899999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecC-CCceEEcccCcccccCCCCCcccccccCCccccccccccCC--CCCCcccchhHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDE-KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL--PITVKADVYSFGVVLL 158 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~ 158 (252)
. +++|+||+|+||+++. ++.++++|||.+........ ......|+..|+|||++.+. .++.++|+||||+++|
T Consensus 141 ~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~ 216 (295)
T 2clq_A 141 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII 216 (295)
T ss_dssp T---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHH
T ss_pred C---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHH
Confidence 9 9999999999999987 89999999999986543221 12234678899999998764 3789999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|++|..||........... ..... ..... .+......+.+++.+||+.||++|||+.++++
T Consensus 217 ~l~~g~~pf~~~~~~~~~~~----~~~~~-~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 217 EMATGKPPFYELGEPQAAMF----KVGMF-KVHPE------IPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHTSCTTGGGSSHHHHHH----HHHHH-CCCCC------CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHCCCCccCCCchhHHHH----hhccc-ccccc------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999999975433321111 11111 11111 11222345778888999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=264.54 Aligned_cols=211 Identities=21% Similarity=0.309 Sum_probs=170.4
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.++.+.+|+.+++++ +||||+++++++...+..++||||++||+|.+++.. ...+++..++.++.||+.||.|||+.
T Consensus 142 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~- 219 (365)
T 2y7j_A 142 VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHAN- 219 (365)
T ss_dssp HHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 367789999999999 899999999999999999999999999999999964 34689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC------CCCCCcccchhHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN------LPITVKADVYSFGVVL 157 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Di~slG~~l 157 (252)
+++|+||||+||+++.++.++++|||.+....... ......|++.|+|||++.+ ..++.++||||||+++
T Consensus 220 --gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il 295 (365)
T 2y7j_A 220 --NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295 (365)
T ss_dssp --TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHH
T ss_pred --CeecCCCCHHHEEECCCCCEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHH
Confidence 99999999999999999999999999988665332 2233568999999999863 2578899999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|+|++|..||........ . .....+....... ........+.+++.+||+.||++|||+.++++
T Consensus 296 ~ell~g~~pf~~~~~~~~---~----~~i~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 296 FTLLAGSPPFWHRRQILM---L----RMIMEGQYQFSSP---EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHSSCSSCCSSHHHH---H----HHHHHTCCCCCHH---HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHCCCCCCCCCHHHH---H----HHHHhCCCCCCCc---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 999999999976533221 1 1122222211110 01112344788888999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=267.28 Aligned_cols=215 Identities=18% Similarity=0.164 Sum_probs=174.4
Q ss_pred HhHHHHHHHHHHHhCCC---CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC----CCCCCCHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTH---HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT----PEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l 76 (252)
...+.+.+|+++++.++ |+||+++++++...+..++||||+++|+|.+++.. ..+.+++..++.++.||+.||
T Consensus 106 ~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L 185 (365)
T 3e7e_A 106 ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185 (365)
T ss_dssp CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHH
T ss_pred CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHH
Confidence 34567889999998886 99999999999999999999999999999999964 456699999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecC-----------CCceEEcccCcccccCCC-CCcccccccCCccccccccccCCCC
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDE-----------KRCAKISDFGLAKLMKPD-QTRTFTGIRGTRAYVAAEWHRNLPI 144 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~-----------~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~ 144 (252)
.|||+. +++||||||+||+++. ++.++|+|||.++..... .........||..|+|||++.+..+
T Consensus 186 ~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 262 (365)
T 3e7e_A 186 EQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW 262 (365)
T ss_dssp HHHHTT---TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB
T ss_pred HHHhhC---CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC
Confidence 999999 9999999999999988 899999999999765322 2223344668999999999999889
Q ss_pred CCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCC-
Q 038713 145 TVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLR- 223 (252)
Q Consensus 145 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R- 223 (252)
+.++||||||+++|+|++|+.||........ ......... .....+.+++..|++.+|.+|
T Consensus 263 ~~~~DiwslG~il~elltg~~pf~~~~~~~~--------------~~~~~~~~~----~~~~~~~~~~~~~l~~~p~~r~ 324 (365)
T 3e7e_A 263 NYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--------------KPEGLFRRL----PHLDMWNEFFHVMLNIPDCHHL 324 (365)
T ss_dssp STHHHHHHHHHHHHHHHHSSCCCEEEETTEE--------------EECSCCTTC----SSHHHHHHHHHHHHCCCCTTCC
T ss_pred CccccHHHHHHHHHHHHhCCCccccCCCCce--------------eechhcccc----CcHHHHHHHHHHHcCCCCCCcc
Confidence 9999999999999999999999975533210 011111111 112345667779999999998
Q ss_pred CCHHHHHHHhhcCcCC
Q 038713 224 RAMKKVLLMLEGTVEI 239 (252)
Q Consensus 224 ps~~~i~~~l~~~~~~ 239 (252)
|++.++.+.|++.++.
T Consensus 325 ~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 325 PSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp CCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHH
Confidence 6788888888876554
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=263.48 Aligned_cols=213 Identities=21% Similarity=0.327 Sum_probs=162.8
Q ss_pred hHhHHHHHHHHHHHhCCCC--CCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 3 AEGEREFKTEMNAIGRTHH--RNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
.+..+.+.+|+.++++++| |||+++++++.+.+..++|||+ .+|+|.+++.. .+.+++..++.++.||+.||.|||
T Consensus 48 ~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH 125 (343)
T 3dbq_A 48 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIH 125 (343)
T ss_dssp HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999976 9999999999999999999995 58899999965 456899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccC-----------CCCCCcc
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRN-----------LPITVKA 148 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-----------~~~~~~~ 148 (252)
+. +++||||||+||+++ ++.++|+|||.+......... ......|++.|+|||++.+ ..++.++
T Consensus 126 ~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 201 (343)
T 3dbq_A 126 QH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 201 (343)
T ss_dssp HT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHH
T ss_pred hC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchh
Confidence 99 999999999999997 678999999999876543322 2234568999999999864 5678899
Q ss_pred cchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 149 DVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 149 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
||||||+++|+|++|+.||......... ............. +......+.+++.+||+.||++|||+.|
T Consensus 202 DiwslG~il~ell~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~------~~~~~~~l~~li~~~L~~dp~~Rpt~~e 270 (343)
T 3dbq_A 202 DVWSLGCILYYMTYGKTPFQQIINQISK-----LHAIIDPNHEIEF------PDIPEKDLQDVLKCCLKRDPKQRISIPE 270 (343)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHHHHCTTSCCCC------CCCSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hHHHHHHHHHHHHhCCCcchhhhhHHHH-----HHHHhcCCcccCC------cccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 9999999999999999999764332211 1111111111111 1111234778888999999999999999
Q ss_pred HHHH
Q 038713 229 VLLM 232 (252)
Q Consensus 229 i~~~ 232 (252)
+++.
T Consensus 271 ~l~h 274 (343)
T 3dbq_A 271 LLAH 274 (343)
T ss_dssp HHTS
T ss_pred HHhC
Confidence 9863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=276.26 Aligned_cols=211 Identities=22% Similarity=0.268 Sum_probs=171.3
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP---EKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
..+.+.+|+.++++++||||+++++++.+.+.+|+||||++||+|.+++... ...+++..++.++.||+.||.|||+
T Consensus 228 ~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~ 307 (543)
T 3c4z_A 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307 (543)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999999999999999999999999998653 3468999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
. +++||||||+||+++.+|.++|+|||+++........ .....||+.|+|||++.+..++.++|+||||+++|+|+
T Consensus 308 ~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyell 383 (543)
T 3c4z_A 308 R---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383 (543)
T ss_dssp T---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred c---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHH
Confidence 9 9999999999999999999999999999876543322 23346899999999999989999999999999999999
Q ss_pred hCCccccccchhh-hHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHH
Q 038713 162 CLRRCLDQNLLED-RAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM-----KKVL 230 (252)
Q Consensus 162 ~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~i~ 230 (252)
+|..||....... ...+ ..... .+.... +......+.+++.+||+.||++||++ ++|+
T Consensus 384 tG~~PF~~~~~~~~~~~~---~~~i~-~~~~~~-------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 384 AARGPFRARGEKVENKEL---KQRVL-EQAVTY-------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp HSSCSSCCTTCCCCHHHH---HHHHH-HCCCCC-------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred hCCCCCCCCccchhHHHH---HHHHh-hcccCC-------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 9999998653221 1111 11111 222111 11223457788889999999999975 5565
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=259.54 Aligned_cols=213 Identities=25% Similarity=0.398 Sum_probs=162.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEec-------------CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFD-------------VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIAR 70 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~ 70 (252)
+..+.+.+|+.++++++||||+++++++.+ .+..++||||+++|+|.+++......+++..++.++.
T Consensus 44 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ 123 (303)
T 1zy4_A 44 EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123 (303)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHH
Confidence 456789999999999999999999998865 3567999999999999999976666788899999999
Q ss_pred HHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCC-------------CcccccccCCccccccc
Q 038713 71 DIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ-------------TRTFTGIRGTRAYVAAE 137 (252)
Q Consensus 71 ~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-------------~~~~~~~~~~~~~~aPE 137 (252)
|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....... ........|+..|+|||
T Consensus 124 qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 200 (303)
T 1zy4_A 124 QILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE 200 (303)
T ss_dssp HHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHH
T ss_pred HHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcc
Confidence 999999999999 99999999999999999999999999987654221 11222345788999999
Q ss_pred cccCC-CCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhcc
Q 038713 138 WHRNL-PITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCI 216 (252)
Q Consensus 138 ~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 216 (252)
++.+. .++.++|+||||+++|+|++ ||....... .. . .......... +...+......+.+++.+||
T Consensus 201 ~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~--~~---~-~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l 268 (303)
T 1zy4_A 201 VLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV--NI---L-KKLRSVSIEF---PPDFDDNKMKVEKKIIRLLI 268 (303)
T ss_dssp HHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH--HH---H-HHHHSTTCCC---CTTCCTTTSHHHHHHHHHHT
T ss_pred cccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH--HH---H-Hhcccccccc---CccccccchHHHHHHHHHHH
Confidence 99865 68999999999999999998 554332111 11 1 1122221111 11122333345778888999
Q ss_pred CCCCCCCCCHHHHHH
Q 038713 217 LDEPSLRRAMKKVLL 231 (252)
Q Consensus 217 ~~~p~~Rps~~~i~~ 231 (252)
+.||++|||+.++++
T Consensus 269 ~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 269 DHDPNKRPGARTLLN 283 (303)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred hcCcccCcCHHHHhC
Confidence 999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=257.56 Aligned_cols=204 Identities=21% Similarity=0.260 Sum_probs=164.9
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP---EKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
...+++.+|+..+..+ +||||+++++++.+.+..++||||+++|+|.+++... ...+++..++.++.||+.||.||
T Consensus 52 ~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l 131 (289)
T 1x8b_A 52 VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131 (289)
T ss_dssp HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999 9999999999999999999999999999999999653 25689999999999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCC-------------------CceEEcccCcccccCCCCCcccccccCCcccccccccc
Q 038713 80 HDECEAQIIHGDIKPQNILMDEK-------------------RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR 140 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~-------------------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 140 (252)
|+. +++|+||||+||+++.+ ..++++|||.+....... ...|+..|+|||++.
T Consensus 132 H~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~ 203 (289)
T 1x8b_A 132 HSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQ 203 (289)
T ss_dssp HHT---TEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHT
T ss_pred HhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhc
Confidence 999 99999999999999844 478999999988654332 234789999999998
Q ss_pred CC-CCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCC
Q 038713 141 NL-PITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDE 219 (252)
Q Consensus 141 ~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 219 (252)
+. .++.++||||||+++|++++|..++...... .....+...... ......+.+++.+||+.|
T Consensus 204 ~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----------~~~~~~~~~~~~------~~~~~~~~~li~~~l~~d 267 (289)
T 1x8b_A 204 ENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW----------HEIRQGRLPRIP------QVLSQEFTELLKVMIHPD 267 (289)
T ss_dssp TCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH----------HHHHTTCCCCCS------SCCCHHHHHHHHHHTCSS
T ss_pred CCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH----------HHHHcCCCCCCC------cccCHHHHHHHHHHhCCC
Confidence 75 5668999999999999999998776543211 112222222211 112244788888999999
Q ss_pred CCCCCCHHHHHH
Q 038713 220 PSLRRAMKKVLL 231 (252)
Q Consensus 220 p~~Rps~~~i~~ 231 (252)
|++|||+.|+++
T Consensus 268 p~~Rps~~~ll~ 279 (289)
T 1x8b_A 268 PERRPSAMALVK 279 (289)
T ss_dssp GGGSCCHHHHHT
T ss_pred cccCCCHHHHhh
Confidence 999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=265.78 Aligned_cols=212 Identities=21% Similarity=0.322 Sum_probs=163.6
Q ss_pred hHhHHHHHHHHHHHhCCC--CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 3 AEGEREFKTEMNAIGRTH--HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
.+..+.+.+|+.++++++ ||||+++++++...+..++||| +.+++|.+++... +.+++..++.++.||+.||.|||
T Consensus 95 ~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH 172 (390)
T 2zmd_A 95 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH 172 (390)
T ss_dssp HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 345688999999999995 5999999999999999999999 5688999999654 36888899999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccC-----------CCCCCcc
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRN-----------LPITVKA 148 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-----------~~~~~~~ 148 (252)
+. +++||||||+||+++ ++.++|+|||+++........ ......|++.|+|||++.+ ..++.++
T Consensus 173 ~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 248 (390)
T 2zmd_A 173 QH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248 (390)
T ss_dssp TT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHH
T ss_pred HC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChh
Confidence 99 999999999999995 588999999999876533321 2234568999999999865 3588899
Q ss_pred cchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 149 DVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 149 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
||||||+++|+|++|..||........ . ............. +.. ....+.+++.+||+.||++|||+.|
T Consensus 249 DiwSlGvil~ell~G~~Pf~~~~~~~~-~----~~~~~~~~~~~~~--~~~----~~~~~~~li~~~L~~dP~~Rps~~e 317 (390)
T 2zmd_A 249 DVWSLGCILYYMTYGKTPFQQIINQIS-K----LHAIIDPNHEIEF--PDI----PEKDLQDVLKCCLKRDPKQRISIPE 317 (390)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCCHHH-H----HHHHHCTTSCCCC--CCC----SCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hHHHHHHHHHHHHHCCCcchhhhHHHH-H----HHHHhCccccCCC--Ccc----chHHHHHHHHHHcccChhhCCCHHH
Confidence 999999999999999999976433211 1 1112221111111 111 1245778888999999999999999
Q ss_pred HHH
Q 038713 229 VLL 231 (252)
Q Consensus 229 i~~ 231 (252)
+++
T Consensus 318 ll~ 320 (390)
T 2zmd_A 318 LLA 320 (390)
T ss_dssp HHT
T ss_pred Hhh
Confidence 985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=263.42 Aligned_cols=218 Identities=20% Similarity=0.213 Sum_probs=163.0
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEec-----CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFD-----VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
..+.+.+|+.++++++||||+++++++.. ....++||||++ |+|.+++......+++..++.++.||+.||.||
T Consensus 72 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l 150 (362)
T 3pg1_A 72 LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVL 150 (362)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 35789999999999999999999999853 346899999996 689999987777899999999999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLL 158 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~ 158 (252)
|+. +++|+||||+||+++.++.++|+|||.+....... ......++..|+|||++.+ ..++.++|+||||+++|
T Consensus 151 H~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 225 (362)
T 3pg1_A 151 HEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA 225 (362)
T ss_dssp HHT---TCCCCCCCGGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHH
T ss_pred HHC---cCEecCCChHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHH
Confidence 999 99999999999999999999999999997543322 2223457889999999887 56899999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcC-------------------Cccccccc--chhcHHHHHHHHHHHhhccC
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENG-------------------NLSQLVED--EEVDQKQLQRMIKVGLRCIL 217 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~--~~~~~~~~~~l~~li~~cl~ 217 (252)
+|++|+.||.......... ... ...... ........ ..........+.+++.+||+
T Consensus 226 ~l~~g~~pf~~~~~~~~~~--~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 302 (362)
T 3pg1_A 226 EMFNRKALFRGSTFYNQLN--KIV-EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLE 302 (362)
T ss_dssp HHHHSSCSCCCSSHHHHHH--HHH-HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTC
T ss_pred HHHhCCCCCCCCCHHHHHH--HHH-HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhc
Confidence 9999999998764332211 111 110000 00000000 01122224558888999999
Q ss_pred CCCCCCCCHHHHHH
Q 038713 218 DEPSLRRAMKKVLL 231 (252)
Q Consensus 218 ~~p~~Rps~~~i~~ 231 (252)
.||++|||+.|+++
T Consensus 303 ~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 303 FNPQRRISTEQALR 316 (362)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhhCCCHHHHHc
Confidence 99999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=268.84 Aligned_cols=209 Identities=20% Similarity=0.322 Sum_probs=159.9
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
..+.+|+.++++++||||+++++++.. +..++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+. +
T Consensus 185 ~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ 259 (419)
T 3i6u_A 185 LNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHEN---G 259 (419)
T ss_dssp CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 358899999999999999999999864 558999999999999999854 45689999999999999999999999 9
Q ss_pred eeeeccCCCCEEecCCC---ceEEcccCcccccCCCCCcccccccCCccccccccccC---CCCCCcccchhHHHHHHHH
Q 038713 87 IIHGDIKPQNILMDEKR---CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN---LPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 87 i~h~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l 160 (252)
++||||||+||+++.++ .++++|||.++...... ......|++.|+|||++.+ ..++.++|+||||+++|+|
T Consensus 260 ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~l 337 (419)
T 3i6u_A 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337 (419)
T ss_dssp CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHH
T ss_pred ccccCCChHhEEEecCCCcceEEEeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHH
Confidence 99999999999997554 49999999998754322 2233568999999999864 4678899999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||........ .......+...... .........+.+++.+||+.||++|||++|+++
T Consensus 338 ltg~~pf~~~~~~~~------~~~~i~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 338 LSGYPPFSEHRTQVS------LKDQITSGKYNFIP---EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHSSCSSCCCSSSCC------HHHHHHTTCCCCCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHCCCCCCCCcchHH------HHHHHhcCCCCCCc---hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 999999976533321 11122222222111 111122345788888999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=262.00 Aligned_cols=222 Identities=23% Similarity=0.248 Sum_probs=168.5
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecC-----CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDV-----SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
...+.+.+|++++++++||||+++++++... ...++||||++ |+|.+++.. +.+++..++.++.|++.||.|
T Consensus 67 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~ 143 (364)
T 3qyz_A 67 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKY 143 (364)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHH
Confidence 3457899999999999999999999999754 47899999996 599998854 358999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--cccccccCCccccccccccCC-CCCCcccchhHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGV 155 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~ 155 (252)
||+. +++|+||||+||+++.++.++|+|||.+........ .......|+..|+|||++.+. .++.++||||||+
T Consensus 144 LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 220 (364)
T 3qyz_A 144 IHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 220 (364)
T ss_dssp HHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHH
T ss_pred HHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHH
Confidence 9999 999999999999999999999999999986643322 112345689999999987644 5899999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHH-----------------HHHHhcCCcccccccchhcHHHHHHHHHHHhhccCC
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWI-----------------CQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILD 218 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 218 (252)
++|+|++|+.||......+........ .........................+.+++.+||+.
T Consensus 221 il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 300 (364)
T 3qyz_A 221 ILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF 300 (364)
T ss_dssp HHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCC
Confidence 999999999999776544322111000 000000000000000011122235578889999999
Q ss_pred CCCCCCCHHHHHH
Q 038713 219 EPSLRRAMKKVLL 231 (252)
Q Consensus 219 ~p~~Rps~~~i~~ 231 (252)
||++|||+.|+++
T Consensus 301 dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 301 NPHKRIEVEQALA 313 (364)
T ss_dssp STTTSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=264.26 Aligned_cols=215 Identities=23% Similarity=0.288 Sum_probs=155.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecC------CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDV------SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
...+++.+|+.+++.++||||+++++++... ...++++|++ +++|.+++.. +.+++..++.++.||+.||.
T Consensus 70 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~ 146 (367)
T 2fst_X 70 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLK 146 (367)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999998754 6689999999 7899998854 46899999999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVV 156 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~ 156 (252)
|||+. +++||||||+||+++.++.++|+|||.++..... .....|+..|+|||++.+ ..++.++|||||||+
T Consensus 147 ~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 219 (367)
T 2fst_X 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 219 (367)
T ss_dssp HHHHT---TCCCCCCCGGGEEECTTCCEEECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHH
T ss_pred HHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHH
Confidence 99999 9999999999999999999999999999865432 233567899999999887 578999999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHHHHhcCC------------------ccccc--ccchhcHHHHHHHHHHHhhcc
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQCFENGN------------------LSQLV--EDEEVDQKQLQRMIKVGLRCI 216 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~--~~~~~~~~~~~~l~~li~~cl 216 (252)
+|+|++|+.||......+.... +........ ..... .-..........+.+++.+||
T Consensus 220 l~ell~g~~pf~~~~~~~~l~~---i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL 296 (367)
T 2fst_X 220 MAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 296 (367)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHS
T ss_pred HHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhC
Confidence 9999999999987654332211 111110000 00000 000011112345788888999
Q ss_pred CCCCCCCCCHHHHHH
Q 038713 217 LDEPSLRRAMKKVLL 231 (252)
Q Consensus 217 ~~~p~~Rps~~~i~~ 231 (252)
..||++|||+.|+++
T Consensus 297 ~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 297 VLDSDKRITAAQALA 311 (367)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred CCCcccCcCHHHHhc
Confidence 999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=254.90 Aligned_cols=212 Identities=23% Similarity=0.287 Sum_probs=171.1
Q ss_pred HhHHHHHHHHHHHhCCC-CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..++.+.+|+.+++++. ||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.
T Consensus 65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~ 143 (298)
T 1phk_A 65 ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKL 143 (298)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34678899999999995 99999999999999999999999999999999964 34689999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc------CCCCCCcccchhHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR------NLPITVKADVYSFGVV 156 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Di~slG~~ 156 (252)
+++|+||+|+||+++.++.++++|||.+....... ......++..|+|||++. ...++.++|+||||++
T Consensus 144 ---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~ 218 (298)
T 1phk_A 144 ---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218 (298)
T ss_dssp ---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHH
T ss_pred ---CcccCCCCcceEEEcCCCcEEEecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHH
Confidence 99999999999999999999999999998654332 223346788999999875 3457889999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|+|++|..||........ ......+........ .......+.+++.+||+.||++|||+.|+++
T Consensus 219 l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 219 MYTLLAGSPPFWHRKQMLM-------LRMIMSGNYQFGSPE---WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHSSCSSCCSSHHHH-------HHHHHHTCCCCCTTT---GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCcCccHHHH-------HHHHhcCCcccCccc---ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 9999999999976543321 111222222211111 1122345788888999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=259.54 Aligned_cols=219 Identities=21% Similarity=0.224 Sum_probs=161.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCC------cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVS------NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
...+.+.+|+.+++.++||||+++++++...+ ..++||||+++ +|.+++. ..+++..++.++.||+.||.
T Consensus 66 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~ 141 (371)
T 2xrw_A 66 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIK 141 (371)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999999998654 78999999964 7888885 34789999999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 157 (252)
|||+. +++|+||||+||+++.++.++|+|||.++...... ......|+..|+|||++.+..++.++||||||+++
T Consensus 142 ~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 216 (371)
T 2xrw_A 142 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 216 (371)
T ss_dssp HHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred HHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHH
Confidence 99999 99999999999999999999999999998654322 22335678999999999998899999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHH----------------HHHHHHhcCCcc----------ccc--ccchhcHHHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQE----------------WICQCFENGNLS----------QLV--EDEEVDQKQLQRMI 209 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~----------------~~~~~~~~~~~~----------~~~--~~~~~~~~~~~~l~ 209 (252)
|+|++|+.||............. .+.......... ... ............+.
T Consensus 217 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (371)
T 2xrw_A 217 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR 296 (371)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHH
Confidence 99999999998764432211100 000000000000 000 00011223356788
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 038713 210 KVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 210 ~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+++.+||+.||++|||++|+++
T Consensus 297 ~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 297 DLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHCcCChhhCCCHHHHhC
Confidence 9999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=271.12 Aligned_cols=220 Identities=17% Similarity=0.174 Sum_probs=174.9
Q ss_pred HHHHHHHHHHhCCCC-CCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 7 REFKTEMNAIGRTHH-RNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
+++.+|+++++.++| +++..+..++......++||||+ +++|.+++....+.+++..++.++.||+.||.|||+.
T Consensus 47 ~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--- 122 (483)
T 3sv0_A 47 PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--- 122 (483)
T ss_dssp CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 458899999999976 55666666667788889999999 9999999976667799999999999999999999999
Q ss_pred CeeeeccCCCCEEe---cCCCceEEcccCcccccCCCCCc------ccccccCCccccccccccCCCCCCcccchhHHHH
Q 038713 86 QIIHGDIKPQNILM---DEKRCAKISDFGLAKLMKPDQTR------TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVV 156 (252)
Q Consensus 86 ~i~h~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~ 156 (252)
+++||||||+|||+ +.++.++|+|||+++........ ......|+..|+|||++.+..++.++||||||++
T Consensus 123 gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvi 202 (483)
T 3sv0_A 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYV 202 (483)
T ss_dssp TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHH
Confidence 99999999999999 57889999999999876543321 1224568999999999999999999999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
+|+|++|+.||..............+...........+ .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 203 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 99999999999876544333332222222111111111 112234588889999999999999999999999885
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=261.76 Aligned_cols=216 Identities=20% Similarity=0.264 Sum_probs=154.5
Q ss_pred HhHHHHHHHHHHHhCCC-CCCCcceeeeEe--------cCCcEEEEEecCCCCCHHhhhcC--CCCCCCHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTH-HRNPVRLLGYSF--------DVSNKILVYDYMSNGSLVDVLFT--PEKQPNWVERMGIARDI 72 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--------~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i 72 (252)
+..+.+.+|+.+++++. ||||+++++++. .....+++|||+. |+|.+++.. ..+.+++..++.++.||
T Consensus 67 ~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi 145 (337)
T 3ll6_A 67 EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQT 145 (337)
T ss_dssp HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHH
Confidence 45678999999999995 999999999984 3445799999995 699998854 45569999999999999
Q ss_pred HHHHHHHhhcCCCC--eeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc-----------cccccCCccccccccc
Q 038713 73 ARGIRYLHDECEAQ--IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT-----------FTGIRGTRAYVAAEWH 139 (252)
Q Consensus 73 ~~~l~~lh~~~~~~--i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-----------~~~~~~~~~~~aPE~~ 139 (252)
+.||.|||+. + ++|+||||+||+++.++.++|+|||.+.......... .....++..|+|||++
T Consensus 146 ~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (337)
T 3ll6_A 146 CRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222 (337)
T ss_dssp HHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC------------------------------
T ss_pred HHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence 9999999999 8 9999999999999999999999999998765432211 1133478899999998
Q ss_pred ---cCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhcc
Q 038713 140 ---RNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCI 216 (252)
Q Consensus 140 ---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 216 (252)
.+..++.++||||||+++|+|++|+.||....... .. .+..... .....+ ..+.+++.+||
T Consensus 223 ~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----------~~-~~~~~~~-~~~~~~----~~~~~li~~~l 286 (337)
T 3ll6_A 223 DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----------IV-NGKYSIP-PHDTQY----TVFHSLIRAML 286 (337)
T ss_dssp -CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------------CCCC-TTCCSS----GGGHHHHHHHS
T ss_pred hccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----------hh-cCcccCC-cccccc----hHHHHHHHHHc
Confidence 55668899999999999999999999997542221 01 1111110 011111 23677888999
Q ss_pred CCCCCCCCCHHHHHHHhhcCcCC
Q 038713 217 LDEPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 217 ~~~p~~Rps~~~i~~~l~~~~~~ 239 (252)
+.||++|||+.|+++.|+.+...
T Consensus 287 ~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 287 QVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999986543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=266.62 Aligned_cols=213 Identities=21% Similarity=0.213 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|+.+++++ +||||+++++++...+..++||||+++|+|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 102 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~-- 178 (355)
T 1vzo_A 102 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKL-- 178 (355)
T ss_dssp GGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 45577899999999 7999999999999999999999999999999999643 4689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC--CCCCcccchhHHHHHHHHHh
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL--PITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~ 162 (252)
+++|+||||+||+++.++.++|+|||.++..............|+..|+|||++.+. .++.++||||||+++|+|++
T Consensus 179 -~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~ 257 (355)
T 1vzo_A 179 -GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257 (355)
T ss_dssp -TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred -CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999999999999986544333333445689999999999863 47899999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLLM 232 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~~ 232 (252)
|..||......... .......... ... .+......+.+++.+||+.||++|| |++++++.
T Consensus 258 g~~pf~~~~~~~~~--~~~~~~~~~~-~~~-------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 258 GASPFTVDGEKNSQ--AEISRRILKS-EPP-------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp SSCTTSCTTSCCCH--HHHHHHHHHC-CCC-------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCCCCccCCccchH--HHHHHHHhcc-CCC-------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 99999754322211 1111112211 111 1122234477888899999999999 99999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=256.32 Aligned_cols=217 Identities=16% Similarity=0.238 Sum_probs=168.0
Q ss_pred HhHHHHHHHHHHHhCCC-CCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 4 EGEREFKTEMNAIGRTH-HRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
...+.+.+|+.++++++ ||||+++++++.+ ....++||||+++++|.+++. .++...++.++.|++.||.|||
T Consensus 72 ~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH 147 (330)
T 3nsz_A 72 VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 147 (330)
T ss_dssp CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999996 9999999999997 677899999999999999984 3788999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCC-ceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKR-CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLL 158 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~ 158 (252)
+. +++|+||||+||+++.++ .++|+|||.+........ .....++..|+|||++.+ ..++.++||||||+++|
T Consensus 148 ~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 222 (330)
T 3nsz_A 148 SM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 222 (330)
T ss_dssp HT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred hC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHH
Confidence 99 999999999999999776 899999999986543332 233467889999999887 56899999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHH--------HHHhcCCcc------------------cccccchhcHHHHHHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWIC--------QCFENGNLS------------------QLVEDEEVDQKQLQRMIKVG 212 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~------------------~~~~~~~~~~~~~~~l~~li 212 (252)
+|++|+.||......... +..... ......... .... ..........+.+++
T Consensus 223 ~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li 300 (330)
T 3nsz_A 223 SMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH-SENQHLVSPEALDFL 300 (330)
T ss_dssp HHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCC-TTTGGGCCHHHHHHH
T ss_pred HHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhcc-ccccccCCHHHHHHH
Confidence 999999999654333211 111100 011111000 0000 011111345588888
Q ss_pred hhccCCCCCCCCCHHHHHH
Q 038713 213 LRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 213 ~~cl~~~p~~Rps~~~i~~ 231 (252)
.+||+.||++|||++|+++
T Consensus 301 ~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 301 DKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTSCSSGGGSCCHHHHHT
T ss_pred HHHhcCCcccCCCHHHHhc
Confidence 9999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=265.91 Aligned_cols=221 Identities=19% Similarity=0.232 Sum_probs=157.3
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEe--cCCcEEEEEecCCCCCHHhhhcC--------CCCCCCHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSF--DVSNKILVYDYMSNGSLVDVLFT--------PEKQPNWVERMGIARDIARG 75 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~~~i~~~i~~~ 75 (252)
.+.+.+|+.++++++||||+++++++. .....++||||++ |+|.+++.. ....+++..++.++.||+.|
T Consensus 62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 140 (405)
T 3rgf_A 62 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140 (405)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHH
Confidence 346889999999999999999999995 4778999999995 588887742 12348999999999999999
Q ss_pred HHHHhhcCCCCeeeeccCCCCEEe----cCCCceEEcccCcccccCCCCC--cccccccCCccccccccccCC-CCCCcc
Q 038713 76 IRYLHDECEAQIIHGDIKPQNILM----DEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNL-PITVKA 148 (252)
Q Consensus 76 l~~lh~~~~~~i~h~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~ 148 (252)
|.|||+. +++||||||+||++ +.++.++|+|||.++....... .......|+..|+|||++.+. .++.++
T Consensus 141 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 217 (405)
T 3rgf_A 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 217 (405)
T ss_dssp HHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHH
T ss_pred HHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchh
Confidence 9999999 99999999999999 6778999999999987643221 223345689999999999875 489999
Q ss_pred cchhHHHHHHHHHhCCccccccchhh-------hHHHHHHHHHHHhcCC---cccccccc-----------------hh-
Q 038713 149 DVYSFGVVLLEIVCLRRCLDQNLLED-------RAILQEWICQCFENGN---LSQLVEDE-----------------EV- 200 (252)
Q Consensus 149 Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~---~~~~~~~~-----------------~~- 200 (252)
|||||||++|+|++|..||....... ...+.... ....... +....... ..
T Consensus 218 DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (405)
T 3rgf_A 218 DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF-NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLI 296 (405)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH-HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHH
T ss_pred hhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH-HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhh
Confidence 99999999999999999997553321 11111111 1111100 00000000 00
Q ss_pred ------cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 201 ------DQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 201 ------~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.......+.+++.+||+.||++|||++|+++
T Consensus 297 ~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 297 KYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000345778899999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=273.31 Aligned_cols=201 Identities=12% Similarity=0.148 Sum_probs=155.4
Q ss_pred HhHHHHHHHH---HHHhCCCCCCCccee-------eeEecCC-----------------cEEEEEecCCCCCHHhhhcCC
Q 038713 4 EGEREFKTEM---NAIGRTHHRNPVRLL-------GYSFDVS-----------------NKILVYDYMSNGSLVDVLFTP 56 (252)
Q Consensus 4 ~~~~~~~~E~---~~l~~l~h~~iv~~~-------~~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~ 56 (252)
...+.|.+|+ +.+++++||||++++ +++.+.+ ..++||||+ +|+|.+++...
T Consensus 115 ~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~ 193 (377)
T 3byv_A 115 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL 193 (377)
T ss_dssp THHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc
Confidence 3567899999 556666899999998 6666554 389999999 68999999653
Q ss_pred CC------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCC
Q 038713 57 EK------QPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGT 130 (252)
Q Consensus 57 ~~------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 130 (252)
.. .+++..++.++.||+.||.|||+. +++||||||+|||++.++.++|+|||+++.... ......|
T Consensus 194 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g- 265 (377)
T 3byv_A 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS- 265 (377)
T ss_dssp HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-
T ss_pred cccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-
Confidence 22 233578888999999999999999 999999999999999999999999999985322 2233456
Q ss_pred ccccccccccCC-----------CCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccch
Q 038713 131 RAYVAAEWHRNL-----------PITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEE 199 (252)
Q Consensus 131 ~~~~aPE~~~~~-----------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (252)
..|+|||++.+. .++.++||||||+++|+|++|..||....... .........
T Consensus 266 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~---------------~~~~~~~~~- 329 (377)
T 3byv_A 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG---------------GSEWIFRSC- 329 (377)
T ss_dssp TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------C---------------CSGGGGSSC-
T ss_pred cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccccccc---------------chhhhhhhc-
Confidence 899999999887 79999999999999999999999997543221 111111100
Q ss_pred hcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 200 VDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 200 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
......+.+++.+||+.||++|||+.|+++
T Consensus 330 --~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 330 --KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp --CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred --cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 111244788888999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=260.05 Aligned_cols=216 Identities=19% Similarity=0.226 Sum_probs=164.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcE------EEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK------ILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
...+++.+|+.+++.++||||+++++++...+.. ++||||+. ++|.+++. ..+++..++.++.|++.||.
T Consensus 83 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~ 158 (371)
T 4exu_A 83 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLK 158 (371)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHH
Confidence 3467899999999999999999999999877655 99999996 68988873 24899999999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVV 156 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~ 156 (252)
|||+. +++|+||||+||+++.++.++|+|||.++..... .....++..|+|||++.+ ..++.++|+||||++
T Consensus 159 ~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (371)
T 4exu_A 159 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCI 231 (371)
T ss_dssp HHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHH
T ss_pred HHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHH
Confidence 99999 9999999999999999999999999999765432 233457899999999887 678999999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHHH-------------------HhcCCcccccccchhcHHHHHHHHHHHhhccC
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQC-------------------FENGNLSQLVEDEEVDQKQLQRMIKVGLRCIL 217 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 217 (252)
+|+|++|+.||......+... ...... ...-..................+.+++.+||+
T Consensus 232 l~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 309 (371)
T 4exu_A 232 MAEMLTGKTLFKGKDYLDQLT--QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLE 309 (371)
T ss_dssp HHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSC
T ss_pred HHHHHhCCCCCCCCChHHHHH--HHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCC
Confidence 999999999998664332211 111100 00000000000001112224568888999999
Q ss_pred CCCCCCCCHHHHHHH
Q 038713 218 DEPSLRRAMKKVLLM 232 (252)
Q Consensus 218 ~~p~~Rps~~~i~~~ 232 (252)
.||++|||+.|+++.
T Consensus 310 ~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 310 LDVDKRLTAAQALTH 324 (371)
T ss_dssp SCTTTSCCHHHHHTS
T ss_pred CChhhcCCHHHHhcC
Confidence 999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=264.48 Aligned_cols=161 Identities=20% Similarity=0.235 Sum_probs=140.3
Q ss_pred hHHHHHHHHHHHhCC------CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRT------HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ 77 (252)
..+++.+|+.+++.+ +|+||+++++++...+..++||||+. ++|.+++.... ..+++..++.++.||+.||.
T Consensus 136 ~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~ 214 (429)
T 3kvw_A 136 FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214 (429)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Confidence 456778888888776 67799999999999999999999995 68999986543 45899999999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCc--eEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRC--AKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGV 155 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 155 (252)
|||+. +++||||||+||+++.++. ++|+|||.+....... ....|+..|+|||++.+..++.++|||||||
T Consensus 215 ~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 287 (429)
T 3kvw_A 215 ALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV----YTYIQSRFYRAPEVILGARYGMPIDMWSLGC 287 (429)
T ss_dssp HHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHH
T ss_pred HHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCCcc----cccCCCCCccChHHHhCCCCCchHHHHhHHH
Confidence 99999 9999999999999999887 9999999997644322 2346789999999999989999999999999
Q ss_pred HHHHHHhCCccccccchh
Q 038713 156 VLLEIVCLRRCLDQNLLE 173 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~ 173 (252)
++|+|++|..||......
T Consensus 288 il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 288 ILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp HHHHHHHSSCSSCCSSHH
T ss_pred HHHHHHhCCCCCCCCCHH
Confidence 999999999999876444
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=266.58 Aligned_cols=215 Identities=23% Similarity=0.268 Sum_probs=159.6
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCC------CCHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQ------PNWVERMGIARDIARGI 76 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~l 76 (252)
+..+.+.+|+.+++++ +||||+++++++.+.+..++||||++ |+|.+++...... .++..++.++.||+.||
T Consensus 50 ~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 128 (434)
T 2rio_A 50 DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128 (434)
T ss_dssp GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHH
Confidence 4456788999999876 89999999999999999999999995 6999999654321 12334578999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCC-------------CceEEcccCcccccCCCCCc---ccccccCCcccccccccc
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEK-------------RCAKISDFGLAKLMKPDQTR---TFTGIRGTRAYVAAEWHR 140 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~-------------~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~ 140 (252)
.|||+. +++||||||+||+++.+ +.++++|||.+......... ......|+..|+|||++.
T Consensus 129 ~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 205 (434)
T 2rio_A 129 AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLE 205 (434)
T ss_dssp HHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHS
T ss_pred HHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhc
Confidence 999999 99999999999999754 47999999999876543221 122356899999999987
Q ss_pred C-------CCCCCcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHH
Q 038713 141 N-------LPITVKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVG 212 (252)
Q Consensus 141 ~-------~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 212 (252)
+ ..++.++||||||+++|+|++ |..||......... ... +..................+.+++
T Consensus 206 ~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~--------i~~-~~~~~~~~~~~~~~~~~~~~~~li 276 (434)
T 2rio_A 206 ESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN--------IIR-GIFSLDEMKCLHDRSLIAEATDLI 276 (434)
T ss_dssp CCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH--------HHH-TCCCCCCCTTCCCHHHHHHHHHHH
T ss_pred cccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH--------Hhc-CCCCcccccccccccchHHHHHHH
Confidence 5 568999999999999999998 89999765433211 111 111110011122344556788999
Q ss_pred hhccCCCCCCCCCHHHHHH
Q 038713 213 LRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 213 ~~cl~~~p~~Rps~~~i~~ 231 (252)
.+||+.||++|||+.++++
T Consensus 277 ~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 277 SQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHTCSSGGGSCCHHHHHT
T ss_pred HHHhhCChhhCCCHHHHHh
Confidence 9999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=256.36 Aligned_cols=210 Identities=20% Similarity=0.313 Sum_probs=164.9
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
...+.+|+.++++++||||+++++++.... .++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.
T Consensus 59 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--- 133 (322)
T 2ycf_A 59 ALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHEN--- 133 (322)
T ss_dssp --CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 346889999999999999999999987654 8999999999999999954 45689999999999999999999999
Q ss_pred CeeeeccCCCCEEecCCCc---eEEcccCcccccCCCCCcccccccCCcccccccccc---CCCCCCcccchhHHHHHHH
Q 038713 86 QIIHGDIKPQNILMDEKRC---AKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR---NLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l~~ 159 (252)
+++|+||||+||+++.++. ++++|||.+....... ......|+..|+|||++. +..++.++|+||||+++|+
T Consensus 134 ~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~ 211 (322)
T 2ycf_A 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 211 (322)
T ss_dssp TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHH
T ss_pred CeeccCCCHHHEEEecCCCCCeEEEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHH
Confidence 9999999999999987664 9999999998654321 222345799999999974 4568899999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|++|..||........ + ......+...... .........+.+++.+||+.||++|||+.++++
T Consensus 212 l~~g~~pf~~~~~~~~--~----~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 212 CLSGYPPFSEHRTQVS--L----KDQITSGKYNFIP---EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHSSCSSCSTTCSSC--H----HHHHHHTCCCCCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhCCCCCcccchHHH--H----HHHHHhCccccCc---hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 9999999976533321 1 1112222221111 111122345788888999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=278.93 Aligned_cols=208 Identities=20% Similarity=0.239 Sum_probs=171.3
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|..++..+ +||+|+++++++.+.+.+|+||||++||+|.+++... +.+++..++.++.||+.||.|||+.
T Consensus 384 ~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~- 461 (674)
T 3pfq_A 384 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK- 461 (674)
T ss_dssp TTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 456788999999988 8999999999999999999999999999999999644 4689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+|+||||||+|||++.++.++|+|||+++....... ......||+.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 462 --gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG 538 (674)
T 3pfq_A 462 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538 (674)
T ss_dssp --SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHS
T ss_pred --CeEeccCChhhEEEcCCCcEEEeecceeeccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcC
Confidence 999999999999999999999999999985432222 23345689999999999999999999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM-----KKVLL 231 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~i~~ 231 (252)
..||......+. . ..+..+.... +......+.+++.+||+.||++||++ +||++
T Consensus 539 ~~Pf~~~~~~~~------~-~~i~~~~~~~-------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 539 QAPFEGEDEDEL------F-QSIMEHNVAY-------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SCSSCCSSHHHH------H-HHHHSSCCCC-------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCCCCCCCHHHH------H-HHHHhCCCCC-------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 999987543321 1 1122222211 11233457888889999999999998 66653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=255.28 Aligned_cols=220 Identities=19% Similarity=0.250 Sum_probs=170.4
Q ss_pred HhHHHHHHHHHHHhCCCCCC------CcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRN------PVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGI 76 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l 76 (252)
...+.+.+|+.+++.++|++ ++++++++.+.+..++||||+ +++|.+++.... ..+++..++.++.|++.||
T Consensus 53 ~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l 131 (339)
T 1z57_A 53 RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 34677899999999886654 999999999999999999999 889999996544 4689999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecC-------------------CCceEEcccCcccccCCCCCcccccccCCccccccc
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDE-------------------KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAE 137 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~-------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE 137 (252)
.|||+. +++|+||||+||+++. ++.++++|||.+....... ....|+..|+|||
T Consensus 132 ~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE 204 (339)
T 1z57_A 132 NFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPE 204 (339)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHH
T ss_pred HHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcccc----ccccCCccccChH
Confidence 999999 9999999999999987 6679999999998644322 2346789999999
Q ss_pred cccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHH-----HHhcCCc---------------------
Q 038713 138 WHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQ-----CFENGNL--------------------- 191 (252)
Q Consensus 138 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~--------------------- 191 (252)
++.+..++.++|+||||+++|+|++|..||......+.......... .......
T Consensus 205 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (339)
T 1z57_A 205 VILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYV 284 (339)
T ss_dssp HHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHH
T ss_pred HhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchh
Confidence 99998999999999999999999999999987654432222111100 0000000
Q ss_pred ----ccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 192 ----SQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 192 ----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
................+.+++.+||+.||++|||+.|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 285 SRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 0000000112334567889999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=256.76 Aligned_cols=211 Identities=24% Similarity=0.319 Sum_probs=162.4
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcceeeeEec------CCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRT-HHRNPVRLLGYSFD------VSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l 76 (252)
..+.+.+|+.+++++ +||||+++++++.. .+..++||||+++|+|.+++... ...+++..++.++.||+.||
T Consensus 63 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l 142 (326)
T 2x7f_A 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142 (326)
T ss_dssp TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Confidence 457789999999998 89999999999986 46789999999999999999653 35689999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc-----CCCCCCcccch
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-----NLPITVKADVY 151 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~ 151 (252)
.|||+. +++|+||+|+||+++.++.++++|||.+........ ......|+..|+|||++. +..++.++|+|
T Consensus 143 ~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 218 (326)
T 2x7f_A 143 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 218 (326)
T ss_dssp HHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHH
T ss_pred HHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHH
Confidence 999999 999999999999999999999999999876543221 122345789999999987 45688999999
Q ss_pred hHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 152 SFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 152 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|||+++|+|++|..||......... ...... ..... ..... ...+.+++.+||..||++|||+.++++
T Consensus 219 slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~-~~~~~-~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 219 SLGITAIEMAEGAPPLCDMHPMRAL------FLIPRN-PAPRL-KSKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHS-CCCCC-SCSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCCCcHHHHH------HHhhcC-ccccC-Ccccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 9999999999999999765433211 111111 11111 11112 234778888999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=251.00 Aligned_cols=210 Identities=25% Similarity=0.328 Sum_probs=168.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|++++++++||||+++++++.+.+..++|+||+++++|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~-- 140 (287)
T 2wei_A 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKH-- 140 (287)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 4678999999999999999999999999999999999999999999988543 3589999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCC---CceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEK---RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++|+||+|+||+++.+ +.++++|||.+........ .....++..|+|||.+.+ .++.++|+||||+++|+|+
T Consensus 141 -~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~ 216 (287)
T 2wei_A 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL 216 (287)
T ss_dssp -TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHH
T ss_pred -CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHH
Confidence 99999999999999754 4699999999886543322 122346788999999887 4899999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||....... . ......+........ .......+.+++.+||+.||++|||+.++++
T Consensus 217 ~g~~p~~~~~~~~---~----~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 217 SGTPPFYGKNEYD---I----LKRVETGKYAFDLPQ---WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HSSCSSCCSSHHH---H----HHHHHHCCCCCCSGG---GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCHHH---H----HHHHHcCCCCCCchh---hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 9999998654332 1 122222322211111 1112344778888999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=258.21 Aligned_cols=223 Identities=20% Similarity=0.246 Sum_probs=168.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecC-----CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDV-----SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
...+++.+|+.++++++||||+++++++... ...++||||+. |+|.+++.. +.+++..++.++.|++.||.|
T Consensus 51 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~ 127 (353)
T 2b9h_A 51 LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKV 127 (353)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHH
Confidence 3467789999999999999999999988753 77899999996 689998854 458999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc---------ccccccCCccccccccccC-CCCCCcc
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR---------TFTGIRGTRAYVAAEWHRN-LPITVKA 148 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~-~~~~~~~ 148 (252)
||+. +++|+||||+||+++.++.++++|||.+......... ......|+..|+|||++.+ ..++.++
T Consensus 128 LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 204 (353)
T 2b9h_A 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM 204 (353)
T ss_dssp HHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHH
T ss_pred HHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchh
Confidence 9999 9999999999999999999999999999876432211 1122457889999998764 5789999
Q ss_pred cchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCC---------------------cccccccchhcHHHHHH
Q 038713 149 DVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGN---------------------LSQLVEDEEVDQKQLQR 207 (252)
Q Consensus 149 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~ 207 (252)
|+||||+++|+|++|..||........... +........ .................
T Consensus 205 Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
T 2b9h_A 205 DVWSCGCILAELFLRRPIFPGRDYRHQLLL---IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPK 281 (353)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHH
Confidence 999999999999999999987654432211 111111000 00000000111223455
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 038713 208 MIKVGLRCILDEPSLRRAMKKVLL--MLEG 235 (252)
Q Consensus 208 l~~li~~cl~~~p~~Rps~~~i~~--~l~~ 235 (252)
+.+++.+||+.||++|||+.|+++ .+++
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 282 GIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 788899999999999999999987 4544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=253.82 Aligned_cols=220 Identities=19% Similarity=0.243 Sum_probs=164.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEe--------------cCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSF--------------DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIA 69 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~ 69 (252)
+..+++.+|+.++++++||||+++++++. +.+..++||||++ |+|.+++.. +.+++..++.++
T Consensus 50 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~ 126 (320)
T 2i6l_A 50 QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFM 126 (320)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHH
Confidence 45678999999999999999999999874 3467899999997 699999953 458999999999
Q ss_pred HHHHHHHHHHhhcCCCCeeeeccCCCCEEec-CCCceEEcccCcccccCCCCC--cccccccCCccccccccccC-CCCC
Q 038713 70 RDIARGIRYLHDECEAQIIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRN-LPIT 145 (252)
Q Consensus 70 ~~i~~~l~~lh~~~~~~i~h~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~ 145 (252)
.|++.||.|||+. +++|+||||+||+++ .++.++++|||.+........ .......++..|+|||.+.+ ..++
T Consensus 127 ~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (320)
T 2i6l_A 127 YQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT 203 (320)
T ss_dssp HHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCC
T ss_pred HHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCC
Confidence 9999999999999 999999999999997 567899999999986543221 12233456889999998765 5789
Q ss_pred CcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHH-----------H-------hcCCcccccccchhcHHHHHH
Q 038713 146 VKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQC-----------F-------ENGNLSQLVEDEEVDQKQLQR 207 (252)
Q Consensus 146 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------~-------~~~~~~~~~~~~~~~~~~~~~ 207 (252)
.++|+||||+++|+|++|+.||.......... ...... . .....................
T Consensus 204 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (320)
T 2i6l_A 204 KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ--LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISRE 281 (320)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHH
T ss_pred chhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHH
Confidence 99999999999999999999998764432211 111000 0 000000000000111123455
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHH
Q 038713 208 MIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 208 l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+.+++.+||+.||++|||+.|+++
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 282 AVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCccccCCHHHHhC
Confidence 888899999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=267.23 Aligned_cols=209 Identities=22% Similarity=0.285 Sum_probs=157.8
Q ss_pred HHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 8 EFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 8 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
.+.+|+.+++++ +||||+++++++.+.+..++||||+. |+|.+++...........++.++.||+.||.|||+. +
T Consensus 63 ~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ 138 (432)
T 3p23_A 63 FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---N 138 (432)
T ss_dssp ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---c
Confidence 457899999999 89999999999999999999999995 699999977665566666788999999999999999 9
Q ss_pred eeeeccCCCCEEecCC-----CceEEcccCcccccCCCCC--cccccccCCcccccccccc---CCCCCCcccchhHHHH
Q 038713 87 IIHGDIKPQNILMDEK-----RCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHR---NLPITVKADVYSFGVV 156 (252)
Q Consensus 87 i~h~di~~~nil~~~~-----~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~ 156 (252)
++||||||+||+++.+ ..++++|||.+........ .......|+..|+|||++. +..++.++|||||||+
T Consensus 139 ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~i 218 (432)
T 3p23_A 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218 (432)
T ss_dssp CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHH
T ss_pred CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHH
Confidence 9999999999999532 3578999999986643321 2223456899999999997 4567889999999999
Q ss_pred HHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 157 LLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 157 l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|+|++ |..||......... ........... .. .......+.+++.+||+.||++|||+.++++
T Consensus 219 l~ellt~g~~pf~~~~~~~~~-------~~~~~~~~~~~-~~---~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 219 FYYVISEGSHPFGKSLQRQAN-------ILLGACSLDCL-HP---EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHTTSCBTTBSTTTHHHH-------HHTTCCCCTTS-CT---TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCCCcchhhHHHHH-------HHhccCCcccc-Cc---cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 999999 88888654333211 11111111111 11 1223344678888999999999999999983
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=255.12 Aligned_cols=215 Identities=19% Similarity=0.228 Sum_probs=163.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCc------EEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSN------KILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
...+++.+|+.++++++||||+++++++...+. .++||||+. |+|.+++.. .+++..++.++.||+.||.
T Consensus 65 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~ 140 (353)
T 3coi_A 65 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLK 140 (353)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHH
Confidence 346789999999999999999999999987654 499999996 688887742 4899999999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVV 156 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~ 156 (252)
|||+. +++|+||||+||+++.++.++++|||.+...... .....++..|+|||++.+ ..++.++|+||||++
T Consensus 141 ~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~i 213 (353)
T 3coi_A 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCI 213 (353)
T ss_dssp HHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHH
T ss_pred HHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHH
Confidence 99999 9999999999999999999999999998764322 223467889999999887 578999999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHH-------------------HHhcCCcccccccchhcHHHHHHHHHHHhhccC
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQ-------------------CFENGNLSQLVEDEEVDQKQLQRMIKVGLRCIL 217 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 217 (252)
+|+|++|..||......+.. ...... ....-.......-..........+.+++.+||+
T Consensus 214 l~el~~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 291 (353)
T 3coi_A 214 MAEMLTGKTLFKGKDYLDQL--TQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLE 291 (353)
T ss_dssp HHHHHHSSCSSBSSCHHHHH--HHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSC
T ss_pred HHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcC
Confidence 99999999999876443221 111110 000000000000001112234557888889999
Q ss_pred CCCCCCCCHHHHHH
Q 038713 218 DEPSLRRAMKKVLL 231 (252)
Q Consensus 218 ~~p~~Rps~~~i~~ 231 (252)
.||++|||+.|+++
T Consensus 292 ~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 292 LDVDKRLTAAQALT 305 (353)
T ss_dssp SCTTTSCCHHHHHT
T ss_pred CCcccCCCHHHHhc
Confidence 99999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=255.39 Aligned_cols=216 Identities=21% Similarity=0.259 Sum_probs=166.0
Q ss_pred HHHHHHHHHHhCC---CCCCCcceeeeEe-----cCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHH
Q 038713 7 REFKTEMNAIGRT---HHRNPVRLLGYSF-----DVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 7 ~~~~~E~~~l~~l---~h~~iv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~ 77 (252)
..+.+|+.+++.+ +||||+++++++. .....++||||++ |+|.+++... ...+++..++.++.|++.||.
T Consensus 56 ~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~ 134 (326)
T 1blx_A 56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134 (326)
T ss_dssp CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Confidence 3567788877766 8999999999987 5667899999997 6999998654 345899999999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 157 (252)
|||+. +++|+||||+||+++.++.++++|||.+....... ......++..|+|||++.+..++.++|+||||+++
T Consensus 135 ~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 209 (326)
T 1blx_A 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIF 209 (326)
T ss_dssp HHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred HHHHC---CceeccCCHHHeEEcCCCCEEEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHH
Confidence 99999 99999999999999999999999999987654222 22335678899999999988899999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcC---Ccccc-------------cccchhcHHHHHHHHHHHhhccCCCCC
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENG---NLSQL-------------VEDEEVDQKQLQRMIKVGLRCILDEPS 221 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~~p~ 221 (252)
|+|++|+.||........ +.... ...... .+... .............+.+++.+||+.||+
T Consensus 210 ~~l~~g~~pf~~~~~~~~--~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 286 (326)
T 1blx_A 210 AEMFRRKPLFRGSSDVDQ--LGKIL-DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 286 (326)
T ss_dssp HHHHHSSCSCCCSSHHHH--HHHHH-HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT
T ss_pred HHHHcCCCCCCCCCHHHH--HHHHH-HHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcc
Confidence 999999999987644332 11111 111100 00000 000011122334577888899999999
Q ss_pred CCCCHHHHHH
Q 038713 222 LRRAMKKVLL 231 (252)
Q Consensus 222 ~Rps~~~i~~ 231 (252)
+|||+.|+++
T Consensus 287 ~Rpt~~e~l~ 296 (326)
T 1blx_A 287 KRISAYSALS 296 (326)
T ss_dssp TSCCHHHHHT
T ss_pred cCCCHHHHhc
Confidence 9999999995
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=268.08 Aligned_cols=215 Identities=12% Similarity=0.028 Sum_probs=148.2
Q ss_pred HhHHHHHHHHHHHhCC--CCCCCccee-------eeEecC-----------------CcEEEEEecCCCCCHHhhhcCCC
Q 038713 4 EGEREFKTEMNAIGRT--HHRNPVRLL-------GYSFDV-----------------SNKILVYDYMSNGSLVDVLFTPE 57 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l--~h~~iv~~~-------~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~ 57 (252)
...+.+.+|+.+++.+ +||||++++ +++... ...++||||++ |+|.+++...+
T Consensus 104 ~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 182 (371)
T 3q60_A 104 SELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD 182 (371)
T ss_dssp HHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc
Confidence 4566778885444444 799988755 444433 33899999998 89999997644
Q ss_pred CCCCHHHH------HHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCc
Q 038713 58 KQPNWVER------MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTR 131 (252)
Q Consensus 58 ~~~~~~~~------~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 131 (252)
..++...+ +.++.||+.||.|||++ +++||||||+|||++.++.++|+|||.++...... ....++.
T Consensus 183 ~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~ 255 (371)
T 3q60_A 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPV 255 (371)
T ss_dssp HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCG
T ss_pred cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCc
Confidence 44455555 67789999999999999 99999999999999999999999999998653221 1345668
Q ss_pred cccccccccC--CCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHH
Q 038713 132 AYVAAEWHRN--LPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMI 209 (252)
Q Consensus 132 ~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 209 (252)
.|+|||++.+ ..++.++||||||+++|+|++|+.||.............. ............ .........+.
T Consensus 256 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~ 330 (371)
T 3q60_A 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP--SLRVPGTDSLAF---GSCTPLPDFVK 330 (371)
T ss_dssp GGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBC--CTTSCCCCSCCC---TTSSCCCHHHH
T ss_pred CCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhh--hhhhccccccch---hhccCCCHHHH
Confidence 9999999987 6789999999999999999999999986643321000000 000000000000 11112345588
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 038713 210 KVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 210 ~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+++.+||+.||++|||+.++++
T Consensus 331 ~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 331 TLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHHHcCCChhhCCCHHHHhc
Confidence 8888999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=260.88 Aligned_cols=220 Identities=22% Similarity=0.267 Sum_probs=169.0
Q ss_pred HhHHHHHHHHHHHhCCC--------CCCCcceeeeEe----cCCcEEEEEecCCCCCHHhhhcC-CCCCCCHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTH--------HRNPVRLLGYSF----DVSNKILVYDYMSNGSLVDVLFT-PEKQPNWVERMGIAR 70 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~--------h~~iv~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~ 70 (252)
...+.+.+|+.+++.++ |+||+++++++. +....++||||+ +++|.+++.. ..+.+++..++.++.
T Consensus 75 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~ 153 (397)
T 1wak_A 75 HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153 (397)
T ss_dssp HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHH
Confidence 45678899999999985 788999999988 566889999999 5566666644 446699999999999
Q ss_pred HHHHHHHHHhhcCCCCeeeeccCCCCEEecCCC-----------------------------------------------
Q 038713 71 DIARGIRYLHDECEAQIIHGDIKPQNILMDEKR----------------------------------------------- 103 (252)
Q Consensus 71 ~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~----------------------------------------------- 103 (252)
||+.||.|||+++ +++||||||+||+++.++
T Consensus 154 qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (397)
T 1wak_A 154 QVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAE 231 (397)
T ss_dssp HHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGG
T ss_pred HHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccccc
Confidence 9999999999952 899999999999998775
Q ss_pred --ceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccccchhh----hHH
Q 038713 104 --CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLED----RAI 177 (252)
Q Consensus 104 --~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~ 177 (252)
.++++|||.+...... .....|+..|+|||++.+..++.++||||||+++|+|++|..||....... ...
T Consensus 232 ~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 307 (397)
T 1wak_A 232 KLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307 (397)
T ss_dssp GCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHH
T ss_pred ccceEecccccccccccc----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHH
Confidence 7999999999875432 223467999999999999889999999999999999999999997553321 111
Q ss_pred HHHHHHHHHhc--------CCcc-----------ccc------------ccchhcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038713 178 LQEWICQCFEN--------GNLS-----------QLV------------EDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226 (252)
Q Consensus 178 ~~~~~~~~~~~--------~~~~-----------~~~------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 226 (252)
+.. +...... +... ... .....+......+.+++.+||+.||++|||+
T Consensus 308 ~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 386 (397)
T 1wak_A 308 IAL-IIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA 386 (397)
T ss_dssp HHH-HHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCH
T ss_pred HHH-HHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCH
Confidence 111 1111110 0000 000 0012345667789999999999999999999
Q ss_pred HHHHH
Q 038713 227 KKVLL 231 (252)
Q Consensus 227 ~~i~~ 231 (252)
+|+++
T Consensus 387 ~e~l~ 391 (397)
T 1wak_A 387 AECLR 391 (397)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=254.18 Aligned_cols=217 Identities=19% Similarity=0.266 Sum_probs=168.5
Q ss_pred HhHHHHHHHHHHHhCCCCCC------CcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRN------PVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l 76 (252)
...+.+.+|+.++++++|++ ++++++++...+..++||||+ ++++.+++... ...+++..++.++.||+.||
T Consensus 58 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L 136 (355)
T 2eu9_A 58 KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence 45678899999999987766 899999999999999999999 66777776543 35689999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEe-------------------cCCCceEEcccCcccccCCCCCcccccccCCccccccc
Q 038713 77 RYLHDECEAQIIHGDIKPQNILM-------------------DEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAE 137 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~-------------------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE 137 (252)
.|||+. +++|+||||+||++ +.++.++++|||.+....... ....|+..|+|||
T Consensus 137 ~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE 209 (355)
T 2eu9_A 137 RFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPE 209 (355)
T ss_dssp HHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHH
T ss_pred HHHHHC---CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCe
Confidence 999999 99999999999999 567889999999998644322 2346799999999
Q ss_pred cccCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhc--------CCcc-----------------
Q 038713 138 WHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFEN--------GNLS----------------- 192 (252)
Q Consensus 138 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~----------------- 192 (252)
++.+..++.++|+||||+++|+|++|..||............. ..... ....
T Consensus 210 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (355)
T 2eu9_A 210 VILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME---KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDG 286 (355)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHH
T ss_pred eeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHcCCCcHHHhhhccchhhhcccccccccccchh
Confidence 9999899999999999999999999999998765443222111 11100 0000
Q ss_pred --------cccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 193 --------QLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 193 --------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
...............+.+++.+||+.||++|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 287 RYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000112233457889999999999999999999984
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=248.10 Aligned_cols=210 Identities=20% Similarity=0.262 Sum_probs=155.0
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
.+.+.++...++.++||||+++++++.+.+..++||||++ |+|.+++.. ....+++..++.++.|++.||.|||++
T Consensus 50 ~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (290)
T 3fme_A 50 KRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128 (290)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 3445555666888899999999999999999999999996 588777643 456799999999999999999999984
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccc----cCCCCCCcccchhHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWH----RNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Di~slG~~l~ 158 (252)
.+++|+||||+||+++.++.++++|||.+......... ....|+..|+|||++ .+..++.++|+||||+++|
T Consensus 129 --~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 204 (290)
T 3fme_A 129 --LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI 204 (290)
T ss_dssp --SCCCCCCCSGGGCEECTTCCEEBCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHH
T ss_pred --CCeecCCCCHHHEEECCCCCEEEeecCCcccccccccc--cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHH
Confidence 28999999999999999999999999999765433221 223578999999996 4556889999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++++|+.||......... ............. ... ....+.+++.+||+.||++|||+.|+++
T Consensus 205 ~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~--~~~----~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 205 ELAILRFPYDSWGTPFQQ-----LKQVVEEPSPQLP--ADK----FSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHTSCSSCCCSCHHHH-----HHHHHHSCCCCCC--TTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCccccCchHHH-----HHHHhccCCCCcc--ccc----CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 999999999754333211 1122222222111 111 2344788888999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=256.91 Aligned_cols=214 Identities=22% Similarity=0.259 Sum_probs=160.5
Q ss_pred HHHHHHHhCCCCCCCcceeeeEecCCc------EEEEEecCCCCCHHhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 10 KTEMNAIGRTHHRNPVRLLGYSFDVSN------KILVYDYMSNGSLVDVLF---TPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 10 ~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
.+|+++++.++||||+++++++...+. .++||||++++ +.+.+. .....+++..++.++.||+.||.|||
T Consensus 80 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH 158 (394)
T 4e7w_A 80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158 (394)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 479999999999999999999965433 78999999765 433332 23556899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEec-CCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLL 158 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~ 158 (252)
+. +++||||||+||+++ .++.++|+|||.++....... .....++..|+|||++.+. .++.++|||||||++|
T Consensus 159 ~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 233 (394)
T 4e7w_A 159 SI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMA 233 (394)
T ss_dssp HT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHH
Confidence 99 999999999999999 789999999999987543322 2234678899999998765 5899999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHH----------H----hcCCccccccc---chhcHHHHHHHHHHHhhccCCCCC
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQC----------F----ENGNLSQLVED---EEVDQKQLQRMIKVGLRCILDEPS 221 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~----~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~ 221 (252)
+|++|+.||......+. +...+... . ........... ..........+.+++.+||+.||+
T Consensus 234 ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (394)
T 4e7w_A 234 ELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPS 311 (394)
T ss_dssp HHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChh
Confidence 99999999987654432 22211110 0 00000000000 001112334688889999999999
Q ss_pred CCCCHHHHHH
Q 038713 222 LRRAMKKVLL 231 (252)
Q Consensus 222 ~Rps~~~i~~ 231 (252)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (394)
T 4e7w_A 312 ARLTAIEALC 321 (394)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=249.16 Aligned_cols=210 Identities=19% Similarity=0.238 Sum_probs=155.1
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD-ECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~ 84 (252)
.+.+.++..+++.++||||+++++++.+.+..++||||+ ++.+..+.......+++..++.++.|++.||.|||+ .
T Consensus 68 ~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-- 144 (318)
T 2dyl_A 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH-- 144 (318)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC--
Confidence 344555566788889999999999999999999999999 556666665445678999999999999999999998 6
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc-----CCCCCCcccchhHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-----NLPITVKADVYSFGVVLLE 159 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~~ 159 (252)
+++|+||+|+||+++.++.++++|||.+........ .....++..|+|||++. +..++.++||||||+++|+
T Consensus 145 -~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 221 (318)
T 2dyl_A 145 -GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221 (318)
T ss_dssp -CCCCCCCCGGGEEECTTSCEEECCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHH
T ss_pred -CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHH
Confidence 899999999999999999999999999876543222 22345788999999985 4567899999999999999
Q ss_pred HHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 160 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|++|..||........ ........ ...........+ ..+.+++.+||+.||.+|||++++++
T Consensus 222 l~~g~~pf~~~~~~~~-----~~~~~~~~-~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 222 LATGQFPYKNCKTDFE-----VLTKVLQE-EPPLLPGHMGFS----GDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHSSCTTTTCCSHHH-----HHHHHHHS-CCCCCCSSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHhCCCCCCCCCccHH-----HHHHHhcc-CCCCCCccCCCC----HHHHHHHHHHccCChhHCcCHHHHhh
Confidence 9999999976433221 11122222 211111111222 34778888999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=258.20 Aligned_cols=214 Identities=21% Similarity=0.281 Sum_probs=161.9
Q ss_pred HHHHHHHHhCCCCCCCcceeeeEecC--------------------------------------CcEEEEEecCCCCCHH
Q 038713 9 FKTEMNAIGRTHHRNPVRLLGYSFDV--------------------------------------SNKILVYDYMSNGSLV 50 (252)
Q Consensus 9 ~~~E~~~l~~l~h~~iv~~~~~~~~~--------------------------------------~~~~lv~e~~~~g~L~ 50 (252)
..+|+++++.++||||+++++++... ...++||||++ |+|.
T Consensus 47 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~ 125 (383)
T 3eb0_A 47 KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLH 125 (383)
T ss_dssp CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHH
T ss_pred HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHH
Confidence 45799999999999999999998543 33889999997 5777
Q ss_pred hhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEec-CCCceEEcccCcccccCCCCCccccc
Q 038713 51 DVLFT---PEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPDQTRTFTG 126 (252)
Q Consensus 51 ~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~ 126 (252)
+.+.. ..+.+++..++.++.||+.||.|||+. +++||||||+||+++ .++.++|+|||.+........ ...
T Consensus 126 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~ 200 (383)
T 3eb0_A 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVA 200 (383)
T ss_dssp HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCC
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcC
Confidence 77642 456789999999999999999999999 999999999999997 688999999999986543322 223
Q ss_pred ccCCccccccccccCC-CCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhc----------CCccc--
Q 038713 127 IRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFEN----------GNLSQ-- 193 (252)
Q Consensus 127 ~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~-- 193 (252)
..++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+. +...+.. ... .....
T Consensus 201 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~-~g~p~~~~~~~~~~~~~~~~ 277 (383)
T 3eb0_A 201 YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQ--LVRIIQI-MGTPTKEQMIRMNPHYTEVR 277 (383)
T ss_dssp CCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHH-HCCCCHHHHHHHCTTC--CC
T ss_pred cccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHHH-hCCCCHHHHHHhCccccccc
Confidence 4578899999998875 489999999999999999999999987644432 2221111 000 00000
Q ss_pred ---cccc---chhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 194 ---LVED---EEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 194 ---~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.... ...+......+.+++.+||+.||++|||+.|+++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 278 FPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0111223345788888999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=255.33 Aligned_cols=232 Identities=19% Similarity=0.283 Sum_probs=173.3
Q ss_pred HhHHHHHHHHHHHhCCC-----------CCCCcceeeeEecCC----cEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTH-----------HRNPVRLLGYSFDVS----NKILVYDYMSNGSLVDVLFTP-EKQPNWVERMG 67 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~ 67 (252)
...+.+.+|+.++++++ ||||+++++++...+ ..++|||++ +++|.+++... .+.+++..++.
T Consensus 57 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ 135 (373)
T 1q8y_A 57 VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHH
T ss_pred cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHH
Confidence 34677899999999886 899999999998644 789999999 88999999653 45589999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeeccCCCCEEec------CCCceEEcccCcccccCCCCCcccccccCCccccccccccC
Q 038713 68 IARDIARGIRYLHDECEAQIIHGDIKPQNILMD------EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN 141 (252)
Q Consensus 68 i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 141 (252)
++.||+.||.|||+++ +++|+||||+||+++ ..+.++|+|||.+....... ....|+..|+|||++.+
T Consensus 136 i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~ 209 (373)
T 1q8y_A 136 ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLG 209 (373)
T ss_dssp HHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhC
Confidence 9999999999999942 899999999999994 34479999999998654322 23457899999999999
Q ss_pred CCCCCcccchhHHHHHHHHHhCCccccccchh----hhHHHHHHHHHHHhc--------CC-----------ccccc---
Q 038713 142 LPITVKADVYSFGVVLLEIVCLRRCLDQNLLE----DRAILQEWICQCFEN--------GN-----------LSQLV--- 195 (252)
Q Consensus 142 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~--------~~-----------~~~~~--- 195 (252)
..++.++||||||+++|+|++|..||...... ....+..... .... +. .....
T Consensus 210 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (373)
T 1q8y_A 210 APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 288 (373)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCC
T ss_pred CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHH-hcCCCCHHHHhccchhhhhcCCcchhccccccc
Confidence 88999999999999999999999999755322 1111211111 1100 00 00000
Q ss_pred ---------ccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCcCCCCCC
Q 038713 196 ---------EDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEGTVEIPIPQ 243 (252)
Q Consensus 196 ---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~~~~~~~~~ 243 (252)
.....+......+.+++.+||+.||++|||++|+++ .+++........
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~ 347 (373)
T 1q8y_A 289 FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 347 (373)
T ss_dssp BCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCC
T ss_pred ccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCccccc
Confidence 001234566778999999999999999999999998 666655544433
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=252.23 Aligned_cols=223 Identities=20% Similarity=0.236 Sum_probs=165.0
Q ss_pred HHHHHHHHHHHhCCCCCCCcceeeeEecCCc-------EEEEEecCCCCCHHhhhc---CCCCCCCHHHHHHHHHHHHHH
Q 038713 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSN-------KILVYDYMSNGSLVDVLF---TPEKQPNWVERMGIARDIARG 75 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-------~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~ 75 (252)
.+.+.+|++.++.++||||+++++++...+. .++||||+++ +|.+.+. .....+++..++.++.|++.|
T Consensus 63 ~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 141 (360)
T 3e3p_A 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141 (360)
T ss_dssp CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHH
Confidence 3467788888899999999999999976433 7899999976 5554442 355678999999999999999
Q ss_pred HHHHh--hcCCCCeeeeccCCCCEEecC-CCceEEcccCcccccCCCCCcccccccCCccccccccccCCC-CCCcccch
Q 038713 76 IRYLH--DECEAQIIHGDIKPQNILMDE-KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP-ITVKADVY 151 (252)
Q Consensus 76 l~~lh--~~~~~~i~h~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~ 151 (252)
|.||| +. +++|+||||+||+++. ++.++|+|||.+........ .....|+..|+|||++.+.. ++.++|||
T Consensus 142 l~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~ 216 (360)
T 3e3p_A 142 IGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIW 216 (360)
T ss_dssp HHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHH
Confidence 99999 88 9999999999999996 89999999999986654332 22345789999999987654 89999999
Q ss_pred hHHHHHHHHHhCCccccccchhhhHHHHHHHHH-----------HHhcCCcccccccch---------hcHHHHHHHHHH
Q 038713 152 SFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQ-----------CFENGNLSQLVEDEE---------VDQKQLQRMIKV 211 (252)
Q Consensus 152 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~---------~~~~~~~~l~~l 211 (252)
|||+++|+|++|..||......... ...... ............... ........+.++
T Consensus 217 slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 294 (360)
T 3e3p_A 217 SVGCIFAEMMLGEPIFRGDNSAGQL--HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDL 294 (360)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHH
T ss_pred HHHHHHHHHHhCCCCcCCCChHHHH--HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHH
Confidence 9999999999999999876444321 111110 000000000000000 011134568889
Q ss_pred HhhccCCCCCCCCCHHHHHH--HhhcC
Q 038713 212 GLRCILDEPSLRRAMKKVLL--MLEGT 236 (252)
Q Consensus 212 i~~cl~~~p~~Rps~~~i~~--~l~~~ 236 (252)
+.+||+.||++|||+.|+++ .+++.
T Consensus 295 i~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 295 LSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHhccCccccCCHHHHhcCcccccc
Confidence 99999999999999999986 34443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=247.96 Aligned_cols=212 Identities=21% Similarity=0.329 Sum_probs=162.0
Q ss_pred hHhHHHHHHHHHHHhCCC--CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 3 AEGEREFKTEMNAIGRTH--HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
.+..+.+.+|+.++++++ ||||+++++++.+.+..++||| +.+++|.+++... +.+++..++.++.|++.||.|||
T Consensus 67 ~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH 144 (313)
T 3cek_A 67 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH 144 (313)
T ss_dssp HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 345688999999999996 5999999999999999999999 5588999999644 46899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccC-----------CCCCCcc
Q 038713 81 DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRN-----------LPITVKA 148 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-----------~~~~~~~ 148 (252)
+. +++|+||||+||++++ +.++++|||.+......... ......|+..|+|||++.+ ..++.++
T Consensus 145 ~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 220 (313)
T 3cek_A 145 QH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220 (313)
T ss_dssp HT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHH
T ss_pred HC---CceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchH
Confidence 99 9999999999999964 88999999999865433221 1223457999999999875 4678899
Q ss_pred cchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 149 DVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 149 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
||||||+++|+|++|+.||......... .............. .. ....+.+++.+||+.||++|||+.|
T Consensus 221 Di~slG~il~el~~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~~--~~----~~~~l~~li~~~l~~dp~~Rps~~e 289 (313)
T 3cek_A 221 DVWSLGCILYYMTYGKTPFQQIINQISK-----LHAIIDPNHEIEFP--DI----PEKDLQDVLKCCLKRDPKQRISIPE 289 (313)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHHHHCTTSCCCCC--CC----SCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHHHHHHHHhCCCchhhHHHHHHH-----HHHHHhcccccCCc--cc----chHHHHHHHHHHccCCcccCcCHHH
Confidence 9999999999999999999765433211 11112111111111 11 1245778888999999999999999
Q ss_pred HHH
Q 038713 229 VLL 231 (252)
Q Consensus 229 i~~ 231 (252)
+++
T Consensus 290 ll~ 292 (313)
T 3cek_A 290 LLA 292 (313)
T ss_dssp HHT
T ss_pred Hhc
Confidence 986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=255.13 Aligned_cols=215 Identities=24% Similarity=0.256 Sum_probs=160.0
Q ss_pred HHHHHHHHhCCCCCCCcceeeeEecC------CcEEEEEecCCCCCHHhhhc---CCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 9 FKTEMNAIGRTHHRNPVRLLGYSFDV------SNKILVYDYMSNGSLVDVLF---TPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 9 ~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
+.+|++++++++||||+++++++... ..+++||||+++ +|.+.+. .....+++..++.++.||+.||.||
T Consensus 94 ~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 172 (420)
T 1j1b_A 94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172 (420)
T ss_dssp CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 45799999999999999999988642 236799999975 6666553 2456789999999999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCC-CceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDEK-RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVL 157 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l 157 (252)
|+. +++||||||+|||++.+ +.++|+|||.++....... .....++..|+|||++.+. .++.++|||||||++
T Consensus 173 H~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 247 (420)
T 1j1b_A 173 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247 (420)
T ss_dssp HTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHH
Confidence 999 99999999999999955 5689999999986543222 2234678999999998765 689999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHH-------Hh--cCCccccccc--ch------hcHHHHHHHHHHHhhccCCCC
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQC-------FE--NGNLSQLVED--EE------VDQKQLQRMIKVGLRCILDEP 220 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~--~~~~~~~~~~--~~------~~~~~~~~l~~li~~cl~~~p 220 (252)
|+|++|+.||......+ .+.+.+... +. .........+ .. ........+.+++.+||..||
T Consensus 248 ~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP 325 (420)
T 1j1b_A 248 AELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325 (420)
T ss_dssp HHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSG
T ss_pred HHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCCh
Confidence 99999999998764432 222222110 00 0000000000 00 111223558888889999999
Q ss_pred CCCCCHHHHHH
Q 038713 221 SLRRAMKKVLL 231 (252)
Q Consensus 221 ~~Rps~~~i~~ 231 (252)
++|||+.|+++
T Consensus 326 ~~R~t~~e~l~ 336 (420)
T 1j1b_A 326 TARLTPLEACA 336 (420)
T ss_dssp GGSCCHHHHHT
T ss_pred hHCCCHHHHhC
Confidence 99999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=253.34 Aligned_cols=212 Identities=19% Similarity=0.227 Sum_probs=141.7
Q ss_pred HHHhCCCCCCCcceeeeEec----CCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 038713 14 NAIGRTHHRNPVRLLGYSFD----VSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDECEAQII 88 (252)
Q Consensus 14 ~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~ 88 (252)
..++.+.||||+++++++.. ....++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+. +++
T Consensus 74 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~iv 150 (336)
T 3fhr_A 74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIA 150 (336)
T ss_dssp HHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred HHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 34566799999999999876 445899999999999999997654 4689999999999999999999999 999
Q ss_pred eeccCCCCEEecC---CCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCc
Q 038713 89 HGDIKPQNILMDE---KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 89 h~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
|+||||+||+++. ++.++++|||.+....... .....+++.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 151 H~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (336)
T 3fhr_A 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227 (336)
T ss_dssp CSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCCHHHEEEEecCCCceEEEeccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 9999999999986 4459999999998654322 223457889999999988888999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhhcCc
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEGTV 237 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~~~ 237 (252)
||........... .......+.... +..........+.+++.+||+.||++|||+.|+++ .+++..
T Consensus 228 pf~~~~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 228 PFYSNTGQAISPG---MKRRIRLGQYGF---PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CC------------------------CC---CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred CCCCccchhhhhh---HHHhhhcccccc---CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 9976543321000 011111111111 00111122345788888999999999999999998 666533
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=249.41 Aligned_cols=163 Identities=22% Similarity=0.274 Sum_probs=138.2
Q ss_pred hHHHHHHHHHHHhCCC-CCC-----CcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTH-HRN-----PVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~-h~~-----iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~ 77 (252)
..+++.+|+.+++.++ |++ |+++++++...+..++||||+. |+|.+++.... +.+++..++.++.|++.||.
T Consensus 93 ~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 171 (382)
T 2vx3_A 93 FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171 (382)
T ss_dssp HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHH
Confidence 3567788999988884 554 9999999999999999999995 59999986543 56899999999999999999
Q ss_pred HHhhcCCCCeeeeccCCCCEEec--CCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHH
Q 038713 78 YLHDECEAQIIHGDIKPQNILMD--EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGV 155 (252)
Q Consensus 78 ~lh~~~~~~i~h~di~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 155 (252)
|||.+ +.+++||||||+||+++ .++.++|+|||.++...... ....|+..|+|||++.+..++.++||||||+
T Consensus 172 ~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 246 (382)
T 2vx3_A 172 FLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGC 246 (382)
T ss_dssp HHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred HhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHH
Confidence 99941 12999999999999995 47789999999998764322 2346788999999999989999999999999
Q ss_pred HHHHHHhCCccccccchh
Q 038713 156 VLLEIVCLRRCLDQNLLE 173 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~ 173 (252)
++|+|++|+.||......
T Consensus 247 il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 247 ILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp HHHHHHHSSCSSCCSSHH
T ss_pred HHHHHHhCCCCCCCCCHH
Confidence 999999999999876444
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=267.94 Aligned_cols=230 Identities=22% Similarity=0.250 Sum_probs=171.4
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEec------CCcEEEEEecCCCCCHHhhhcCCC--CCCCHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFD------VSNKILVYDYMSNGSLVDVLFTPE--KQPNWVERMGIARDIAR 74 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~ 74 (252)
...++++.+|+.++++++||||+++++++.. .+..++||||++||+|.+++.... ..+++..++.++.|++.
T Consensus 53 ~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~ 132 (676)
T 3qa8_A 53 PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132 (676)
T ss_dssp HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHH
Confidence 4567889999999999999999999998765 677899999999999999997643 35888999999999999
Q ss_pred HHHHHhhcCCCCeeeeccCCCCEEecCCCc---eEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccch
Q 038713 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRC---AKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVY 151 (252)
Q Consensus 75 ~l~~lh~~~~~~i~h~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 151 (252)
||.|||+. +++|+||+|+||+++.++. ++++|||.+........ .....|+..|+|||++.+..++.++|+|
T Consensus 133 aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIw 207 (676)
T 3qa8_A 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYW 207 (676)
T ss_dssp HHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHH
T ss_pred HHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccccccccccc--cccccCCcccCChHHhccCCCCchhHHH
Confidence 99999999 9999999999999997765 89999999987654332 2335689999999999998999999999
Q ss_pred hHHHHHHHHHhCCccccccchhhhHH--HHHHHHH-HH----hcCCcc--c-ccccchhcHHHHHHHHHHHhhccCCCCC
Q 038713 152 SFGVVLLEIVCLRRCLDQNLLEDRAI--LQEWICQ-CF----ENGNLS--Q-LVEDEEVDQKQLQRMIKVGLRCILDEPS 221 (252)
Q Consensus 152 slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~~~~-~~----~~~~~~--~-~~~~~~~~~~~~~~l~~li~~cl~~~p~ 221 (252)
|||+++|++++|..||.......... ....... .. ..+... . ...+..........+.+++.+||++||+
T Consensus 208 SLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~ 287 (676)
T 3qa8_A 208 SFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQR 287 (676)
T ss_dssp HHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC
T ss_pred HHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHh
Confidence 99999999999999997642221100 0000000 00 000000 0 0111123344566788999999999999
Q ss_pred CCCCHHH-----HHHHhhcCc
Q 038713 222 LRRAMKK-----VLLMLEGTV 237 (252)
Q Consensus 222 ~Rps~~~-----i~~~l~~~~ 237 (252)
+|||+.+ ..+.+++.+
T Consensus 288 kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 288 QRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp ---CCTTCCCCTTHHHHHHHH
T ss_pred hCcCHHHHhcCHHHHHHHHHH
Confidence 9999977 444555433
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=248.27 Aligned_cols=215 Identities=22% Similarity=0.272 Sum_probs=146.3
Q ss_pred HhHHHHHHHHH-HHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMN-AIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT----PEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 4 ~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
...+++.+|+. +++.++||||+++++++.+.+..++||||+++ +|.+++.. ....+++..++.++.|++.||.|
T Consensus 62 ~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~ 140 (327)
T 3aln_A 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140 (327)
T ss_dssp HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHH
Confidence 34456667776 67788999999999999999999999999975 78777742 35678999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccc----cCCCCCCcccchhHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWH----RNLPITVKADVYSFG 154 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Di~slG 154 (252)
||+. .+++|+||||+||+++.++.++|+|||.+........ .....|+..|+|||++ .+..++.++|+||||
T Consensus 141 lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG 216 (327)
T 3aln_A 141 LKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216 (327)
T ss_dssp HHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------------CCSHHHHHHHH
T ss_pred Hhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHH
Confidence 9994 2899999999999999999999999999976543222 1223578899999998 455689999999999
Q ss_pred HHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 155 VVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 155 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+++|+|++|+.||........ .... ...+....+.. .........+.+++.+||+.||++|||+.++++
T Consensus 217 ~il~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 217 ITLYELATGRFPYPKWNSVFD-----QLTQ-VVKGDPPQLSN--SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHHHHHHSCCCSSCC------------CC-CCCSCCCCCCC--CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHCCCCCCCcchHHH-----HHHH-HhcCCCCCCCC--cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 999999999999976432210 0000 11111111111 011122345888888999999999999999865
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=268.75 Aligned_cols=199 Identities=21% Similarity=0.280 Sum_probs=159.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCc-----EEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSN-----KILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
+.++.|.+|+.++++++||||+++++++.+.+. .|+||||++|++|.+++.. .+++..++.++.||+.||.|
T Consensus 121 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~ 197 (681)
T 2pzi_A 121 EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSY 197 (681)
T ss_dssp HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999987665 7999999999999987744 68999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
||+. +++||||||+||+++.+ .++|+|||.+...... ....|++.|+|||++.+. ++.++||||||+++|
T Consensus 198 lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~ 267 (681)
T 2pzi_A 198 LHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLA 267 (681)
T ss_dssp HHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHH
T ss_pred HHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHH
Confidence 9999 99999999999999875 8999999999865433 334689999999998764 488999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHhhc
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-MKKVLLMLEG 235 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~i~~~l~~ 235 (252)
+|++|..||....... .. ...........+.+++.+||+.||++||+ ++++...|..
T Consensus 268 ~l~~g~~~~~~~~~~~----------------~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 268 ALTLDLPTRNGRYVDG----------------LP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHSCCCEETTEECSS----------------CC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHhCCCCCccccccc----------------cc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 9999998886532111 00 00111122345788899999999999995 5556655554
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=250.78 Aligned_cols=199 Identities=24% Similarity=0.407 Sum_probs=158.7
Q ss_pred HHHHHHHHHHHhCC----CCCCCcceeeeEecCCcEEEEEec-CCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 6 EREFKTEMNAIGRT----HHRNPVRLLGYSFDVSNKILVYDY-MSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 6 ~~~~~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
...+.+|+.++.++ +||||+++++++.+.+..++|+|+ +.+++|.+++.. .+.+++..++.++.||+.||.|||
T Consensus 78 ~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH 156 (312)
T 2iwi_A 78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCH 156 (312)
T ss_dssp -CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34566899999888 899999999999999999999999 789999999965 345899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEec-CCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCC-CCcccchhHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-TVKADVYSFGVVLL 158 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~ 158 (252)
+. +++|+||+|+||+++ .++.++++|||.+....... .....|+..|+|||++.+..+ +.++|+||||+++|
T Consensus 157 ~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 230 (312)
T 2iwi_A 157 SR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLY 230 (312)
T ss_dssp HH---TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHH
T ss_pred HC---CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHH
Confidence 99 999999999999999 88999999999998765432 233457889999999887665 45899999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++++|+.||...... . ..... . +......+.+++.+||+.||++|||++|+++
T Consensus 231 ~l~~g~~pf~~~~~~------------~-~~~~~---~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 231 DMVCGDIPFERDQEI------------L-EAELH---F----PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHSSCSCCSHHHH------------H-HTCCC---C----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHCCCCCCChHHH------------h-hhccC---C----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999754111 1 11111 0 1112344778888999999999999999997
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=249.51 Aligned_cols=198 Identities=22% Similarity=0.333 Sum_probs=163.2
Q ss_pred HHHHHHHHHHhCCC--CCCCcceeeeEecCCcEEEEEecCCC-CCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 7 REFKTEMNAIGRTH--HRNPVRLLGYSFDVSNKILVYDYMSN-GSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 7 ~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+.+.+|+.++++++ ||||+++++++.+.+..++|+|++.+ ++|.+++.. .+.+++..++.++.|++.||.|||+.
T Consensus 91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~- 168 (320)
T 3a99_A 91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC- 168 (320)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 45678999999995 59999999999999999999999976 899999964 34689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEec-CCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCC-CCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-TVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~ 161 (252)
+++|+||||+||+++ +++.++|+|||.+....... .....|+..|+|||++.+..+ +.++|+||||+++|+|+
T Consensus 169 --~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 243 (320)
T 3a99_A 169 --GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243 (320)
T ss_dssp --TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred --CcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHH
Confidence 999999999999999 78899999999998765332 223457899999999887665 68899999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||...... .. +... .+... ...+.+++.+||+.||++|||++++++
T Consensus 244 ~g~~pf~~~~~~------------~~-~~~~---~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 244 CGDIPFEHDEEI------------IR-GQVF---FRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HSSCSCCSHHHH------------HH-CCCC---CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HCCCCCCChhhh------------hc-cccc---ccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999754211 11 1111 11122 234778888999999999999999987
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=241.59 Aligned_cols=193 Identities=15% Similarity=0.181 Sum_probs=152.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+.|.+|+.++++++||||+++++++.+.+..|+||||++|++|.+++... ....++.+++.|++.||.|||++
T Consensus 73 ~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~- 148 (286)
T 3uqc_A 73 DVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA- 148 (286)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHC-
Confidence 45688999999999999999999999999999999999999999999999432 36667889999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++|+||||+||+++.++.+++++++. ++ .++.++||||||+++|+|++|
T Consensus 149 --givH~Dikp~NIll~~~g~~kl~~~~~---------------------~~-------~~~~~~Di~slG~il~elltg 198 (286)
T 3uqc_A 149 --GVALSIDHPSRVRVSIDGDVVLAYPAT---------------------MP-------DANPQDDIRGIGASLYALLVN 198 (286)
T ss_dssp --TCCCCCCSGGGEEEETTSCEEECSCCC---------------------CT-------TCCHHHHHHHHHHHHHHHHHS
T ss_pred --CCccCCCCcccEEEcCCCCEEEEeccc---------------------cC-------CCCchhHHHHHHHHHHHHHHC
Confidence 999999999999999999999884432 22 368899999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
+.||.......... .......................+.+++.+||+.||++| |+.++++.|+++..
T Consensus 199 ~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 199 RWPLPEAGVRSGLA-------PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp EECSCCCSBCCCSE-------ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCCCCcCCcchhhH-------HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 99998653321000 000000000111112222334558888999999999999 99999999998544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=235.31 Aligned_cols=202 Identities=18% Similarity=0.239 Sum_probs=151.8
Q ss_pred HHHHHHHHHH-hCCCCCCCcceeeeEec----CCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHh
Q 038713 7 REFKTEMNAI-GRTHHRNPVRLLGYSFD----VSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 7 ~~~~~E~~~l-~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
..+.+|+.++ +..+||||+++++++.. .+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||
T Consensus 55 ~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH 134 (299)
T 3m2w_A 55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134 (299)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4678899998 56699999999999886 677899999999999999997543 46899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecC---CCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDE---KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 157 (252)
+. +++|+||||+||+++. ++.++++|||.+.... +..++.++|+||||+++
T Consensus 135 ~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il 188 (299)
T 3m2w_A 135 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIM 188 (299)
T ss_dssp HT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHH
T ss_pred hC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-----------------------cccCCchhhHHHHHHHH
Confidence 99 9999999999999997 7889999999886432 12467789999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEG 235 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~ 235 (252)
|+|++|..||......... ..............+..........+.+++.+||+.||++|||+.|+++ .+++
T Consensus 189 ~el~tg~~pf~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 189 YILLCGYPPFYSNHGLAIS------PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp HHHHHSSCSCCC-------------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHHHHCCCCCCCCcchhhh------HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 9999999999755322100 0000000000000010111223456888889999999999999999997 4555
Q ss_pred CcCCC
Q 038713 236 TVEIP 240 (252)
Q Consensus 236 ~~~~~ 240 (252)
....+
T Consensus 263 ~~~~~ 267 (299)
T 3m2w_A 263 STKVP 267 (299)
T ss_dssp GGGSC
T ss_pred cccCC
Confidence 44333
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=236.41 Aligned_cols=202 Identities=10% Similarity=0.042 Sum_probs=153.2
Q ss_pred HHHHHHHHHHHhCCC---------CCCCcceeeeE-----------------ec-------------CCcEEEEEecCCC
Q 038713 6 EREFKTEMNAIGRTH---------HRNPVRLLGYS-----------------FD-------------VSNKILVYDYMSN 46 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~---------h~~iv~~~~~~-----------------~~-------------~~~~~lv~e~~~~ 46 (252)
.+.+.+|+.+++.++ ||||+++.+++ .+ .+..++||||+++
T Consensus 67 ~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~ 146 (336)
T 2vuw_A 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146 (336)
T ss_dssp HHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECC
T ss_pred HHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCC
Confidence 478899999998886 66666665543 32 6889999999999
Q ss_pred CCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeeeeccCCCCEEecCCC--------------------ce
Q 038713 47 GSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH-DECEAQIIHGDIKPQNILMDEKR--------------------CA 105 (252)
Q Consensus 47 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~i~h~di~~~nil~~~~~--------------------~~ 105 (252)
|++.+.+.. +.+++..++.++.||+.||.||| +. +++||||||+|||++.++ .+
T Consensus 147 g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~v 221 (336)
T 2vuw_A 147 GIDLEQMRT--KLSSLATAKSILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQV 221 (336)
T ss_dssp CEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEE
T ss_pred CccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceE
Confidence 977777743 56899999999999999999999 89 999999999999999887 89
Q ss_pred EEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHH-HHHHHhCCccccccchhhhHHHHHHHHH
Q 038713 106 KISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVV-LLEIVCLRRCLDQNLLEDRAILQEWICQ 184 (252)
Q Consensus 106 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~-l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 184 (252)
+|+|||+++..... ...||..|+|||++.+.. +.++||||+|++ .+++++|..||...... ......
T Consensus 222 kL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~-----~~~~~~ 289 (336)
T 2vuw_A 222 SIIDYTLSRLERDG------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL-----HYLTDK 289 (336)
T ss_dssp EECCCTTCBEEETT------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH-----HHHHHH
T ss_pred EEeeccccEecCCC------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh-----hHHHHh
Confidence 99999999865432 246899999999999866 889999998777 77788899998532100 001111
Q ss_pred HHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 185 CFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
........ ..............+.+++.+||+.| |++|++
T Consensus 290 ~~~~~~~~-~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 290 MLKQMTFK-TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHTCCCS-SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhhhccC-cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 12111111 11222344556778999999999976 899987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=234.13 Aligned_cols=197 Identities=14% Similarity=0.162 Sum_probs=147.1
Q ss_pred HHHHHHHHHHHhCCCC-CCCc---------ceeee------------Eec-----CCcEEEEEecCCCCCHHhhhc----
Q 038713 6 EREFKTEMNAIGRTHH-RNPV---------RLLGY------------SFD-----VSNKILVYDYMSNGSLVDVLF---- 54 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h-~~iv---------~~~~~------------~~~-----~~~~~lv~e~~~~g~L~~~l~---- 54 (252)
.+.|.+|+.+++.++| +|.. ...+. +.. ....+++|+++ +++|.+++.
T Consensus 122 ~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~ 200 (413)
T 3dzo_A 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS 200 (413)
T ss_dssp CHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhc
Confidence 5679999999999977 3221 11111 111 23567788866 679999883
Q ss_pred --CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcc
Q 038713 55 --TPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRA 132 (252)
Q Consensus 55 --~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 132 (252)
..++.+++..++.++.||+.||.|||+. +++||||||+|||++.++.++|+|||+++..... .....| ..
T Consensus 201 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~ 272 (413)
T 3dzo_A 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RG 272 (413)
T ss_dssp HTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TT
T ss_pred ccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-Cc
Confidence 3345577888999999999999999999 9999999999999999999999999998764332 233456 89
Q ss_pred ccccccc----------cCCCCCCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccc-cchhc
Q 038713 133 YVAAEWH----------RNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVE-DEEVD 201 (252)
Q Consensus 133 ~~aPE~~----------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 201 (252)
|+|||++ .+..++.++||||||+++|+|++|+.||........ ...... ....+
T Consensus 273 y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~---------------~~~~~~~~~~~~ 337 (413)
T 3dzo_A 273 FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG---------------SEWIFRSCKNIP 337 (413)
T ss_dssp TCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC---------------SGGGGSSCCCCC
T ss_pred eeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh---------------HHHHHhhcccCC
Confidence 9999998 555678899999999999999999999976533221 111111 11222
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 202 QKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 202 ~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
..+.+++.+||+.||++|||+.+++
T Consensus 338 ----~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 338 ----QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred ----HHHHHHHHHHccCChhhCcCHHHHH
Confidence 4588888899999999999976653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-33 Score=243.50 Aligned_cols=155 Identities=16% Similarity=0.165 Sum_probs=118.2
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
.++++|.+|+++|+++ +|+||+++++++++++..||||||++|++|.++|... +.++.. +++.||+.||.|+|++
T Consensus 283 ~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~ 358 (569)
T 4azs_A 283 RNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQ 358 (569)
T ss_dssp HHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHC
Confidence 4567899999999999 8999999999999999999999999999999999654 456654 4789999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
||+||||||+|||++.+|.+||+|||+++....... ......||+.|+|||++.+ .+..++|+||+|++.+.+.+
T Consensus 359 ---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~ 433 (569)
T 4azs_A 359 ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQ 433 (569)
T ss_dssp ---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHHHHHHHHHHHHHC------------------CCCCT
T ss_pred ---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhcc
Confidence 999999999999999999999999999986654332 2234568999999999987 46778999999999988877
Q ss_pred CCccc
Q 038713 163 LRRCL 167 (252)
Q Consensus 163 g~~p~ 167 (252)
+..++
T Consensus 434 ~~~~~ 438 (569)
T 4azs_A 434 PWSNW 438 (569)
T ss_dssp THHHH
T ss_pred ccchh
Confidence 66554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-25 Score=195.14 Aligned_cols=149 Identities=20% Similarity=0.232 Sum_probs=125.3
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+++|.+|++++++++||||+++..++...+..++||||+++++|.+++.. +..++.|+++||.|||++
T Consensus 382 ~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~-- 450 (540)
T 3en9_A 382 RKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKN-- 450 (540)
T ss_dssp HHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHC--
Confidence 356799999999999999999666666677788999999999999999965 557999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc------cccccCCccccccccccC--CCCCCcccchhHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT------FTGIRGTRAYVAAEWHRN--LPITVKADVYSFGVV 156 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~------~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~ 156 (252)
+++||||||+||+++. .++|+|||+++......... .....||+.|+|||++.+ ..|+...|+|+..+-
T Consensus 451 -gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~ 527 (540)
T 3en9_A 451 -DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILE 527 (540)
T ss_dssp -TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHH
T ss_pred -cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHH
Confidence 9999999999999998 99999999998765432211 124568999999999987 567888999998888
Q ss_pred HHHHHhCCccc
Q 038713 157 LLEIVCLRRCL 167 (252)
Q Consensus 157 l~~l~~g~~p~ 167 (252)
..+-+-++.+|
T Consensus 528 ~l~~v~~r~rY 538 (540)
T 3en9_A 528 LMKDVERRARY 538 (540)
T ss_dssp HHHHHHTCSCC
T ss_pred HHHHHHhcccc
Confidence 77776665554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=6.9e-19 Score=142.25 Aligned_cols=107 Identities=14% Similarity=0.129 Sum_probs=88.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+..+.+|+.++++++ | +++.+++.. +..++||||++||+|.+ +.. .....++.|++.||.+||+.
T Consensus 147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~-- 212 (282)
T 1zar_A 147 AIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHR-- 212 (282)
T ss_dssp HHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHC--
Confidence 5678999999999999 5 666665544 56799999999999999 522 12446899999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN 141 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 141 (252)
+++|+||||+||+++ ++.++++|||.++. +..+.|||++..
T Consensus 213 -giiHrDlkp~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 213 -GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp -TEECSCCSTTSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred -CCEeCCCCHHHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 999999999999999 99999999999864 234578887653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2e-15 Score=120.37 Aligned_cols=97 Identities=18% Similarity=0.313 Sum_probs=77.2
Q ss_pred HHHHHHHHHHhCCCCCCC--cceeeeEecCCcEEEEEecCCC-C----CHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 7 REFKTEMNAIGRTHHRNP--VRLLGYSFDVSNKILVYDYMSN-G----SLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
..+.+|+.++.++.|+++ .++++. +..++||||+.+ | +|.+.... .++..+..++.|++.||.+|
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHH
Confidence 478999999999988864 344432 367899999942 3 67766532 12345678999999999999
Q ss_pred h-hcCCCCeeeeccCCCCEEecCCCceEEcccCccccc
Q 038713 80 H-DECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116 (252)
Q Consensus 80 h-~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~ 116 (252)
| +. +++||||||+|||++. .++++|||.+...
T Consensus 187 H~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 187 YQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9 88 9999999999999998 8999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.25 E-value=1.2e-11 Score=103.18 Aligned_cols=98 Identities=19% Similarity=0.172 Sum_probs=71.3
Q ss_pred HHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 038713 10 KTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIH 89 (252)
Q Consensus 10 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h 89 (252)
.+|...|.++.+.++.-. ..+.. +..++||||++|+.|.+..... ....++.|++.+|.+||+. +++|
T Consensus 161 ~kE~~nL~rL~~~gv~vp-~p~~~-~~~~LVME~i~G~~L~~l~~~~-------~~~~l~~qll~~l~~lH~~---gIVH 228 (397)
T 4gyi_A 161 IKEFAFMKALYEEGFPVP-EPIAQ-SRHTIVMSLVDALPMRQVSSVP-------DPASLYADLIALILRLAKH---GLIH 228 (397)
T ss_dssp HHHHHHHHHHHHTTCSCC-CEEEE-ETTEEEEECCSCEEGGGCCCCS-------CHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred HHHHHHHHHHHhcCCCCC-eeeec-cCceEEEEecCCccHhhhcccH-------HHHHHHHHHHHHHHHHHHC---CCcC
Confidence 457777777755443221 11111 2347999999998887755321 2346789999999999999 9999
Q ss_pred eccCCCCEEecCCC----------ceEEcccCcccccCCC
Q 038713 90 GDIKPQNILMDEKR----------CAKISDFGLAKLMKPD 119 (252)
Q Consensus 90 ~di~~~nil~~~~~----------~~~l~d~~~~~~~~~~ 119 (252)
|||||.|||+++++ .+.++||+.+....++
T Consensus 229 rDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~hp 268 (397)
T 4gyi_A 229 GDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMDHP 268 (397)
T ss_dssp SCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETTST
T ss_pred CCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCCCC
Confidence 99999999998776 3889999988765443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=1.4e-09 Score=86.44 Aligned_cols=103 Identities=16% Similarity=0.122 Sum_probs=81.8
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC- 83 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~- 83 (252)
..++.+|+.+++.+ .+..+.++++++.+.+..++|||+++|.+|.+.+... .....++.+++.++..||+..
T Consensus 53 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~------~~~~~~~~~l~~~l~~LH~~~~ 126 (263)
T 3tm0_A 53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDI 126 (263)
T ss_dssp TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCTT------TCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCCc------ccHHHHHHHHHHHHHHHhCCCc
Confidence 34688999999988 4677889999999888999999999999998864211 123467889999999999810
Q ss_pred -------------------------------------------------------CCCeeeeccCCCCEEecCCCceEEc
Q 038713 84 -------------------------------------------------------EAQIIHGDIKPQNILMDEKRCAKIS 108 (252)
Q Consensus 84 -------------------------------------------------------~~~i~h~di~~~nil~~~~~~~~l~ 108 (252)
...++|+|+++.||++++++.+.++
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lI 206 (263)
T 3tm0_A 127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFI 206 (263)
T ss_dssp TTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEEC
T ss_pred ccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEE
Confidence 0359999999999999875556799
Q ss_pred ccCccc
Q 038713 109 DFGLAK 114 (252)
Q Consensus 109 d~~~~~ 114 (252)
||+.+.
T Consensus 207 Dwe~a~ 212 (263)
T 3tm0_A 207 DLGRSG 212 (263)
T ss_dssp CCTTCE
T ss_pred Echhcc
Confidence 998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.80 E-value=1.7e-08 Score=83.92 Aligned_cols=107 Identities=18% Similarity=0.255 Sum_probs=83.7
Q ss_pred HHHHHHHHHHHhCCC--CCCCcceeeeEecC---CcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 6 EREFKTEMNAIGRTH--HRNPVRLLGYSFDV---SNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
..++.+|+.+++.+. +..+.+++.++.+. +..++|||+++|..+.+.. ...++......++.+++.+|..||
T Consensus 80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH 156 (359)
T 3dxp_A 80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMH 156 (359)
T ss_dssp --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHh
Confidence 457889999999886 45578899888776 4589999999998775422 223677788889999999999999
Q ss_pred hcC-------------------------------------------------------CCCeeeeccCCCCEEecCCCc-
Q 038713 81 DEC-------------------------------------------------------EAQIIHGDIKPQNILMDEKRC- 104 (252)
Q Consensus 81 ~~~-------------------------------------------------------~~~i~h~di~~~nil~~~~~~- 104 (252)
... ...++|+|+++.||+++.++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~ 236 (359)
T 3dxp_A 157 TVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPR 236 (359)
T ss_dssp HSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSC
T ss_pred CCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCc
Confidence 730 147999999999999987653
Q ss_pred -eEEcccCcccc
Q 038713 105 -AKISDFGLAKL 115 (252)
Q Consensus 105 -~~l~d~~~~~~ 115 (252)
+.++||+.+..
T Consensus 237 v~~viDwe~a~~ 248 (359)
T 3dxp_A 237 VLAVLDWELSTL 248 (359)
T ss_dssp EEEECCCTTCEE
T ss_pred EEEEECcccccc
Confidence 58999998865
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.78 E-value=1.9e-08 Score=79.42 Aligned_cols=99 Identities=17% Similarity=0.189 Sum_probs=74.7
Q ss_pred HHHHHHHHHHhCCCCCC--CcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-
Q 038713 7 REFKTEMNAIGRTHHRN--PVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC- 83 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~- 83 (252)
..+.+|+.+++.+.+.+ +.+++++....+..++||||++|.+|. ... .+ ...++.+++..+..||+..
T Consensus 58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~ 128 (264)
T 1nd4_A 58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDP 128 (264)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCG
T ss_pred hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCC
Confidence 35778999999884434 567888888888899999999998884 211 12 2256778888888888741
Q ss_pred ------------------------------------------------------CCCeeeeccCCCCEEecCCCceEEcc
Q 038713 84 ------------------------------------------------------EAQIIHGDIKPQNILMDEKRCAKISD 109 (252)
Q Consensus 84 ------------------------------------------------------~~~i~h~di~~~nil~~~~~~~~l~d 109 (252)
...++|+|++|.||++++++.+.++|
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD 208 (264)
T 1nd4_A 129 ATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFID 208 (264)
T ss_dssp GGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECC
T ss_pred CCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEc
Confidence 01299999999999998766567999
Q ss_pred cCccc
Q 038713 110 FGLAK 114 (252)
Q Consensus 110 ~~~~~ 114 (252)
|+.+.
T Consensus 209 ~~~a~ 213 (264)
T 1nd4_A 209 CGRLG 213 (264)
T ss_dssp CTTCE
T ss_pred chhcc
Confidence 99865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.61 E-value=1.3e-08 Score=82.76 Aligned_cols=159 Identities=18% Similarity=0.208 Sum_probs=99.7
Q ss_pred hHHHHHHHHHHHhCC-CCCC--CcceeeeEecCC---cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRT-HHRN--PVRLLGYSFDVS---NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
....+.+|+.+++.+ .+.. +.+++....... ..++||++++|..+..... ..++..+...++.+++..++.
T Consensus 53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~ 129 (304)
T 3sg8_A 53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSE 129 (304)
T ss_dssp HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHH
Confidence 456789999999887 4333 345554443332 3478999999988765332 235667777788888888888
Q ss_pred Hhhc-------------------------------------------------------CCCCeeeeccCCCCEEecC--
Q 038713 79 LHDE-------------------------------------------------------CEAQIIHGDIKPQNILMDE-- 101 (252)
Q Consensus 79 lh~~-------------------------------------------------------~~~~i~h~di~~~nil~~~-- 101 (252)
||+. ....++|+|+++.||+++.
T Consensus 130 LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~ 209 (304)
T 3sg8_A 130 LHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK 209 (304)
T ss_dssp HHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT
T ss_pred HHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC
Confidence 8861 0135899999999999998
Q ss_pred CCceEEcccCcccccCCCCCcccccccCCcccccccccc----CCC----------CCCcccchhHHHHHHHHHhCCccc
Q 038713 102 KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR----NLP----------ITVKADVYSFGVVLLEIVCLRRCL 167 (252)
Q Consensus 102 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~----------~~~~~Di~slG~~l~~l~~g~~p~ 167 (252)
.+.+.++||+.+...... .+... ......-..|+... +.. .....+.|++|.++|.+.+|..+|
T Consensus 210 ~~~~~~iD~~~~~~~~~~-~Dl~~-~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 210 NTICGIIDFGDAAISDPD-NDFIS-LMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TEEEEECCCTTCEEECTT-HHHHT-TCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCEEEEEeCCCCccCChH-HHHHH-HHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 455789999988654321 11000 00000001121110 000 112257899999999999998776
Q ss_pred c
Q 038713 168 D 168 (252)
Q Consensus 168 ~ 168 (252)
.
T Consensus 288 ~ 288 (304)
T 3sg8_A 288 Y 288 (304)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=6.4e-06 Score=65.38 Aligned_cols=106 Identities=17% Similarity=0.161 Sum_probs=77.7
Q ss_pred hHHHHHHHHHHHhCCC-CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-
Q 038713 5 GEREFKTEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE- 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~- 82 (252)
....+.+|+..|+.+. +--+.+++.++.+.+..++|||+++|.++.+..... ......++.+++..|+.||..
T Consensus 62 ~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~ 136 (272)
T 4gkh_A 62 VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIP 136 (272)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSC
T ss_pred CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCC
Confidence 3456889999998773 334678899999999999999999998887765321 122334566777777777752
Q ss_pred ------------------------------------------------------CCCCeeeeccCCCCEEecCCCceEEc
Q 038713 83 ------------------------------------------------------CEAQIIHGDIKPQNILMDEKRCAKIS 108 (252)
Q Consensus 83 ------------------------------------------------------~~~~i~h~di~~~nil~~~~~~~~l~ 108 (252)
....++|+|+++.||+++..+.+-++
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~vi 216 (272)
T 4gkh_A 137 VCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCI 216 (272)
T ss_dssp GGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEEC
T ss_pred cccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEE
Confidence 01238999999999999887767799
Q ss_pred ccCcccc
Q 038713 109 DFGLAKL 115 (252)
Q Consensus 109 d~~~~~~ 115 (252)
||+.+..
T Consensus 217 Dwe~a~~ 223 (272)
T 4gkh_A 217 DVGRVGI 223 (272)
T ss_dssp CCTTCEE
T ss_pred ECccccc
Confidence 9988653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=4.1e-05 Score=62.05 Aligned_cols=108 Identities=19% Similarity=0.182 Sum_probs=73.6
Q ss_pred hHHHHHHHHHHHhCCCCC---CCcceeeeEe-cCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 5 GEREFKTEMNAIGRTHHR---NPVRLLGYSF-DVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
....+.+|+.+|+.+.+. .+.+++.+.. ..+..++||++++|..+.+.... .++......++.++...|..||
T Consensus 52 ~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH 128 (306)
T 3tdw_A 52 GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELS 128 (306)
T ss_dssp HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHh
Confidence 456789999999998653 2556666664 45567899999999887663211 1234444455555555555555
Q ss_pred hc---------------------------------------------------------CCCCeeeeccCCCCEEecC--
Q 038713 81 DE---------------------------------------------------------CEAQIIHGDIKPQNILMDE-- 101 (252)
Q Consensus 81 ~~---------------------------------------------------------~~~~i~h~di~~~nil~~~-- 101 (252)
+. ....++|+|+++.||+++.
T Consensus 129 ~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~ 208 (306)
T 3tdw_A 129 AFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNS 208 (306)
T ss_dssp HSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTC
T ss_pred cCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCC
Confidence 42 1125699999999999987
Q ss_pred -CCce-EEcccCcccc
Q 038713 102 -KRCA-KISDFGLAKL 115 (252)
Q Consensus 102 -~~~~-~l~d~~~~~~ 115 (252)
++.+ .++||+.+..
T Consensus 209 ~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 209 RQTPLTGIIDFGDAAI 224 (306)
T ss_dssp SSCCEEEECCCTTCEE
T ss_pred CCCceEEEEehhhcCC
Confidence 4554 7999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.03 E-value=1.8e-05 Score=60.22 Aligned_cols=103 Identities=13% Similarity=0.049 Sum_probs=68.2
Q ss_pred CCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCccccc
Q 038713 47 GSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG 126 (252)
Q Consensus 47 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 126 (252)
-+|.+.|...+.+++++++|.++.|.+.+|.-+-.+ ..-..+-+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc------------
Confidence 479999988888999999999999999998876221 0112333456889999999888764 1110
Q ss_pred ccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCcc
Q 038713 127 IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRC 166 (252)
Q Consensus 127 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 166 (252)
.....+.|||... ...+.+.-|||||+++|.-+--+.|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122567888764 2445777899999999999855444
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=6.9e-05 Score=61.87 Aligned_cols=45 Identities=11% Similarity=0.049 Sum_probs=32.7
Q ss_pred HHHHHHHHHHhCCC-C--CCCcceeeeEecC---CcEEEEEecCCCCCHHh
Q 038713 7 REFKTEMNAIGRTH-H--RNPVRLLGYSFDV---SNKILVYDYMSNGSLVD 51 (252)
Q Consensus 7 ~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~---~~~~lv~e~~~~g~L~~ 51 (252)
..+.+|+.+++.+. + -.+.+++.+..+. +..++|||+++|..+.+
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence 45778899888883 3 3567888877654 45789999998876543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0073 Score=48.90 Aligned_cols=45 Identities=11% Similarity=0.141 Sum_probs=36.5
Q ss_pred hHHHHHHHHHHHhCCC---CCCCcceeeeEecCCcEEEEEecCCCCCH
Q 038713 5 GEREFKTEMNAIGRTH---HRNPVRLLGYSFDVSNKILVYDYMSNGSL 49 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 49 (252)
....|.+|+..|+.+. ...+.+++.+....+..++|||+++|..+
T Consensus 71 ~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 71 YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 3567889999998883 35678899888888889999999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0085 Score=50.04 Aligned_cols=30 Identities=30% Similarity=0.492 Sum_probs=25.4
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
..++|+|+.+.||+++.++ +.++||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~~-~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCCC-eEEEeCccccc
Confidence 3899999999999998654 88999977654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.98 E-value=0.02 Score=45.88 Aligned_cols=30 Identities=23% Similarity=0.212 Sum_probs=25.2
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
..++|+|+.+.||+ ..++.+.++||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 35899999999999 5666789999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.52 E-value=0.021 Score=47.54 Aligned_cols=105 Identities=16% Similarity=0.167 Sum_probs=64.4
Q ss_pred HHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhh--------------h---cCC----CCCCC--
Q 038713 6 EREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDV--------------L---FTP----EKQPN-- 61 (252)
Q Consensus 6 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~--------------l---~~~----~~~~~-- 61 (252)
..+..+|..+++.+ .+.-..++++.+.+ .+|+||++|..|..- + ... .+...
T Consensus 97 ~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l 172 (379)
T 3feg_A 97 VDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWL 172 (379)
T ss_dssp HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccH
Confidence 45667999999888 33334677766653 289999988544211 0 111 12222
Q ss_pred HHHHHHHHHHHHH-------------------HHHHHhhc-----CCCCeeeeccCCCCEEecCC----CceEEcccCcc
Q 038713 62 WVERMGIARDIAR-------------------GIRYLHDE-----CEAQIIHGDIKPQNILMDEK----RCAKISDFGLA 113 (252)
Q Consensus 62 ~~~~~~i~~~i~~-------------------~l~~lh~~-----~~~~i~h~di~~~nil~~~~----~~~~l~d~~~~ 113 (252)
+..+.++..++-. .+..|.+. ....++|+|+.+.||+++.+ +.+.++||..+
T Consensus 173 ~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 173 FGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred HHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 3444555544322 22333221 12479999999999999876 68899999876
Q ss_pred c
Q 038713 114 K 114 (252)
Q Consensus 114 ~ 114 (252)
.
T Consensus 253 ~ 253 (379)
T 3feg_A 253 S 253 (379)
T ss_dssp E
T ss_pred C
Confidence 5
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.30 E-value=0.031 Score=45.24 Aligned_cols=30 Identities=20% Similarity=0.278 Sum_probs=27.0
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAK 114 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~ 114 (252)
..++|+|+++.||+++.++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 489999999999999878889999999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=93.61 E-value=0.076 Score=44.65 Aligned_cols=31 Identities=16% Similarity=0.393 Sum_probs=27.2
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCccccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~ 116 (252)
..++|+|+++.||+++.++ +.++||+.+...
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 3899999999999998776 999999888753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.27 E-value=0.38 Score=36.55 Aligned_cols=115 Identities=10% Similarity=0.072 Sum_probs=76.7
Q ss_pred CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeeeeccCCCCEE
Q 038713 20 HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR-YLHDECEAQIIHGDIKPQNIL 98 (252)
Q Consensus 20 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~-~lh~~~~~~i~h~di~~~nil 98 (252)
.||++ -..+-.+.+.+.+.++.-+++.=...+ +..+..++++.+.+|+.... +++ .-.|--++|+|++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence 67777 445556777777778766444323333 24678899999999887665 444 4578889999999
Q ss_pred ecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCcccc
Q 038713 99 MDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLD 168 (252)
Q Consensus 99 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 168 (252)
++.++.+++.-.|....+.+.. +. ..-=.-..=|++..++.++..|.
T Consensus 117 f~~~~~p~i~hRGi~~~lpP~e------------------~~-----ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESLPPDE------------------WD-----DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTTCCEEESCCEETTTBSSCS------------------CC-----HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCCCcEEEEEcCCcccCCCCC------------------CC-----HHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999888754332211 11 11112355677778888877775
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.98 E-value=0.3 Score=36.98 Aligned_cols=116 Identities=10% Similarity=0.085 Sum_probs=78.3
Q ss_pred CCCCCcceeeeEecCCcEEEEEecCCCC-CHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEE
Q 038713 20 HHRNPVRLLGYSFDVSNKILVYDYMSNG-SLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNIL 98 (252)
Q Consensus 20 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil 98 (252)
.||+++.. .+-.+.+.+.+.++.-+.+ ++.. + +..+...+++++.+|+....+++. -.|--++|.|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence 68888866 5666666666666654322 3322 2 246788999999999987755553 478889999999
Q ss_pred ecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCCccccc
Q 038713 99 MDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQ 169 (252)
Q Consensus 99 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 169 (252)
++.++.+++.-.|......+.. .+...-.-..=+++..+++++..|..
T Consensus 112 f~~~~~p~i~~RGik~~l~P~~-----------------------~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVVDPLP-----------------------VSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp ECTTSCEEESCCEETTTBSCCC-----------------------CCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EcCCCCEEEEEccCccCCCCCC-----------------------CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999877644322211 11111233567788888999888863
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=90.88 E-value=0.38 Score=38.77 Aligned_cols=32 Identities=31% Similarity=0.343 Sum_probs=27.4
Q ss_pred CCeeeeccCCCCEEecCC----CceEEcccCccccc
Q 038713 85 AQIIHGDIKPQNILMDEK----RCAKISDFGLAKLM 116 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~----~~~~l~d~~~~~~~ 116 (252)
..++|+|+.+.||+++.+ +.+.++||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 489999999999999874 67899999987653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=89.97 E-value=0.1 Score=41.98 Aligned_cols=30 Identities=27% Similarity=0.393 Sum_probs=25.6
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAK 114 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~ 114 (252)
.+++|+|+++.||+++.++.+.++||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 479999999999999877656799998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=88.97 E-value=0.48 Score=37.99 Aligned_cols=29 Identities=28% Similarity=0.321 Sum_probs=24.9
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
..++|+|+++.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3689999999999998 4 789999987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=88.21 E-value=0.43 Score=38.77 Aligned_cols=31 Identities=26% Similarity=0.388 Sum_probs=27.4
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999878899999987654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=86.39 E-value=0.7 Score=39.35 Aligned_cols=36 Identities=11% Similarity=0.075 Sum_probs=24.3
Q ss_pred HHHHHHHhCCCCCCC-cceeeeEecCCcEEEEEecCCCCCH
Q 038713 10 KTEMNAIGRTHHRNP-VRLLGYSFDVSNKILVYDYMSNGSL 49 (252)
Q Consensus 10 ~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~g~L 49 (252)
.+|+.+++.+...++ .++++.+. + ..|+||++|..|
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 478888888854444 57777663 2 359999987433
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=86.17 E-value=0.35 Score=39.71 Aligned_cols=30 Identities=23% Similarity=0.433 Sum_probs=24.5
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
..++|+|+++.||+++.++ +.++||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 3699999999999997655 89999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=85.14 E-value=0.34 Score=40.89 Aligned_cols=38 Identities=13% Similarity=0.107 Sum_probs=25.7
Q ss_pred HHHHHHHHHHhCCCCCCC-cceeeeEecCCcEEEEEecCCCCC
Q 038713 7 REFKTEMNAIGRTHHRNP-VRLLGYSFDVSNKILVYDYMSNGS 48 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~g~ 48 (252)
..+.+|+.+++.+...++ .++++.+.+ .+|+||++|..
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~ 158 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP 158 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence 456689999988843333 577766542 38999997633
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=81.72 E-value=0.055 Score=46.53 Aligned_cols=32 Identities=16% Similarity=0.092 Sum_probs=25.0
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecC
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDV 34 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 34 (252)
.++.++|..|++.+.+++|+|+|++.|||...
T Consensus 320 ~~g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~ 351 (487)
T 3oja_A 320 GQGSETERLECERENQARQREIDALKEQYRTV 351 (487)
T ss_dssp -----CHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred cccHHHHHHHHHHHhcccccchhhHHHHhcCh
Confidence 34577899999999999999999999988753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=81.06 E-value=0.8 Score=38.14 Aligned_cols=30 Identities=30% Similarity=0.440 Sum_probs=24.6
Q ss_pred CeeeeccCCCCEEe------cCCCceEEcccCcccc
Q 038713 86 QIIHGDIKPQNILM------DEKRCAKISDFGLAKL 115 (252)
Q Consensus 86 ~i~h~di~~~nil~------~~~~~~~l~d~~~~~~ 115 (252)
.++|+|+.+.||++ ++.+.+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 3456789999988753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 252 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-50 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-42 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-38 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-37 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-37 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-32 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-32 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-29 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-27 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-27 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-26 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-25 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-25 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-24 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-23 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-21 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-17 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-17 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-11 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-50
Identities = 59/236 (25%), Positives = 111/236 (47%), Gaps = 16/236 (6%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ + FK E+ + +T H N + +GYS +V + SL L E +
Sbjct: 45 PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEM 103
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLM-KPDQT 121
++ + IAR A+G+ YLH + IIH D+K NI + E KI DFGLA + + +
Sbjct: 104 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160
Query: 122 RTFTGIRGTRAYVAAEWHRNL---PITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAIL 178
F + G+ ++A E R P + ++DVY+FG+VL E++ + + +R +
Sbjct: 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN--INNRDQI 218
Query: 179 QEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
+ + + + +LS++ + + M ++ C+ + R ++L +E
Sbjct: 219 IFMVGRGYLSPDLSKVRSNC------PKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-46
Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 17/233 (7%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP-N 61
+ F E N + + H+ VRL ++ +YM NGSLVD L TP
Sbjct: 49 SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLT 107
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
+ + +A IA G+ ++ + IH D++ NIL+ + KI+DFGLA+L++ ++
Sbjct: 108 INKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEW 181
G + + A E T+K+DV+SFG++L EIV R + I +
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--QN 222
Query: 182 ICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
+ + + +V + + + ++ C + P R + +LE
Sbjct: 223 LERGYR------MVRPDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-44
Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 15/236 (6%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
A E +F E + + H V+L G + + LV+++M +G L D L T
Sbjct: 41 AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAA 100
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
+G+ D+ G+ YL + C +IH D+ +N L+ E + K+SDFG+ + + DQ
Sbjct: 101 ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWI 182
+ TG + + + E + K+DV+SFGV++ E+ + +N + E I
Sbjct: 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV--EDI 215
Query: 183 CQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238
F L + + ++ C + P R A ++L L E
Sbjct: 216 STGFR------LYKPRLAS----THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-43
Identities = 45/232 (19%), Positives = 94/232 (40%), Gaps = 15/232 (6%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ E EF E + H V+L G ++ +YM+NG L++ L +
Sbjct: 40 SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 99
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
+ + + +D+ + YL + +H D+ +N L++++ K+SDFGL++ + D+
Sbjct: 100 QQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWI 182
+ G + + E + K+D+++FGV++ EI L + + E I
Sbjct: 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--EHI 214
Query: 183 CQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
Q +++ + C ++ R K +L +
Sbjct: 215 AQGLR----------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (361), Expect = 4e-42
Identities = 53/241 (21%), Positives = 108/241 (44%), Gaps = 19/241 (7%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ R+F +E + +G+ H N + L G + +++ ++M NGSL L + Q +
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI 128
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-- 121
+ +G+ R IA G++YL D +H D+ +NIL++ K+SDFGL++ ++ D +
Sbjct: 129 QLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 122 --RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQ 179
+ G + + A E + T +DV+S+G+V+ E++ ++ I
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI-- 243
Query: 180 EWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239
I Q + + ++ L C + + R +++ L+ +
Sbjct: 244 NAIEQDYR----------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
Query: 240 P 240
P
Sbjct: 294 P 294
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 4e-42
Identities = 54/242 (22%), Positives = 98/242 (40%), Gaps = 17/242 (7%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT-PEKQPN 61
F E + + H V+L +V +YMS GSL+D L K
Sbjct: 53 TMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR 111
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
+ + +A IA G+ Y+ +H D++ NIL+ E K++DFGLA+L++ ++
Sbjct: 112 LPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEW 181
G + + A E T+K+DV+SFG++L E+ R ++ + +
Sbjct: 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL--DQ 226
Query: 182 ICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIPI 241
+ + + + + + + +C EP R + + LE
Sbjct: 227 VERGY----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276
Query: 242 PQ 243
PQ
Sbjct: 277 PQ 278
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-42
Identities = 38/160 (23%), Positives = 77/160 (48%), Gaps = 6/160 (3%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
+ E+ + + V G + + ++M GSL VL + P
Sbjct: 48 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP-EQIL 106
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
++ + +G+ YL ++ +I+H D+KP NIL++ + K+ DFG++ + +F
Sbjct: 107 GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 164
Query: 126 GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
GTR+Y++ E + +V++D++S G+ L+E+ R
Sbjct: 165 ---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-41
Identities = 54/239 (22%), Positives = 107/239 (44%), Gaps = 17/239 (7%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ +F E +G+ H N +RL G +++ +YM NG+L L + + + +
Sbjct: 51 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL 110
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ--T 121
+ +G+ R IA G++YL + +H D+ +NIL++ K+SDFGL+++++ D T
Sbjct: 111 QLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEW 181
T +G + + A E T +DV+SFG+V+ E++ L + +
Sbjct: 168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM--KA 225
Query: 182 ICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIP 240
I F + ++ ++C E + R ++ +L+ + P
Sbjct: 226 INDGFR----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 5e-41
Identities = 50/235 (21%), Positives = 96/235 (40%), Gaps = 19/235 (8%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQPNW 62
+F TE + H N + LLG +V YM +G L + + P
Sbjct: 70 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 129
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ-- 120
+ +G +A+G + + +H D+ +N ++DEK K++DFGLA+ M +
Sbjct: 130 KDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186
Query: 121 -TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQ 179
TG + ++A E + T K+DV+SFGV+L E++ ++
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTF 241
Query: 180 EWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
+ + L Q + + +V L+C + +R + +++ +
Sbjct: 242 DITVYLLQGRRLLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-41
Identities = 52/233 (22%), Positives = 94/233 (40%), Gaps = 21/233 (9%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQP-N 61
+ F E + + + H N V+LLG + + +V +YM+ GSLVD L + +
Sbjct: 42 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG 101
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
+ + D+ + YL +H D+ +N+L+ E AK+SDFGL K Q
Sbjct: 102 GDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEW 181
+ A E R + K+DV+SFG++L EI R + +
Sbjct: 159 TGK----LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV--PR 212
Query: 182 ICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
+ + + + + +V C + ++R + ++ LE
Sbjct: 213 VEKGY----------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 1e-40
Identities = 53/260 (20%), Positives = 100/260 (38%), Gaps = 39/260 (15%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP-- 60
A+ + +F+ E + + N V+LLG L+++YM+ G L + L +
Sbjct: 57 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116
Query: 61 ---------------------NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILM 99
+ E++ IAR +A G+ YL + +H D+ +N L+
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLV 173
Query: 100 DEKRCAKISDFGLAKLMKP-DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158
E KI+DFGL++ + D + ++ E T ++DV+++GVVL
Sbjct: 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILD 218
EI + E + +GN+ E+ + + C
Sbjct: 234 EIFSYGLQPYYGMAH------EEVIYYVRDGNILACPENCP------LELYNLMRLCWSK 281
Query: 219 EPSLRRAMKKVLLMLEGTVE 238
P+ R + + +L+ E
Sbjct: 282 LPADRPSFCSIHRILQRMCE 301
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 1e-40
Identities = 54/229 (23%), Positives = 99/229 (43%), Gaps = 16/229 (6%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQP-NWVER 65
EF E + H N V+LLG ++ ++M+ G+L+D L +Q + V
Sbjct: 58 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 117
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+ +A I+ + YL + IH D+ +N L+ E K++DFGL++LM D
Sbjct: 118 LYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174
Query: 126 GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQC 185
G + + A E ++K+DV++FGV+L EI D + + E + +
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQVYELLEKD 232
Query: 186 FENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
+ E + +++ ++ C PS R + ++ E
Sbjct: 233 YRM----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 8e-40
Identities = 42/233 (18%), Positives = 87/233 (37%), Gaps = 18/233 (7%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
E E + + + VRL+G +LV + G L L ++
Sbjct: 51 ADTEEMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVS 109
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-- 121
+ ++ G++YL ++ +H D+ +N+L+ + AKISDFGL+K + D +
Sbjct: 110 NVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEW 181
+ + + A E + ++DV+S+GV + E + + + + +
Sbjct: 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK--MKGPEVMAF 224
Query: 182 ICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
I Q + E + + + C + + R V +
Sbjct: 225 IEQG----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 5e-39
Identities = 48/237 (20%), Positives = 97/237 (40%), Gaps = 21/237 (8%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKIL--VYDYMSNGSLVDVLFTPEK 58
M ++ +E+N + H N VR D +N L V +Y G L V+ K
Sbjct: 42 MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK 101
Query: 59 QP---NWVERMGIARDIARGIRYLHD--ECEAQIIHGDIKPQNILMDEKRCAKISDFGLA 113
+ + + + + ++ H + ++H D+KP N+ +D K+ K+ DFGLA
Sbjct: 102 ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161
Query: 114 KLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLE 173
+++ D + GT Y++ E + K+D++S G +L E+ L +
Sbjct: 162 RILNHDTSFA-KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 220
Query: 174 DRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230
+ + G ++ +L +I R + + R +++++L
Sbjct: 221 E-------LAGKIREGKFRRIPYRYS---DELNEIIT---RMLNLKDYHRPSVEEIL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 5e-39
Identities = 52/235 (22%), Positives = 91/235 (38%), Gaps = 22/235 (9%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK----ILVYDYMSNGSLVDVLFTP 56
+ + FK E + H N VR +LV + M++G+L L
Sbjct: 47 LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR- 105
Query: 57 EKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRC-AKISDFGLAKL 115
K R I +G+++LH IIH D+K NI + KI D GLA L
Sbjct: 106 FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164
Query: 116 MKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDR 175
+ + GT ++A E + DVY+FG+ +LE+ + ++
Sbjct: 165 KRASFAKAV---IGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC--QNA 218
Query: 176 AILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230
A + + + + ++ E ++ +I+ CI R ++K +L
Sbjct: 219 AQIYRRVTSGVKPASFDKVAIPE------VKEIIE---GCIRQNKDERYSIKDLL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-38
Identities = 47/232 (20%), Positives = 95/232 (40%), Gaps = 20/232 (8%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
E ++ E++ + H N V+LL + +N ++ ++ + G++ V+ E+
Sbjct: 51 EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTES 110
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
+ + + + YLH + +IIH D+K NIL K++DFG++ R
Sbjct: 111 QIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167
Query: 124 FTGIRGTRAYVAAEW-----HRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAIL 178
+ GT ++A E ++ P KADV+S G+ L+E+ + + L +L
Sbjct: 168 DS-FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE--LNPMRVL 224
Query: 179 QEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230
+ L + + +K +C+ R ++L
Sbjct: 225 LKIA-----KSEPPTLAQPSRWS-SNFKDFLK---KCLEKNVDARWTTSQLL 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-38
Identities = 53/254 (20%), Positives = 98/254 (38%), Gaps = 33/254 (12%)
Query: 4 EGEREFKTEMNAIGR-THHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLF-------- 54
+E+ + +H N V LLG +++ +Y G L++ L
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 55 ---------TPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA 105
E + + + + +A+G+ +L + IH D+ +NIL+ R
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT 184
Query: 106 KISDFGLAKLMKPDQTRTFTG-IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
KI DFGLA+ +K D G R ++A E N T ++DV+S+G+ L E+ L
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224
+ D + + I + F + M + C +P R
Sbjct: 245 SSPYPGMPVD-SKFYKMIKEGFR----------MLSPEHAPAEMYDIMKTCWDADPLKRP 293
Query: 225 AMKKVLLMLEGTVE 238
K+++ ++E +
Sbjct: 294 TFKQIVQLIEKQIS 307
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-38
Identities = 51/258 (19%), Positives = 93/258 (36%), Gaps = 30/258 (11%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI----LVYDYMSNGSLVDVLFTPEKQ 59
E + E+ H N + + + LV DY +GSL D L
Sbjct: 39 ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYT 96
Query: 60 PNWVERMGIARDIARGIRYLHDEC-----EAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114
+ +A A G+ +LH E + I H D+K +NIL+ + I+D GLA
Sbjct: 97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156
Query: 115 LMKPDQTRTF---TGIRGTRAYVAAEW------HRNLPITVKADVYSFGVVLLEIVCLRR 165
GT+ Y+A E ++ +AD+Y+ G+V EI R
Sbjct: 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RC 215
Query: 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVD---------QKQLQRMIKVGLRCI 216
+ + + + + + ++V ++++ + L+ M K+ C
Sbjct: 216 SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECW 275
Query: 217 LDEPSLRRAMKKVLLMLE 234
+ R ++ L
Sbjct: 276 YANGAARLTALRIKKTLS 293
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 7e-38
Identities = 49/233 (21%), Positives = 90/233 (38%), Gaps = 19/233 (8%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ E E N + + + VR++G + + +LV + G L L
Sbjct: 50 ALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVK-DK 107
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-- 121
+ + ++ G++YL + +H D+ +N+L+ + AKISDFGL+K ++ D+
Sbjct: 108 NIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164
Query: 122 RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEW 181
+ T + + A E + K+DV+SFGV++ E + R +
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ------KPYRGMKGSE 218
Query: 182 ICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
+ E G E + M + C + R V L L
Sbjct: 219 VTAMLEKG------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-37
Identities = 44/232 (18%), Positives = 95/232 (40%), Gaps = 17/232 (7%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ +E E + + + RLLG S L+ M G L+D + +
Sbjct: 53 KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 111
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR- 122
+ IA+G+ YL D +++H D+ +N+L+ + KI+DFGLAKL+ ++
Sbjct: 112 YLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWI 182
G + ++A E + T ++DV+S+GV + E++ + + + +
Sbjct: 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSIL 226
Query: 183 CQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
+ E + + ++C + + R +++++
Sbjct: 227 EKG----------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-37
Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 21/228 (9%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
A E + + E+ H N +RL GY D + L+ +Y G++ L K
Sbjct: 47 AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-E 105
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
++A + Y H ++IH DIKP+N+L+ KI+DFG + +
Sbjct: 106 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWI 182
T GT Y+ E K D++S GV+ E + + + N ++ + I
Sbjct: 163 TL---CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRI 216
Query: 183 CQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230
+ V + + +I R + PS R +++VL
Sbjct: 217 SRV--EFTFPDFVTEG------ARDLIS---RLLKHNPSQRPMLREVL 253
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-37
Identities = 47/255 (18%), Positives = 92/255 (36%), Gaps = 38/255 (14%)
Query: 4 EGEREFKTEMNAIGR-THHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPN- 61
+E+ + + H N V LLG L+++Y G L++ L + ++ +
Sbjct: 82 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 141
Query: 62 ---------------------WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMD 100
+ + + A +A+G+ +L +H D+ +N+L+
Sbjct: 142 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVT 198
Query: 101 EKRCAKISDFGLAKLMKPDQTRTF-TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLE 159
+ KI DFGLA+ + D R ++A E T+K+DV+S+G++L E
Sbjct: 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258
Query: 160 IVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDE 219
I L + D + L Q + + + + C +
Sbjct: 259 IFSLGVNPYPGIPVDANFYK-----------LIQNGFKMDQPFYATEEIYIIMQSCWAFD 307
Query: 220 PSLRRAMKKVLLMLE 234
R + + L
Sbjct: 308 SRKRPSFPNLTSFLG 322
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 5e-37
Identities = 54/231 (23%), Positives = 96/231 (41%), Gaps = 21/231 (9%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ K E+ +H N V+ G+ + + + L +Y S G L D + P+
Sbjct: 45 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEP 103
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD-QTR 122
+ + G+ YLH I H DIKP+N+L+DE+ KISDFGLA + + + + R
Sbjct: 104 DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160
Query: 123 TFTGIRGTRAYVAAEWHRNLPI-TVKADVYSFGVVLLEIVCLRRCLDQ--NLLEDRAILQ 179
+ GT YVA E + DV+S G+VL ++ DQ + ++ + +
Sbjct: 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 220
Query: 180 EWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230
E + ++ + +++ PS R + +
Sbjct: 221 EKKTYLNPWKKIDSAPLA----------LLH---KILVENPSARITIPDIK 258
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 5e-37
Identities = 63/251 (25%), Positives = 106/251 (42%), Gaps = 33/251 (13%)
Query: 4 EGEREFKTEMNAIGR-THHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLF-------- 54
+ R+F E+ + + HH N + LLG L +Y +G+L+D L
Sbjct: 52 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111
Query: 55 -------TPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKI 107
+ + + + A D+ARG+ YL + Q IH D+ +NIL+ E AKI
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKI 168
Query: 108 SDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCL 167
+DFGL++ + +T R ++A E T +DV+S+GV+L EIV L
Sbjct: 169 ADFGLSRGQEVYVKKTMG--RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 226
Query: 168 DQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK 227
A L E + Q + E + + +C ++P R +
Sbjct: 227 YCG--MTCAELYEKLPQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFA 274
Query: 228 KVLLMLEGTVE 238
++L+ L +E
Sbjct: 275 QILVSLNRMLE 285
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (320), Expect = 7e-36
Identities = 48/231 (20%), Positives = 88/231 (38%), Gaps = 26/231 (11%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
E ++ E+ + + H N ++ G LV +Y + + +K V
Sbjct: 57 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEV 115
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
E + +G+ YLH +IH D+K NIL+ E K+ DFG A +M P +
Sbjct: 116 EIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-- 170
Query: 124 FTGIRGTRAYVAAEW---HRNLPITVKADVYSFGVVLLEIVCLRRCL-DQNLLEDRAILQ 179
GT ++A E K DV+S G+ +E+ + L + N + +
Sbjct: 171 ---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227
Query: 180 EWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230
+ ++G+ S+ + + C+ P R + +L
Sbjct: 228 QNESPALQSGHWSE----------YFRNFVD---SCLQKIPQDRPTSEVLL 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-35
Identities = 39/162 (24%), Positives = 74/162 (45%), Gaps = 6/162 (3%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ E+ + + N V L +V +Y++ GSL DV+ E +
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEG 116
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
+ + R+ + + +LH Q+IH DIK NIL+ K++DFG + P+Q++
Sbjct: 117 QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
+ + GT ++A E K D++S G++ +E++
Sbjct: 174 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 6e-35
Identities = 52/233 (22%), Positives = 88/233 (37%), Gaps = 17/233 (7%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
E +F E+NA+ HRN +RL G +V + GSL+D L +
Sbjct: 53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLG 111
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
A +A G+ YL + IH D+ +N+L+ + KI DFGL + + +
Sbjct: 112 TLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 124 F--TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEW 181
+ A+ A E + + +D + FGV L E+ + L +
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQI 223
Query: 182 ICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
+ + + G ED Q + V ++C +P R + L
Sbjct: 224 LHKIDKEGERLPRPEDCP------QDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 8e-35
Identities = 43/231 (18%), Positives = 86/231 (37%), Gaps = 16/231 (6%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+F E + + H + V+L+G + ++ + + G L L + +
Sbjct: 50 SVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLA 108
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
+ A ++ + YL + +H DI +N+L+ C K+ DFGL++ M+
Sbjct: 109 SLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 165
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWIC 183
+ + ++A E T +DV+ FGV + EI+ Q + + I I
Sbjct: 166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--GRIE 223
Query: 184 QCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
E + + + +C +PS R ++ L
Sbjct: 224 NG----------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 9e-35
Identities = 54/257 (21%), Positives = 105/257 (40%), Gaps = 26/257 (10%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQ---- 59
EF E + + + + VRLLG +++ + M+ G L L +
Sbjct: 65 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 124
Query: 60 -----PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114
P+ + + +A +IA G+ YL+ + +H D+ +N ++ E KI DFG+ +
Sbjct: 125 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 181
Query: 115 LMKP-DQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLE 173
+ D R +++ E ++ T +DV+SFGVVL EI L Q L
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241
Query: 174 DRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLML 233
E + + G L ++ + ++ C P +R + +++ +
Sbjct: 242 ------EQVLRFVMEGGLLDKPDNC------PDMLFELMRMCWQYNPKMRPSFLEIISSI 289
Query: 234 EGTVEIPIPQNPTSFLS 250
+ +E P + + + S
Sbjct: 290 KEEME-PGFREVSFYYS 305
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 1e-33
Identities = 58/253 (22%), Positives = 100/253 (39%), Gaps = 32/253 (12%)
Query: 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKI-LVYDYMSNGSLVDVLFTPEKQP- 60
R +E+ + HH N V LLG + ++ ++ G+L L + +
Sbjct: 58 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 117
Query: 61 --------------NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAK 106
+ + +A+G+ +L + IH D+ +NIL+ EK K
Sbjct: 118 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVK 174
Query: 107 ISDFGLAKLMKPDQTRTFTG-IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
I DFGLA+ + D G R ++A E + T+++DV+SFGV+L EI L
Sbjct: 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
Query: 166 CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225
+ D E C+ + G + + M + L C EPS R
Sbjct: 235 SPYPGVKID-----EEFCRRLKEGTRMRAPDYT------TPEMYQTMLDCWHGEPSQRPT 283
Query: 226 MKKVLLMLEGTVE 238
+++ L ++
Sbjct: 284 FSELVEHLGNLLQ 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 5e-33
Identities = 34/162 (20%), Positives = 74/162 (45%), Gaps = 7/162 (4%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
+ K E++ + HRN + L + +++++++S + + + T + N E
Sbjct: 45 QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI 104
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA--KISDFGLAKLMKPDQTRT 123
+ + +++LH I H DI+P+NI+ +R + KI +FG A+ +KP
Sbjct: 105 VSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
Y A E H++ ++ D++S G ++ ++
Sbjct: 162 LL--FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-32
Identities = 58/253 (22%), Positives = 103/253 (40%), Gaps = 32/253 (12%)
Query: 4 EGEREFKTEMNAIGR-THHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLF-------- 54
+ + +EM + H+N + LLG ++ +Y S G+L + L
Sbjct: 60 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 119
Query: 55 -------TPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKI 107
PE+Q + + + A +ARG+ YL + IH D+ +N+L+ E KI
Sbjct: 120 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKI 176
Query: 108 SDFGLAKLMKPDQTRTFT-GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRC 166
+DFGLA+ + T R ++A E + T ++DV+SFGV+L EI L
Sbjct: 177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
Query: 167 LDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAM 226
+ E + + + G+ + + + C PS R
Sbjct: 237 PYPGVPV------EELFKLLKEGHRMDKPSNC------TNELYMMMRDCWHAVPSQRPTF 284
Query: 227 KKVLLMLEGTVEI 239
K+++ L+ V +
Sbjct: 285 KQLVEDLDRIVAL 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-32
Identities = 37/163 (22%), Positives = 62/163 (38%), Gaps = 5/163 (3%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
E + + R H V+L D Y NG L+ +
Sbjct: 50 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC 109
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
A + L IIH D+KP+NIL++E +I+DFG AK++ P+ +
Sbjct: 110 ----TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165
Query: 124 FTG-IRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
GT YV+ E +D+++ G ++ ++V
Sbjct: 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 119 bits (299), Expect = 2e-32
Identities = 39/165 (23%), Positives = 74/165 (44%), Gaps = 7/165 (4%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ + E+ + H V L D + +++Y++MS G L + + + +
Sbjct: 64 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 123
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRC--AKISDFGLAKLMKPDQ 120
E + R + +G+ ++H+ +H D+KP+NI+ KR K+ DFGL + P Q
Sbjct: 124 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
+ T GT + A E P+ D++S GV+ ++
Sbjct: 181 SVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 223
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 116 bits (292), Expect = 2e-31
Identities = 42/165 (25%), Positives = 78/165 (47%), Gaps = 7/165 (4%)
Query: 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ K E++ + + HH + L D +L+ +++S G L D + + + +
Sbjct: 67 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE 126
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCA--KISDFGLAKLMKPDQ 120
E + R G++++H E I+H DIKP+NI+ + K+ + KI DFGLA + PD+
Sbjct: 127 AEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
T T + A E P+ D+++ GV+ ++
Sbjct: 184 IVKVT--TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS 226
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 113 bits (283), Expect = 4e-30
Identities = 36/180 (20%), Positives = 69/180 (38%), Gaps = 8/180 (4%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM 66
+ ++ + V + + D M+ G L L + +
Sbjct: 52 LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMR 110
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTG 126
A +I G+ ++H+ +++ D+KP NIL+DE +ISD GLA +
Sbjct: 111 FYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HA 164
Query: 127 IRGTRAYVAAE-WHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQC 185
GT Y+A E + + AD +S G +L +++ Q+ +D+ +
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-29
Identities = 37/163 (22%), Positives = 64/163 (39%), Gaps = 6/163 (3%)
Query: 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ E + H + N V +Y++ G L+ + + K
Sbjct: 44 DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD-L 102
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
A +I G+++L I++ D+K NIL+D+ KI+DFG+ K +
Sbjct: 103 SRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
GT Y+A E D +SFGV+L E++ +
Sbjct: 160 -TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 107 bits (267), Expect = 2e-28
Identities = 50/237 (21%), Positives = 99/237 (41%), Gaps = 23/237 (9%)
Query: 1 MLAEGEREFKTEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQ 59
+ E E++ + + H N ++L + LV+D M G L D L T +
Sbjct: 48 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVT 106
Query: 60 PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD 119
+ E I R + I LH + I+H D+KP+NIL+D+ K++DFG + + P
Sbjct: 107 LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 163
Query: 120 QTRTFTGIRGTRAYVAAEWHR------NLPITVKADVYSFGVVLLEIVCLRRCLDQNLLE 173
+ + GT +Y+A E + + D++S GV++ ++
Sbjct: 164 EKL--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH---R 218
Query: 174 DRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230
+ ++ I +GN + + ++ ++ R ++ +P R ++ L
Sbjct: 219 KQMLMLRMIM----SGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEAL 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (267), Expect = 3e-28
Identities = 36/240 (15%), Positives = 74/240 (30%), Gaps = 18/240 (7%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ E + + + + ++ + SL D+ ++ +
Sbjct: 44 TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLK 103
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKI---SDFGLAKLMKPDQ 120
+ +A + I Y+H IH D+KP N LM + + DFGLAK + +
Sbjct: 104 TVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160
Query: 121 TRTF------TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLED 174
T + GT Y + H + + + D+ S G VL+
Sbjct: 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220
Query: 175 RAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234
+ E I + + + L + + + C + + +
Sbjct: 221 KRQKYERISEKKMSTPIEVLCKG---YPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (261), Expect = 3e-27
Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 9/163 (5%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
E + E+ + + H N V L + L+ +S G L D + + +
Sbjct: 51 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDA 109
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNIL---MDEKRCAKISDFGLAKLMKPDQTR 122
+ + ++YLHD I+H D+KP+N+L +DE ISDFGL+K+ P
Sbjct: 110 SRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
+ GT YVA E P + D +S GV+ ++C
Sbjct: 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 102 bits (256), Expect = 6e-27
Identities = 36/168 (21%), Positives = 67/168 (39%), Gaps = 10/168 (5%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI----LVYDYMSNGSLVDVLFTPEKQ 59
F+ E +H V + + +V +Y+ +L D++ T
Sbjct: 49 SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM 108
Query: 60 PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPD 119
+ + D + + + + IIH D+KP NI++ K+ DFG+A+ +
Sbjct: 109 T-PKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164
Query: 120 QTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
+ GT Y++ E R + ++DVYS G VL E++
Sbjct: 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 102 bits (256), Expect = 9e-27
Identities = 31/203 (15%), Positives = 68/203 (33%), Gaps = 14/203 (6%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
+ + E + + Y ++ + SL D+L ++ +
Sbjct: 44 APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTV 103
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEK-----RCAKISDFGLAKLMKPDQ 120
A+ + ++ +H E +++ DIKP N L+ + DFG+ K +
Sbjct: 104 AMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160
Query: 121 TRTF------TGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLED 174
T+ + GT Y++ H + + D+ + G V + +
Sbjct: 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220
Query: 175 RAILQEWICQCFENGNLSQLVED 197
E I + ++ L +L
Sbjct: 221 NKQKYERIGEKKQSTPLRELCAG 243
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 2e-26
Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ E + H +R+ G D ++ DY+ G L +L ++ PN V
Sbjct: 46 KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV 105
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
+ A ++ + YLH + II+ D+KP+NIL+D+ KI+DFG AK + PD T T
Sbjct: 106 AKF-YAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTYT 160
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
G Y+A E P D +SFG+++ E++
Sbjct: 161 LCGTPD---YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-25
Identities = 48/233 (20%), Positives = 87/233 (37%), Gaps = 22/233 (9%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK----ILVYDYMSNGSLVDVLFTPEKQP- 60
RE + A + VR++ ++ ++V + + G L + Q
Sbjct: 52 RREVELHWRAS---QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 108
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRC---AKISDFGLAKLMK 117
E I + I I+YLH I H D+KP+N+L KR K++DFG AK
Sbjct: 109 TEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAI 177
+ T T YVA E D++S GV++ ++C N
Sbjct: 166 SHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLA 220
Query: 178 LQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230
+ + G + ++++ +I+ + EP+ R + + +
Sbjct: 221 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFM 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 2e-25
Identities = 44/160 (27%), Positives = 66/160 (41%), Gaps = 6/160 (3%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
R E+ + H N + LL SN LV+D+M ++
Sbjct: 44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHI 102
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+G+ YLH I+H D+KP N+L+DE K++DFGLAK R +T
Sbjct: 103 KAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYT 158
Query: 126 GIRGTRAYVAAE-WHRNLPITVKADVYSFGVVLLEIVCLR 164
TR Y A E V D+++ G +L E++
Sbjct: 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.6 bits (245), Expect = 2e-25
Identities = 38/185 (20%), Positives = 70/185 (37%), Gaps = 12/185 (6%)
Query: 4 EGEREFKTEMNAIGR--THHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPN 61
E+ + + + +RLL + + +L+ + + T
Sbjct: 49 PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ 108
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKR-CAKISDFGLAKLMKPDQ 120
+ +R+ ++H DIK +NIL+D R K+ DFG L+K
Sbjct: 109 EELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 165
Query: 121 TRTFTGIRGTRAYVAAEWHRNLP-ITVKADVYSFGVVLLEIVCLRR--CLDQNLLEDRAI 177
F GTR Y EW R A V+S G++L ++VC D+ ++ +
Sbjct: 166 YTDFD---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 222
Query: 178 LQEWI 182
++ +
Sbjct: 223 FRQRV 227
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 5e-25
Identities = 39/162 (24%), Positives = 59/162 (36%), Gaps = 5/162 (3%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ TE + T H L V +Y + G L L
Sbjct: 47 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER 106
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
R +I L +++ DIK +N+++D+ KI+DFGL K D
Sbjct: 107 ARF-YGAEIVSA---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
T GT Y+A E + D + GVV+ E++C R
Sbjct: 163 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 7e-25
Identities = 39/174 (22%), Positives = 63/174 (36%), Gaps = 13/174 (7%)
Query: 1 MLAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK------ILVYDYMSNGSLVDVLF 54
+ + +R E+ + + H N VRL + + K LV DY+
Sbjct: 52 KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 111
Query: 55 TPEKQP--NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNI-LMDEKRCAKISDFG 111
+ + + R + Y+H I H DIKPQN+ L + K+ DFG
Sbjct: 112 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG 168
Query: 112 LAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
AK + + + I T DV+S G VL E++ +
Sbjct: 169 SAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 2e-24
Identities = 38/165 (23%), Positives = 63/165 (38%), Gaps = 11/165 (6%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNK-----ILVYDYMSNGSLVDVLFTPEKQP 60
RE + + H N VRL LV++++ + PE
Sbjct: 55 IREVA-VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 113
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
+ + RG+ +LH ++H D+KPQNIL+ K++DFGLA++
Sbjct: 114 PTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 170
Query: 121 TRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
T + T Y A E D++S G + E+ +
Sbjct: 171 --ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 95.3 bits (236), Expect = 5e-24
Identities = 35/161 (21%), Positives = 65/161 (40%), Gaps = 4/161 (2%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
E++ + H N V+L +LV++++ + L +L E V
Sbjct: 42 GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV 100
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
+ GI Y H + +++H D+KPQN+L++ + KI+DFGLA+ +
Sbjct: 101 TAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
I + + D++S G + E+V
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 4e-23
Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 12/165 (7%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGY----SFDVSNKILVYDYMSNGSLVDVLFTPEKQPNW 62
+ E+ + R H N + + + + + + ++ L +L + +
Sbjct: 51 QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSN 108
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR 122
I RG++Y+H A ++H D+KP N+L++ KI DFGLA++ PD
Sbjct: 109 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165
Query: 123 --TFTGIRGTRAYVAAE-WHRNLPITVKADVYSFGVVLLEIVCLR 164
T TR Y A E + T D++S G +L E++ R
Sbjct: 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 4e-23
Identities = 29/162 (17%), Positives = 61/162 (37%), Gaps = 3/162 (1%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
E++ + +H N V+LL + LV++++ + +
Sbjct: 43 GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP 102
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
+ +G+ + H ++H D+KPQN+L++ + K++DFGLA+
Sbjct: 103 LIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
+ + D++S G + E+V R
Sbjct: 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 6e-23
Identities = 44/228 (19%), Positives = 89/228 (39%), Gaps = 20/228 (8%)
Query: 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERM 66
+ + E++ + H N + L + ++ IL+ + ++ G LF + +
Sbjct: 58 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEE 113
Query: 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDE----KRCAKISDFGLAKLMKPDQTR 122
+ + + ++ QI H D+KP+NI++ + K KI DFGLA +
Sbjct: 114 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
Query: 123 TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWI 182
I GT +VA E P+ ++AD++S GV+ ++ + ++
Sbjct: 174 KN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------T 224
Query: 183 CQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230
N E + I+ R ++ +P R ++ L
Sbjct: 225 LANVSAVNYEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSL 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.3 bits (228), Expect = 1e-22
Identities = 39/242 (16%), Positives = 82/242 (33%), Gaps = 17/242 (7%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKI--------LVYDYMSNGSLVDVLFTPE 57
E+ + H N V L+ ++ LV+D+ + +L
Sbjct: 53 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVL 111
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
+ E + + + G L+ +I+H D+K N+L+ K++DFGLA+
Sbjct: 112 VKFTLSEIKRVMQMLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168
Query: 118 PDQT---RTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCLRRCLDQNLLE 173
+ +T T Y E D++ G ++ E+ + N +
Sbjct: 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 228
Query: 174 DRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL-M 232
+ L +C + E ++ +L + K ++ L ++ +
Sbjct: 229 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 288
Query: 233 LE 234
L
Sbjct: 289 LV 290
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 88.3 bits (218), Expect = 5e-21
Identities = 36/162 (22%), Positives = 67/162 (41%), Gaps = 8/162 (4%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWV 63
+ E + + V+L D SN +V +Y++ G + L + +
Sbjct: 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEP 141
Query: 64 ERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT 123
A I YLH +I+ D+KP+N+L+D++ +++DFG AK +K
Sbjct: 142 HARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----R 194
Query: 124 FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
+ GT +A E + D ++ GV++ E+
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.3 bits (215), Expect = 5e-21
Identities = 27/160 (16%), Positives = 55/160 (34%), Gaps = 4/160 (2%)
Query: 6 EREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVER 65
E+ + H+N VRL LV+++ + +
Sbjct: 45 PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIV 103
Query: 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFT 125
+ +G+ + H ++H D+KPQN+L++ K+++FGLA+
Sbjct: 104 KSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
Query: 126 GIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLRR 165
+ + D++S G + E+ R
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.0 bits (204), Expect = 3e-19
Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 7/166 (4%)
Query: 3 AEGEREFKTEMNAIGR-THHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPN 61
A+ +TE + V L + L+ DY++ G L L E+
Sbjct: 69 AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE 128
Query: 62 WVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT 121
+ + + L + II+ DIK +NIL+D ++DFGL+K D+T
Sbjct: 129 HE----VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
Query: 122 RTFTGIRGTRAYVAAEWHR--NLPITVKADVYSFGVVLLEIVCLRR 165
GT Y+A + R + D +S GV++ E++
Sbjct: 185 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 83.0 bits (204), Expect = 3e-19
Identities = 31/165 (18%), Positives = 69/165 (41%), Gaps = 14/165 (8%)
Query: 6 EREFKTEMNAIGR-THHRNPVRLLGYSFDVSNK--ILVYDYMSNGSLVDVLFTPEKQPNW 62
+++ K E+ + N + L D ++ LV+++++N + +
Sbjct: 73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTD 128
Query: 63 VERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEK-RCAKISDFGLAKLMKPDQT 121
+ +I + + Y H I+H D+KP N+++D + R ++ D+GLA+ P Q
Sbjct: 129 YDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 122 RTFTGIRGTRAYVAAEWHRNLP-ITVKADVYSFGVVLLEIVCLRR 165
+R + E + D++S G +L ++ +
Sbjct: 186 YNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.1 bits (191), Expect = 2e-17
Identities = 38/167 (22%), Positives = 66/167 (39%), Gaps = 15/167 (8%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGY------SFDVSNKILVYDYMSNGSLVDVLFTPE 57
+ E+ + +H+N + LL + + LV + M + +
Sbjct: 58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQ 113
Query: 58 KQPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMK 117
+ + + + GI++LH IIH D+KP NI++ KI DFGLA+
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170
Query: 118 PDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164
T TR Y A E + D++S G ++ E+V +
Sbjct: 171 TSFMMTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (189), Expect = 4e-17
Identities = 38/165 (23%), Positives = 64/165 (38%), Gaps = 11/165 (6%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVL---FTPEKQP 60
+ E+ + H N + LL D+ + ++
Sbjct: 59 LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL 118
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQ 120
+ + +G+RY+H IIH D+KP N+ ++E KI DFGLA+
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS-- 173
Query: 121 TRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCLR 164
TG TR Y A E N + T D++S G ++ E++ +
Sbjct: 174 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.9 bits (183), Expect = 2e-16
Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 15/167 (8%)
Query: 4 EGEREFKTEMNAIGRTHHRNPVRLLGY-----SFDVSNKILVYDYMSNGSLVDVLFTPEK 58
+ E+ + H N + LL S + N + + ++ L + +
Sbjct: 59 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQ 116
Query: 59 QPNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKP 118
+ + I RG++Y+H IIH D+KP N+ ++E KI DFGLA+
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 119 DQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLLEIVCLR 164
TG TR Y A E N + D++S G ++ E++ R
Sbjct: 174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 68.9 bits (167), Expect = 3e-14
Identities = 34/174 (19%), Positives = 69/174 (39%), Gaps = 8/174 (4%)
Query: 20 HHRNPVRLLGY----SFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARG 75
+ ++LL + + + ++V++ + L + + + I++ + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 76 IRYLHDECEAQIIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAY 133
+ Y+H C IIH DIKP+N+LM+ + +A L +T TR Y
Sbjct: 138 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 134 VAAEWHRNLPITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFE 187
+ E P AD++S ++ E++ + + + I Q E
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 59.4 bits (143), Expect = 2e-11
Identities = 17/114 (14%), Positives = 34/114 (29%), Gaps = 16/114 (14%)
Query: 5 GEREFKTEMNAIGRTHHRNPVRLLG----YSFDVSNKILVYDYMSNGSLVDVLFTPEKQP 60
G+ F R R +L G + ++ + + +
Sbjct: 49 GDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRV 100
Query: 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114
+ I + + I+HGD+ N+L+ E+ I DF +
Sbjct: 101 RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 252 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.96 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.51 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.87 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.99 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.09 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 83.46 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-51 Score=332.50 Aligned_cols=220 Identities=24% Similarity=0.388 Sum_probs=174.5
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
.+.+++|.+|+.+|++++|||||++++++.+.+..++||||+++|+|.+++....+.+++..++.++.||++||.|||+.
T Consensus 68 ~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 147 (299)
T d1jpaa_ 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 147 (299)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 45678899999999999999999999999999999999999999999999987777899999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc----ccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR----TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
+++||||||+|||++.++.+||+|||+++........ ...+..+++.|+|||.+.+..++.++||||||+++|
T Consensus 148 ---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ 224 (299)
T d1jpaa_ 148 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 224 (299)
T ss_dssp ---TCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred ---CCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHH
Confidence 9999999999999999999999999999876543221 122345788999999999989999999999999999
Q ss_pred HHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 159 EIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 159 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
+|+| |..||......+ +. ..+..+.... . +...+..+.+++.+||+.||++|||+.||++.|++++
T Consensus 225 el~t~g~~Pf~~~~~~~---~~----~~i~~~~~~~--~----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 225 EVMSYGERPYWDMTNQD---VI----NAIEQDYRLP--P----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp HHHTTSCCTTTTCCHHH---HH----HHHHTTCCCC--C----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHH---HH----HHHHcCCCCC--C----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 9998 889997654432 11 1222222111 1 2223345788899999999999999999999999876
Q ss_pred C
Q 038713 238 E 238 (252)
Q Consensus 238 ~ 238 (252)
+
T Consensus 292 ~ 292 (299)
T d1jpaa_ 292 R 292 (299)
T ss_dssp H
T ss_pred c
Confidence 5
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=325.64 Aligned_cols=225 Identities=27% Similarity=0.411 Sum_probs=177.7
Q ss_pred chHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 2 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
..+..+.|.+|+.++++++|||||++++++.+ +..++||||+++|+|.+++......+++..++.++.||++||.|||+
T Consensus 44 ~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~ 122 (276)
T d1uwha_ 44 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122 (276)
T ss_dssp CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 35667899999999999999999999998764 56899999999999999998777789999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCC---CCCCcccchhHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNL---PITVKADVYSFGVVL 157 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~~l 157 (252)
+ +++||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+. .++.++||||||+++
T Consensus 123 ~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l 199 (276)
T d1uwha_ 123 K---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199 (276)
T ss_dssp T---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHH
T ss_pred C---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHH
Confidence 9 999999999999999999999999999987653322 233445789999999998653 478999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
|+|+||+.||........ + ......+...... ...+...+..+.+++.+||+.||++|||++||++.|+.+.
T Consensus 200 ~el~tg~~Pf~~~~~~~~--~----~~~~~~~~~~p~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 200 YELMTGQLPYSNINNRDQ--I----IFMVGRGYLSPDL--SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp HHHHHSSCTTTTCCCHHH--H----HHHHHHTSCCCCG--GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCCCChHHH--H----HHHHhcCCCCCcc--hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 999999999986544332 1 1122222221111 1122233455888889999999999999999999998754
Q ss_pred C
Q 038713 238 E 238 (252)
Q Consensus 238 ~ 238 (252)
+
T Consensus 272 ~ 272 (276)
T d1uwha_ 272 R 272 (276)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=323.94 Aligned_cols=220 Identities=25% Similarity=0.380 Sum_probs=171.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+++|.+|++++++++||||+++++++.+.+..++||||+++|+|.+++......+++..++.++.||+.||.|||+.
T Consensus 42 ~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~- 120 (263)
T d1sm2a_ 42 MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA- 120 (263)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc-
Confidence 3567899999999999999999999999999999999999999999999987777899999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.+||+|||+++..............|+..|+|||++.+..++.++||||||+++|+|+|+
T Consensus 121 --~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~ 198 (263)
T d1sm2a_ 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 198 (263)
T ss_dssp --TCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --ceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHC
Confidence 999999999999999999999999999987655444444445688999999999999999999999999999999996
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
+.|+....... .+.. . ...+... ..+.. ....+.+++.+||+.||++|||++||++.|+++.+
T Consensus 199 ~~~~~~~~~~~--~~~~---~-i~~~~~~--~~p~~----~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 199 GKIPYENRSNS--EVVE---D-ISTGFRL--YKPRL----ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp SCCTTCSCCHH--HHHH---H-HHHTCCC--CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHH--HHHH---H-HHhcCCC--CCccc----cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 65554433221 1111 1 1222111 11112 23457888889999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=320.86 Aligned_cols=217 Identities=19% Similarity=0.282 Sum_probs=180.6
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
+...++|.+|+++|++++|||||++++++.+ +..++||||+++|+|.+++...++.+++..++.++.||+.||.|||++
T Consensus 50 ~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~ 128 (285)
T d1u59a_ 50 KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 128 (285)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4567889999999999999999999999875 568999999999999999877777899999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--ccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++||||||+||+++.++.+|++|||+++........ ......|++.|+|||++.+..++.++||||||+++|+|
T Consensus 129 ---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~ 205 (285)
T d1u59a_ 129 ---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 205 (285)
T ss_dssp ---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred ---CeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHH
Confidence 9999999999999999999999999999876543332 22234578899999999988899999999999999999
Q ss_pred Hh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 161 VC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 161 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
+| |..||......+ + ...+..+..... +...+..+.+++.+||+.||++|||+.+|.+.|+.+
T Consensus 206 lt~G~~Pf~~~~~~~---~----~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 206 LSYGQKPYKKMKGPE---V----MAFIEQGKRMEC------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HTTSCCTTTTCCTHH---H----HHHHHTTCCCCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCCCCCCCCCHHH---H----HHHHHcCCCCCC------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 98 899998654332 1 122333332221 122334578889999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=317.27 Aligned_cols=206 Identities=23% Similarity=0.339 Sum_probs=173.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++.+.+|++++++++||||+++++++.+.+..++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++
T Consensus 49 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~-- 125 (263)
T d2j4za1 49 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSK-- 125 (263)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 467899999999999999999999999999999999999999999999964 34689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+||+++.++.+|++|||.+....... .....||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 126 -~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~ 201 (263)
T d2j4za1 126 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 201 (263)
T ss_dssp -TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -CeeeeeeccccceecCCCCEeecccceeeecCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCC
Confidence 99999999999999999999999999997654332 23356899999999999989999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.||........ . .....+.... +...+..+.+++.+||+.||++|||++|+++
T Consensus 202 ~Pf~~~~~~~~------~-~~i~~~~~~~-------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 202 PPFEANTYQET------Y-KRISRVEFTF-------PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CTTCCSSHHHH------H-HHHHTTCCCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCHHHH------H-HHHHcCCCCC-------CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 99976543321 1 1122222211 1112344778888999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=317.49 Aligned_cols=212 Identities=25% Similarity=0.326 Sum_probs=170.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..++|.+|+.++++++||||+++++++.+.+..|+||||+++|+|.+++.. .+.+++..++.++.||++||.|||++
T Consensus 46 ~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~-- 122 (271)
T d1nvra_ 46 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI-- 122 (271)
T ss_dssp ---CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc--
Confidence 456789999999999999999999999999999999999999999999964 45689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCC-CCcccchhHHHHHHHHHh
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPI-TVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+|||++.++.+||+|||.++....... .......||+.|+|||++.+..+ +.++||||+|+++|+|++
T Consensus 123 -~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~ 201 (271)
T d1nvra_ 123 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 201 (271)
T ss_dssp -TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred -CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHh
Confidence 999999999999999999999999999987643322 23344679999999999988765 578999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|+.||........... ......... ...... ...+.+++.+||+.||++|||++|+++
T Consensus 202 G~~pf~~~~~~~~~~~-----~~~~~~~~~--~~~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 202 GELPWDQPSDSCQEYS-----DWKEKKTYL--NPWKKI----DSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp SSCSCSSSSTTSHHHH-----HHHTTCTTS--TTGGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCChHHHHHH-----HHhcCCCCC--CccccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9999976544332111 111111111 111122 234667888999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-49 Score=320.38 Aligned_cols=221 Identities=23% Similarity=0.332 Sum_probs=184.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT-PEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
...++|.+|+++|++++|||||++++++.+.+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++
T Consensus 55 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~ 134 (287)
T d1opja_ 55 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134 (287)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC
Confidence 3467899999999999999999999999999999999999999999999864 456789999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+|||++.++.+||+|||.++..............|+..|+|||++.+..++.++||||||+++|+|++
T Consensus 135 ---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~ 211 (287)
T d1opja_ 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211 (287)
T ss_dssp ---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred ---CcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHh
Confidence 99999999999999999999999999998776555544455668889999999999899999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~ 239 (252)
|+.||........ +. .....+.... .+...+..+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 212 ~~~p~~~~~~~~~--~~----~~i~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 212 YGMSPYPGIDLSQ--VY----ELLEKDYRME------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp TSCCSSTTCCHHH--HH----HHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCCCCcchHHH--HH----HHHhcCCCCC------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 8887765433321 11 2222222111 1122234588889999999999999999999999987653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=315.61 Aligned_cols=210 Identities=22% Similarity=0.312 Sum_probs=174.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++.+.+|+.++++++||||+++++++.+.+..|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++
T Consensus 60 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~-- 135 (293)
T d1yhwa1 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN-- 135 (293)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 467899999999999999999999999999999999999999999998854 3589999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+|||++.++.++++|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 136 -~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~ 213 (293)
T d1yhwa1 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (293)
T ss_dssp -TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCC
Confidence 999999999999999999999999999987654332 223456899999999999989999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.||........ .......+.. ....+ ......+.+++.+||+.||++|||++|+++
T Consensus 214 ~Pf~~~~~~~~------~~~~~~~~~~-~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 214 PPYLNENPLRA------LYLIATNGTP-ELQNP----EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CTTTTSCHHHH------HHHHHHHCSC-CCSSG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCCHHHH------HHHHHhCCCC-CCCCc----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99976543321 1112222221 11111 222345778888999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=320.62 Aligned_cols=213 Identities=21% Similarity=0.317 Sum_probs=174.3
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..++|.+|+++|++++|||||++++++.+.+..++||||+++|+|.+++.+..+.+++..+..++.||+.||.|||++
T Consensus 51 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~- 129 (288)
T d2jfla1 51 EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN- 129 (288)
T ss_dssp GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 4557799999999999999999999999999999999999999999999876667799999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc-----CCCCCCcccchhHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-----NLPITVKADVYSFGVVLL 158 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~~l~ 158 (252)
+++||||||+|||++.++.+||+|||+++...... .......||+.|+|||++. +..++.++|||||||++|
T Consensus 130 --~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvily 206 (288)
T d2jfla1 130 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 206 (288)
T ss_dssp --TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHH
T ss_pred --CEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHH
Confidence 99999999999999999999999999987543211 1223456899999999984 445789999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|++|+.||......+. + .. ...+.......+.. .+..+.+++.+||+.||++|||++|+++
T Consensus 207 emltg~~Pf~~~~~~~~--~----~~-i~~~~~~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 207 EMAEIEPPHHELNPMRV--L----LK-IAKSEPPTLAQPSR----WSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHSSCTTTTSCGGGH--H----HH-HHHSCCCCCSSGGG----SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhhCCCCCCCCCHHHH--H----HH-HHcCCCCCCCcccc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999999976644431 1 11 12222222222222 2344778888999999999999999976
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=318.26 Aligned_cols=216 Identities=20% Similarity=0.340 Sum_probs=164.1
Q ss_pred chHhHHHHHHHHHHHhCCCCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcC---CCCCCCHHHHHHHHHHHHHHH
Q 038713 2 LAEGEREFKTEMNAIGRTHHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFT---PEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 2 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l 76 (252)
++..++.|.+|++++++++||||+++++++.+ .+.+|+|||||++|+|.+++.+ ..+.+++..++.++.||+.||
T Consensus 43 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al 122 (269)
T d2java1 43 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122 (269)
T ss_dssp CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999865 5678999999999999999854 345799999999999999999
Q ss_pred HHHhhcC--CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHH
Q 038713 77 RYLHDEC--EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFG 154 (252)
Q Consensus 77 ~~lh~~~--~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 154 (252)
.|||++. ..+++||||||+|||++.++.+||+|||.++....... ......||+.|+|||++.+..++.++||||||
T Consensus 123 ~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlG 201 (269)
T d2java1 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLG 201 (269)
T ss_dssp HHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHH
T ss_pred HHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhC
Confidence 9999971 12399999999999999999999999999987654332 22345789999999999998999999999999
Q ss_pred HHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 155 VVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 155 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|++|+|++|+.||......+ + ...+..+....+. ...+..+.+++.+||+.||++|||++|+++
T Consensus 202 vilyel~tg~~Pf~~~~~~~---~----~~~i~~~~~~~~~------~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 202 CLLYELCALMPPFTAFSQKE---L----AGKIREGKFRRIP------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHHSSCSCCCSSHHH---H----HHHHHHTCCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCCCCCCCHHH---H----HHHHHcCCCCCCC------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 99999999999997654332 1 1222333333221 122335788888999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=317.62 Aligned_cols=215 Identities=22% Similarity=0.298 Sum_probs=175.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+++|.+|+++|++++|||||++++++.+ +..++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.
T Consensus 50 ~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~- 126 (277)
T d1xbba_ 50 ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES- 126 (277)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhC-
Confidence 456789999999999999999999999965 568999999999999999864 44689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc--ccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR--TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++||||||+||+++.++.++++|||+++........ ......|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 127 --~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ell 204 (277)
T d1xbba_ 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 204 (277)
T ss_dssp --TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred --CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHh
Confidence 9999999999999999999999999999876543332 222346788999999999888999999999999999999
Q ss_pred h-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 162 C-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 162 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
| |+.||......+ + ...+..+..... +...+..+.+++.+||+.||++|||+++|++.|+..
T Consensus 205 t~g~~Pf~~~~~~~---~----~~~i~~~~~~~~------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 205 SYGQKPYRGMKGSE---V----TAMLEKGERMGC------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TTTCCSSTTCCHHH---H----HHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHH---H----HHHHHcCCCCCC------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 8 899998654332 1 122333332221 122334578889999999999999999999998874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-49 Score=312.44 Aligned_cols=216 Identities=20% Similarity=0.331 Sum_probs=182.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+++|.+|+.++++++||||+++++++.+++.+++||||+++|+|.+++......+++..+++++.|+++||.|||+.
T Consensus 41 ~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~- 119 (258)
T d1k2pa_ 41 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK- 119 (258)
T ss_dssp SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc-
Confidence 3567899999999999999999999999999999999999999999999888777899999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh-
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC- 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 162 (252)
+++||||||+||+++.++.+||+|||.++..............++..|+|||++.+..++.++||||||+++|+|+|
T Consensus 120 --~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~ 197 (258)
T d1k2pa_ 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 197 (258)
T ss_dssp --TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhc
Confidence 99999999999999999999999999998765544444444668899999999999899999999999999999998
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
|+.||......+ + ...+..+... ..+.. .+..+.+++.+||+.||++|||+++|++.|.+
T Consensus 198 g~~Pf~~~~~~~---~----~~~i~~~~~~--~~p~~----~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 198 GKMPYERFTNSE---T----AEHIAQGLRL--YRPHL----ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp SCCTTTTSCHHH---H----HHHHHTTCCC--CCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCCCCHHH---H----HHHHHhCCCC--CCccc----ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 788997664432 1 1222233221 11122 22457888889999999999999999999876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-49 Score=316.33 Aligned_cols=222 Identities=23% Similarity=0.384 Sum_probs=176.9
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
...+++|.+|++++++++|||||++++++.+.+..++||||+.+|++.+++....+.+++..++.++.||+.||.|||+.
T Consensus 50 ~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~ 129 (283)
T d1mqba_ 50 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 129 (283)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc
Confidence 45567899999999999999999999999999999999999999999999877777899999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--cccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++||||||+|||++.++.+||+|||+++....... .......||..|+|||++.+..++.++||||||+++|+|
T Consensus 130 ---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el 206 (283)
T d1mqba_ 130 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 206 (283)
T ss_dssp ---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred ---ccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHH
Confidence 999999999999999999999999999987643322 222335678899999999999999999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCC
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEI 239 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~ 239 (252)
++++.|+........ +. ..+..+..... +...+..+.+++.+||+.||++|||+.||++.|+++++.
T Consensus 207 ~t~~~~~~~~~~~~~--~~----~~i~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 207 MTYGERPYWELSNHE--VM----KAINDGFRLPT------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HTTSCCTTTTCCHHH--HH----HHHHTTCCCCC------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HhCCCCccccCCHHH--HH----HHHhccCCCCC------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 998777655433321 11 22223222111 122334588889999999999999999999999987764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=311.96 Aligned_cols=210 Identities=25% Similarity=0.343 Sum_probs=168.9
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEec----CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFD----VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
...+++|.+|+++|++++|||||++++++.+ ...+++||||+++|+|.+++.+ .+.+++..++.++.||++||+|
T Consensus 49 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~y 127 (270)
T d1t4ha_ 49 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQF 127 (270)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHH
Confidence 4567789999999999999999999999875 4567999999999999999964 3468999999999999999999
Q ss_pred HhhcCCCC--eeeeccCCCCEEec-CCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHH
Q 038713 79 LHDECEAQ--IIHGDIKPQNILMD-EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGV 155 (252)
Q Consensus 79 lh~~~~~~--i~h~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 155 (252)
||++ + ++||||||+|||++ +++.+||+|||+++..... ......||+.|+|||++.+ .++.++|||||||
T Consensus 128 LH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGv 200 (270)
T d1t4ha_ 128 LHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGM 200 (270)
T ss_dssp HHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHH
T ss_pred HHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHH
Confidence 9998 7 99999999999997 5789999999999864332 2234678999999999876 5999999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|+|++|+.||........ +......+..... .+......+.+++.+||++||++|||++|+++
T Consensus 201 ilyel~~g~~Pf~~~~~~~~------~~~~i~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 201 CMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPAS-----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCGG-----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHCCCCCCCcccHHH------HHHHHHcCCCCcc-----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 99999999999975543321 1122222222111 11112234778888999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=314.89 Aligned_cols=218 Identities=28% Similarity=0.411 Sum_probs=176.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
...+.|.+|+.++++++|||||++++++.+ +..++||||+++|+|.+++.... ..+++..++.++.||++||.|||++
T Consensus 50 ~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~ 128 (272)
T d1qpca_ 50 MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128 (272)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 346789999999999999999999998764 56799999999999999885533 3589999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||++++++.+||+|||+++..............|+..|+|||++.+..++.++||||||+++|+|+|
T Consensus 129 ---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt 205 (272)
T d1qpca_ 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205 (272)
T ss_dssp ---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred ---CcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHh
Confidence 99999999999999999999999999998776544444445668899999999998889999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
|+.|+.......+ . . ..+..+.... .+ ...+..+.+++.+||+.||++|||+++|++.|++.+
T Consensus 206 ~~~~~~~~~~~~~--~---~-~~i~~~~~~~--~p----~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 206 HGRIPYPGMTNPE--V---I-QNLERGYRMV--RP----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp TTCCSSTTCCHHH--H---H-HHHHTTCCCC--CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHH--H---H-HHHHhcCCCC--Cc----ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 7776654433321 1 1 1222222111 11 122345788889999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=313.94 Aligned_cols=219 Identities=20% Similarity=0.286 Sum_probs=170.5
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
.+.++.|.+|+.++++++||||+++++++. .+..++||||+++|+|.+++......+++..++.++.||++||.|||+.
T Consensus 49 ~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 127 (273)
T d1mp8a_ 49 DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 127 (273)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc
Confidence 345788999999999999999999999986 4678999999999999999877777899999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++.+|++|||+++..............|++.|+|||++.+..++.++||||||+++|+|++
T Consensus 128 ---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt 204 (273)
T d1mp8a_ 128 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 204 (273)
T ss_dssp ---TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred ---CeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHh
Confidence 99999999999999999999999999998765444434444567899999999999899999999999999999998
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
|..||......+. ...+..+..... +...+..+.++|.+||+.||++|||+.||++.|+++++
T Consensus 205 ~g~~P~~~~~~~~~-------~~~i~~~~~~~~------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 205 HGVKPFQGVKNNDV-------IGRIENGERLPM------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp TSCCTTTTCCGGGH-------HHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHH-------HHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 7888876544431 122223332221 22233458888899999999999999999999987653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=320.10 Aligned_cols=216 Identities=21% Similarity=0.308 Sum_probs=176.5
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC----------------------CCC
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE----------------------KQP 60 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~ 60 (252)
..++.|.+|+.+++++ +|||||++++++.+.+..++|||||++|+|.+++.... ..+
T Consensus 82 ~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 161 (325)
T d1rjba_ 82 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161 (325)
T ss_dssp --CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------C
T ss_pred HHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCC
Confidence 3456799999999998 99999999999999999999999999999999996543 247
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccc
Q 038713 61 NWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWH 139 (252)
Q Consensus 61 ~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~ 139 (252)
++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++........ ......||+.|+|||++
T Consensus 162 ~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l 238 (325)
T d1rjba_ 162 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH
Confidence 8899999999999999999999 9999999999999999999999999999876544332 23345679999999999
Q ss_pred cCCCCCCcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCC
Q 038713 140 RNLPITVKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILD 218 (252)
Q Consensus 140 ~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 218 (252)
.+..++.++|||||||++|+|+| |..||........ + ......+.... .+...+..+.++|.+||+.
T Consensus 239 ~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~--~----~~~~~~~~~~~------~p~~~~~~l~~li~~cl~~ 306 (325)
T d1rjba_ 239 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN--F----YKLIQNGFKMD------QPFYATEEIYIIMQSCWAF 306 (325)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--H----HHHHHTTCCCC------CCTTCCHHHHHHHHHHTCS
T ss_pred cCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH--H----HHHHhcCCCCC------CCCcCCHHHHHHHHHHcCC
Confidence 99899999999999999999997 8999976544321 1 12223322111 1122234588888899999
Q ss_pred CCCCCCCHHHHHHHhh
Q 038713 219 EPSLRRAMKKVLLMLE 234 (252)
Q Consensus 219 ~p~~Rps~~~i~~~l~ 234 (252)
||++|||++||++.|.
T Consensus 307 dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 307 DSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SGGGSCCHHHHHHHHH
T ss_pred ChhHCcCHHHHHHHHh
Confidence 9999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=315.26 Aligned_cols=208 Identities=20% Similarity=0.244 Sum_probs=170.4
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|++++++++||||+++++++.+.+..|+||||++||+|.+++.. .+.+++..++.++.|++.||.|||+.
T Consensus 51 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~-- 127 (288)
T d1uu3a_ 51 KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGK-- 127 (288)
T ss_dssp CHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccc--
Confidence 456799999999999999999999999999999999999999999999854 34689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+||+++.++.++++|||.++....... .......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 128 -~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g 206 (288)
T d1uu3a_ 128 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206 (288)
T ss_dssp -TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred -cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhC
Confidence 999999999999999999999999999987654332 233345689999999999999999999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVL 230 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~ 230 (252)
..||........ ......+.... +.. ....+.++|.+||+.||++|||++|++
T Consensus 207 ~~Pf~~~~~~~~-------~~~i~~~~~~~---p~~----~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 207 LPPFRAGNEYLI-------FQKIIKLEYDF---PEK----FFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp SCSSCCSSHHHH-------HHHHHTTCCCC---CTT----CCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCCCCCcCHHHH-------HHHHHcCCCCC---Ccc----CCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 999986543321 11222232211 112 233477888899999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.6e-47 Score=313.09 Aligned_cols=213 Identities=21% Similarity=0.294 Sum_probs=177.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..++.+.+|+.+|++++|||||++++++.+.+.+|+|||||+||+|.+++......+++..++.++.||+.||.|||+.
T Consensus 68 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~- 146 (352)
T d1koba_ 68 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH- 146 (352)
T ss_dssp HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 3467889999999999999999999999999999999999999999999877777799999999999999999999999
Q ss_pred CCCeeeeccCCCCEEec--CCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMD--EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++||||||+|||++ .++.++|+|||++........ .....|++.|+|||++.+..++.++|||||||++|+|+
T Consensus 147 --~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 222 (352)
T d1koba_ 147 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 222 (352)
T ss_dssp --TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred --CeeecccccccccccccCCCeEEEeecccceecCCCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHH
Confidence 999999999999997 678999999999987654332 23356899999999999999999999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||........ . .....+....... .....+..+.++|.+||+.||++|||++|+++
T Consensus 223 tG~~Pf~~~~~~~~------~-~~i~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 223 SGLSPFAGEDDLET------L-QNVKRCDWEFDED---AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HSCCSSCCSSHHHH------H-HHHHHCCCCCCSS---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCCCHHHH------H-HHHHhCCCCCCcc---cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999986644431 1 1122222221111 11222344778888999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-48 Score=309.82 Aligned_cols=226 Identities=25% Similarity=0.374 Sum_probs=176.1
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
...+.|.+|+.++++++|||||++++++.+ +..++||||+++|+|..++... .+.+++..++.++.||+.||+|||+.
T Consensus 54 ~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~ 132 (285)
T d1fmka3 54 MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132 (285)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh
Confidence 345789999999999999999999999854 5689999999999999998653 35689999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++.++|+|||+++..............|++.|+|||++.+..++.++||||||+++|+|++
T Consensus 133 ---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t 209 (285)
T d1fmka3 133 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 209 (285)
T ss_dssp ---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---heecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHh
Confidence 99999999999999999999999999998765444434444568999999999999899999999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcCCCCC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVEIPIP 242 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~~~~~ 242 (252)
|+.|+........ ... . +..+.... .+...+..+.+++.+||+.||++|||+++|+++|++.+....|
T Consensus 210 ~~~p~~~~~~~~~--~~~---~-i~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 210 KGRVPYPGMVNRE--VLD---Q-VERGYRMP------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp TTCCSSTTCCHHH--HHH---H-HHTTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCCCCCCHHH--HHH---H-HHhcCCCC------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 8777765543321 111 1 22222111 1222334578888899999999999999999999997766655
Q ss_pred CCC
Q 038713 243 QNP 245 (252)
Q Consensus 243 ~~~ 245 (252)
+-+
T Consensus 278 ~~~ 280 (285)
T d1fmka3 278 QYQ 280 (285)
T ss_dssp CCC
T ss_pred CCC
Confidence 443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=318.28 Aligned_cols=217 Identities=19% Similarity=0.315 Sum_probs=171.4
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD- 81 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~- 81 (252)
+..++++.+|+.+|++++|||||++++++.+.+..++||||++||+|.+++.+. +.+++..++.++.|++.||.|||+
T Consensus 45 ~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~ 123 (322)
T d1s9ja_ 45 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK 123 (322)
T ss_dssp TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 345678999999999999999999999999999999999999999999999643 468999999999999999999996
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
. +|+||||||+|||++.++.+||+|||+++...... .....||..|+|||++.+..++.++||||+||++|+|+
T Consensus 124 ~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell 197 (322)
T d1s9ja_ 124 H---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197 (322)
T ss_dssp H---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHH
T ss_pred C---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 6 89999999999999999999999999998654322 22357899999999999999999999999999999999
Q ss_pred hCCccccccchhhhHHHHHH-HHH----------------------------------HHhcCCcccccccchhcHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEW-ICQ----------------------------------CFENGNLSQLVEDEEVDQKQLQ 206 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~-~~~----------------------------------~~~~~~~~~~~~~~~~~~~~~~ 206 (252)
+|+.||.............. ... ......... .. ......
T Consensus 198 ~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~s~ 272 (322)
T d1s9ja_ 198 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK-LP----SGVFSL 272 (322)
T ss_dssp HSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCC-CC----BTTBCH
T ss_pred HCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCcc-Cc----cccCCH
Confidence 99999976544322111000 000 000000000 00 001124
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 207 RMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 207 ~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.+.+++.+||..||++|||++|+++
T Consensus 273 ~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 273 EFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhh
Confidence 5778888999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-47 Score=309.62 Aligned_cols=211 Identities=22% Similarity=0.273 Sum_probs=159.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++.+.+|+.+|++++||||+++++++.+.+.+|+|||||+||+|.+++.. .+.+++..+..++.||+.||.|||+.
T Consensus 50 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~-- 126 (307)
T d1a06a_ 50 KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDL-- 126 (307)
T ss_dssp -----CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhc--
Confidence 356788999999999999999999999999999999999999999999965 45699999999999999999999999
Q ss_pred CCeeeeccCCCCEEec---CCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMD---EKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 85 ~~i~h~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++||||||+||++. .++.++++|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 127 -~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell 203 (307)
T d1a06a_ 127 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 203 (307)
T ss_dssp -TCCCSCCCGGGEEESSSSTTCCEEECCC--------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred -eeeeEEecccceeecccCCCceEEEeccceeEEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHH
Confidence 999999999999995 47889999999998654332 223356899999999999999999999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||........ . .....+....... .....+..+.+++.+||+.||++|||++|+++
T Consensus 204 ~g~~Pf~~~~~~~~------~-~~i~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 204 CGYPPFYDENDAKL------F-EQILKAEYEFDSP---YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HSSCSCCCSSHHHH------H-HHHHTTCCCCCTT---TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCHHHH------H-HHHhccCCCCCCc---cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 99999976543321 1 1122222221111 11222344788888999999999999999988
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.8e-47 Score=312.20 Aligned_cols=213 Identities=19% Similarity=0.307 Sum_probs=175.9
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|+.+|++++|||||++++++.+.+..++||||++||+|.+++....+.+++..++.++.||+.||.|||++
T Consensus 65 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~- 143 (350)
T d1koaa2 65 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN- 143 (350)
T ss_dssp HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc-
Confidence 3467899999999999999999999999999999999999999999999977777799999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecC--CCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDE--KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++||||||+||+++. ++.++|+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 144 --~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell 219 (350)
T d1koaa2 144 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 219 (350)
T ss_dssp --TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHH
T ss_pred --CCeeeeechhHeeeccCCCCeEEEeecchheecccccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHH
Confidence 9999999999999964 67899999999987654332 23457899999999999989999999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
+|..||......+. + .....+...... ......+..+.+++.+||+.||++|||++|+++
T Consensus 220 ~G~~Pf~~~~~~~~--~-----~~i~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 220 SGLSPFGGENDDET--L-----RNVKSCDWNMDD---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HSSCSSCCSSHHHH--H-----HHHHHTCCCSCC---GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCHHHH--H-----HHHHhCCCCCCc---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999976543321 1 111222221111 111122344778888999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-47 Score=308.56 Aligned_cols=207 Identities=23% Similarity=0.287 Sum_probs=169.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..++|.+|+++|++++|||||++++++.+.+..|+|||||.+|+|..++. ..+.+++..++.++.||+.||.|||++
T Consensus 57 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~- 134 (309)
T d1u5ra_ 57 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH- 134 (309)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 456789999999999999999999999999999999999999999877664 345689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC---CCCCCcccchhHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN---LPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l 160 (252)
+++||||||+|||++.++.+||+|||.+...... ....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 135 --~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel 207 (309)
T d1u5ra_ 135 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (309)
T ss_dssp --TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHH
T ss_pred --CEeccCCCcceEEECCCCCEEEeecccccccCCC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHH
Confidence 9999999999999999999999999999865432 23568999999999864 3478999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||........ .......... ... .... +..+.+++.+||+.||++|||++|+++
T Consensus 208 ~~g~~Pf~~~~~~~~------~~~i~~~~~~-~~~-~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 208 AERKPPLFNMNAMSA------LYHIAQNESP-ALQ-SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHSSCTTTTSCHHHH------HHHHHHSCCC-CCS-CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHCCCCCCCCCHHHH------HHHHHhCCCC-CCC-CCCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 999999976543321 1122222221 111 1122 234778888999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-46 Score=305.47 Aligned_cols=208 Identities=22% Similarity=0.242 Sum_probs=173.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.+|++++||||+++++++.+.+.+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++
T Consensus 48 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~-- 124 (337)
T d1o6la_ 48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR-- 124 (337)
T ss_dssp CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhc--
Confidence 467899999999999999999999999999999999999999999999864 44689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+||+++.+|.++|+|||.++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|+
T Consensus 125 -~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~ 202 (337)
T d1o6la_ 125 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202 (337)
T ss_dssp -TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred -CccccccCHHHeEecCCCCEEEeecccccccccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCC
Confidence 999999999999999999999999999986543322 233457899999999999999999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-----MKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~i~~ 231 (252)
.||........ . .....+.+.. +...+ ..+.++|.+||++||++||+ +.|+++
T Consensus 203 ~pf~~~~~~~~------~-~~i~~~~~~~---p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 203 LPFYNQDHERL------F-ELILMEEIRF---PRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CSSCCSSHHHH------H-HHHHHCCCCC---CTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCcCHHHH------H-HHHhcCCCCC---CccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 99987654321 1 2222233221 11223 34677888999999999995 788775
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=305.75 Aligned_cols=226 Identities=23% Similarity=0.360 Sum_probs=182.8
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEec-CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFD-VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHD 81 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 81 (252)
.+..++|.+|+++|++++||||+++++++.+ ++..++|||||++|+|.+++.......++..+++++.|++.||.|||+
T Consensus 69 ~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~ 148 (311)
T d1r0pa_ 69 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148 (311)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc
Confidence 3456889999999999999999999999875 568999999999999999998887788999999999999999999999
Q ss_pred cCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc---ccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 82 ECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR---TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 82 ~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
. +++||||||+|||+++++.++|+|||+++........ ......|+..|+|||.+.+..++.++||||||+++|
T Consensus 149 ~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~ 225 (311)
T d1r0pa_ 149 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 225 (311)
T ss_dssp T---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred c---CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHH
Confidence 9 9999999999999999999999999999876543322 223356889999999999889999999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCcC
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 238 (252)
+|+||+.||.......+ + . .....+... ..+.. ....+.+++.+||+.||++|||+.||++.|+++++
T Consensus 226 El~t~~~p~~~~~~~~~--~---~-~~i~~g~~~--~~p~~----~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 226 ELMTRGAPPYPDVNTFD--I---T-VYLLQGRRL--LQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp HHHTTSCCSCC--------C---H-HHHHTTCCC--CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHCCCCCCCCCCHHH--H---H-HHHHcCCCC--CCccc----CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999998876543321 1 1 122223221 11112 23457888889999999999999999999999776
Q ss_pred CCCCC
Q 038713 239 IPIPQ 243 (252)
Q Consensus 239 ~~~~~ 243 (252)
.-...
T Consensus 294 ~~~~~ 298 (311)
T d1r0pa_ 294 TFIGE 298 (311)
T ss_dssp TCCSC
T ss_pred hhhhh
Confidence 54443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-46 Score=306.28 Aligned_cols=220 Identities=23% Similarity=0.327 Sum_probs=179.2
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-----------------------CCC
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-----------------------EKQ 59 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----------------------~~~ 59 (252)
.+.+++|.+|++++++++||||+++++++...+..+++|||+++|+|.+++... ...
T Consensus 57 ~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (301)
T d1lufa_ 57 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136 (301)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CC
T ss_pred hHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCC
Confidence 456788999999999999999999999999999999999999999999998432 124
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCcccccccc
Q 038713 60 PNWVERMGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEW 138 (252)
Q Consensus 60 ~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~ 138 (252)
+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++....... .......+++.|+|||.
T Consensus 137 l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~ 213 (301)
T d1lufa_ 137 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES 213 (301)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHH
Confidence 78889999999999999999999 999999999999999999999999999986543332 22234567889999999
Q ss_pred ccCCCCCCcccchhHHHHHHHHHhCCc-cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccC
Q 038713 139 HRNLPITVKADVYSFGVVLLEIVCLRR-CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCIL 217 (252)
Q Consensus 139 ~~~~~~~~~~Di~slG~~l~~l~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 217 (252)
+.+..++.++||||||+++|+|++|+. ||......+ +...+..+..... +...+..+.+++.+||+
T Consensus 214 ~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e-------~~~~v~~~~~~~~------p~~~~~~~~~li~~cl~ 280 (301)
T d1lufa_ 214 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-------VIYYVRDGNILAC------PENCPLELYNLMRLCWS 280 (301)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTC
T ss_pred HccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCCCC------CccchHHHHHHHHHHcC
Confidence 999999999999999999999999975 565543332 1122334433222 12223458889999999
Q ss_pred CCCCCCCCHHHHHHHhhcCcC
Q 038713 218 DEPSLRRAMKKVLLMLEGTVE 238 (252)
Q Consensus 218 ~~p~~Rps~~~i~~~l~~~~~ 238 (252)
.+|++|||+.||+++|+++++
T Consensus 281 ~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 281 KLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp SSGGGSCCHHHHHHHHHHTTC
T ss_pred CChhHCcCHHHHHHHHHHhcC
Confidence 999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=302.12 Aligned_cols=211 Identities=24% Similarity=0.340 Sum_probs=173.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.++.|.+|+.+|++++|||||++++++.+.+..|+|||||+||+|.+++... +.+++..++.++.|++.||.|||+.
T Consensus 56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~-- 132 (293)
T d1jksa_ 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSL-- 132 (293)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhc--
Confidence 4678999999999999999999999999999999999999999999999643 4689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCC----ceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKR----CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEI 160 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l 160 (252)
+++||||||+||+++.++ .++++|||.+....... ......|++.|+|||++.+..++.++||||+|+++|+|
T Consensus 133 -~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyel 209 (293)
T d1jksa_ 133 -QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 209 (293)
T ss_dssp -TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred -ceeecccccceEEEecCCCcccceEecchhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHH
Confidence 999999999999998776 49999999998764332 22335678999999999998899999999999999999
Q ss_pred HhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 161 VCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 161 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
++|..||......+. . .....+..... ...+...+..+.+++.+||+.||++|||++|+++
T Consensus 210 l~g~~Pf~~~~~~~~------~-~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 210 LSGASPFLGDTKQET------L-ANVSAVNYEFE---DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHSSCSSCCSSHHHH------H-HHHHTTCCCCC---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HcCCCCCCCCCHHHH------H-HHHHhcCCCCC---chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999999986543321 1 11222222111 1111223345778888999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=307.70 Aligned_cols=216 Identities=21% Similarity=0.331 Sum_probs=175.6
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..++|.+|+.++++++|||||++++++.+. ..+++++++.+|+|.+++......+++..++.++.||+.||.|||++
T Consensus 53 ~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~- 130 (317)
T d1xkka_ 53 KANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130 (317)
T ss_dssp CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc-
Confidence 4577899999999999999999999999864 57788899999999999987788899999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++.+||+|||+++........ ......||..|+|||++.+..++.++||||||+++|+|+|
T Consensus 131 --~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t 208 (317)
T d1xkka_ 131 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208 (317)
T ss_dssp --TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred --CcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHH
Confidence 9999999999999999999999999999876543332 2233467999999999999899999999999999999998
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcC
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGT 236 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~ 236 (252)
|..||.......- ...+..+..... +...+..+.+++.+||+.||++|||+.||++.|++.
T Consensus 209 ~g~~p~~~~~~~~~-------~~~i~~~~~~~~------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 209 FGSKPYDGIPASEI-------SSILEKGERLPQ------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp TSCCTTTTSCGGGH-------HHHHHHTCCCCC------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHH-------HHHHHcCCCCCC------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 7788876544331 122223322111 122234578888899999999999999999988764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=301.89 Aligned_cols=216 Identities=23% Similarity=0.297 Sum_probs=175.7
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..++|.+|+.++++++||||+++++++.+ ...++||||+++|++.+++....+.+++..++.++.||+.||.|||++
T Consensus 53 ~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~- 130 (273)
T d1u46a_ 53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 130 (273)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC-
Confidence 456789999999999999999999999976 567899999999999999877777799999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcc--cccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRT--FTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++||||||+||+++.++.++++|||+++......... .....++..|+|||++.+..++.++||||||+++|+|+
T Consensus 131 --~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~eml 208 (273)
T d1u46a_ 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208 (273)
T ss_dssp --TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred --CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHH
Confidence 99999999999999999999999999999765443322 22345678899999999988999999999999999999
Q ss_pred h-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 162 C-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 162 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
| |..||......+. .......+.... .+... +..+.+++.+||+.||++|||+.+|.+.|++
T Consensus 209 t~G~~Pf~~~~~~~~------~~~i~~~~~~~~--~~~~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 209 TYGQEPWIGLNGSQI------LHKIDKEGERLP--RPEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp TTSCCTTTTCCHHHH------HHHHHTSCCCCC--CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hCCCCCCCCcCHHHH------HHHHHhCCCCCC--Ccccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 8 8999875533321 222223322211 11122 2457888899999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-45 Score=297.20 Aligned_cols=220 Identities=20% Similarity=0.297 Sum_probs=170.6
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCC----cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVS----NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
++..+.|.+|+++++.++||||+++++++...+ ..|+||||++||+|.+++.. .+.+++.+++.++.||+.||.|
T Consensus 48 ~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~ 126 (277)
T d1o6ya_ 48 PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNF 126 (277)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999998644 37899999999999998854 3468999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--cccccccCCccccccccccCCCCCCcccchhHHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVV 156 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~ 156 (252)
||++ +++||||||+||+++.++..+++|||.+........ .......||+.|+|||++.+..++.++||||||++
T Consensus 127 lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 203 (277)
T d1o6ya_ 127 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 203 (277)
T ss_dssp HHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred HHhC---CccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHH
Confidence 9999 999999999999999999999999998875433222 23334568999999999999899999999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhhc
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-AMKKVLLMLEG 235 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~i~~~l~~ 235 (252)
+|+|+||+.||......+ ........+.......... .+..+.+++.+||+.||++|| |+++++..|.+
T Consensus 204 lyelltG~~Pf~~~~~~~------~~~~~~~~~~~~~~~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 204 LYEVLTGEPPFTGDSPVS------VAYQHVREDPIPPSARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHSSCSCCCSSHHH------HHHHHHHCCCCCGGGTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCcCHHH------HHHHHHhcCCCCCchhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999999999997654332 1222333333222111112 234578888899999999999 89999988875
Q ss_pred C
Q 038713 236 T 236 (252)
Q Consensus 236 ~ 236 (252)
+
T Consensus 274 ~ 274 (277)
T d1o6ya_ 274 V 274 (277)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=304.35 Aligned_cols=222 Identities=27% Similarity=0.374 Sum_probs=176.4
Q ss_pred hHhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC---------------CCCCCHHHHH
Q 038713 3 AEGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP---------------EKQPNWVERM 66 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~ 66 (252)
.+.+++|.+|+++|+++ +||||+++++++.+.+.+++||||+++|+|.+++... ...+++..++
T Consensus 51 ~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 130 (309)
T d1fvra_ 51 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130 (309)
T ss_dssp ----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHH
T ss_pred hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHH
Confidence 34567899999999999 7999999999999999999999999999999999643 3568999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCC
Q 038713 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITV 146 (252)
Q Consensus 67 ~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 146 (252)
.++.||+.||.|+|+. +++||||||+|||++.++.+||+|||.++........ ....|+..|+|||.+.+..++.
T Consensus 131 ~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~ 205 (309)
T d1fvra_ 131 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTT 205 (309)
T ss_dssp HHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECH
T ss_pred HHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEccccccccccccccc--cceecCCcccchHHhccCCCCc
Confidence 9999999999999999 9999999999999999999999999999754432221 2345788999999999889999
Q ss_pred cccchhHHHHHHHHHhCCc-cccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 147 KADVYSFGVVLLEIVCLRR-CLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 147 ~~Di~slG~~l~~l~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
++||||||+++|+|++|+. ||....... + ...+..+.... . +...+..+.++|.+||+.||++|||
T Consensus 206 ~sDvwSfGvil~ell~~~~~p~~~~~~~~---~----~~~i~~~~~~~--~----~~~~~~~~~~li~~cl~~dP~~RPs 272 (309)
T d1fvra_ 206 NSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L----YEKLPQGYRLE--K----PLNCDDEVYDLMRQCWREKPYERPS 272 (309)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H----HHHGGGTCCCC--C----CTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred cceeehhHHHHHHHHhcCCCCCCCCCHHH---H----HHHHHhcCCCC--C----CccCCHHHHHHHHHHcCCChhHCcC
Confidence 9999999999999999775 555433222 1 12222332211 1 1122345788888999999999999
Q ss_pred HHHHHHHhhcCcCCCCC
Q 038713 226 MKKVLLMLEGTVEIPIP 242 (252)
Q Consensus 226 ~~~i~~~l~~~~~~~~~ 242 (252)
+++|++.|+++++....
T Consensus 273 ~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 273 FAQILVSLNRMLEERKT 289 (309)
T ss_dssp HHHHHHHHHHHHHSSSC
T ss_pred HHHHHHHHHHHHhcCcC
Confidence 99999999987765443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=300.08 Aligned_cols=217 Identities=20% Similarity=0.293 Sum_probs=176.4
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+.+.+|+++|++++||||+++++++++.+.+|+|||||+||+|.+++......+++.+++.++.||+.||.|||+.
T Consensus 43 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~- 121 (321)
T d1tkia_ 43 TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH- 121 (321)
T ss_dssp HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-
Confidence 3456788999999999999999999999999999999999999999999977766799999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCC--CceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEK--RCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 161 (252)
+++||||||+||+++.+ +.++++|||.++...... ......+++.|+|||...+..++.++||||+||++|+|+
T Consensus 122 --~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll 197 (321)
T d1tkia_ 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp --TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred --CCCcccccccceeecCCCceEEEEcccchhhccccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHH
Confidence 99999999999999854 479999999998754322 233356789999999999989999999999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEG 235 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~ 235 (252)
+|..||......+. . .....+..... ..........+.+++.+||..||++|||++|+++ .+++
T Consensus 198 ~G~~Pf~~~~~~~~------~-~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 198 SGINPFLAETNQQI------I-ENIMNAEYTFD---EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HSSCTTCCSSHHHH------H-HHHHHTCCCCC---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred hCCCCCCCCCHHHH------H-HHHHhCCCCCC---hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 99999987644321 1 11222222111 1111122344778888999999999999999987 3544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=299.87 Aligned_cols=213 Identities=26% Similarity=0.351 Sum_probs=165.8
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEec-CCcEEEEEecCCCCCHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFD-VSNKILVYDYMSNGSLVDVLFTPE-KQPNWVERMGIARDIARGIRYLHDE 82 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~ 82 (252)
..++|.+|++++++++||||+++++++.+ .+..++||||+++|+|.+++.... ..+++..+++++.||+.||.|||+.
T Consensus 43 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~ 122 (262)
T d1byga_ 43 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122 (262)
T ss_dssp --HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC
Confidence 45789999999999999999999999865 567899999999999999996533 3589999999999999999999999
Q ss_pred CCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHh
Q 038713 83 CEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 83 ~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++.++++|||.++...... ....++..|+|||++.+..++.++||||||+++|+|+|
T Consensus 123 ---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t 195 (262)
T d1byga_ 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195 (262)
T ss_dssp ---TCCCSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---ceeccccchHhheecCCCCEeecccccceecCCCC----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHH
Confidence 99999999999999999999999999998644322 22346889999999998899999999999999999998
Q ss_pred -CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhcCc
Q 038713 163 -LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 163 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 237 (252)
|..||......+ +. ..+..+..... +......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 196 ~~~~p~~~~~~~~---~~----~~i~~~~~~~~------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 196 FGRVPYPRIPLKD---VV----PRVEKGYKMDA------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TSCCSCTTSCGGG---HH----HHHTTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHH---HH----HHHHcCCCCCC------CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 577776553332 11 12222222221 1122245778888999999999999999999998753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=299.81 Aligned_cols=220 Identities=25% Similarity=0.335 Sum_probs=180.3
Q ss_pred hHhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCC---------------CCCCHHHHH
Q 038713 3 AEGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPE---------------KQPNWVERM 66 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~ 66 (252)
.+...++.+|...+.++ +|||||++++++.+++..++||||+++|+|.+++.... +.+++..++
T Consensus 59 ~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 138 (299)
T d1fgka_ 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138 (299)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHH
Confidence 45568899999999888 89999999999999999999999999999999995432 458999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCC
Q 038713 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPIT 145 (252)
Q Consensus 67 ~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~ 145 (252)
.++.||+.||+|||+. +++||||||+|||++.++.+|++|||.++........ ......+++.|+|||.+.+..++
T Consensus 139 ~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~ 215 (299)
T d1fgka_ 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215 (299)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC
Confidence 9999999999999999 9999999999999999999999999999876544332 22335578899999999988999
Q ss_pred CcccchhHHHHHHHHHh-CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 146 VKADVYSFGVVLLEIVC-LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 146 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
.++||||||+++|+|++ |..||....... +...+..+..... +.. .+..+.+++.+||+.||.+||
T Consensus 216 ~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-------~~~~i~~~~~~~~--p~~----~~~~l~~li~~cl~~dP~~Rp 282 (299)
T d1fgka_ 216 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LFKLLKEGHRMDK--PSN----CTNELYMMMRDCWHAVPSQRP 282 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHTTCCCCC--CSS----CCHHHHHHHHHHTCSSGGGSC
T ss_pred chhhhHHhHHHHHHhccCCCCCCCCCCHHH-------HHHHHHcCCCCCC--Ccc----chHHHHHHHHHHccCCHhHCc
Confidence 99999999999999998 577776544332 1122333322221 112 234578889999999999999
Q ss_pred CHHHHHHHhhcCcC
Q 038713 225 AMKKVLLMLEGTVE 238 (252)
Q Consensus 225 s~~~i~~~l~~~~~ 238 (252)
|+.||++.|++++.
T Consensus 283 s~~eil~~L~~i~a 296 (299)
T d1fgka_ 283 TFKQLVEDLDRIVA 296 (299)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhh
Confidence 99999999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.5e-45 Score=293.86 Aligned_cols=211 Identities=22% Similarity=0.278 Sum_probs=173.0
Q ss_pred hHHHHHHHHHHHhCCC-CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
.++++.+|+.++++++ ||||+++++++.+++..|+||||+++|+|.+++.. ++.+++..++.++.||++||.|||++
T Consensus 52 ~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~- 129 (277)
T d1phka_ 52 LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKL- 129 (277)
T ss_dssp HHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-
Confidence 4567999999999996 99999999999999999999999999999999964 44689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccC------CCCCCcccchhHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN------LPITVKADVYSFGVVL 157 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Di~slG~~l 157 (252)
+++||||||+||+++.++.++|+|||.++...... ......||..|+|||.+.+ ..++.++||||+|+++
T Consensus 130 --~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvil 205 (277)
T d1phka_ 130 --NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 205 (277)
T ss_dssp --TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred --CCcccccccceEEEcCCCCeEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhh
Confidence 99999999999999999999999999998765432 2234568999999998753 3467899999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|+|++|+.||........ ......+........ ....+..+.+++.+||+.||++|||++|+++
T Consensus 206 yeml~g~~Pf~~~~~~~~-------~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 206 YTLLAGSPPFWHRKQMLM-------LRMIMSGNYQFGSPE---WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHSSCSSCCSSHHHH-------HHHHHHTCCCCCTTT---GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hhhccCCCCCCCCCHHHH-------HHHHHhCCCCCCCcc---cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 999999999987644331 122223333221111 1123345788888999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-45 Score=298.52 Aligned_cols=205 Identities=23% Similarity=0.287 Sum_probs=171.5
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+.++++++||||+++++++.+.+..|+||||++||+|..++.. ....++..+..++.||+.||.|||++
T Consensus 47 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~-- 123 (316)
T d1fota_ 47 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSK-- 123 (316)
T ss_dssp CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccC--
Confidence 457899999999999999999999999999999999999999999998854 44578888889999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+|||++.+|.+||+|||.++...... ....||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 124 -~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~ 198 (316)
T d1fota_ 124 -DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 198 (316)
T ss_dssp -TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred -cEEccccCchheeEcCCCCEEEecCccceEecccc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCC
Confidence 99999999999999999999999999998765332 2356899999999999989999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
.||........ . .....+.... +......+.+++.+||..||.+|+ |++++++
T Consensus 199 ~Pf~~~~~~~~------~-~~i~~~~~~~-------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 199 TPFYDSNTMKT------Y-EKILNAELRF-------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CTTCCSSHHHH------H-HHHHHCCCCC-------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCcCHHHH------H-HHHHcCCCCC-------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 99986543321 1 1122222211 111223477888899999999996 8999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=299.03 Aligned_cols=221 Identities=24% Similarity=0.251 Sum_probs=172.1
Q ss_pred HHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 038713 7 REFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQ 86 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 86 (252)
+.+.+|+.++++++|||||++++++.+.+..|+||||+.++++.... ...+.+++..+..++.||++||.|||++ +
T Consensus 45 ~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~---~ 120 (299)
T d1ua2a_ 45 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQH---W 120 (299)
T ss_dssp THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHT---T
T ss_pred HHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcc---c
Confidence 46899999999999999999999999999999999999887666655 4556788899999999999999999999 9
Q ss_pred eeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhCCc
Q 038713 87 IIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCLRR 165 (252)
Q Consensus 87 i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~ 165 (252)
++||||||+||+++.++.+||+|||.++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 121 iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~ 199 (299)
T d1ua2a_ 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199 (299)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eecccCCcceEEecCCCccccccCccccccCCCccc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcC
Confidence 999999999999999999999999999865543322 2235689999999998754 57999999999999999999999
Q ss_pred cccccchhhhHHHHHHHHHHHhcCCccccc---------------cc--chhcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038713 166 CLDQNLLEDRAILQEWICQCFENGNLSQLV---------------ED--EEVDQKQLQRMIKVGLRCILDEPSLRRAMKK 228 (252)
Q Consensus 166 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 228 (252)
||......+... . +.+........... .. ..........+.+++.+||+.||++|||++|
T Consensus 200 pf~~~~~~~~l~--~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e 276 (299)
T d1ua2a_ 200 FLPGDSDLDQLT--R-IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 276 (299)
T ss_dssp SSCCSSHHHHHH--H-HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHH--H-HHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 997665443211 1 11111110000000 00 0111122356888899999999999999999
Q ss_pred HHH--Hhhc
Q 038713 229 VLL--MLEG 235 (252)
Q Consensus 229 i~~--~l~~ 235 (252)
+++ .+++
T Consensus 277 ~L~Hp~f~~ 285 (299)
T d1ua2a_ 277 ALKMKYFSN 285 (299)
T ss_dssp HHTSGGGTS
T ss_pred HhCCHhhCC
Confidence 997 4654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=300.11 Aligned_cols=214 Identities=20% Similarity=0.234 Sum_probs=168.9
Q ss_pred HHHHHHHHHHhC-CCCCCCcceeeeEec----CCcEEEEEecCCCCCHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 7 REFKTEMNAIGR-THHRNPVRLLGYSFD----VSNKILVYDYMSNGSLVDVLFTP-EKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 7 ~~~~~E~~~l~~-l~h~~iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
+.+.+|+.++.+ .+||||+++++++++ .+.+|+|||||+||+|.+++.+. ...+++..++.++.||+.||.|||
T Consensus 49 ~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH 128 (335)
T d2ozaa1 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128 (335)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 457899998765 489999999999875 46689999999999999999764 356899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecC---CCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDE---KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVL 157 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l 157 (252)
+. +++||||||+||+++. .+.++++|||+++....... .....|++.|+|||++.+..++.++|||||||++
T Consensus 129 ~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvil 203 (335)
T d2ozaa1 129 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 203 (335)
T ss_dssp HT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHH
T ss_pred Hc---CCccccccccccccccccccccccccccceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhH
Confidence 99 9999999999999985 45799999999987654332 2345689999999999998999999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
|+|+||+.||.......... .+......+.. ..+.......+..+.+++.+||+.||++|||+.|+++
T Consensus 204 y~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 204 YILLCGYPPFYSNHGLAISP---GMKTRIRMGQY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHHTTSSCSCEETTCC-----------CCCSCSS---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhCCCCCCCCCHHHHHH---HHHHHHhcCCC---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 99999999997654332110 01111111111 1111222334556888899999999999999999988
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=300.31 Aligned_cols=220 Identities=25% Similarity=0.376 Sum_probs=169.0
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEec-CCcEEEEEecCCCCCHHhhhcCC---------------CCCCCHHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFD-VSNKILVYDYMSNGSLVDVLFTP---------------EKQPNWVERM 66 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~ 66 (252)
...+.+.+|...+.++ +|+||+++++++.. ...+++|||||++|+|.+++... ...+++..++
T Consensus 58 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 137 (299)
T d1ywna1 58 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137 (299)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHH
Confidence 4567788899888877 79999999998876 45689999999999999998542 2347899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCCC
Q 038713 67 GIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPIT 145 (252)
Q Consensus 67 ~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~ 145 (252)
.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++
T Consensus 138 ~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 214 (299)
T d1ywna1 138 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214 (299)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC
Confidence 9999999999999999 999999999999999999999999999986544332 233345689999999999999999
Q ss_pred CcccchhHHHHHHHHHhCC-ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 146 VKADVYSFGVVLLEIVCLR-RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 146 ~~~Di~slG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
.++||||||+++|+|++|+ .||........ +...+..+..... +...+..+.+++.+||+.||++||
T Consensus 215 ~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~------~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rp 282 (299)
T d1ywna1 215 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRA------PDYTTPEMYQTMLDCWHGEPSQRP 282 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH------HHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cccceeehHHHHHHHHhCCCCCCCCCCHHHH------HHHHHhcCCCCCC------CccCCHHHHHHHHHHcCCChhHCc
Confidence 9999999999999999875 46654433221 1122233332221 112234578889999999999999
Q ss_pred CHHHHHHHhhcCcC
Q 038713 225 AMKKVLLMLEGTVE 238 (252)
Q Consensus 225 s~~~i~~~l~~~~~ 238 (252)
|++||++.|+++++
T Consensus 283 t~~eil~~L~~ilq 296 (299)
T d1ywna1 283 TFSELVEHLGNLLQ 296 (299)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHh
Confidence 99999999998653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-44 Score=297.58 Aligned_cols=205 Identities=19% Similarity=0.178 Sum_probs=172.2
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..+.+.+|+++|++++||||+++++++.+.+..++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++
T Consensus 84 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~-- 160 (350)
T d1rdqe_ 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSL-- 160 (350)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 3567899999999999999999999999999999999999999999999543 4689999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCLR 164 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 164 (252)
+++||||||+|||++.+|.++|+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 161 -~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~ 235 (350)
T d1rdqe_ 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235 (350)
T ss_dssp -TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCC
Confidence 99999999999999999999999999998765332 2356899999999999999999999999999999999999
Q ss_pred ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038713 165 RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR-----AMKKVLL 231 (252)
Q Consensus 165 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~i~~ 231 (252)
.||....... . . .....+.... +.. ....+.+++.+||+.||++|+ |++++++
T Consensus 236 ~Pf~~~~~~~---~---~-~~i~~~~~~~---p~~----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 236 PPFFADQPIQ---I---Y-EKIVSGKVRF---PSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CSSCCSSHHH---H---H-HHHHHCCCCC---CTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCcCHHH---H---H-HHHhcCCCCC---Ccc----CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 9997653332 1 1 1122222221 112 234477888899999999994 8999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.3e-44 Score=297.91 Aligned_cols=203 Identities=19% Similarity=0.198 Sum_probs=164.5
Q ss_pred HHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeee
Q 038713 11 TEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEAQIIHG 90 (252)
Q Consensus 11 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~ 90 (252)
+|+.+++.++||||+++++++.+.+.+|+||||++||+|.+++.+ ...+++..++.++.||+.||.|||++ +++||
T Consensus 56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHr 131 (364)
T d1omwa3 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR---FVVYR 131 (364)
T ss_dssp HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHC---Cccce
Confidence 447778888999999999999999999999999999999999964 34678999999999999999999999 99999
Q ss_pred ccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCcccccccccc-CCCCCCcccchhHHHHHHHHHhCCccccc
Q 038713 91 DIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHR-NLPITVKADVYSFGVVLLEIVCLRRCLDQ 169 (252)
Q Consensus 91 di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 169 (252)
||||+|||++.+|.+||+|||+++....... ....||+.|+|||++. +..++.++|||||||++|+|++|+.||..
T Consensus 132 DlKP~NILl~~~g~iKl~DFGla~~~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 132 DLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp CCSGGGEEECSSSCEEECCCTTCEECSSSCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eeccceeEEcCCCcEEEeeeceeeecCCCcc---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654332 3356899999999986 45689999999999999999999999987
Q ss_pred cchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038713 170 NLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-----MKKVLL 231 (252)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~i~~ 231 (252)
....+...+. ....... ...+... +..+.++|.+||+.||++||| ++|+++
T Consensus 209 ~~~~~~~~~~----~~~~~~~---~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 209 HKTKDKHEID----RMTLTMA---VELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SCSSCHHHHH----HHSSSCC---CCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCHHHHHHHH----HhcccCC---CCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 6444322111 1111111 1111122 334788888999999999999 688864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=292.98 Aligned_cols=221 Identities=22% Similarity=0.307 Sum_probs=179.6
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcC---------CCCCCCHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFT---------PEKQPNWVERMGIARDIAR 74 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~i~~~i~~ 74 (252)
+.+..|.+|++++++++||||+++++++...+..++||||+++|+|.+++.. ....+++..+..++.|++.
T Consensus 65 ~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~ 144 (308)
T d1p4oa_ 65 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144 (308)
T ss_dssp HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHH
Confidence 4567799999999999999999999999999999999999999999999843 2234788999999999999
Q ss_pred HHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCc-ccccccCCccccccccccCCCCCCcccchhH
Q 038713 75 GIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTR-TFTGIRGTRAYVAAEWHRNLPITVKADVYSF 153 (252)
Q Consensus 75 ~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 153 (252)
||.|||++ +++||||||+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|+|||
T Consensus 145 gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~ 221 (308)
T d1p4oa_ 145 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 221 (308)
T ss_dssp HHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHhhC---CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccH
Confidence 99999999 9999999999999999999999999999866443332 2233457899999999999899999999999
Q ss_pred HHHHHHHHhCC-ccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038713 154 GVVLLEIVCLR-RCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 154 G~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~ 232 (252)
|+++|+|+||+ .||........ . .....+..... +...+..+.+++.+||+.||++|||+.+|++.
T Consensus 222 G~il~El~t~~~~p~~~~~~~~~------~-~~i~~~~~~~~------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 222 GVVLWEIATLAEQPYQGLSNEQV------L-RFVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp HHHHHHHHHTSCCTTTTSCHHHH------H-HHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHH------H-HHHHhCCCCCC------cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999986 56654433221 1 12223332221 11223458888999999999999999999999
Q ss_pred hhcCcCCC
Q 038713 233 LEGTVEIP 240 (252)
Q Consensus 233 l~~~~~~~ 240 (252)
|++.++..
T Consensus 289 L~~~~~~~ 296 (308)
T d1p4oa_ 289 IKEEMEPG 296 (308)
T ss_dssp HGGGSCTT
T ss_pred HHHhcCCC
Confidence 99977643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=298.34 Aligned_cols=221 Identities=23% Similarity=0.356 Sum_probs=177.9
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCC-----------------CCCCCHHHH
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTP-----------------EKQPNWVER 65 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~ 65 (252)
..+..|.+|+.+++++ +|||||++++++.+....++|||||++|+|.+++... ...+++..+
T Consensus 68 ~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 147 (311)
T d1t46a_ 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147 (311)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHH
Confidence 4567899999999999 7999999999999999999999999999999998542 235889999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC-cccccccCCccccccccccCCCC
Q 038713 66 MGIARDIARGIRYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT-RTFTGIRGTRAYVAAEWHRNLPI 144 (252)
Q Consensus 66 ~~i~~~i~~~l~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~ 144 (252)
..++.||+.|+.|||++ +++||||||+||+++.++.++++|||.++....... .......|++.|+|||++.+..+
T Consensus 148 ~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 224 (311)
T d1t46a_ 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224 (311)
T ss_dssp HHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhC---CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC
Confidence 99999999999999999 999999999999999999999999999987654333 22334568999999999998899
Q ss_pred CCcccchhHHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 145 TVKADVYSFGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 145 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
+.++||||||+++|+|+|++.|+........ .+ ......+..... +...+..+.++|.+||+.||++||
T Consensus 225 ~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~-~~----~~~i~~~~~~~~------~~~~~~~l~~Li~~cl~~dP~~RP 293 (311)
T d1t46a_ 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDS-KF----YKMIKEGFRMLS------PEHAPAEMYDIMKTCWDADPLKRP 293 (311)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-HH----HHHHHHTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CCcccccchHHHHHHHHhCCCCCCCCCCHHH-HH----HHHHhcCCCCCC------cccccHHHHHHHHHHcCCChhHCc
Confidence 9999999999999999996555543322221 11 122233322111 112234588888899999999999
Q ss_pred CHHHHHHHhhcCcC
Q 038713 225 AMKKVLLMLEGTVE 238 (252)
Q Consensus 225 s~~~i~~~l~~~~~ 238 (252)
|++||+++|++.++
T Consensus 294 s~~~il~~L~~~i~ 307 (311)
T d1t46a_ 294 TFKQIVQLIEKQIS 307 (311)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhhc
Confidence 99999999998543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=292.92 Aligned_cols=227 Identities=19% Similarity=0.198 Sum_probs=173.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+..+++.+|++++++++||||+++++++.+.+..|+||||+.++.+........+.+++..++.++.||+.||.|||++
T Consensus 43 ~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~- 121 (298)
T d1gz8a_ 43 GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 121 (298)
T ss_dssp -CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC-
Confidence 3467899999999999999999999999999999999999976544444445566799999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC-CCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP-ITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++.++++|||.++....... ......|++.|+|||++.... ++.++|+||+|+++|+|++
T Consensus 122 --~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~ 198 (298)
T d1gz8a_ 122 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198 (298)
T ss_dssp --TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred --CEEccccCchheeecccCcceeccCCcceeccCCcc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhh
Confidence 999999999999999999999999999987654332 233456899999999877655 5789999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHh--cCCccccccc---------------chhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFE--NGNLSQLVED---------------EEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---------------~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
|+.||......+. +......... ...+...... ..........+.+++.+||+.||++|||
T Consensus 199 G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t 276 (298)
T d1gz8a_ 199 RRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS 276 (298)
T ss_dssp SSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred CCCCCCCCCHHHH--HHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcC
Confidence 9999986644332 2211111100 0000000000 0011122356788888999999999999
Q ss_pred HHHHHHH--hhcC
Q 038713 226 MKKVLLM--LEGT 236 (252)
Q Consensus 226 ~~~i~~~--l~~~ 236 (252)
+.|+++- ++++
T Consensus 277 ~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 277 AKAALAHPFFQDV 289 (298)
T ss_dssp HHHHHTSGGGTTC
T ss_pred HHHHhCCHhhccC
Confidence 9999984 5543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=296.44 Aligned_cols=207 Identities=20% Similarity=0.243 Sum_probs=170.0
Q ss_pred hHHHHHHHHHHHh-CCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 5 GEREFKTEMNAIG-RTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 5 ~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
..+.+.+|..++. .++||||+++++++.+++..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++
T Consensus 45 ~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~- 122 (320)
T d1xjda_ 45 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSK- 122 (320)
T ss_dssp CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 4556788888765 68999999999999999999999999999999999964 44589999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHHHHHhC
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 163 (252)
+++||||||+|||++.++.++++|||.++....... ......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 123 --~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG 199 (320)
T d1xjda_ 123 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199 (320)
T ss_dssp --TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred --CeeeccCcccceeecCCCceeccccchhhhcccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhC
Confidence 999999999999999999999999999986543322 22335689999999999999999999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMK-KVL 230 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~i~ 230 (252)
+.||.+...... ......+.... +.. .+..+.+++.+||+.||++|||+. +++
T Consensus 200 ~~PF~~~~~~~~-------~~~i~~~~~~~---p~~----~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 200 QSPFHGQDEEEL-------FHSIRMDNPFY---PRW----LEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp SCSSCCSSHHHH-------HHHHHHCCCCC---CTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCCCCCHHHH-------HHHHHcCCCCC---Ccc----CCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 999986544321 11222232211 112 234477888899999999999996 675
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=290.72 Aligned_cols=232 Identities=22% Similarity=0.209 Sum_probs=172.3
Q ss_pred HhHHHHHHHHHHH--hCCCCCCCcceeeeEecCC----cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAI--GRTHHRNPVRLLGYSFDVS----NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIR 77 (252)
Q Consensus 4 ~~~~~~~~E~~~l--~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 77 (252)
+..+.+.+|.+++ .+++||||+++++++.+.+ ..++||||+++|+|.+++.+. .+++..++.++.|++.||+
T Consensus 37 ~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~ 114 (303)
T d1vjya_ 37 REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLA 114 (303)
T ss_dssp GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHH
Confidence 3455566665554 5679999999999998643 579999999999999999643 5889999999999999999
Q ss_pred HHhhcC-----CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC---cccccccCCccccccccccCCC------
Q 038713 78 YLHDEC-----EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT---RTFTGIRGTRAYVAAEWHRNLP------ 143 (252)
Q Consensus 78 ~lh~~~-----~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~------ 143 (252)
|+|+.. +.+++||||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..
T Consensus 115 ~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 194 (303)
T d1vjya_ 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 194 (303)
T ss_dssp HHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHH
T ss_pred HHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCC
Confidence 999731 24999999999999999999999999999987644332 1223456899999999987643
Q ss_pred CCCcccchhHHHHHHHHHhCCccccccchhhhH--------HHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhc
Q 038713 144 ITVKADVYSFGVVLLEIVCLRRCLDQNLLEDRA--------ILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRC 215 (252)
Q Consensus 144 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 215 (252)
++.++||||||+++|+|+||..||......... ............+...........+.+....+.+++.+|
T Consensus 195 ~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~c 274 (303)
T d1vjya_ 195 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC 274 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTT
T ss_pred cCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHH
Confidence 567899999999999999999887543211100 011112222333333222222233445566788999999
Q ss_pred cCCCCCCCCCHHHHHHHhhcCc
Q 038713 216 ILDEPSLRRAMKKVLLMLEGTV 237 (252)
Q Consensus 216 l~~~p~~Rps~~~i~~~l~~~~ 237 (252)
|+.||++|||+.||++.|+++.
T Consensus 275 l~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 275 WYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCHhHCcCHHHHHHHHHHHH
Confidence 9999999999999999998754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=283.60 Aligned_cols=218 Identities=21% Similarity=0.243 Sum_probs=166.6
Q ss_pred HHHHHHHHHHhCC---CCCCCcceeeeEec-----CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 7 REFKTEMNAIGRT---HHRNPVRLLGYSFD-----VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 7 ~~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
..+.+|+.+++.+ +||||+++++++.. ....+++|||+++|++..........+++..++.++.|++.||.|
T Consensus 52 ~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~y 131 (305)
T d1blxa_ 52 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131 (305)
T ss_dssp CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 3567788877665 89999999999863 346899999999887776666667779999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVVLL 158 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~ 158 (252)
||++ +++||||||+|||++.++.++++|||.+...... .......||+.|+|||++.+..++.++||||+||++|
T Consensus 132 LH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ 206 (305)
T d1blxa_ 132 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 206 (305)
T ss_dssp HHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HHhC---CEEecCCCccEEEEcCCCCeeecchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHH
Confidence 9999 9999999999999999999999999998754322 2233467899999999999999999999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHHHHHhcC--Cccc-------c------cccchhcHHHHHHHHHHHhhccCCCCCCC
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWICQCFENG--NLSQ-------L------VEDEEVDQKQLQRMIKVGLRCILDEPSLR 223 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~-------~------~~~~~~~~~~~~~l~~li~~cl~~~p~~R 223 (252)
+|++|+.||......+. +........... .+.. . .............+.+++.+||++||++|
T Consensus 207 ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R 284 (305)
T d1blxa_ 207 EMFRRKPLFRGSSDVDQ--LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 284 (305)
T ss_dssp HHHHSSCSCCCSSHHHH--HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTS
T ss_pred HHHHCCCCCCCCCHHHH--HHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHC
Confidence 99999999987654432 211111110000 0000 0 00001112223457788889999999999
Q ss_pred CCHHHHHH
Q 038713 224 RAMKKVLL 231 (252)
Q Consensus 224 ps~~~i~~ 231 (252)
||++|+++
T Consensus 285 ~sa~e~L~ 292 (305)
T d1blxa_ 285 ISAYSALS 292 (305)
T ss_dssp CCHHHHHT
T ss_pred cCHHHHhc
Confidence 99999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-42 Score=280.13 Aligned_cols=219 Identities=21% Similarity=0.224 Sum_probs=166.6
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
..++|.+|+.+|++++||||+++++++.+.+..++++|++.++.+..+. ...+.+++..++.++.||+.||.|||+.
T Consensus 43 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~-- 119 (286)
T d1ob3a_ 43 IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDR-- 119 (286)
T ss_dssp CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccC--
Confidence 3578999999999999999999999999999999999999776555554 5567799999999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHHHHHhC
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLLEIVCL 163 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g 163 (252)
+|+||||||+||+++.++.++++|||.+........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|
T Consensus 120 -~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G 197 (286)
T d1ob3a_ 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197 (286)
T ss_dssp -TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred -cEEecCCCCceeeEcCCCCEEecccccceecccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHC
Confidence 999999999999999999999999999987654332 22334578899999998765 468999999999999999999
Q ss_pred CccccccchhhhHHHHHHHHHHHhcC---Cccccc---------------ccchhcHHHHHHHHHHHhhccCCCCCCCCC
Q 038713 164 RRCLDQNLLEDRAILQEWICQCFENG---NLSQLV---------------EDEEVDQKQLQRMIKVGLRCILDEPSLRRA 225 (252)
Q Consensus 164 ~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 225 (252)
+.||......+. +..... ..... .+.... ............+.+++.+||+.||++|||
T Consensus 198 ~~pf~~~~~~~~--~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s 274 (286)
T d1ob3a_ 198 TPLFPGVSEADQ--LMRIFR-ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274 (286)
T ss_dssp SCSCCCSSHHHH--HHHHHH-HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred CCCCCCCCHHHH--HHHHHH-hhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcC
Confidence 999976543332 111111 11000 000000 000111122345778888999999999999
Q ss_pred HHHHHH
Q 038713 226 MKKVLL 231 (252)
Q Consensus 226 ~~~i~~ 231 (252)
++|+++
T Consensus 275 ~~ell~ 280 (286)
T d1ob3a_ 275 AKQALE 280 (286)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=281.77 Aligned_cols=202 Identities=22% Similarity=0.333 Sum_probs=163.8
Q ss_pred HHHHHHHHHHhCCC--CCCCcceeeeEecCCcEEEEEecCCC-CCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 7 REFKTEMNAIGRTH--HRNPVRLLGYSFDVSNKILVYDYMSN-GSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 7 ~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
+++.+|+.++++++ ||||+++++++.+.+..++||||+.+ +++.+++.. .+.+++..++.++.||++||.|||+.
T Consensus 52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~- 129 (273)
T d1xwsa_ 52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC- 129 (273)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34678999999986 89999999999999999999999976 678887754 44689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecC-CCceEEcccCcccccCCCCCcccccccCCccccccccccCCCC-CCcccchhHHHHHHHHH
Q 038713 84 EAQIIHGDIKPQNILMDE-KRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPI-TVKADVYSFGVVLLEIV 161 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~ 161 (252)
+++||||||+||+++. ++.++++|||.++...... .....||+.|+|||++.+..+ +.++||||+||++|+|+
T Consensus 130 --~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell 204 (273)
T d1xwsa_ 130 --GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204 (273)
T ss_dssp --TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred --CCccccCcccceEEecCCCeEEECccccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHh
Confidence 9999999999999985 5789999999998654332 234568999999999987665 56789999999999999
Q ss_pred hCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhhc
Q 038713 162 CLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLL--MLEG 235 (252)
Q Consensus 162 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~--~l~~ 235 (252)
+|+.||..... .. .+... .+...+ ..+.+++.+||+.||++|||++|+++ .+++
T Consensus 205 ~g~~Pf~~~~~------------i~-~~~~~---~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 205 CGDIPFEHDEE------------II-RGQVF---FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp HSSCSCCSHHH------------HH-HCCCC---CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred hCCCCCCCchH------------Hh-hcccC---CCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 99999975311 11 11111 111222 34778888999999999999999987 3544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=276.01 Aligned_cols=225 Identities=20% Similarity=0.212 Sum_probs=170.3
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEecCC------cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFDVS------NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l 76 (252)
....+.+.+|+++|++++|||||++++++...+ .+|+||||+ +++|..+... +.+++..++.++.||+.||
T Consensus 58 ~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL 134 (346)
T d1cm8a_ 58 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGL 134 (346)
T ss_dssp HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999998654 579999999 6678877743 4589999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHH
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGV 155 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~ 155 (252)
.|||++ +++||||||+||+++.++.++++|||.++...... ....|++.|+|||++.+. .++.++||||+||
T Consensus 135 ~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv 207 (346)
T d1cm8a_ 135 RYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 207 (346)
T ss_dssp HHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHH
T ss_pred HHHHhC---CCcccccCcchhhcccccccccccccceeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchH
Confidence 999999 99999999999999999999999999998764332 335679999999998764 5689999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHHH-----------------HHHhcCCcccccccchhcHHHHHHHHHHHhhccCC
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWIC-----------------QCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILD 218 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 218 (252)
++|+|++|..||................ ........................+.+++.+||..
T Consensus 208 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~ 287 (346)
T d1cm8a_ 208 IMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 287 (346)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCS
T ss_pred HHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcC
Confidence 9999999999998764443221111000 00000000000000011112234577888899999
Q ss_pred CCCCCCCHHHHHHH--hhcCc
Q 038713 219 EPSLRRAMKKVLLM--LEGTV 237 (252)
Q Consensus 219 ~p~~Rps~~~i~~~--l~~~~ 237 (252)
||++|||++|+++. +++..
T Consensus 288 dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 288 DAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp STTTSCCHHHHHHSGGGTTTC
T ss_pred ChhHCcCHHHHhcChhhCcCC
Confidence 99999999999973 65543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=274.83 Aligned_cols=224 Identities=21% Similarity=0.231 Sum_probs=165.8
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCC----cEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVS----NKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYL 79 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l 79 (252)
...+++++|+.+|++++||||+++++++.... ..+++++++.+|+|.+++... .+++..++.++.||+.||.||
T Consensus 48 ~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yL 125 (345)
T d1pmea_ 48 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYI 125 (345)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999999987543 234444556699999999543 589999999999999999999
Q ss_pred hhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC--cccccccCCccccccccccC-CCCCCcccchhHHHH
Q 038713 80 HDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT--RTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVV 156 (252)
Q Consensus 80 h~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~ 156 (252)
|++ +|+||||||+||+++.++.++|+|||.+........ .......|++.|+|||++.. ..++.++||||+|++
T Consensus 126 H~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~i 202 (345)
T d1pmea_ 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 202 (345)
T ss_dssp HHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHH
T ss_pred HHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCce
Confidence 999 999999999999999999999999999986543222 22334568999999999854 467899999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHHHHHH-----------------HHhcCCcccccccchhcHHHHHHHHHHHhhccCCC
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQEWICQ-----------------CFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDE 219 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 219 (252)
+|+|++|..||......+.......... ....-..................+.+++.+||+.|
T Consensus 203 l~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 282 (345)
T d1pmea_ 203 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN 282 (345)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSS
T ss_pred ehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCC
Confidence 9999999999977654432222111100 00000000000000111112245788899999999
Q ss_pred CCCCCCHHHHHHH
Q 038713 220 PSLRRAMKKVLLM 232 (252)
Q Consensus 220 p~~Rps~~~i~~~ 232 (252)
|++|||++|+++.
T Consensus 283 P~~R~ta~e~L~h 295 (345)
T d1pmea_ 283 PHKRIEVEQALAH 295 (345)
T ss_dssp TTTSCCHHHHHTS
T ss_pred hhHCcCHHHHhcC
Confidence 9999999999973
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=271.20 Aligned_cols=221 Identities=18% Similarity=0.190 Sum_probs=165.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEec--------CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFD--------VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l 76 (252)
..+++.+|+++|++++||||+++++++.. .+..++||||+.++.+.. ........++..++.++.|++.||
T Consensus 52 ~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l 130 (318)
T d3blha1 52 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGL 130 (318)
T ss_dssp SCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHH
Confidence 35678999999999999999999998864 456899999997765554 445666789999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCC---cccccccCCccccccccccCC-CCCCcccchh
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQT---RTFTGIRGTRAYVAAEWHRNL-PITVKADVYS 152 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s 152 (252)
.|||+. +++||||||+|||++.++.++++|||++........ .......||+.|+|||++.+. .++.++||||
T Consensus 131 ~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwS 207 (318)
T d3blha1 131 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 207 (318)
T ss_dssp HHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred HHhccC---CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHccc
Confidence 999999 999999999999999999999999999976553322 222334689999999998765 5899999999
Q ss_pred HHHHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcc---cc------------cccchh------cHHHHHHHHHH
Q 038713 153 FGVVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLS---QL------------VEDEEV------DQKQLQRMIKV 211 (252)
Q Consensus 153 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~------------~~~~~~------~~~~~~~l~~l 211 (252)
+||++|+|++|+.||........... +......-... .. ...... .......+.++
T Consensus 208 lGvil~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dL 284 (318)
T d3blha1 208 AGCIMAEMWTRSPIMQGNTEQHQLAL---ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 284 (318)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHH
T ss_pred CCceeeeHhhCCCCCCCCCHHHHHHH---HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHH
Confidence 99999999999999986544432222 11111110000 00 000000 11113456788
Q ss_pred HhhccCCCCCCCCCHHHHHHH
Q 038713 212 GLRCILDEPSLRRAMKKVLLM 232 (252)
Q Consensus 212 i~~cl~~~p~~Rps~~~i~~~ 232 (252)
+.+||++||++|||++|+++.
T Consensus 285 l~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 285 IDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHCcCChhHCcCHHHHHcC
Confidence 999999999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-41 Score=275.01 Aligned_cols=212 Identities=22% Similarity=0.218 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHhCCCC-CCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHH-RNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+.+.+|++++++++| |||+++++++.+....+++|||+.+|+|.+++.... ..++..++.++.||+.||.|+|+.
T Consensus 72 ~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~-- 148 (322)
T d1vzoa_ 72 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKL-- 148 (322)
T ss_dssp GGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcC--
Confidence 4568899999999955 899999999999999999999999999999996444 567888999999999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC--CCCCcccchhHHHHHHHHHh
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL--PITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++.++|+|||.++..............|++.|+|||.+.+. .++.++|||||||++|+|++
T Consensus 149 -~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt 227 (322)
T d1vzoa_ 149 -GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227 (322)
T ss_dssp -TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred -CEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh
Confidence 999999999999999999999999999987655554445556789999999998764 46789999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRA-----MKKVLL 231 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~i~~ 231 (252)
|..||........... +.......... .+......+.+++.+||++||++||| ++|+++
T Consensus 228 G~~PF~~~~~~~~~~~---i~~~~~~~~~~-------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 228 GASPFTVDGEKNSQAE---ISRRILKSEPP-------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp SSCTTSCTTSCCCHHH---HHHHHHHCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCCCCCCHHHHHHH---HHHhcccCCCC-------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 9999976543322111 11111111111 11223345888888999999999995 788875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-40 Score=269.79 Aligned_cols=221 Identities=17% Similarity=0.159 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHhCCCCCCCcc-eeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 6 EREFKTEMNAIGRTHHRNPVR-LLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 6 ~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
.+++.+|++++++++|+|++. +.+++.+.+..++||||+ +|++.+.+....+.+++..+..++.|++.||.|||++
T Consensus 46 ~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-- 122 (299)
T d1ckia_ 46 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK-- 122 (299)
T ss_dssp SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC--
Confidence 346889999999997776554 455567788889999999 6678777766777899999999999999999999999
Q ss_pred CCeeeeccCCCCEEecC---CCceEEcccCcccccCCCCCc------ccccccCCccccccccccCCCCCCcccchhHHH
Q 038713 85 AQIIHGDIKPQNILMDE---KRCAKISDFGLAKLMKPDQTR------TFTGIRGTRAYVAAEWHRNLPITVKADVYSFGV 155 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~ 155 (252)
+++||||||+||+++. +..++++|||.++........ ......||+.|+|||.+.+..++.++||||||+
T Consensus 123 -~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 201 (299)
T d1ckia_ 123 -NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 201 (299)
T ss_dssp -TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHH
T ss_pred -CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCH
Confidence 9999999999999864 456999999999876543321 223456899999999999999999999999999
Q ss_pred HHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhhc
Q 038713 156 VLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLEG 235 (252)
Q Consensus 156 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~~ 235 (252)
++|+|++|+.||......................... ......+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus 202 ~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 202 VLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 9999999999997654443222211111111111111 1111223457888889999999999999999988887
Q ss_pred C
Q 038713 236 T 236 (252)
Q Consensus 236 ~ 236 (252)
.
T Consensus 276 ~ 276 (299)
T d1ckia_ 276 L 276 (299)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-40 Score=267.74 Aligned_cols=221 Identities=14% Similarity=0.133 Sum_probs=176.9
Q ss_pred HHHHHHHHHHhCCCC-CCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 038713 7 REFKTEMNAIGRTHH-RNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECEA 85 (252)
Q Consensus 7 ~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 85 (252)
+.+.+|++.++.++| +|++++++++.+....++||||+ +++|.+++....+.++..++..++.|++.||.|||+.
T Consensus 45 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~--- 120 (293)
T d1csna_ 45 PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK--- 120 (293)
T ss_dssp CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---
Confidence 457889999999955 89999999999999999999999 7899999977777899999999999999999999999
Q ss_pred CeeeeccCCCCEEecC-----CCceEEcccCcccccCCCCCc------ccccccCCccccccccccCCCCCCcccchhHH
Q 038713 86 QIIHGDIKPQNILMDE-----KRCAKISDFGLAKLMKPDQTR------TFTGIRGTRAYVAAEWHRNLPITVKADVYSFG 154 (252)
Q Consensus 86 ~i~h~di~~~nil~~~-----~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 154 (252)
+++||||||+||+++. ++.++++|||.++........ ......||+.|+|||++.+..++.++||||||
T Consensus 121 giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG 200 (293)
T d1csna_ 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALG 200 (293)
T ss_dssp TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhh
Confidence 9999999999999964 577999999999876543221 22345689999999999998999999999999
Q ss_pred HHHHHHHhCCccccccchhhhHHHHHHHHHHHhcCCcccccccchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhh
Q 038713 155 VVLLEIVCLRRCLDQNLLEDRAILQEWICQCFENGNLSQLVEDEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLMLE 234 (252)
Q Consensus 155 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~l~ 234 (252)
+++|+|++|..||..............+........... .....+..+.+++..|+..+|++||+.+.+.+.|+
T Consensus 201 ~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 201 HVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp HHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred HHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 999999999999986544433333222222222111111 11122345778888999999999999999998888
Q ss_pred cCc
Q 038713 235 GTV 237 (252)
Q Consensus 235 ~~~ 237 (252)
+++
T Consensus 275 ~~~ 277 (293)
T d1csna_ 275 KVL 277 (293)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-40 Score=265.12 Aligned_cols=221 Identities=18% Similarity=0.161 Sum_probs=171.0
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDEC 83 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 83 (252)
...+++.+|+.+++.++||||+++++++.+....+++++++.+++|..++. ..+..++..++.++.|++.||+|||++
T Consensus 43 ~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~- 120 (292)
T d1unla_ 43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR- 120 (292)
T ss_dssp THHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcC-
Confidence 456889999999999999999999999999999999999999988888774 455689999999999999999999999
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCC-CCCcccchhHHHHHHHHHh
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLP-ITVKADVYSFGVVLLEIVC 162 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~ 162 (252)
+++||||||+||+++.++.++++|||.++........ .....++..|.|||++.+.. ++.++||||+||++|+|++
T Consensus 121 --~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~ 197 (292)
T d1unla_ 121 --NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_dssp --TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT
T ss_pred --CEeeecccCcccccccCCceeeeecchhhcccCCCcc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhh
Confidence 9999999999999999999999999999876543322 22234677899999987665 6899999999999999999
Q ss_pred CCccccccchhhhHHHHHHHHHHHhcCCcccc------------------cccchhcHHHHHHHHHHHhhccCCCCCCCC
Q 038713 163 LRRCLDQNLLEDRAILQEWICQCFENGNLSQL------------------VEDEEVDQKQLQRMIKVGLRCILDEPSLRR 224 (252)
Q Consensus 163 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 224 (252)
|+.||.......+. +.. +............ .............+.+++.+||+.||++||
T Consensus 198 g~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 275 (292)
T d1unla_ 198 AGRPLFPGNDVDDQ-LKR-IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275 (292)
T ss_dssp TSCCSCCCSSHHHH-HHH-HHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred CCCCCCCCCCHHHH-HHH-HHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCc
Confidence 99997654433221 111 1111111000000 000011222334577888899999999999
Q ss_pred CHHHHHH
Q 038713 225 AMKKVLL 231 (252)
Q Consensus 225 s~~~i~~ 231 (252)
|++|+++
T Consensus 276 sa~e~L~ 282 (292)
T d1unla_ 276 SAEEALQ 282 (292)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=269.79 Aligned_cols=220 Identities=22% Similarity=0.242 Sum_probs=161.5
Q ss_pred hHhHHHHHHHHHHHhCCCCCCCcceeeeEec------CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 038713 3 AEGEREFKTEMNAIGRTHHRNPVRLLGYSFD------VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGI 76 (252)
Q Consensus 3 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l 76 (252)
.+..+++.+|+.++++++||||+++++++.. .+..|+||||+.++ +.+.+. +.+++..++.++.||+.||
T Consensus 57 ~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl 132 (355)
T d2b1pa1 57 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGI 132 (355)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHH
Confidence 4566789999999999999999999999963 46889999999665 444442 3578999999999999999
Q ss_pred HHHhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHH
Q 038713 77 RYLHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVV 156 (252)
Q Consensus 77 ~~lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~ 156 (252)
.|||+. |++||||||+||+++.++.++++|||.++...... ......+|..|+|||++.+..++.++||||+||+
T Consensus 133 ~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~ 207 (355)
T d2b1pa1 133 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 207 (355)
T ss_dssp HHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred HHhhhc---ccccccCCccccccccccceeeechhhhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccch
Confidence 999999 99999999999999999999999999987654322 2233457899999999999999999999999999
Q ss_pred HHHHHhCCccccccchhhhHHHHH----------------HHHHHHhcCCccc------------ccccchhcHHHHHHH
Q 038713 157 LLEIVCLRRCLDQNLLEDRAILQE----------------WICQCFENGNLSQ------------LVEDEEVDQKQLQRM 208 (252)
Q Consensus 157 l~~l~~g~~p~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l 208 (252)
+++|++|+.||............- ............. ..............+
T Consensus 208 l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 287 (355)
T d2b1pa1 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 287 (355)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHH
T ss_pred HHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHH
Confidence 999999999997654332211100 0000011100000 000112234456678
Q ss_pred HHHHhhccCCCCCCCCCHHHHHH
Q 038713 209 IKVGLRCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 209 ~~li~~cl~~~p~~Rps~~~i~~ 231 (252)
.+++.+||..||++|||++|+++
T Consensus 288 ~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 288 RDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHCcCChhHCcCHHHHhc
Confidence 89999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-40 Score=271.48 Aligned_cols=216 Identities=23% Similarity=0.232 Sum_probs=159.7
Q ss_pred HHHHHHHHhCCCCCCCcceeeeEec------CCcEEEEEecCCCCCHHhhh--cCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 9 FKTEMNAIGRTHHRNPVRLLGYSFD------VSNKILVYDYMSNGSLVDVL--FTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 9 ~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
+.+|+++|++++||||+++++++.. ...+++||||+++|.+.... ......+++..+..++.||+.||.|||
T Consensus 60 ~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH 139 (350)
T d1q5ka_ 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139 (350)
T ss_dssp CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4589999999999999999999864 23478999999765433332 134556899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCC-ceEEcccCcccccCCCCCcccccccCCccccccccccC-CCCCCcccchhHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKR-CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRN-LPITVKADVYSFGVVLL 158 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~ 158 (252)
++ +|+||||||+|||++.++ .++|+|||.+........ .....|+..|+|||.+.+ ..++.++||||+||++|
T Consensus 140 ~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~ 214 (350)
T d1q5ka_ 140 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214 (350)
T ss_dssp TT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred hc---CCcccCCCcceEEEecCCCceeEecccchhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEE
Confidence 99 999999999999999765 799999999986643322 233568999999998765 46899999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHH-----------HHH---hcCCccccccc---chhcHHHHHHHHHHHhhccCCCCC
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWIC-----------QCF---ENGNLSQLVED---EEVDQKQLQRMIKVGLRCILDEPS 221 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~-----------~~~---~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~ 221 (252)
+|++|..||......+. +....+ ... ........... ..........+.+++.+||+.||+
T Consensus 215 el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~ 292 (350)
T d1q5ka_ 215 ELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292 (350)
T ss_dssp HHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGG
T ss_pred ehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChh
Confidence 99999999976654332 111111 000 00000000000 011112334578888899999999
Q ss_pred CCCCHHHHHH
Q 038713 222 LRRAMKKVLL 231 (252)
Q Consensus 222 ~Rps~~~i~~ 231 (252)
+|||+.|+++
T Consensus 293 ~R~ta~e~L~ 302 (350)
T d1q5ka_ 293 ARLTPLEACA 302 (350)
T ss_dssp GSCCHHHHHT
T ss_pred HCcCHHHHhc
Confidence 9999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-39 Score=267.27 Aligned_cols=218 Identities=15% Similarity=0.242 Sum_probs=165.4
Q ss_pred HhHHHHHHHHHHHhCC-CCCCCcceeeeEec--CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038713 4 EGEREFKTEMNAIGRT-HHRNPVRLLGYSFD--VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLH 80 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh 80 (252)
...+++.+|+++|+++ .||||+++++++.. ....++||||+.+|+|.++. +.+++..+..++.||+.||.|||
T Consensus 71 ~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH 146 (328)
T d3bqca1 71 VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 146 (328)
T ss_dssp SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999 49999999999974 45699999999999997764 35899999999999999999999
Q ss_pred hcCCCCeeeeccCCCCEEecCCC-ceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHHH
Q 038713 81 DECEAQIIHGDIKPQNILMDEKR-CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVLL 158 (252)
Q Consensus 81 ~~~~~~i~h~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~ 158 (252)
++ +|+||||||+|||++.++ .++++|||.++....... .....+|..|+|||.+.+. .++.++|+||+||++|
T Consensus 147 ~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~ 221 (328)
T d3bqca1 147 SM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221 (328)
T ss_dssp HT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred hc---ccccccccccceEEcCCCCeeeecccccceeccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhH
Confidence 99 999999999999998655 689999999987654332 2334678999999998775 4799999999999999
Q ss_pred HHHhCCccccccchhhhHHHHHHHH--------HHHhcCCcc---c---cc-----------ccchhcHHHHHHHHHHHh
Q 038713 159 EIVCLRRCLDQNLLEDRAILQEWIC--------QCFENGNLS---Q---LV-----------EDEEVDQKQLQRMIKVGL 213 (252)
Q Consensus 159 ~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~---~---~~-----------~~~~~~~~~~~~l~~li~ 213 (252)
++++|+.||........... .... ......... . .. ............+.+++.
T Consensus 222 e~~~g~~pf~~~~~~~~~~~-~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 300 (328)
T d3bqca1 222 SMIFRKEPFFHGHDNYDQLV-RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 300 (328)
T ss_dssp HHHHTCSSSSCCSSHHHHHH-HHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHH
T ss_pred HhccCCCCCCCCchhHHHHH-HHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHH
Confidence 99999999976644332111 0000 000000000 0 00 000111122345788888
Q ss_pred hccCCCCCCCCCHHHHHH
Q 038713 214 RCILDEPSLRRAMKKVLL 231 (252)
Q Consensus 214 ~cl~~~p~~Rps~~~i~~ 231 (252)
+||..||++|||++|+++
T Consensus 301 ~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 301 KLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHSCSSGGGSCCHHHHHT
T ss_pred HHccCChhHCcCHHHHhc
Confidence 999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-39 Score=265.96 Aligned_cols=220 Identities=22% Similarity=0.265 Sum_probs=163.2
Q ss_pred HhHHHHHHHHHHHhCCCCCCCcceeeeEec-----CCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 038713 4 EGEREFKTEMNAIGRTHHRNPVRLLGYSFD-----VSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRY 78 (252)
Q Consensus 4 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~ 78 (252)
...+++.+|+++|++++||||+++++++.. ....+++++++.+|+|.+++.. +.+++..+..++.||+.||.|
T Consensus 59 ~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~ 136 (348)
T d2gfsa1 59 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKY 136 (348)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999863 3344666777889999999943 458999999999999999999
Q ss_pred HhhcCCCCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCC-CCCCcccchhHHHHH
Q 038713 79 LHDECEAQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL-PITVKADVYSFGVVL 157 (252)
Q Consensus 79 lh~~~~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l 157 (252)
||++ +++||||||+||+++.++.++++|||.+..... ......|+..|+|||+..+. .++.++||||||+++
T Consensus 137 LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l 209 (348)
T d2gfsa1 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 209 (348)
T ss_dssp HHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHH
T ss_pred HHhC---CCcccccCCccccccccccccccccchhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHH
Confidence 9999 999999999999999999999999999875432 22334578899999987765 468999999999999
Q ss_pred HHHHhCCccccccchhhhHHHHHHHHHHHhcCC------------------ccccccc--chhcHHHHHHHHHHHhhccC
Q 038713 158 LEIVCLRRCLDQNLLEDRAILQEWICQCFENGN------------------LSQLVED--EEVDQKQLQRMIKVGLRCIL 217 (252)
Q Consensus 158 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~--~~~~~~~~~~l~~li~~cl~ 217 (252)
|+|++|..||........... +........ ....... ..........+.+++.+||+
T Consensus 210 ~~ll~g~~pF~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~ 286 (348)
T d2gfsa1 210 AELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 286 (348)
T ss_dssp HHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSC
T ss_pred HHHHhCCCCCCCCCHHHHHHH---HHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCc
Confidence 999999999976644332211 111100000 0000000 00111123457788889999
Q ss_pred CCCCCCCCHHHHHH--Hhhc
Q 038713 218 DEPSLRRAMKKVLL--MLEG 235 (252)
Q Consensus 218 ~~p~~Rps~~~i~~--~l~~ 235 (252)
.||++|||++|+++ .+++
T Consensus 287 ~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 287 LDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp SSGGGSCCHHHHHTSGGGTT
T ss_pred CChhhCcCHHHHhcCHhhCC
Confidence 99999999999997 5655
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-33 Score=233.26 Aligned_cols=236 Identities=20% Similarity=0.243 Sum_probs=163.0
Q ss_pred hHHHHHHHHHHHhCCC-----------CCCCcceeeeEec--CCcEEEEEecCCCCC-HHh-hhcCCCCCCCHHHHHHHH
Q 038713 5 GEREFKTEMNAIGRTH-----------HRNPVRLLGYSFD--VSNKILVYDYMSNGS-LVD-VLFTPEKQPNWVERMGIA 69 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~--~~~~~lv~e~~~~g~-L~~-~l~~~~~~~~~~~~~~i~ 69 (252)
..+.+.+|+++++.++ |+||+++++++.. ....+++++++..+. ... .........++..+..++
T Consensus 52 ~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~ 131 (362)
T d1q8ya_ 52 YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131 (362)
T ss_dssp HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHH
T ss_pred chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHH
Confidence 3567889999998875 4789999998864 445566666654433 222 223455678999999999
Q ss_pred HHHHHHHHHHhh-cCCCCeeeeccCCCCEEecCCC------ceEEcccCcccccCCCCCcccccccCCccccccccccCC
Q 038713 70 RDIARGIRYLHD-ECEAQIIHGDIKPQNILMDEKR------CAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNL 142 (252)
Q Consensus 70 ~~i~~~l~~lh~-~~~~~i~h~di~~~nil~~~~~------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 142 (252)
.||+.|+.|||+ . +|+||||||+||+++.++ .++++|||.+....... ....|++.|+|||++.+.
T Consensus 132 ~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~ 204 (362)
T d1q8ya_ 132 KQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGA 204 (362)
T ss_dssp HHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTC
T ss_pred HHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccceeeEeeccccccccccc----ccccccccccChhhcccc
Confidence 999999999998 6 999999999999998654 38999999987654322 334679999999999998
Q ss_pred CCCCcccchhHHHHHHHHHhCCccccccchhh----hHHHHHHHHHH-------HhcC-----------Ccccccc----
Q 038713 143 PITVKADVYSFGVVLLEIVCLRRCLDQNLLED----RAILQEWICQC-------FENG-----------NLSQLVE---- 196 (252)
Q Consensus 143 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~-------~~~~-----------~~~~~~~---- 196 (252)
.++.++|+||+|+++++|++|+.||....... ...+...+... ...+ .......
T Consensus 205 ~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
T d1q8ya_ 205 PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 284 (362)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBC
T ss_pred CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCC
Confidence 99999999999999999999999997442211 11111111100 0000 0000000
Q ss_pred --------cchhcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hhcC---cCCCCCCCCCC
Q 038713 197 --------DEEVDQKQLQRMIKVGLRCILDEPSLRRAMKKVLLM--LEGT---VEIPIPQNPTS 247 (252)
Q Consensus 197 --------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~i~~~--l~~~---~~~~~~~~~~~ 247 (252)
...........+.+++.+||++||.+|||++|+++- +++. -+...|..|.+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 285 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp CHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred chhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCcccCCCCCcccC
Confidence 002234567789999999999999999999999873 5543 23444444443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.62 E-value=5e-16 Score=116.50 Aligned_cols=132 Identities=14% Similarity=0.146 Sum_probs=92.7
Q ss_pred hHHHHHHHHHHHhCCCCCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 038713 5 GEREFKTEMNAIGRTHHRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDECE 84 (252)
Q Consensus 5 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 84 (252)
....+.+|...+.++.|+++++.+++.. .+++|||++++.+.+. +......++.|++.++++||+.
T Consensus 57 ~~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~l--------~~~~~~~i~~ql~~~l~~lH~~-- 122 (191)
T d1zara2 57 AIRSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFYHR-- 122 (191)
T ss_dssp HHHHHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHHHT--
T ss_pred HHHHHHHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccch--------hhHHHHHHHHHHHHHHHHHhhC--
Confidence 3455678999999999999998876532 3799999988655442 2233567899999999999999
Q ss_pred CCeeeeccCCCCEEecCCCceEEcccCcccccCCCCCcccccccCCccccccccccCCCCCCcccchhHHHH
Q 038713 85 AQIIHGDIKPQNILMDEKRCAKISDFGLAKLMKPDQTRTFTGIRGTRAYVAAEWHRNLPITVKADVYSFGVV 156 (252)
Q Consensus 85 ~~i~h~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~ 156 (252)
+++||||||+||++++++ ++++|||.+....+......... ... .-.+.+ ..+|..++|+||+.--
T Consensus 123 -giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~~~l~r--d~~-~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 123 -GIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILER--DVR-NIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp -TEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHHHHHHH--HHH-HHHHHH-HHHHCCCCCHHHHHHH
T ss_pred -CEEEccCChhheeeeCCC-EEEEECCCcccCCCCCcHHHHHH--HHH-HHHHHH-cCCCCCcccHHHHHHH
Confidence 999999999999998655 88999999876543332111000 000 001112 2357788999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.96 E-value=2.1e-05 Score=60.07 Aligned_cols=101 Identities=16% Similarity=0.150 Sum_probs=71.5
Q ss_pred HHHHHHHHHhCCC-CCCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc----
Q 038713 8 EFKTEMNAIGRTH-HRNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE---- 82 (252)
Q Consensus 8 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---- 82 (252)
.+.+|...++.+. +--+.+++.+..+.+..++||++++|..+.+...... . ...++.+++..++.||+.
T Consensus 55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~---~---~~~~~~~l~~~l~~lH~~~~~~ 128 (263)
T d1j7la_ 55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ---S---PEKIIELYAECIRLFHSIDISD 128 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS---C---HHHHHHHHHHHHHHHHTSCCTT
T ss_pred hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccccc---c---HHHHHHHHHHHHHHHhccCccc
Confidence 4567888877663 3335688888888889999999999988866553211 1 223455666666666652
Q ss_pred ----------------------------------------------------CCCCeeeeccCCCCEEecCCCceEEccc
Q 038713 83 ----------------------------------------------------CEAQIIHGDIKPQNILMDEKRCAKISDF 110 (252)
Q Consensus 83 ----------------------------------------------------~~~~i~h~di~~~nil~~~~~~~~l~d~ 110 (252)
....++|+|+.+.||++++++..-++||
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDw 208 (263)
T d1j7la_ 129 CPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDL 208 (263)
T ss_dssp CSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCC
T ss_pred cccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeec
Confidence 0123799999999999987766679999
Q ss_pred Cccc
Q 038713 111 GLAK 114 (252)
Q Consensus 111 ~~~~ 114 (252)
+.+.
T Consensus 209 e~a~ 212 (263)
T d1j7la_ 209 GRSG 212 (263)
T ss_dssp TTCE
T ss_pred hhcc
Confidence 8765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.51 E-value=0.00012 Score=55.31 Aligned_cols=98 Identities=17% Similarity=0.179 Sum_probs=65.3
Q ss_pred HHHHHHHHHhCCCC--CCCcceeeeEecCCcEEEEEecCCCCCHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc---
Q 038713 8 EFKTEMNAIGRTHH--RNPVRLLGYSFDVSNKILVYDYMSNGSLVDVLFTPEKQPNWVERMGIARDIARGIRYLHDE--- 82 (252)
Q Consensus 8 ~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--- 82 (252)
.+.+|+..++.+.. -.+.+++.+..+.+..++||++++|.++.+.. .... ..+.++...++-||+.
T Consensus 50 ~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~------~~~~---~~~~~l~~~la~LH~~~~~ 120 (255)
T d1nd4a_ 50 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH------LAPA---EKVSIMADAMRRLHTLDPA 120 (255)
T ss_dssp CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC------CCHH---HHHHHHHHHHHHHTTSCGG
T ss_pred HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc------ccHH---HHHHHHHHHHHHHccCChh
Confidence 46678888876632 23567888888888899999999886653321 1111 1223444444455431
Q ss_pred ----------------------------------------------------CCCCeeeeccCCCCEEecCCCceEEccc
Q 038713 83 ----------------------------------------------------CEAQIIHGDIKPQNILMDEKRCAKISDF 110 (252)
Q Consensus 83 ----------------------------------------------------~~~~i~h~di~~~nil~~~~~~~~l~d~ 110 (252)
....++|+|+.+.||+++.+..+-++||
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~ 200 (255)
T d1nd4a_ 121 TCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDC 200 (255)
T ss_dssp GCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCC
T ss_pred hCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEc
Confidence 0124899999999999988766779999
Q ss_pred Cccc
Q 038713 111 GLAK 114 (252)
Q Consensus 111 ~~~~ 114 (252)
+.+.
T Consensus 201 ~~~~ 204 (255)
T d1nd4a_ 201 GRLG 204 (255)
T ss_dssp TTCE
T ss_pred hhcc
Confidence 8765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.87 E-value=0.0056 Score=49.21 Aligned_cols=30 Identities=30% Similarity=0.453 Sum_probs=25.6
Q ss_pred CeeeeccCCCCEEecCCCceEEcccCccccc
Q 038713 86 QIIHGDIKPQNILMDEKRCAKISDFGLAKLM 116 (252)
Q Consensus 86 ~i~h~di~~~nil~~~~~~~~l~d~~~~~~~ 116 (252)
.++|+|+.+.|||+++++ ++++|+..+...
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G 253 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYG 253 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence 699999999999998765 899999887643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.99 E-value=0.008 Score=48.28 Aligned_cols=39 Identities=13% Similarity=0.080 Sum_probs=26.9
Q ss_pred HHHHHHHHHHhCC-CCCCCcceeeeEecCCcEEEEEecCCCCCH
Q 038713 7 REFKTEMNAIGRT-HHRNPVRLLGYSFDVSNKILVYDYMSNGSL 49 (252)
Q Consensus 7 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 49 (252)
.+-.+|..+++.+ .+.-..++++++.+ ..|+||++|..+
T Consensus 89 idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 89 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 3456888888888 44334588887753 679999987443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.09 E-value=0.022 Score=43.90 Aligned_cols=31 Identities=26% Similarity=0.375 Sum_probs=27.3
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCccc
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAK 114 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~ 114 (252)
..+++|+|+.+.|++++.+...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4589999999999999988777899999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=83.46 E-value=0.76 Score=35.06 Aligned_cols=30 Identities=27% Similarity=0.345 Sum_probs=24.0
Q ss_pred CCCeeeeccCCCCEEecCCCceEEcccCcccc
Q 038713 84 EAQIIHGDIKPQNILMDEKRCAKISDFGLAKL 115 (252)
Q Consensus 84 ~~~i~h~di~~~nil~~~~~~~~l~d~~~~~~ 115 (252)
..+++|+|+.+.||++++ + ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 357999999999999964 3 45899988764
|